0001828185-24-000036.txt : 20240513 0001828185-24-000036.hdr.sgml : 20240513 20240513081341 ACCESSION NUMBER: 0001828185-24-000036 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 75 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Barinthus Biotherapeutics plc. CENTRAL INDEX KEY: 0001828185 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40367 FILM NUMBER: 24936986 BUSINESS ADDRESS: STREET 1: UNIT 6-10, ZEUS BUILDING STREET 2: RUTHERFORD AVENUE, HARWELL CITY: DIDCOT STATE: X0 ZIP: OX11 0DF BUSINESS PHONE: 44 (0) 1865 818808 MAIL ADDRESS: STREET 1: UNIT 6-10, ZEUS BUILDING STREET 2: RUTHERFORD AVENUE, HARWELL CITY: DIDCOT STATE: X0 ZIP: OX11 0DF FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech plc DATE OF NAME CHANGE: 20210407 FORMER COMPANY: FORMER CONFORMED NAME: Vaccitech Ltd DATE OF NAME CHANGE: 20201014 10-Q 1 brns-20240331.htm 10-Q brns-20240331
00018281852024Q1false12/3100-0000000http://fasb.org/us-gaap/2023#LicenseMemberhttp://fasb.org/us-gaap/2023#LicenseMemberxbrli:sharesiso4217:USDiso4217:GBPxbrli:sharesiso4217:USDxbrli:sharesbrns:segmentbrns:votexbrli:pureiso4217:GBPutr:sqft00018281852024-01-012024-03-310001828185dei:AdrMember2024-01-012024-03-310001828185us-gaap:CommonStockMember2024-01-012024-03-3100018281852024-05-0800018281852024-03-3100018281852023-12-310001828185brns:DeferredShares.Member2023-12-310001828185brns:DeferredShares.Member2024-03-310001828185us-gaap:LicenseMember2024-01-012024-03-310001828185us-gaap:LicenseMember2023-01-012023-03-3100018281852023-01-012023-03-310001828185us-gaap:RelatedPartyMember2023-01-012023-03-310001828185us-gaap:RelatedPartyMember2024-01-012024-03-310001828185us-gaap:CommonStockMember2023-12-310001828185brns:DeferredSharesMemberbrns:DeferredShares.Member2023-12-310001828185us-gaap:AdditionalPaidInCapitalMember2023-12-310001828185us-gaap:RetainedEarningsMember2023-12-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001828185us-gaap:ParentMember2023-12-310001828185us-gaap:NoncontrollingInterestMember2023-12-310001828185us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001828185us-gaap:ParentMember2024-01-012024-03-310001828185us-gaap:CommonStockMember2024-01-012024-03-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001828185us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001828185us-gaap:RetainedEarningsMember2024-01-012024-03-310001828185us-gaap:CommonStockMember2024-03-310001828185brns:DeferredSharesMemberbrns:DeferredShares.Member2024-03-310001828185us-gaap:AdditionalPaidInCapitalMember2024-03-310001828185us-gaap:RetainedEarningsMember2024-03-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001828185us-gaap:ParentMember2024-03-310001828185us-gaap:NoncontrollingInterestMember2024-03-310001828185us-gaap:CommonStockMember2022-12-310001828185brns:DeferredSharesMemberbrns:DeferredShares.Member2022-12-310001828185brns:DeferredSharesMemberbrns:DeferredBSharesMember2022-12-310001828185brns:DeferredSharesMemberbrns:DeferredCSharesMember2022-12-310001828185us-gaap:AdditionalPaidInCapitalMember2022-12-310001828185us-gaap:RetainedEarningsMember2022-12-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001828185us-gaap:ParentMember2022-12-310001828185us-gaap:NoncontrollingInterestMember2022-12-3100018281852022-12-310001828185us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001828185us-gaap:ParentMember2023-01-012023-03-310001828185us-gaap:CommonStockMember2023-01-012023-03-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001828185us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001828185brns:DeferredSharesMemberbrns:DeferredBSharesMember2023-01-012023-03-310001828185brns:DeferredSharesMemberbrns:DeferredCSharesMember2023-01-012023-03-310001828185us-gaap:RetainedEarningsMember2023-01-012023-03-310001828185us-gaap:CommonStockMember2023-03-310001828185brns:DeferredSharesMemberbrns:DeferredShares.Member2023-03-310001828185brns:DeferredSharesMemberbrns:DeferredBSharesMember2023-03-310001828185brns:DeferredSharesMemberbrns:DeferredCSharesMember2023-03-310001828185us-gaap:AdditionalPaidInCapitalMember2023-03-310001828185us-gaap:RetainedEarningsMember2023-03-310001828185us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001828185us-gaap:ParentMember2023-03-310001828185us-gaap:NoncontrollingInterestMember2023-03-3100018281852023-03-310001828185us-gaap:DevelopedTechnologyRightsMember2024-03-310001828185us-gaap:DevelopedTechnologyRightsMember2023-12-310001828185brns:CoalitionForEpidemicPreparednessInnovationsMember2023-12-200001828185brns:CoalitionForEpidemicPreparednessInnovationsMember2023-12-202023-12-200001828185brns:CoalitionForEpidemicPreparednessInnovationsMember2024-01-012024-03-310001828185brns:CoalitionForEpidemicPreparednessInnovationsMember2024-03-310001828185us-gaap:IPOMember2024-01-012024-03-310001828185us-gaap:IPOMember2021-04-212021-04-2100018281852023-11-060001828185us-gaap:IPOMember2023-11-062023-11-060001828185brns:DeferredBSharesMember2023-03-290001828185brns:DeferredCSharesMember2023-03-290001828185brns:DeferredShares.Member2023-03-290001828185brns:AvideaMember2024-03-310001828185brns:ContingentConsiderationLiabilityMember2023-12-310001828185brns:ContingentConsiderationLiabilityMember2022-12-310001828185brns:ContingentConsiderationLiabilityMember2024-01-012024-03-310001828185brns:ContingentConsiderationLiabilityMember2023-01-012023-03-310001828185brns:ContingentConsiderationLiabilityMember2024-03-310001828185brns:ContingentConsiderationLiabilityMember2023-03-310001828185brns:RestrictedShareUnitsStockOptionsShareAppreciationRightsAndRestrictedSharesMemberbrns:BarinthusBiotherapeuticsPlcShareAwardPlan2021Member2024-01-012024-03-310001828185brns:EnterpriseManagementIncentiveShareOptionSchemeMember2024-01-012024-03-310001828185brns:EnterpriseManagementIncentiveShareOptionSchemeMember2023-01-012023-03-310001828185us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001828185us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310001828185us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001828185us-gaap:GeneralAndAdministrativeExpenseMember2024-01-012024-03-310001828185us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310001828185brns:InLicenseAgreementsMembersrt:MinimumMember2024-01-012024-03-310001828185brns:InLicenseAgreementsMembersrt:MaximumMember2024-01-012024-03-310001828185brns:OxfordshireMember2021-09-032021-09-030001828185brns:OxfordshireMember2021-09-030001828185stpr:MD2022-06-142022-06-140001828185stpr:MD2022-06-140001828185brns:OxfordUniversityInnovationLimitedMemberbrns:ExpensesMember2024-01-012024-03-310001828185brns:OxfordUniversityInnovationLimitedMemberbrns:ExpensesMember2023-01-012023-03-310001828185us-gaap:RelatedPartyMemberbrns:OxfordUniversityInnovationLimitedMember2024-03-310001828185us-gaap:RelatedPartyMemberbrns:OxfordUniversityInnovationLimitedMember2023-12-310001828185us-gaap:LicenseMemberus-gaap:RelatedPartyMemberbrns:OxfordUniversityInnovationLimitedMember2024-01-012024-03-310001828185us-gaap:LicenseMemberus-gaap:RelatedPartyMemberbrns:OxfordUniversityInnovationLimitedMember2023-01-012023-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
o       TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________to ________
Commission File Number: 001-40367
BARINTHUS BIOTHERAPEUTICS PLC
(Exact Name of Registrant as Specified in its Charter)
England and Wales
Not Applicable
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
Unit 6-10, Zeus Building, Rutherford Avenue,
Harwell, Didcot, United Kingdom
OX11 0DF
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: +44 (0) 1865 818 808

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
American Depositary Shares*
BRNSThe Nasdaq Global Market
Ordinary shares, nominal value £0.000025 per share**
*American Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) ordinary share.
**Not for trading, but only in connection with the listing of American Depositary Shares on The Nasdaq Global Market.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  x     No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  x     No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
Accelerated filer o
Non-accelerated filer x
Smaller reporting company x
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o    No  x
As of May 8, 2024, the registrant had 39,033,158 ordinary shares, nominal value £0.000025 per share, outstanding.

Table of Contents
We own the registered trademark BARINTHUS in the United Kingdom, and we have filed applications at the UK Intellectual Property Office and other intellectual properties to register trademarks for BARINTHUS, SNAP-TI, SNAP-CI and a design logo globally. We also own various trademark registrations and applications, and unregistered trademarks, including the registered trademark VACCITECH, and trademarks relating to the technologies acquired as part of our acquisition of Avidea Technologies, Inc. in December 2021 including the registered trademarks TRAPD, SNAPVAX and SYNTHOLYTIC. All other trade names, trademarks and service marks of other companies appearing in this Quarterly Report on Form 10-Q, or this Quarterly Report, are the property of their respective holders. Solely for convenience, the trademarks and trade names in this Quarterly Report may be referred to without the ® and ™ symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies’ trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
From time to time, we may use our website, our X (formerly known as Twitter) account at @Barinthusbio and our LinkedIn account at linkedin.com/company/barinthus-bio to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at www.barinthusbio.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website, our X (formerly known as Twitter) posts and our LinkedIn posts are not incorporated into, and does not form a part of, this Quarterly Report.
i
PART I -  FINANCIAL INFORMATION
Item 1. Financial Statements.
INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

BARINTHUS BIOTHERAPEUTICS PLC
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT NUMBER OF SHARES AND PER SHARE AMOUNTS)
(UNAUDITED)
As of
March 31,
2024		As of
December 31,
2023
ASSETS
Cash, cash equivalents and restricted cash$129,971 $142,090 
Research and development incentives receivable5,196 4,908 
Prepaid expenses and other current assets7,964 9,907 
Total current assets143,131 156,905 
Goodwill12,209 12,209 
Property and equipment, net11,532 11,821 
Intangible assets, net24,317 25,108 
Right of use assets, net7,408 7,581 
Other assets885 882 
Total assets$199,482 $214,506 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable1,162 $1,601 
Accrued expenses and other current liabilities8,330 9,212 
Deferred income1,434 — 
Operating lease liability - current1,909 1,785 
Total current liabilities12,835 12,598 
Non-Current liabilities:
Operating lease liability - non-current10,897 11,191 
Contingent consideration1,867 1,823 
Other non-current liabilities1,330 1,325 
Deferred tax liability, net537 574 
Total liabilities$27,466 $27,511 
Commitments and contingencies (Note 15)
Stockholders’ equity:
Ordinary shares, £0.000025 nominal value; 38,952,956 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding:38,643,540)
1 1 
Deferred A shares, £1 nominal value; 63,443 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding: 63,443)
86 86 
Additional paid-in capital388,720 386,602 
Accumulated deficit(192,079)(176,590)
Accumulated other comprehensive loss – foreign currency translation adjustments(24,895)(23,315)
Total stockholders’ equity attributable to Barinthus Biotherapeutics plc shareholders171,833 186,784 
Noncontrolling interest183 211 
Total stockholders’ equity$172,016 $186,995 
Total liabilities and stockholders’ equity$199,482 $214,506 

The accompanying notes are an integral part of these condensed consolidated financial statements.
F-1
BARINTHUS BIOTHERAPEUTICS PLC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(IN THOUSANDS, EXCEPT NUMBER OF SHARES AND PER SHARE AMOUNTS)
(UNAUDITED)
Three months ended
March 31, 2024March 31, 2023
License revenue 1
$— $468 
Total revenue— 468 
Operating expenses
Research and development11,125 9,814 
General and administrative5,994 12,138 
Total operating expenses17,119 21,952 
Other operating income205 — 
Loss from operations(16,914)(21,484)
Other income/(expense):  
Interest income775 1,588 
Interest expense(12)— 
Research and development incentives594 1,157 
Total other income, net1,357 2,745 
Loss before income tax(15,557)(18,739)
Tax benefit37 516 
Net loss (15,520)(18,223)
Net loss attributable to noncontrolling interest31 43 
Net loss attributable to Barinthus Biotherapeutics plc shareholders(15,489)(18,180)
Weighted-average ordinary shares outstanding, basic 38,773,48238,013,399
Weighted-average ordinary shares outstanding, diluted38,773,48238,013,399
Net loss per share attributable to ordinary shareholders, basic$(0.40)$(0.48)
Net loss per share attributable to ordinary shareholders, diluted$(0.40)$(0.48)
Net loss$(15,520)$(18,223)
Other comprehensive (loss)/gain – foreign currency translation adjustments(1,577)4,580 
Comprehensive loss(17,097)(13,643)
Comprehensive loss attributable to noncontrolling interest28 37 
Comprehensive loss attributable to Barinthus Biotherapeutics plc shareholders$(17,069)$(13,606)
1Includes license revenue from related parties for the three months ended March 31, 2024 and 2023 of nil and $0.5 million, respectively.

The accompanying notes are an integral part of these condensed consolidated financial statements.
F-2
BARINTHUS BIOTHERAPEUTICS PLC
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN
STOCKHOLDERS’ EQUITY
(IN THOUSANDS, EXCEPT NUMBER OF SHARES)
(UNAUDITED)
Three months ended March 31, 2024
Ordinary SharesDeferred A Shares
SharesAmountSharesAmountAdditional Paid-in-CapitalAccumulated DeficitAccumulated Other Comprehensive LossTotal stockholders’ equity attributable to Barinthus Biotherapeutics plc stockholdersNon-Controlling InterestTotal Stockholders' Equity
Balance, January 1, 202438,643,540$1 63,443$86 $386,602 $(176,590)$(23,315)$186,784 $211 $186,995 
Share based compensation—— —— 1,615 — — 1,615 — 1,615 
Issue of ordinary shares, net of issuance costs309,4160 1—— 503 — — 503 — 503 
Foreign currency translation adjustments—— —— — — (1,580)(1,580)3 (1,577)
Net loss—— —— — (15,489)— (15,489)(31)(15,520)
Balance, March 31, 202438,952,956$1 63,443$86 $388,720 $(192,079)$(24,895)$171,833 $183 $172,016 

Three months ended March 31, 2023
Ordinary SharesDeferred A SharesDeferred B SharesDeferred C Shares
SharesAmountSharesAmountSharesAmountSharesAmountAdditional Paid-in-CapitalAccumulated DeficitAccumulated Other Comprehensive LossTotal stockholders’ equity attributable to Barinthus Biotherapeutics plc stockholdersNon-Controlling InterestTotal Stockholders' Equity
Balance, January 1, 202337,683,531$1 63,443$86 570,987$8 27,828,231$0 1$379,504 $(103,243)$(33,460)$242,896 $305 $243,201 
Share based compensation—— —— —— —— 2,222 — — 2,222 — 2,222 
Issue of ordinary shares, net of issuance costs673,4940 1—— —— —— 1,789 — — 1,789 — 1,789 
Foreign currency translation adjustments—— —— —— —— — — 4,574 4,574 6 4,580 
Cancellation of deferred shares—— —— (570,987)(8)(27,828,231)01 8 — — — — — 
Net loss—— —— —— —— — (18,180)— (18,180)(43)(18,223)
Balance, March 31, 202338,357,025$1 63,443$86 —$— —$— $383,523 $(121,423)$(28,886)$233,301 $268 $233,569 
1Indicates amount less than one thousand
The accompanying notes are an integral part of these condensed consolidated financial statements
F-3
BARINTHUS BIOTHERAPEUTICS PLC
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
Three months ended
March 31, 2024March 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss(15,520)(18,223)
Adjustments to reconcile net (loss)/income to net cash used in operating activities:
Share based compensation1,615 2,222 
Depreciation and amortization1,430 1,221 
Non-cash lease expenses359 279 
Unrealized foreign exchange (gain)/loss(1,026)3,504 
Change in contingent consideration60 85 
Non cash interest expense12 — 
Deferred tax benefit(37)(516)
Changes in operating assets and liabilities:
Accounts receivable (including related parties)— 4,961 
Prepaid expenses and other current assets1,875 4,090 
Research and development incentives receivable(331)2,102 
Accounts payable(524)(1,707)
Accrued expenses and other current liabilities(823)(1,315)
Deferred income1,434 — 
Operating lease liabilities(346)— 
Other assets— 123 
Net cash used in operating activities(11,822)(3,174)
CASH FLOWS FROM INVESTING ACTIVITIES:  
Purchases of property and equipment(308)(2,507)
Net cash used in investing activities$(308)$(2,507)
CASH FLOWS FROM FINANCING ACTIVITIES:  
Proceeds from issue of ordinary shares, net of issuance costs503 1,789 
Issue of shares from the exercise of stock options0 
1
0 
1
Payment of contingent consideration— (100)
Net cash provided by financing activities$503 $1,689 
Effect of exchange rates on cash, cash equivalents and restricted cash(492)935 
Net decrease in cash, cash equivalents and restricted cash(12,119)(3,057)
Cash, cash equivalents and restricted cash, beginning of the period142,090 194,385 
Cash, cash equivalents and restricted cash, end of the period$129,971 $191,328 
Supplemental cash flow disclosures:
Cash paid for interest$— $0 1
Cash paid for income taxes$— $0 1
Non-Cash investing and financing activities
Issue of ordinary shares$— $0 1
Purchases of property and equipment included in accounts payable and accrued liabilities$95 $2,247 
Asset retirement obligation$— $282 
Changes to right-of-use asset resulting from lease reassessment event$— $4 
1Indicates amounts less than one thousand
The accompanying notes are an integral part of these condensed consolidated financial statements.
F-4
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1.    Nature of Business and Basis of Presentation
Barinthus Biotherapeutics plc is a public limited company incorporated pursuant to the laws of England and Wales in March 2021. Barinthus Biotherapeutics plc and its direct and indirect subsidiaries, Barinthus Biotherapeutics (UK) Limited, Barinthus Australia Pty Limited, Vaccitech Oncology Limited (“VOLT”), Barinthus Biotherapeutics North America, Inc., Barinthus Biotherapeutics Switzerland GmbH and Barinthus Biotherapeutics S.R.L., are collectively referred to as the “Company” or “Barinthus Bio”. The Company is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. The Company is headquartered in Harwell, Oxfordshire, United Kingdom.
The Company operates in an environment of rapid technological change and substantial competition from pharmaceutical and biotechnology companies. The Company is subject to risks common to companies in the biopharmaceutical industry in a similar stage of its life cycle including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its vaccine product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of any of its products that are approved, and protection of proprietary technology. There can be no assurance that the Company’s research and development will be successfully completed, that adequate protection for the Company’s intellectual property will be obtained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company’s development efforts are successful, it is uncertain when, if ever, the Company will generate significant product sales. If the Company does not successfully commercialize any of its products or mitigate any of these other risks, it will be unable to generate revenue or achieve profitability.
Basis of presentation
The Company’s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Certain notes or other information that are normally required by GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes as of and for the year ended December 31, 2023. The condensed consolidated balance sheet as of December 31, 2023, was derived from the audited financial statements but does not contain all of the footnote disclosures from the annual financial statements.
As of March 31, 2024, the Company had cash, cash equivalents and restricted cash of $130.0 million and an accumulated deficit of $192.1 million, and the Company expects to incur losses for the foreseeable future. The Company expects that its cash, cash equivalents and restricted cash will be sufficient to fund current operations for at least the next twelve months from the issuance of the financial statements. The Company expects to seek additional funding through equity financing, government or private-party grants, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or rights of the Company’s stockholders. If the Company is unable to obtain sufficient capital, the Company will be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects, or the Company may be unable to continue operations. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.
The unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.
F-5
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Unaudited Condensed Financial Information
The accompanying Condensed Consolidated Balance Sheets as of March 31, 2024, and December 31, 2023, the Condensed Consolidated Statements of Operations and Comprehensive Loss, Condensed Consolidated Statements of Changes in Stockholders’ Equity and the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 are unaudited. These unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities Exchange Commission (the “Annual Report”) on March 20, 2024. In our opinion, the unaudited condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2024, our results of operations for the three months ended March 31, 2024, and 2023, and our cash flows for the three months ended March 31, 2024, and 2023. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other interim periods.
2.    Summary of Significant Accounting Policies
The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Annual Report, except as discussed below related to newly adopted accounting pronouncements.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue, income and expenses during the reporting period. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.
As of the date of issuance of these unaudited condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the unaudited condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.
Segment information
Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker ("CODM"), the Company’s Chief Executive Officer, in making decisions regarding resource allocation and assessing performance. The CODM approves key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts and approves the Company's consolidated operating budget. The Company views its operations and manages its business as one operating segment, the research and development of vaccines and immunotherapies. As the Company operates in one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.

F-6
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Recently issued accounting pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” of the extended transition period related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company.
We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our condensed consolidated financial statements or do not otherwise apply to our current operations.
3.     Foreign Currency Translation in General and Administrative Expenses
The aggregate, net foreign exchange gain or loss recognized in general and administrative expenses for the three months ended March 31, 2024, was a gain of $1.2 million (three months ended March 31, 2023: $3.5 million loss).
4.    Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2024, and 2023 (in thousands, except number of shares):
Three months ended March 31,
20242023
Numerator:
Net loss$(15,520)$(18,223)
Net loss attributable to noncontrolling interest31 43 
Net loss attributable to Barinthus Biotherapeutics plc shareholders$(15,489)$(18,180)
Denominator:
Weighted-average ordinary shares outstanding, basic38,773,48238,013,399
Weighted-average ordinary shares outstanding, diluted38,773,48238,013,399
Net loss per share attributable to ordinary shareholders, basic$(0.40)$(0.48)
Net loss per share attributable to ordinary shareholders, diluted$(0.40)$(0.48)
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential ordinary share equivalents outstanding would have been anti-dilutive. As of March 31, 2024, 7,645,076 potential ordinary shares issuable for stock options were excluded from the computation of diluted weighted-average shares outstanding because including them would have had an anti-dilutive effect (March 31, 2023: 6,807,859).

5.    Property and Equipment, Net
During the three months ended March 31, 2024, the Company’s additions to property and equipment, net were $0.4 million which primarily related to an increase in leasehold improvements from the Company’s U.S. office in Germantown, Maryland (three months ended March 31, 2023: $4.8 million).
Depreciation expense for the three months ended March 31, 2024 was $0.6 million (three months ended March 31, 2023: $0.4 million, respectively).
F-7
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
6.    Intangible Assets, Net
The gross amount of amortizable intangible assets, consisting of acquired developed technology, was $31.6 million as of March 31, 2024 and December 31 2023, respectively, and accumulated amortization was $7.3 million and $6.5 million as of March 31, 2024 and December 31, 2023, respectively. The amortization expense for the three months ended March 31, 2024 was $0.8 million (three months ended March 31, 2023: $0.8 million). The estimated annual amortization expense is $3.2 million for the years 2024 through to 2031.
7.    Prepaid Expenses and Other Current Assets (in thousands):
March 31,
2024		December 31,
2023
Prepayments and accrued income$5,093 $5,402 
Value Added Tax receivable1,196 3,031 
Other1,675 1,474 
Total$7,964 $9,907 
8.    Accrued Expenses and Other Current Liabilities (in thousands):
March 31,
2024		December 31,
2023
Accrued manufacturing and clinical expenses$4,437 $4,003 
Accrued bonus660 2,412 
Accrued payroll and employee benefits1,152 789 
Accrued professional fees1,048 942 
Accrued other1,033 1,066 
Total$8,330 $9,212 

9. Grant Income

Coalition for Epidemic Preparedness Innovations (“CEPI”) Funding Agreement

On December 20, 2023, Barinthus Biotherapeutics (UK) Limited (the “Company”), the Chancellors, Masters and Scholars of the University of Oxford (“Oxford,” together with the Company, the “Partners”) and the Coalition for Epidemic Preparedness Innovations (“CEPI”) entered into a Funding Agreement (the “Funding Agreement”) pursuant to which CEPI will provide funding of up to $34.8 million to the Company to advance the development of VTP-500, the Company’s vaccine candidate against Middle East Respiratory Syndrome (“MERS,” and such development activities, the “Project”). In December 2023, VTP-500 received PRIME (PRIority MEdicines) designation by the European Medicines Agency.

Pursuant to the Funding Agreement, the Company has agreed to pay CEPI on a country-by-country basis increasing mid-single digit percentage royalties of net sales and net income with respect to future cash sales of VTP-500, less certain deductions, for a period starting on December 20, 2023 (“Effective Date”) and ending the later of: (i) the expiration of the last valid patent claim included in intellectual property developed under the Project covering VTP-500 in such country, (ii) the expiration of Regulatory Exclusivity (as defined in the Funding Agreement) for VTP-500 in such country, and (iii) the tenth (10th) anniversary of the first commercial sale of VTP-500 (the “Royalty Term”). The Company shall also pay CEPI a mid-double digit percentage of net revenue earned on VTP-500 until CEPI has received payments from the Company under the Funding Agreement equaling the total amount of funding paid by CEPI to the Company and a low double-digit percentage of such net revenue thereafter. Sales for the benefit of end users in specified low and middle income countries (“LMICs”) and upper and middle income countries (“UMICs”) are excluded from the calculations of net sales and net revenue. Sales of product for the benefit of end users in LMICs and UMICs are subject to tiered discounted pricing requirements under the Funding Agreement. The Company is further required to pay a mid-double digit percentage of any proceeds earned on any priority review voucher related to VTP-500 during the Royalty Period.

F-8
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
For the period ended March 31, 2024, $1.6 million proceeds have been received and $0.2 million income has been recognized in relation to this contract. This is presented as other operating income in the Statements of Operations and Comprehensive Loss.

The Funding Agreement cash payments are restricted as to the use and management of the funds. The remaining unused amounts of the Funding Agreement cash payments of $1.4 million as at March 31, 2024 are reflected in Cash, cash equivalents and restricted cash in the condensed consolidated balance sheets until expenditures contemplated in the Funding Agreement are incurred.

Deferred income

Deferred income primarily relates to payments received from CEPI in advance of the eligible research and development expenses being incurred and are disclosed as deferred income separately in the condensed consolidated balance sheets. Deferred income is released to the condensed consolidated statement of operations and comprehensive loss in the period in which such research and development activities are actually performed in a manner that satisfies the conditions of the Funding Agreement.

Changes in the deferred income during the three months ended March 31, 2024 and 2023, are as follows (in thousands):

Three Months Ended March 31,
20242023
Beginning balance$— $— 
Cash payments received1,629 — 
Other income recognized related to the Funding Agreement(205)— 
Foreign exchange translation10 — 
Ending balance$1,434 $— 
10.    Ordinary Shares
All ordinary shares rank pari passu as a single class. The following is a summary of the rights and privileges of the holders of ordinary shares as of March 31, 2024:
Liquidation preference: in the event of the liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to holders of the ordinary shares shall be distributed amongst all holders of the ordinary shares in proportion to the number of shares held irrespective of the amount paid or credited as paid on any share.
Dividends: The Company may, subject to the provisions of the Companies Act 2006 and our Articles, by ordinary resolution from time to time declare dividends to be paid to shareholders not exceeding the amount recommended by the Company’s board of directors. Subject to the provisions of the Companies Act 2006, in so far as, in the board of directors’ opinions, the Company’s profits justify such payments, the board of directors may pay interim dividends on the Company’s ordinary shares.
Voting Rights: Each holder of ordinary shares has the right to receive notice of, and to vote at, the Company’s general meetings. Each holder of ordinary shares who is present (in person or by proxy) at a general meeting on a show of hands has one vote and, on a poll, every such holder who is present (in person or by proxy) has one vote in respect of each share of which they are the holder.
Preemption rights: Pursuant to section 561 of the Companies Act 2006, shareholders are granted preemptive rights when new shares are issued for cash. However, it is possible for our Articles, or shareholders at a general meeting representing at least 75% of our ordinary shares present (in person or by proxy) and eligible to vote at that general meeting, to disapply these preemptive rights by passing a special resolution. Such a disapplication of preemption rights may be for a maximum period of up to five years from the date on which the shareholder resolution was passed. In either case, this disapplication would need to be renewed by our shareholders upon its expiration (i.e., at least every five years) to remain effective.
F-9
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
On April 21, 2021, our shareholders approved the disapplication of preemptive rights for a period of five years from the date of approval by way of a special resolution of our shareholders. This included the disapplication of preemption rights in relation to the allotment of our ordinary shares in connection with the IPO. This disapplication will need to be renewed upon expiration (i.e., at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).
On November 6, 2023, we held a general meeting where our shareholders approved resolutions granting our board of directors or any duly authorized committee of the board of directors the authority to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company free from pre-emption rights. Pursuant to such approval, our board of directors was authorized to allot shares up to an aggregate nominal amount of £1,928 free from statutory pre-emption rights. The granting of this authority and the corresponding disapplication of preemptive rights was in addition to all subsisting authorities. This disapplication will need to be renewed upon expiration (i.e., at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).
11.  Deferred Shares
All deferred shares rank pari passu as a single class. The deferred shares do not have rights to dividends or to any other right of participation in the profits of the Company. On a return of assets on liquidation, the deferred shares shall confer on the holders thereof an entitlement to receive out of the assets of the Company available for distribution amongst the shareholders (subject to the rights of any new class of shares with preferred rights) the amount credited as paid up on the deferred shares held by them respectively after (but only after) payment shall have been made to the holders of the ordinary shares of the amounts paid up or credited as paid up on such shares and the sum of £1.0 million in respect of each ordinary share held by them respectively. The deferred shares shall confer on the holders thereof no further right to participate in the assets of the Company.
On March 29, 2023, all deferred B shares (nominal value of £0.01 each) and deferred C shares (nominal value of £0.00000736245954692556 each) previously in issue were transferred back to the Company and subsequently cancelled. These deferred shares had previously been issued to certain pre-IPO shareholders in connection with the implementation of certain stages of the Company’s pre-IPO share capital reorganization. The Company received shareholder approval on April 21, 2021 (pursuant to the shareholder resolutions passed on that date) in order to effect the transfer back and cancellation of the deferred shares for nil consideration in accordance with sections 659 and 662 of the Companies Act 2006.
The Company’s deferred A shares with a nominal value of £1.00 each remain in issue for the purposes of satisfying the minimum share capital requirements for a public limited company as prescribed by the Companies Act 2006.
12.  Fair Value
The Company’s financial instruments consist of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, certain accrued expenses, and contingent consideration. The carrying amounts of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair value due to the short-term nature and maturity of these instruments.
As of March 31, 2024, the Company had a contingent consideration liability of $1.9 million related to the acquisition of Avidea Technologies, Inc. The fair value of the contingent consideration is a Level 3 valuation with the significant unobservable inputs being the probability of success of achievement of the milestones and the expected date of the milestone achievement. Significant judgment is employed in determining the appropriateness of certain of these inputs.
F-10
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The following table summarizes changes to our financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy (in thousands):
Three Months Ended March 31,
20242023
Beginning balance$1,823 $1,711 
Change in fair value recognized in net loss/(gain)60 (38)
Foreign exchange translation recognized in other comprehensive loss(16)37 
Ending balance$1,867 $1,710 
13.  Goodwill
The Company identified qualitative indicators of impairment due to a sustained decline in the price of the Company’s American Depositary Shares, whereby the market capitalization continues to be below the value of the net assets of the Company. Therefore, the Company performed an interim qualitative assessment as of March 31, 2024 to determine whether it was more likely than not that the fair value of the reporting unit is less than its carrying amount. Based on this assessment, management determined it is not more likely than not that the fair value of the reporting unit is less than its carrying amount and hence no impairment loss has been recognized.
14.  Share-Based Compensation
During the three month period ended March 31, 2024, in accordance with the terms of the Annual Increase of the Barinthus Biotherapeutics plc Award Plan 2021 (the “Plan”), the total number of ordinary shares available for issuance under the Plan increased by 4% of the Company’s issued and outstanding ordinary shares as of January 1, 2023.
For the three months ended March 31, 2024, the Company granted 1,627,958 options to employees and directors with a weighted average grant date fair value of $2.90 and a weighted average exercise price of $3.67 per share (March 31, 2023: granted 1,987,289 options, weighted average grant date fair value of $2.01 and a weighted average exercise price of $2.53 per share). For the three months ended March 31, 2024, 70,946 options (March 31, 2023: 57,970 ) were forfeited.
The fair value of each stock option issued to employees was estimated at the date of grant using the Black-Scholes model with the following weighted-average assumptions:
Three Months Ended March 31,
20242023
Expected volatility108.8 %97.4 %
Expected term (years)6.06.0
Risk-free interest rate4.0 %3.6 %
Expected dividend yield— %— %
As of March 31, 2024, 7,645,076 options with a weighted average exercise price of $6.20 were outstanding. As of March 31, 2024, there was $6.2 million unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted average period of 1.9 years. As of March 31, 2023, 6,807,859 options with a weighted average exercise price of $9.69 were outstanding.
Share based compensation expense is classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended March 31,
20242023
Research and development$712 $1,119 
General and administrative903 1,103 
Total$1,615 $2,222 
F-11
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
15.  Commitments and Contingencies
In-License Agreements
The Company is party to a number of licensing agreements, most of which are with related parties. These agreements serve to provide the Company with the right to develop and exploit the counterparties’ intellectual property for certain medical indications. As part of execution of these arrangements, the Company paid certain upfront fees, which have been expensed as incurred because the developing technology has not yet reached technical feasibility, the lack of alternative use, and the lack of proof of potential value. The agreements cover a variety of fields, including influenza, cancer, human papillomavirus infection, (“HPV”), hepatitis B virus (“HBV”) and MERS. The Company’s obligations for future payments under these arrangements are dependent on its ability to develop promising drug candidates, the potential market for these candidates and potential competing products, and the payment mechanisms in place in countries where the Company retains the right to sell. Each agreement provides for specific milestone payments, typically triggered by achievement of certain testing phases in human candidates, and future royalties ranging from 1 to 5% for direct sales of a covered product to 3 to 7% of net payments received for allowable sublicenses of technology developed by the Company. The obligation to make these payments is contingent upon the Company’s ability to develop candidates for submission for phased testing and approvals, and for the development of markets for the products developed by the Company. The Company has not made or accrued any material payments under these license agreements during the three month periods ended March 31, 2024 and 2023.
Leases
The Company leases certain laboratory and office space under operating leases, which are described below.
The Harwell Science and Innovation Campus, Oxfordshire
On September 3, 2021, the Company entered into a lease agreement for the lease of approximately 31,000 square feet in Harwell, Oxfordshire which expires in September 2031. The property is the Company’s corporate headquarters. As the Company’s leases typically do not provide an implicit rate, the Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date, being the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The Company has provided the lessor with a refundable security deposit of $0.7 million which is included in Other assets.
Germantown, Maryland
On June 14, 2022, the Company entered into a lease agreement for the lease of approximately 19,700 square feet in Germantown, Maryland. The site will house the Company’s, state-of-the-art wet laboratory in the United States of America. The lease expires on February 28, 2034, with the Company having a single right to extend for an additional five years on the same terms and conditions other than for the base rent. The Company has a rent-free period up to February 29, 2024, and is entitled to up to $3.5 million for leasehold improvements to the premises desired by the Company. The Company has provided the lessor with a refundable security deposit of $0.2 million which is included in Other assets.
The Company recorded a right-of-use asset and a lease liability on the effective date of the lease term. The Company’s right-of-use asset and lease liability are as follows (in thousands):
March 31,
2024		December 31,
2023
Right-of-use asset$7,408 $7,581 
Lease liability, current1,909 1,785 
Lease liability, non-current10,897 11,191 
F-12
BARINTHUS BIOTHERAPEUTICS PLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Three months ended March 31,
20242023
Other information
Operating cash flows from operating leases$346$220
Weighted average remaining lease term (years)8.719.71
Weighted average discount rate7.5 %7.6 %
Three months ended March 31,
20242023
Lease Cost
Short-term lease costs$—$152
Fixed lease costs359279
Total lease cost$359$431
Future annual minimum lease payments under operating leases as of March 31, 2024, were as follows (in thousands):
Remainder of 2024$1,430 
20251,926 
20261,951 
20271,975 
20282,001 
Thereafter7,974 
Total minimum lease payments$17,257 
Less: imputed interest(4,451)
Total lease liability$12,806 
Other contingencies
As of the date of this Quarterly Report on Form 10-Q, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. However, from time to time, we could be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Regardless of the outcome, legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
16.  Related Party Transactions
During the three months ended March 31, 2024, the Company incurred expenses of $0.2 million (three months ended March 31, 2023: $0.1 million) from Oxford University Innovation Limited which is a wholly owned subsidiary of the Company’s shareholder, the University of Oxford. As of March 31, 2024, the Company owed $0.01 million (December 31, 2023: $0.002 million) to Oxford University Innovation Limited.
During the three months ended March 31, 2024, the Company recognized license revenue of nil (three months ended March 31, 2023: $0.5 million), from Oxford University Innovation Limited. As of March 31, 2024, the Company was owed nil (December 31, 2023: nil) from Oxford University Innovation Limited.

F-13
Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations.
You should read the following discussion and analysis of our financial condition and results of operations together with our condensed consolidated financial statements and the related notes appearing elsewhere in this unaudited Quarterly Report on Form 10-Q and our audited financial statements and related notes thereto for the year ended December 31, 2023 included in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on March 20, 2024. Some of the information contained in this discussion and analysis or set forth elsewhere in this report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks, uncertainties, and assumptions. Factors that might cause future results to differ materially from those projected in the forward-looking statements include, but are not limited to, those set forth in our Annual Report on Form 10-K and in other filings with the SEC.
Overview
We are a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. Helping patients and their families is the guiding principle at the heart of Barinthus Bio. We stand apart through our broad pipeline, built around four proprietary platform technologies; two viral vector platforms, ChAdOx and MVA; and two synthetic SNAP platforms, SNAP-Tolerance Immunotherapy, or SNAP-TI and SNAP-Cancer Immunotherapy, or SNAP-CI. These platforms are enabling us to develop antigen-specific immunotherapeutic candidates designed to optimize the disease fighting capabilities of T cells and guide them towards a healthy balance. Our immunotherapeutic candidates are designed to work by increasing disease-specific CD8+ T cell activity in the case of chronic infectious diseases and cancers, or by dampening CD4+ and CD8+ T cells, and increasing regulatory T cells in autoimmunity.

Harnessing our range of proprietary viral vector and synthetic platform technologies, we are advancing a pipeline of four product candidates across a diverse range of therapeutic areas, including: VTP-300, a Phase 2 immunotherapeutic candidate designed as a potential component of a functional cure for chronic infection; VTP-200, a Phase 2 nonsurgical product candidate for persistent high-risk HPV; VTP-1000, our first preclinical autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; and VTP-850, a second-generation Phase 2 immunotherapeutic candidate designed to treat recurrent prostate cancer.
Alongside these proprietary programs, we have partnerships in place to advance three additional prophylactic and therapeutic product candidates in Middle East Respiratory Syndrome, or MERS, Zoster and Non-Small Cell Lung Cancer, or NSCLC. We also coinvented a COVID-19 vaccine with the University of Oxford, which has been exclusively licensed worldwide to AstraZeneca. The co-invention of the COVID-19 vaccine demonstrated our ability to navigate a changing environment with speed and efficiency and lead the way in responding to urgent medical needs, as well as providing a strong proof of concept for the ChAdOx platform.
We believe our proven scientific expertise, diverse portfolio and focus on product candidate development uniquely positions us to navigate towards delivering treatments for patients with infectious diseases, autoimmune-disorders and cancers that have a significant impact on their every day lives.
On August 9, 2022, we filed a Registration Statement on Form S-3, as amended, or the Shelf, with the Securities and Exchange Commission in relation to the registration and potential future issuance of ordinary shares, including ordinary shares represented by ADSs, debt securities, warrants and/or units of any combination thereof in the aggregate amount of up to $200.0 million. The Shelf was declared effective on August 17, 2022. We also simultaneously entered into a sales agreement with Jefferies LLC, as sales agent, providing for the offering, issuance and sale by us of up to an aggregate of $75.0 million of our ordinary shares represented by ADSs from time to time in “at-the-market” offerings under the Shelf. As of March 31, 2024, we have sold 1,329,260 ordinary shares represented by ADSs under the sales agreement, amounting to net proceeds of $3.5 million.
We incurred net losses each year since inception through to December 31, 2021. For the year ended December 31, 2022, we generated net income of $5.3 million, primarily as a result of revenues arising from AstraZeneca sales of Vaxzevria and our agreement with OUI. For the year ended December 31, 2023, we generated a net loss of $73.4 million. For the three months ended March 31, 2024, we incurred a net loss of $15.5 million. As of March 31, 2024, we had an accumulated deficit of $192.1 million and we do not currently expect positive cash flows from operations in the foreseeable future. We expect to incur net operating losses for at least the next several years as we advance our product candidates through clinical development, seek regulatory approval, prepare for approval, and in some cases proceed to commercialization of our product candidates, as well as continue our research and development efforts and invest to establish a commercial manufacturing facility, as and when appropriate.
14
At this time, we cannot reasonably estimate, or know the nature, timing and estimated costs of all of the efforts that will be necessary to complete the development of any of our product candidates that we develop through our programs. We are also unable to predict when, if ever, material net cash inflows will commence from sales of product candidates we develop, if at all. This is due to the numerous risks and uncertainties associated with developing product candidates to approval and commercialization, including the uncertainty of:
•successful completion of preclinical studies and clinical trials;
•sufficiency of our financial and other resources to complete the necessary preclinical studies and clinical trials;
•acceptance of investigational new drug applications, or INDs, for our planned clinical trials or future clinical trials;
•successful and timely enrollment and completion of clinical trials;
•data from our clinical program supporting approvable and commercially acceptable risk/benefit profiles for our product candidates in the intended populations;
•receipt and maintenance of necessary regulatory and marketing approvals from applicable regulatory authorities, in the light of the commercial environment then existent;
•availability and successful procurement of raw materials required to manufacture our products for clinical trials, scale-up of our manufacturing processes and formulation of our product candidates for later stages of development and commercial production;
•establishing either our own manufacturing capabilities or satisfactory agreements with third-party manufacturers for clinical supply for later stages of development and commercial manufacturing;
•entry into collaborations where appropriate to further the development of our product candidates;
•obtaining and maintaining intellectual property and trade secret protection or regulatory exclusivity for our product candidates as well as qualifying for, maintaining, enforcing and defending such intellectual property rights and claims;
•successfully launching or assisting with the launch of commercial sales of our product candidates following approval;
•acceptance of each product’s benefits and uses by patients, the medical community and third-party payors following approval;
•the prevalence and severity of any adverse events experienced with our product candidates in development;
•establishing and maintaining a continued acceptable safety profile of the product candidates following approval;
•obtaining and maintaining healthcare coverage and adequate reimbursement from third-party payors if necessary or desirable; and
•effectively competing with other therapies.

A change in the outcome of any of these or other variables with respect to the development of any of our current and future product candidates could significantly change the costs and timing associated with the development of that product candidate, in either direction. Furthermore, our operating plans may change in the future owing to research outcomes or other opportunities, and we may need additional funds to meet operational needs and capital requirements associated with such altered operating plans. Unless and until we can generate a substantial amount of revenue from our product candidates, if approved, we expect to finance our future cash needs through public or private equity offerings, debt financings, collaborations, licensing arrangements or other sources, or any combination of the foregoing. Based on our research and development plans, we expect that our existing cash, cash equivalents and restricted cash and other financial resources, will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2025. These estimates are based on assumptions that may prove to be wrong, and we could use our available capital resources more quickly than we expect.

15
If we raise additional funds through collaborations, strategic alliances, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds when needed, we would be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.
Recent Development
Pipeline - May 24.jpg
These are estimated timelines only and our pipeline may be subject to change.
VTP-1000: Celiac disease
In April 2024, IND clearance was received from the FDA to progress VTP-1000 in a first in human clinical trial in Celiac disease. GLU001 is a randomized, placebo-controlled Phase 1 trial with a controlled gluten challenge to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-1000 in adults with celiac disease. The study is designed in two parts; a single ascending dose part followed by a multiple ascending dose part, each randomized and placebo-controlled with three dose levels. The primary endpoint is assessment of the safety and tolerability of single and multiple dosing, and determination of a dose and schedule for further investigation. The trial also aims to demonstrate proof-of-principle of induction of immune tolerance and early proof-of-concept for VTP-1000 as a potential treatment for celiac disease based on assessment of pharmacodynamics and preliminary efficacy determined by means of a controlled gluten challenge. This Phase 1 trial has also received Ethics Committee approval to proceed in Australia.
Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus ("hrHPV") Infections
On April 18, 2024, we announced topline final data from the APOLLO trial, (also known as HPV001) a Phase 1b/2 dose-ranging study of VTP-200 in women with low-grade cervical lesions associated with persistent hrHPV infection. APOLLO was a randomized, placebo-controlled Phase 1b/2 multi-center trial of 108 participants across the UK and EU evaluating the safety, tolerability and immunogenicity of VTP-200 in women aged 25-55 with persistent hrHPV infection and low-grade cervical lesions. The primary objective was to evaluate the safety and tolerability of VTP-200. The trial was also designed to assess the effect of VTP-200 on clearance of hrHPV infection and cervical lesion(s), as well as select appropriate doses for further development.
16

The APOLLO study met its primary safety endpoint, demonstrating that VTP-200 was generally well-tolerated and was administered with no treatment-related grade 3 or higher unsolicited AEs and no treatment-related SAEs.

The highest hrHPV clearance rate of 60% at Month 12 was observed in group 2, which included the highest dose of ChAdOx, compared to a 33% clearance rate in the placebo group. Groups 1, 3, 4 and 5 showed 12%, 11%, 33% and 36% hrHPV clearance rates, respectively.

The study also evaluated cervical lesion clearance rates in participants with both reported lesions at screening and visualization of the cervical transformation zone at 12 months (n=57). The highest cervical lesion clearance rate of 67% was observed in group 2 and group 5, both received the highest dose of ChAdOx, compared to 39% in the placebo group. Groups 1, 3 and 4 showed 40%, 20% and 33% cervical lesion clearance rates, respectively.

Pooled data from the five active dose groups showed no significant improvement in hrHPV clearance or cervical lesion clearance rates in comparison to the placebo group. Future development options for the VTP-200 program are currently being evaluated with further analyses ongoing.
Management Team
On May 1, 2024, we announced the appointment of Dr. Leon Hooftman as Chief Medical Officer. Dr. Hooftman will join the company on June 3, 2024, and brings significant drug development expertise across a broad array of therapeutic areas including immunology, autoimmunity, hematology, oncology and infectious diseases.
VTP-300 interim data update at the European Association for the Study of the Liver ("EASL") Congress
On June 5-8, 2024, we will present interim data at the EASL Congress in Milan, Italy, following the acceptance of an abstract on HBV003, an ongoing Phase 2b trial designed to further evaluate the safety and efficacy of VTP-300 when combined with a low-dose anti-PD-1 antibody, and standard-of-care (SoC) nucleos(t)ide analogue (NUC) therapy. An abstract has also been accepted at the EASL Congress for interim data from the Phase 2a AB-729-202 trial combining Arbutus Biopharma Corporation’s RNAi therapeutic candidate, imdusiran (AB-729), with Barinthus Bio’s T cell stimulating immunotherapeutic candidate, VTP-300, and SoC NUC therapy.
Impact of Israel and Gaza Conflict
In respect of the international situation in Israel and Gaza, we have no operations or suppliers based in Israel or Gaza, and as a result, as of the date of this Quarterly Report on Form 10-Q, we believe the impact on our business, operations and financial condition will be minimal.
Impact of the Ukraine Crisis
In respect of the international situation in Ukraine, we have no operations or suppliers based in Ukraine, Belarus or Russia, and as a result, as of the date of this Quarterly Report on Form 10-Q, we believe the impact on our business, operations and financial condition will be minimal.
Impact of Global Economic Conditions and Inflationary Pressures
Instability in global economic conditions and geopolitical matters, as well as volatility in financial markets, could have a material adverse effect on our results of operations and financial condition. These inflationary pressures and rising interest rates in the United States, the United Kingdom and elsewhere have given rise to increasing concerns that the U.S., U.K. and other economies are now in, or may soon enter, economic recession. Sustained inflationary pressures, increased interest rates, an economic recession or continued or intensified disruptions in the global financial markets could adversely affect our future financing capability or ability to access the capital markets. Additionally, we may incur future increases in operating costs due to additional inflationary increases.
17
Components of Our Operating Results
Revenue
To date, we have not generated any revenue from direct product sales and do not expect to do so in the near future, if at all. Most of our revenue to date has been derived from the OUI License Agreement Amendment with OUI relating to Vaxzevria.
In April 2020, we entered into the OUI License Agreement Amendment with OUI in respect of our rights to use the ChAdOx1 technology in COVID-19 vaccines to facilitate the license of those rights by OUI to AstraZeneca. Under this agreement, we are entitled to receive from OUI a share of payments, including royalties and milestones, received by OUI from AstraZeneca in respect of this vaccine. In March 2022, we were notified by OUI of the commencement of revenue relating to commercial sales of Vaxzevria. Our revenue for the three months ending March 31, 2024 was nil (three months ending March 31, 2023: $0.5 million), representing the amounts we have been notified of as due by OUI to date and an estimate of future receipts, constrained to the extent that it is probable that a significant reversal of revenue would not occur. In May 2024, AstraZeneca announced its planned withdrawal of Vaxzevria as demand had declined, and therefore we do not expect to receive any significant future revenue relating to commercial sales of Vaxzevria.
Operating Expenses
Our operating expenses since inception have consisted of research and development costs and general and administrative costs.
Research and Development Expenses
Since our inception, we have focused significant resources on our research and development activities, including establishing and building on our adenovirus platform, further enhancing our in-licensed ChAdOx1, ChAdOx2 and MVA vectors, developing a new next-generation adenoviral vector, acquiring new technology platforms including SNAP (SNAP-TI and SNAP-CI), conducting preclinical studies, developing various manufacturing processes, and advancing clinical development of our programs including Phase 2 clinical trials for VTP-100, which we subsequently discontinued development of, as well as initiating the clinical trials for VTP-200, VTP-300, VTP-600 and VTP-850 and readying VTP-500, and VTP-1000 for clinical trials. Research and development activities account for a large portion of our operating expenses, and we expect research and development expenses to increase in the future. Research and development costs are expensed as incurred. These costs include:
•salaries, benefits, and other related costs, including share-based compensation, for personnel engaged in research and development functions;
•expenses incurred in connection with the development of our programs including preclinical studies and clinical trials of our product candidates, under agreements with third parties, such as consultants, contractors, academic institutions and contract research organizations, or CROs;
•the cost of manufacturing drug products for use in preclinical development and clinical trials, including agreements with third parties, such as contract manufacturing organizations, consultants and contractors;
•laboratory costs; and
•leased facility costs, equipment depreciation and other expenses, which include direct and allocated expenses.
General and Administrative Expenses
Our general and administrative expenses consist primarily of personnel-related expenses, including share-based compensation, in our executive, finance, business development and other administrative functions. Other general and administrative expenses include consulting fees and professional service fees for auditing, tax and legal services, rent expenses related to our offices, depreciation, foreign exchange gains and losses on our cash balances, other central non-research costs and changes in the fair value of contingent consideration. When determining the fair value of contingent consideration, significant judgment is used to determine the probability of success of achievement of the technology and clinical milestones and the date of the expected milestone. We expect our general and administrative expenses to continue
18
to increase in the future as we expand our operating activities in both the United Kingdom and United States and potentially prepare for manufacturing and/or commercialization of our current and future product candidates. These costs will increase as our headcount rises to allow full support for our operations as a public company, including increased expenses related to legal, accounting, regulatory and tax-related services associated with maintaining compliance with requirements of the Nasdaq Global Market and the Securities and Exchange Commission, directors’ and officers’ liability insurance premiums and investor relations activities.
Other Operating Income
Other operating incomes include the CEPI Funding Agreement pursuant to which CEPI will provide funding to us to advance the development of VTP-500, our vaccine candidate against MERS. When there is reasonable assurance that we will comply with the conditions attached to a received grant, and when there is reasonable assurance that the grant will be received, grant income is recognized as other operating income on a gross basis in the condensed consolidated statements of operations and comprehensive loss on a systematic basis over the periods in which we recognize expenses for the related costs for which the grants are intended to compensate. Payments received in advance of incurring reimbursable expenses are recorded as deferred income. Any remaining unused amounts of the cash payments received on the balance sheet will be disclosed as restricted cash in the notes of the financial statement.
Other Income/(Expense)
Interest Income
Interest income results primarily from the interest earned on our short-term cash deposits and cash balances held by Barinthus Biotherapeutics (UK) Limited.
Interest Expense
Interest expense results primarily from the asset retirement obligation discounted over the length of the relevant lease.
Research and Development Incentives
Research and development incentives contain payments receivable from the United Kingdom government related to corporation tax relief on research and development projects in the United Kingdom. We account for such relief received as other income.
We benefit from the United Kingdom research and development tax credit regime, being the Small and Medium-sized Enterprises R&D tax relief program, or SME Program, and, to the extent that our projects are grant funded or relate to work subcontracted to us by third parties, the Research and Development Expenditure Credit program, or RDEC Program.
Until March 2023 under the SME program, we were able to surrender some of its trading losses that arise from qualifying research and development activities for a cash rebate of up to 33.35% of such qualifying research and development expenditure. Qualifying expenditures largely comprise employment costs for research staff, consumables, outsourced contract research organization costs and utilities costs incurred as part of research projects. Certain subcontracted qualifying research and development expenditures are eligible for a cash rebate of up to 21.67%. A large portion of costs relating to research and development, clinical trials and manufacturing activities are eligible for inclusion within these tax credit cash rebate claims.
From April 2023, under the SME Program, the enhanced rate of deduction has decreased from 230% to 186%, the SME credit rate has been reduced from 14.5% to 10% (except for R&D intensive SMEs, which will benefit from a credit rate of 14.5%), and our SME cash rebate has been reduced from an effective rate of 33.35% to 18.6% (or 26.97% for R&D intensive SMEs) and from 21.67% to 12.1% for subcontractors. We are assessing if we can claim under the loss-making R&D Intensive Scheme for SMEs, which will provide benefits consistent with those claimed under the current SME Programs.
We may not be able to continue to claim research and development tax credits under the SME program in the future because we may no longer qualify as a small or medium-sized company. In addition, the EU State Aid cap limits the total aid claimable in respect of a given project to €7.5 million which may impact our ability to claim R&D tax credits in future. Further, the U.K. Finance Act of 2021 introduced a cap on payable credit claims under the SME Program in excess of
19
£20,000 with effect from April 2021 by reference to, broadly, three times our the total Pay As You Earn, or PAYE, and National Insurance Contributions, or NICs, liability, subject to an exception which prevents the cap from applying. That exception requires us to create, take steps to create or manage intellectual property, as well as having qualifying research and development expenditure in respect of connected parties, which does not exceed 15% of the total claimed. If such an exception does not apply, this could restrict the amount of payable credit that we claim.
Unsurrendered UK losses may be carried forward indefinitely to be offset against future taxable profits, subject to numerous utilization criteria and restrictions. The amount that can be offset each year is limited to £5.0 million plus an incremental 50% of UK taxable profits.
Critical Accounting Policies and Use of Estimates
This discussion and analysis of financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States, or GAAP. The preparation of financial statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue, income and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to fair value of contingent consideration and impairment of goodwill and intangible assets. Management bases its estimates on historical experience and on various other market specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.
We believe that the following accounting policies are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.
Goodwill
We assess goodwill for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying amounts may not be recoverable. We have elected to assess goodwill for impairment by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount as a basis of determining whether it is necessary to perform the quantitative goodwill impairment test. We have one reporting unit. Accordingly, our review of goodwill impairment indicators is performed at the entity-wide level. This requires us to assess and make judgments regarding a variety of factors, including clinical data results, business plans, anticipated future cash flows, economic projections and other market data. Because there are inherent uncertainties involved in these factors, significant differences between these estimates and actual results could result in future impairment charges and could materially impact our future financial results. The goodwill of $12.2 million recognized as of March 31, 2024 related to the acquisition of Avidea on December 10, 2021. We performed an interim assessment as of March 31, 2024 to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. Based on this assessment, we have not recognized any impairment losses related to goodwill for the three months ending March 31, 2024.
Long-lived assets
The Company reviews long-lived assets to be held and used, including property and equipment, intangible assets and operating lease right-of-use assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets or asset group may not be recoverable. Evaluation of recoverability is first based on an estimate of undiscounted future cash flows resulting from the use of the asset or asset group and its eventual disposition. In the event such cash flows are not expected to be sufficient to recover the carrying amount of the asset or asset group, the assets are written down to their estimated fair values. No such impairments were recorded during the three months ended March 31, 2024.
20
Contingent consideration
We recognize a contingent consideration liability related to the acquisition of Avidea. The liability is remeasured to fair value at each reporting date until the contingency is resolved. The fair value of the contingent consideration is a Level 3 valuation determined using significant unobservable inputs being the probability of success of achievement of the milestones and the expected date of the milestone achievement. Changes in fair value are recognized in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss. Avidea’s stockholders may be entitled to receive an aggregate of up to $40.0 million in additional payments, payable in a combination of cash and ADSs, upon the achievement of certain milestones. This contingent consideration is included within the purchase price and is recognized at its fair value on the acquisition date, and subsequently remeasured to fair value at each reporting date until the contingency is resolved. Changes in fair value are recognized in general and administrative expenses in the condensed consolidated statements of operations and comprehensive loss. The fair value of contingent consideration is based on the probability of pursuit of the activity associated with the milestone, the probability of success of the achievement of the milestone, the expected date of milestone achievement and applying the relevant discount rate.
Results of Operations
Comparison of the Three Months Ended March 31, 2024 and 2023
The following table sets forth the significant components of our results of operations (in thousands):
Three months ended March 31, 2024Three months ended March 31, 2023Change
Revenue from Licenses, Grants & Services$— $468 $(468)
Operating expenses:   
Research & development11,125 9,814 1,311 
General and administrative5,994 12,138 (6,144)
Total operating expenses17,119 21,952 (4,833)
Other operating income205 — 205 
Loss from operations
(16,914)(21,484)4,570 
Other income (expense)  
Interest income775 1,588 (813)
Interest expense(12)— (12)
Research and development incentives594 1,157 (563)
Total other income1,357 2,745 (1,388)
Loss before income tax
(15,557)(18,739)3,182 
Tax benefit37 516 (479)
Net loss
$(15,520)$(18,223)$2,703 
Revenue
For the three months ended March 31, 2024, and 2023, our revenue consisted of nil and $0.5 million respectively, from the OUI License Agreement Amendment with respect to payments from OUI in connection with commercial sales of Vaxzevria. The decrease in revenue from the OUI License Agreement Amendment, compared to the prior period, resulted from substantially declined sales of Vaxzevria due to a decrease in demand. In May 2024, AstraZeneca announced its planned withdrawal of Vaxzevria as demand had declined, and therefore we do not expect to receive any significant future revenue relating to commercial sales of Vaxzevria.
21
Research and Development Expenses
The following table summarizes our research and development expenses for the three months ended March 31, 2024 and 2023 (in thousands):
Three months
ended March
31, 2024		Three months
ended March
31, 2023		Change
Direct research and development expenses by program:
VTP-200 HPV$1,253 $1,338 $(85)
VTP-300 HBV1,913 2,118 (205)
VTP-500 MERS1
172 — 172 
VTP-600 NSCLC2
164 275 (111)
VTP-850 Prostate cancer178 215 (37)
VTP-1000 Celiac 1,374 1,572 (198)
Other and earlier stage programs3
784 280 504 
Total direct research and development expenses5,838 5,798 40 
Indirect research and development expenses:  
Personnel-related (including share-based compensation)4,335 3,601 734 
Facility related390 371 19 
Other indirect costs562 44 518 
Total indirect research and development expenses5,287 4,016 1,271 
Total research and development expenses$11,125 $9,814 $1,311 
1The development of VTP-500 is funded pursuant to an agreement with the Coalition for Epidemic Preparedness Innovations (CEPI).
2The VTP-600 NSCLC Phase 1/2a trial is sponsored by Cancer Research UK.
Research and development expenses related to VTP-1100 HPV Cancer were previously included with VTP-1000 Celiac but are now included in 'Other and earlier stage programs' because we are focusing resources on other clinical programs and deferring the planned IND application for VTP-1100 in HPV cancer.
Our research and development expenses for the three months ended March 31, 2024 and 2023 were $11.1 million and $9.8 million, respectively.
Direct expenses for the three months ended March 31, 2024 and 2023 were $5.8 million and $5.8 million, respectively, and consisted of outside services, consultants, laboratory materials, clinical trials, manufacturing of clinical trial materials, as well as costs for external preclinical services and sample testing. Of the $0.04 million increase, $0.5 million pertains to an increase in other and earlier stage programs mainly due to the reclassification of VTP-1100 HPV cancer cost in the current period to other earlier stage programs. These increases were partially offset by $0.1 million decrease in VTP-200 HPV and $0.2 million for VTP-300 HBV due to a reduction in clinical trial and manufacturing development costs.
Indirect research and development expenses for the three months ended March 31, 2024 and 2023 were $5.3 million and $4.0 million, respectively. Of the $1.3 million increase, $0.7 million related to an increase in headcount across locations in the United Kingdom and United States and $0.5 million increase in other indirect costs was primarily due to research and development overhead costs related to the new U.S. laboratory and office facility that we relocated to in June 2023.
General and Administrative Expenses
General and administrative expenses for the three months ended March 31, 2024 and 2023 were $6.0 million and $12.1 million, respectively. The decrease of $6.1 million relates primarily to a gain of $1.2 million on foreign exchange for the three months ended March 31, 2024, compared to a loss of $3.5 million for the three months ended March 31, 2023 a decrease in personnel expenses, including share-based payment charges of $0.8 million, primarily due to a reduction in non-cash share-based payment charges, and a decrease in insurance costs of $0.9 million due to a reduction in insurance premiums.
22
Other Operating Income
For the three months ended March 31, 2024 and 2023, other operating income was $0.2 million and nil, respectively, resulting from the funding provided by CEPI under the Funding Agreement, dated December 20, 2023, entered into by and among us, the Chancellors, Masters and Scholars of the University of Oxford and the CEPI in the three months ended March 31, 2024.
Interest Income
For the three months ended March 31, 2024 and 2023, interest income was $0.8 million and $1.6 million, respectively, resulting from the interest earned on our short-term cash deposits held by Barinthus Biotherapeutics (UK) Limited.
Research and Development Incentives
For the three months ended March 31, 2024 and 2023 research and development incentives were $0.6 million and $1.2 million, respectively. Such research and development incentives relate to corporation tax relief on research and development projects incentive programs in the United Kingdom.
Tax benefit
For the three months ended March 31, 2024 and 2023, the tax benefit was $0.04 million and $0.5 million respectively, which primarily relates to movements in deferred tax.
Liquidity and Capital Resources
Sources of Liquidity
Since our inception, we have funded our operations primarily through private and public placements of our ordinary and preferred shares as well as from grants and research incentives, various agreements with public funding agencies, the issuance of convertible loan notes, and most recently from upfront, royalty and milestone payments from OUI in connection with the OUI License Agreement Amendment. Through March 31, 2024, we received gross proceeds of approximately $328.4 million from the issuance of our ordinary and preferred shares and convertible loan notes. As of March 31, 2024, we had cash, cash equivalents and restricted cash of $130.0 million. Recent financing and corporate milestones include the following:
•Between July 2020 and November 2020, we raised gross proceeds of $41.2 million from the issuance of convertible loan notes;
•In March 2021, we raised gross proceeds of $125.2 million from the issuance of our series B shares;
•In May 2021, we raised gross proceeds of $110.5 million from the initial public offering of our ordinary shares on NASDAQ;
•Between April 2022 and June 2023, we received $44.5 million of cash from OUI for the commercial sales of Vaxzevria;
•Between December 2022 and March 2024, we raised net proceeds of $3.5 million from the issuance of shares represented by ADSs through “at-the-market” offerings under the sales agreement with Jefferies LLC.
On August 9, 2022, we filed the Shelf, with the Securities and Exchange Commission in relation to the registration and potential future issuance of ordinary shares, including ordinary shares represented by ADSs, debt securities, warrants and/or units of any combination thereof in the aggregate amount of up to $200.0 million. The Shelf was declared effective on August 17, 2022. We also simultaneously entered into a sales agreement with Jefferies LLC, as sales agent, providing for the offering, issuance and sale by us of up to an aggregate of $75.0 million of our ordinary shares represented by ADSs from time to time in “at-the-market” offerings under the Shelf. As of March 31, 2024, we have sold 1,329,260 ordinary shares represented by ADSs under the sales agreement amounting to net proceeds of $3.5 million.
23
We do not currently expect positive cash flows from operations in the foreseeable future, if at all. In most periods, we have incurred operating losses as a result of ongoing efforts to develop our immunotherapy platforms and our product candidates, including conducting ongoing research and development, preclinical studies, clinical trials, providing general and administrative support for these operations and developing our intellectual property portfolio. We expect to continue to incur net negative cash flows from operations for at least the next few years as we progress clinical development, seek regulatory approval, prepare for and, if approved, proceed to manufacture and commercialization of our most advanced product candidates. Operating profits may arise earlier if programs are licensed or sold to third parties before final approval, but this cannot be guaranteed.
Cash Flows
The following table sets forth a summary of the primary sources and uses of cash (in thousands) for each period presented:
Three months
ended March
31, 2024		Three months
ended March 31, 2023
Net cash used in operating activities$(11,822)$(3,174)
Net cash used in investing activities(308)(2,507)
Net cash provided by financing activities503 1,689 
Effect of exchange rates on cash, cash equivalents and restricted cash(492)935 
Net decrease in cash, cash equivalents and restricted cash$(12,119)$(3,057)
Cash Used in Operating Activities
During the three months ended March 31, 2024, net cash used in operating activities was $11.8 million, primarily resulting from our net loss of $15.5 million adjusted by share based compensation of $1.6 million, depreciation and amortization of $1.4 million, non-cash lease expenses of $0.4 million, unrealized foreign exchange gain of $1.0 million and changes in our operating assets and liabilities, net of $1.3 million primarily related to a $1.9 million decrease in prepaid expenses and other current assets, $1.4 million increase in deferred revenue, a $0.8 million decrease in accrued expenses, $0.5 million decrease in accounts payable and $0.3 million decrease in operating lease liabilities.

During the three months ended March 31, 2023, net cash used in operating activities was $3.2 million, primarily resulting from our net loss of $18.2 million adjusted by share based compensation of $2.2 million, depreciation and amortization of $1.2 million, foreign exchange loss of $3.5 million, and changes in our operating assets and liabilities, net of $8.3 million.
Net Cash Used in Investing Activities
During the three months ended March 31, 2024 and 2023, cash used in investing activities was $0.3 million and $2.5 million, respectively. These amounts resulted primarily from capital expenditures related to leasehold improvements on our new office in Germantown, Maryland, United States.
Net Cash Provided by/(Used in) Financing Activities

During the three months ended March 31, 2024 and 2023, cash provided by financing activities was $0.5 million and $1.7 million, respectively. These amounts primarily related to net proceeds received from the issuance of ordinary shares through the “at-the-market” sales agreement.
Effect of exchange rates on cash, cash equivalents and restricted cash
During the three months ended March 31, 2024 and 2023, the effect of foreign exchange on cash, cash equivalents and restricted cash was a loss of $0.5 million and a gain of $1.0 million respectively, primarily as a result of fluctuations between the United States dollar and pound sterling exchange rates.
Future Funding Requirements
To date, we have devoted substantially all of our resources to organizing and staffing our company, business planning, raising capital, undertaking preclinical studies and conducting clinical trials of our product candidates. As a result, we have
24
incurred losses in each year since our inception in 2016, through to December 31, 2021. We were profitable in 2022, however we have negative operating cash flows for the period ended March 31, 2024. As of March 31, 2024, we had an accumulated deficit of $192.1 million. We expect to continue to incur significant losses and negative cash flows from operations for the foreseeable future. We anticipate that our expenses will increase substantially as we:
•pursue the clinical and preclinical development of our current product candidates;
•use our technologies to advance additional product candidates into preclinical and clinical development;
•seek marketing authorizations for product candidates that successfully complete clinical trials, if any;
•attract, hire and retain additional clinical, regulatory, quality control and other scientific personnel;
•establish our manufacturing capabilities through third parties or by ourselves and scale-up manufacturing to provide adequate supply for clinical trials and commercialization, including any manufacturing finishing and logistics personnel;
•expand our operational, financial and management systems and increase personnel appropriately, including personnel to support our manufacturing and commercialization efforts and our operations as a public company;
•maintain, expand, enforce, and protect our intellectual property portfolio as appropriate;
•establish sales, marketing, medical affairs and distribution teams and infrastructure to commercialize any products for which we may obtain marketing approval and intend to commercialize on our own or jointly;
•acquire or in-license other companies, product candidates and technologies; and
•incur additional legal, accounting and other expenses in operating our business, including office expansion and the additional costs associated with operating as a public company.
Even if we succeed in commercializing one or more of our product candidates, we will continue to incur substantial research and development and other expenditure to develop and market additional product candidates. We may encounter unforeseen expenses, difficulties, complications, delays and other factors that may adversely affect our business. The size of our future net losses will depend on the rate of future growth of our expenses combined with our ability to generate revenue. Our prior losses and expected future losses have had and will continue to have an adverse effect on our stockholders’ equity and working capital unless and until eliminated by revenue growth.
We may require substantial additional financing in the future to meet any such unanticipated factors and a failure to obtain this necessary capital could force us to delay, limit, reduce or terminate our product development programs, commercialization efforts or other operations.
Since our foundation, we have invested a significant portion of our efforts and financial resources in research and development activities for our ChAdOx1, ChAdOx2 and MVA technologies, acquisition of additional complementary platforms such as SNAP-TI and SNAP-CI, development of new technologies in house, and our product candidates derived from these technologies. Preclinical studies and especially clinical trials and additional research and development activities will require substantial funds to complete. We believe that we will continue to expend substantial resources for the foreseeable future in connection with the development of our current product candidates and programs as well as any future product candidates we may elect to pursue, as well as the gradual gaining of control over our required manufacturing capabilities and other corporate functions. These expenditures will include costs associated with conducting preclinical studies and clinical trials, obtaining regulatory approvals, and potentially in-house manufacturing and supply, as well as marketing and selling any products approved for sale. In addition, other unanticipated costs may arise as outlined above. Because the outcome of any preclinical study or clinical trial is uncertain and the rate of change of third-party costs is also unpredictable, we cannot reasonably estimate now the actual amounts which will be necessary to complete the development and commercialization of our current or future product candidates successfully.
25
Our future capital requirements may depend on many factors, including:
•the scope, progress, results and costs of researching and developing our current and future product candidates and programs, and of conducting preclinical studies and clinical trials;
•the number and development requirements of other product candidates that we may pursue, and of other indications for our current product candidates that we may pursue;
•the stability, scale and yield of future manufacturing processes as we scale-up production and formulation of our product candidates either internally or externally for later stages of development and commercialization;
•the timing of success achieved and the costs involved in obtaining regulatory and marketing approvals and developing our ability to establish license or sale transactions and/or sales and marketing capabilities, if any, for our current and future product candidates if clinical trials and approval processes are successful;
•the success of our collaborations with CanSino, CRUK and the Ludwig Institute and any future collaboration partners;
•our ability to establish and maintain collaborations, strategic licensing or other arrangements and the financial terms of such agreements;
•the cost to the company of commercialization activities for our current and future product candidates that we may take on, whether alone or with a collaborator;
•the costs involved in preparing, filing, prosecuting, maintaining, expanding, defending and enforcing patent and other intellectual property claims, including litigation costs and the outcome of such litigation;
•the timing, receipt and amount of sales of, or royalties or other income from, our future products, if any; and
•the emergence and success or otherwise of competing oncology and infectious disease therapies and other market developments.
A change in the outcome of any of these or other variables with respect to the development of any of our current and future product candidates could significantly change the costs and timing associated with the development of that product candidate, in either direction. Furthermore, our operating plans may change in the future owing to research outcomes or other opportunities, and we may need additional funds to meet operational needs and capital requirements associated with such altered operating plans. Unless and until we can generate a substantial amount of revenue from our product candidates, we expect to finance our future cash needs through public or private equity offerings, debt financings, collaborations, licensing arrangements or other sources, or any combination of the foregoing.
Based on our research and development plans, we expect that our existing cash, cash equivalents and restricted cash and other financial resources, will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2025. These estimates are based on assumptions that may prove to be wrong, and we could use our available capital resources more quickly than we expect.
If we raise additional funds through collaborations, strategic alliances, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds when needed, we would be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.
Lease, Purchase, and Other Obligations
We have operating lease obligations related to our property, plant and equipment. The obligations related to both short- and long-term lease arrangements are set forth in Note 15 “Commitment and Contingencies” to our condensed consolidated financial statements.
We enter into contracts in the normal course of business with CROs and other third parties for clinical trials and preclinical research studies and testing. These contracts are generally cancellable by us upon prior notice. Payments due upon
26
cancellation consist only of payments for services provided or expenses incurred, including noncancellable obligations of our service providers, up to the date of cancellation.
We have contingent payment obligations that we may incur upon achievement of clinical, regulatory and commercial milestones, as applicable, or royalty payments that we may be required to make under our licenses; however, the amount, timing and likelihood of such payments are not known as of March 31, 2024.
Emerging Growth Company Status
We are an emerging growth company under the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. As an emerging growth company, we may delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.
We will remain an emerging growth company until the earliest of (1) the last day of the fiscal year (a) following the fifth anniversary of the date of the closing of our IPO, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in which we are deemed to be a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our ADSs held by non-affiliates exceeded $700.0 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.
Recent Accounting Pronouncements
A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our condensed consolidated financial statements.
Item 3.     Quantitative and Qualitative Disclosure About Market Risk
Foreign Currency and Currency Translation
We are subject to the risk of fluctuations in foreign currency exchange rates, specifically with respect to the euro, pound sterling, Swiss franc and Australian dollar. Our reporting currency is the United States dollar, and the functional currency of Barinthus Biotherapeutics plc and its consolidated subsidiaries, Barinthus Biotherapeutics (UK) Limited and Vaccitech Oncology Limited, is the pound sterling. The functional currency of our wholly owned foreign subsidiary, Barinthus Biotherapeutics North America, Inc. is the United States dollar. The functional currency of our wholly owned foreign subsidiary, Barinthus Australia Pty, is the Australian dollar. The functional currency of our wholly owned foreign subsidiary, Barinthus Biotherapeutics Italia S.R.L, is the euro. The functional currency of our wholly owned foreign subsidiary, Barinthus Biotherapeutics Switzerland GmbH, is the Swiss franc. Our cash, cash equivalents and restricted cash as of March 31, 2024 consisted primarily of cash balances held by Barinthus Biotherapeutics (UK) Limited in United States dollars.
Assets and liabilities are translated into United States dollars at the exchange rate in effect on the balance sheet date. Revenue and expenses are translated at the average exchange rate in effect during the period. Translation adjustments are included in the condensed consolidated Balance Sheets as a component of accumulated other comprehensive loss. Adjustments that arise from exchange rate changes on transactions denominated in a currency other than the local currency are included in operating expenses, net in the condensed consolidated Statements of Operations and Comprehensive Loss as incurred.
We incur significant operating costs in the U.K. and face exposure to changes in the exchange ratio of the United States dollar and the pound sterling arising from expenses and payables at our U.K. operations that are settled in pound sterling. For the three months ended March 31, 2024, an average 10% weakening in the United States dollar relative to the pound sterling would have resulted in an immaterial change to our expenses denominated in pound sterling for the three months ended March 31, 2024 and 2023.
Interest Rate Sensitivity
We are not currently exposed significantly to market risk related to changes in interest rates, as we have no significant interest-bearing liabilities. We had cash, cash equivalents and restricted cash of $130.0 million as of March 31, 2024, which were primarily held as account balances with banks in the United Kingdom, United States and Australia. A
27
hypothetical 10% relative change in interest rates during any of the periods presented would not have had a material impact on our condensed consolidated financial statements.
Item 4.     Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2024.
The term “disclosure controls and procedures”, means controls and other procedures of a company that are designed to provide reasonable assurance that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide reasonable assurance that the information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on our evaluation, our management, with the participation of our principal executive officer and principal financial officer, has concluded that, as of such date, our disclosure controls and procedures were effective.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
28
PART II - OTHER INFORMATION
Item 1.      Legal Proceedings.
From time to time, we may become subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Although the results of litigation and claims cannot be predicted with certainty, as of March 31, 2024, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
Item 1A     Risk Factors.
There have been no material changes from the risk factors previously disclosed in our most recent Annual Report on Form 10-K as filed with the SEC on March 20, 2024.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report contains express or implied forward-looking statements that involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements by the words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “ongoing,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. The forward-looking statements and opinions contained in this Quarterly Report are based upon information available to our management as of the date of this Quarterly Report and, while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. Forward-looking statements contained in this Quarterly Report include, but are not limited to, statements about:
•the success, cost and timing of our product development activities and clinical trials;
•the timing, scope or likelihood of regulatory filings and approvals, including timing of Investigational New Drug Application, or IND and Biological License Application filings for our current and future product candidates, and final U.S. Food and Drug Administration, or FDA, European Medicines Agency, or EMA, United Kingdom Medicines and Healthcare products Regulatory Agency, or MHRA, or other foreign regulatory authority approvals relating to our current and future product candidates;
•our ability to develop and advance our current and future product candidates and programs into, and successfully complete, clinical trials;
•our ability to establish future or maintain current collaborations or strategic relationships;
•the rate and degree of market acceptance and clinical utility of our current and future product candidates;
•any expectations surrounding the payments we could potentially receive pursuant to our collaborations and license agreements;
•the ability and willingness of our third-party collaborators to continue research and development activities relating to our product candidates;
•our ability to obtain, maintain, defend and enforce our intellectual property protection for our product candidates, and the scope of such protection;
•our manufacturing, commercialization and marketing capabilities and strategy;
29
•future agreements with third parties in connection with the commercialization of our product candidates, if approved, and any other approved products;
•regulatory developments in the United States and foreign countries;
•competitive companies, technologies and our industry and the success of competing therapies that are or may become available;
•our ability to attract and retain key scientific or management personnel;
•our ability to obtain funding for our operations, including funding necessary to complete further development and commercialization of our product candidates;
•the accuracy of our estimates of our annual total addressable markets, future revenue, expenses, capital requirements and needs for additional financing;
•our expectations about market trends;
•our ability to anticipate and overcome challenges posed to the conduct of our business in the event of a global pandemic, such as COVID-19, or similar event;
•the impact of global economic and political developments on our business, including rising or sustained high inflation and capital market disruptions, the conflict in Ukraine, the conflict in Israel and Gaza, disruptions in the banking industry, economic sanctions and economic slowdowns or recessions that may result from such developments; and
•our expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act.
If our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You should read this Quarterly Report and the documents that we reference in this Quarterly Report with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements in this Quarterly Report by these cautionary statements.
This Quarterly Report contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Unless the context otherwise requires, reference in this Quarterly Report to the terms “Barinthus Bio,” “the Company,” “we,” “us,” “our,” and similar designations refer to Barinthus Biotherapeutics plc and, where appropriate, our wholly-owned subsidiaries. As used herein, all references before November 7, 2023 to (i) Barinthus Biotherapeutics plc shall refer to Vaccitech plc, (ii) Barinthus Biotherapeutics (UK) Limited shall refer to Vaccitech (UK) Limited, (iii) Barinthus Biotherapeutics North America, Inc., or Barinthus Bio NA shall refer to Vaccitech North America, Inc., (iv) Barinthus Biotherapeutics Switzerland GmbH shall refer to Vaccitech Switzerland GmbH (v) Barinthus Biotherapeutics S.R.L. shall refer to Vaccitech Italia S.R.L. and (vi) Barinthus Biotherapeutics Pty Limited shall refer to Vaccitech Australia Pty Limited, after which the name change described herein shall have taken effect.
Item 2.      Unregistered Sales of Equity Securities and Use of Proceeds.
Set forth below is information regarding shares of equity securities sold, and options granted, by us during the three months ended March 31, 2024 that were not registered under the Securities Act.
Recent Sales of Unregistered Equity Securities
None.
30
Use of Proceeds from Initial Public Offering
On May 4, 2021, we completed our initial public offering, or the IPO, of 6,500,000 ADSs at a price of $17.00 per ADS for an aggregate offering price of approximately $110.5 million. Morgan Stanley & Co., Jefferies LLC, Barclays Capital Inc., William Blair & Company, L.L.C. and H.C. Wainwright & Co., LLC served as the underwriters of the IPO. The offer and sale of all of the ADSs in the offering were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-255158), which became effective on April 29, 2021.
We received aggregate net proceeds from the offering of approximately $102.8 million, after deducting underwriting discounts and commissions, as well as other offering expenses. No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or persons owning ten percent or more of any class of our equity securities or to any other affiliates.
There has been no material change in our planned use of the net proceeds from the IPO as described in the final prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act.
Item 3.      Defaults Upon Senior Securities.
Not Applicable.
Item 4.      Mine Safety Disclosures.
Not Applicable.
Item 5.      Other Information.
Rule 10b5-1 Trading Plans
None of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted, modified, or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the fiscal quarter ended March 31, 2024.
Item 6.      Exhibits.
Exhibit NumberDescription
3.1
31.1*
31.2*
32.1**
101.INS*Inline XBRL Instance Document
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*Cover Page Interactive Data File (formatted in as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
_______________________________________________
*Filed herewith.
31
**This certification will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.
32
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
BARINTHUS BIOTHERAPEUTICS PLC
Date: May 13, 2024
By:/s/ William Enright
William Enright
Chief Executive Officer
(Principal Executive Officer)
Date: May 13, 2024
By:/s/ Gemma Brown
Gemma Brown
Chief Financial Officer
(Principal Financial
and Accounting Officer)
33
 EX-31.1 2 brns-20240331xexx311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, William Enright, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Barinthus Biotherapeutics plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 13, 2024
/s/ William Enright
Name: William Enright
Title: Chief Executive Officer

 EX-31.2 3 brns-20240331xexx312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Gemma Brown, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Barinthus Biotherapeutics plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 13, 2024
/s/ Gemma Brown
Name: Gemma Brown
Title: Chief Financial Officer

 EX-32.1 4 brns-20240331xexx321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Barinthus Biotherapeutics plc (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to the best of his or her knowledge that:
(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
Date: May 13, 2024
/s/ William Enright
Name: William Enright
Title: Chief Executive Officer
Date: May 13, 2024
/s/ Gemma Brown
Name: Gemma Brown
Title: Chief Financial Officer

 EX-101.SCH 5 brns-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Foreign Currency Translation in General and Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Prepaid Expenses and Other Current Assets link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Accrued Expenses and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Grant Income link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Ordinary Shares link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Deferred Shares link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Fair Value link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Grant Income (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Fair Value (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Nature of Business and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Foreign Currency Translation in General and Administrative Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Net Loss Per Share - Computation (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Net Loss Per Share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Grant Income - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Grant Income - Changes in deferred income (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Ordinary Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Deferred Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Fair Value - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Fair Value - Change in Financial Instruments Classified within Level 3 (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Share-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Share-Based Compensation - Weighted-average assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Share-Based Compensation - Share based compensation expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Commitments and Contingencies - Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Commitments and Contingencies - Maturities of minimum lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Commitments and Contingencies - Maturities of minimum lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 brns-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 brns-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 brns-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Change in fair value recognized in net loss/(gain) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Additions to property and equipment Property, Plant and Equipment, Additions Net loss attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Deferred Shares Deferred Shares [Member] Represents information pertaining to deferred shares. Statistical Measurement [Domain] Statistical Measurement [Domain] Research and development Research and Development Expense Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Related Party Transaction [Line Items] Related Party Transaction [Line Items] Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Foreign Currency Translation in General and Administrative Expenses Foreign Currency Disclosure [Text Block] Accounts payable Amounts owed to other party Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Total other income, net Nonoperating Income (Expense) Commitments and contingencies (Note 15) Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Ordinary Shares Equity [Text Block] Proceeds from issue of ordinary shares, net of issuance costs Proceeds from Issuance of Common Stock American Depositary Shares ADR [Member] Geographical [Axis] Geographical [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Current liabilities: Liabilities, Current [Abstract] Percentage of ordinary shares present to exercise preemptive rights Percentage Of Shares Necessary To Exercise Preemptive Rights The minimum percentage of shares required to exercise preemptive rights. Payment of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Net loss per share attributable to ordinary shareholders, diluted (in usd per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Amounts owned from other party Accounts Receivable, after Allowance for Credit Loss, Current Foreign Currency [Abstract] Foreign Currency [Abstract] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Options outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accrued payroll and employee benefits Accrued Employee Benefits, Current Expenses Expenses [Member] Expenses Trading Symbol Trading Symbol Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Weighted average exercise price of options granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted-average grant date fair value of options granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Deferred shares, outstanding (in shares) Deferred Stock, Shares Outstanding Number of shares of deferred stock outstanding. Net loss attributable to Barinthus Biotherapeutics plc shareholders Net Income (Loss) Attributable to Parent Net Income (Loss) Total current liabilities Liabilities, Current Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Beginning balance (in shares) Ending balance (in shares) Shares, Issued LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Entity Ex Transition Period Entity Ex Transition Period Intangible Assets, net Finite-Lived Intangible Assets [Line Items] Ordinary shares, liquidation preference Ordinary Shares, Liquidation Preference The amount of liquidation preference on ordinary shares to be paid after which the deferred shares have the entitlement to receive out of the assets of the Company. Schedule of computation of basic and diluted net loss per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Amounts of related party transactions Related Party Transaction, Amounts of Transaction Executive Category: Executive Category [Axis] Effect of exchange rates on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Other Commitments [Table] Other Commitments [Table] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Name Measure Name Name Forgone Recovery, Individual Name Goodwill Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Enterprise Management Incentive Share Option Scheme Enterprise Management Incentive Share Option Scheme [Member] Information pertaining to the Enterprise Management Incentive Share Option Scheme. Schedule of accrued expenses and other current liabilities Accrued Liabilities And Other Current Liabilities [Table Text Block] Tabular disclosure of the components of accrued liabilities and other current liabilities. Options granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Estimated annual amortization expense for 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Accounts receivable (including related parties) Increase (Decrease) in Accounts Receivable Unrealized foreign exchange (gain)/loss Unrealized Gain (Loss), Foreign Currency Transaction, before Tax Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Operating lease liability - non-current Lease liability, non-current Operating Lease, Liability, Noncurrent Maximum period to exercise preemptive rights Period Of Preemptive Rights To Be Exercised The period allowed to exercise preemptive rights. Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Depreciation expense Depreciation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Income Statement Location [Axis] Income Statement Location [Axis] Deferred shares, authorized (in shares) Deferred Stock, Shares Authorized The maximum number of deferred shares permitted to be issued by an entity's charter and bylaws. Deferred tax liability, net Deferred Tax Liability, Net Amount of classified as non-current liabilities, net value of deferred tax liability. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Schedule of maturities of minimum lease liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Non-cash lease expenses Non-Cash Lease Expenses The amount of non-cash lease expenses. Accrued Expenses and Other Current Liabilities Accrued Liabilities And Other Current Liabilities [Text Block] The entire disclosure of the components of accrued liabilities and other current liabilities. Payables and Accruals [Abstract] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of lease cost Lease, Cost [Table Text Block] Research and development Research and Development Expense [Member] Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Award Type [Axis] Award Type [Axis] Shares issuable for stock options that were excluded from the computation of diluted weighted-average shares outstanding (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Plan Name [Domain] Plan Name [Domain] Document Quarterly Report Document Quarterly Report Non-Cash investing and financing activities Noncash Investing and Financing Items [Abstract] Interest expense Interest Expense Purchases of property and equipment included in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid General and administrative General and Administrative Expense [Member] Trading Arrangement: Trading Arrangement [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Use of Estimates Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Entity File Number Entity File Number Prepayments and accrued income Prepaid Expense, Current Operating lease liability - current Lease liability, current Operating Lease, Liability, Current License revenue License [Member] Deferred shares, nominal value (in gbp per share) Deferred Stock, Par Or Stated Value Per Share Face amount or stated value per share of deferred stock. Contingent Consideration Liability Contingent Consideration Liability [Member] Represents the information pertaining to contingent consideration liability. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Amortization expense for intangible assets Amortization of Intangible Assets Entity Shell Company Entity Shell Company 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Restricted share units, options, share appreciation rights and restricted shares Restricted Share Units Stock Options Share Appreciation Rights And Restricted Shares [Member] Information pertaining to aggregate awards under a specific share-based compensation plan. Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Recently issued accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Counterparty Name [Domain] Counterparty Name [Domain] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash, beginning of the period Cash, cash equivalents and restricted cash, end of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated amortization for amortizable intangible assets Finite-Lived Intangible Assets, Accumulated Amortization 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Fixed lease costs Operating Lease, Cost Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Ordinary shares, issued (in shares) Common Stock, Shares, Issued Schedule of weighted-average assumptions of fair value stock option issued to employees Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Security Exchange Name Security Exchange Name Estimated annual amortization expense for 2024 Finite-Lived Intangible Asset, Expected Amortization, Current Year Finite-Lived Intangible Asset, Expected Amortization, Current Year Additional lease term Lessee Operating Lease, Extended Term Term of lessee's operating lease extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Barinthus Biotherapeutics plc Share Award Plan 2021 Barinthus Biotherapeutics plc Share Award Plan 2021 [Member] Barinthus Biotherapeutics plc Share Award Plan 2021 Stock options Employee Stock Option [Member] Weighted-average period over which unrecognized compensation cost is expected to be recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive loss attributable to Barinthus Biotherapeutics plc shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Short-term lease costs Short-Term Lease, Cost Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Share-Based Compensation Share-Based Payment Arrangement [Text Block] Business Acquisition [Axis] Business Acquisition [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Research and development incentives receivable Increase (Decrease) in Research and Development Incentives Receivable Amount of increase (decrease) in research and development incentives receivable. Income Statement [Abstract] Income Statement [Abstract] Issue of ordinary shares, net of issuance cost (in shares) Stock Issued During Period, Shares, New Issues Leasehold improvement expense Leasehold Improvements, Gross Value Added Tax receivable Value Added Tax Receivable, Current Deferred A shares, £1 nominal value; 63,443 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding: 63,443) Deferred Stock, Value Issued Aggregate par or stated value of issued deferred stock. Title of 12(b) Security Title of 12(b) Security Maximum aggregate nominal amount of shares authorized to be allotted free from pre-emption rights Maximum Aggregate Nominal Amount Of Shares Authorized To Be Allotted Free From Statutory Pre-emption Rights Amount of maximum aggregate nominal amount of shares that the board of directors are authorized to allot free from statutory Pre-emption rights. Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Related Party [Domain] Related Party, Type [Domain] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Other Other Assets, Current Deferred shares [Line items] Class of Stock [Line Items] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Changes to right-of-use asset resulting from lease reassessment event Changes to right-of-use asset resulting from lease reassessment event Amount of changes to right-of-use asset resulting from lease reassessment event. Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Total lease cost Lease, Cost Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Percentage of issued and outstanding ordinary shares available for issuance under the Plan Share-Based Compensation, Percentage Of Shares Available For Issuance As A Percentage Of Issued And Outstanding Shares Total number of shares available for issuance under the Plan as a percentage of the Company's issued and outstanding shares. Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Foreign exchange translation Deferred Income, Foreign Exchange Translation Gain (Loss) Deferred Income, Foreign Exchange Translation Gain (Loss) Total stockholders’ equity attributable to Barinthus Biotherapeutics plc stockholders Parent [Member] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Refundable security deposit Security Deposit Commitment and Contingencies Other Commitments [Line Items] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Counterparty Name [Axis] Counterparty Name [Axis] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] IPO IPO [Member] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Estimated annual amortization expense for 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows from operating leases Operating Lease, Payments Schedule of share based compensation expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Ordinary shares, outstanding (in shares) Common Stock, Shares, Outstanding Cancellation of deferred shares (in shares) Shares Cancelled During Period, Shares, Deferred Shares The number of deferred shares cancelled during the period. Other income/(expense): Other Income and Expenses [Abstract] PEO PEO [Member] Ordinary shares, nominal value (in gbp per share) Common Stock, Par or Stated Value Per Share Sale of Stock [Axis] Sale of Stock [Axis] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Total lease liability Operating Lease, Liability Total liabilities Liabilities Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Schedule of right-of-use assets, lease liabilities and other information Lessee Operating Lease Right of Use asset and Other Information [Table Text Block] Tabular disclosure for Company's right-of-use asset and lease liability and other information. Nature of Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] All Executive Categories All Executive Categories [Member] Deferred Shares Stockholders Equity Deferred Shares Disclosure [Text Block] The entire disclosure for Deferred Shares as disclosed by the entity. Non-Current liabilities: Liabilities, Noncurrent [Abstract] In-License Agreements In-License Agreements [Member] Represents the information pertaining to In-License Agreements. Accrued bonus Accrued Bonuses, Current Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Plan Name [Axis] Plan Name [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Ordinary shares, £0.000025 nominal value; 38,952,956 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding:38,643,540) Common Stock, Value, Issued General and administrative General and Administrative Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Accrued professional fees Accrued Professional Fees, Current Deferred B Shares Deferred B Shares [Member] Represents information pertaining to deferred B shares. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Segment information Segment Reporting, Policy [Policy Text Block] Total current assets Assets, Current Deferred C Shares Deferred C Shares [Member] Represents information pertaining to deferred C shares. All Individuals All Individuals [Member] Supplemental cash flow disclosures: Supplemental Cash Flow Information [Abstract] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Current Fiscal Year End Date Current Fiscal Year End Date PEO Name PEO Name Contingent consideration liability Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Restricted cash Restricted Cash, Current Estimated annual amortization expense for 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Schedule of prepaid expenses and other current assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Class of Stock [Axis] Class of Stock [Axis] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Deferred A shares Deferred A Shares Deferred A Shares. [Member] This member stands for deferred A shares Accrued other Other Accrued Liabilities, Current Depreciation and amortization Depreciation, Depletion and Amortization Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Total stockholders’ equity attributable to Barinthus Biotherapeutics plc shareholders Equity, Attributable to Parent Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Accrued manufacturing and clinical expenses Accrued Manufacturing and Clinical Expenses, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing and clinical expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Goodwill impairment loss Goodwill, Impairment Loss Deferred income Increase (Decrease) in Deferred Revenue Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Deferred shares, issued (in shares) Deferred Stock, Shares Issued Total number of deferred shares of an entity that have been sold or granted to shareholders Oxfordshire Oxfordshire [Member] Oxfordshire Deferred Income [Roll Forward] Deferred Income [Roll Forward] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Other comprehensive (loss)/gain – foreign currency translation adjustments Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Deferred shares [Table] Schedule of Stock by Class [Table] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Loss before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Research and development incentives Research And Development Incentive Income (Expense) Represents the research and development incentives (expenses) for the period. Non cash interest expense Non-Cash Interest Expense On Convertible Loan Notes Amount of non-cash interest expense on convertible loan notes. Entity Emerging Growth Company Entity Emerging Growth Company Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Percentage of future royalties for direct sales of a covered product Percentage of Future Royalties for Direct Sales of Covered Product , License Agreement Percentage of future royalties for direct sales of a covered product under the In-License Agreements. Number of votes per common share (in votes) Common Stock Number of Votes Per Share The number of votes that each common share is entitled. Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Weighted average exercise price of options outstanding (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share based compensation Share-Based Payment Arrangement, Noncash Expense Deferred Income [Table] Deferred Income [Table] Prepaid Expenses and Other Current Assets Prepaid Expense and Other Assets, Current [Text Block] The entire disclosure on prepaid expense and other current assets. Ordinary shares Ordinary Shares Common Stock [Member] Individual: Individual [Axis] Schedule of changes in deferred income Deferred Income [Table Text Block] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Cancellation of deferred shares Shares Cancelled During Period, Value, Deferred Shares The value of deferred shares cancelled during the period. Net Loss Per Share Earnings Per Share [Text Block] Product and Service [Axis] Product and Service [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Schedule of financial instruments carried at fair value and classified within Level 3 Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total stockholders’ equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Property and equipment, net Property, Plant and Equipment, Net Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Four Amount of lessee's undiscounted obligation for lease payment for operating lease due in year four and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Net foreign exchange gain (loss) Gain (Loss), Foreign Currency Transaction, before Tax Operating lease liabilities Increase (Decrease) in Operating Lease Liability Other operating income Other Operating Income Net loss Net loss Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Cash paid for income taxes Income Taxes Paid, Net Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Developed technology Developed Technology Rights [Member] Accumulated Deficit Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Net loss per share attributable to ordinary shareholders, basic (in usd per share) Earnings Per Share, Basic Right of use assets, net Right-of-use asset Operating Lease, Right-of-Use Asset Unrecognized compensation cost related to options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sale of Stock [Domain] Sale of Stock [Domain] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Remainder of 2024 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Related Parties Related Party [Member] Issue of ordinary shares Stock Issued Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Foreign exchange translation recognized in other comprehensive loss Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Foreign Exchange Translation Amount of foreign exchange translation of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Avidea Avidea [Member] This member stands for Avidea. Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Asset retirement obligation Asset Retirement Obligations Amount of asset retirement obligations. Research and development incentives receivable Research and development incentives receivable Amount of research and development incentives receivable. Termination Date Trading Arrangement Termination Date Accumulated other comprehensive loss – foreign currency translation adjustments Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Estimated annual amortization expense for 2031 Finite-Lived Intangible Asset, Expected Amortization, Year Seven Finite-Lived Intangible Asset, Expected Amortization, Year Seven Accounts payable Increase (Decrease) in Accounts Payable Ordinary shares, authorized (in shares) Common Stock, Shares Authorized Document Information [Table] Document Information [Table] Grant Income Other Operating Income and Expense [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Address, Country Entity Address, Country Adjustments to reconcile net (loss)/income to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Net payments received for allowable sublicenses of technology developed Percentage Of Net Payments Received For Allowable Sublicenses Of Technology Developed License Agreement Percentage of net payments received for allowable sublicenses of technology developed under the In-License Agreements. Liability Class [Axis] Liability Class [Axis] Related Party Transactions [Abstract] Related Party Transactions [Abstract] All Trading Arrangements All Trading Arrangements [Member] All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Oxford University Innovation Limited Oxford University Innovation Limited Represents the information pertaining to Oxford University Innovation Limited. Compensation Amount Outstanding Recovery Compensation Amount Comprehensive loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Deferred tax benefit Deferred Income Tax Expense (Benefit) Document Information Document Information [Line Items] Deferred Income [Line Items] Deferred Income [Line Items] Prepaid expenses and other current assets Total Prepaid Expense and Other Assets, Current Estimated annual amortization expense for 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Deferred income Deferred Income, Current Insider Trading Arrangements [Line Items] Related Party [Axis] Related Party, Type [Axis] Other assets Other Assets Maximum royalty payment period Royalty Payment, Term, Maximum Royalty Payment, Term, Maximum Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Other assets Increase (Decrease) in Other Operating Assets Estimated annual amortization expense for 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Maryland MARYLAND Adjustment to Compensation, Amount Adjustment to Compensation Amount Change in contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Noncontrolling interest Equity, Attributable to Noncontrolling Interest Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Maximum funding amount Funding Amount, Maximum Funding Amount, Maximum Entity Central Index Key Entity Central Index Key Coalition for Epidemic Preparedness Innovations Coalition For Epidemic Preparedness Innovations [Member] Coalition For Epidemic Preparedness Innovations Share based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Gross amount of amortizable intangible assets Finite-Lived Intangible Assets, Gross Tax benefit Income Tax Expense (Benefit) Fair Value Fair Value Disclosures [Text Block] Number of operating segments Number of Operating Segments Other income recognized related to the Funding Agreement Other income recognized related to the Funding Agreement Deferred Income, Revenue Recognized Name Trading Arrangement, Individual Name Issue of ordinary shares, net of issuance costs Stock Issued During Period, Value, New Issues Equity [Abstract] Equity [Abstract] Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Total revenue Revenue recognized Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Intangible Assets, Net Intangible Assets Disclosure [Text Block] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Estimated annual amortization expense for 2030 Finite-Lived Intangible Asset, Expected Amortization, Year Six Finite-Lived Intangible Asset, Expected Amortization, Year Six Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Other information Other Information, Lessee [Abstract] Other Information, Lessee Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Goodwill Goodwill Disclosure [Text Block] Weighted-average ordinary shares outstanding, diluted (in shares) Weighted-average ordinary shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Operating expenses Operating Expenses [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional Paid-in-Capital Additional Paid-in Capital [Member] Size of space under lease agreement (in square feet) Number Of Square Feet Under Lease Agreement Represents the information pertaining to number of Square Feet Under Lease Agreement. Cash payments received Deferred Income, Addition Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Cover [Abstract] Share based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Other non-current liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Total minimum lease payments Lessee, Operating Lease, Liability, to be Paid Options forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Total operating expenses Operating Expenses Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Beginning balance Ending balance Deferred Income Adjustment to Compensation: Adjustment to Compensation [Axis] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-average ordinary shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) Accrued expenses and other current liabilities Total Accrued Liabilities and Other Liabilities, Current Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Issue of shares from the exercise of stock options Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Related Party Transaction [Axis] Related Party Transaction [Axis] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Stockholders’ equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Non-Controlling Interest Noncontrolling Interest [Member] EX-101.PRE 9 brns-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 10 brns-20240331_g1.jpg begin 644 brns-20240331_g1.jpg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
M>2_LF_%+P_\ M+O\ @HS\2&\17<6G6FN:GK6D0WEPX2**=[\2)N8\ -Y14'U85]M_MB?L2Z1^ MUQ'H%U)XEN/"^LZ.LD4-W':BZBDAW*VDL/VF1E8H2\Q\V0@ \OTSQWK\Q/^"F4BR?ME>-=ISMAL%/U^QPU^ MHO[+/P?^&W[,]OJ/PQ\*^(%UCQ7L75]8%Q*K7; X17=%XC3H%7K@YYR2?S'_ M ."H7AVZT/\ :]\17<\96#5K*RO;=C_$@@6(G_ON)Q^%9824'F/-!MQ:=F]W MM?\ )F_O1P=2,TD^J73WDU\[6_,_4OXL?\F:>*O^Q&N/_2$U^67_ 2_M[>X M_;"\,M.J,\5E?20[NS_9W&1[X+?K7ZN> Y-$_:"_93GVK7!5(PQ%?#3=I3O%>MI?D(_ VLG0]9DMGLWN1;:]/F)F5F7;*C+U13G&>*][^)GP\^&?_!0# MX&V26>N_:]+DE6]T_5M-93/8W 4@JZ-T.&*O&P!Y[$ CSOX _P#!-_X8? /2 M]=U#QM/IOQ$GGB^>\\0:9#%9V4*Y8LD;M($;^](7Z 8V\Y\VC*E1I3A7G*,E MT6E_P^^YWU>:JX2I)27=]-?Z^9\;?\%-/V@_AK^T%KO@&_\ A]KPUY].MKR" M_D^PW%L8PS1-$/WT:;NDG3./;-?$]>Y_MDZ_\+=:^--_#\(]"M-(\+6,8MFN M;)I/*OYPQ+S(K,0J3BI2E6;DT MWIMMH@HHHKT#D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZPM_^47] MS_V4\?\ IO6OD^OK"W_Y1?W/_93Q_P"F]:Y,1]C_ !(VI?:]&?)]%%%=9B%% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]8?L?_ /)O M/[47_8KVW_HR6OD^OK#]C_\ Y-Y_:B_[%>V_]&2UQXO^%\U^:-J/Q_?^1\GT M445V&(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %?6'[,?\ R9G^U5_UZZ#_ .E4]?)]?6'[,?\ R9G^ MU5_UZZ#_ .E4]?\ 8B:M M_P"TJ^5*PH_QZG_;OZF[_AQ^85^Y/_!-K_DS+P!];_\ ]+KBOPVK]R/^";?_ M "9CX ^M_P#^EUQ7+G7^X/\ Q1_*1MA/XZ^9Y9_P37^(S:EX\^/7A"X90\/B M>?6H$!Z^;-)'+@>@,47_ 'U7T5\"?@A8? F]^*&I(42'Q'XCN-<#\?NX&C1@ MA] KF;'L:_-7]A/XC_\ "*_M\:A%*WE6_B:[U/3)!N^4,TC31_7YXE4?[U?I M)^V=X]_X5O\ LO?$364E,-PVEO8V[J<$2W!$"$>X,F?PKYC'0J4_9\F]2G%? M/1??>*^\]7#J,ZLZ4]HS;^^_^[ MX_](37YQ?\$C?^3G-6_P"Q:NO_ $?;5^COQ8_Y M,U\5?]B/B?\%D0&\7?"L'I]DOL_]_(*_0GXH#P;9_!G7T\;#;X%72FCU01B8@6FS#@> M1^\QM_NG_!9;_D:/A=_UYW__ *'!7TS^QO\ M#^$OVJO@-;^$->N;:Y\ M36^E'2M=T6Y<"2ZA">49U'!9'7!)7[K,0>Q/#*G.IE-*4%\,IW^\M9DG@F7_A(\I(K!E89]" :W_VU?VU MO@;\8OV:?&'A3PUXR&KZ_>+;-96ATJ]AWNES$Y^>2!5&%5CR1TK;\!?\$E? MGA#XJ6_B/4/$UYXD\,VDXN+?PW?V,>'8'*K/-N(E3/5?+7=T.1D'P[_@IA#\ M!O MO9^$? WA#0;7X@F=9;ZZT1/(338!SY;I$PC,KG'RLI*KD\94GI3PV(K4 MHQG.;O??;5=UY:V%#VM'FJ&9/'5K:?9]:LM2 MA%S=LX&TW,1F+,%?ALIPA;'&!67=?\$;_#;^*_M5K\2M4M_#WFAO[/;3(WN@ MF>5%SY@7/H?*_ U>,^JRQ4_:.5.7?=/STUUW\SGPSJJ@O9VDNW;R^7_#:'+? MMC_\$R?#O@?P#K?CSX87=Y:1Z1"][>^'[Z7SXS;J 7:"0_."JAF*N7W:_X(Y_\E=\>?]@./_TH2OK[]N3X\>%_@'^SOK?AF74ENO$FM:0^C:9ILD_F MW3K)&8FGDS\VU5W$NWWF &8X7 MS98Y4EK..K7K)_HK_P#!.G&/EQ<*[^'17]()/\3Y<_:M MOM1U']I;XGS:HTCWG_"17L9\PDD(DS+&.>P15 ]@*^SO^"--Y??VY\4+4,YT MW[-82LN3M67=, <>I7=^0KWS]I[_ ()Q^$/VE/&!\:Z3XEF\(ZY?+&;R>WM5 MO+6\"KA9-F]"'*A1N#X(4?+G)/;?#SP%\*O^">GP5O7O=;%I:/(;B^U74&7[ M5J5P%.U(XQU( (6-=3%>TCLW M>_X_\!]+'QA_P42M[2']O/X;O!M%Q+;:0UQM'\0OI I/OM _ "OMC_@H%?SZ M;^Q[\29;=S&[6<,)(_N/OU?_P""B'_)F_Q'_P"N%K_Z605ABJ,J-#"4 MZBUN[_-QT_$Z,'.-3,)N.WN+[KH_'7]F%VC_ &D/A858J?\ A*-,&0<=;J,& MOUI_X*??\F>>*/\ K\L/_2F.OR5_9D_Y./\ A9_V-.F?^E4=?K5_P4^_Y,\\ M4?\ 7Y8?^E,=>GG'\3"_X_\ VZ!PX+:K_A_21>_X)IPPQ?L:^!FB50TDE^TF MWNWVV<<^^ *\(\<2?\$_I?&FOOXCS_PD+:A<-J6X>(0?M1D;SZD"1S&3'F6P8\!MXW*"?F+L!R M#ZQ\*[[PK%JER;O5--ALDN$FD8@NT+EE\HLBV]4:4)>TPW+!)R3V?S_ !_X)T?@_P#; MH_95^'_@FP\):!XW-EH%A;FUMK1M*U6;RX^?EWR0,Q')ZDU\"?L._MDV?[*_ MC;Q!:ZM87&I^"===3.+( SVSQEO+E16(##:Q#*2#C!!^7!^S?VP/AW^S5^SK M\#7MM3\!>';CQ$;'['HEE%&(=0O)E3:LTLD121E4X9Y&//3)9@#\T?\ !->3 MX%>)-4U+PK\2_#.AW?B^XN!)I%_K@,D-U&5 -N$0,XKHPD:$J M5>K&,I)[WM[VO3S6[_S)KN4(TZ=G\8?V9OVH[>TC MO=5\%^*;EB8K>S\10117BD]1''YN? ?VCP M/KNQGM_)N'N;&5R<@21R%F4'H#&R@9SM;&*S?CC_ ,$G_!OQ,\:7&O\ A+Q, MWP_ANB>FWTF.XLT(4#]RBR1>4#C)'S#).,=*]W\"^'O!'["G[/,6GZSXIF M;0='$L[WVJ2*)+B9R7,<,8[DYVQKD_4DD^.ZE*C34\+5DI?R_P!:/[G<[5&I M*?+4BI+N?A)XH\-W_@[Q+JN@ZK#]GU/2[N6RNHLYV2QN4<9[\@\UF5U7Q6\< M-\3/B9XK\6M!]E.MZI]\,^(-5\.WCKL>XTF]EM9&7T+1L"170Z]\?OB?XHTV;3]:^(_BW M5["9=LMK?ZY=3Q.#V96D((^HK@Z*B4(R=Y*XU)QV85/8WUSI=Y!>6=Q+:7=N MZRPW$#E)(W!R&5AR"#R"*@HJR3N]<^/7Q-\3:/-I.L?$7Q9JVES+LEL;[7+J M:!U]&1I"I'L153P?\9/'_P /=-DT[PKXX\2>&=/DE,[VNCZO<6D32$ %RD;@ M%B%49QG 'I7'T5')!)I+.OB-:6]KXL\:>(?$]M;N988=9U6>[2)R,%E61V M ..,BN3HHY(::;;!S/77I&-H3>:1>26LQC)!* M;XV!VD@9&<<"KGC3XH>,_B1]D_X2WQ;KOBC[)N^S_P!M:E->>3NQNV>8S;<[ M5SCK@>E2VN87$D4T+E'1@N0:UHFKW^CZS S-%J.GW+P7$98$,5D0A@2"0<'D$UF44*_&OB+Q/9P2>=%;ZSJL]W'&^"-ZK(Y ;!(R.<$U MR:.T;JZ,5=3D,IP0?6DHHC%1^%6!MRW/0+K]H7XJ7VEOIMS\2_&%QISIY36< MNO730E,8VE#)C&.V*I^$_C9\1/ 6D_V7X9\>^)_#NF>8TOV+2=8N+6'>V-S; M(W R<#)QVKBZ*GV<-59:AS/378L:CJ-WK&H75_?W4U[?74K3W%U<2&26:1B6 M9W8G+,2223R2:[72?V@/BAH&DPZ7I?Q(\7:;ID*"**RM-=NHH40# 5460*!C ML!7!453C%KE:T"[O?J=#X9^(WBSP5K=SK/A[Q/K.@ZO=*R3ZAIFH2VUQ*K,& M97D1@S L 2">2 :/&7Q&\6?$:ZM[GQ9XGUGQ/#PIXQ\0>&(9VWRQZ/JD]HLC8QEA M&XR<=S6?XL\<>(_'FH+?^)M?U3Q%?*NQ;G5KV2ZE"YS@-(Q./:L6BCEC?FMJ M%VE;H;OA+QYXF\ WLEYX8\1:MX/M/ M%AXG\<^)?$=B&#BUU;5[BZBW#H=LCD9KCJ*'&,G=K4%)K9A1115""BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH *^L+?_E%_<_\ 93Q_Z;UKY/KZ MPM_^47]S_P!E/'_IO6N3$?8_Q(VI?:]&?)]%%%=9B%%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 5]8?L?\ _)O/[47_ &*]M_Z,EKY/ MKZP_8_\ ^3>?VHO^Q7MO_1DM<>+_ (7S7YHVH_']_P"1\GT445V&(4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %?6'[,?_)F?[57_7KH/_I5/7R?7UA^S'_R9G^U5_UZZ#_Z53UR8K^& MO6/_ *4C:C\7R?Y,^3Z***ZS$**** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZP^ /\ R8;^TY_U MW\/_ /I:*^3Z^L/@#_R8;^TY_P!=_#__ *6BN3%? O\ %'_TI&U'XGZ/\F?) M]%%%=9B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110!]8?"O_ )1T_&W_ +&32?\ T9%7R?7UA\*_ M^4=/QM_[&32?_1D5?)]YBS;8T<*,L M23@(-4TK7(=:LM2O+/6(9_M,>H6\[I<)+G/F M+(#N#9YW YS73>*?C?\ $;QSH[Z3XD\?^*/$&ER,KO8ZIK-SAQQ7%44G"+M=;#YG=N^YU'@SXJ>-?AS'=1^$_%^O>%TNBK7"Z+J<]H)BN=I M<1LN[&3C/3)K,\3>*];\:ZS-J_B'6-0U[5I@HEO]3NGN9Y JA5#2.2QP ,G M@ "LJBGRQYN:VH)M*RV._N_V@_BEJ&C2Z1=?$KQ?TN/BCXTGM77:T$GB"[9"OH5,F,5YV26)).2:2 MBE&$8_"K#0W=G<2VEW"XDBG@(KS;CTQYE>;442C&7Q*XDW'5%K4]4O=:U">^U&[GO[V=M\M MS=2-))(QZEF8DD^YJ&WN);.XBG@E>&>)@\]1T5:TT0/7<] M U#]H;XJ:MILFGWWQ+\87EA(AC>UN->NGB92,%2ADP1CMBO/Z**B,(Q^%6&Y M-[L[+PK\:/B#X$TX:?X:\=^)O#UADM]ETK5[BUBR>IVQN!FL;Q5XU\0^.M06 M_P#$FO:GXAOE78+K5;R2YE"]<;G8G'M6-11R1YN:VH-U.596'(((!!%=KXB^/7Q-\7Z-ZM9&CEAD4AE='4@JP(!!!R"*Z[Q1\72/$?Q \4Z_I4K*TECJ MFM7-S Y4Y4E'NHHD47T[332'&,L[$DG [FJ-%%-))60-MZL[[1?V@?BCX;T^&PTCXD^+M M+L85"16MEKMU#$BCH%59 /I7.>*_'/B3QY?)>^)O$&J>(KQ%V+<:M>R74BK MZ!I&) K$HJ>2-^:VH^9VM?0****LD**** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K[H_X(__ M /)R'BC_ +%.X_\ 2RSKX7K[H_X(_P#_ "&[Z;4]5O)KZZD75KA \TKEW(4/@ LQX' K#^U:'MO:6=K6_'U-/J=3D MY=-S\,Z*_;G_ (=??L^?]"OJ'_@XNO\ XNC_ (=??L^?]"OJ'_@XNO\ XNM_ M[8P_9_Z/Q&HK]N M?^'7W[/G_0KZA_X.+K_XNC_AU]^SY_T*^H?^#BZ_^+H_MC#]G]R_S#ZC5[H_ M$:BOVY_X=??L^?\ 0KZA_P"#BZ_^+H_X=??L^?\ 0KZA_P"#BZ_^+H_MC#]G M]R_S#ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_ (NC_AU]^SY_T*^H?^#BZ_\ MBZ/[8P_9_Z/Q&HK]N?\ AU]^SY_T*^H?^#BZ_P#BZ/\ AU]^SY_T M*^H?^#BZ_P#BZ/[8P_9_Z/Q&HK]N?^'7W[/G_ $*^H?\ M@XNO_BZ/^'7W[/G_ $*^H?\ @XNO_BZ/[8P_9_Z/Q&HK]N?^'7W[ M/G_0KZA_X.+K_P"+H_X=??L^?]"OJ'_@XNO_ (NC^V,/V?W+_,/J-7NC\1J* M_;G_ (=??L^?]"OJ'_@XNO\ XNC_ (=??L^?]"OJ'_@XNO\ XNC^V,/V?W+_ M ##ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_BZ/^'7W[/G_0KZA_X.+K_XNC^V M,/V?W+_,/J-7NC\1J*_;G_AU]^SY_P!"OJ'_ (.+K_XNC_AU]^SY_P!"OJ'_ M (.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU]^SY_T*^H?^#BZ_\ BZ/^'7W[ M/G_0KZA_X.+K_P"+H_MC#]G]R_S#ZC5[H_$:BOVY_P"'7W[/G_0KZA_X.+K_ M .+H_P"'7W[/G_0KZA_X.+K_ .+H_MC#]G]R_P P^HU>Z/Q&HK]N?^'7W[/G M_0KZA_X.+K_XNC_AU]^SY_T*^H?^#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X M=??L^?\ 0KZA_P"#BZ_^+H_X=??L^?\ 0KZA_P"#BZ_^+H_MC#]G]R_S#ZC5 M[H_$:BOVY_X=??L^?]"OJ'_@XNO_ (NC_AU]^SY_T*^H?^#BZ_\ BZ/[8P_9 M_Z/Q&HK]N?\ AU]^SY_T*^H?^#BZ_P#BZ/\ AU]^SY_T*^H?^#BZ M_P#BZ/[8P_9_Z/Q&HK]N?^'7W[/G_ $*^H?\ @XNO_BZ/ M^'7W[/G_ $*^H?\ @XNO_BZ/[8P_9_Z/Q&KZPM_^47]S_P!E/'_I MO6OT)_X=??L^?]"OJ'_@XNO_ (NNR7]AKX1+\)&^&HT*[_X1)M6_MLVO]HS[ M_M7E"+?YF[=C:,;>&?%V@:)H5W;Z9XJM%L=5C?49Y#+$I) 5F;*G+ M'D8K"OFM"I#E2>Z_!I]S2G@ZD97=C\%**_;G_AU]^SY_T*^H?^#BZ_\ BZ/^ M'7W[/G_0KZA_X.+K_P"+K?\ MC#]G]R_S,_J-7NC\1J*_;G_ (=??L^?]"OJ M'_@XNO\ XNC_ (=??L^?]"OJ'_@XNO\ XNC^V,/V?W+_ ##ZC5[H_$:BOVY_ MX=??L^?]"OJ'_@XNO_BZ/^'7W[/G_0KZA_X.+K_XNC^V,/V?W+_,/J-7NC\1 MJ*_;G_AU]^SY_P!"OJ'_ (.+K_XNC_AU]^SY_P!"OJ'_ (.+K_XNC^V,/V?W M+_,/J-7NC\1J*_;G_AU]^SY_T*^H?^#BZ_\ BZ/^'7W[/G_0KZA_X.+K_P"+ MH_MC#]G]R_S#ZC5[H_$:BOVY_P"'7W[/G_0KZA_X.+K_ .+H_P"'7W[/G_0K MZA_X.+K_ .+H_MC#]G]R_P P^HU>Z/Q&HK]N?^'7W[/G_0KZA_X.+K_XNC_A MU]^SY_T*^H?^#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?\ 0KZA_P"# MBZ_^+H_X=??L^?\ 0KZA_P"#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^ M?]"OJ'_@XNO_ (NC_AU]^SY_T*^H?^#BZ_\ BZ/[8P_9_Z/Q&HK] MN?\ AU]^SY_T*^H?^#BZ_P#BZ/\ AU]^SY_T*^H?^#BZ_P#BZ/[8P_9_Z/Q&HK]N?^'7W[/G_ $*^H?\ @XNO_BZ/^'7W[/G_ $*^H?\ M@XNO_BZ/[8P_9_Z/Q&HK]N?^'7W[/G_0KZA_X.+K_P"+H_X=??L^ M?]"OJ'_@XNO_ (NC^V,/V?W+_,/J-7NC\1J*_;G_ (=??L^?]"OJ'_@XNO\ MXNC_ (=??L^?]"OJ'_@XNO\ XNC^V,/V?W+_ ##ZC5[H_$:BOVY_X=??L^?] M"OJ'_@XNO_BZ/^'7W[/G_0KZA_X.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU M]^SY_P!"OJ'_ (.+K_XNC_AU]^SY_P!"OJ'_ (.+K_XNC^V,/V?W+_,/J-7N MC\1J*_;G_AU]^SY_T*^H?^#BZ_\ BZ/^'7W[/G_0KZA_X.+K_P"+H_MC#]G] MR_S#ZC5[H_$:BOVY_P"'7W[/G_0KZA_X.+K_ .+H_P"'7W[/G_0KZA_X.+K_ M .+H_MC#]G]R_P P^HU>Z/Q&HK]N?^'7W[/G_0KZA_X.+K_XNC_AU]^SY_T* M^H?^#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?\ 0KZA_P"#BZ_^+H_X M=??L^?\ 0KZA_P"#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?]"OJ'_@ MXNO_ (NC_AU]^SY_T*^H?^#BZ_\ BZ/[8P_9_Z/Q&HK]N?\ AU]^ MSY_T*^H?^#BZ_P#BZ/\ AU]^SY_T*^H?^#BZ_P#BZ/[8P_9_Z/Q&HK]N?^'7W[/G_ $*^H?\ @XNO_BZ/^'7W[/G_ $*^H?\ @XNO_BZ/ M[8P_9_Z/Q&HK]N?^'7W[/G_0KZA_X.+K_P"+H_X=??L^?]"OJ'_@ MXNO_ (NC^V,/V?W+_,/J-7NC\1J*_;G_ (=??L^?]"OJ'_@XNO\ XNC_ (=? M?L^?]"OJ'_@XNO\ XNC^V,/V?W+_ ##ZC5[H_$:OK#]F/_DS/]JK_KUT'_TJ MGK]"?^'7W[/G_0KZA_X.+K_XNNR\)_L-?"+P3X%\8>$-)T*[@T+Q8ELFK0/J M,[M*('9XMK%LI@NWW2,UA6S6A4ARI/=/[FGW-*>#J1=W;K^1^"E%?MS_ ,.O MOV?/^A7U#_P<77_Q='_#K[]GS_H5]0_\'%U_\76_]L8?L_N7^9G]1J]T?B-1 M7[<_\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ <77_Q=']L8?L_N7^8? M4:O='XC45^W/_#K[]GS_ *%?4/\ P<77_P 71_PZ^_9\_P"A7U#_ ,'%U_\ M%T?VQA^S^Y?YA]1J]T?B-17[<_\ #K[]GS_H5]0_\'%U_P#%T?\ #K[]GS_H M5]0_\'%U_P#%T?VQA^S^Y?YA]1J]T?B-17[<_P##K[]GS_H5]0_\'%U_\71_ MPZ^_9\_Z%?4/_!Q=?_%T?VQA^S^Y?YA]1J]T?B-17[<_\.OOV?/^A7U#_P ' M%U_\71_PZ^_9\_Z%?4/_ <77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_ M *%?4/\ P<77_P 71_PZ^_9\_P"A7U#_ ,'%U_\ %T?VQA^S^Y?YA]1J]T?B M-17[<_\ #K[]GS_H5]0_\'%U_P#%T?\ #K[]GS_H5]0_\'%U_P#%T?VQA^S^ MY?YA]1J]T?B-17[<_P##K[]GS_H5]0_\'%U_\71_PZ^_9\_Z%?4/_!Q=?_%T M?VQA^S^Y?YA]1J]T?B-17[<_\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ M <77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_ *%?4/\ P<77_P 71_PZ M^_9\_P"A7U#_ ,'%U_\ %T?VQA^S^Y?YA]1J]T?B-17[<_\ #K[]GS_H5]0_ M\'%U_P#%T?\ #K[]GS_H5]0_\'%U_P#%T?VQA^S^Y?YA]1J]T?B-17[<_P## MK[]GS_H5]0_\'%U_\71_PZ^_9\_Z%?4/_!Q=?_%T?VQA^S^Y?YA]1J]T?B-1 M7[<_\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ <77_Q=']L8?L_N7^8? M4:O='XC45^W/_#K[]GS_ *%?4/\ P<77_P 71_PZ^_9\_P"A7U#_ ,'%U_\ M%T?VQA^S^Y?YA]1J]T?B-17[<_\ #K[]GS_H5]0_\'%U_P#%T?\ #K[]GS_H M5]0_\'%U_P#%T?VQA^S^Y?YA]1J]T?B-17[<_P##K[]GS_H5]0_\'%U_\71_ MPZ^_9\_Z%?4/_!Q=?_%T?VQA^S^Y?YA]1J]T?B-17[<_\.OOV?/^A7U#_P ' M%U_\71_PZ^_9\_Z%?4/_ <77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_ M *%?4/\ P<77_P 71_PZ^_9\_P"A7U#_ ,'%U_\ %T?VQA^S^Y?YA]1J]T?B M-17[<_\ #K[]GS_H5]0_\'%U_P#%T?\ #K[]GS_H5]0_\'%U_P#%T?VQA^S^ MY?YA]1J]T?B-17[<_P##K[]GS_H5]0_\'%U_\71_PZ^_9\_Z%?4/_!Q=?_%T M?VQA^S^Y?YA]1J]T?B-17[<_\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ M <77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_ *%?4/\ P<77_P 71_PZ M^_9\_P"A7U#_ ,'%U_\ %T?VQA^S^Y?YA]1J]T?B-17[<_\ #K[]GS_H5]0_ M\'%U_P#%T?\ #K[]GS_H5]0_\'%U_P#%T?VQA^S^Y?YA]1J]T?B-17[<_P## MK[]GS_H5]0_\'%U_\71_PZ^_9\_Z%?4/_!Q=?_%T?VQA^S^Y?YA]1J]T?B-1 M7[<_\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ <77_Q=']L8?L_N7^8? M4:O='XC45^W/_#K[]GS_ *%?4/\ P<77_P 71_PZ^_9\_P"A7U#_ ,'%U_\ M%T?VQA^S^Y?YA]1J]T?B-7UA\ ?^3#?VG/\ KOX?_P#2T5^A/_#K[]GS_H5] M0_\ !Q=?_%UV7AO]AKX1>$_AWXL\#Z;H5W%X=\4-;-JENVHSLTI@D\R+#EMR MX;T(SWK"MFM"I%))[I_Z/Q&HK]N?^'7W[/G_0KZA_X.+K_XNC_AU]^SY_T*^H?^#BZ_ M^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?\ 0KZA_P"#BZ_^+H_X=??L^?\ M0KZA_P"#BZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_ (NC M_AU]^SY_T*^H?^#BZ_\ BZ/[8P_9_Z/Q&HK]N?\ AU]^SY_T*^H? M^#BZ_P#BZ/\ AU]^SY_T*^H?^#BZ_P#BZ/[8P_9_Z/Q&H MK]N?^'7W[/G_ $*^H?\ @XNO_BZ/^'7W[/G_ $*^H?\ @XNO_BZ/[8P_9_Z/Q&HK]N?^'7W[/G_0KZA_X.+K_P"+H_X=??L^?]"OJ'_@XNO_ (NC M^V,/V?W+_,/J-7NC\1J*_;G_ (=??L^?]"OJ'_@XNO\ XNC_ (=??L^?]"OJ M'_@XNO\ XNC^V,/V?W+_ ##ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_BZ/^'7 MW[/G_0KZA_X.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU]^SY_P!"OJ'_ (.+ MK_XNC_AU]^SY_P!"OJ'_ (.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU]^SY_ MT*^H?^#BZ_\ BZ/^'7W[/G_0KZA_X.+K_P"+H_MC#]G]R_S#ZC5[H_$:BOVY M_P"'7W[/G_0KZA_X.+K_ .+H_P"'7W[/G_0KZA_X.+K_ .+H_MC#]G]R_P P M^HU>Z/Q&HK]N?^'7W[/G_0KZA_X.+K_XNC_AU]^SY_T*^H?^#BZ_^+H_MC#] MG]R_S#ZC5[H_$:BOVY_X=??L^?\ 0KZA_P"#BZ_^+H_X=??L^?\ 0KZA_P"# MBZ_^+H_MC#]G]R_S#ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_ (NC_AU]^SY_ MT*^H?^#BZ_\ BZ/[8P_9_Z/Q&HK]N?\ AU]^SY_T*^H?^#BZ_P#B MZ/\ AU]^SY_T*^H?^#BZ_P#BZ/[8P_9_Z/Q&HK]N?^'7W M[/G_ $*^H?\ @XNO_BZ/^'7W[/G_ $*^H?\ @XNO_BZ/[8P_9_Z/ MQ&HK]N?^'7W[/G_0KZA_X.+K_P"+H_X=??L^?]"OJ'_@XNO_ (NC^V,/V?W+ M_,/J-7NC\1J*_;G_ (=??L^?]"OJ'_@XNO\ XNC_ (=??L^?]"OJ'_@XNO\ MXNC^V,/V?W+_ ##ZC5[H_$:BOVY_X=??L^?]"OJ'_@XNO_BZ/^'7W[/G_0KZ MA_X.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU]^SY_P!"OJ'_ (.+K_XNC_AU M]^SY_P!"OJ'_ (.+K_XNC^V,/V?W+_,/J-7NC\1J*_;G_AU]^SY_T*^H?^#B MZ_\ BZ/^'7W[/G_0KZA_X.+K_P"+H_MC#]G]R_S#ZC5[H_/;X5_\HZ?C;_V, MFD_^C(J^3Z_>O1_V&OA#H7PPU_X?V>A7:XW_AU]^SY_T*^H?^#BZ_^+K"EFM"#FVGJ[_@O,TG@ZDE&UM$?B-17[<_ M\.OOV?/^A7U#_P '%U_\71_PZ^_9\_Z%?4/_ <77_Q=;_VQA^S^Y?YF?U&K MW1^(U%?MS_PZ^_9\_P"A7U#_ ,'%U_\ %T?\.OOV?/\ H5]0_P#!Q=?_ !=' M]L8?L_N7^8?4:O='XC45^W/_ Z^_9\_Z%?4/_!Q=?\ Q='_ Z^_9\_Z%?4 M/_!Q=?\ Q=']L8?L_N7^8?4:O='XC45^W/\ PZ^_9\_Z%?4/_!Q=?_%T?\.O MOV?/^A7U#_P<77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_H5]0_\ !Q=? M_%T?\.OOV?/^A7U#_P '%U_\71_;&'[/[E_F'U&KW1^(U%?MS_PZ^_9\_P"A M7U#_ ,'%U_\ %T?\.OOV?/\ H5]0_P#!Q=?_ !=']L8?L_N7^8?4:O='XC45 M^W/_ Z^_9\_Z%?4/_!Q=?\ Q='_ Z^_9\_Z%?4/_!Q=?\ Q=']L8?L_N7^ M8?4:O='XC45^W/\ PZ^_9\_Z%?4/_!Q=?_%T?\.OOV?/^A7U#_P<77_Q=']L M8?L_N7^8?4:O='XC45^W/_#K[]GS_H5]0_\ !Q=?_%T?\.OOV?/^A7U#_P ' M%U_\71_;&'[/[E_F'U&KW1^(U%?MS_PZ^_9\_P"A7U#_ ,'%U_\ %T?\.OOV M?/\ H5]0_P#!Q=?_ !=']L8?L_N7^8?4:O='XC45^W/_ Z^_9\_Z%?4/_!Q M=?\ Q='_ Z^_9\_Z%?4/_!Q=?\ Q=']L8?L_N7^8?4:O='XC45^W/\ PZ^_ M9\_Z%?4/_!Q=?_%T?\.OOV?/^A7U#_P<77_Q=']L8?L_N7^8?4:O='XC45^W M/_#K[]GS_H5]0_\ !Q=?_%T?\.OOV?/^A7U#_P '%U_\71_;&'[/[E_F'U&K MW1^(U%?MS_PZ^_9\_P"A7U#_ ,'%U_\ %T?\.OOV?/\ H5]0_P#!Q=?_ !=' M]L8?L_N7^8?4:O='XC45^W/_ Z^_9\_Z%?4/_!Q=?\ Q='_ Z^_9\_Z%?4 M/_!Q=?\ Q=']L8?L_N7^8?4:O='XC45^W/\ PZ^_9\_Z%?4/_!Q=?_%T?\.O MOV?/^A7U#_P<77_Q=']L8?L_N7^8?4:O='XC45^W/_#K[]GS_H5]0_\ !Q=? M_%T?\.OOV?/^A7U#_P '%U_\71_;&'[/[E_F'U&KW1^(U%?MS_PZ^_9\_P"A M7U#_ ,'%U_\ %T?\.OOV?/\ H5]0_P#!Q=?_ !=']L8?L_N7^8?4:O='XC45 M^W/_ Z^_9\_Z%?4/_!Q=?\ Q='_ Z^_9\_Z%?4/_!Q=?\ Q=']L8?L_N7^ M8?4:O='XC45^W/\ PZ^_9\_Z%?4/_!Q=?_%T?\.OOV?/^A7U#_P<77_Q=']L M8?L_N7^8?4:O='XC45^W/_#K[]GS_H5]0_\ !Q=?_%T?\.OOV?/^A7U#_P ' M%U_\71_;&'[/[E_F'U&KW1^(U%?MS_PZ^_9\_P"A7U#_ ,'%U_\ %T?\.OOV M?/\ H5]0_P#!Q=?_ !=']L8?L_N7^8?4:O='XC45^W/_ Z^_9\_Z%?4/_!Q M=?\ Q='_ Z^_9\_Z%?4/_!Q=?\ Q=']L8?L_N7^8?4:O='XC45^W/\ PZ^_ M9\_Z%?4/_!Q=?_%T?\.OOV?/^A7U#_P<77_Q=']L8?L_N7^8?4:O='XC45^W M/_#K[]GS_H5]0_\ !Q=?_%T?\.OOV?/^A7U#_P '%U_\71_;&'[/[E_F'U&K MW1^(U%?MS_PZ^_9\_P"A7U#_ ,'%U_\ %T?\.OOV?/\ H5]0_P#!Q=?_ !=' M]L8?L_N7^8?4:O='Y[?\$W_^2M>//^Q$U;_VE7RI7[S?"W]AKX1?!O6M1U7P MMH5W97NH:=-I5P\NHSRAK>7;O4!F(!.T&[/[E_F'U*IW1^)5%?MK_ M ,.P?V??^A7U#_P<7/\ \71_P[!_9]_Z%?4/_!Q<_P#Q=']MX;L_N7^8?4JG M='XE45^VO_#L']GW_H5]0_\ !Q<__%T?\.P?V??^A7U#_P '%S_\71_;>&[/ M[E_F'U*IW1^)5%?MK_P[!_9]_P"A7U#_ ,'%S_\ %T?\.P?V??\ H5]0_P#! MQ<__ !=']MX;L_N7^8?4JG='XE45^VO_ [!_9]_Z%?4/_!Q<_\ Q='_ [! M_9]_Z%?4/_!Q<_\ Q=']MX;L_N7^8?4JG='XE45^VO\ P[!_9]_Z%?4/_!Q< M_P#Q='_#L']GW_H5]0_\'%S_ /%T?VWANS^Y?YA]2J=T?B517[:_\.P?V??^ MA7U#_P '%S_\71_P[!_9]_Z%?4/_ <7/_Q=']MX;L_N7^8?4JG='XE45^VO M_#L']GW_ *%?4/\ P<7/_P 71_P[!_9]_P"A7U#_ ,'%S_\ %T?VWANS^Y?Y MA]2J=T?B517[:_\ #L']GW_H5]0_\'%S_P#%T?\ #L']GW_H5]0_\'%S_P#% MT?VWANS^Y?YA]2J=T?B517[:_P##L']GW_H5]0_\'%S_ /%T?\.P?V??^A7U M#_P<7/\ \71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_Z%?4/_ <7/_Q='_#L M']GW_H5]0_\ !Q<__%T?VWANS^Y?YA]2J=T?B517[:_\.P?V??\ H5]0_P#! MQ<__ !='_#L']GW_ *%?4/\ P<7/_P 71_;>&[/[E_F'U*IW1^)5%?MK_P . MP?V??^A7U#_P<7/_ ,71_P .P?V??^A7U#_P<7/_ ,71_;>&[/[E_F'U*IW1 M^)5%?MK_ ,.P?V??^A7U#_P<7/\ \71_P[!_9]_Z%?4/_!Q<_P#Q=']MX;L_ MN7^8?4JG='XE45^VO_#L']GW_H5]0_\ !Q<__%T?\.P?V??^A7U#_P '%S_\ M71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_P"A7U#_ ,'%S_\ %T?\.P?V??\ MH5]0_P#!Q<__ !=']MX;L_N7^8?4JG='XE45^VO_ [!_9]_Z%?4/_!Q<_\ MQ='_ [!_9]_Z%?4/_!Q<_\ Q=']MX;L_N7^8?4JG='XE45^VO\ P[!_9]_Z M%?4/_!Q<_P#Q='_#L']GW_H5]0_\'%S_ /%T?VWANS^Y?YA]2J=T?B517[:_ M\.P?V??^A7U#_P '%S_\71_P[!_9]_Z%?4/_ <7/_Q=']MX;L_N7^8?4JG= M'XE45^VO_#L']GW_ *%?4/\ P<7/_P 71_P[!_9]_P"A7U#_ ,'%S_\ %T?V MWANS^Y?YA]2J=T?B517[:_\ #L']GW_H5]0_\'%S_P#%T?\ #L']GW_H5]0_ M\'%S_P#%T?VWANS^Y?YA]2J=T?B517[:_P##L']GW_H5]0_\'%S_ /%T?\.P M?V??^A7U#_P<7/\ \71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_Z%?4/_ <7 M/_Q='_#L']GW_H5]0_\ !Q<__%T?VWANS^Y?YA]2J=T?B517[:_\.P?V??\ MH5]0_P#!Q<__ !='_#L']GW_ *%?4/\ P<7/_P 71_;>&[/[E_F'U*IW1^)5 M%?MK_P .P?V??^A7U#_P<7/_ ,71_P .P?V??^A7U#_P<7/_ ,71_;>&[/[E M_F'U*IW1^)5%?MK_ ,.P?V??^A7U#_P<7/\ \71_P[!_9]_Z%?4/_!Q<_P#Q M=']MX;L_N7^8?4JG='XE45^VO_#L']GW_H5]0_\ !Q<__%T?\.P?V??^A7U# M_P '%S_\71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_P"A7U#_ ,'%S_\ %T?\ M.P?V??\ H5]0_P#!Q<__ !=']MX;L_N7^8?4JG='XE45^VO_ [!_9]_Z%?4 M/_!Q<_\ Q='_ [!_9]_Z%?4/_!Q<_\ Q=']MX;L_N7^8?4JG='XE45^VO\ MP[!_9]_Z%?4/_!Q<_P#Q='_#L']GW_H5]0_\'%S_ /%T?VWANS^Y?YA]2J=T M?B517[:_\.P?V??^A7U#_P '%S_\71_P[!_9]_Z%?4/_ <7/_Q=']MX;L_N M7^8?4JG='XE45^VO_#L']GW_ *%?4/\ P<7/_P 71_P[!_9]_P"A7U#_ ,'% MS_\ %T?VWANS^Y?YA]2J=T?B517[:_\ #L']GW_H5]0_\'%S_P#%T?\ #L'] MGW_H5]0_\'%S_P#%T?VWANS^Y?YA]2J=T?B517[:_P##L']GW_H5]0_\'%S_ M /%T?\.P?V??^A7U#_P<7/\ \71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_Z% M?4/_ <7/_Q='_#L']GW_H5]0_\ !Q<__%T?VWANS^Y?YA]2J=T?B517[:_\ M.P?V??\ H5]0_P#!Q<__ !='_#L']GW_ *%?4/\ P<7/_P 71_;>&[/[E_F' MU*IW1^)5%?MK_P .P?V??^A7U#_P<7/_ ,71_P .P?V??^A7U#_P<7/_ ,71 M_;>&[/[E_F'U*IW1^)5%?MK_ ,.P?V??^A7U#_P<7/\ \71_P[!_9]_Z%?4/ M_!Q<_P#Q=']MX;L_N7^8?4JG='XE45^VO_#L']GW_H5]0_\ !Q<__%T?\.P? MV??^A7U#_P '%S_\71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_P"A7U#_ ,'% MS_\ %T?\.P?V??\ H5]0_P#!Q<__ !=']MX;L_N7^8?4JG='XE45^VO_ [! M_9]_Z%?4/_!Q<_\ Q='_ [!_9]_Z%?4/_!Q<_\ Q=']MX;L_N7^8?4JG='X ME45^VO\ P[!_9]_Z%?4/_!Q<_P#Q='_#L']GW_H5]0_\'%S_ /%T?VWANS^Y M?YA]2J=T?B517[:_\.P?V??^A7U#_P '%S_\71_P[!_9]_Z%?4/_ <7/_Q= M']MX;L_N7^8?4JG='XE45^VO_#L']GW_ *%?4/\ P<7/_P 71_P[!_9]_P"A M7U#_ ,'%S_\ %T?VWANS^Y?YA]2J=T?B517[:_\ #L']GW_H5]0_\'%S_P#% MT?\ #L']GW_H5]0_\'%S_P#%T?VWANS^Y?YA]2J=T?B517[:_P##L']GW_H5 M]0_\'%S_ /%T?\.P?V??^A7U#_P<7/\ \71_;>&[/[E_F'U*IW1^)5%?MK_P M[!_9]_Z%?4/_ <7/_Q='_#L']GW_H5]0_\ !Q<__%T?VWANS^Y?YA]2J=T? MB517[:_\.P?V??\ H5]0_P#!Q<__ !='_#L']GW_ *%?4/\ P<7/_P 71_;> M&[/[E_F'U*IW1^)5%?MK_P .P?V??^A7U#_P<7/_ ,71_P .P?V??^A7U#_P M<7/_ ,71_;>&[/[E_F'U*IW1^)5%?MK_ ,.P?V??^A7U#_P<7/\ \71_P[!_ M9]_Z%?4/_!Q<_P#Q=']MX;L_N7^8?4JG='XE45^VO_#L']GW_H5]0_\ !Q<_ M_%T?\.P?V??^A7U#_P '%S_\71_;>&[/[E_F'U*IW1^)5%?MK_P[!_9]_P"A M7U#_ ,'%S_\ %T?\.P?V??\ H5]0_P#!Q<__ !=']MX;L_N7^8?4JG='XE45 M^VO_ [!_9]_Z%?4/_!Q<_\ Q='_ [!_9]_Z%?4/_!Q<_\ Q=']MX;L_N7^ M8?4JG='XE5]T?\$?_P#DY#Q1_P!BGA?!']CKX7_L\^*;OQ#X)T:ZT[5+JS:PEEFOYIP86='(VNQ .Z-.>O%\DM MPLT/(VXZ8'3!'7FM'^SO&W_06TW_ +\'_"D^&G_'MKW_ &%I_P"2UV5 ''?V M=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%']G>- MO^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V-% '' M?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_ M9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% M''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%' M]G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V- M% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^# M_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5 MV-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX M/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_ MX5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ M -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#? M@_X5V-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+: M;_WX/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO M_?@_X5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H M+:;_ -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF M_P#?@_X5V-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC; M_H+:;_WX/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^ M@MIO_?@_X5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9W MC;_H+:;_ -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_ MZ"VF_P#?@_X5V-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_ M9WC;_H+:;_WX/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G M>-O^@MIO_?@_X5V-% ' ZT?&>CZ5=7LFJ:>R01ER$@^;CTR*DTV'QIJ&GVMT MFJZ>$GB64!H#G# 'G Z\UN>._P#D3]7_ .O=JM>%_P#D6=(_Z\X?_0!0!A?V M=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%']G>- MO^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V-% '' M?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_ M9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% M''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%' M]G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V- M% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^# M_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5 MV-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX M/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_ MX5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ M -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#? M@_X5V-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+: M;_WX/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO M_?@_X5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H M+:;_ -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X5E6-[XQO/$& MI:6NJ6(ELUC9F:#Y3N7(QQGOWKT:N.T#_DI'BG_KG;?^BQ0 ?V=XV_Z"VF_] M^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_9WC;_H+:;_WX M/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% ''?V=XV_Z"VF M_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%']G>-O^@MIO\ MWX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V-% ''?V=XV_Z" MVF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_9WC;_H+: M;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% ''?V=XV_ MZ"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%']G>-O^@M MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V-% ''?V=X MV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_9WC; M_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% ''?V M=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%']G>- MO^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V-% '' M?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^#_A1_ M9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5V-% M''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX/^%' M]G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_X5V- M% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ -^# M_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#?@_X5 MV-% ''?V=XV_Z"VF_P#?@_X4?V=XV_Z"VF_]^#_A78T4 <=_9WC;_H+:;_WX M/^%']G>-O^@MIO\ WX/^%=C10!QW]G>-O^@MIO\ WX/^%']G>-O^@MIO_?@_ MX5V-% ''?V=XV_Z"VF_]^#_A1_9WC;_H+:;_ -^#_A78T4 <=_9WC;_H+:;_ M -^#_A1_9WC;_H+:;_WX/^%=C10!QW]G>-O^@MIO_?@_X4?V=XV_Z"VF_P#? M@_X5V-% ''?V=XV_Z"VF_P#?@_X5BWVJ>,+'Q!;Z8^I632S0&8,L'RX!(YXS MGBO2ZX/Q%_R4C3?^O!__ $)J &>;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^ M%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D M_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A M6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ M?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^ M%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D M_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A M6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ M?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^ M%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D M_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A M6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ M?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^ M%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D M_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A M6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^%;E% &'YOC+_ *">G_\ M?D_X4>;XR_Z">G_]^3_A6Y10!A^;XR_Z">G_ /?D_P"%'F^,O^@GI_\ WY/^ M%;E% &'YOC+_ *">G_\ ?D_X4>;XR_Z">G_]^3_A6Y10!E6\/C2X5V&J:<-O MK"?\*3R?&G_04T[_ +\G_"NGTS_4S_Y[4E ',^3XT_Z"FG?]^3_A1Y/C3_H* M:=_WY/\ A7344 3XT_Z"FG?]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_W MY/\ A7344 3XT_Z"FG?]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ MA7344 3XT_Z"FG?]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A734 M4 3 MXT_Z"FG?]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A7344 3XT_Z M"FG?]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A7344 3XT_Z"FG? M]^3_ (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A7344 3XT_Z"FG?]^3_ M (5TU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A7344 3XT_Z"FG?]^3_ (5T MU% ',^3XT_Z"FG?]^3_A1Y/C3_H*:=_WY/\ A7344 3XT_Z"FG?]^3_ (5TU% ' M-_9_&ODM)_:NG87MY!_PJOYOC+_H)Z?_ -^3_A78_P#+C-650!A^;XR_Z">G M_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#W MY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z M?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ M 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G M_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#W MY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z M?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ M 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G M_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#W MY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z M?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ M 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G M_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#W MY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z M?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G_P#?D_X4>;XR_P"@GI__ M 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#WY/\ A6Y10!A^;XR_Z">G M_P#?D_X4>;XR_P"@GI__ 'Y/^%;E% &'YOC+_H)Z?_WY/^%'F^,O^@GI_P#W MY/\ A6Y10!A^;XR_Z">G_P#?D_X58CM_&DD'FC5=. Z8\@_X5J5IVO\ R#OQ M_K0!RWD^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^ M3_A1Y/C3_H*:=_WY/^%=-10!S/D^-/\ H*:=_P!^3_A1Y/C3_H*:=_WY/^%= M-10!SZ6/C:10PU;3>?\ I@?\*=_9WC;_ *"VF_\ ?@_X5UMO_J5J2@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP? M\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3 M?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3 M?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP? M\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3 M?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3 M?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP? M\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3 M?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3 M?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP? M\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3 M?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3 M?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP? M\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3 M?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3 M?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\ M;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@#CO[.\;?]!;3?^_!_P */[.\ M;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP?\*/[.\;?]!;3?^_!_P *[&B@ M#CO[.\;?]!;3?^_!_P */[.\;?\ 06TW_OP?\*[&B@#CO[.\;?\ 06TW_OP? M\*SM8OO%OAZ339+O4;*:"XO([N1TP#TYKT*N.^)?_'KH7_86@_DU M '8T444 <;\-/^/;7O\ L+3_ ,EKLJXWX:?\>VO?]A:?^2UV5 !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &#X[_Y$_5_^O=J MM>%_^19TC_KSA_\ 0!57QW_R)^K_ /7NU6O"_P#R+.D?]>U)2Z9_J M9_\ /:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH E_Y<9JRJU?^7&:LJ@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "M.U_Y!WX_UK,K3M?\ D'?C_6@!E%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M7[?_ %*U)4=O_J5J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ KCOB7_P >NA?]A:#^35V-<=\2_P#CUT+_ +"T'\FH [&BBB@#C?AI M_P >VO?]A:?^2UV5<;\-/^/;7O\ L+3_ ,EKLJ "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** ,'QW_ ,B?J_\ U[M5KPO_ ,BS MI'_7G#_Z *J^._\ D3]7_P"O=JM>%_\ D6=(_P"O.'_T 4 :E%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QV@?\E(\ M4_\ 7.V_]%BNQKCM _Y*1XI_ZYVW_HL4 =C1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !7!^(O^2D:;_UX/_Z$U=Y7!^(O^2D: M;_UX/_Z$U &S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 :.F?ZF?_/:DI=,_P!3/_GM24 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 2_P#+C-656K_RXS5E4 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5IV MO_(._'^M9E:=K_R#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +]O_J5J2H[?_4K M4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'?$O_CU MT+_L+0?R:NQKCOB7_P >NA?]A:#^34 =C1110!QOPT_X]M>_["T_\EKLJXWX M:?\ 'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?\ T 55\=_\B?J__7NU M6O"__(LZ1_UYP_\ H H U**** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ KCM _P"2D>*?^N=M_P"BQ78UQV@?\E(\4_\ M7.V_]%B@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *X/Q%_R4C3?^O!_P#T)J[RN#\1?\E(TW_KP?\ ]":@#9HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** -'3/]3/_ )[4E+IG^IG_ ,]J2@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"7 M_EQFK*K5_P"7&:LJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "M.U_P"0=^/]:S*T[7_D'?C_ M %H 91110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% %^W_ -2M25';_P"I6I* "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "N.^)?\ QZZ%_P!A:#^35V-< M=\2_^/70O^PM!_)J .QHHHH XWX:?\>VO?\ 86G_ )+795QOPT_X]M>_["T_ M\EKLJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* ,'QW_R)^K_ /7NU6O"_P#R+.D?]>#_\ H35WE<'XB_Y*1IO_ %X/_P"A-0!LT444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% &CIG^IG_SVI*73/]3/_GM24 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2_\N,U95:O M_+C-650 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !6G:_\@[\?ZUF5IVO_ "#OQ_K0 RBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** +]O_J5J2H[?_4K4E !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !7'?$O_CUT+_L+0?R:NQKCOB7_ ,>NA?\ 86@_ MDU '8T444 <;\-/^/;7O^PM/_):[*N-^&G_'MKW_ &%I_P"2UV5 !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &#X[_P"1/U?_ M *]VJUX7_P"19TC_ *\X?_0!57QW_P B?J__ %[M5KPO_P BSI'_ %YP_P#H M H U**** "BBB@ HHHH **** "BBB@ HHKP']L3XV^-/@'X)TKQ+X4T_2-0M M7O/LE^NJ02R>7N7,;+YJ]*TITW5FJ<=WH3*2A%R>RU^X]^HKY9_ M8R_:VUK]HC4O$FE>)K+2M/U33XHKFU72XY(UEB)*R$AY'.5;9T(^]7U-6N(P M]3"U/9U%J8T*\,1#GI[!17RO^V9^UUK7[/.K>'='\,66E:AJE]#)=72ZI')( ML40(6/:$D0Y8A^I/W:P/#?[6WQ'O_P!E?Q1\5M1TCP[#>6M_%:Z9;Q6MP(94 M\Q$D=P9RSP?Q6O^%_R/L>BOS% M_P"'G?Q2_P"@!X0_\ [K_P"2:/\ AYW\4O\ H >$/_ .Z_\ DFN[^Q<7V7WG M%_:N&[O[C].J*_,7_AYW\4O^@!X0_P# .Z_^2:^C_CE^U7XM^&?[._PX\>:7 MIVBSZQXD2V:[AO()FMT\RV,K>6JRJP^88&6/'YUA5RO$4>522]YV6O4UIYA0 MJ\RBWHF_DCZKHK\Q?^'G?Q2_Z 'A#_P#NO\ Y)J:U_X*>_$M9@;GPYX4EBSR ML5O9?VIAN[^X_32BOGO]F/]L3P_P#M$--I4MDWA[Q5 M;QF5M.>7S8YXQP7B? SCC*D C/<9-?0E>36H5,//V=569Z-&M3KQYZ;N@HHK MF?B/\1-#^%/@W4?$_B*Z^RZ78INIKUK]G/_ (*#Z=\4 M/$=GX8\9Z5!X4G C*MEHR3@#+,"3C(XSZ\LJQ<8>T3_M$?M&>'?V M=?"L6I:LCZAJ=X62PTJ!PLEPP')+'.Q!D9;!QD8!/%?%5U_P5 ^(+:D7M_"W MAF+3]V1!*EP\NWT\P2@9]]GX48; 8C%Q>F[H****P-@HHHH **** "BBB@ HHHH *X[0/^2D>*?^N=M_Z+ M%=C7':!_R4CQ3_USMO\ T6* .QHHHH **^3/VMOV_-!_9ZOI?#&@64?B?QLJ M@S0/(5M;#(ROG,.68Y!\M<'!R67C/POKG_!2;X]ZM?O<6OBFRT6)CD6MCI%J MT:^P,T*N=*4%=[$1J1D^7J:5%?G_P#M<_\ !0#XA_ /XX:MX-\/Z-X9O-+M M(+>6.;4K6X>8F2)7;)2=%QD\?+7VS\+O%%UXV^&OA3Q#?1PQ7NK:5:WT\=NI M6-7DB5V"@DD+ECC))]ZB,7*G[5;?\/\ Y%2DHS]F][7_ "_S.GHHHJ2@HHHH M **** "BBB@ HHHH ***^;OVY/VDO$W[,WP]T#7?"]CI-_=W^J?8I4U>&62, M)Y4CY41R( M_P"U?_P4)^(OP*^.WB'P5H.B^%[O2M/6V:*;4K6Y>=O,MXY&W%+A%ZN<84<8 MK[9^#_B^\^('PH\'>)]1B@AO]9TBUO[B.U5EB626)78(&)(7+'&23CN:N,7* MG[5;:?C_ ,,*349^S>]K_E_F=?17 ?'SQ_J'PK^#/B_Q;I,-M<:EH^GR7<$5 MXK-"SKT#A64D?0BOD?\ 8[_;X^('[0GQJM/!_B+1_#5EIDUE<7#2Z7:W$*4(NHW&/17_/\ R%.2II2EU=OR_P S[WHHHJ2@HHHH **** "B MBB@ HHHH ***^3_BA_P4'\(>&_B=HOP_\(0?\)3KMWJ]OI=[>[BEG9%YEC$X-,U75H[">6UM+I9EC9]I*EKAE#8]5(]J=.+JS]G'?_,4Y*G3= M26R/TEHKG?'_ ,0/#_PM\)W_ (E\4:G%I&BV2AIKJ4$@9("J% )9B2 22: M\3_9I_;&L/VG/B)XNTK0=%ET_P /:):PR07EXW^D73.[*6*#A%PO R2;[6WX_P"1]6T445)04444 %%%?!W[9?[> M7C_]G?XS/X2\.:1X;O=-73X+OS=4MKB2;>^[(RDZ#'RC'%'51[_\./HWV/O& MBOR:_P"'LWQ=_P"A<\$_^ -Y_P#)57-*_P""MGQ-AO(VU+PGX3N[4$;X[6*Z M@&KJZTR"31]=T_:-0T:XD$ MCP[ONNC@#?&<$;L Y&"!QGV^HE&4':149*:O$****@H**** "BBB@ HHHH * MX/Q%_P E(TW_ *\'_P#0FKO*X/Q%_P E(TW_ *\'_P#0FH V:*** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@#1TS_4S_Y[4E+IG^IG_P ]J2@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"7_EQ MFK*K5_Y<9JRJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH *T[7_D'?C_6LRM.U_P"0=^/]: &4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110!?M_\ 4K4E1V_^I6I* "BJNJ:G;:+I=YJ-[)Y- MG:0O<32;2VR-%+,< $G !X S7SU_P\2_9[_Z*!_Y1=0_^1Z%J[('HKL^CZ*^ M<5_X*(?L^.P4?$$9)QSHVH ?G]GKUKX;_&CP-\7K62X\&^*=-\0+$H:6*TF! MFB!Z%XCATS_M 57++>Q/-':YVE%<=\5/B]X2^"GAE?$/C35O[&T=ITMA<_9I MI_WC E5VQ(S6\?F1.,JVUP M&&0>A -2M4VNA3T:3ZFM1110 4444 %%%% !1110 4444 %%%% !137=8U9F M8*JC)9C@ >M>&>*OVY/@7X,U1]/U+XB:>]S&<-_9\%Q?(".H+P1NN?;-&[L@ MZ7/=:*XGX9_&KP-\8[&2[\&>*-/U^.( RQVTF)H@>A>)@'3/;1+-M9V"*-D:LQRQ X%.2<=):!'WMCJ**P/ G MCK0_B9X2TWQ-X;OO[2T/44,EK=>5)%YBABI.UU5ARI'('2M^AIQ=GN)-25UL M%%%%(8445Y!\2OVN/A#\(]:?2/%/CBQL=4C.);.WBFNY83Z2+ CE#[-@T=;! MYGK]%2[NKCRV?RXD4LS;5!8X / !-2VDK MLI)MV1J45\X?\/$OV>_^B@?^474/_D>G1_\ !0_]GR1PH^((!/\ >T?4 /S- MO5\LNQ',NY]&T5R?P]^+'@[XKZ<]]X/\2Z;XAMX\"7[#.KO$3T#I]Y"?1@*H M_%SXX>"?@5HMGJWCC6O[$T^\N/LL$WV6>XWR[2VW$2.1PI.2,<4FG'1C7O;' M=452T76+3Q#H]AJNGS?:+"^@CNK>;:5WQNH96PP!&00<$ U=H:<79@FI*ZV" MBBBD,**** "BBB@ HHHH **** "BBH[BXBL[>2>>5(8(U+O)(P554#)))Z " M@"2BO!/$'[=WP&\,ZF]A>?$6QEG0X+6%K:^-/VCOAW\/?B'HW@;Q!XA_L_Q3K!A%C8?8KF3S?-D,;?%C]HSX>? V_P!(LO&_B'^Q+G5@YLD^Q7%QYNTJ M&YBC8+@NOWL=:](5@RAAR",BG9VYN@KV?*]Q:***0PHHHH **** "BBB@ HH MHH **** "BBB@ HHKA?BY\7'V6";[+/<;Y=I;;B) M'(X4G)&.* .ZHJEHNL6GB'1[#5=/F^T6%]!'=6\VTKOC=0RMA@",@@X(!J[3 M:<79B34E=;!1112&%%%% !17$?%KXU>#/@;H-MK7C?6?[$TRYN!:13_99KC= M*59@NV)'(X5CDC'%=)X9\2:=XR\.:7KVCW'VS2M3MH[RTN-C)YD4BAD;:P## M((." ?44[-IM;('HTGU-.BBBD 4444 %%%% !1110 4444 %%%% !1110 5Q MWQ+_ ./70O\ L+0?R:NQKCOB7_QZZ%_V%H/Y-0!V-%%% '&_#3_CVU[_ +"T M_P#):[*N-^&G_'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?_ $ 55\=_ M\B?J_P#U[M5KPO\ \BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ HHHH *\ M^^/_ ,.E^*WP=\5>&?+#W%W9.UKD=+A/GB/_ 'VJ_G7H-%%VM8[H:MU/QS_9 M#^(#_"W]HCPQ=W#&"UNK@Z5>JW&$F.SYO3:^QO\ @-?L97X[_MB?#IOA;^T+ MXDMK:,V]E?3#5;(KD )+\QQ_NOO'X5^@=_\ M#Q_\,:_\+*$RC49M%$2G/\ MR_G]P0/I+D_05]3FR^M4*.+IK66GS>R^^Z/GLO\ ]GQ-7"R>BU^2Z_=9GY[? MM3>.+CXR?M&>(KBPW7<7VQ=)TZ-.=R1GRU"_[S[F_P"!5^IWP_\ @]H?A?X. MZ!X"U/3+'6=,L;.**XMKVW2>&>48=W*,"#F3+F7MS'Y MUAX?1M6G9AD&12!",^OF,K?\ -?K34YM)8>E1P<'\*O^B^>[^89??$5JN*DM M]%^=OR1Y])^S[\+O+;_BVWA#I_T K7_XW7Y'?!?2[+5/CYX.T^]M(+RPGU^V MAEM;B)7BDC,Z@HR$8*D<8(Q7[82?ZMOH:_%CX$_\G&^!_P#L9+7_ -*%JLCJ M3E4K1ZV(A&-&HXJWNO\CS_P#X)M_#KPIXZT7QV_B3 MPQHWB%[:XLU@;5=/BN3$&67<%+J=N<#./05]/_%+]DOX5^-/!VIV:^#M'T&Z M\AV@U#1[*.TE@D"DJV8P P!ZAL@U^;?P!_:G\5_LYV>LV_AO3]&ODU5XI)SJ ML$LA4QA@NW9*F/OG.<]JZ[XC?M_?%3XC>&[S1'?2= M+R,PSOHUM)'*\9&&7 M?)(Y4$?W<'WKZ/'X'&5\3*I0E9.UM=M%^IX& Q>&H4(PK*[5[Z;W;?Y'G/[- MNM77AG]H+P#=6%=%E%W;W$R%1>W"_ZM8\_>56^8L./EQU/'Z1>*OB%X5\"M;CQ)XFT M?P\;G<8!JM_%;>;MQNV[V&[&1G'J*X\\G&I6A3AK))W_ ,CIRB$HPG4EI%VL M=!7A7[6G[/>L_M%>$=)T72_$4&AQ65TUW+%<0,Z7#;-J9*GY=N6['K[5VW_# M07PM_P"BE>$/_!]:_P#QRNYL[RWU&S@N[2>.ZM9XUEBGA<.DB,,JRL.""""" M.N:^>C[2A)5+6:VT_P SW&X54X7O<^8_V??V*_!_PE\#WG_"?Z3X?\3Z]-)( M]S?7D0N+:"$<(L?G(-G'); .2>< 5^>'Q*T/2;KXZZSI7PW5[S2Y-7\C1TM& M+EB7 41GJ1NR%/H =6(HFU M#2[:";4[V&1C_I&T@!6(YP7=2?49'>OT _:J\26'BW]D'Q5KFDW(N=-U'3(+ MFWF7C?&\L9'TX/(KY'_X)B@?\+N\0''/]@R?^CX:Y'M.\.W^EW444ZZ7;+;QSPR' M9\R( I8,4.[&>M,_X)>>.+B]\-^,O"<\I>&PGAO[5&.=HE#+(![9C0_5CZU[ M'^WI_P FO>*_]^U_]*(Z^7O^"7;2?\+0\8*%'DG1U+-W#>>F!^6[\J6$E*OE ME>-1WL]/NB_S_,K&1C1QM"<%:_\ FU^7Y'G'[>_CBX\8_M':W9M(6M-#CBTV MW3.0,*'<_4N[?D*^Z? _[&OPSL_@_8>'-3\*:=>:E<6"B\U:6!3>?:&0%W28 MC>F&)P 0!@<5^OM MTK*K?D:773[]#6BDZBN?F!^S7\*KO]J+]H;3]'UN]GFBOYYM3UF\W?O7B4EY M3GLSL0N>Q?/:OVO\%_#WPU\.= AT3PSH=CHFEQ*$%O9P*BMQC+$#+,>[-DGN M:_+3_@E'Y?\ PT=K&_;N_P"$;N-F[&<_:+?I^&:_6RO3Q'N0A".BM^K7Z'!2 M]^D>)OA3X=LK77;B=H=7LX98K2"1""1.KG3;A(KUKC34L+EYC!$X!>-LHH MWY88)^^W2OHJBN2$W"#IK9G1.*G)3>Z/QF_X*4?\G:>)/^O.R_\ 2=*]GU3_ M (*=1?#?X;^#_"?@#P];ZUJ&F:)96MWJFL&1;99D@171(E*LX!!&XLHR#@$8 M)\8_X*4?\G:>)/\ KSLO_2=*_1S]BKX/:!\,?V>_"+V.FVR:KK6FPZCJ5[Y: MF:XDF02;6;J54,% Z #W-70_W1-[7_'7\-R*W^\JV_+^%HW_ $/F+X'_ /!5 MJ[UCQ39Z5\2_#FFZ?I]Y,L7]L:(9(TM6)Q'&7V[\-MSCK@]>AK\>?^"@G@C2O ?[47B:S MT:QATVQNHK>^%M;J%C5Y(E+D*.!E@S8',>!?^"L&@^(%U^7Q! MX';P[;Z;IKWEOY6L"ZEO9Q)&B6Z(8(\%O,+%LG 1C@U@? 3_ (*5>/\ XM?& MW0O"5QX)T*33-:O!;Q1V,DT=S;1G):1I&9E?8@9B BYV]J^)OV:OA$GQT^-G MA?P9//):V5_.S7:G>;A8:-9D?:+DCJ>>$09&7/KP">*^#==_ MX*W?$6XU-WT;P=X7L-.S\L%\+FZE ]Y%EC!_[X%>*_M;^-=2^.'[5WB. 2M( ML>JC0-.B;D1QQR>2H ]WW-]6-?L!\(_@KX5^#/@&R\*Z!I5K#:1PJEU+Y2^9 M>R;Q5:7VME_7RO^!TU)?O71CTW?]?,^9_V:?\ M@I9X=^+GB"R\+^,])3P?KUXRQ6M[%/YEC M(;0WPLK<;([>X5RL@C4?=4_(P X!8XP,"OT$_9S^)5Y\6/V-M,U_4I6GU,Z) M=6=U,_+220"2(N3W+! Q]R:FLU+"RKTU9J_Z_JOR'33AB(T9ZIV_3]#QKX4? M\%4- \<>(KJT\3>#T\&Z/:V,U[+J3:S]J;,8!6-(OLZ;F&/E21JA(_A^;'J:^5?V8?AW8_%? MX^^"?"VIJ9-,O]07[5&IQOB16D=,]MRH1QSS7[2?%+X2>%_$OP5U[P:V@V$> MBC3)H[6RAMT2.V=8SY;1@ !&5@"",8(K7$1A1A[6W?3TZ_IVT,Z+E5G[*^]M M?72WX7/'/V0/V[-*_:6U"X\-ZKI"^&_%]O ;A((IO,M[R-<;VC) 96&<;/[Z!J?BCX<:3\2[2ZU3[-%I^KF(1P/Y4C>:OF0RC.%*\ M '#'GM7YI?L&W\VG_M:?#QX6*F2[FA;!ZJUO*I'ZU]K?\%;O^2+^#O\ L8!_ MZ3348F"BH2CU:7XK]&&'DY2E&71-_@_\CU']ACXR^&/C/X(\1ZAX7^&ND_#2 MUL]16WEL=(,12X'_\$CO^23^-_P#L-I_Z(2OB/XK:M>?M M!?M=:I%>7#_\3OQ.NDP-NSY4'GB"(+]$ _&JJ4N?$QH0TNE^2_5BIU%&A*K+ MHW^;_1'NES_P5K^)S:@SV_A/PE%8;LB&2&Z>4+Z&03@$^^W\*^MOV3?V[O#G M[2=^_AZ^TT^%_&,<1E2Q:<2P7:+]XPO@'GA86_V5M,-NIB=",'<,?,QZECR2F:494G)P:]WO_7]>@253E4D_>[? MU_7J?:%%%%%C1? MXG8\ ?R&37YT>./^"M_C"XUF7_A#O!FAV&DJQ$?]N&:YGD7/#'RI(U0D8^7Y ML>IJ_P#\%N>)+?3_'.HO)+JTIT>\FE4;V$<7F)"PVA IPK8RS'J37/1CSPE M5?1V2_#_ #_ Z:TN24::W>K?X_Y'8?LY_P#!4#2?B'XDLO#?Q"T6W\+7UZZP MV^KV4S-9-*QP%D1_FB!. &W,,GG:.:^WM>U3^Q-#U'4?*\[[';27'E[MN_8I M;&<'&<=<5^+/[;_B+X5>-/B['XC^%%_#=:=J5H)-2BM[&>T1+L.P9@DL:??7 M:3M&,@D\DU^F_P"S[X\NOB1^QGH>NWTS7%])X>N+:XF8Y:22%9(68GU)CR?< MT5_]UE7BN5J_ZZ_A\U85/3$1I-W3_P"!I^/RLSP_X6?\%5="\:^*'L?$G@Q? M"&C0VD]W/JAUDW97RT+*BQ"W0LSD!0 W4BO*_&W_ 5N\7S>(93X1\&Z)::$ MK$1KK7G3W,B@\,3'(BH2/X<-CU-?*'[-OPWM?B[\=/!GA*_+#3]2OU6Z"MM9 MH4!DD4'L2J,,^]?N#K7PA\&Z]\/Y/!%WX;TX^%F@^SKIL=NJQ1+C * #Y6'4 M,.01G.:WJPC3BII?+]?QMVT,J=)I;2^9'<1C ,D+X&<9&5(R,_Q#)KU;XX_&SPY\ /A_>>+/$TL@ MM(6$4%K 9KJ9L[8HP3U.")S822'@ MR0K.89 ?]Z/<#]:_8/\ :&^!OP\^-/A6$?$8M#I.CF2Y2\.HM9QVN0 TC'<$ MZ#JX..?4UE6C%TX5:>BE_P #]']YI2;C5E2J:N/_ =/O7W>9\#^)O\ @K?X M_N=1=O#W@SPWIMA_#%J9N+N7\722(?\ CM=E\'?^"L5QJ'B*ST_XD>%[&QTZ MXD6-]7T-I%%MGC<\,C.64'J0^0.@;I7;>!/VEOV7?V0?"]YX=\&ZQ?>)I_/> M6YFT^T^TW-RQ/ -P5BB=5& NUL #U))_/_\ :=^*WA[XU?&+5_%OAKP\WAK3 MKU8P;60IODD5=K2L$&U6; R 3R"1$E+E;$W4%NEJE[]F#K+G#B38_&!Z=Y7F;?^ [MOOCM7[:?"7PWI'Q'_9S^'EKXLT.PUZTF MT'3IY++5K6.ZB\P6Z88HZD$C)YQ7XX:/HNGR?M46>DO86SZ4WC);4V+0J8## M]M"^7LQMV;>-N,8XIT8.GC/9IZW=GV2<5^>I-2?M,*JCVLKKSLW^6A^K_P"R M+^UI_P -5:/XGOCX4_X1@:+-#%Y?]H_;/.\Q7.<^5'MQL]\YKY@^"O[8GPR\ M7_&WPKX?TW]F_P )^'=3OM6CM8-;M6M?.M9"^!*NVR5MP//# ^]?H#X5^'?A M3X>VMY%X6\,:-X:BNL-.FCZ?%:+*5!"EQ&HW$9.,^IK\3OV5_P#DZ[X=_P#8 MQP?^C:FAR5,5RI65H_\ !'5YJ>$G)N[3_P [?H?8G_!3;]IC[%:ZM\%O^$;W M_;(++4/[<^W8V8EW[/(\OG_5XSO[]*^5_P!D/]K#_AE76O$>H?\ "+?\)1_; M%O#!Y?\ :/V3RMC,V<^5)NSN]NE??G_!2OP+X:E_9S\1^*'\/:4_B:.:QA36 MFLHC>+']H0;!-MWA<$C&<8)KYD_X):_#OPK\0O%OCV'Q3X9T?Q+#;6-J\$>L M6$5VL3&1P2HD4[20!T]*6$VFNNM_N_RT+Q7V+[:6^_\ SU/K_P#:0^/GA_PY M^S'X8^(/B3XU66-XH7GA:0-O>%PQ3D9V#.3TZ5E_L(_'3P ME\:K7QB_A7X5:+\,5T][47"Z.82+S>)=I?RX(ON[3C.?O'IWP?\ @I]I]KI/ M[*VGV-C;0V5E;:S9PP6UO&(XXD6.4*JJ!A5 X&*\U_P""07_(.^)W_773 M_P"4]%'EJ+$22T3T_P#)?OWZDUN:FJ*;U>_WL]:_:P_X*#:)^SYXAD\)Z!I" M^*?%<2*UV))_*M;+<,JKD L[XP=@Q@$9;/%?+VW,?M,6>K_ P_:Z\67VO:;%J4T/B%M7CMM1C+6][;M-YL M88?Q1LF%('N.U?8^@_\ !2[X0_$CPJWACXB>!;[1]/NXC;SV\4,=_8JA&,\; M''MMC)'8\9J*4;T(U$KR?3^ON-*KY:KIO2*Z_P!?>>T_LE_MO>'OVG)+O1Y= M-;PUXMM(O/?39)Q-'<1 X+POA2<$C*D COV"K\??^"HG_)T7\FW.?N\5A? M%2U^.$VDQR_$J'X@2:7"X*/XJ6^,*.<@$&?Y0>HKKQ$'4E*SM=_<9+J%].LZZIL!.R)PJ^7M&XB(CID[F.*[+ M[]6_U,\/]I]W^B7Z!1117&=84444 %%%% !1110 5P?B+_DI&F_]>#_^A-7> M5Y!\:_\ 6:O_ -BW>_\ HN2M*BC_5/_I__P"2_P#VP?Z_?]0O_D__ -J?HQ17YST4?ZI_]/\ M_P E_P#M@_U^_P"H7_R?_P"U/T8HK\YZ*/\ 5/\ Z?\ _DO_ -L'^OW_ %"_ M^3__ &I^C%%?G/11_JG_ -/_ /R7_P"V#_7[_J%_\G_^U/T8HK\YZ*/]4_\ MI_\ ^2__ &P?Z_?]0O\ Y/\ _:GZ,45^<]%'^J?_ $__ /)?_M@_U^_ZA?\ MR?\ ^U/T8HK\YZ*/]4_^G_\ Y+_]L'^OW_4+_P"3_P#VI^C%%?G/11_JG_T_ M_P#)?_M@_P!?O^H7_P G_P#M3]&**_.>BC_5/_I__P"2_P#VP?Z_?]0O_D__ M -J?HQ17YST4?ZI_]/\ _P E_P#M@_U^_P"H7_R?_P"U/T8HK\YZ*/\ 5/\ MZ?\ _DO_ -L'^OW_ %"_^3__ &I^C%%?G/11_JG_ -/_ /R7_P"V#_7[_J%_ M\G_^U/T8HK\YZ*/]4_\ I_\ ^2__ &P?Z_?]0O\ Y/\ _:GZ,45^<]%'^J?_ M $__ /)?_M@_U^_ZA?\ R?\ ^U/T8HK\YZ*/]4_^G_\ Y+_]L'^OW_4+_P"3 M_P#VI^C%%?G/7Z,5\_FV4_V7R>_S;[GUV09__ &Y[7]URE?I1\4O^28^+_^P/>?^B7K\TO^ M""_&WPVO;JSTN^:2>"SFF,AB:)D$UN6/+Q.DBCYLGD\G -?:DW_!1 M;]GV*)G7QXTS*,B--&OP6]AF #\S7Q3\?OBC?_\ !0SX\>$/"/@+2+V'0--+ MQI=74>'5)&3S[J4 D(BJBX!.3@=V"C2G[7VT.7OK?:UGO_7X7"7LO9SY]K?. M_E_7XV/I?_@ICJT6O_LDZ/J< (@O=5L;F,-U"O#(PS^!KV/]G7QAH/@K]E?X M97_B'6].T&Q_L&S7[5J=W';19\H<;G(&:\?_ ."G&FPZ+^RAI>GVPVV]IJ]C M!&/15BE4?H*\R_98_8CMOC]\,_#?CCXM:]J^K6C6:VNAZ';W'DPVUE%F--Q MR-VW< FWU8L6.%3LX5E'1)='\1Q1'$DFDW\5TJ'W,;'%=!7Y2?M;_L\K^P_XR\&_$3X7:WJ%A;W%VT0 MM[J;>\$R@-L# #?$Z[@5;/0Y)!X_1'Q[\0-?A^ =YXN\'Z--K7B*ZT>.[TS3 M[:/S6::5%*?+_$%W[B.X4U$N7V3JQUMHUUO_ ,$N/-[14Y==4_P_ ZSQ5X]\ M,^!;=)_$GB+2?#T#_=DU6^BME;Z%V&:I>%?BQX(\=736OAKQEX?\0W*C7XSZ3=_$#X]7'B2?Q)J=U)LTJ]E>VF6-6*[YMR[ MQD@[54J H'4$8P?VS/V%?"GP)^'$GQ)^'>IZMH]WI%U 9;.6Z,@ >0(LD4F MZ.K,IY8\=,$$_ *Q-XG\4:-X< M67_5MJVH0VH?Z>8PS7C'PH^-VO:U^Q';?$BZ7[?XCM/#MUU2)I.-Y4DE M5VD* F.V W3:JSI_R;_?;02J)TH5/YMONOJ?I3X5\?\ ACQW!)-X:\2:1XAA MC^_)I5]%=*OU,;'%;]?GE\9_^"=VN_#?Q%X>\6_L\7FI6NLP7>)[.YU&-/LZ MX)$J2N5)3C:T;;BP;TR*^LOC-\9;SX(?L\ZAXWUVS@77[/3HLV*ONB-_(%01 MAAU02-U'\(-1-PC#G3\K=?EWN7%2%/'T(TB_P!8VDZA%=!/KY;'%?GO M^S3^R!=_M<:?)\7OC/XCU;51JTTGV"Q@F\LR1H[*2S$'9'N#!8X]N ,YP<5L M?M*?L(6'P)\*W7Q3^#>N:QX>UCPVOVV:S:Z,G[E?OO%)C<"!DE6+!E!''0U* M*I:579];=/7]>Q,9.I_"U[7ZGZ)45XQ^R+\=)/VA/@?H_BB\2./6HV>QU-(A MA?M$>,L!V#*5?';=CM7L]%2#IR<6$)JI'F1\/_\ !43XH>(?#_@7PUX&\/&Y M@'B:>3^T)[<,-T*;0L)8= [/DCN$(Z$UZ%\'?^"?/PF\ >"[&RU[PS:>+/$# MP+]OU+4MTF^0C+"-"=L:@Y P,X R2:^GJKZAJ%MI5C<7M[<16EG;QM+-<3N$ M2-%&2S,> .YJ(R5.#7=W;_)?(J2/ MIMR@/4*\\3#]#7S/\8_%%[_P4._:=T'P=X.29O /AUF$VJ;"%\HL#/H^(-9T_0M/6SD4W>I74=O$ M";B7C>Y _6O'M!M9O)00+(V^1CC(5I"_"X8[US5-*BTVZCCO+2:?S&MP[ *RM@%XBV$9'W9W#DC('37Y? M;2=1VYG]UWI?^M#EPZE[&,8*_*OOLM;?UJ?IM17G_P OBM!\;?@_P"&/&D, M:POJ=J&N(4Z13J2DJ#V#JP'MBO0*YYQ=.3A+=&\)*<5)=3SO]HGQ1JW@KX$^ M/-=T(LNKZ?H]S/;2*,F-Q&?G'NOWOPKXA_X)R_L_?##XP?#WQ)XF\8:9;^+_ M !5_:,HK*^S/+.2YWG)^7 (P:^\_BM\0_"7PQ\#ZCK7C;4+; M3_#X0PS?:5W^?N!'E*@!+LPS\H!R,]LU^+DWCCQ!\+_%'BKQM\&'\4>%? &I M7$FF0:A/#M 5QN\AI!N3>O)7!WJ #D'FBB_?J+NDK]G?];V_K6JJO"'D[^JM M^FY]+?"'PY;?!+_@I;-X.^',\K>&)C)!>V2RM*D41M?->)F.2?+D P2200 3 MG-?IY7R;^P?\&?AOX)^&J_$?0M=;Q3K6N6[/J7B+4L1R6^#NE@*ECY6UAER6 M)8C);&W'U#H?B+2?%%@E]HVIV>K63\K,8TF[N*LW_70R M@U.4JJ5E+;^NYHUYC^T]_P FY_$O_L7K[_T0U>G5YC^T]_R;G\2_^Q>OO_1# M5PUOX%X]GB+\_N[66WHKGGT;&]05;D6LTF]OL_F!;BU<_QKC!4GD97JR[C] ?\ !6J0 M2_!/P8Z_=;7P1^-M-7@GCWQ=J/\ P46_:G\-6/AK1KRS\(:2J12372#=#:"3 M?-/+@E49ONJN3DA1G)->]_\ !6M1'\%/!JJ,*NO@ ?\ ;M-7/4YOJ])5/BYO MPYE;^O7J;1Y?K$^3;EU]>5_T_D?3O@+QSX;\"_!'P#=^)?$&E^'K1]#L56?5 M;V.VC8_9X^ TC $UV/A7QSX;\=6;W?AKQ!I?B&U0[6GTJ]CN44^A:-B :^&O MV>?V$=/^-?@'P]X_^,6NZQXAU+4M/A.GZ7#<^3!:600"!"0-V=@5L*5 W<@G M)KQ_]H[X0R_\$_\ XU^"/&7P[UK4%TC4GD;[)=2AG C9/.MW( #Q.KKC<,C' M4D UO4C&6(<).SDW\GV9A1YHT$X*_*E\[=C]8:YWQ9\1O"?@-8V\3>*-&\.K M)RAU;4(;4-]/,89KD/VAO&'BSPW\$==U;X?Z/=:YXJFME33K>RA\YT:0@>:% M_BV*2V,') &.:^2?V=?^"=^G_$7PJGC?XVS^(K_Q;K,CSR:9=W#P20KDA3.6 M'F&0XW?> (&*Y8Q%DOM^P%1;VL:;^UJOOL>P>+/BAX-\ R11^)_%NA^' M))1F-=6U*&U+CU D89JYX7\;>'?'%FUWX)-0\5>+KF]F%[IRZCL>WYPKRX_>,S_ '@V0N#C M'!KJ?B1^P'XQ^#7Q(\->+_V=[R]\U)C]KL[_ %&.,6X!! +L5,D3C*LA#'Z@ M\:^S4)*%1V;^Y7,^=S3E36WXV/T.K \6?$'PMX#ABF\3>)=(\.PRG$" .WN$QWKY, M_9I_8:C_ &B/#L7Q7^-&O:QKFH^(";FULDN=A:')"O*^"V&ZJB;0J[?7 RC% MR6,T_F[(F=5W1MC+)D@-')N# D MYP,'[5_9M^,4?QX^"_AOQD(DM[N]A,=Y!']V.XC8I*![%E)'L15\L90FU\$_\%-_'?B;5-0\"_"?P\\UK;>(IEDOI4#*DQ:41 M01,P_AW;F([X7TK[VHK)) 8_V _P!I7P5XO^'M MSXNKEPD<2*,EF)Z"OS(U;4+_ /X*)?M>:7_8]M/%\-O"I3?=RQE1]F63 M<[MQQ).R[54\A0"1\K5T49REB8.^BUEVY=?Z^_S,*D8PP\DUTLN]]/Q_KL?J M)'()(U=?NL 17+^*OBMX)\"W"V_B7QAH'AZ=AE8M5U."V8CU D8&O,OVSO%' MQ"\,_!2\A^&&C:IJGB;4)EM!-I$#2S64!!,DJA>0V %! R"V1TKPGX&_\$S_ M =J7@?3M=^*,FM:QXOU:%;R]MGNV@6V>3YMC8&]I!G#%F/S9X%817-S/9+^ MOZ9H_=44]6_Z_I'V=X4^('A?QY#+-X:\2:1XBABQYDFDWT5TJ9Z9,;'%;]?E M%^UU^SC'^Q'XG\'?$#X8>(-4LH[B\>(0W4P>2"5 '"AU WQ.NX%6!ZSL_(GF<9\DNJNC4KYK^-' MP3^#_C/]H;P=XL\6^/?["\=Z:UD=,T/^V;.W^U&.X9X?W$B&5]TA*_*1G&!S M7TI7YK_MH?\ *0WX._\ 731O_3@]*BN:O2BM&WOVT9=32A5EV7WZH_0_Q5XR M\/\ @73!J7B37=-\/:<9!$+O5;N.VBWG)"[W(&3@\9[&H=6^('A?0/#]OKNI M^)-(T[1+A%DAU*[OHHK:56&599&8*00000>17RW_ ,%3O^398/\ L/6O_H$M M>9?LT?L90?M'_#WP[\0/B_KNK:O#+9I::)H5K/Y$%K91#RH\D#/S!-P"E?5B MQ8XFG'VD9R>G*TOPO]X5'R2@M^97_&WW?\!'WAX3^(7A;Q]#+-X8\2Z/XCAA M.))-)OXKI4/H3&QQ^-8/QL^(6A_#WX>ZU<:OXET_PU=7%A=)I\E]?QVKRSB) MBHB+,"S@XP%YZ5^/N/]H+X3>$OVBO@G;ZUXGL)Y3I^DS:S81PW+1>5*]MO&[: M?F P.#Q6==1>'E4B]-GW7]+5%TG)5XPDM]5Y_P!,^:_^"7_Q8\,Z'X)\8VWB MKQEI.GZ]JNO))%#K&J1175X[Q(-RB1PTA+<9&E_MU?&+QEX\^,'A[]GSX M>Z@VFW.K"(:M=0R&-G,N2(F8# = 0>W$+FJQA%>\[*W396_P"" M6.>"10R2Q,&5@>A!'!%?'?AS_@EC\(M.\,K8ZO=:[J^KO&!+ MJBW@@*OCDQQA2JC/0-O]R:\>^'NH>)OV!/VI](^&E]KUQKGPS\4R1FU6Y/$/ MG.8TE"]$D20;7VX#*+/B%X6 M\!+:-XF\2Z/X<%XQ2V.K7\5KYS#&0GF,-Q&1P/455\0?%;P3X3UB'2=<\8Z! MHVJ3@-%8ZAJ<$$\@/0JCL&.?85\1?\%=)GM_#_PREC.V2.^O&4XS@A(B*Z/X M;_\ !.GPA\1_AY:>)_B7JNO:OX\\20)J=]J,5X(S;R2J'V(I4J=H(!W \C@* M, 137/!S>R=G^GZW]/,N;Y91BMVK_BU_E]YZC^U=\%_@]\7-:\(7OQ*\?#PA M=6"2G3(UUFSLA=JS1EB!.C%\%4^[C[WN*^@-=\1:1X/T2;5=;U6RT;2;95\V M^U"X2"",$A5+2.0HR2!R>I%?F_\ \%0]"L?"^O?!/1M,@6UT[3[.>UMH4Z)& MCVZJH^@ KZF_;^_Y,[\=_P#7&S_]*X*4GRX>,XO3FDOQ2O\ ,<5S8E4Y+5J/ MXK;Y'MK?$/PJOA:+Q,?$VCCPW*-T>L&_B^QN,D9$V[81D$=>H-,\(_$CPEX_ M68^&/%.B^(Q#_K3I&H0W6S_>\MCC\:_.?]C?]E(_M1?#C2_$'Q+UW5+CPAH3 M/I>@:!93>3%M5BTLC'!X+N1E<,2O+8 %"\4BO@JV>C G!&-90C3JGW"3Q-CKAT)!_.OC;X;_L!:'\6/#]OXZ^,NL:UXH\<>(K M=+VY5;OR(;(2*&2) HSE%(&,[1C 4 <^._ _P_J'[(__ 4"C^&FCZM=W_A; M6P(6BN&&98I(&EB9P,*9(W&-P XW=-Q%$::]I[&3][7TNN@Y3]SVL-8K[[=_ MZU/T]HHHK U*VH:E::19RWE_=0V5I$-TEQ<2".-!ZEB< 5Q5I^T#\+M0O5L[ M7XD^$;F[9MJV\.NVKR$YQ@*),YKXK\4? SXE?MD?M0ZY:?$6V\2>$?A;H;2' M3X3"T44T:MLC\DL#&9).79\,0OR^F/2_%_\ P2U^$6K>'9K;0I-9T'5EC/D7 MWVTSJ9,<&1'!!7/4+M/H135E!5)==;+?^O(3^-PCTZ]/Z\S[&5@RAE(((R". M]8#?$/PJOBY?"K>)M''BAEWC1#?Q?;2NW?GR-V_&WYNG3FOB/_@EC\0/$4J^ M/?AWK5[+?67AV2*2R61RXMLO)'+&A/1"44A>@.[UKR7]JC_A++G_ (*'R:;X M(U!M)\2ZM#9Z7;7Z\-;K/:K')(#U&$9CD.ZMIE#QS0N'1U/0@C@BOC[3_\ @EK\)_\ A&WM=5U#Q#JFO3*6 MFUPWH23S3RS+'M*XSDX8,>>2>M>0_L&ZEXC^!_[5GC7X(WFIR:GH,8N3&A)" M+-$59)T4GY"\9.X#J=O7:*<8QDW!/6S?D[;BG*48J=M+I>>NQ^DMM917-'G>U[>;M^7ZFDG:2BM]_)'UEH7B'2O%& MFQZAHVIV>KV$GW+JQG2:)OHRD@_G7Q/_ ,%;O^2+^#O^Q@'_ *335XYX9\'Z ME^Q)^W=X6\'>'->OK_PMXD>UCDM[EAF:WG=H@LH7"L\;@L& '3MDBO8_^"MW M_)%_!W_8P#_TFFHJ17)"I%Z-K[U)7'3DU.5.2U2;^33L?3?@/QQX<\!? WP# MJ'B;7]+\.V$FC:?"EUJUY':Q-(;92$#2, 6P"<=>#7H.CZQ8>(-+M=2TJ^MM M2TZZC$MO>6C(ZDA@?4&OGWXD?"4?&K]B&Q\-1Q"746\,6-WI_'(N8 MK='C _WB-OT8UY[_ ,$M_BLWB[X)W_@Z\E)U'PK>&.-'/S?99B73\G$J^P K MIJ1YZM;O%W^3=OOO^!RT7R4*+Z-6^=OZ^9]A:UKFF^&M*N=4U?4+72M-M4\R M>\O9EAAB7^\SL0%'N35?PSXMT/QMI*:IX=UG3]>TQV9%O=,NH[F%F4X8!T)! M(/49KXY_X*C?$JXT_P"&WASX/7::D_:: MDUC]D?\ 85T#PSX2GDL-1+6VCW6HVIVR1M*DDEQ*K#[I=U90W4;^#G%WMY M1_P!W!_2NCT77M,\2:?'?Z1J-IJMC)]RZLIUFB;Z,I(-?!W[,O[ OP7^)?P? MT+Q/J>JWWB[5M4M4GO)K74?+CM9V&7B"H,AD)VG>2203@9Q5GX?_ +'?Q*_9 MI_: MO?I_7F8>TTBM.W7^O(^B?VLOA=\-_BQX"TW2_B=XN_P"$-T2#45N(+W^T MK:Q\R<1NHCWSJRGY68X SQ[&O2/AEH>C^&?ASX8TCP[J']JZ#8Z;;VUA?>SFMF9=P23[-&H/EK%/EP]6IT4EIW]V]_T-Y1YJ MM.'=/Y>];_@GMGBSXH>#? ,D4?B?Q;H?AR249C75M2AM2X]0)&&:N>%_&WAW MQQ9M=^'->TS7[13@SZ7>1W* _P"\C$5^<7[%_P"RC\./VF/!VH>-O'WB34/% M7BZYO9A>Z\O M?-28_:[._P!1CC%N 00"[%3)$XRK(0Q^H/&OLU"2A4=F_N5S'GVO?]A:?^2UV5 !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% &#X[_ .1/U?\ Z]VJUX7_ .19 MTC_KSA_] %5?'?\ R)^K_P#7NU6O"_\ R+.D?]>,OS(3[! MU(_[:5\4R?&+4Y/@;!\-27_L^/6FU7S-W&TQA1'CTW;G^IK]?OC5\/8_BK\* M?$WA9U4R:C9.D#-C"S#YHFY]'"FOS"M?V"?CA-=0QR^#5MXG=5>9M5LB$4GE MB!,20.O S7UN3XBBZ+H5Y)-F&#]FA)1/S#?"]GX(\)Z M-X?T]=EEI=I%:1#_ &44*"?M@Z/U>A&F M]^OJ]QLG^K;Z&OQ8^!/_ "<;X'_[&2U_]*%K]IW!9& ZXK\POA-^QG\8O#/Q MJ\*Z]J7@_P"S:38ZW;W=Q2U:=*=9U))72W= MOYCAS:G.I02@FW?IZ'Z?U\9?\%0O^22>%/\ L.?^V\M?9M?,O[>/P=\7_&?X M=^'M,\':1_;%]:ZK]IFB^TPP;8_)D7=F5U!Y8< YYKR\')1Q-.4G9)H]/$)R MHS2WL_R/#/\ @FW\.O"GCK1?';^)/#&C>(7MKBS6!M5T^*Y,099=P4NIVYP, MX]!7VO8_ _X<:7<+/9?#_P +V-O@II/C.'QG MHG]C2ZA/:O;+]K@G\P(LH8_NG;&-R]<=:^L:[LTQ#GBYNG.\=-GILCSLLH\N M%BJD;.\MUK\3$50BA5 50, <"OF#]M']E_Q5^T9-X5?PWJ&CV(TI;@3_P!J MS2Q[O,,>W;LB?/W#G..U?4%%>71JRH5(U8;K_*WZGJ5(*I!TY;,_,7_AV)\4 MO^@_X0_\#+K_ .1J^A_V@OVAO%7[(_@GX>Z'9^'M.UEI-)2SEOYII/)2>".- M&55 4D'J,D$CL*^LZ\_^.'P5T+X\> [KPUK@:(,WG6E[$ 9+68 A9%SUZD$= MP2/>O1GF,\1."Q2YH)ZK;R_X)PPP,*"DZ#M)JR?X_H3Y M=W97\,.5[;DF9"#[#(]S7IWP!_X)PZP=>M-8^)\MK:Z;;N)/["M)A-+<,#G; M*Z_*J=,A2Q(R/EZU[-.G@,/7^N0JJW2/77\?E;YGESJ8VI1>%E3U>[^=_3YW M/9_ G@#4]<_X)\P^'9XW;4;KPY<301,/F^9GFA7\MGYU\??L#?$33?A[^T#: M?VO=QV%EJ]E-IAGG?9&DC%'3<3P,M&%R>[5^LD,,=O"D,4:QQ(H1(T "JH& M .PQ7P%^TA_P3OU;4_$U]XB^&;VDMK>R-/-H-S*(6BD8Y;R7/RE">=K%=O0$ MCIQ8/&TI5:\*_NQJW^5[_P"?X'3B<'.-"C[+65.WSM;_ "_$]+_X*.?$;2]% M^"/_ C O(GU?6[N$QVJ2 N(8V$C2$9^[E57//>"O^"=OQ<\1:O'!K>GV/A6PW#S;R[O8;@A<\[$ MA=RS8Z E1[BOTF^$GPMT;X-> =,\*:$C?8[-#OFDQYD\K'+R/[L?R& . *TK M3H8'!SPU*ISRF]U\O7HK$PC6QF*A6J0Y8P77Y_J_P/RU_;@\+S^$OVFO%;,I MCCU!XM2@;IN5T7)'_ PX_"OTX\$?&?PQXB^$%AXZ?6+2'2!8+/=S-,H%NX0& M2-^> &.N?K7#?M6_LJ:?\ M&Z':SVUU'I'BO3E9;.^D4F.1"Q:I;"(C^]AI ^/^ Y]J*(IPYHS[=]WWZW^\Y/X7V$OQF_:DT=H(7D M35_$G]H21GDK#YQFDS]$#?E7[+U\O?LA?L;I\ 9+CQ'XBN[;5/%]S$8$^RY, M%E$3EE1F +.V!EL# X'&2?J&N3-,33K2A2HN\8*W]?#?B!X;^(7AZ#7/#>MV.LZ3,F];JTF5U ]&[J1W5L$'@@5 M\T?M;?\ !/\ T+]H'4)?%'AN]A\+^-&7$\CQ$VFH$#@S!>5?H/,4$XZJW&/A MG6O^";?Q[TN_>WMO"EGK$2G NK+5[58V]P)9$;\U%=GM%6@HSTDCG=/VQNOM>J:KI$X:-"H*K;;AE7Y)9UY VJ#SD# MV_\ 8!^+7Q+^-'PIO_$?Q!N+:\@-Y]FTR[2S6WEN%0?O7?9A"-Q"C:HY5LYK MY6^"W_!*GQ=K&K6M[\2M4L] T=&#RZ;ILPN+R7U0N!Y<8/\ >!<^W>OTS\+^ M%]*\%>'=.T+1+&+3=)T^%;>VM81A8T48 ]_G_@9O M'_?:<^EEK_X"?G)_P3)A23]JW2689,>FWK+['R\?R)K]CJ_-?]A/]D'XM_!O M]H"R\2>,/"?]CZ+'874+77]I6D^'=0%&V*5FY/M7Z45U8B2ER6?3]6<="+BY MW77]$?AE^T5H][\'/VMO%4DT#"2R\1'5[<,/]9&\HN(R,]$]*\2:%=QWVE:E;K<031L""I'0^C Y!'4$$&O"_VNOV+]!_:>L+;4(;Q M?#_C*QC,5MJGE;XYH\Y$4RC!*@DX8'*Y/!Z5\.V_[$W[5?PS-UHOA.YOETFX M;,S>'?%*VEK,2,$LCRQ,>/5*QIR3HQHRWCM_7R7H;U(OVSK1VEO_ %]Y-_P5 M*^)NE>-?C=I.@Z5<1WG_ C=@UM>2Q-N5;B1RS1Y]54)GT)(Z@U]K?LJ>![W MX?\ [$>DZ=J*/%>W&C7FH/$XP4$_F2HI'8['7/OFOG_]FG_@F%>Z3XEL_$WQ M:O+.[CMI!/%X=LY#,LT@.1]ID( *@]47<&[MC(/W_P"*]/FU#PGK%C:1[YY[ M*:&*,$+EFC(49/ Y(J:R5/"2HQ=V[O\ -_BV53;J8F-5JR5OT7Y'XM?L$_\ M)V_P\_Z^9_\ TFEK]JO$W_(MZK_UZ2_^@&OS$_9'_8J^,WPQ_:)\&^)_$W@W M^S=#T^>5[FZ_M2RE\L-!(H.R.9F/S,!P#UK]/])?LJ?L2_&GX;?M">"?$WB/P9_9VB:=>-+=77]J64OE MJ8G7.U)F8\D= :^I_P#@HE\#_&WQU^&/AK2? ^B_VWJ%GK NIX?M4%OLB\B1 M=V970'E@, YYJL3)2IP2?VOUB1ATXU)M_P OZ2///^"1W_))_&__ &&T_P#1 M"5\,^,(9_@C^UI?2ZE&T9\/^+1>L,9+1)="56'KN3:1]:_2+_@G5\"_''P)^ M'OBK3/'.B?V'?7NJ+"0:7]LS]A2R_:.N(_$_AR^ MM]"\;P1"%WN5/V:_C7[JRE02K+T#@'C@@\$.I4]GBHUHZI)?E'_(5.GSX>5* M6EV_S?\ F?4^FZU8ZQH]MJME=PW.FW$*W$5U&X,;QD;@X;IC'.:^-=#_ ."H M7A76/B7+X23P5J]XLNJG3-/OM*N8KG[9F7RXY C>7M#<'&3@'J:^6U_8O_:P MT?2)O"5DFJ#PM(6C>SM?%4*:?(I/),!G7(/H4_"OIG]C?_@GC)\&?%%MXW\? M7UGJGB.T!.G:;8EGM[-R"/-=V WR ' &U3DY8X(484^?FD_=[=0E*?)RQ7O M=^A]Q4445RG0?BS_ ,%&/^3O/&O_ %SL?_2.&OU;_9E_Y-S^&'_8M:=_Z3)7 MP;^VE^QI\8?BU^T=XH\4>%/"']JZ%>I:B"Z_M.SAW[+:)&^2296&&5AR.U?H M)\"_#>H^#?@OX$T'6+?['JNF:'9V=W;[U?RY8X45UW*2IP01D$CT-;TFE@E% M[^[I\F9U=<2I+;E_2)RG[8__ ":Y\3/^P+-_2OS8_P""8O\ R=5IO_8+O?\ MT 5^H'[2O@_5_B!\!?'/AS0+3[?K.I:9+;VEMYB1^9(<8&YR%'U) KXB_83_ M &0?BW\&_P!H"R\2>,/"?]CZ+'874+77]I6D^'=0%&V*5FY/M2PS4:DV_P"7 M])$XA.5."7\WZQ.?_P""MOA&YL_BAX-\3"(_8;[26L?, ./-AE9R"?7;,OY& MN^_8F_9>^ GQX^ ^DZQJ_A1-4\4VDDMIJ[_VM>1,)0[%"4CF55!C*$8 '7OF MOKW]H;X!Z!^T9\.;KPKKK/:MO%Q9:A"H:2SG (610>HP2"O&02,@X(_-ZZ_8 M%_:2^#WB&Y?P!>R722@Q_P!I>&M>73GDCSP)!))$P_WYZTJ$E&$J4N]T M_P ?U?X,NM%SE&JO1K\/T7X]SZ.\9? S]BCX>^-)/"?B2TT[1=>CB2:2VN]: MU-%17&5W2>=L!(YP6S@@XY%?27AOPGX-\%? &YTKX?I;KX072KN;3S:7;W43 M)(LDA996=BP+,QSN/6O@;X/_ /!,7X@>-/%T6M_%S4H]*TYYO/O;9;[[9J-X MWMXAA(HTA*JH'8 M"L\5[N&DG*[:?ILRJ'O5XVCHFO7^OZU/Q _9:\?V/PO_ &A/ OB74Y!!IMGJ M*K=3'I'%(IB=S[*')_"OW9O=YO8(=+A@-U)>/(!$L07<7+=-N.< M^E?@Q^SO\-K'XP?&?PQX-U*XFM+/6)I+=[BWQOC/E.RL,\'# ''?I7T=XW_8 M6_:5-IZ$@*P!Z$]:[JWO0C'9ZV M?W?DZTO^)X7I_F?'+]K%)=-C:9?$GBTW$0VD'RI+HN6('3"9)^AKZN M_P""M7Q(UB/Q%X0\"PSRV^AM9-JMQ$A(2XE,C1IN]=@0D#U?/I7LO[%'[!H^ M &HGQCXRN;75/&;1M%:06A+P:\- M:9=:->V^F>+]&WBTEN]P@N(GP6AD*@E>0"& .#D8YR.:KRPC2IQU4'K]UOG: MR?Y;'13YISJU9:.2T^^_XW:/ /V'?V&OA=\3?@[I/COQ?'<>)]0U&28&P%V\ M%M:^7*R!2(BK,WR[CN;&& QW/S!^W7IO@O0?VAM5T3P)8:=IVBZ3:V]E)#IB M!8A<*I,F2/O."VUB23E<'I7H7@G]B#]JCPW<7.A:-)>>$M'O7(NKBV\3I!9R M\8W21P2EV&/6,G':M'XO?\$P/B'X5M?#:^!XF\.5))X _T\5^Q/[,>D^*/#OP'\&Z)XRT M=M#\0Z38IIT]J;B*<;8ODC_X)T_$JZ^+.N^)_AW:6 M_B'2=8OI-02W2^BM;FTDD8NZGS612 Q.UE8G&,@8Y;J*&.]KNKO\TQ1IN6#] MGULOR:/U$F_U3_[IK\+?V5_^3KOAW_V,<'_HVOTD_87^%/QG^'=OXPN?BYJ% MY>S:DMJMC'J.LG49XO+\W<"VYU53O7HW;I7RA\ ?V'?C9X)_:#\&>)=:\%?8 MM$T_6HKNYNO[5L9/+B5\EMJS%CQV )JWR9] M?_\ !2?_ )-(\3_]?=C_ .E,=?,__!(=U_X3;XBKD;CIUH0N>2!*^3^H_.OO M?]H#X2P_'+X0>)/!4UR+)M3@ ANBI813(RO&Q Z@,JY'IFOR_P!'_8-_:;^' M/B:X_P"$5M)M.=U-N^L:'XCAM$EB)&03YJ2E#@<%>PXK+#24)33Z_JK&N(CS MQ@UT_1W/K_\ X*G?\FRP?]AZU_\ 0):\M_X)!_\ (-^)_P#UUT_^4]>H?M*? M 'XD_$#]C/P7X$L-/7Q#XVTU[ 7R)?QJ',4+H[^;,R!CDCJJG_!.']GK MX@? 6S\=Q^.] _L)]3DLVM!]LM[CS @FW_ZF1\8WKUQUJZ*5-8B-^NGG\.WW M&=>]149)>OEK(H_&K]I?]EKXU>)-/\(>,=-NO$%Y]M&G)JG]GR6;:>[/M8M. M[1R(BMRP&1QD@USGC[_@DCX:ODDN/!?CG4=*;!9;;6;=+N-CV D3RRJ^Y#'Z MUH?M++[QI\.;ZRTO5[]S-J&CWY:.">4\M+$Z@[&;J5(P22($\/!/LXM!XPB%D(\8V^5]I^[CMM_"LJ=G3T=I=>W] M?TS6I?G[Q_'^OZ1XY^S7K^N?"O\ :@\(QZ3>9O8]>BTFY^QR%HKJ)YQ%*F1] MY&!)''H>H%?NM7PU^QS_ ,$[9O@WXLM/''C[4+/4O$%GEM/TO3RSP6KD8\UW M8#>X!. !A3SEN,?I/$?@WPI_;&C'3+:W%S_:-I!^\ M3?N&V656XR.<8KC7\2#\_P!&=/V)+R_5'UI^Q1_R:K\-O^P6/_0WKT+XH>)O M"GA;P+K%WXTO+&T\.FVD2[&H.HCE0J08\-]XMG 4UOP/,/@(UXW[0G@,Z )8[H^(K/[*H)+!?M"\$CMMSGVS7[ MZ5\3_L8_\$^Y/@9XDC\;>.+^SU3Q1 C+86-@6>WLMPPTC.P!>3!*C 7)Y;( M(^V*NM./)&G%WM?\;?Y"IJ3G*HU:_P#P?\PHHHKD.@**** "BBB@ HHHH *\ M@^-?^LU?_L6[W_T7)7K]>0?&O_6:O_V+=[_Z+DKHPW\>'JOS.3&?[M4_PO\ M(^(Z***_>S^4@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "OT8K\YZ_1BOSWBS_ )OS7_ .";O[.OP[^.7A_QS<^./#<>O3:? M=6L=JSW4\/EJZ2%A^[=^&OB#%XI\,:SX:ENKNS:!-8T^6T:4*DH8H M)%&X#(SCU%70TE6?]V/_ *4S.M>U%+^:7_I)[+#^P'\ K>9)%^'=J64Y >_N MW7\09B#^->N^!_AIX3^&>GR67A/PWI?AVVD(,B:;:)#YI' +E1EC[G)KI:*7 M-*UKE7?\%)/!OB#QU^SS#IOAO0M2\0ZB-:MI3::59R7,NP)*"VQ 3@9'..XKU_\ M9ETF^T']GOX=Z=J=E<:=J%KH=K#<6EW$T4L+B, JZ, 5(/4$9IT?X-7_ !K_ M -)"K_$I_P"%_P#I1\Q_\%;O^2+^#O\ L8!_Z335[7XD^-^G_L]?LC^&_&5_ M;&^>WT'3H;2R5]AN+AX$")NP<#J2<(;7 M2M.N+9+U6C"74,"@Q2C&5R"ZGC*D].,5"NJ%2W\\?NMK^ W9XBG?^67WWT/G MWP'J/[8/[56@CQ9HWBW1_ /A6_=C91;5M]Z E28RL4LQ&01EV&<9'%++'3-T5C<6]C/)Y2EB=IG@#QNH)..A'<^B?'+X6?M M,_M3?#_5/$'C72;;PKHVAP-?:7X-TV)I;J_F'&3&K.Q?86 WG.>%C^8FMZEH MZTK,JP M[#=3 ARW&"#CGUKPKQQ_P3-\'_$">7Q5\'/B%#IMM+-))!;JZWMFDH8Y6*XB M;=&%((P0Y'KQ7K/[)?PUN?&W[$Z?#CQQH.K^'Y6COM,NK;5+&2TG57E>2.5% MD520!(I#!G^)7@B6Z:>V;3X);H<]7C\DF2 M$L -RNA&0<=2QNM9XFI*]GNGWU_R_KQAUG6 M/$:^+/!\4Z12RW-V=3M,GA8V,H6>)3T!7:,X&><'UC]M'XC?\+S_ & ]$\<@9.*^R]'_9R\-6/[.T'P?N@]YH(TS[!- M.0%D=R=S3CJ WF'S!Z''I6552E1?.O>4DUWLM=?G_6YI3:C67)\+33[7>FGR M_K8^(/V=/V(_$_Q8^#/AGQ1H?Q\UK0-/OH&(TJTLYFCM'61E>,%;M!PP/\(Z M]*[;Q'_P3H\3V6@ZA/K_ .TQJT&BI"QO)-2LY5MEBQ\WF%[[:%QUSQ7)^#?! MW[2O[">L:GI7ACPR?B=X"NIS-''9PO< D\;UCC/FPR$ !AM9#_M8S4_Q(\1? MM1?ME6"^"XOAO-\./"EQ(AOY-2AEM/,4$'][),%9T! .V),G'.:UJ2=1WI;/ MOT];D07LU:KNNW7TL?4'[%/P/TCX$_#?5M*T/Q[8_$&POM2:]&H:?$B11L8H MU*?)-*"<*#G(ZCBOH6O-_P!GOX):7^S[\*])\':9*;HVP::[O67:UU+-(\"^&]0U_7]0ATO1["(S7 M-W<-A$4?S). .22 .37YP^-OB=\3/\ @HSXXG\%?#^&;PQ\*[*9?M^H7 *B M50\$>$/!WB;6O#%O -1OKC2-*N M+B&>X9F5$9XT(.Q5)VYZR ]A7!?"G]H+]HSX+^!=-\)^&/V=9[33+),;F\+: MJ9)W/WI9&##<['DG\!@ "HHQ4KU):VV7ZO\ 1?/TNK*4+0AUW?Z+]?N]?OKX M#_ +PI^SQX)A\.^%[3:6P]YJ$P!N+V7&#)(W\E'"CIWKR;_@I1_R:1XG_P"O MNQ_]*8Z\,_X;6_:N_P"B S_^$MJW_P 77NO[;FA^)OB-^QW>VVG^']0U+Q'> MKIL\FDZ;9RS3J_FQ/(HB4%_E^;.>0!S2K1G*TY/[4?S0Z+C%N$>TOR.M_8AO M[74/V4_AQ)9E3&FF^2^TYQ(DCJ_X[@U9/_!0+4K33OV2?'8NW5?M$=O!"K8^ M:0W,6T#WX)_"OECX)V7[2/[(_P /='O=!\%77CGPAK4(O;GP[/9S+?Z5=$D. MGE#]ZA. <[&4CDA3R;'B;P'^T1^WEXFTFR\9^&Y/A?\ #RPG\Z2"ZA>!L]"W ME2'S)I=I(4E50<],G.N(I^WJ2Y7HWKY:Z_\ [Z,RP\_8PBY+9:>?;_@]M3Z M(_X)N:?3Q!NZ&X< _B5-?3]8W@WPCIG@'PGI'AS1K?[+ MI6EVL=I;19R0B* ,GN3C)/R _P!YAM0'MM^M?H%X@^#_ (0\2?#*?X?W M6AVJ>$I+7[&NG0($2)!]TIC[K*<,&'((SUKY[_;J_8WOOV@K73?%7@^>*U\< MZ/%Y212OY2WL(8LJ>9_!(K$E2>/F()'!'D&D_M1_M=>#-'3PUJ7P9NM>UFU1 M8$UF31;N57QQND>%O*<_[2LH]:SA:5#V76[?K?;[C2=XUO:K:R7I;?[SP+XE M0_$K]@[Q#XY^'=G?-<^%/%UA+%;7,H/ESPO\GGI@_).JDQM]>XV&ONC_ ()N M_"-OAG^SM9:K=*G]I>*IO[6D*D$K 5"P*2/]D%L=C(17@WAG]@WXI_M+ZUJW MC;XZ^([C0]2N;9HM/LH3')-$V#Y>Y%S'%"I.?+4[FRV=IY/I/["?PW^.OP3\ M9>(/ 7BVTA?X=:>K2VUY-(70RN25-FPY*-RSHP&T_P!UB0W3%^XX3?OV6ODF MW:_?;\O3&=G)3@O=3V\VDK^G_#^OVW7F/[3W_)N?Q+_[%Z^_]$-7IU>=_M%: M7>ZY\!?B%I^G6D]_?W6A7D,%K:Q-)+*[0L%1%4$LQ/ &37G5OX1 MGFOK6U_8'^ =G<)-'\.[1G0Y EO;N1?Q5I2#^(KS;_@F#X#\3> /A#XHL_%' MAW5O#=Y-KAFBM]7L9;61T\B(;E6102,@C(XX-?9->CB)6J>Z^B_)'GT5>'O+ MJ_S9@>#? /AKX=Z6=-\+Z!IOAZQ+;VM]-M4@1FQC4;F6-20,D#)XR17#-MV;[K\T=E.RO;L_R9]+?!.)(/@SX#CC7:BZ#8 #T_ MT=*^*_\ @KQ_R+?PT_Z_+W_T"*OMWX2V5QIOPJ\&6EW!+:W=OHME%-!,A1XW M6! RLIY!!!!!Z8KY#_X*D_#OQ7\0= ^'L?A;PQK/B62UN[MIUT?3Y;LQ!DBV MEQ&IV@X.,^AKHKZXI/\ O_J88/2C%/\ E_\ ;3W;]H3]H:R_9I^!-GXHFLQJ M6HS1P66G6+.46:=H\C<1T555F/KC'4U\Q>"]-_;'_:5\-VWBF#QSI7@3PYJJ M^?9VZA;9S">C1^5"\NT]O,D!(YZ$5[_^UY^SEJ/[1/[/^GZ%I,B6WB/2F@O[ M**Y.Q)9%B*-$Q/W25 M3^!NJ^*!H\*V5E M?1Z?]_\ MK'GO[87[*'BOX4_"6+QEX]^+FJ^/-8:_ALK:QNS*\4;.'9B'EE8G"H> JU]T M?LT?V(W['?@.'Q&]DFAW'AZ*"[_M!U2!HW4JRN6(&"#CGUKX]_:(^"_[2O[1 MG@&_\;>.M,ATN/10CZ1X%T6%I[B8NZ*\GEHSG<$)/S,S?*0$4&OICX.?"=_C M#^PSH_P[\8:5JGAN]?3&TZ6'4[)[>XM9HI2891'(JD@%8V'J.,]:4N;ZO4B[ M-W6GE9_UZNQ2Y?;TY*Z5FK^=U_7R/#_%G_!,+1/$3)XJ^#'Q)6TM9F::Q2>3 M[3 &#$?NKR%MP52"OW7/'+$UQ/B/QS^U9^Q"^GW_ (KUA?%_@]KE8/,O;K^T M+:9B"?+\UP+B([0<9PO'0XQ6_P##76/VG_V+;.;P6OPWE^(OA*&>1[*338)K ML(&.28GARR(Q);;(F02<8RA%KFNE3E>/GVZWOU_4GW=?:JSUV_"UCI/\ @HQX MM'Q6_9#^'7C32X9(=+U+4K6^DB?EHO-M9<*WT8E<_P"-<]\%_P!A'Q7\1/A/ MX3\2Z/\ M":[I>G:EIT-Q%86]E,8[7*C=""+Q1\C97@#[O05]F>*/V+O^"=.OV/AR]F\4_M,ZE;Z % NI-7M)%M0I8 "0R7VW M!) Y[D5],?L?_"#3?@E\'T\.Z1XSM/'=@U_-=QZK91JD7SA/D 660<8SG=_% MTKY$^(47[3G[<#6GA>^\"O\ #3P2+A9+K^TH9+4';R&E\W$DNWJJH@&<9Z9' MWI\&?A3I/P3^&NA^#-%W/9:9#L,\@ >>1B6DE;W9B3CMG':B\HPES.U^FFV^ MOS_KVM_P.UKG?B#\0= ^%OA'4?$WB;48]+T:PC\R:>3OV"J.K,Q MP HY).*Z*OS;_P""EEG\5?BA\0]+\*>&_!'BG6/!^CVZ7)FTO2+F>WN;N0'+ M;T0JVQ,*.>"7]:Y7=M177^OZ\SIC:SD^ADZMXD^*/_!2[QQ+HVAI-X.^$&F7 M(\^:4$JQ!R&EP?WTY'(C!VID9/\ $?T!^#GP9\+? GP3:^&/"=@+2RB^>69\ M-/=2X^:65\?,Q_(# %? ?P_\ VF/VD?A?X/TSPQX;_9RDT[1].B$4,*>% MM6R?5F._YF8Y)8\DDFNB3]M3]JUG4'X S@$\G_A%M6_^+KNY/^75+9_CYLY5 M+F?/4W_!>A]&_MG?M5)^R_X$L;FQL8=4\3ZQ*\&G6UP2(4" %YI,8)5=RC:" M"2PY'->!:#\,_P!LWXU:'::SJOQ*L/!&G:@@GCLHV%M_:,\ Z#J'A=8Y?%&@-))'I\L@B%U%*J[T5F( <%%(W$#J,] M*\I\%?M6_M0^%]"M/#.I_ ;4]=U>SC6UCU9]-NX8Y-H"AI"JF-CQRRLJGVKF MI)"_MM?LRZW\#_#GAK6_%GQ-U/XA>(=6NI(!_ M: D(AC1 S$-)*[-\S+SP.>E?JY\,?^2:^$_^P1:?^B4K\S_VH/V=_P!HSXM> M%X?B3X[L#J&LQW,=E9^"_#ML]U)8VSABT@2(OCYE3/+L=PW,-H%?H_\ !"\N M[[X.^"I=0L+S2[\:/:QW-GJ%NT$\,J1*KJZ, 5.Y3V]ZU5_8R4GKS+3MH_Z? MFS*5O;0:6G*]?FOZ^5SMZ_-?]M#_ )2&_!W_ *Z:-_Z<'K]**_/S]K;X9^,/ M$G[=?PIU_2/"FN:IH5D^DFZU2RTZ::U@V7SL^^55*KM4@G)X!R:G#Z8FBW_- M^C-JG^[UE_=_5'H'_!4[_DV6#_L/6O\ Z!+7M/[)<:Q?LS?#)4&T?V!:'\3& M"?U->7?\%)/!OB#QU^SS#IOAO0M2\0ZB-:MI3::59R7,NP)*"VQ 3@9'..XK MU_\ 9ETF^T']GOX=Z=J=E<:=J%KH=K#<6EW$T4L+B, JZ, 5(/4$9J*/\&K_ M (U_Z2%7^)3_ ,+_ /2CY8_X*Y?\DK\#?]AJ3_T0U?3.E?\ )J%G_P!B2G_I M *\$_P""HG@#Q1\0/AMX-M?"_AO5_$ES;ZM))-#I%C+=/&GDL-S"-20,\9-? M2O@_PS<:E\ ]$\.W:2:?=W'AF"PF29"KPNUJL;!E/(*DG(/I64DY86M%;M_^ MVE)\N*HR>R3_ /2D?)W_ 2._P"23^-_^PVG_HA*\(^/'PYO_'W_ 4@U7PR MWB>X\%W6L7,(L];MXV=X,_,5V<,.6_"M7X WG[1G['.O:KX1L_A3 M?:_HU]J44MW=Q:/=7L>T81I(9H#MP4YPV<8&0.17TS^V]^QUJ?QRN-)\=> [ MM-.^(&C(JHC2>1]L1&WQ[9/X)4;.UC@]II_CC0QXM_:5AGU MZ!X[FSL]:M0+IT$F1Y8DOBV"RD9 QD'TK7TG]K+]JGP;I?\ 86O? K4/$6MV MZ")=6M]+NFCD8#&^0PAHW/J491]*?\"_V4_B?\8OCI;_ !C^.\::>]E*EQ8: M&2N]F3F%?+4D11(>=K'>Q'S#DDE-RC44N966M]/P\Q5%&5-Q:=WI;_/R*_\ MP5X_Y%OX:?\ 7Y>_^@15][^&5">&]*50%46D0 X'R"OBG_@J3\._%?Q!T#X M>Q^%O#&L^)9+6[NVG71]/ENS$&2+:7$:G:#@XSZ&OMG0(WAT+3HY$9)%MHU9 M6&""%&017/3_ ($E_>?Y'14_B0_PO\S\Z_\ @K%_R/GPD_W+O_T;;U]+?M_? M\F=^._\ KC9_^E<%>&_\%-OAGXP\?>-/A?/X8\*:WXCALTNAZSJMQ%:"&QT^W>>>0BZA8[40% MC@ DX'0&HE_N<%_?E_Z4BX_[\GTM']#$_P""Y^V3#^ M0%>%_P#!7K_D6?AK_P!?E[_Z!%7T5^P;X9UCP?\ LL^#M)U[2;[1-5@:\\VQ MU&V>WGCW7&-9\2R6MU=M.F MCZ?+=F(,D6TN(U.T'!QGT-;8S7$:?S&6%T@[]I?J?9W@C_D2] _[!]O_ .BU MKX"^*G_*5SP9_N6O_I+)7Z ^#X)+7PEHD,T;131V,"/'(I5E81J""#T(-?$/ MQ*^&_BZ^_P""F/A+Q1;>%M:N/#,"6PEUJ+3IFLX\6T@.Z8+L&"0.3U-:2:^O M0?3G?ZF4?]TDO[J_0^]:9+*D,;R2,$C0%F9N .II]175LEY:S6\HW12HT;C MU!'*]GR[G2K75]C\\IOVJOCI^UA\3M9\-_ @6'AGPUI3'S-8O(XV=XRQ5 M9)7D1]N\@E4C3<,').#CH/\ AB#X]>/TE7XB?M!7L5E(/W]GI$MS/#(O<;"T M*#_OD_2O,/#/PQ^/G[!OQ/\ $%UX(\&3?$'P?JSB/%E:R77GQ*S&(LL/[R*5 M S#)4K\Q^]QCT_4/B%^U7^TYILWAG2OA_%\(] OU,%_K.K++#?O+UKHY5[./L=7;KW\S.3:J2]H[*^ENWEW.&_X)0VL%C\3?BK;6LK3 MVL-O!'%*V,N@FE"L<>H -7_&T:R_\%:O#X89 $##ZC3V(K1_X)\_"+QA\!_V M@OB)XO%;1:]MAY7NN5Z_>9-?N\ M0K6\O_ ?O/O>OS:^&?\ REB\3?\ 72]_](A7Z2U^?_P]^&?C"R_X*;>(?%-Q MX4UR#PQ+)=F/6I=.F6R?=:!5Q,5V'+<#GKQ7/0TKW?\ )/\ )%XC6C9?S0_, M[G]L3]L3Q5\.OB!H_P *?A=I<.I>.M56+==3H)/L[2G$4<:$A2Y^\6?Y5!&0 MCW$DNO%EYXTU2;4-,OKW5+U"CM(]R1MP7<_=53RQ/-?2'_! M6[_DB_@[_L8!_P"DTU>%>-?V)8^5.F86,:$#$8&,*%&"%R%S7TC_ ,%/_ ?B;X@?"/PI:>%_#NK>)+N' M7!-+;Z38RW4D:?9Y1N98U) R0,GN155&WAZ:;N^9_G'\N_7( =/E MN$:,>@-?>OPELKC3?A5X,M+N"6UN[?1;**:"9"CQNL"!E93R""""#TQ7R5_P M5(^'LTG@'PM\3-*D^RZSX5U%(S.I 812L"C#/4K*J8'^V:JI-4\7[1[-M/TE MI^=C.C!U,(J:WY4UZQ5_\SDO#J&2!BJ#TR; MAI''J(Z^T?C;H?@/Q7\/=1T'XBW>FV?AS4%\N234KM+958+M34MKGC*[;499I,;S I*Q9/N3(_\ VTKT;]L+]G!/ MVE_A/)H5M<166OV,PO=+NI\^6)@I4QN0"0CJ2"0#@X.#C%95X^SA&CORVOZO M63]?\C:E)5*DJJTOMZ+2*_KN?*GB+_@ESXD\,Z@NN_"#XHM:NV'M?MSR6LRH M1D$75MG=GU$:BL'3?VEOVA?V._B!H/A_XQ.?$?A>^8*LUW)'<2/"&"O+#JG?VL4W>G?6_;_,PE;D;:M.W3O\ Y'??\%8G$GP"\,.I MRK>((B#_ -N\]>^?!'^Q&_91\ P^(WLDT.X\*6,%W_:#JD#1O:HK*Y8@8(.. M?6O'_P#@IMX#\1^._@EX=T_PMX>U3Q%>0Z['*]KI%E+=2)&()AN*QJ2%R0,] M.17I.A?!>+XI?L:^&OAWXEM[C2IKKPO8VLJW$)2>RN$AC*ED;!#)(HRIQT(- MJK7]Y:?]NG2[^VHMNWNO7_MX^9O%G_!,+1/$3)XJ^#'Q)6TM9F::Q2> M3[3 &#$?NKR%MP52"OW7/'+$UQ/B/QS^U9^Q"^GW_BO6%\7^#VN5@\R]NO[0 MMIF()\OS7 N(CM!QG"\=#C%;_P -=8_:?_8MLYO!:_#>7XB^$H9Y'LI--@FN MP@8Y)B>'+(C$EMLB9!)QC)S)\0M)_:2_;JDTOPWK'@,?#+P1;7BW-Q)J4,D# M;@" ["7$DI 9MJH@&3\QZ$;+FNE3E>/GVZWOU_4Q]W7VJL]=OPM8^_\ X9^. MK3XG?#WP[XLL8G@M=9L8KU(9#EH]Z@E">Y!R,^U=-7/_ _\%V'PX\#Z%X6T MO=_9^CV45E"7^\RHH7_["T_\EKLJXWX:?\>VO?\ 86G_ )+794 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/CO_ )$_5_\ KW:K M7A?_ )%G2/\ KSA_] %5?'?_ ")^K_\ 7NU6O"__ "+.D?\ 7G#_ .@"@#4H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "N.T#_DI'BG_KG;?^BQ78UQV@?\E(\4_P#7.V_]%B@#L:*** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "L+QY_R(_B+_L'7'_HIJW:*BI'G@X]RX2Y)*78_#C]AO\ Y.P^ M''_80;_T3)7[CT45U5*O/%1MM?\ &W^1S0I\LG*^_P#P0HHHK V"BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *\@^-?^LU?_L6[W_T7)7K]>0?&O_6:O_V+=[_Z+DKHPW\>'JOS.3&? M[M4_PO\ (^(Z***_>S^4@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "OT8K\YZ_1BOSWBS_ )_:&N50#(+R2;$4;5+[8\$LQ'IQ^ MHE%5"T9\TE>UK+S7Y^@I7<>6+L]=?)E'0]%L_#>BV&DZ= MM86-O':V\*CA( MT4*JCZ "KU%%)MR=WN"2BDEL%%%%(84444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !7'?$O\ X]="_P"PM!_)J[&N.^)?_'KH7_86@_DU '8T444 M<;\-/^/;7O\ L+3_ ,EKLJXWX:?\>VO?]A:?^2UV5 !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% &#X[_Y$_5_^O=JM>%_^19T MC_KSA_\ 0!57QW_R)^K_ /7NU6O"_P#R+.D?]>0*6@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KC MM _Y*1XI_P"N=M_Z+%=C7':!_P E(\4_]<[;_P!%B@#L:*** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\@^-?\ K-7_ .Q;O?\ MT7)7K]>0?&O_ %FK_P#8MWO_ *+DKHPW\>'JOS.3&?[M4_PO\CXCHHHK][/Y M2"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH *_1BOSGK]&*_/>+/^7'_ &]_[:?KG /_ #%?]N?^W!1117Y\?K@4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:=K_P @[\?Z MUF5IVO\ R#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** +]O_ *E:DJ.W_P!2M24 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=\2_\ CUT+ M_L+0?R:NQKCOB7_QZZ%_V%H/Y-0!V-%%% '&_#3_ (]M>_["T_\ ):[*N-^& MG_'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110!@^._P#D3]7_ .O=JM>%_P#D6=(_Z\X?_0!57QW_ ,B?J_\ MU[M5KPO_ ,BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ HHHH **** "L;Q M9XLT[P7HLVIZG-Y4$?"J/O2-V51W)I_BCQ1IW@[19]4U.<0VT0X'5G;LJCN3 M_GBOC+XI_%*]\DQ6L>5M+)6RL:_P!6/<__ %A7%B,0J*LMSQLRS*&! MI_WOZU?]:FWJ_P ;O$.H>.(O$$-Q]F,&4@L@GN#V/?\Q7YZR7TTESY^[#CICH/:N[^'_P 0 M+_PKJ\.IZ9+Y5S'Q+"WW)4[JP[@_I7E4<5.G*\W=/<^*RS/I1KR51W3?]-?Y M'WQ17,^ /'VF_$+0TO[!MDJX6XM6/SPOZ'U'H>_Y@=-7T$9*2YH['Z7"<:D5 M.#NF%%%%46%%%% !1110 444UW6-69F"JHR68X 'K0 ZBO"/B)^UAH?AJ:2R M\/6_]OWB$JUQOV6R'V;&7_# ]Z\:U/\ :J\?WTCM;WMGIRL>$M[1&"_]][OU MKCGBZ4':]_0^9Q7$6 PLG#F30Z??H=!U>0[4AG?=#*W8))@XSD?2LZE^6\=UK]W^>QI3:YK2V>GWGYN?\ !)GX MG_V3X\\5> [F7$.KVJZC:*QX\Z$[7 ]V1\_2.OU"K\&OA+XFO_V<_P!H_1=0 MU -;W/AO6S:Z@@R/W:N8;A?Q0O7[JZIKUCH_A^[UJYG5=-M;9[R2<'Y1$J%R MV?3:,UWXB494XU[Z6_+K]UON.*C&4:DJ+6M_^ U]_P"9^5G_ 52^*7_ E/ MQJTKP?;3;[/PS9 S*IX^TSX=ORC$7YFOIW]COX'WGA;]B'5+:VL_,\1^--,O M+\1$A&;GQ9KK338/,-NSEWQ M[)$#_P!\U^TWQ.4^%_@OXJ72'?3CIV@70M&MF,;0>7;ML*$:3L:0E[2<*<5\3MZ'WG17Y(?L$?&WXB^,?VHO"NE M:_X^\3ZYI)]!/^"??QF^.GA'3_',FMZ*J M:O"+N!M=U.>2ZFC;E7)2*0#<,'YFSSSBF_!GX@_'C]ECXU'PH]AXBU^UTVY2 M'5/#$"RW\$L#8.^$*&"DJ0RNN,\ Y&16BHKG]FY6D2ZCY>>*NC]B:*BMIQ=6 M\4RJZ+(@<+(A1AD9P5/(/L:EKGVT9JG=71E^*?$NG^#?#6J:]JTXMM,TVVDN M[F9OX8T4LQ_(5^6W[,JZE^V9^VW=>//$<32Z1HS'51:R'=';QQMML[<=N&*L M?4HY[FOI3_@J1\2IO!_P"M/#MI*8[CQ-?K;2E6P?L\0\R0?BPC!]B:R/^"4/ M@./1?@MX@\4O&!=:YJAA5\(=#NOMVCZEJ M\]S:7/EO'YD;.2K;7 89'8@&HH1DL5!M:6?YQ-YR7L6KZW7Y,_=-O^2=G_L% M?^T:_G^\(^$]6\>>*-,\.Z%:_;M8U.=;6TMO,2/S)&.%7Q'S#L:_4G_AXE^SW_ -% _P#* M+J'_ ,CU\)_\% OVH/"W[2GB/PGI/@>"YU"RT?SA_:$MLT;W4LQC 2-"-^T; M!U )+=.,E*I5YXI1W+]G3<9-L_1?]G/XN67[47P#LM=O[*.)]0AFTW5K)>8Q M*!LE"_[+ A@#R X%?CEKECJO[-O[0=Q!'O74?".NAX23@R+%*&0_1T"GZ-7Z MU?L'_!O5?@G^SSI6EZ[ UIK>I7$FJW5J_P!ZW,@4)&P[,$1,CL21VKXN_P"" MK/PK_P"$;^+6A^-K6';:>(K/R+EE''VF#"Y)]3&T?_?!HE)4,6I0ZZ?/?[D[ MKYBIQ=;"N,_7Y;?BK-^A^HOAGQ!9^+/#>E:WI\@EL-2M8KR"0'[T_\ @K5\4/MOB3PA\/[: M7,=C"VK7B \>9)F.('W"K(?^!BL,532J>Q6TG^#U_P#23;"S;A[1[Q7XK3\S MR;_@FM\*/^%B?M&6>L7,/F:9X6@;4Y"PRIG/R0+]=S%Q_P!7J7BJZ-YN8?-]FCS'"/H?WCCV<4O\ P5"\"1>)_P!FUM;$>;KP[J4% MTK@COOT[5[2.ZBSU7<.4/\ M*K"IU&EMNOGJ.C)RAKN MM/Z]=RMJ,3W&GW448W.\3*H]200*_*[]FO\ 8A^-7P__ &A/!?B;7O!?V#1- M/U-;BZNO[5LI/+C ;G:DQ8]1P 37ZH:H[1Z9=LK%66%R&4X(.T\U^.O[*/QX M^)?B+]IKP'I>K?$3Q7J>F7.K+'/97FMW,T,J8;Y61G*L/8BIPM_;^[OI^;+Q M%OJSYMM?R/V4HKY)_P""F7C;Q%X#^ >DZAX9U_5/#M^_B""%KK2;R2UE:,P3 MDH7C8$J2H.,XX'I7QQ\"_C;^T#\;O",_PH\$Z[K&H:W>7LNH:CXFU+5)7FM; M,I$BQ"=R6A0,&)V?,2^%'WLYTXNJI<$X./ MT*_8+_:"\1?'[X&ZW;Z[^*M!=K$WV0LERCQEH9&/&'R&4GOM!/)-6X?NI M5(._+NB5+]Y&$E;FZGD7_!4SX\>*_!^J>&? OA[6+K1;"^L7O]0DL9C%+< R M&-(RRD,$&QR1T;/.<5\_? ']A'XJ_%CPCI'Q!\/:[I.B6%Y,S0O-J$\-ZRI( M49U\N)@#E6QE@>*\G_:&\'_%?P5XOL;/XO7&JW'B&2R66V;5M774I!;%W D M663:N\/\N1SDXYKZ+_8J^&?[1%UKOPW\1:;>>(%^$JZBDLD,?B1$L_LRS,)0 M;3SP2NX/E?+YY.#FNC"P5./,FKWWZ;O?TV^3,,3-MVMI;;KMT]=S]6+:$6UO M%"&9A&@0,Q))P,9)/4U+7YO_ /!0;]MCQ'H?C&Z^&'P_U.;1Q9*JZOJUDY6Y M>9@#Y$3CE H(W,N&).,@ Y\9A_X)Z?'J3PD/'BM:KJ[1?;AIIU&4:N>-V?N; M?,QSM\S=GC&>*Y8^]'VLG://L/\ :P_:'M?V:_A+=^)# M E[K%Q(++2K.0G;+<,"07QSL4*S'UQC()IUH^Q2>Z>W]=Q4Y>T;CLUO_ %V/ M9J*_%OP-\._CG^WQXBU:_DUY]1M;-P9[W6KQX=/MG;E8HXT5@IQSM1..IQD9 MI>)+'XU_L#_$:QLO[(OA$;_3O&.H30>9;Z7J@L9K>2 M.7;<1B9GC^7@_P 0W*1ZU^34VD^)U^)$FF2O<_\ "9C5C;,YN@9_MWG;2?.W M8W^;_'NZ\Y[TZ$''$I37PO;OL[KN*I)2H-Q?Q+?MOH^S/Z%6Y4CVK\G_ (2_ ML._&WPS^T5X8\3ZEX*^S:'9^(H;^>Z_M6Q?9 LXFYO-JG%2EUV/VCHK\8?B%\$?CM^PO=6'B&WUU["PGE5!JGAR^ MDDLS+R1%-&ZKG.#PZ%3SUK]$?V*?VK(_VFO -P=2BALO&&C%(M3MX>(Y0P.R M>,=E;:P*]B#V(K3V:E%R@[VW,^=QDHS5K['T;17Y;_\ !2?XQ>/? O[0]MIO MAKQOXC\/:<=#MIC::5JUQ;0ES),"VR-P,D I30QZE-'&JRR2F-7>=V8$DL-JYP#G<3$(.I#G7]:V+G)0G MR/\ K9V_KL?J;17X4+K'Q5_8Q^+5SI4.IW7A_6]-F1Y[6"X+V=[&1E2R9VRQ MLIXR,C/\+#C]K?A7XZA^)WPU\,>+((OL\>LZ=!>^3G/ELZ LF>^#D?A5NFO9 MJI%W1"F^?V_P#HN2O7Z\@^-?\ MK-7_ .Q;O?\ T7)71AOX\/5?F_]M/US@'_ )BO^W/_ &X****_/C]<"BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K3M?\ D'?C_6LRM.U_Y!WX M_P!: &4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110!?M_P#4K4E1V_\ J5J2@ KXH_:_\;:E M\^*KV \PVJ_O/)/I\@WD'J6B';J>I7@LXI&Y*>8Q MFE4>P'D*/855**G4][:*YG^45Z-[^@JDG"G[N\G9?J_DOS/NS0]%TGP+X7LM M*T^*'3=%TFU6"&/(5(88UP,GT ')-?G?\1OVI/BU^UU\4+SX>_ =Y]$\-VS% M9M<@D,$LL8.#/).!N@B)^ZJ?.WOG:/IO_@H%XZNO G[+'BV:RD:*ZU+RM+61 M3@A9G"R?G&''XUR?_!,CX>V7A/\ 9KL]>2%1J7B2\GN[B;'S%(Y&AC3/H C- MCUU/I_P29U76U^W^(/B]+/ MK<@WRRKI+W #_P#71[@,_/<@&N5\30_M$_\ !/G4K+57\12>/?APTRPNMQ+) M-;!3TC='RUJQYPR$J3C);[M?J#7.?$;P/IWQ*\":]X7U6%9[#5K.2UD5AG&Y M>&'NIPP/8@5,JTX+FCTZ=RHTX2=I??\ J9'P3^,.A?';X\&KKUZ?*]_P #*$I\DH;33M?\_G:WEN?(5U_P2?M[?3/MNF_% M+5D\7K^\749;0+$TG7HK^8N3_%O8CK@]*T/V(OVBO'FE_%S6_@3\5;R75-T[POHM]J^K7D.GZ98PM<7 M-U.VU(HU&68GTQ7YO?LFM>?M(?MY>*OBY96$[?XI_\ !23Q_P"(KJ;Q9>>"_A?IG7=R;N:!)Y9 M0TI54+9D9B/E11@'''3DUR?[5WQNTGX$_!?7M:OYX_[1NK>2RTNS8C=[_JY-.'M)_OM;OY)?\!?U8Y3]AO]I2[_ M &D/A-)>:TL:^*-%G%EJ31($2?*[HY@HX7<,@@<;E; P*^?OV@?BQX__:F_ M:0E^!GPSUR;PWX?TIG36=4M9&0R&/ G=V4AC&A/EB,$!V/)P05ZK_@EO\.M2 M\#_!3Q-XOU*![:/Q!*/A9\1]8/C'3HC<&%A]F:\*C++')&V48\X5MP M)(!(ZU[W^PC^TW>?M$?#.ZA\0NA\8^'Y$MM1=4"?:$8'RY]HX4MM8,!QN0G M! KZ9K\V_P!AV3_A$?V\/C%X:M3MT^0ZFHC4< Q7R[/R#,/QK*E*524J4M;I MM>5O\S2I%0@JL=TTGYW_ ,CJ?VPOCU\0_B)\>-.^ /PGU&71KR0QIJ>I6LIA ME+LGFLOFK\T<4<>&8K\QY';!CD_X)/VK::;T?%/5SXO_ -;_ &DUH/*\SKG; MO\SK_%OSWQVKZ]TW]G_P!I'Q1N/B-9^'8X/&EP'$NJ+<3%GWKM;*%]F2./NU MW&J:I9Z)IMUJ&H7,5E8VL333W$[A$B11EF8G@ 9S649*G35M'NW_71&C3G4 M?;HOZZL^#/V.?C_\0? /QUU+X _%?4)-9OH3)'INHW$K32K(B>:$\UOFDC>/ M+*6Y' [X'W[7YE? >^G_ &IO^"A^J_$G2+:1?"FA,TXN60J#&D!M[<'_ &I# M\^T\X#>E?=G[0GQQT7]GSX8ZGXLUAUDDB7RK&RW8>[N6!V1+^62>R@GM5U9? MNJ=2:]YK7]/F^Q,(KVLZ<-D_N[_)=SP;_@H)^T]=?#/PLOP]\'223^.?$%NY ME-F29;"SP=\@V\AV 8 ]@&;C KF_^"2?_)$_%W_8P'_TGAK(^ ?P1UK5?A7\ M3_CU\1@;KQMXLT+4)M/CE7'V.T>W?#*I^Z74 */X8P!_$:U_^"2?_)$_%W_8 MP'_TGAK2C'V:K0E\7+%ORO+;Y6^^Y-27/[."\C!*88<@-RI_WL]0*YG]B/\ :'F^/7PH$>MO MM\:>'I!IVLQ2<.[ $),1VW@'/^TKU]$5^=GA2^;]GO\ X*<:UH<'[C0/''S- M"O"[YT\U&QZB=74>SFLJ.LW2?VE=?XE_FM/DBJND%4ZQ_P#27O\ <]?O/T3H MHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "N.^)?_'KH7_86@_DU=C7' M?$O_ (]="_["T'\FH [&BBB@#C?AI_Q[:]_V%I_Y+795QOPT_P"/;7O^PM/_ M "6NRH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH P?'?_ ")^K_\ 7NU6O"__ "+.D?\ 7G#_ .@"JOCO_D3]7_Z]VJUX7_Y% MG2/^O.'_ - % &I1110 4444 %%%% !1110 4444 %97B;Q-I_A'1I]3U.<0 M6L(^K.W95'=CZ4OB3Q)I_A/1Y]3U.<6]K".3W8]E4=R?2OC7XK_%:]\>:H;N MZ)@L(25M+)6X0>I]6/^.]4-Y>$P M641*VEBK9"#U]V/<_P!,"O*KJZDO)C)(>>P[#VHNKI[R8R.?H.PJ&OGVW)N4 MMV?C>-QM3&5'*3"GPS/;R*Z':PIE%(\Y-IW1Z-\._B'?^$M8BU/3)?+G3Y9K M=ON2IW5AW!_0U]H^ _'FF_$'0TU#3WVN,+/;,?GA?^Z?;T/?\Q7YUPS/;R+( MAVL*]%^'7Q$O_".L1:GIDFR9?EGMV/R2IW5AZ>_8UU8?$.@[/X3[G)=%NCKZ&,E)76Q^H MPG&I%3@[IA1115%A1110 5\H?M0?&BXO]3N/!VCSM%96QV:A-&V#-)WBS_=7 MOZGCMS](^//$@\(^"]:UGJ]G:R2H,9R^/D'XL17PG\+O"+_$KXC:9I=R\DD= MU,TUW+GYC&H+N<^IQC/JPKSL74EI2CNSXKB/%U4J> P_Q5-_3:WS?Y':_!?] MG.^^)%NNKZK-)I6@[L(53]]<^NS/ 7_:.>> #SCZ4T7X!^ M#MUBC\-VMT1U MDO09V;W.XG],5F>*_P!H#P;\.?$47AJX6YW6Z)'(UG"K0VHP-JGD'@8X4''U MXKTS3]0MM5L8+RSGCN;6=!)%-$VY74C((-:4:-&/NJS:W.S*\NRV@G2I\LZD M?B;U=_T//?$7[.O@+Q%;M&=#CTV4_=GT]C"R^^!\I_$&OEGXR?!#4OA/=0SF M==0T:Y+/%FF>"=!N=7U>X%M9P#)/5G;LJC MNQ["OA;XI?%#5OBYXF%Q,KQVB-Y=CI\9+"-2<#_><\9/?H. !7/C(THK;WCQ M>):67T:22@E5>UM/O\OQ[=3-C\;>+_$%_I-M'K.J7EY;LL-C&D[EPQ;Y0N#R MO0= *_03P^M\N@Z:NJ%6U,6T8NBF,&7:-^,=MV:_/+2[S5/ASXTMKEXY M;+5-+NE9X6X8%3\R'V(R#Z@U^BMC>1:A9P74)W0SQK*C>JL,C]#1@=>:[U*X M4DY.M[23D 7F[Q%J6 MWPE-\V7_ '7^L8_[T"KD_P#345Z]_P %//A;_P )Q^SZ/$5M#OO_ M>+=Y4 M9;[/(1'*/H"8V/LE?DC)K5])HT.DM=2-IL,[W4=KGY%E=55G ]2J(/\ @-:4 M5[2A+#OHU]V_W6;0JGN5HUUV?WV_.Z3/N[_@DW\*/[6\;^)_B#=P[H-(MQIM MDS#_ );R_-(P]UC '_;6OT,^-G_)&_'?_8!OO_2=Z\__ &)_A1_PJ#]G'PGI M_"?\S3_P OPL?D?_P3E_Y.X\'_ /7*]_\ 266OH#_@K]_Q^?#' M_KGJ'\X*^?\ _@G+_P G<>#_ /KE>_\ I++7T!_P5^_X_/AC_P!<]0_G!73B MOCH?U_,8X7>MZ?HCTK_@E'X1M-+^!.N:^L"C4-5UF2)Y]OS&**- BY] S2'Z MDU]3?&S_ )(WX[_[ -]_Z3O7S]_P3!_Y-8L_^PO>?^A+7TI\1-#F\4?#_P 3 M:/;_ .OU#3+FTC_WGB91^IKFS"\E-?W?_;37 -1<6_YG_P"E'X^?\$Y?^3N/ M!_\ URO?_266OUB_:'_Y(%\2?^Q;U'_TFDK\7OV;?B='^S]^T!X<\4:U9W)M MM(NI8+^UC&)E1XWAD^4D99=Q.T]2N*^[_P!J;_@H9\./$7P>USPO\/[Z[\2Z M]XAM'T[*V4UO':I*-KLQE12S;20 @//4XZ[8U.K1BH:Z-?B_PUW(PG[JNW/3 M5/[O^&/D_P#X)R_\G<>#_P#KE>_^DLM?9?\ P46_9)\1_'"'1?&7@NV74M>T MFW:SNM,WJDEQ;[BZM&6(!92S_+G)#<_%&FQ>%TTRS\):I;#[-JS:>9IDN!GS(F9V*9QAA\G()ZX-7B]Z M-M^GWR_X8SPV]7MI?\/^'/@_PK\=/C;^S7>'0K'7O$'A)K?_ )@NJP$Q1Y.2 M1;W"E5R<\A1FOI_X,?\ !5[7K34[6P^)F@6>H:8Y6-]6T5&AN(AW=XB2LGT7 M9QT!Z5Z=\)_^"A'P?^(WPKT_3?C-+!'X@@B$-_#J6B/>VMZX&/.18HG4;NI4 MJN#D 8P:^#OVG/$'P^\>?&B[N?A)H+Z7X=F2*"*UAMS$MQ<9(9XH>J*V5 7 MZ9P,XJKR]IR3C?S_ *_X<+1Y.>+M_7]>1^YVCZO9^(-)LM4TZXCO-/O84N+> MXB.5DC=0RL#Z$$&KE>>?L\^#]1\ _ SP+X=U<;=4T[2+>"Y3.=D@0;DS_LGC M\*]#KFJQ4*DHQ=TFS:G)RA&4MVC\SO\ @KUJ$K>)OAM9;CY$=G>S!?\ :9X@ M3^2BOJ3_ ()ZVD=G^R+X%$8QY@NY6/JQNYLU\[?\%>?"\LEC\.?$:)F&*2[T M^5L=&81R(,_1)/RKW?\ X)N:\FM?LF^&85;=)IUU>60#_OF1:JA_NL MX]5+]7_FA8B_MZ;Z-?I_P&>;?\%;O^2+^#O^Q@'_ *335\C?L@_L7_\ #5FE M>);W_A,?^$7_ +&G@A\O^R_MGG>8KG.?.CVXV>^&_AUI=O_M18AOGHKO\ _;,R?^'/?_56 M_P#RV_\ [KKX1^+'@'_A5OQ0\2^$/MW]I_V+J$EE]L\GR?.V-C=LW-MSZ9/U MK^@ROP@_:T_Y.<^)?_8>NO\ T8:5&K-XF$&]+/\ ./\ F:2IQ5)R2UNOR9^W MC?\ ).S_ -@K_P!HU^"WPA\ ?\+4^)WACP?]O_LO^VK^*R^V>3YWD[VQNV;E MW8],CZU^]+?\D[/_ &"O_:-?A#\"_'5A\,?C%X.\6:I#*1J&G_:E@@UG2_,L[JTN"K$;E#$J" V&5ST(.,C/V M%_P]F^$7_0N>-O\ P!L__DJOF;]M7]O/3?VC?!]EX0\*Z%?Z5HB7:7MS=ZJ4 M6>9D#!4$:,RJHW;B=Q)(' QSDY5DUR]U]W7\#91I-/F[/_@?B?7/_!/?]JC6 M/V@_!NKZ-XKE2Y\4^'S%OOD0(;RW?(1V XW@J0< Y4XSFNA_P""A7PK_P"% MG?LT:]+;P^;J7A]EUFVP,G$8(E _[9-(?J!7A'_!)7X7ZCINC^,/'EY"\%AJ M7E:;8%@1YPC9FE<>JABBY]58=J_06_L8-3L;BSNHUFMKB-HI8V&0RL""#]03 M1C(:^[O9/Y[K]&Q825OBU5VOEU_5'Y-_\$M?BFO@[XWZEX7O+@0V'B6P8('; M"_:(,R(?^^/.'Y5X[\4]:O\ ]J;]J[4FTUFE?Q%KB:?IYZA+<,(HF^@C4,?Q MKD_BCX5U7X"?&OQ)H-IH306US&V%F7C[5."BX^D8E/XBNNGRUIPQ#V4?^#_ )(PJ5E8?J!7M5>!?MX:_'X=_9/\ B!,[;6N+2.S0>IEF1,?D MQ_*O*Q#_L<_\G8?#K_L,K_)JQP?^\_^ _FS?%?[I+Y_D??O M_!5W_DW'1O\ L9+?_P!)[BO/O^"0>G0#1_B7?[/]),]C!O\ ]@+,V/S->@_\ M%7?^3<=&_P"QDM__ $GN*X?_ ()"?\BK\2O^OVR_]%RT87^'7^7_ +8+%?'0 M7]?;._\ ^"JEI':?\$@F/]F_$X9X\[3SC_@, M]>H_\%3O^398/^P]:_\ H$M>6_\ !(+_ )!WQ._ZZZ?_ "GHPG\/$?U_(+%; MT?ZZR/-?^"LW_)??#/\ V+<7_I3<5]L_\$_O^31_ '_7*Y_]*IJ^)O\ @K-_ MR7WPS_V+<7_I3<5]L_\ !/[_ )-'\ ?]LP6/]K:TWBB:YAL)8FE^T3"Z++$44[FRV%V@Y.<" MOM7_ (;2_:Z_Z(1_Y9^K_P#QZOG+]L?X:ZQ^SU^U%J>J6D+06=[J/_"0Z-=% M3L;=)YI4'U23*D=< 'N*^[-%_P""GWP?NOAZFL:C=W]EXE6WW2>'5L97D:8# ME4E"^5M)Z,SCCJ >*5-_[)3>]NGR7^5F.HG]9GTOU^?_ 3X(\)?"?XR2?'; M1_&<_P *_%FESR>(H=5E%OX>O(H(";D2,%W(=J#)ZDX'4U])_P#!7S4KC[7\ M,K#?!34/B1\']-\4:-:O>7_A2>2>>&)35OS?X[?,U_^"8&G MVMG^RS:3P*HFN]6O);@KU+AE09_X"BU]-:[X(\.^*+VRO-9T#2]7N[+=]EN+ MZSCGD@W8W;&925S@9QC.!7YD?\$^_P!M/PI\#_#.J^"?'MQ<:=I$MVU_8ZI% M \Z1,RJLD3I&"^"5# A3R6SCBE_;-_X* W'C3Q-H-E\'O$^L:3I6EB22YU2U M:2T%]*^W:OEMABB!3]]1DL>. 3KB$Y55R];?+0QH65-IZ6O^9^IMO;Q6L*10 MQI#$HPL<:A5 ] !7X5:E_P G@77_ &/;?^G U^M7[&]Q\1-3^!>CZO\ $W5+ MC4O$.J.UY$MU!'%);VK ")&"*N20-_S<_O,'I7Y'?$:Z/@/]JSQ%>ZE%(%TO MQC-=S1J/F*)>&3C/JHX^M%&/LL;",GM_G'\BJDO:824HK?\ RD?N\_W6^E?A M7\!_^3M_!?\ V-T'_I4*_83X._M*_#_X_P ^L0^!M8DU_@/_P G;^"_^QN@_P#2H5.$BXXV":[?F@Q,E+!U+?UH MS["_X*]ZQ=QZ7\-=+5F6PFFO;EU[-(BPJI^H#M_WU7IG_!*[0[/3_P!F^\U" M!5-WJ&MW#7#@#=\B1JJGZ#G_ ($?6M7_ (*0? O4_C!\$X-4T*U>]UKPQ<-? M+:Q+NDFMV7;,JCNP 5\=3L(')KY%_8#_ &SM$_9]AU7PCXU%Q%X8U&Y^VP:C M;Q&4V<^T*^]%^8HP5?N@D%>AR2)PO\.K3Z_GJG^6GRL5B?BI3Z+_ (/^:?S/ MT$_;.T6SUS]EOXDPWL2RQPZ1+=1[A]V2+$B$>X917YZ?\$K=5N;/]I.\LXI" MMO>:%[N-8_MC:FH:L]M);Q M1P!@QC19%5RS$ $[0 N>23QM?\$KO@!J7A^TUCXHZU:/:)J=M_9^CI*N&DAW MAI9@/[I*(JGOACTP36%BXNI4DK*UOG9K]5]W86(:E&G!:N]_Q7^7],\2_P"" MJ/\ RE_A_ M2)^>'_!5:UCA_:2TZ51AYO#]LS^Y$LX_D!7Z"?L4DG]E7X:Y.?\ B5K_ .AM M7P#_ ,%7/^3C-(_[%ZW_ /1\]??W[%'_ ":K\-O^P6/_ $-Z5+_='_B_605O M][C_ (?TB>VT445@:A1110 5Y!\:_P#6:O\ ]BW>_P#HN2O7Z\V\?:3#KWBY M-,N&=(+W2)K:1HR P5]RD@D$9P?2MJ,E"I&3V31SXB#J49PCNTU^!\&T5]7_ M /#)_A'_ *".M?\ ?^'_ .-4?\,G^$?^@CK7_?\ A_\ C5?JG^LF [O[C\)_ MU,S;^6/_ ($?*%%?5_\ PR?X1_Z".M?]_P"'_P"-4?\ #)_A'_H(ZU_W_A_^ M-4?ZR8#N_N#_ %,S;^6/_@1\H45]7_\ #)_A'_H(ZU_W_A_^-4?\,G^$?^@C MK7_?^'_XU1_K)@.[^X/]3,V_EC_X$?*%%?5__#)_A'_H(ZU_W_A_^-4?\,G^ M$?\ H(ZU_P!_X?\ XU1_K)@.[^X/]3,V_EC_ .!'RA17U?\ \,G^$?\ H(ZU M_P!_X?\ XU1_PR?X1_Z".M?]_P"'_P"-4?ZR8#N_N#_4S-OY8_\ @1\H45]7 M_P##)_A'_H(ZU_W_ (?_ (U1_P ,G^$?^@CK7_?^'_XU1_K)@.[^X/\ 4S-O MY8_^!'RA17U?_P ,G^$?^@CK7_?^'_XU1_PR?X1_Z".M?]_X?_C5'^LF [O[ M@_U,S;^6/_@1\H45]7_\,G^$?^@CK7_?^'_XU1_PR?X1_P"@CK7_ '_A_P#C M5'^LF [O[@_U,S;^6/\ X$?*%%?5_P#PR?X1_P"@CK7_ '_A_P#C5'_#)_A' M_H(ZU_W_ (?_ (U1_K)@.[^X/]3,V_EC_P"!'RA17U?_ ,,G^$?^@CK7_?\ MA_\ C5'_ R?X1_Z".M?]_X?_C5'^LF [O[@_P!3,V_EC_X$?*%%?5__ R? MX1_Z".M?]_X?_C5'_#)_A'_H(ZU_W_A_^-4?ZR8#N_N#_4S-OY8_^!'RA17U M?_PR?X1_Z".M?]_X?_C5'_#)_A'_ *".M?\ ?^'_ .-4?ZR8#N_N#_4S-OY8 M_P#@1\H45]7_ /#)_A'_ *".M?\ ?^'_ .-4?\,G^$?^@CK7_?\ A_\ C5'^ MLF [O[@_U,S;^6/_ ($?*%%?5_\ PR?X1_Z".M?]_P"'_P"-4?\ #)_A'_H( MZU_W_A_^-4?ZR8#N_N#_ %,S;^6/_@1\H45]7_\ #)_A'_H(ZU_W_A_^-4?\ M,G^$?^@CK7_?^'_XU1_K)@.[^X/]3,V_EC_X$?*%%?5__#)_A'_H(ZU_W_A_ M^-4?\,G^$?\ H(ZU_P!_X?\ XU1_K)@.[^X/]3,V_EC_ .!'RA17U?\ \,G^ M$?\ H(ZU_P!_X?\ XU1_PR?X1_Z".M?]_P"'_P"-4?ZR8#N_N#_4S-OY8_\ M@1\H45]7_P##)_A'_H(ZU_W_ (?_ (U1_P ,G^$?^@CK7_?^'_XU1_K)@.[^ MX/\ 4S-OY8_^!'RA17U?_P ,G^$?^@CK7_?^'_XU1_PR?X1_Z".M?]_X?_C5 M'^LF [O[@_U,S;^6/_@1\H45]7_\,G^$?^@CK7_?^'_XU1_PR?X1_P"@CK7_ M '_A_P#C5'^LF [O[@_U,S;^6/\ X$?*%%?5_P#PR?X1_P"@CK7_ '_A_P#C M5'_#)_A'_H(ZU_W_ (?_ (U1_K)@.[^X/]3,V_EC_P"!'RA17U?_ ,,G^$?^ M@CK7_?\ A_\ C5'_ R?X1_Z".M?]_X?_C5'^LF [O[@_P!3,V_EC_X$?*%% M?5__ R?X1_Z".M?]_X?_C5'_#)_A'_H(ZU_W_A_^-4?ZR8#N_N#_4S-OY8_ M^!'RA17U?_PR?X1_Z".M?]_X?_C5'_#)_A'_ *".M?\ ?^'_ .-4?ZR8#N_N M#_4S-OY8_P#@1\H45]7_ /#)_A'_ *".M?\ ?^'_ .-4?\,G^$?^@CK7_?\ MA_\ C5'^LF [O[@_U,S;^6/_ ($?*%%?5_\ PR?X1_Z".M?]_P"'_P"-4?\ M#)_A'_H(ZU_W_A_^-4?ZR8#N_N#_ %,S;^6/_@1\H45]F)X?\ XU1_PR+X/_Z"6N?]_P"'_P"-4?ZR8#N_N#_4S-OY8_\ @1\C45]< M_P##(O@__H):Y_W_ (?_ (U1_P ,B^#_ /H):Y_W_A_^-4?ZR8#N_N#_ %,S M;^6/_@1\C45]<_\ #(O@_P#Z"6N?]_X?_C5'_#(O@_\ Z"6N?]_X?_C5'^LF M [O[@_U,S;^6/_@1\C45]<_\,B^#_P#H):Y_W_A_^-4?\,B^#_\ H):Y_P!_ MX?\ XU1_K)@.[^X/]3,V_EC_ .!'R-17US_PR+X/_P"@EKG_ '_A_P#C5'_# M(O@__H):Y_W_ (?_ (U1_K)@.[^X/]3,V_EC_P"!'R-17US_ ,,B^#_^@EKG M_?\ A_\ C5'_ R+X/\ ^@EKG_?^'_XU1_K)@.[^X/\ 4S-OY8_^!'R-17US M_P ,B^#_ /H):Y_W_A_^-4?\,B^#_P#H):Y_W_A_^-4?ZR8#N_N#_4S-OY8_ M^!'R-17US_PR+X/_ .@EKG_?^'_XU1_PR+X/_P"@EKG_ '_A_P#C5'^LF [O M[@_U,S;^6/\ X$?(U%?7/_#(O@__ *"6N?\ ?^'_ .-4?\,B^#_^@EKG_?\ MA_\ C5'^LF [O[@_U,S;^6/_ ($?(U%?7/\ PR+X/_Z"6N?]_P"'_P"-4?\ M#(O@_P#Z"6N?]_X?_C5'^LF [O[@_P!3,V_EC_X$?(U%?7/_ R+X/\ ^@EK MG_?^'_XU1_PR+X/_ .@EKG_?^'_XU1_K)@.[^X/]3,V_EC_X$?(U%?7/_#(O M@_\ Z"6N?]_X?_C5'_#(O@__ *"6N?\ ?^'_ .-4?ZR8#N_N#_4S-OY8_P#@ M1\C45]<_\,B^#_\ H):Y_P!_X?\ XU1_PR+X/_Z"6N?]_P"'_P"-4?ZR8#N_ MN#_4S-OY8_\ @1\C45]<_P##(O@__H):Y_W_ (?_ (U1_P ,B^#_ /H):Y_W M_A_^-4?ZR8#N_N#_ %,S;^6/_@1\C45]<_\ #(O@_P#Z"6N?]_X?_C5'_#(O M@_\ Z"6N?]_X?_C5'^LF [O[@_U,S;^6/_@1\C45]<_\,B^#_P#H):Y_W_A_ M^-4?\,B^#_\ H):Y_P!_X?\ XU1_K)@.[^X/]3,V_EC_ .!'R-17US_PR+X/ M_P"@EKG_ '_A_P#C5'_#(O@__H):Y_W_ (?_ (U1_K)@.[^X/]3,V_EC_P"! M'R-17US_ ,,B^#_^@EKG_?\ A_\ C5'_ R+X/\ ^@EKG_?^'_XU1_K)@.[^ MX/\ 4S-OY8_^!'R-17US_P ,B^#_ /H):Y_W_A_^-4?\,B^#_P#H):Y_W_A_ M^-4?ZR8#N_N#_4S-OY8_^!'R-17US_PR+X/_ .@EKG_?^'_XU1_PR+X/_P"@ MEKG_ '_A_P#C5'^LF [O[@_U,S;^6/\ X$?(U%?7/_#(O@__ *"6N?\ ?^'_ M .-4?\,B^#_^@EKG_?\ A_\ C5'^LF [O[@_U,S;^6/_ ($?(U%?7/\ PR+X M/_Z"6N?]_P"'_P"-4?\ #(O@_P#Z"6N?]_X?_C5'^LF [O[@_P!3,V_EC_X$ M?(U%?7/_ R+X/\ ^@EKG_?^'_XU1_PR+X/_ .@EKG_?^'_XU1_K)@.[^X/] M3,V_EC_X$?(U%?7/_#(O@_\ Z"6N?]_X?_C5'_#(O@__ *"6N?\ ?^'_ .-4 M?ZR8#N_N#_4S-OY8_P#@1\C45]<_\,B^#_\ H):Y_P!_X?\ XU1_PR+X/_Z" M6N?]_P"'_P"-4?ZR8#N_N#_4S-OY8_\ @1\C45]<_P##(O@__H):Y_W_ (?_ M (U1_P ,B^#_ /H):Y_W_A_^-4?ZR8#N_N#_ %,S;^6/_@1\C45]<_\ #(O@ M_P#Z"6N?]_X?_C5'_#(O@_\ Z"6N?]_X?_C5'^LF [O[@_U,S;^6/_@1\C45 M]<_\,B^#_P#H):Y_W_A_^-4?\,B^#_\ H):Y_P!_X?\ XU1_K)@.[^X/]3,V M_EC_ .!'R-17UY_PR%X.^S22?VEKFY>G[^''_HJJ7_#)_A'_ *".M?\ ?^'_ M .-4?ZR8#N_N#_4S-OY8_P#@1\H45]7_ /#)_A'_ *".M?\ ?^'_ .-4?\,G M^$?^@CK7_?\ A_\ C5'^LF [O[@_U,S;^6/_ ($?*%%?5_\ PR?X1_Z".M?] M_P"'_P"-4?\ #)_A'_H(ZU_W_A_^-4?ZR8#N_N#_ %,S;^6/_@1\H45]7_\ M#)_A'_H(ZU_W_A_^-4?\,G^$?^@CK7_?^'_XU1_K)@.[^X/]3,V_EC_X$?*% M%?5__#)_A'_H(ZU_W_A_^-4?\,G^$?\ H(ZU_P!_X?\ XU1_K)@.[^X/]3,V M_EC_ .!'RA17U?\ \,G^$?\ H(ZU_P!_X?\ XU1_PR?X1_Z".M?]_P"'_P"- M4?ZR8#N_N#_4S-OY8_\ @1\H45]7_P##)_A'_H(ZU_W_ (?_ (U1_P ,G^$? M^@CK7_?^'_XU1_K)@.[^X/\ 4S-OY8_^!'RA17U?_P ,G^$?^@CK7_?^'_XU M1_PR?X1_Z".M?]_X?_C5'^LF [O[@_U,S;^6/_@1\H45]7_\,G^$?^@CK7_? M^'_XU1_PR?X1_P"@CK7_ '_A_P#C5'^LF [O[@_U,S;^6/\ X$?*%%?5_P#P MR?X1_P"@CK7_ '_A_P#C5'_#)_A'_H(ZU_W_ (?_ (U1_K)@.[^X/]3,V_EC M_P"!'RA17U?_ ,,G^$?^@CK7_?\ A_\ C5'_ R?X1_Z".M?]_X?_C5'^LF M[O[@_P!3,V_EC_X$?*%%?5__ R?X1_Z".M?]_X?_C5'_#)_A'_H(ZU_W_A_ M^-4?ZR8#N_N#_4S-OY8_^!'RA17U?_PR?X1_Z".M?]_X?_C5'_#)_A'_ *". MM?\ ?^'_ .-4?ZR8#N_N#_4S-OY8_P#@1\H45]7_ /#)_A'_ *".M?\ ?^'_ M .-4?\,G^$?^@CK7_?\ A_\ C5'^LF [O[@_U,S;^6/_ ($?*%%?5_\ PR?X M1_Z".M?]_P"'_P"-4?\ #)_A'_H(ZU_W_A_^-4?ZR8#N_N#_ %,S;^6/_@1\ MH5^C%>+?\,G^$?\ H(ZU_P!_X?\ XU7M-?)9]F6'S#V7L&_=O>Z[V_R/O^%, MEQ>4>W^M)>_RVL[[\3 _H M:\#_ ."4<*1_LZZS(JX>3Q%<%F]<00 5]7_$7PJGCKP!XD\.28":MIMQ8DGM MYD;)G\,U\3?\$H/$3Z;H/Q'\!WRFWU32M42\>!^""R^3(/\ @+0 'ZBM:&]9 M=XK\):_<16^&D^TG^,=/O/8?^"C7A6Z\4?LI^)FM$,DFF3VVHLJ]3&D@#G\% M9F_"J?\ P37\86?B;]EC0K""1#=Z)=75C58RM*A(]TD7\C7TUJ^DV>O: M3>Z9J%NEW87D+V]Q!(,K)&ZE64CT()%?F)K'@?XJ?\$X?BEJ?B;PGITWBSX7 MZ@W[]<.T7DAB52X*@F&5,D+*05.>^2HFC)1YZO7]PD.FZ?:27DTS,-HC12Q.?H*^ _BE_P4&^!GQ\^%]YX4\:>'/&]E!= MA))8=+%ON21#N4I(9@& ;!^=,' RM?%UQ\6O'O\ PK;Q)X+\-ZYXBOOA4MRC MR17EN"((]_[I)'7<(@QQE%<*S#I2=*(O MBK\2_&DL1$'V5;//'N@?#/PK?\ B/Q-J<.D:-8I MOFN9SQ[*H'+,3P% )). *\*_8*M_AEH7P1T_1_A_XEL_$-Y_Q^:O(!Y5T;EP M QDA;YT48"KG@A1@G.:^#OVP/VD+/X\?M!+HFNZGJ5C\+?#M^UH(=+19)9MA M*RSJC,JM(Y!52QPJD'N0=ZT;U8X>&B2M\EN_O>AE2?N3KSZN_P WLON6IZ=X MP\=_$G_@I-X[/A3P;;W'A;X3:=<*UY?7"G:^#D23X.'DQRD"G ."3QN'W]\% M_@SX9^ _@2R\*^%K3R+.'YYKB3!FNIB!NEE8#EC@>P & *^2_ '_!1K]GW MX7^$[#PWX8\+^*-)T>R39%;PZ=;_ (LQ-QEF)Y+'))ZUZG\(/^"@WPU^-GQ$ MTGP9H&G^(X-6U,R"&2^LX4A&R)Y&W,LS$?*AZ \XI\K4?9TEIN^[\W_D3S)O MVE1_Y(^FZ**Y/XL?$2Q^$OPW\1>,-24R6FCV;W)B4X,K 81 ?5F*K^-<?=L._\ L1@]7/ [ M9. ?C?X1_ 7Q[^W5\0+?XJ?&%YM-\#1-G2]%3=&+F+.1'"IY2$\;I#\S]CW7 MYV^'OQO\%>.?CKJ/Q'^/@UCQ-\XEL](T^V2:W+!B4C% L<487:JJHZ # P*_/3_@DO,= M*\2?%G0I\QW$1LV\D@<;'N$?WX)45]<_L[_M4>#_ -IJ'7)?"=KJULNCM"MQ M_:EO'$29 Y7;LD?/W#G..U?&GQ3L_$7[!?[6U_\ $^QT2?5OASXJDD^U?9^% M7SF#RPYZ)(L@WINP&'&?O$33O3K2C4TYXV^>\?O*E:I1]S7E:?RZGZ75^;7[ M%J?\)!_P4%^,.L6I+649U9_, R#OOD"C/O@G\*]!^*G_ 5*\!P^!IU\ 6>K M:KXLO83':0WEGY,5I(PP&E.X[B,Y"IN!(QD=:Z;_ ()S_L[ZS\(_ 6K^+/%M MM+:^*O%K:?HEW/J7QAXPT7P#X;O]?\0ZE!I.CV,9EN+NX;:B+_ %). .22 ,F MOSD^(GQ8^(O_ 44\=/X"^'%K<>'_AA9RJVH:GSB[/J_T7ZO^G]8_ GX$^&/V>_ =MX8\,V^$7]Y= MWTH'GWDV,&20COV Z 8 K\VOVAOVDO#OQ&_:Y(^)=IJ]Q\./!5]-:6V@Z7%% M,UU-$^UFD#R(N)'7+').Q0N.2:^Q_A;_ ,%%/AC\7/'^B^#]%T[Q+#JFK3&& M![RSA2(,%+?,5F8@84] :]LOO@;\.-4O9[R\^'_A:[N[B1I9KB?1;9Y)'8Y9 MF8IDDDY)-5[\:JK3\_OT_(E"2)5:..,!B\R$'*GH#Q7WE\8/@7\-M/^$OC6ZM?A[X5MKF#1 M;V2*:'1;9'C<0.0RL$R"",@BOF+_ ();?#?PEXP^$?B>_P!>\+:+K=];Z]LA MNM1T^&XEC401$!6=20,DGCN:N@X$A;O< M./NI]F0SG_R-(J?4UGA_]YI/L[OT2=S2K_N]5=U;YMK0_1VBBBLB@HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH *X[XE_\>NA?]A:#^35V-<=\2_^/70O^PM! M_)J .QHHHH XWX:?\>VO?]A:?^2UV5<;\-/^/;7O^PM/_):[*@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\=_\B?J__7NU M6O"__(LZ1_UYP_\ H JKX[_Y$_5_^O=JM>%_^19TC_KSA_\ 0!0!J4444 %% M%% !1110 4444 %%%% 'RS^TG_PDG_"41_VG_P @3_F'^3GRNG.[_IIZY[=. M*^=]6\_[6WG_ / <=,>U?HUXD\-Z?XLT>?3-3@%Q:S#D=U/9E/8CUKXU^*_P MIO? >J&TN@9["8EK2]5>''H?1AW%>!BZ$H2=3=,_.L_RNJVZT6VG^'D_+L>1 M45-=6KV=]I3R,^9GC_Z_M4<,+W$BQH- MS&O1?AU\.[_Q=K$6F:9'OF;YI[AA\D2=V8^GMW-&K=EN=V#PM3$U$H'5_ W_ M (27_A-K;_A'OOY6A4>Q^?Y\_JN98;%S^%67W.[_!GN/[2_P+N9[R\\9Z$C7 M<;]0LU&67 ,J>HP/F';KTSC@?@7\>+KX9W0TW4S+>>&YFRT:\O;,?XT]CW7 M\1SU^T-'UBS\0:5:ZCI\Z75E=1B2*5#D,I_K[=C7S=\ M>V;G2XV5-K'^./) P>Z]CTXX#K490E[:B5F>65L-6_M++-]VEK>_5=T^J^:/ M(OBU\6-4^+GB)7*20Z;$^RQT].=N3C<0/O.?_K"OH7]GOX IX*@A\0Z_"KZ_ M(N8+=AD6:D?^C".I[=/6HO@!^SS_ ,(:R>(/$L"/KG6VM"0ZV@_O$C@O].!] M>GKOCCQE8> O"]]K6H.!#;H2D><-+)_#&ON3_4]!3HT6OWU;$:!OUS7VQ\/4DC\ ^&DF.9ET MRV#G_:\I<_K7P=X>TO4/BI\1H+=@TEYJ]\9;AUS\JLQ:1_H!N/X5^AMO!':P M1PQ((XHU"(J] , 4L'[TISZ,SX:3K5\3BTK1D]/FV_PT)****]0^^"BBB@ MHHHH **** "BBB@ HHHH **** "N.T#_ )*1XI_ZYVW_ *+%=C7':!_R4CQ3 M_P!<[;_T6* .QHHHH R?%GAFP\:^%]6\/ZI&9M-U2TEL[E!C)CD4JV,]#@\5 M\DZ5_P $I_A#I>J6=X=:\7W@MYDF^SW-[:F*7:P.QP+8$J<8."#@]17V9150 MDZ.C_ ,A22G'EEL(JA5"J,*!@ =JS/%'A^W\6^&=6T.\>6.TU*TELYG@( M$BI(A1BI((!P3C(/TK4HJ))233ZE1;BTX]#YA^"O_!/?X=_ GXC:;XTT#6O$ M]WJE@LJQ0ZE=6SP'S(VC;<$MT;HQQAAS78?M'_LD>#_VH)-"?Q5J6MV!T83+ M;_V//#'N\S9NW^9%)G[@QC'?K7MU%7*3DTY/;;^OF3&*C?EZGG?P'^!VA?L\ M^ 8_"'AR[U&]TV.XEN1+JDD:QK*HR0ZGK5P)Y8-PP6C4*L:L.S;,CL:^BZ*2;C'D6Q3]Y\SW/F'X M*_\ !/?X=_ GXC:;XTT#6O$]WJE@LJQ0ZE=6SP'S(VC;<$MT;HQQAAS7T%XT M\#Z!\1O#MUH/B;2;76M(NAB6TNX]RGT([JP[,,$=C6Y13E)U$E+6Q,8J#O'0 M^.M>_P""5OP8UC4)+BTNO%&APL["OF+_ ()'_$=&LO&_ M@.>7$J21ZS:1D]5($4V![$0_]]5^B]?$FA_L.>,?A7^UI'\2_A[JN@VWA":[ M::ZTF^N)XIUAF!%Q"BI"RE0263+#D*#C&:UP[49RA+X9K[GT_)?=YD5DY0C) M?%%_AU_7[_(^A/VB?V;?#/[3/AC3="\47VK6%I87GVV)](FBCD+[&3#&2-QC M#GH *TO+585=SDA ULQ ^I/UKZTHJ8^[)36Z'NN7H4CI,)T7^S-S^1]G^S;L MC=MV[U?6]%7[27CZ/8>'=*M-,TNS@T[3K2-8;>UM8Q'%$BC 5 M5' '85.WE72+F". M*38"%=A)"YW8P,YQA1Q7H?[/G[.WA;]FOP?=>'?"TNH75M=7;7L]UJDDZ_P"&"O@O_@K-\1H]+^&_A7P5 M#-BZU:_-_/&IY\B%2!D>A>0$?[AK[TKXF^+G[#_C/X]_M2V_C?QEJ^A?\*^M M9(HHM+M;B=[MK2(%EB*F$(#(Y8MA^ YQG J%%3J1C)V5[M^G_!L7S&"VZL1SV85]6T5 MG%N$N:.YI)*4>26QYC^T'^S[X=_:2\%6WA?Q->ZI8V%O?)?K)I,L<V>!S65^SC^RSX4_9AT_7+/PMJ&LW\6KRQ2SG6)HI&4QA@NSRXDP/ MF.;?'[X"^'_VC/ J>%/$EYJ5CIRW M<=X)=*ECCEWH& &7C<8^8]O3FL#]G#]E'PE^R_#KL7A74=:OUUAH6N/[8GAD M*^6'"[/+BCQ]\YSGM7M%%$6X)J/7?\/\D$DIVYNFQ\]_M#?L1^!OVEO%]CXC M\3ZKXAL+ZSLEL(X])N8(XS&'=P2)(7.[,A[XP!Q7J/P?^%>D_!/X,M#M];T[=O19LK)"_\ ?CD4AD;W4C(X/%?,DW_!*;X.2Z@; ME=3\6PP[MWV1-0@\K']W)@+X_P"!9]Z^RZ*46XNZ&_>5FAI:*)26 MHHI1T1\O?$S_ ()Q?!CXE:Q-JBZ;J/A6\G17TS151E M*"M%V%**GK)7"OG?XZ?L(_"WX^>))/$.LV^I:-KLP47-_H=RD+7.T8!D5T=" M0 !N"@G R3@5]$45'6Y72QXO^SS^R9X'_9G756\*/JMSP8''>OK&BM/:24U4OJB.2+BX6T85\Z_%W]@?X/?&+5+C5;W0Y] UBY M;?/?^'YA;-*Q.2S1E6B+$DDMLR>Y-?15%9];FG2Q\K?#W_@FK\%O 6JQZA/8 M:IXLFB8/''X@NUEA4CUCB2-7'LX8>U?4T,,=M#'##&L44:A$C10%50, #H* M?15RG*2LV0HJ+ND?.7Q^_84\!?M&^.H_%?B75_$=CJ*6<=D(M*N;>.'8C.P. M)('.^.G%>T?#;P%I_PM\!Z%X2TJ:YN--T>U2TMY;QE:9D4<%RJJ"?H!72 MT4E)J/(MOZ_S&TG+F>_]?Y'SO^T%^PWX$_:2\:6WB?Q-JWB*QOX+)+%8])N8 M(XBBL[ D20.=V7/?'3BO7_A?\.]-^$OP_P!#\'Z1/=7.F:1;_9X);YU>9ER3 MERJJ">>P%=3123:CR+;^O\P:YI<[WV_K[@HHHI#"BBB@ K@_$7_)2--_Z\'_ M /0FKO*X/Q%_R4C3?^O!_P#T)J -FBBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T=,_U,_\ GM24 MNF?ZF?\ SVI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** )?^7&:LJM7_ )<9JRJ "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH *T[7_ )!WX_UK,K3M?^0=^/\ 6@!E%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 7[?\ U*U)4=O_ *E:DH *^!OBII)_9!_;8T3XGQ)]G^'_ (\=K#6) M%XCMKB3!J39[XE]*^^:YKXB?#?PU\6/"=WX:\6:5'K.B714RVLCNG*D M,K!T(92".JD&G%N$XU%T_%/=?UU"24H.#Z_@ULSHU99%#*0RL,A@<@BE(# @ MC(-9_A[0;+PKH.GZ/IJ21Z?80);6\ MRON<'J7P#^&.L:@]]?\ PY\)7U\[;FN;G0[621CZEC&23750^&=(M]$;1HM* ML8M':,PMIZ6Z"W*$8*F,#;@CMC%:5%+I;H/K?J>0?#3]E#X:_!_XB:GXS\): M&=(U/4+4VKV\;_P##-?PB_P"B5^"?_"=L_P#XW6EX=^!_ MPY\(ZQ;ZMH7@#POHNJV^[R;[3M&MH)X\J5.UT0,,J2#@]"17;44^9]PL@K.\ M0^&])\7:/<:3KNEV6M:5<8$UCJ%ND\$N&##D44[L5D*[M9E MV20SH'1U/8J>"*GHI/WMQK38XWP]\&?A]X1U0:GH7@7PUHNI+R+S3](MX)AG M_;1 ?UKLJ**=VQ'GMW^SM\*=0NIKJZ^&/@VYN9G:26:;0+1GDD447:T0SAM#^!/PU\+ZM;:IHWP\\*Z3 MJ=LV^"]L=$MH9HFP1E75 RG!(X/>NYHHHNQ61!?6-OJ5G/9WEO%=VEQ&T4UO M.@>.1&&&5E/!!!((/7-9/A'P'X:\ 6,UGX7\.Z3X;LYI/.EM](L8K6-WP!N9 M8U )P ,GG@5NT4MAG'?:9\'?AKX@\8:LZK:Z7:M,L9.#-)TCC'NSE5'U MKYI_X)U_"#4]/\.^(?B[XLC8^*O'5P]U&95PR6K.7W<]/-<[L?W5CKZ5^)_P MA\)?&;1[32?&.E-K.F6MRMY':-=30QF500I=8W4.!D_*V1STKKH(([6&.&&- M8H8U")'&H554# Z "JIODYI=7HO)=?F_R7F3-VO?]A:?^2U MV5 !117&?%SXK:-\&/!-SXGUV.ZGL8)(XO)LD5YG9VV@*&91[\D< T =G17C MOP._:B\+_'[5M2L/#VEZU:/I\"SS2ZE!"D>&;:%!25SD\GIT!KV*KE"4':2L M3&2E\(4445!045'//':PR332+%%&I=Y'("JH&223T %?-?B3_@H-\+/#^KS6 M,":WK:1,5-YIMI&8&(.#M,DJ$CW P>V:J,7-VBKBDU%79],45Y_\'?CCX7^. M6C7>I>&9+MH[218KB.\MVB>-B,@9Y4\?W2(4445) M04444 %%%8WBGQAHG@G3#J&O:I;:5:;@BR7,@7>QZ*HZLQ[* 2?2@#9HJ"\O M(K"RGNYVV00QM*['LH&2?R%?/_PW_;@\#_%+QQIGA71M&\2)J&H2,D4ES;0+ M$NU68LQ6Q,I*"YI/0^AZ***@H**** "BBB@ HHHH *** M* "BBB@ HKPOXR?MA>"O@CXP_P"$;UNPUN]U 6Z7+-IL$+QJKYPI+RH=W&>G M0BN&_P"'D7PT_P"@'XK_ / 2V_\ DBM8TIS5XK0B4XQ=I,^K:*\2^&/[8GPS M^*>I0Z99:K-I&JSMMAL]8A$#2GLJN"R%CV7=D]@:]MJ90E#XE8(RC+X6%%>/ M_'+]J+PG\ =2TNP\06>K7MSJ$3SQKI<,4FQ58+EM\B8R2<8ST-=G\*_B5IWQ M<\#V'BK2;2^LM.OC)Y,>H(B2X1RA)",PP2IQS0H2<.>V@W)*7(]SK:***@H* M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@#!\=_\ (GZO_P!>[5:\+_\ (LZ1_P!>)O#.G M^+M>O4X!/:S#Z,C=F4]F'K6K12:35F3**DG&2NF?#_ ,5OA5>^!-4-G> S MV4I+6E\JX#CT]F'OT?\4>%].\8Z+/I>IP":VE' M!Z,C=F4]B/\ /%?&7Q3^%M[X&U9K&]!EM9,M:7JKA9%_HP[C_P"L:^?Q.'=% M\T?A_(_,\[R7V;]K2V_+R?Z,\GI\,+W$BHB[F-2R6,T=SY&S+GICH?>N[^'_ M ,/[_P 5:O#IFF1>;P'ZUQJ[=EN?'8;"5,14Y$A_P ._AY? M^+=8BTS3(O,G?YIKAA\D2=V8]@/U-?:/@/P'IOP^T--/T]-SG#3W+#YYG_O' MV]!V_,TWP!X!TWX>Z&EA8+OE;#7%TP^>9_4^@]!V_,GIJ]_#8945S2^(_8CD?\ ML[7].N8\_*;I)(21[A0]> %'T /J30Z>(Q&D]$$\'G.;VABVJ=/JO^!=M_-V. M2_9S^";_ ]T]]:UF(#7[R/8(3@_98C@[?\ >. 3Z<#US[9117I4Z<:<5&)] MQA,)2P5&-"BM%_5V%%%%:'8%%%% !1110 4444 %%%% !1110 4444 %<=H' M_)2/%/\ USMO_18KL:X[0/\ DI'BG_KG;?\ HL4 =C1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !7!^(O^2D:;_P!>#_\ H35W ME<'XB_Y*1IO_ %X/_P"A-0!LT444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &CIG^IG_SVI*73/]3/ M_GM24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 2_\N,U95:O_+C-650 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !6G:_\@[\?ZUF5IVO_ "#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +]O M_J5J2H[?_4K4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !7'?$O_CUT+_L+0?R:NQKCOB7_ ,>NA?\ 86@_DU '8T444 <;\-/^/;7O M^PM/_):[*N-^&G_'MKW_ &%I_P"2UV5 !7QM_P %*/%7V/P1X3\/))AKZ^DO M)%'=8DVC\,R_I7V37YJ?\%#_ !4=:^-UMI"L#%H^FQ1%1VDD)D;_ ,=9*TI1 MYJL(^?Y:_G84GRTY2\OST_4]J_X)M>%?L'P[\3:^Z8?4=16V1L;G_ ("5'X5^;?PX\*:]\7/BEI^E:/.T.LZK=O(; MK<1Y.QPT9K=_P##_JC]'/B3^VW\ M,?AKK$NE27M[X@OH6*3QZ'"DRQ,.H+NZ(2.X4G'0UVOP;_: \'_'33[FX\,W MDOVFUQ]IT^\C$=Q"#T)4$@@^JDCM7@/Q-_8H^&?P]^!/B/4-M]/KNF:?)=+K M4MR^]Y57(7R@?+VLV!C;G!ZYYKP__@GO]L/[0 ^S,ZVXTJY-T%/!3*8S_P # M*5E3I4JD9J+=XJ]_O_R-*E2I#EDUHW:WW?YGTI^UY^TIX1T'X?>,_!%AK>_Q MG)"MD]BEO-\BR;=_[S9L_P!6Q_B[XZU\8_LVVOPFD\2ZG/\ %N\:+28K8"TM M52Z(FF+>*+'7;'4-4O=?\37=U>7<=Y+ M&T42 K@(JQJ0,O@9)X7\:VOV4_V-_"_Q>^&UOXM\2WNL03RWTBV\%C-$D+PQ ME1\P>)B^[_#3T=R<2Y.HJ:7I^>OJD?7GA31_AQ^SY\. MYKS2S;^%_"DSB_>6ZGE.YG10#^])W)Z!T/8X.",@X."<5VEU=P6%K--I#%DCV8*P]U%>L_ M\%#/C9?2:]:_#G3+EX+""%+K5!&V/.D;F.)L?PJN&QW+#T%34HIN#I/2>W]> MG^0Z=1^_&IO'_AOS_P SVKQA^WQ\*O">I/9V]SJ?B-HR5>;1[57B!'H\CH&^ MJY'O75_"']K#X>_&?45TS1M0N+#66!9--U2(0S2 #)V$%D8XYP&)P"<8%>%? MLR?L0^$]<^'>G^)?'MG/JM]J\(N+>P%Q)!';0MRA/ELK,Y&&Y. "!C@FO/\ MQ=^PU\1/#?Q7N;GX>VVW0K6YCN=,U.ZU"*.2,_*V",[\HV1G;R%K7V=",_92 M;OWZ?U_5S/GJRA[2"T[?U_7D?<'Q2^,WA+X-Z9;7OBO5?[-CNV>.V402RF5U M7)4"-6QVY.!S7Y>:/\4IO'WQQ\/^)/B'K]S+I<.J1W,\USOF2W@60/L2- <+ MP!A5[U]J?MN_#C3/$OP9C\7^)KR^M=:T&S5;>RLIHQ;---6T_7+J_L]*T^Q^T-+ISHDAD+JJ+ET88QO/3M3P<8Q*/BIX#\4?!'5/$]SXBGL_!6HVTEF^KP6TJ2JKL M8"41HB^=Q(!V'UZ5XG^RO\+_ (&P_$*77?AOXLUWQ)K&EVS;XM1B9(HED^3= M\UM%EL9 PW<\5C?MO66G_"7]G/P=\/M&>7[$UXL:&=@9'BA1F9F( !)=T)P M,GI4W_!.W1X/#/PK\9^+[W]U#-=[&D(_Y96\6]C],R-^51348PK58MI+3U7G M][*FY2=*G)7;U]'_ $CZA^(OQ4\*_"?1QJ?BK6;?2;9B1$LF6EF(ZA(U!9CR M.@XSSBO!9O\ @HS\,([LPKIOB:6/=C[0EG!L/O@S!L?A7QIX@UWQ-^UE\=K> M(RM]JU:[^S64+Y,=E; D@8'94!9O4@GO7V_8_L _"BW\+_V;<6>H7>IF/:=9 M:]D68/C[RH#Y8YZ H?QZTO8QI04ZV[Z(;J.F^-@"!UY&0<'!-=1X@UZP\+:'?ZQJMRMGIMC ]SZ\X[$# MTK[H_;J\7_\ "+?L]ZM;))LN-8N(=/3U(+;W_P#'8V'XUG7I1C&$Z3NI;?A^ M&J+HS)5 M';J>]=-\1?B=X9^$^@IK7BO4QI6FO,MNLQADES(P)"A8U9NBGMVKXS_X)I^# MO.UOQAXID3Y;>"+3H6QW=O,D_()'^=:/_!2[Q9B'P9X9C?EFFU&9<^F(XS^L ME56HQA5C2CUM_G^1-&HYPE.6RO\ U]^A]7?#/XS>#OC%;W]QX0U=2T%G$C2W$H'<(H) [; MC@>]>5_L ^$?^$=^ 5OJ#Q[9M:OI[PDCDHI$2_A^[)_&OA[XX:U+K'[2'B2? MQK]MEM(=;>"ZAMV'G+:))M"1;N!^[ V]N<]ZIT(RQ'L8O3_AK_BQ1JOV'MI+ M^M;?@C[-C_X*-?#![D1'2_$Z(3CSFLX-@]^)]V/PKWKX;_%3PM\6]#.K>%=6 MBU2U5MDJJ"DD+8^ZZ, RGZCGMFOD>P^$/[,7QD\.MIW@K68_#OB22/%LUW?S MQSF;'RJT5PQ609ZB/WP:[W]EK]D;Q/\ ?Q=-KNH^++*XBN+9K:YTNQ@=XYL M\JWF,5P5(R/D/4CC-.5.C9IWBUWZDJ=2Z:LT_P #ZHHHK,\4:W%X:\-:MJ\Q M AL+26Z?*7*G)]#LBG)I(_*']ISQ!)\0/VB_%LMN?.SJ/]GVX' M?RL0@#ZE?UK[RTO]AOX/PZ3:0WGA,SWJP(DUP-3O 7D"@,V!+@9.3@#'M7P/ M^SKHDOQ%_:*\)Q7(\YI]5%_<9YR(R9GS]=I_.OUWKU*UZ%"G33L_\K?\$X8V MK5YSZ=/Z]+'Y=?M@_LW6?P%\1:7?>'YIW\/:MO\ )CG?=);3)@LF[NN&!!// M!!SC-?:/[&?Q6O/BM\%;&?5)S54_V5C )_-A5W_@FS;R0_#'Q7']*LALN]0 M=4(B W&21B% /))X'?@5^6T.[XT?M/+G]['KGB7)[_N3/_(1C]*^Q/\ @HQK M&KZ;\(]&M+!I(M+O=2$5\8\@,%1FC1L?PD@G'JHK*<'&A3C?63VZ)Z?YLU4E M+$3T^%;];?TC>\4?\% /A3X:'J-PXC@@UF 1"5CT4.K,@)Z %AD]*^-/V:(_V?[S2+BT M^*45VFO23GR9[B6XCM/+(&T*8&!5LYR7XZ8->GZ]^P-I'COQ!'JWPS\:Z8?! MTZY+-<&\>&3/*HR<,N,?>8,.ASUK:5&E3?+._KT,55J37-&WH?>E>)?%#]L/ MX:?"G4IM,OM4GU?586VS6.CQ"=XCW#,2J CNN[([BN2_:D^)FM? 7]GO2=&C MUEM0\5:A&FE+JZH89&"I^]G W$JV !G)P7S7S9^QG^S#IGQPN=5\1>*S<3>' M]/F%NEK%(8S=SD;F#./F"J"N=I!)8<\'//2HJ?-)OW8_B;3J."BK>]+IV/JG MX?\ [='PO^(&MPZ5]HU'P]=7#B.%M:MTBCD8]%WH[JO_ (@5]"5^;?[;?[- MOAGX,?V!K?A**6PTW49)+::PDF>98Y%4,K(SDM@C=D$GH,=:^L/V5_&6M_$+ M]FC2+D72C7H;>?3XKRY!=?,C+)$[]VP-F?7!IU*<)475I7TW7]?UJ*,IQJ*G M4Z]?Z_K0V?BS^U+\//@U>-I^N:L]SJZJ&;3--B\^=0>1NY"H>G#,#@YKSO1_ M^"B/PLU2^CM[FV\0Z3$QP;J\LHVC7W(BE=OR4UX9;_LDZ1H?Q-:\^+'Q4\*R M:>TCW%]#_;'D7]S(><$2 8!;.2#G XQG(Y']JKP_\#=%T[2?^%67T M6]G=3W,!AVD[R\A8;MV!A6[GBKA3I6BG>3?;9"E*;;MHEW/TQT+7M.\3Z/:: MKI-[#J&FW<8E@NK=PR2*>X(_R*X+XL?M&> _@NRP>)-9":BZ>9'IMI&9KAE[ M$J.%![%B >U>/_\ !.>74)/@GJPN'9[./6)5M%8_='E1E@/;M=$\5%/]$BN+^X5I9,?=DAN"7*^IC''7GH?4_P!E7]F'Q!^SU>:M>:IX MKM=0M=0MU2;3+6!_*613E91(S#D#>,;.=W7BB<:*B[WBUW%&52ZM9I]CVWQ[ M\1O#7PQT-M7\4:O;Z18@[5>8DM(V,[40 L[>R@FOG^X_X*+?"Z&^,"6'B2>( M-C[5'90B,CUPTP;'_ Y-+2.]?Q%Y!VZ\UU('\['!\H'R]F?X=N<=\\U*IP MI4E5K7UZ?U_7J7*[?#GXG>&?BQX?76O"^J1ZG9;MC[05DB?&2C MHP!4_4<]1D$K?8]8BGM+F 'Y2\2-(C_4%&&?1C MZU^FU+$4E2DN5Z-7%1J.=XRW04445RG0%%%% !1110 4444 %%%% !1110 4 M444 8/CO_D3]7_Z]VJUX7_Y%G2/^O.'_ - %5?'?_(GZO_U[M5KPO_R+.D?] M>Z=\.]#6RLE\RX?#7-TP^>9O7V [#M^9KJ- MHW!LU)2Z9_J9_\]J2 M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@"7_ )<9JRJU?^7&:LJ@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "M.U_Y!WX_P!:S*T[7_D'?C_6@!E%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 7[?_4K M4E1V_P#J5J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M KCOB7_QZZ%_V%H/Y-78UQWQ+_X]="_["T'\FH [&BBB@#C?AI_Q[:]_V%I_ MY+795QOPT_X]M>_["T_\EKLJ "OR!^,VJ2_%+]H?Q)):MYC:EK;6=L>N5$@A MC_15K];/$DE]'X=U1]+@-SJ2VLIM80RKYDNP[%RQ &6P,D@5^??P"_8^^)FA M_&GPOK?BSPT+'1K&]^VW%R]_:S?,@+I\J2LQRX7H.]=F#<8UN>>R7WW?_ _$ MY\5S>QY8[M_DO^"?3G[6NK0_#O\ 9>URQM3Y:R6L&CVZCCY6*H1_WP&KYP_X M)L^$UOO'GBGQ%)'N&G6*6D;$='F?)Q[[8B/QKWC]M[X9^./BQX+T#0O!NC'5 ME2^:[O,74$ 3:A5!^]=N\]>]51FHTZLY/WG_P !?JR:T/>I4XK1?U^B(/V^/%?_ CO M[/M[9*^R;6+R"R4#J5#>:WZ1X_&O(?\ @FCX3W77C3Q+(GW$@TZ%OJ3)(/TC M_.O0/VY/A'\0?C$OA33_ ?H1U73[$SW%T_VRW@ D;:J#$DBDX ;H.]=[^Q_ M\)M6^#_P=ATK7[)=/URZO9KNZMQ*DNPDA$!9"5/R(IX)ZTJ$E##U'?5_?T7Z M/[QUDY5:<>BW_%_Y'QY_P4(\5'7/CL-,63=#H^G0V^T'@.^96_'#K^5?=G[. MOA4^"_@?X+TED\N6/38I95]))!YCC_OIS7Q;\2/V4/BU\2/CIK.O7?A8QZ+J M6LES=-J5H=EKY@56VB7=Q&!QC/'3M7Z*PPI;PI%&H2-%"JHZ 8 HHC14FUZ6SNM0EBWBW# M3E3(5++D#.>HX[U]2W'_ 3/AM;:2XF^)\<-O&AD>631 J*H&2Q)N< 8[UWG M[5'[%K?%K6I?%GA"YMK#Q%*H%Y9W64AO"!@.'&=KX '(P<#D';XZBF@+B-;>\\1QO9HHZ?NEF;@>@2M:=7FHQC&7+):.Y%2%JLI-7BSU M7X-_L/\ A_3/&V@^*=*^*MAXIM]*O(KS[/I]BA678P8+YB7+;>1UP:^W^2'&GS4I+ELW;\/^'9[]IVJZ1HW@NTU M$75O;Z';6"3+TPZO!JEY-Y%M'3D%&; P")X=C;Y+:XU^)K&/G.X1"4XY MYX3-?5G[+O[(MA\"6DUS5[N'6?%L\7E>="I$%HA^\L61DD]W(!QP .#8KT7=_!: MZY%Y$VT9PT44QW;BJJ>.0>>*,,X^QG!NS;_R_1%8A2YX32NDO\_U9C?\%(/% M7]I?%+0-"1\QZ7IOFLN>DDSDG_QU$_.OH#X4^"KO0_V&9-.LHV74=0\.WMX M!\S-.DCJ/KM917A/[1'[,'Q<^*OQP\1:_9>%_-TBZN4BMKEM1M%'D(JHK;3* M&'"YQC//2OO[1=)@T31;'3(% MK2WCMD7MM10H'Y"LI-?4E33UE^&[U^_P# MUU^M\]M(_I9?HS\POV$]7TW2/VB=(.HS1P&XMKBVMGE.!YS)\J@]B0& ]2<= MZ_3#QIXPTKP#X7U'7]:NEM--L8C++(QY..BKZL3@ =R17Q5\=_\ @G_K$WB. M\UWX;SVLEG<2&8Z-4E:Z>IYU\.]/U'X\_ MM)6$R0MYNKZV=1N0O/DP^;YLA)]%4$?E7T'_ ,%+O%C/J'@SPTC_ "1Q3:C* MOJ6(C0_^.R?G7T%^S7^R_HW[/NESS_:/[7\37J!+K4BFQ53.?*B7/"YY)/+$ M9.. .%_;0_9(_"K03ZS86YM)K"XD$7GQ;BRE'/RA@6;AB 0>O', M5*E/GI0C\,?\O^&*IPFU4G+XI?Y_\%F]^PGX=MO"_P"SGIVH-)$AU.YN;^>3 M< %PYC&3VPL0Z].:^)_VO/B?:?%OXX:E>Z3/]LTJRCCTVSE0Y654SN9?4%V? M![C!KT_X7_L6_&/5H?[ \2ZQ=>#O!KR^9=V":J)UF]=D,3M&6..KXQUYQBJ? MA7]BGQ_#\:M.N;CPF=.\%PZTLWFR:C;2E;1)=PRHE+DE0!TSDUT+V3Q/M)2T M_+9;^FWS,+SCAW",=?SZ_F?9VGZ[X>_9Q^!_AT^([A]/TW2[*VLY9(K>2;]\ M4 /"*2,OGD\9/7FO%9['X'_MP>(M5BLDU+2_%-C C?VDBK;37,7(#!"6$BJ= MH.Y0P!4 XKZA\9>#]+\?>%]2\/:U;_:M,U"$PS1YP<'H0>Q!P0>Q K\_?&/[ M!7Q-\"^(C?\ @._CUF"*0M:7%M>BRO8AVW;BJ@XXRK\^@Z5Q4Y0J5)2J.S>J M?]?U8ZI1E3IQC#6VC_K^M3F/VAOV,]9^!?A]_$<.O6>N:"LR0LS(;>Y1G.%_ M=DL&'N&SWQC./H?_ ()W_$S7_&'A+Q'X?UBZFO[30WMS97$[%G1)!)F+<>JK MY8(';=CIC'B9_9$_:"^)FH6\/B^[N%@C;Y;GQ!KHO%C'Y)-=4JBC1E&<_(Y5(N$;6W_K^NYZ57B/[9OBK_A%?V=?%3JVV:^2/3X\'&?-E:8RJV.DDKA1_XZLE?HGJ M6I6FC:?<7U_;MSMW;+@9QDXSTR:TKK]E/]HWXA21VGB:>]DMMV?,UWQ$MS$A M]<++(?R7M7JXB,:TDU-*RL>=1;I)WB]6<=^U9\:#\?/BR&T59+G1;$#3]+C5 M#NGRWS2!<9R[8P.N O>OM+PWX5?]FG]CW58IR(]7M]*N+RZ93TNYEP%S_LED M3_@-4/V:Y:TH*DL-3V>[] M?^'NSHI*3K>WJ=-EZ?U9'Q3^P/X7_P"$A_:#LKUTWQ:/97%Z2>@8J(E_67/X M5]8?&7]JGX-12:KX'\5Q7NNIYWV._LET]PD3!L$EG*?=(R&0D\97/%8'[#7[ M/OBKX.R>*]1\8:0-)O[T06]JGVF&K-XI\ M+7=MI?B9T"74%UD07FT85BR@E' &,X(.!G&,UMB)TYUHJ6L4NGW_ / 9CAXS MC"36DF]/Z_(XWQU_P3IT'Q!:C5/A]XI:SAN(_.@M=1'VBW=6&5V3)\RK@CDA MS[U\O_#_ ,2>+/V=OC8EG97>S4;'4187]K:RF2"[4/M:,@?>!YQQD'!X(KTF MQ_9H_:8\.6+:-I7]L6ND#*^18^)8HK8@GG]WYZ\'_=KUS]F_]A*^\(^*K+Q7 M\0+JUN+FRD%Q::3:N90)@0JY!."3V.]*:IRO.=X]NO]?UH8U8NI M#EC"TN_0I_\ !3+3KE]/\!WXW&SCENX&XX5V$3#GW"M^5>4_L]_L;V?Q\\!G MQ!!X\32KJ.X>VN-.&EBX:$CE26\]?O*01\H[]<5^@/Q>^%.C?&;P-?>&=:5E M@GP\-Q']^WF&=DB^XST[@D=Z^#;O]C7XZ_"_7K@^"+R:ZBD^4:AH>L+8/(F> M ZO)&0?8%A[FN7#5%&G*E>SZ/\3JQ$'*49I72W.FO_\ @GSX?TO5TTJ]^,^F M6>J2()$L;C38TG92<5L_M!1ZM^RA^S?X;\ >'M>EN9]7O;DW.L M01?9W:+.]D0!V*9WH,AN0IZ9K%^&7[ OC+Q9XFCUGXH:F+2T,@DN;9;O[5>W M1'\+2 E5!_O;F/L.M?2?[2'[-UG\9?AC8>']':WT>_T4JVD[E*P(H7886P"0 MA4#D#@J.O2G6J648RGS*ZNK=/ZZ=14HIR;4;:.WK;^O0^6OV5?V-=!^,O@E? M%WB;6[U;::XDABT_361&&PX)D=E;J<_* #C!SSQY7^U9X3\#> /B9_PC7@:% MEMM-MECOYGN6G+W))+*23@;5V@@8YSGFNW\+_LE_M$>'YKC2=)-UX>TVZ?;/ M-;>($AMI1TW.D4FYACU3..U5?''[!/Q0T/64MM!TR/Q/:?9XWDOXKRW@4S$? M.@6616P#P"1SUXZ#IE.+JJ7/[O;Y=?ZW,(Q:@X\NO?Y]/Z[GU+\%?&'AC]FO M]EOP5?\ BNYFT^'44-QNBM9)C)+,6E53L4X.S'WL#Y:Y/_A ?@I^VY>:YJ^@ M_P!I>'_$UHZBYN8U2*2<%<+*T.65UR"-WRMD_T MK4187*J?[P=DVGV5F'O7->$ZU1RE9W=GTM_7X&T5.-&"BKZ:K^OZN<9^T1^R M;KG[/=G::M+K=EK.C75S]FAGB!@N!)M+#=$2>,*>58^^.*^L?V*OB%XC^*'P M)U_3]7NI;V\TR233[2^F):1T:$%59C]XJ6QDGH1Z5X#:_L9_'3XGZS WC6_D MM8X_E-[KNL"_=$SR$"/(2?8E1[BON[X/?"?1O@MX%LO#.B[Y(H29)[F7_67$ MS8W2-Z9P !V [55:2>'E3G)2;VMT_K]14TU6C4A&R7]?UZ'Y-?"WX?V_P 0 M/B9I7A+5-87PV+Z=K4WTT'FB*4*VU2A=>68!>HY85]5:I_P3:LM$T^>_U'XJ MV]A8P+OFN;K1ECBC7U9FN@ /.9[O1[A_ M*#2GEI(GZ L>2K8&.EM]'\0SWHTJ,C9_;7B%;BVBQP"$26 M0C'LM:JM[6$7&7*^I#I*G-W5UT/;_P!G?]C/1_A_\0M(\;:;\1[3Q;!IXE*0 MV5DBHY>)H\^8L[CC<3TYKZ\KQC]FO]FG2?V?=!N MP-5\17X'VW4MFT;1R(H MQU" \^K'D]@/9ZXL1/GE;FND;T8\JO:S84445S'0%%%% !1110 4444 %%%% M !1110 4444 8/CO_D3]7_Z]VJUX7_Y%G2/^O.'_ - %5?'?_(GZO_U[M5KP MO_R+.D?]>U)2Z9_J9_P#/:DH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH E_Y< M9JRJU?\ EQFK*H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ K3M?\ D'?C_6LRM.U_Y!WX_P!: M &4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110!?M_P#4K4E1V_\ J5J2@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ KCOB7_ ,>NA?\ 86@_DU=C7'?$ MO_CUT+_L+0?R:@#L:*** .-^&G_'MKW_ &%I_P"2UV5<;\-/^/;7O^PM/_): M[*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@# M!\=_\B?J_P#U[M5KPO\ \BSI'_7G#_Z *J^._P#D3]7_ .O=JM>%_P#D6=(_ MZ\X?_0!0!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !7':!_R4CQ3_ -<[;_T6*[&N.T#_ )*1XI_ZYVW_ *+% '8T M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P?B+ M_DI&F_\ 7@__ *$U=Y7!^(O^2D:;_P!>#_\ H34 ;-%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110! MHZ9_J9_\]J2ETS_4S_Y[4E !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $O_+C-656K_RX MS5E4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 5IVO_(._'^M9E:=K_P @[\?ZT ,HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@"_;_ZE:DJ.W_U*U)0 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 5QWQ+_X]="_["T'\FKL:X[XE_P#'KH7_ &%H/Y-0 M!V-%%% '&_#3_CVU[_L+3_R6NRKC?AI_Q[:]_P!A:?\ DM=E0 4452UC6M.\ M.Z;/J.K7]KIFGP &6[O)EABC!( +.Q ') Y/>@"[17"_\+X^&G_11/"G_@[M MO_BZ?#\A!'45)4E!1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &# MX\_Y$_5_^O=J9X;US38O#NE(^H6J.MI$&5IE!!"#@\T[QX W@[5\C/[AC6;X M?\"Z#=:#ILTNF0O+);1.['.2Q0$GK0!T/_"0:7_T$K/_ +_I_C1_PD&E_P#0 M2L_^_P"G^-9O_"O?#O\ T"8/U_QH_P"%>^'?^@3!^O\ C0!I?\)!I?\ T$K/ M_O\ I_C1_P )!I?_ $$K/_O^G^-9O_"O?#O_ $"8/U_QH_X5[X=_Z!,'Z_XT M :7_ D&E_\ 02L_^_Z?XT?\)!I?_02L_P#O^G^-9O\ PKWP[_T"8/U_QH_X M5[X=_P"@3!^O^- &E_PD&E_]!*S_ ._Z?XT?\)!I?_02L_\ O^G^-9O_ KW MP[_T"8/U_P :/^%>^'?^@3!^O^- &E_PD&E_]!*S_P"_Z?XT?\)!I?\ T$K/ M_O\ I_C6;_PKWP[_ - F#]?\:/\ A7OAW_H$P?K_ (T :7_"0:7_ -!*S_[_ M *?XT?\ "0:7_P!!*S_[_I_C6;_PKWP[_P! F#]?\:/^%>^'?^@3!^O^- &E M_P )!I?_ $$K/_O^G^-'_"0:7_T$K/\ [_I_C6;_ ,*]\._] F#]?\:/^%>^ M'?\ H$P?K_C0!I?\)!I?_02L_P#O^G^-'_"0:7_T$K/_ +_I_C6;_P *]\._ M] F#]?\ &C_A7OAW_H$P?K_C0!I?\)!I?_02L_\ O^G^-'_"0:7_ -!*S_[_ M *?XUF_\*]\._P#0)@_7_&C_ (5[X=_Z!,'Z_P"- &E_PD&E_P#02L_^_P"G M^-'_ D&E_\ 02L_^_Z?XUF_\*]\._\ 0)@_7_&C_A7OAW_H$P?K_C0!I?\ M"0:7_P!!*S_[_I_C1_PD&E_]!*S_ ._Z?XUF_P#"O?#O_0)@_7_&C_A7OAW_ M *!,'Z_XT :7_"0:7_T$K/\ [_I_C1_PD&E_]!*S_P"_Z?XUF_\ "O?#O_0) M@_7_ !H_X5[X=_Z!,'Z_XT :7_"0:7_T$K/_ +_I_C1_PD&E_P#02L_^_P"G M^-9O_"O?#O\ T"8/U_QH_P"%>^'?^@3!^O\ C0!I?\)!I?\ T$K/_O\ I_C1 M_P )!I?_ $$K/_O^G^-9O_"O?#O_ $"8/U_QH_X5[X=_Z!,'Z_XT :7_ D& ME_\ 02L_^_Z?XT?\)!I?_02L_P#O^G^-9O\ PKWP[_T"8/U_QH_X5[X=_P"@ M3!^O^- &E_PD&E_]!*S_ ._Z?XT?\)!I?_02L_\ O^G^-9O_ KWP[_T"8/U M_P :/^%>^'?^@3!^O^- &E_PD&E_]!*S_P"_Z?XT?\)!I?\ T$K/_O\ I_C6 M;_PKWP[_ - F#]?\:/\ A7OAW_H$P?K_ (T :7_"0:7_ -!*S_[_ *?XT?\ M"0:7_P!!*S_[_I_C6;_PKWP[_P! F#]?\:/^%>^'?^@3!^O^- &E_P )!I?_ M $$K/_O^G^-'_"0:7_T$K/\ [_I_C6;_ ,*]\._] F#]?\:/^%>^'?\ H$P? MK_C0!I?\)!I?_02L_P#O^G^-'_"0:7_T$K/_ +_I_C6;_P *]\._] F#]?\ M&C_A7OAW_H$P?K_C0!I?\)!I?_02L_\ O^G^-'_"0:7_ -!*S_[_ *?XUF_\ M*]\._P#0)@_7_&C_ (5[X=_Z!,'Z_P"- &E_PD&E_P#02L_^_P"G^-'_ D& ME_\ 02L_^_Z?XUF_\*]\._\ 0)@_7_&C_A7OAW_H$P?K_C0!I?\ "0:7_P!! M*S_[_I_C1_PD&E_]!*S_ ._Z?XUF_P#"O?#O_0)@_7_&C_A7OAW_ *!,'Z_X MT :7_"0:7_T$K/\ [_I_C7)Z'JUC'\0O$LS7MNL,D=N$D:50K809P<\UM?\ M"O?#O_0)@_7_ !KF-&\(Z/<>.O$-G)I\3VMND!BC.<)N0$XY[F@#N?\ A(-+ M_P"@E9_]_P!/\:/^$@TO_H)6?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/ MU_QH TO^$@TO_H)6?_?]/\:/^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ MC1_PKWP[_P! F#]?\: -+_A(-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK M-_X5[X=_Z!,'Z_XT?\*]\._] F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+ M_P"@E9_]_P!/\:S?^%>^'?\ H$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ M *"5G_W_ $_QH_X2#2_^@E9_]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7 M_&@#2_X2#2_^@E9_]_T_QH_X2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"- M'_"O?#O_ $"8/U_QH TO^$@TO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW M_A7OAW_H$P?K_C1_PKWP[_T"8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ M *"5G_W_ $_QK-_X5[X=_P"@3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ MH)6?_?\ 3_&C_A(-+_Z"5G_W_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\ M: -+_A(-+_Z"5G_W_3_&C_A(-+_Z"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T? M\*]\._\ 0)@_7_&@#2_X2#2_^@E9_P#?]/\ &C_A(-+_ .@E9_\ ?]/\:S?^ M%>^'?^@3!^O^-'_"O?#O_0)@_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ MH)6?_?\ 3_&LW_A7OAW_ *!,'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@ ME9_]_P!/\:/^$@TO_H)6?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH M TO^$@TO_H)6?_?]/\:/^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_P MKWP[_P! F#]?\: -+_A(-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5 M[X=_Z!,'Z_XT?\*]\._] F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@ ME9_]_P!/\:S?^%>^'?\ H$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5 MG_W_ $_QH_X2#2_^@E9_]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@# M2_X2#2_^@E9_]_T_QH_X2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O M?#O_ $"8/U_QH TO^$@TO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7O MAW_H$P?K_C1_PKWP[_T"8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5 MG_W_ $_QK-_X5[X=_P"@3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6? M_?\ 3_&C_A(-+_Z"5G_W_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+ M_A(-+_Z"5G_W_3_&C_A(-+_Z"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T?\*]\ M._\ 0)@_7_&@#2_X2#2_^@E9_P#?]/\ &C_A(-+_ .@E9_\ ?]/\:S?^%>^' M?^@3!^O^-'_"O?#O_0)@_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ H)6? M_?\ 3_&LW_A7OAW_ *!,'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@E9_] M_P!/\:/^$@TO_H)6?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH TO^ M$@TO_H)6?_?]/\:/^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_PKWP[ M_P! F#]?\: -+_A(-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5[X=_ MZ!,'Z_XT?\*]\._] F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@E9_] M_P!/\:S?^%>^'?\ H$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5G_W_ M $_QH_X2#2_^@E9_]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@#2_X2 M#2_^@E9_]_T_QH_X2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O?#O_ M $"8/U_QH TO^$@TO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7OAW_H M$P?K_C1_PKWP[_T"8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5G_W_ M $_QK-_X5[X=_P"@3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6?_?\ M3_&C_A(-+_Z"5G_W_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+_A(- M+_Z"5G_W_3_&N)U_5;*3XA:?,EY;M"MDRF195*@[CQG/6ND_X5[X=_Z!,'Z_ MXUR&N>%-)M_'5C9Q6,:6LEFTC1C."VX\]: .B_MK3_\ G^MO^_R_XT?VUI__ M #_6W_?Y?\:H?\(7HG_0.A_7_&C_ (0O1/\ H'0_K_C0!?\ [:T__G^MO^_R M_P"-']M:?_S_ %M_W^7_ !JA_P (7HG_ $#H?U_QH_X0O1/^@=#^O^- %_\ MMK3_ /G^MO\ O\O^-']M:?\ \_UM_P!_E_QJA_PA>B?] Z']?\:/^$+T3_H' M0_K_ (T 7_[:T_\ Y_K;_O\ +_C1_;6G_P#/];?]_E_QJA_PA>B?] Z']?\ M&C_A"]$_Z!T/Z_XT 7_[:T__ )_K;_O\O^-']M:?_P _UM_W^7_&J'_"%Z)_ MT#H?U_QH_P"$+T3_ *!T/Z_XT 7_ .VM/_Y_K;_O\O\ C1_;6G_\_P!;?]_E M_P :H?\ "%Z)_P! Z']?\:/^$+T3_H'0_K_C0!?_ +:T_P#Y_K;_ +_+_C1_ M;6G_ //];?\ ?Y?\:H?\(7HG_0.A_7_&C_A"]$_Z!T/Z_P"- %_^VM/_ .?Z MV_[_ "_XT?VUI_\ S_6W_?Y?\:H?\(7HG_0.A_7_ !H_X0O1/^@=#^O^- %_ M^VM/_P"?ZV_[_+_C1_;6G_\ /];?]_E_QJA_PA>B?] Z']?\:/\ A"]$_P"@ M=#^O^- %_P#MK3_^?ZV_[_+_ (T?VUI__/\ 6W_?Y?\ &J'_ A>B?\ 0.A_ M7_&C_A"]$_Z!T/Z_XT 7_P"VM/\ ^?ZV_P"_R_XT?VUI_P#S_6W_ '^7_&J' M_"%Z)_T#H?U_QH_X0O1/^@=#^O\ C0!?_MK3_P#G^MO^_P O^-']M:?_ ,_U MM_W^7_&J'_"%Z)_T#H?U_P :/^$+T3_H'0_K_C0!?_MK3_\ G^MO^_R_XT?V MUI__ #_6W_?Y?\:H?\(7HG_0.A_7_&C_ (0O1/\ H'0_K_C0!?\ [:T__G^M MO^_R_P"-']M:?_S_ %M_W^7_ !JA_P (7HG_ $#H?U_QH_X0O1/^@=#^O^- M%_\ MK3_ /G^MO\ O\O^-']M:?\ \_UM_P!_E_QJA_PA>B?] Z']?\:/^$+T M3_H'0_K_ (T 7_[:T_\ Y_K;_O\ +_C1_;6G_P#/];?]_E_QJA_PA>B?] Z' M]?\ &C_A"]$_Z!T/Z_XT 7_[:T__ )_K;_O\O^-']M:?_P _UM_W^7_&J'_" M%Z)_T#H?U_QH_P"$+T3_ *!T/Z_XT 7_ .VM/_Y_K;_O\O\ C1_;6G_\_P!; M?]_E_P :H?\ "%Z)_P! Z']?\:/^$+T3_H'0_K_C0!?_ +:T_P#Y_K;_ +_+ M_C1_;6G_ //];?\ ?Y?\:H?\(7HG_0.A_7_&C_A"]$_Z!T/Z_P"- %_^VM/_ M .?ZV_[_ "_XT?VUI_\ S_6W_?Y?\:H?\(7HG_0.A_7_ !H_X0O1/^@=#^O^ M- %_^VM/_P"?ZV_[_+_C1_;6G_\ /];?]_E_QJA_PA>B?] Z']?\:/\ A"]$ M_P"@=#^O^- %_P#MK3_^?ZV_[_+_ (T?VUI__/\ 6W_?Y?\ &J'_ A>B?\ M0.A_7_&C_A"]$_Z!T/Z_XT 7_P"VM/\ ^?ZV_P"_R_XT?VUI_P#S_6W_ '^7 M_&J'_"%Z)_T#H?U_QH_X0O1/^@=#^O\ C0!?_MK3_P#G^MO^_P O^-']M:?_ M ,_UM_W^7_&J'_"%Z)_T#H?U_P :/^$+T3_H'0_K_C0!?_MK3_\ G^MO^_R_ MXT?VUI__ #_6W_?Y?\:H?\(7HG_0.A_7_&C_ (0O1/\ H'0_K_C0!?\ [:T_ M_G^MO^_R_P"-']M:?_S_ %M_W^7_ !JA_P (7HG_ $#H?U_QH_X0O1/^@=#^ MO^- &]IVN::L,V=0M1GUF7T^M)_;FF_]!"U_[_+_ (U0L/ N@2PS%M,A8CIU M_P :3_A!= _Z!D/Z_P"- &A_;FF_]!"U_P"_R_XT?VYIO_00M?\ O\O^-9__ M @N@?\ 0,A_7_&C_A!= _Z!D/Z_XT :']N:;_T$+7_O\O\ C1_;FF_]!"U_ M[_+_ (UG_P#""Z!_T#(?U_QH_P"$%T#_ *!D/Z_XT :']N:;_P!!"U_[_+_C M1_;FF_\ 00M?^_R_XUG_ /""Z!_T#(?U_P :/^$%T#_H&0_K_C0!H?VYIO\ MT$+7_O\ +_C1_;FF_P#00M?^_P O^-9__""Z!_T#(?U_QH_X070/^@9#^O\ MC0!H?VYIO_00M?\ O\O^-']N:;_T$+7_ +_+_C6?_P (+H'_ $#(?U_QH_X0 M70/^@9#^O^- &A_;FF_]!"U_[_+_ (T?VYIO_00M?^_R_P"-9_\ P@N@?] R M']?\:/\ A!= _P"@9#^O^- &A_;FF_\ 00M?^_R_XT?VYIO_ $$+7_O\O^-9 M_P#P@N@?] R']?\ &C_A!= _Z!D/Z_XT :']N:;_ -!"U_[_ "_XT?VYIO\ MT$+7_O\ +_C6?_P@N@?] R']?\:/^$%T#_H&0_K_ (T :']N:;_T$+7_ +_+ M_C1_;FF_]!"U_P"_R_XUG_\ ""Z!_P! R']?\:/^$%T#_H&0_K_C0!H?VYIO M_00M?^_R_P"-']N:;_T$+7_O\O\ C6?_ ,(+H'_0,A_7_&C_ (070/\ H&0_ MK_C0!H?VYIO_ $$+7_O\O^-']N:;_P!!"U_[_+_C6?\ \(+H'_0,A_7_ !H_ MX070/^@9#^O^- &A_;FF_P#00M?^_P O^-']N:;_ -!"U_[_ "_XUG_\(+H' M_0,A_7_&C_A!= _Z!D/Z_P"- &A_;FF_]!"U_P"_R_XT?VYIO_00M?\ O\O^ M-9__ @N@?\ 0,A_7_&C_A!= _Z!D/Z_XT :']N:;_T$+7_O\O\ C1_;FF_] M!"U_[_+_ (UG_P#""Z!_T#(?U_QH_P"$%T#_ *!D/Z_XT :']N:;_P!!"U_[ M_+_C1_;FF_\ 00M?^_R_XUG_ /""Z!_T#(?U_P :/^$%T#_H&0_K_C0!H?VY MIO\ T$+7_O\ +_C1_;FF_P#00M?^_P O^-9__""Z!_T#(?U_QH_X070/^@9# M^O\ C0!H?VYIO_00M?\ O\O^-']N:;_T$+7_ +_+_C6?_P (+H'_ $#(?U_Q MH_X070/^@9#^O^- &A_;FF_]!"U_[_+_ (T?VYIO_00M?^_R_P"-9_\ P@N@ M?] R']?\:/\ A!= _P"@9#^O^- &A_;FF_\ 00M?^_R_XT?VYIO_ $$+7_O\ MO^-9_P#P@N@?] R']?\ &C_A!= _Z!D/Z_XT :']N:;_ -!"U_[_ "_XT?VY MIO\ T$+7_O\ +_C6?_P@N@?] R']?\:/^$%T#_H&0_K_ (T :']N:;_T$+7_ M +_+_C1_;FF_]!"U_P"_R_XUG_\ ""Z!_P! R']?\:/^$%T#_H&0_K_C0!H? MVYIO_00M?^_R_P"-']N:;_T$+7_O\O\ C6?_ ,(+H'_0,A_7_&C_ (070/\ MH&0_K_C0!H?VYIO_ $$+7_O\O^-']N:;_P!!"U_[_+_C6?\ \(+H'_0,A_7_ M !H_X070/^@9#^O^- &A_;FF_P#00M?^_P O^-']N:;_ -!"U_[_ "_XUG_\ M(+H'_0,A_7_&C_A!= _Z!D/Z_P"- &A_;FF_]!"U_P"_R_XT?VYIO_00M?\ MO\O^-9__ @N@?\ 0,A_7_&C_A!= _Z!D/Z_XT :']N:;_T$+7_O\O\ C1_; MFF_]!"U_[_+_ (UG_P#""Z!_T#(?U_QH_P"$%T#_ *!D/Z_XT :']N:;_P!! M"U_[_+_C1_;FF_\ 00M?^_R_XUG_ /""Z!_T#(?U_P :/^$%T#_H&0_K_C0! MJ_V]IOV*4?VC:Y]//7_&LS^VM/\ ^?ZV_P"_R_XT[_A _#_V.5O[+AW#H>?\ M:SO^$+T3_H'0_K_C0!?_ +:T_P#Y_K;_ +_+_C1_;6G_ //];?\ ?Y?\:H?\ M(7HG_0.A_7_&C_A"]$_Z!T/Z_P"- %_^VM/_ .?ZV_[_ "_XT?VUI_\ S_6W M_?Y?\:H?\(7HG_0.A_7_ !H_X0O1/^@=#^O^- %_^VM/_P"?ZV_[_+_C1_;6 MG_\ /];?]_E_QJA_PA>B?] Z']?\:/\ A"]$_P"@=#^O^- %_P#MK3_^?ZV_ M[_+_ (T?VUI__/\ 6W_?Y?\ &J'_ A>B?\ 0.A_7_&C_A"]$_Z!T/Z_XT 7 M_P"VM/\ ^?ZV_P"_R_XT?VUI_P#S_6W_ '^7_&J'_"%Z)_T#H?U_QH_X0O1/ M^@=#^O\ C0!?_MK3_P#G^MO^_P O^-']M:?_ ,_UM_W^7_&J'_"%Z)_T#H?U M_P :/^$+T3_H'0_K_C0!?_MK3_\ G^MO^_R_XT?VUI__ #_6W_?Y?\:H?\(7 MHG_0.A_7_&C_ (0O1/\ H'0_K_C0!?\ [:T__G^MO^_R_P"-']M:?_S_ %M_ MW^7_ !JA_P (7HG_ $#H?U_QH_X0O1/^@=#^O^- %_\ MK3_ /G^MO\ O\O^ M-']M:?\ \_UM_P!_E_QJA_PA>B?] Z']?\:/^$+T3_H'0_K_ (T 7_[:T_\ MY_K;_O\ +_C1_;6G_P#/];?]_E_QJA_PA>B?] Z']?\ &C_A"]$_Z!T/Z_XT M 7_[:T__ )_K;_O\O^-']M:?_P _UM_W^7_&J'_"%Z)_T#H?U_QH_P"$+T3_ M *!T/Z_XT 7_ .VM/_Y_K;_O\O\ C1_;6G_\_P!;?]_E_P :H?\ "%Z)_P! MZ']?\:/^$+T3_H'0_K_C0!?_ +:T_P#Y_K;_ +_+_C1_;6G_ //];?\ ?Y?\ M:H?\(7HG_0.A_7_&C_A"]$_Z!T/Z_P"- %_^VM/_ .?ZV_[_ "_XT?VUI_\ MS_6W_?Y?\:H?\(7HG_0.A_7_ !H_X0O1/^@=#^O^- %_^VM/_P"?ZV_[_+_C M1_;6G_\ /];?]_E_QJA_PA>B?] Z']?\:/\ A"]$_P"@=#^O^- %_P#MK3_^ M?ZV_[_+_ (T?VUI__/\ 6W_?Y?\ &J'_ A>B?\ 0.A_7_&C_A"]$_Z!T/Z_ MXT 7_P"VM/\ ^?ZV_P"_R_XT?VUI_P#S_6W_ '^7_&J'_"%Z)_T#H?U_QH_X M0O1/^@=#^O\ C0!?_MK3_P#G^MO^_P O^-']M:?_ ,_UM_W^7_&J'_"%Z)_T M#H?U_P :/^$+T3_H'0_K_C0!?_MK3_\ G^MO^_R_XT?VUI__ #_6W_?Y?\:H M?\(7HG_0.A_7_&C_ (0O1/\ H'0_K_C0!?\ [:T__G^MO^_R_P"-']M:?_S_ M %M_W^7_ !JA_P (7HG_ $#H?U_QH_X0O1/^@=#^O^- %_\ MK3_ /G^MO\ MO\O^-']M:?\ \_UM_P!_E_QJA_PA>B?] Z']?\:/^$+T3_H'0_K_ (T 7_[: MT_\ Y_K;_O\ +_C1_;6G_P#/];?]_E_QJA_PA>B?] Z']?\ &C_A"]$_Z!T/ MZ_XT 7_[:T__ )_K;_O\O^-']M:?_P _UM_W^7_&J'_"%Z)_T#H?U_QH_P"$ M+T3_ *!T/Z_XT 7_ .VM/_Y_K;_O\O\ C1_;6G_\_P!;?]_E_P :H?\ "%Z) M_P! Z']?\:/^$+T3_H'0_K_C0!?_ +:T_P#Y_K;_ +_+_C1_;6G_ //];?\ M?Y?\:H?\(7HG_0.A_7_&C_A"]$_Z!T/Z_P"- %_^VM/_ .?ZV_[_ "_XT?VU MI_\ S_6W_?Y?\:H?\(7HG_0.A_7_ !H_X0O1/^@=#^O^- %_^VM/_P"?ZV_[ M_+_C6C;Z[IHT_!U"U!ST\]?7ZUS_ /PA>B?] Z']?\:T+?P'H#6.\Z7"6SUY M]?K0!=_MS3?^@A:_]_E_QH_MS3?^@A:_]_E_QK/_ .$%T#_H&0_K_C1_P@N@ M?] R']?\: -#^W--_P"@A:_]_E_QH_MS3?\ H(6O_?Y?\:S_ /A!= _Z!D/Z M_P"-'_""Z!_T#(?U_P : -#^W--_Z"%K_P!_E_QH_MS3?^@A:_\ ?Y?\:S_^ M$%T#_H&0_K_C1_P@N@?] R']?\: -#^W--_Z"%K_ -_E_P :/[^'?^@3!^O^ M-'_"O?#O_0)@_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ H)6?_?\ 3_&L MW_A7OAW_ *!,'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@E9_]_P!/\:/^ M$@TO_H)6?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH TO^$@TO_H)6 M?_?]/\:/^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_PKWP[_P! F#]? M\: -+_A(-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5[X=_Z!,'Z_XT M?\*]\._] F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@E9_]_P!/\:S? M^%>^'?\ H$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5G_W_ $_QH_X2 M#2_^@E9_]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@#2_X2#2_^@E9_ M]_T_QH_X2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O?#O_ $"8/U_Q MH TO^$@TO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7OAW_H$P?K_C1_ MPKWP[_T"8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5G_W_ $_QK-_X M5[X=_P"@3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6?_?\ 3_&C_A(- M+_Z"5G_W_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+_A(-+_Z"5G_W M_3_&C_A(-+_Z"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T?\*]\._\ 0)@_7_&@ M#2_X2#2_^@E9_P#?]/\ &C_A(-+_ .@E9_\ ?]/\:S?^%>^'?^@3!^O^-'_" MO?#O_0)@_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ H)6?_?\ 3_&LW_A7 MOAW_ *!,'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@E9_]_P!/\:/^$@TO M_H)6?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH TO^$@TO_H)6?_?] M/\:/^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_PKWP[_P! F#]?\: - M+_A(-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5[X=_Z!,'Z_XT?\*] M\._] F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@E9_]_P!/\:S?^%>^ M'?\ H$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5G_W_ $_QH_X2#2_^ M@E9_]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@#2_X2#2_^@E9_]_T_ MQH_X2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O?#O_ $"8/U_QH TO M^$@TO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7OAW_H$P?K_C1_PKWP M[_T"8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5G_W_ $_QK-_X5[X= M_P"@3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6?_?\ 3_&C_A(-+_Z" M5G_W_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+_A(-+_Z"5G_W_3_& MC_A(-+_Z"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T?\*]\._\ 0)@_7_&@#2_X M2#2_^@E9_P#?]/\ &C_A(-+_ .@E9_\ ?]/\:S?^%>^'?^@3!^O^-'_"O?#O M_0)@_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ H)6?_?\ 3_&LW_A7OAW_ M *!,'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@E9_]_P!/\:/^$@TO_H)6 M?_?]/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH TO^$@TO_H)6?_?]/\:/ M^$@TO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_PKWP[_P! F#]?\: -+_A( M-+_Z"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5[X=_Z!,'Z_XT?\*]\._] M F#]?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@E9_]_P!/\:S?^%>^'?\ MH$P?K_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5G_W_ $_QH_X2#2_^@E9_ M]_T_QK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@#2_X2#2_^@E9_]_T_QH_X M2#2_^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O?#O_ $"8/U_QH TO^$@T MO_H)6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7OAW_H$P?K_C1_PKWP[_T" M8/U_QH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5G_W_ $_QK-_X5[X=_P"@ M3!^O^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6?_?\ 3_&C_A(-+_Z"5G_W M_3_&LW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+_A(-+_Z"5G_W_3_&C_A( M-+_Z"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T?\*]\._\ 0)@_7_&@#2_X2#2_ M^@E9_P#?]/\ &C_A(-+_ .@E9_\ ?]/\:S?^%>^'?^@3!^O^-'_"O?#O_0)@ M_7_&@#2_X2#2_P#H)6?_ '_3_&C_ (2#2_\ H)6?_?\ 3_&LW_A7OAW_ *!, M'Z_XT?\ "O?#O_0)@_7_ !H TO\ A(-+_P"@E9_]_P!/\:/^$@TO_H)6?_?] M/\:S?^%>^'?^@3!^O^-'_"O?#O\ T"8/U_QH TO^$@TO_H)6?_?]/\:/^$@T MO_H)6?\ W_3_ !K-_P"%>^'?^@3!^O\ C1_PKWP[_P! F#]?\: -+_A(-+_Z M"5G_ -_T_P :/^$@TO\ Z"5G_P!_T_QK-_X5[X=_Z!,'Z_XT?\*]\._] F#] M?\: -+_A(-+_ .@E9_\ ?]/\:/\ A(-+_P"@E9_]_P!/\:S?^%>^'?\ H$P? MK_C1_P *]\._] F#]?\ &@#2_P"$@TO_ *"5G_W_ $_QH_X2#2_^@E9_]_T_ MQK-_X5[X=_Z!,'Z_XT?\*]\._P#0)@_7_&@#2_X2#2_^@E9_]_T_QH_X2#2_ M^@E9_P#?]/\ &LW_ (5[X=_Z!,'Z_P"-'_"O?#O_ $"8/U_QH TO^$@TO_H) M6?\ W_3_ !H_X2#2_P#H)6?_ '_3_&LW_A7OAW_H$P?K_C1_PKWP[_T"8/U_ MQH TO^$@TO\ Z"5G_P!_T_QH_P"$@TO_ *"5G_W_ $_QK-_X5[X=_P"@3!^O M^-'_ KWP[_T"8/U_P : -+_ (2#2_\ H)6?_?\ 3_&C_A(-+_Z"5G_W_3_& MLW_A7OAW_H$P?K_C1_PKWP[_ - F#]?\: -+_A(-+_Z"5G_W_3_&C_A(-+_Z M"5G_ -_T_P :S?\ A7OAW_H$P?K_ (T?\*]\._\ 0)@_7_&@#2_X2#2_^@E9 M_P#?]/\ &N4^(.J6=]#H:6]W!<.-5@8K%(K$##EJ^V76-1A@V@]43,K?JB? MG7T_7Y__ /!2KQ3]J\7^$/#J/E;.REO9%']Z5PJY_"(_G50CS5(1\_RU_0&^ M6$I=E^>GZGE_[,_[*$_[1.EZYJ#>(O\ A';;39HX$;[!]I\YV4LP_P!8FW:- MOKG=7;_%S_@G[J?PW\!ZKXET[Q?#KPTR%KF>UDT\VK&->6*MYK@D#G!QG'6N MU_8]_:%^%GP=^#J:7K_B86&N75[/>7-LNGW4I7.$0;DB*GY44\'O47[3W[<' MAKQ=X!U+PGX'6[O9-4C\BYU.XA,,<<)^\J*WS,S#CD $]:]/$3K^T<:6VG3 M3S."A&ERWJ^?YG*?\$\_BIJ^F_$B7P/-=23Z'J=M+/#;.Q98)XQOW)_=W*&! MQU(7TK]%*_/W_@G3\*;Z\\6:GX]NH'BTRRMWL;.1A@33/C>5]0J@@^[^QKQ3 M]K+Q4/%G[1'C"[+>;;VUV+% I_AA41D _56_.C$057$1IIV=M?O_ ,F@H2=. ME*;VOI]W_ 9^JOB3QCH'@VVCN-?US3=#MY&VI+J5W';HQ] 7(!-7M+U2RUNP MAOM.O+>_LIANBN;659(W'JK*2"/I7YQ6O[,/Q@_:6>/QEJC6&B6-PB)86VJS MR1^7:@8188E1BJ!>F[;NZ\YR=3]J;XY7'P]M+/X-> ;N72M%T&U2TU&\M7*2 MW,FT%H]PY Y)?!^9F(/ YY70M:"=YOIV7G^!O&KS>];W;;^?D?=&L_%KP/X= MOGLM6\9>']+O$.&M[S5((9%^JLX(K>T?7-.\0V*7NE7]KJ=F_P!VXLYEEC;Z M,I(-?GA\+?\ @GOXE\=^$K;7-<\0P^%WO(A/;6+6;7,NPC*F3YT"$C!Q\Q / M.#Q7FL-_XX_8V^-$MFEWBYLW1KB&&1C:ZC;-R,@]01GDC*G..16BP\'+V?/[ MQ'MI\OM%'0_6:LGQ%XNT/PA:K>G)K"E1E4DXO11W-9U8P@I;WV/U2\/^*-&\66 M/VW0]7L=9L\[?M&GW*3QY]-R$C-:E?G/XP^#?CK]AW5+#QMX?\0KK^B3/]DO M=D+6X;<#A)8]SC:>=K9.& X'&>4_80\.MXF_:+T^^E'F+IEK"=+\->'H8=.\'Z*\C-N'8&OE6;X6_$']FC]G<^'_!& MDS:WXXUZ[D?5-4T5&E^R1 87RR0&SMP%.."SD*M1 MN?!C&=D6/4]/DEN[A^"SLCLA"DG[Q))(/'>J5*$I2:E[J_$GVDE&-XZL_1/P M[XQT#QA \V@ZWINMPH<-)IUW'<*OU*$XK8K\?O$-CXB_9@^-5W9:7K2MK&AW M";;RS)5)E95?:R^A5@&0Y'4<]:_2?]H+QPV@_LW^*->_X]I[G2/+C4GE9)U$ M8'U!D_2IK4E"FJL'=/\ I?>73FY5'2FK,]:KF+[XI>#-+UC^R;WQ=H5GJNX) M]AGU*%)]QZ#86W9]L5^5'[._ACQKXR\?-H_@6X_L_5;RSDAGU(L4^QVQ*^9) MO'*Y&%R.?FP.N:WOVF/V9[K]G>XT$S^(8O$":NDK;UMC \;IMW @NV0=XPV1 MWXK:6&C"<8REOM^/^1C&LYQ;C'8_5V2:.&%I9)%CB5=S2,0% ]2?2N M#O$>J?V9I/BS0]4U'G_0[/4H9IN.OR*Q/'TK\_?@OX2^*7[57@BQ\(-XD;1O M 7AX>1+>2*SF=R=R1E0P,I12 %)"J,=\5X[\9?AG?? /XI77AY-8%]=:>8;F M#4;53"_S*'5MN248?4],YH6&BJGLYRUZ>G]= ]M*4.>*VW/V*K'\1>,M \(0 MI+KNN:;HL3_=?4;N.W5OH7(S7EOC+XP:MX+_ &5H?'KPK)KS:):3A73*BXF6 M-0S#T#/NQ[8KX'^"_P *K[]JCQYJW]O>.H-,U0J)FGU'-Q^)7A#Q==&VT+Q5HFM7(&3#I^HP MSOCUPC$UTE?F-\6/V(/'_P +=1TVY\,O<>,H)I0L=SI-J\=Q;R#D,Z ML''# MAL9'..,_=O[.UUXYG^%NF1?$2PELO$EL6@>2:6-WN(QC9*VQCAB#@YP25)/6 MB=.')SPE<(U)\W+.)Z91117*;A1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M &#X[_Y$_5_^O=JM>%_^19TC_KSA_P#0!57QW_R)^K_]>[5:\+_\BSI'_7G# M_P"@"@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "N.T#_ )*1XI_ZYVW_ *+%=C7':!_R4CQ3_P!<[;_T6* .QHHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@_$7_) M2--_Z\'_ /0FKO*X/Q%_R4C3?^O!_P#T)J -FBBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH T=,_U M,_\ GM24NF?ZF?\ SVI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )?^7&:LJM7_ )<9 MJRJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH *T[7_ )!WX_UK,K3M?^0=^/\ 6@!E%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 7[?\ U*U)4=O_ *E:DH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH *X[XE_P#'KH7_ &%H/Y-78UQWQ+_X]="_["T' M\FH [&BBB@#C?AI_Q[:]_P!A:?\ DM=E7&_#3_CVU[_L+3_R6NRH *_)[]LC MQ0WB[]HSQ24/F1V4L>G1!>?]4@5A_P!][Z_5G4;Z+2]/NKR=ML%O$TTC>BJ" M2?R%?D+\,[&7XL_M#:&EPOF'6->6ZN >?D,IED_\=#5V8**GB-=DOS_IG/BI MG2ZEK7B9-1DMHVN5@NK<1B4J"X4& D#.<9) M^M=5X9_X)_\ PH\/WBSW4&KZ^%.1%J=Z-F?<1+'GZ'BOI*BLY8BHVW>PXT8) M)-7,6X_LSP#X0N'M+2#3])TFS>1+>W01QQQQH6PH' &!7Y0? ?PF?C)^T%H- MCJ*?:(=0U%[Z^4\AXUW32 ^S;2/QK]%?VO\ Q3_PB?[._C"/QG^TU;P:P-\6 MI>*PMTLAZA[KYE.?KBOU\K\ZOVN?V6/%'AGX@:CXW\(:==:IHNH3F^E73D+S MV,Y.YSM7YMI;+!@,#)!Q@$YX2I&G74I;?\%&F(INI0E"._\ PY^B@ 4 8 K M\LOVY/%UGXM_:$U86,BS1:9;PZV;O<)G\>:Z[]E;]COQ#XD\66?C'Q_I\^FZ/:RBZBL-0 M4BXOY0<@NA^94SR=W+=,8)-;TJ'LJGM*CT7XF4ZW-3Y(+5FW^V-#?>%OV7_A M%X=N-TZBO@CX0?&W MXC?LXZYJ.D:1I^)[IPMSH>KV4C?O1P&V JZMCC@C/&0<"G1E[:%6*TE)W_)_ MH34A[+V3W45;\_\ .Y]G?\%"/$]II'P)_LJ5U^V:MJ$,<,>>2L9\QV^@VJ/^ M!"O+_P#@F?X9W7/C;Q"Z_=2WL(FQZEGPTV1/)-O;AL9$/6,%L_>^8[ MOEIB,'Z8B)_&E&/U?#5)2>__ %;[DQU)>VKTXI;?\%_FT?'?[9?B1_&/[2' MB5(=3+_ &GKQU"<-SE!(T[@_P# 5-?KE4U4Z6&I MTWOU_KU;*BU4Q$YK9;?UZ)'PM^UG^UYXMT?XAW7@/P%ZOH8EDN) MYV )CCW [0-P' W$YY%0Z/\ LJ?'CQ?I@N_&/Q2N]%M9$\R6UN-6N;J2)<9. MY PC&!Z,17G7[9GPA\3_ _^,FI^-;2UN9=%U*Y74+?5((RR6TW!*.0,*P89 M&>HQCH<7Y/VCOCO^T+X9N?#6CZ9$MFUNR7^H:38O$7B"DOYLK,RID \)M)S@ M=<44X_[.I4K'H9VOX;_5 MH[8W#+@R1F4!G(R<97)ZFONK_@HQXF&C_!_1M#B.UM4U)25!ZQQ(6(_[Z,=? M+'[$L=G)^TIX4^V%0%^TM#NZ&3[/)M'UKTC_ (*1>*?[0^)GAS04?*:;IIG= M>P>9S_[+&OYUOB$W.C2\[_=_^S^)C0:_>U/*WW_\/^!Z)_P37\(+:^#_ !9X MFDBQ+>7D=C%(1_!$F]L>Q,@_[YKR_P#X*->*?[4^+VCZ*C9CTK3%9AGI)*Y8 M_P#CJI7UM^QWX5_X1/\ 9V\(PLFR:\@;4)/4^7<7MM_:,YQ@L\QW@GW"E!_P&OSO^-%_+\7/VFM>CMG,Q MU+7!IMNPYRJNL"8_!17ZC^*-2M_AK\,=3O8\1VVAZ5(\8/3$41VC_P = K\S M_P!C7PV_C3]I'PY).#*MG)+JDS'GF-2RD_\ ;0I2P\E4Q^'_"5U\.;KPQXGN[2P\/3V8LW-U,=+B&J>!M1L?&^AS*)K9[>9(;AHR,A@"=CC&,%7Y["O;_VW?V7] M5^)LEKXT\)6OVW6[6 6][IZ8$ES$I)5TSU=I&,&SCMBL<.I23G"7O=OZ_KH;5;1Y8 M./N]_P"OZZE#P7^T3\6_V>_$B:7J=UJ;06K*)] \0!V7R_1=_P T8(Z%"!WY M%?I]X)\5VOCKPAHWB&Q5TM-4M([N-)/O*'4-M/N,X_"OS)M/!?Q5_;(^(T6L M7]A(D4H2"357M3!8VD"DG"D_>(R2%!+$G\1^G/@_PQ:>"_"ND:!89^QZ9:16 MD1;J510H)]SC)^M:XFWLTYI<_EV_JWXF5'^(^3X?U_JYL4445YIW!1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% &#X[_P"1/U?_ *]VJUX7_P"19TC_ *\X M?_0!57QW_P B?J__ %[M5KPO_P BSI'_ %YP_P#H H U**** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCM _Y*1XI_ZY MVW_HL5V-<=H'_)2/%/\ USMO_18H [&BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "N#\1?\E(TW_KP?_T)J[RN#\1?\E(TW_KP M?_T)J -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH T=,_U,_P#GM24NF?ZF?_/:DH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH E_P"7&:LJM7_EQFK*H **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K3M?^0= M^/\ 6LRM.U_Y!WX_UH 91110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %^W_U*U)4=O\ ZE:D MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X[XE_\>NA M?]A:#^35V-<=\2_^/70O^PM!_)J .QHHHH XWX:?\>VO?]A:?^2UV5<;\-/^ M/;7O^PM/_):[*@ HHHH **** "BBB@ HHHH **** /CG]NS4OB7X&U;0O%OA M'7-:T[P^+8VEZFGW#B&&8.S*\B#Y?F#8W$?P >E>9_#G_@HMXD\*^&(]-\2> M'D\6ZA$6VZFU]]ED9220'41,&(SC(QP!WYK]$'19$9'4,K#!5AD$>E<;=_!7 MX>:A<-/=> _#-S.QRTLVCV[,3ZDE,UT4JD8PY)QNOQ,JD'*7/%V9^9.O:IXX M_;&^,:36^G"2_N EO'#;*?L]A;J3RS'HHRS%CU)..H%?J=X'\)VG@7P?HOAZ MQYM=,M([5&(P6V*!N/N3D_C5S1?#^E^&[,6FD:;9Z5: Y$%E D*?]\J *T*J MI64H*G!62)C3:FZDW=A1117*;A1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110!@^._^1/U?_KW:K7A?_D6= M(_Z\X?\ T 55\=_\B?J__7NU6O"__(LZ1_UYP_\ H H U**** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCM _P"2D>*? M^N=M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:YCXHZS>>'?AGXLU73IOL]_8Z3 M=W-O-M5MDB0LRMA@0<$ X((KIZXOXV?\D;\=_P#8!OO_ $G>L*[<:4VNS_(V MHI.K%/NC\A_^'B7[0G_10/\ RBZ?_P#(]*O_ 44_:#5@3X_# '.TZ+I^#_Y M+UG?L$_\G;_#S_KYG_\ 2:6OVUO+*WU"WDM[J"*YMY!M>*9 ZL#U!!X->K52 MIQC*U[GGP;G)J^Q^87P#_P""I7BNQ\366F_%&"SU?0;AQ'+J]E;""ZM@W8&!@5^I_[)_B#R/V3O MA_JVM72V\-KH,;SW-PVU4AC4@,Q/8(H.?2LI.%3#^VM:S_S_ ,M^I=I0K^RO M>ZO^7^9[717Y?_&C_@IEX\\:>,7\/?!K3A86+3>1:7AL!>:A?,#]Y(F#*H/9 M=C-W)'0U^YI*2BVM[=C]8Z*XGX-_%S0/CE\/=+\8>&YF?3[U2&AE $MO M*IP\4@'1E/X$8(R"#7Q'^T;_ ,%%OB)\'?CYXE\%:7HWA:?1=+NH88[B^M+E MYRC11NQ8K<*I(+GHHZ"DH/VOLGH_^&_S'S+V?M%M_P /_D?HE17Y,_&[_@IQ M\1M<\=W/_"NM0@\-^%K60QVP:QAGFO5!_P!9(9D;;NQD*NT@'!)/-?6?Q"_; M+U/X'_LQ^"?%WC#3+.]^(GB:S66UTBV5H(,E0_F2 EF551H]P!R6; P.0G%J MG[1]TK===OZ^\%).I[-;VO\ =N?6=%?DA9_ME?M:?%#SM7\(6FJ3:8'*D>'/ M":7EM&PZKO:&4Y'NU=3\&?\ @ISX^\)^,K?0_BU80:EI?G_9[V[6R^R7]D_8Z1HRD[=2'425^A^HDC%8V(Z@$U^4/P!_;B^-GC;]H/P9X: MUKQK]MT34-:BM+FU_LJQC\R)GP5W+"&''<$&OU8M[V&]L8KNVE6>WFC$L4B' M*NI&00?0C%?G%\%?^"DWQ-^(WQM\*^#M2T+PG!IFJZM'83RVMI=+,L;/M)4M M<,H;'JI'M4X=/ZQRVOMH_4=9KZM*5[+NO1GZ2T5XA^UE^T_I?[+_ ,/XM7FM M!JNNZC(UOI>FERBRN "SNP'"(""<&O"BWEO&W7;O>&5LC(ZM6<$ZE[=#27N)-]3];Z*_+3X1_\%-_B+X+\ M8PZ+\6-/AU735G\B_F^P_8]1LSG!8HH53M[H4!/J*^V/VL/CYJ?P4^ 1YQF\[;C=NV;N,;LX[]Z_6C]A']J[Q;^T]9 M^,9?%6GZ+IYT9[58/['@FB#"02EM_F2OG&P8QCO6_L6J"?VEJ_P7YFIXCT:)["\@D^SZCI:4HN$U3EN_\K_D.+4X.<=E_G;\S[;HK\X_&O_!17XC? M$#2=$T'X/^$Y-9\3G2K>YUO4-.TJ:]\BY>-3(EO -V%1R5W2;@2,8XW'R?P1 M_P %*?C7\/?%S6WCKR?$EM#-Y5]IFHZ;%8W4(!^94,2)LS35(G:(QSR(IWJC MHVX!C_%P1WK\:=8\?:AK7Q&N_&D\-LFJ76J-JSPQJP@$S2^:5 +%MN[MNSCO MWHHPO6M/:+L_70*LOW#-%\5:;HFGC119 MFW_L>":/=YOG;M_F2R9QY:XQCJ>M?6M34IRIOEE_5QQFIWMT/G[]N?XI>*/@ M[^SYJ7B7PAJ?]D:W#>VL*77V>*?"O( PVRJR\CVKPW_@G1^TW\2_COXX\7:? MXY\2?VY:6&G13V\?V"VM]CF7:3F*-">/7(KT?_@II_R:CK'_ &$;+_T:*^:/ M^"1?_)2O'O\ V"(?_1U5A4I>TYM;7_\ 241BFXJG;R_]*/U#K\POVTOVR_C# M\)?VCO%'A?PIXO\ [*T*R2U,%K_9EG-LWVT3M\\D+,>-?\ KG8_^D<-80_C172S_0Z?^79+)"C.VU0%&22< >@KN:\T_9E_Y-S^&'_8M:=_Z3)7Q'X1_ MX*4?$W7_ (\:/X*N-"\)II5YXCBTB2:.SNA.(6N1$6!-P5W[3G.W&>W:NNK# MGQ4J,%JV[??;]3DIRY<.JLNB7Y'Z3T4C'"DU^:7@/_@I?\3_ !1\:O#_ (0N M]"\)1Z;J&OP:5++#9W0F$3W"QEE)N2-VT]2",]NU<].+JU%2CNS>;Y(.H]D? MI=17SK^W!^T5XD_9I^&>D>(O#%EI5]>WFJI8R1ZM%+)&$,4CD@1R(=V4'?'7 MBOE[0_\ @J+XV\1?#T:?I_A'3]7^*.H:C);V5GI-C<-;16PCC*N8O,=Y968R M *K +D^C$8N:;CT_P"!_F.7N6YNO_!_R/TKHK\@V_X*!_M'_#'QH(O&3_O$ M(DE\/Z]H,=D?+/3[L<+/B)#I6@_ [PA?76OW5FL]]* MU@]]<6TF/GC@A0$-L/61@0?[O>K=.5DUK?L0IJ[3T/T7HK\D/ O_ 4F^-/P MY\;?9/B$$\0V<,XBU#2]0TR*QO(!GY@GEI'M<>CJ1].M?JWX8\26'C#PWI>O M:7,+C3-2M8[RVF_O1R*&4_D11*FXQY^@E43ER=34HK\UOVCO^"EWBL^/;[PG M\([2T2TMK@V2ZO+;?:KB\F#;8:Q^V1^UK\-A;ZGXL_ MMC3]/=PJ#7O"<5I;RGKMW_9XR>!V;-3"+G%2V3+F^23CU1^O%%?.'[%O[7$? M[47A/4AJ.G0Z3XJT5HUO[>V),$J/G9+'N)(!*L"I)P0.3FN)_;K_ &Q?&?[, M/B/PII_A;3-!OX=6M)IYVUBWFD961U4!?+F3 P3US1.+IS4);O\ RN*$E.+D MNG_#'V+17YQ^(O\ @I%X^\:^%/#>A?#+PFFN?$&[L!#_\ H35WE<'XB_Y*1IO_ %X/_P"A-0!LT444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% &CIG^IG_SVI*73/]3/_GM24 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 2_\N,U95:O_+C-650 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !6G:_\@[\?ZUF5IVO_ "#O MQ_K0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** +]O_J5J2H[?_4K4E !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !7'?$O_CUT+_L+0?R:NQKCOB7_ M ,>NA?\ 86@_DU '8T444 <;\-/^/;7O^PM/_):[*N-^&G_'MKW_ &%I_P"2 MUV5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M&#X[_P"1/U?_ *]VJUX7_P"19TC_ *\X?_0!57QW_P B?J__ %[M5KPO_P B MSI'_ %YP_P#H H U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ KCM _Y*1XI_ZYVW_HL5V-<=H'_)2/%/\ USMO_18H M [&N+^-G_)&_'?\ V ;[_P!)WKM*XOXV?\D;\=_]@&^_])WKGQ'\&?H_R-Z' M\6'JOS/P8\ ^/==^&/B[3O$_AF^_LW7-/9GMKKR8Y?++*4)VR*RGY6(Y!ZU[ M3=?\% ?V@M6@:U;X@3XD&W_1M+LHI/P9( P/T-5?V"?^3M_AY_U\S_\ I-+7 M[>5[%:T8QYE>]SS*=W)I:;'XC? _]DOXG?M*>-8[R[T[5+/1[J?[1J7B;6$= M596.79&DYFD//"YY(W$#FOT'_;RNH/@]^Q?>>'?#X-C9,MEH-NJGE;?(W+GO MF.,@^N37UE7S=_P4)\!WGCS]EKQ/'81&:ZTIX=5$:C)9(FS)CZ1ES^%<&(J\ MU-02M%-7]+J_X7.RA3M4YF[R:=O7I^-C\[/V'/VA/ '[-_C#Q!XC\9:-J^JZ MC/:QVNFR:5;0S&!2S&8GS)4VD@1@$9XW#COZA^VA^VK\*OVEOA3%HFD>'O$E MKXDLKR.ZL+W4[.V2.,?=E4ND[L RGH 02JYZ9KE/^"<.K?#.;XC:[X8^(VA^ M'M4.LV\/]E7'B&R@GC2>-FS$AE4A6D#]L;C&!UQ7VS\?M3_9F_9OM=+D\5_# M;PC-5OO_S.:@W[_)\_ MN_R/#?\ @D/XLN9+7XB>&9'+6D+VNHPISA78/'(?Q"1_]\U\L_MY?\G;_$7_ M *^X/_2:&OU1_9D\7?!GX@Z5JNM_"/P_I>CQ1NEK?R6&@KIK%L;E1F$:A\ Y MP"V,CIFORN_;R_Y.W^(O_7W!_P"DT-9SDY8F+:L^5_\ MMOPL7"/+AY6=US+ M\G?\;GZ2?LT_L@_#+PY\$/"B:UX'T'Q!K5]I\-]?7^K:=%=3--*@=E5I%)55 MW;0%QTSU)->(?\%7OA1K6K:!X,\8Z39R7&B:''/8WT=NF1:*Y0QR$#HGRE2> M@^7UK[M\"HL?@GP\B*%1=.MP% P /*7BO"/VIOVU-!_9EU>RT/5_".KZ[<:E M9FY@DB,4=I*NXJR%V8MN&!D;.C#UJ,2W[=V>JD[?C^EQX9?N5?MK^'ZV/@[] MG3_@HQXN^ _@_3?"-UX0.-\D:< G@"NN^'/ MP5_9R_;:\"1^*;+PE9^%?$$NY+^QT&^\BXL9 Q'S1J!&VX88.8N<_6OA#]L# MX'^%/@#\5%\->$O%#^)+,VBSS+.\;SV4A9AY,C1@*6P W12 PR.A.TI1=5*K M'WG_ %O^IG&+]FW2?NK_ #[>O0_;RQL;/3-'M[/3H(+73[>!8K>"V0)%'&JX M54 X"@ <8K\-_V5_\ DZ[X=_\ 8QP?^C:_6/\ 8KO-5O\ ]E+X?3:R96O/ M[-*JTV=QA61Q">>WEA,>V*_)S]E?_DZ[X=_]C'!_Z-HH1]GCW!N]K?FQ59<^ M7RE:U[?DS[:_X*P?"W7?$OA/PCXRTRVFO=-T%KBWU!(5+>0DOEE9B!_#F,J3 MVRM?.'[-_P#P40\7? 'P?8>$9O#VF>)?#=B7-O$SM:W4>]RY7S5#*1N9CRA/ M/6OO[]J;]L[0OV8=1TW2M7\*:OKD^J6K3V\MN8H[5P&*M&79BVX?*2-A&'%> M7?#/X1_LY?MP>"/^$FMO!]EX5\2,7CO]/T.^\BYLGW'#,B!8W###!VBYR1U! MKGH.4:QO6Y92CS.TOZ_3[SD/"_[3W[+/[0WQ M]:^(G@>/ M0/%]Q%';->Z\OGV#[RLM)M[>TTNWA M2*U@LT5(8X@H"*@7@*!C '&*_$O]LCX#^$?V?/B9;^'O"/BF3Q';26@GN(;A MXY)[*3<0(Y&C 4D@!L;5(!Y'()_47]A&\U:^_9/^'TNLF5KH6LJ1M-G<8%GD M6'KV\L)CVQ6W+"=#VE/1)VM]_P#D9-RA54)ZMKY]/P/RBU+_ )/ NO\ L>V_ M].!K]@_VJO&%SX#_ &<_B#K=E*8+R#29HX)5."DD@\M6'N"X/X5^/'B"XCTO M]KC4KB\=;:&W\<222R2/?"VF2Q7.J7>D2- M! CAF+@;XACL&9, US5O^1?#T?\ Z3$Z:>F.GZK_ -*9^0/[(?Q8\%_!+XR6 MOC#QMI6H:O9V%K*;*'38(II$NFVJLA$DB# 4R$$\->*AJ-U$)-.N+VRM1'!=(=T;EEN691G() )PQ&#FOFW]A_Q!X$\ M.?'RSM?B5I.CZAX?U*UET\G7[2*>VM9V96CD82@JO*%-QZ;ST&:_2CXW:=^S MA\ ?!8\2^)_AQX+>VD=([:TL?#UA)(- #G[%JVBO*\?.#+#(A M1OP5Y!^-'_!6;_DOOAG_ +%N+_TIN*^T?V8?B-\ /BCK5_=_"KPII.C:[86X M-U):^&DL)XHG.-IF2,*=Q'W0YSM/'%?%W_!6;_DOOAG_ +%N+_TIN*QK2]OSB?8G_ 3H\$Z=X3_99\,WUK;QI>ZVT]_>3J/FE;SG M1,G_ &410!]?6OC3_@JYX?MM+_: T34;>*.*74M"B>X91@R2)+*FX^IVA!G_ M &:^[?V$_P#DTOX<_P#7E+_Z42U\3?\ !6[_ )+)X._[ /\ [<248E_[8E_> M:^23_P B<+_NK?>*?WM,^T?V!KF2Z_9)^'S2-N*V]Q&/]U;F4 ?D*_*CX@?\ MG>:]_P!CM+_Z6FOU2_X)_?\ )H_@#_KE<_\ I5-7Y4_$V9--_:U\2S73?9XH M/&<[RM)P$47I))^@KJ_YF?S?_I2,/^9;+Y?E(_=RBJ\&H6MU)Y<-S#+)L679 M'(&.QONM@=CV/>K%><=I\I_\%-/^34=8_P"PC9?^C17Y7?"+X$>.?CQJ5_I_ M@;0_[*_$;X;^(OA+XOO?"_BO3O[*UVR$9GM?/CFV;T5U^>-F4Y5E/![U_0M M7XL_\%&/^3O/&O\ USL?_2.&B-:3J*'1I_H5[*/)*7;_ #1^K?[,O_)N?PP_ M[%K3O_29*_'+X:_\G?\ AG_L>+?_ -+UK]C?V9?^3<_AA_V+6G?^DR5^,>GZ MM'\/_P!J*#4]4/V>+1O& N+HLI.Q8KWN LNR_] M)9^\K_=;Z5^#WP>_Y.J\&?\ 8XVG_I:M?M;XY^,7A#P#\.[CQIJFO6*: ML; MB"Z2=66ZRN46(@_O&;@ +G.:_$?X#WIU+]I/X?W;*%:X\5V$I4=MUVAQ^M88 M)/ZY'RM^9MB6OJDO/_)_YGZ(_P#!6;_D@OAK_L88_P#TGGKSG_@D3X1T^XN? MB%XFE@234[86MA!,R@M%&_F/(%/;<43/^[7HW_!6;_D@OAK_ +&&/_TGGKE/ M^"0G_(J_$K_K]LO_ $7+2PNE.N_Z^RAXKXJ"[_\ VS_-'-?\%>]/@37OAK?+ M&!=26U]"\F.616A*@_0NWYFO5/\ @E+X+L=)^!.L>)%MT&IZOJ\D4EQM&\PP MH@1,]W_ /!,'_DUBS_["]Y_Z$M&&=L/ M/Y_^E!BOXU+Y?^DL^/?^"IVEP6'[3%O*\2_9 \(>"OB-^T'X?T?XBW*_V%=F5F2XN#"MU<;28XWD!!&YO<$G S MS7WI^W1_PJCX%?LY>(/"?AW1_#WA_P 1Z^D%M;6.F6D,=U(@E1WDDVC?M"HP MWMU) Y-55@J<(^T]YO9=-_\ /7\2:<_:57R:6W?6W?\ KT/%?^"1CS#XH>.T M7'D'1XB_/.X3C;^A:KG_ 5X_P"1X^'?_8.NO_1J55_X)%L/^%F>/%R-QTB$ M@=_]_^ M"7O@G3=!_9MBUZ"WC&IZYJ%Q)":11AG$4BE<^N/--?4G_!-O_DTCPM_U\WW_ *4R5\W?\%?/ M^1D^&7_7I?\ _H<%+%?[U!=G_P"VLTP_\"?S_P#2D?1?_!-.X>;]DSP\KMD1 M7M\B>P\]CC\R:^I:^5O^"9O_ ":?H?\ V$+W_P!'&OJFGB?XK]%^2(H?!\W^ M;"BBBN4Z HHHH **** "BBB@ HHHH **** "N#\1?\E(TW_KP?\ ]":N\K@_ M$7_)2--_Z\'_ /0FH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#1TS_4S_P">U)2Z9_J9_P#/ M:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH E_Y<9JRJU?\ EQFK*H **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ K3M?\ D'?C_6LRM.U_Y!WX_P!: &4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!?M M_P#4K4E1V_\ J5J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ KCOB7_ ,>NA?\ 86@_DU=C7'?$O_CUT+_L+0?R:@#L:*** .-^&G_' MMKW_ &%I_P"2UV5<;\-/^/;7O^PM/_):[*@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@#!\=_\B?J_P#U[M5KPO\ \BSI'_7G M#_Z *J^._P#D3]7_ .O=JM>%_P#D6=(_Z\X?_0!0!J4444 %%%% !1110 44 M44 %%%% !7E?Q[_:*T#]G?2]*U'Q%I>LW]GJ,S6Z2Z3#%((W5=V'WRIC(SC& M?NGI7JE>*_MB?#?_ (6=^S]XGL(8O-O[&'^T[0 9/F0Y8@>[)O7_ (%6M+D] MI'VGPW5_3K]Q,E)Q:AO;3UZ?B7O@%^TYX2_:,CUD^&K;4[*72C&)X=5BCC((GTN7)X\QL-$?KO4+_P M,U^LU>GFF#C@ZRC#X6K_ .?]>9YF7XJ6*IMSW3_K^O(\B^/G[3WA']G-=''B M2WU.]FU0R>1!I44N6E/U\QF7_ ("*^Y/AQ^S#I5[^RAH_PUU]KS3UOX(KW4I+!D2<7#.LS#+J MPR"%3D=%K9X2C1P5*O5^*;7_ (#>_P#Z3^+%]8J5,9*A#X8I_?;_ .2_!'%? M\/._A;_T /%__@':_P#R31_P\[^%O_0 \7_^ =K_ /)--;_@F+\+E4G^WO%_ M S_Q^6O_ ,C5^>_PU\'V7C+XL>'/#%[+/%8:EJT-A+);LHE6-Y0A*D@@-@]P M1[5Z.&PN6XMR5*_NZOY_\,<&(Q&.PT5.I:Q^A7_#SOX6_P#0 \7_ /@':_\ MR37JWQ$_:K\)_#/X7>%/'FJ:=K4^C^)%A:TALX(6N$\R$RKYBM*JCY1@X8\_ MG7E/_#L3X6_]!_Q?_P"!EK_\C5RO_!0[PK:>!?V=?ASX*KCQ)J&LV+Z5-;QP#2IHHPPD60MNWQ/G[@QC'>O9_B7_P $ MR?#EIX4O[OP9XDU@:Q;Q-+%;ZPT,L4Y4$[-T<:%">SMC\3!5*=FG?\';\SZT^%WQB\(?&;0WU7PCK,.JV\;!)HP&CF@8]!)& MP#+T."1@X.":[2OQS_8_^(FH_#?]H+PH]K,\=MJE['I-[ "=LL+V._ 8QXJ+4U:2"JVI:E::/87%]?W4-E96Z&2:XN) MD<:CJS,> !ZFK-?$7_!3#QAXA3P_X<\):3;7C:5>>9?:E+;Q.48(0(HW8#&, M[FP>ZJ>U>?0I/$58TD[79Z%2HJ5.51]/Z_,[WQ9_P47^$7AG4GM+636O$80E M6N-)LE\K(]#-)'GZ@$'UKK?A)^V?\,/C%JL.DZ9JMQI.LSG;!I^LPB"28^B, M&9&;T4-N/85\C?LH_L*Z1\:/A[_PEWBW6-3T^UNIY(;*STLQQOMC8HSNTB/U M8,-H4?=SGG \8_:@^!#_ +./Q030[34Y=0L9[9-0L;IP$F5"S+AMO\2LAY&, M\' Z5],L!E\JKPBD^?OYGS_US&^S^L\JY/Z1^R=>2_&;]J3X>_ F9+3Q)JLD MFK2)YB:5I\7G7)7L2,A4![;V7/;-9GP@^,EQ>_LHZ5\0M>!=:_:O^/(LM2U-XKO5IIK_4=0*[S%&HW,5'_?**.@ MR.PKS<+EZJ5JL:SM&G>[^_\ R9WU\=R4*=2FKNI:R^[_ #7](^^O!7_!1#X2 M>,-7BL+B;5_#32L$2XUJU1(2Q. "\4D@4>[8 [FOIF&:.YACFAD66*10Z2(0 M592,@@CJ*_,7]KS]BG2_@-X-L?%/A?5M2U+3/M"VM[#J9C>2-F!V2*R(HVY& MW!&PTP?'_ <^U?-__!1OXJW?BKXP)X0AN&_LCP["@:%3\K74BAWI:CXCU*U\9WUDMU'#&L?V.!W3>(>&PR5UNW_7R]3[0^&OQ6\*_%[P^- M:\):Q#JUCNV2; 4DA?\ NR(P#(?J.1R,CFNMK\D/V,_B-J?P?_:,TO2;B1X+ M/5KO^Q-2M2WREV8I&2/5)<<^A8=Z_6^N3,,&L'47([QDKHVP6*>(C)35I1W" MBBBO*/2"BBB@ HHHH **** "BBB@ KCM _Y*1XI_ZYVW_HL5V-<=H'_)2/%/ M_7.V_P#18H [&N>^(GA^Y\6^ ?$NAV;Q1W>I:;6'5AQFOT6HHK>=24TD^AE&"BVT%,FACN(7BE198I%*NCC M*L",$$=Q3Z*QWT99^>_QS_X)3VOB#7KO5_AGXAM="AN7,AT/5DAZ5^HE%:PJ2@K(F45-W9Q_P )OA/X<^"G@73_ GX6L_LFEV8)W.=TLTA M^]+(W\3L>IZ= !\,?M,?\$Y_B3\9OCEXK\9Z+K?A6UTO5IXY8(;^[N4G4 M+#&AW!+=E!RAZ,>,5^B]%3S-S]H]_P#AO\AI)0]FMOZ_S,[P[I\FD>'],L9F M5IK6UB@=HR2I94"DC(Z9%<#^T#^SQX3_ &C_ 7_ &!XGADC>%S+8ZE:D+<6 M#QW (]/HI5'[1N4NNH0_=I*/0_+'Q-_P20\?VNH.OA[QIX; MU*Q_AEU,7%I+^*)'*/\ QZNX^#O_ 2;&G:S:ZA\2?%-MJ5I X=]'T-) D^# MG:\[A6"GH0J D'AA7Z+45K&M./4B5.,BK9Z;;:7IL%A901VMI;Q+!#!$H5(T M4850!T K\Y/@K_ ,$V?B;\.?C;X5\8ZEKOA.?3-*U:._GBM;NZ:9HU?<0H M:W52V/5@/>OTEHJ(3=.I[5;E2BITW2>S_P"&/-?CU\ /"G[17@E_#GBBWDQ& M_G6=_;$+<6WA7:D4:@*JJ.P M %6Z*TE4E)6>QG&G&+NMS\_OVGO^"9NJ_$SXDZMXP\!^(=+L&UB(M>TO4Y=:CMT^RZ6)62 M,Q&0AB[JI.?,(QM_&OK&BIISE3AR1VV^14XJI+FEN?$'[2W_ 3-T?XJ>)K[ MQ3X&UF'PKK%\[37>G74)>RGF8Y+J5^:(DY)P&!)X [^&^'O^"2/Q#N-31-=\ M9>&=/T_/S3Z?]HNI0/:-XX@?^^Z_5&BBG)TURQV"<5-W>YYA^SY^SSX6_9O\ M$#P]X:CDE>9_.OM2N<&>\EQC9_LU_#/5/@Y\#_"?@W6I[2ZU32;=XIYK!W>%B97<;2RJQ&&'517 MSQ^W)^Q7XW_:9\?:!KGA?5?#]A::?IOV.5-7N)XY"_FN^5$<+C&&'4CZ5]IT M43DZE3VDM[W^^_\ F*$53I^SCM:WW6_R/*_V7_A7JWP3^!?ACP7KEQ9W6J:6 MDRS3:>[O V^:20;2ZJQX<=5'.:^6?VI_^":FI_%;XDZIXS\"^(=,TZ?6)?M% M[IFL"2.-9B/GDCDC1SACR5*]2>><#[ZHIRDYU/:O?_,(14(>S6Q\C_L,_L=> M*?V7]0\37_B/7M)U)]8@AA%KI8E=4,;,0Q=U3/WB,;?QKZXHHISG*I;FZ"C! M0O;J>*?M@?!/7/V@?@E?^#O#MUI]EJ=Q=V\ZRZG))'"%C?-?V8_%WB;5?%.J:#?V^IV,=M"ND7$\CJRR;B6$D* #'H37V514TY. MGS_[5__ 3V^(OQU^.WB'QKH.M>%[32M06V$4.I M75RDZ^7;QQMN"6[KU0XPQXQ7Z$45*TDIK=%WT<>YR'P?\(7GP_\ A1X.\,:C M+!-?Z-I%K87$EJS-$TD42HQ0L 2N5.,@''85\F_M6?\ !-R'XQ^,K_QGX(UR MUT'6]1;S;[3]21OLD\O>570%HR<9(VL"3GCG/W#153DYU/:O?_,F*4(>S6Q^ M9OPT_P""2>N'6H)O'_C'3(M+C<-):>'UEFEG7^[YDJ((\^NUOZUH^'?^"9_C MKPK^T#I?B[3=4\*VWA/3O$D6IV]BMY=&X2SCN1(L8!@P7" #E\9_B[U^D-%: MQK3C-373^OT,W2C*+B^I\Z_MP?LZ^)/VEOAGI'AWPQ>Z587MGJJ7TDFK2RQQ ME!%(A ,<;G=EQVQUYK$_82_99\5_LPZ+XNL_%.H:-?RZO<6\L!T>:615$:N& MW^9$F#\PQC/>OJ6BLH2<%**^UO\ A_D7.*J.+E]G;\?\V?)'[=W[)'C#]J"X M\'/X5U+1+ :,MTMQ_;$\T>[S#%MV>7%)G[ASG';K7HW[''P.U[]GGX+P>$/$ M=WIU[J4=]<7)ETN222':Y! RZ(<\<\5[C11"3A!P6S_SN.:]I*,GT_X8^'/V MV?V&_'?[27Q7L?$_AG5O#MC80:5%8M'JUS/'*7621B0(X'&W#COGKQ7TS\!/ MA?=_#7X%>%_ WB V6H76GZ>;*\^REI+>7);J*KU2M^7^2/S6^+O_!)O5KKQ-=7GPX\4:7#H]Q(TB:;KQEC:U!.=BRQ MI)YBCG!*J0, Y/)V?AM_P2%;[0;VQEL;Z#3[RY:?!*NC(KVZJ2'1>K#@FNF_;K_8Z\9_M/>(_"FH>% MM3T&PATFTF@G76+B:-F9W5@5\N%\C /7%?8M%.%M2T.PCT>"YBN!K$\T98R-&5V>7$^1\ASG':OKZBE. M3J3526Z_RL5%*$7!;/\ SN>*_L@?!77/V?\ X(Z=X.\0W6GWFIVUU<3O+IDC MR0E9)"R@%T1LX//RU[5111.;F^9BC%05D%%%%04%%%% !1110 4444 %%%% M!1110 5P?B+_ )*1IO\ UX/_ .A-7>5P?B+_ )*1IO\ UX/_ .A-0!LT444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% &CIG^IG_P ]J2ETS_4S_P">U)0 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110!+_RXS5E5J_\ +C-650 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6G:_\ (._'^M9E:=K_ M ,@[\?ZT ,HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@"_;_P"I6I*CM_\ 4K4E !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'?$O_ (]="_["T'\F MKL:X[XE_\>NA?]A:#^34 =C1110!QOPT_P"/;7O^PM/_ "6NRKC?AI_Q[:]_ MV%I_Y+794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 8/CO\ Y$_5_P#KW:K7A?\ Y%G2/^O.'_T 55\=_P#(GZO_ ->[5:\+ M_P#(LZ1_UYP_^@"@#4HHHH **** "BBB@ HHHH **** "FR1K+&R.H9&&&5A MD$'M3J*-P/Q9^-7A&\^!7Q^US3K$M;2:1J@O-.DQC$982P,/H"OY5^L%Y\9- M-A^ K_$M67["=%_M14SGYC'N$?UWG;]:^//^"GWPU%MJWA;QU;186Z1M+O&4 M?QKEXB?JID'_ $5XC& ME(]F1@?]ZI^J_,];$_P*G^%_D?/O[%W[4_A3]G/3/%5OXDT_6;Y]5F MMY(#I4$4@41K(&W;Y4Q]\8QGO7LOQ,_X*:^'KSPK?V?@OPUJ_P#:]S"T,5SK M"Q110%AC?MCDRCK;[W?\ $^+?V-_AGJ7Q,^/WAEK:%VLM'NX] M6OKC!VQI$X=03ZLX50/<^AK]AJY/X^*\G%8E9IB84X^['5*_I>[^ZQZ>%PSP-&=26LMW;\OQ/L"BOR'_P",I/\ MJKW_ )5*_3[0?%47@?X+Z+KWC"\EL/L&B6TVI7&H%O.600IOW[OF,A;(P?F+ M''6N;%X'ZK%2YU*_8VPV,^LSY.1KU.D\5>*M)\$>'K[7-//VXOBE:^%?"UG-%H*2EK'2]^U$1>#=7+=,X/N%SM7)/S?=/[ M-/[*_AS]G?1"\.W5O%5U&%O=8D3!QP3%$/X(\CZMC)Z #TL/3AE4?K%?6HU[ ML>WF_P"O(XZ]2>/;P]#X/M2_1?U^&_._'CP7#\)_V(==\+Z?)OBTO1HK,S8Q MYA,B"1\=MQ9C^-?*W_!,BW23XY:Y*RY>/09=I],SP9K[A_:NT67Q!^SGX_M( M5+RC2Y)U51R?+(D_]DKX0_X)KZY!I?[05U9S.J-J6C7$$(/5G5XY,#_@*.?P MJLOG*KA<5*3O)W?X/_@F>.@J53#1CHDTON<3["_;XC63]E[Q3N7.V6T8>Q^T M1\U\R?\ !+F^:/XD>,[/61 M5FU"\M;:%6ZLPE$AQ_P%&/X5X/\ \$M=#ED\0^/=9((@AM;:T![%G=W/Y",? MG48#WU_TB:8_7&8=+?_ .V?_!/G']IR1M0_:8\=^<=V[6Y(S_NA@H'Y M 5^REG&L=K"BC:JHH '88K\=_P!KS2IO#7[3GCA70J6U$7B;AU61%D!^GS5^ MO?AW6;;7/#>FZM;2*]G>6D=S'(#P49 P.?H:68_\B_"OI;_VV(873,,0GU;_ M #?_ #\;?'EU_8O[36NW,.8_LOBR65=G4;;LGC\J_:6OQ@MXQ\1OVI$6Q;S M(]8\6YB>/H4>[R&'_ 3FOV?JLVTP^&B]TOTB&!UQ>):VO^L@HHHKYD]T**** M "BBB@ HHHH **** "N.T#_DI'BG_KG;?^BQ78UQV@?\E(\4_P#7.V_]%B@# ML:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\I M^+&HW&CZK>W]I)Y5W:Z!=3PR;0VUU5V4X(P<$#K7JU>0?&O_ %FK_P#8MWO_ M *+DK?#I2K03[K\SEQ4G'#U)1=FD_P CYI_X:&^(/_0P?^25O_\ &Z/^&AOB M#_T,'_DE;_\ QNO.:*_:_P"SL%_SYC_X"O\ (_FC^V,R_P"@F?\ X'+_ #/1 MO^&AOB#_ -#!_P"25O\ _&Z/^&AOB#_T,'_DE;__ !NO.:*/[.P7_/F/_@*_ MR#^V,R_Z"9_^!R_S/1O^&AOB#_T,'_DE;_\ QNC_ (:&^(/_ $,'_DE;_P#Q MNO.:*/[.P7_/F/\ X"O\@_MC,O\ H)G_ .!R_P ST;_AH;X@_P#0P?\ DE;_ M /QNC_AH;X@_]#!_Y)6__P ;KSFBC^SL%_SYC_X"O\@_MC,O^@F?_@:T4?V=@O\ GS'_ ,!7^0?VQF7_ $$S_P# Y?YGI7_#1WQ$ M_P"AA_\ )*V_^-T?\-'?$3_H8?\ R2MO_C=>:T4?V=@O^?,?_ 5_D']L9E_T M$S_\#E_F>E?\-'?$3_H8?_)*V_\ C='_ T=\1/^AA_\DK;_ .-UYK11_9V" M_P"?,?\ P%?Y!_;&9?\ 03/_ ,#E_F>E?\-'?$3_ *&'_P DK;_XW1_PT=\1 M/^AA_P#)*V_^-UYK11_9V"_Y\Q_\!7^0?VQF7_03/_P.7^9Z5_PT=\1/^AA_ M\DK;_P"-T?\ #1WQ$_Z&'_R2MO\ XW7FM%']G8+_ )\Q_P# 5_D']L9E_P!! M,_\ P.7^9Z5_PT=\1/\ H8?_ "2MO_C='_#1WQ$_Z&'_ ,DK;_XW7FM%']G8 M+_GS'_P%?Y!_;&9?]!,__ Y?YGI7_#1WQ$_Z&'_R2MO_ (W1_P -'?$3_H8? M_)*V_P#C=>:T4?V=@O\ GS'_ ,!7^0?VQF7_ $$S_P# Y?YGI7_#1WQ$_P"A MA_\ )*V_^-T?\-'?$3_H8?\ R2MO_C=>:T4?V=@O^?,?_ 5_D']L9E_T$S_\ M#E_F>E?\-'?$3_H8?_)*V_\ C='_ T=\1/^AA_\DK;_ .-UYK11_9V"_P"? M,?\ P%?Y!_;&9?\ 03/_ ,#E_F>E?\-'?$3_ *&'_P DK;_XW1_PT=\1/^AA M_P#)*V_^-UYK11_9V"_Y\Q_\!7^0?VQF7_03/_P.7^9Z5_PT=\1/^AA_\DK; M_P"-T?\ #1WQ$_Z&'_R2MO\ XW7FM%']G8+_ )\Q_P# 5_D']L9E_P!!,_\ MP.7^9Z5_PT=\1/\ H8?_ "2MO_C='_#1WQ$_Z&'_ ,DK;_XW7FM%']G8+_GS M'_P%?Y!_;&9?]!,__ Y?YGI7_#1WQ$_Z&'_R2MO_ (W1_P -'?$3_H8?_)*V M_P#C=>:T4?V=@O\ GS'_ ,!7^0?VQF7_ $$S_P# Y?YGI7_#1WQ$_P"AA_\ M)*V_^-T?\-'?$3_H8?\ R2MO_C=>:T4?V=@O^?,?_ 5_D']L9E_T$S_\#E_F M>E?\-'?$3_H8?_)*V_\ C='_ T=\1/^AA_\DK;_ .-UYK11_9V"_P"?,?\ MP%?Y!_;&9?\ 03/_ ,#E_F>E?\-'?$3_ *&'_P DK;_XW1_PT=\1/^AA_P#) M*V_^-UYK11_9V"_Y\Q_\!7^0?VQF7_03/_P.7^9Z5_PT=\1/^AA_\DK;_P"- MT?\ #1WQ$_Z&'_R2MO\ XW7FM%']G8+_ )\Q_P# 5_D']L9E_P!!,_\ P.7^ M9Z5_PT=\1/\ H8?_ "2MO_C='_#1WQ$_Z&'_ ,DK;_XW7FM%']G8+_GS'_P% M?Y!_;&9?]!,__ Y?YGI7_#1WQ$_Z&'_R2MO_ (W1_P -'?$3_H8?_)*V_P#C M=>:T4?V=@O\ GS'_ ,!7^0?VQF7_ $$S_P# Y?YGI7_#1WQ$_P"AA_\ )*V_ M^-T?\-'?$3_H8?\ R2MO_C=>:T4?V=@O^?,?_ 5_D']L9E_T$S_\#E_F>E?\ M-'?$3_H8?_)*V_\ C='_ T=\1/^AA_\DK;_ .-UYK11_9V"_P"?,?\ P%?Y M!_;&9?\ 03/_ ,#E_F>E?\-'?$3_ *&'_P DK;_XW1_PT=\1/^AA_P#)*V_^ M-UYK11_9V"_Y\Q_\!7^0?VQF7_03/_P.7^9Z5_PT=\1/^AA_\DK;_P"-T?\ M#1WQ$_Z&'_R2MO\ XW7FM%']G8+_ )\Q_P# 5_D']L9E_P!!,_\ P.7^9Z5_ MPT=\1/\ H8?_ "2MO_C='_#1WQ$_Z&'_ ,DK;_XW7FM%']G8+_GS'_P%?Y!_ M;&9?]!,__ Y?YGI7_#1WQ$_Z&'_R2MO_ (W1_P -'?$3_H8?_)*V_P#C=>:T M4?V=@O\ GS'_ ,!7^0?VQF7_ $$S_P# Y?YGI?\ PTA\1?+*?\)%\K=1]AMO M_C=1?\-#?$'_ *&#_P DK?\ ^-UYS11_9V"_Y\Q_\!7^0?VQF7_03/\ \#E_ MF>C?\-#?$'_H8/\ R2M__C='_#0WQ!_Z&#_R2M__ (W7G-%']G8+_GS'_P ! M7^0?VQF7_03/_P #E_F>C?\ #0WQ!_Z&#_R2M_\ XW1_PT-\0?\ H8/_ "2M M_P#XW7G-%']G8+_GS'_P%?Y!_;&9?]!,_P#P.7^9Z-_PT-\0?^A@_P#)*W_^ M-T?\-#?$'_H8/_)*W_\ C=>C? M\-#?$'_H8/\ R2M__C='_#0WQ!_Z&#_R2M__ (W7G-%']G8+_GS'_P !7^0? MVQF7_03/_P #E_F>C?\ #0WQ!_Z&#_R2M_\ XW1_PT-\0?\ H8/_ "2M_P#X MW7G-%']G8+_GS'_P%?Y!_;&9?]!,_P#P.7^9Z-_PT-\0?^A@_P#)*W_^-T?\ M-#?$'_H8/_)*W_\ C=>C?\-#? M$'_H8/\ R2M__C='_#0WQ!_Z&#_R2M__ (W7G-%']G8+_GS'_P !7^0?VQF7 M_03/_P #E_F>C?\ #0WQ!_Z&#_R2M_\ XW1_PT-\0?\ H8/_ "2M_P#XW7G- M%']G8+_GS'_P%?Y!_;&9?]!,_P#P.7^9Z-_PT-\0?^A@_P#)*W_^-U]I5^<] M?HQ7PW$^'HX?V/L8*-^;9)?R]C]1X(QF)Q?UGZQ4E.W);F;=OBVN%%%%?#'Z M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6G:_\ M@[\?ZUF5IVO_ "#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +]O_J5J2H[?_4K4 ME !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'?$O_CUT M+_L+0?R:NQKCOB7_ ,>NA?\ 86@_DU '8T444 <;\-/^/;7O^PM/_):[*N-^ M&G_'MKW_ &%I_P"2UV5 !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% &#X[_P"1/U?_ *]VJUX7_P"19TC_ *\X?_0!57QW_P B M?J__ %[M5KPO_P BSI'_ %YP_P#H H U**** "BBB@ HHHH **** "BBB@ H MHHH \A_:P^&W_"T_@+XITB*+S;^&W^WV8[^=#\X ]V 9?^!5^-EK:S7UU#;6 M\;2SS.L<<:C)9B< #W)-?OC17LY?F3P*E'EYD]=[?H]]/N/,QV"6,Y7S6:OT MO_EMK]YQ/P5^'L/PJ^%7ACPK$%#:=9(DS*.'F/S2M^+LQ_&NVHHKRJE256VU_7N6OLVBN.A5]C M5C4M>SN==2'M(2AW37WGPG_P2Q_Y /Q$_P"OFR_] FK[LHHK;&8GZW7E6M:] MM/1)?H<^$P_U6BJ5[VO^+;_4****XCL"OSW_ ."G'Q6NVUCP_P##ZTG:.RC@ M&J7Z(<>:[,RQ*WLH5FQZL#VK]"**Z<-6CAZT:LH\UNG]=MS&M3=6E*FG:^E_ MZ\M#\)?"WCKQ+X&FGF\-^(=5\/S7"A)I-+O9;9I%!R Q1AD ^M='_P -!?%+ M_HI7B_\ \'UU_P#'*_;>BOHI9Y"3O*BG\_\ @'AK*915E5_#_@GA_P"R'J=[ MXZ_9C\+W'B*]NM.3T%? 7QP_9M\??LR_$ M%M=\.Q:C+H5O<&YTOQ!IR,QMQG*I*5^XP'!W<,.F> M#K-M1UFUMQ;:AID(S+<1*24DC'\3KD@KU(QCD8/QI9?'KXO^$O"LGPZA\0:O MIVF;6M?[)DMU%Q&K9!C5F3S4')&T,/I7[.44\+F3HTO858*<5M?I^8\1@?;5 M/;4YN$NZ_I'Y_?L%_LGZ_H_BR'XB^,M+FT>*SC8:3I][&4GDD8%3,R'E552V MW(!)(/0 G] :**X\9BYXRI[2>G9=C?"X6&%AR1Z[A1117"=@4444 %%%% !1 M110 4444 %<=H'_)2/%/_7.V_P#18KL:X[0/^2D>*?\ KG;?^BQ0!V-07U]; MZ;9SWEY<16EI;QM+-<3N$CC11EF9CP "23TQ4]<7\;/^2-^._\ L WW_I.] M9U)>SA*:Z(TIQYYQCW9E_P##2GPB_P"BJ>"?_"BL_P#XY3E_:2^$<5]07G_!*#XPVMO)+'K7@Z[=1D0PW]R&;V&ZV4?F17=*DH*\FKV.LV9./M&GW*3QY_P!Y"16I7X)^%_%7Q#_9-^+D MCVYNO#GB?2)Q%>Z?*V8YU&"8I5!VR1L#D$9&"&4YP:_/O# M'@6".;Q+XCTGP]#)]R35;Z*V5OH9&&:S?#?QD\ >,[Y;+P_XX\-Z[>-TM]-U M>WN)#_P%')K!:[&STW.PHHHI %%8WBGQIX>\#Z>M]XDUW3/#]DS;!1VT M9;TW.P&:7POXQT#QMI_V_P .ZYINOV.[;]JTN[CN8L^FY"1FC?8#3NKJ&QM9 MKFYFCM[>%&DEFE8*B*!DLQ/ R2:X[P[\'Q'^!_P =O#'C77=:\+W>E:6;@S0Z==W+SMOMY(QM#VZJ M?F<9RPXS5TDI3:F[*WXZ_P# ^\FHW&'-'5Z_H?=_B[Q_X7^']K!=>*/$FD>& M[:X?RX9M7OHK5)'QG:ID8 G'.!3O"/CSPUX_L9KSPOXBTGQ)9PR>3+<:1?17 M4:/@':S1L0#@@X//(KXI_P""N7_)*_ W_8:D_P#1#5=_X))_\D3\7?\ 8P'_ M -)X:JE'VD*DG]G_ .U_S%4ER2@OYO\ @_Y'U=KWQT^&WA75[G2M:^(7A71] M4MB%GL;_ %JV@GB) (#([AE."#R.A%=I!/'=0QS0R++#(H=)(V#*RD9!!'4$ M5^(O[>7_ "=O\1?^ON#_ -)H:_:/P1_R)>@?]@^W_P#1:THQYJ"K=[?BKA.7 M+6=+M?\ !FW15+6-:T[P]I\M_JM_:Z98Q#,EU>3+%$@]2S$ 5S/AWXT_#WQ= MJ2Z=H7COPSK6H-]VUT[6+>XE/T1')_2LUKL7MN=G1110 452UC6M.\.Z;-J& MJW]KIEA"-TMU>3+%%&/5F8@ ?4UC>$OB=X.\?23)X8\6:'XC>$9E72=2ANB@ M]6\MCC\:%KL&VYTU%8OBGQMX=\#6*WOB37M,\/V;-M6XU2\CMHR?0,[ 9H\+ M>-O#WCFQ:]\-Z]IGB"S5MK7&EWD=S&#Z%D8C-&^P;&U116#XJ\?>&/ L$'_''AO7;QNEOINKV] MQ(?^ HY-=A3LUN*Z84444AA6+XL\;>'? >FIJ'B;7]+\.V#RB%;K5KR.UB:0 M@D('D8 L0I.,YX/I6U7S[^VU^S[XB_:2^$^G^%_#-[I=C?V^KQ7[2:M+)'$8 MUBE0@&.-SNS(.V.#S4MM6MW7YE12>_G^1[#X/^(GA3XA0W,OA;Q/HWB6*U95 MG?1]0BNUB+9*AS&QVDX.,^AKH:^6OV$OV6?%?[,.B^+K/Q3J&C7\NKW%O+ = M'FED51&KAM_F1)@_,,8SWKZEK:I&,96B[K3\C&G*4HWDK/7\PHKFO%7Q,\(> M!;JUMO$GBO1/#UQ=A! M'44[,5^@^BBBD,*Y;PS\5?!7C75KC2_#WC#0=>U.W5GFLM,U."YFB4,%)9$8 ME0"0"2.I KP?_@H3\?I?@I\$)K'2KCR/$GB9FTZT=&P\,6W]_,/0A2%![&13 MVKA_^"6/PA7PE\'=1\;W< 74?$]R5@=A\RVD)**/;=)YA]P%JZE7UMJ>FW2"6WO+.9989D/1D=20P/J#7X_\ M_!3C_DZS5/\ L&67_HNOTK_8\_Y->^&7_8$@_E3A'FH.KYV_/_(4Y#_P#KE>_^DLM.A#VLY1?17_/_ ""M+V5)5%U=OR_S/V-\ M4>,-!\#Z6=3\1ZWIV@::'6,WFJ7<=M"&/1=[D#)[#-<=_P -*?"+_HJG@G_P MHK/_ ..5XA_P5!_Y-9N?^PQ9_P WK\W/VPFTF&.> M=M8FEC5E=BH"^7$^3E3UQ4T8^UY_)_HG^HZK]GR^?^;1^R]O^T7\*+R41P?$ M_P &S2'HD>OVC$_@)*[RSOK?4K6*ZM)XKJVE7='-"X=''J"."*_(/QI_P3!^ M,O@_P_=ZK _A_P 2&V0R-9:->2M<,HY.U988PQ [ Y/0 GBN;_8A_:4U_P"! M?Q"[B4-=>';[SH M$)Y^S7&6 'TD67_OH5E2A[2E*?6/^?\ E9^AI5E[.<5T?^7^>A]Q5QWBCXS? M#_P/JITSQ'XY\-Z!J2HLAL]4U>WMI@IZ-L=P<'L<5U\DBPQL[L$1069F. . MIK\)?C9XKO\ ]I#]IC7+[30UU-KVLK8Z8G)S%O$, _[Y"G\344XNI55*/7^O MQ_0N;4*;J2Z'[4:A\:_AYI&CZ;JU]X\\,V6E:F'-C?7&L6\<%V$.',3E]K[3 MP=I.#UKKK.\@U"T@NK6>.YM9T66*:%PZ2(PRK*PX(((((KY0_; _9ML-0_8U M3PYH]N)+KP-8PWFGN%^9E@CVS=.[1^8WNP%<9_P2X^/TWC3P%J/PXU>Y,NI> M&U$^G-(V6>Q8XV>_EN<>RR*.U:1C&;J*+^';S7?^NS,G)QC3E)?%OY/M_7<^ MZ****Q-0HHHH *\@^-?^LU?_ +%N]_\ 1OUY!\:_]9J__ &+=[_Z+DKHP MW\>'JOS.3&?[M4_PO\CXCHHHK][/Y2"BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH *_1BOSGK]&*_/>+/^7'_;W_ +:? MKG /_,5_VY_[<%%%%?GQ^N!1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 5IVO_(._'^M9E:=K_P @[\?ZT ,HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@"_;_ZE:DJ.W_U*U)0 45SGQ(NI['X=^*;FVFDM[B'2KJ2*:)BKHPA8 MAE(Y!!&017Y3_LU^$?VB?VH-/UV\\-_&O7-,CT>6**9=4\2ZBI_9[^'>HZG>W&HZA=:':S7 M%W=RM++,YC!+.[$EB3U).:SC'FA*?\K2^]7+D^648_S*_P"-CTRBBBI&%%%% M !1110 4444 %%%% !1110 445\>_MH?MV:'\&]$U#PGX-OX=6\?7$;0-);. M'BTG((+R,.#*/X8^H(RV!@-+=M%JRHQOOHC["HKYA_X)T^+]>\_P ,_AWX)US4M!\2>+-;13=:3A#!2\H/7_EF:B*#X?[5\=:S$([62Z!N&MXAB,2E3DR2.W"@Y!(8G.,'RS2?V4?VJ MO'&DC7]?^.FH>&];N4$R:1!J5TD<9(SLD$!6-".X16'UIQCS)R7PK2_^1+?+ M9/=ZV_S/T$HKX ^ _P"U-\4/@]\=K;X,?'65-1DO9$M]/UQMN\,_$+>8H'FQ M2$;=S#>&/S'@@??]5*-DI)W3$I7;BU9H****S+"BBB@ HHHH **** "BBB@ MHHHH **** "BBO@?]E7XE>+O$7[>WQ=\/ZKXJUK4] L1JOV72KS49I;6WV7T M2IY<3,57:I*C & 2!54X^TGR+LW]PI>[#G\TOO/OBBBBI&%%%>,?M;_'>^_9 MU^#-]XNTS2[?5M0%Q%9P0W4C+$CR9P[!>6 Q]T%<^HJ9245=_P!7T*2YF>ST M5YW^SQXVU3XD?!'P9XHUIXY-5U;3H[NY:&,(F]LDA5'05Z)6LXNG)P>Z,XR4 MXJ2ZA1114%!1110 4444 %%%% !1110 4444 %%%% !17(_%Z^N=-^$_C2\L M[B6TN[?1;R6&X@1$=JM(Q(&23@<]B>P.KZTNIL(@ MA#;66638-V.,C-?3U:SCRNR=S*$G)7:L%%%%06%%%% !1110 4444 %%%% ! M1110 4444 %%%% !17R-JOP^^.DO[=%MXDMKK7!\'5DC+PKKZ+98%EL;_0_. MR?WW_3/K\WO7US56]R,^_3MZ@])./I^/^04445(!1110 4444 %%%% !1110 M 4444 %%%% !7'?$O_CUT+_L+0?R:NQKCOB7_P >NA?]A:#^34 =C1110!QO MPT_X]M>_["T_\EKLJXWX:?\ 'MKW_86G_DM=E0 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\ MX?\ T 55\=_\B?J__7NU6O"__(LZ1_UYP_\ H H U**** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCM _P"2D>*?^N=M M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:XOXV?\D;\=_\ 8!OO_2=Z[2N+^-G_ M "1OQW_V ;[_ -)WKGQ'\&?H_P C>A_%AZK\S\9_V*/$.E>%?VH/ FJZWJ=G MH^EVUQ,T]]?SI!!$#;R@%G-!DB#6[ M:9_P5'+'\!7XA_"/X7ZK\9_B)HW@S1+BSM=4U61XX)K]W2!2J,YW%%9APIZ* M><5]41_\$F/BV7 ?Q)X+5>Y6]NR?R^RBO8K>]&*EIN>93TDVM=CQ;]LSXQ:+ M\\3^'5D.C%(;2VGD0HUPL2!?-VGD!CG /.,9P>*_5#X-Z;XN^&W[&/ MAJVT;16U3QG9^'%DM-*D98BUPZET1R[*!M+C()'W2.M>'?L]_P#!+O1O 'B2 MR\1?$#78O%-W9NLT&D64)CLQ(IR&D9OFE ."%VH..=PXKZX^,GQ6T;X(_#;6 MO&6N;VL--B#""+&^>1B%CB7/=F('MG/:N6HZ=/#^QB_G]_XMOI\CH@IU*ZJM M;:6^[\-.I^6O@?\ 8A^-7[0_Q6UB7XB_VIX6E*FYO=?URV:?S6+86.$!@LAZ M_*K!54=N ><_:T_8IU7]E/3]!UE?%$?B73-1N&MEN([,VDL$RKO4%?,?((#$ M$-_#TKO+K]N+]H[]HSQ9+HOPVLVTH.K,NG>'[))I(XLX#RW$H;;C(&\&-U6>\DO;PV5O;:AK!O[F-BC.3PSHJ83LW<<5?OQ M4=HK_@_TM"?=E*7VG_P/Z>I^B_\ P3M^+VM_%W]GF&?Q#>RZEJNBW\NE->W# M%I9HU2-XR['EF"R!=QY.W)R_B.13Z8%M;X_F:^*O^"@G_)W/CW_KI:_^DL-74]S&Q<>U_G:+"A_N MLO7]6>Z>%?V.?B;^VWIO_"TO'GC>/PY'JBE]&L'LVNMEMG"!4\Q!#&<<8W%O MO$9.3\[32?$?]A/X]RVL5Z+36-.9&D%N[&TU.U;D!@0-T;#/495@<892VC^$O@E;(*MF-$LA"$Z;/(3&/PK\V_P#@K9;VD?QE\'S1X%[)H6)L?W1/ M)L/ZO^51*HZ&(5.&D;M6^3_RU]2:<%6P[G/>R?Y:>BOIZ(_0B\\<6/Q,_9UO M_%>FY%CK'AJ>\C5CDIOMV)4^ZG(/N*_)K_@GK_R=]X!_WKS_ -(IZ^__ -DN M6XE_X)[V)N,EAHFK*F3GY!)-K1CL ME_\ )D5).>#@WOK^2/KW_@KE_P DK\#?]AJ3_P!$-5W_ ())_P#)$_%W_8P' M_P!)X:I?\%]:^(6F_"?X$_\ "7ZN3]@TC1(K MET4X:0B)=L:^[,54>["OR$_;R_Y.W^(O_7W!_P"DT-?>_P"W]-=0_L/VXMRP MCD;2UGVG_EG\IY]MP2LDVL#!+KR+[U8TDD\;*^RYG]SN?":WWQ3_ ."@GQO3 M3WOA+-)YD\=O+(RZ?I%J" 2%&< 95<@%G)&'_ M !7#XP?38C1^=G_!.']L+6_$?B"/X5^-M2FU5YHFDT/4KMR\X**6 M:V=SRXV@LI/(VEGA?X?>%(_[+TN+[*UP))E&Y MV6'>@9OG^:1FSR% P"!X3\2O!?BK]DGX[W6DVFM-%KV@3QSVFK6.8Q(C('1] MI/ *MAE.1]X'(Z_J'_P39C6/]DGPR54 M=WS-CN?M+C/Y 5\)_\ !3C_ ).L MU3_L&67_ *+JZLW1Q*C'J]?6U[_>9TX*I0DY=-O1.UON._\ ?[('Q,_;DTN MX^*_CGQU%HIU0O\ V7!)9M<[HU9EVJGF((80P(7&XG!)'.6^<_AOXP\4_LH? MM#KLNS:W^AZJVG:K##(?)NH5EV2QMTW(P!()''RMP17[$?LLVD=E^S;\,8HQ MA?\ A';%_P 6@5C^I-?C_P#MB(L?[57Q("J%']M2' &.N":TIOV>.5"/PZK[ MFE^-]1./M<+[23]YVU]4_P NA^U?Q&U;7]*^'VN7_A+2O[<\1QV;OIM@9$03 M3D?("795P"03R. <%I2IN;W7]ORJP55';@']1/BM\5]'^"/PIU/QEKN]K'3;96$,6/,GD;"QQKG MNS$#VSGM7YJ77[<7[1W[1GBR71?AM9MI0=69=.\/V2321Q9P'EN)0VW&0-X, M:Y(X%<5)/VLN57?Y;_T_E M27MX;*WMM0U@W]S&Q1G)X9T5,)V;N.*^U_\ @DO J_ 7Q/,,[W\1R*?3 MK? M'\S75&/M*%6-1\UO\U^C,I/EJTY05O\ AG_E^!\'^&KK4?V1_P!K"V^ULZOX M6UPP7#8YFM"VUFP/[\+DC_>%?M_=ZY8V.AS:S+VV%-H]P*^ M\/\ @JE:PV/[,^@6UO&L,$/B&UCCC48"J+:X ]@!7F/_!)?X1^9<^*_B3>0 M?+&!HVG,P[G;).P_#RER/5A7J?\ P5=_Y-QT;_L9+?\ ])[BGBDJ5.E1CLG' M\U;\+?>PP\G5JU*SZJ7Y._X_DBD\))/\ F?YS+,?P"^/?[5UQ??$N#PQ=^((M4G9A M?37D%NC!3@)"LTJL8UQM&T$#;C/!KZ=_;O\ ANGPB_8E^%OA!2#)I>I6T4[# MHTQMIVE8>Q=F-?DV\0AAL]&M(0B@<$0KG\2ZI1_!V-\,N>U:6[C+\8F!_P2)_Y)[\0/\ ML*6__HDUJ?\ !6[_ )(OX._[& ?^DTU9?_!(G_DGOQ _["EO_P"B36I_P5N_ MY(OX._[& ?\ I--1C/XJ_P"W/_;2<'\#_P"W_P#VXR_^"1/_ "3WX@?]A2W_ M /1)KYE_;$^+OB+]H/\ :6O?!\VL1Z9X=T[6?[#TZWNYC%9V[++Y+7,O;);< MQ//AM#!K$.K2 MF[OM$:989XYSR[Q%R%=6.6(+!@2< YXTKN,<5&4U>*2^^T?^#J30N\-*,=&V M_NN_^ 9&O?\ !(_6K7PK/?:+\1K/6=76#S8;"32C!#,V,[5F\YNO8E,=P/\-? M'EIXL^.'[-=U#:K?>,? :QN3'9W7GP6SGU$3CRW'X$5]A_L?_P#!1[Q%XO\ M'6C^!_B9%:W[:M,MI9:_:Q+!*)V.$2:-<(0Q(4,H7!(R#G(U@IMOD?,GT_K^ MK[&<^5)!_%JPL,GE1,J ?D *_;RMJ>F#IM?:U?W7_]N9E4UQO@+_P4I^&7PM^#?@_PEJNA>++C4M'TZ*TN);. MSM6A9U')0M<*2/J!7@O_ 4X_P"3K-4_[!EE_P"BZ]Z^ O\ P36^&7Q2^#?@ M_P 6ZKKOBRWU+6-.BN[B*SO+585=AR$#6[$#ZDT\/_NSOMS/\Y?\$*W\=6WL MORC_ , N?&/_ (*;?"_XA?"CQ?X8T[0?%T-_K&E7-C!)=6=JL2O)&RJ7*W)( M7)YP"?:OF+_@G+_R=QX/_P"N5[_Z2RU]._&/_@F3\+_A[\*/%_B?3M>\737^ MCZ56K1,\<;,H<+; E#_^N5[_ .DLM=&& M]G[2?+ORO\I?\$QQ//[&/-M?_P"1O^A]V_\ !4'_ )-9N?\ L,6?\WKY>_X) M:_$3PK\/?%OCV;Q3XFT?PU#]7U?_ *2C?$[4[]E_Z4S]<_&W[8WP:\#Z#=:I/\0] U7R4++9 MZ-J$5[<3-V14B9CDGC)P!U) YK\:_"-G>?%?X\:9%IEHRW>O>(%DBMT&[R_, MGW'IV4$DGT4FOIVS_P""2WQ4DG47?BCP?##GYGAN;N1@/8&W7/YU]>_LJ?L' M^%_V;=0/B&[U%_%/C!HVC34)(1##:*PPPACR2&(."[$DCH%R0=J/LZ-15F[M M;?UY_P!>>5;GJTW2MN=Q^V-\+/\ A;_[.OC#1(H?.U&"U.HV('WO/@_>*![L M R?\#K\S/^"<_P 3_P#A7/[3&C6D\OEZ?XCB?1YLG WOAH3]?,15_P"!FOV; M90RD$9!X(-?A7^TKX"N_V??VEO$>G:=NLUT_4UU/2I%&-L3L)H2O^[D+]4-8 MX62IU^66TE_P'\[/\#;$1=2A=;Q?_!7R37XGZP_MM?% _"?]FSQ?J<,ODZC? M0?V59$'#>;/\A(]U0NW_ &OSW_X)B_"C_A.OV@&\1W4/F:=X5M3>988_U05T?_!1K]HJU^+'AOX6:3I,P-G=:5'XCO(E/W99EV1H?= )?^^J M^J?^":OPI_X5Y^SG::QK^>OY67S/JF]LX=0LY[6XC66WGC:*2-AD,K#!!]B#7 MXO\ [.&M3_L^_MN:;IGFM';6_B"?P[=!C@/%)*T W?1MC_517[3U^(7[1['2 M_P!M;Q9+:_NY(O%*RH0>C>:C9_.L\)_O<(]T[_>E^K+Q3MA)R[?Y/_)'[>T4 M45B:A1110 5Y!\:_]9J__8MWO_HN2O7Z\@^-?^LU?_L6[W_T7)71AOX\/5?F M\6?\ +C_M[_VT_7. ?^8K M_MS_ -N"BBBOSX_7 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH *T[7_D'?C_ %K,K3M?^0=^/]: &4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M!?M_]2M25';_ .I6I* .7^*7_),?%_\ V![S_P!$O7P__P $A/\ D5?B5_U^ MV7_HN6ON#XI?\DQ\7_\ 8'O/_1+U^1?['?P,^+WQ>TGQ-/\ #+XB2>![:QG@ M2]B35KRR^T,RN4.(%(; #?>Z9XJ\/\59?W8_^E,SK_#2?:4O_23]G*_,K_@K M!XFTKQ-XZ^'WA/27CO\ Q'8QW!N8+?#R1^>T(AC;'1B48A>N"#W%=#_PQ#^U M+=_N;OX^SM;/Q(/^$EU63Y>_RE0#],UZA^SG_P $X_#WPA\96_C+Q9X@E\;^ M);:7[1:AX/)MH)NOFD%F:5P>0S$ 'G;D BHTX<\93EHM?-C=22C)16KT\C)_ MX*/:;/H_[&_ARPNFWW5KJ&G02L3G+K!(K'\P:\V^"_QJ_:#^+?PM\+>%/@EX M>M= T+P[IMOIMYXIU=8CYMPD8#B/S-R;0>RH[="2N<5[!_P5._Y-E@_[#UK_ M .@2UZW^QGHEMH/[+GPVM[:)(EETB*Z?8,;GES(S'W)%:']1?/]HV]O"CF+(5I( M)( J,4R"4==V,?=R#7W_ .*O'&C^#/!.I>+-3NUBT.PLVOI;A>N-&K8Z*UO(2/S1?RKZ6TO2?"_B;]F70;?QV MMK-X7D\.64VI&^E,4/EK!&Y9V!& " >O:HE)SH2EHG%VOZJ_X?UY-)0KPCJU M)7MZ.VGJ?)F@_M,?M,_M6WVI7?P=T/2_"'A*TG,"ZG?+#(^[ .UWF#*S8()$ M%YIEA:=;>W$)8\[!);K&\;$ X+J M1[-TKK=-_P""A7P*^!6BIX,^&?A/7-3TBRDD-N+1/+MY&=B[%7FD,S98G[R_ M3@"O+/VI/VM/B1\=O@EK.GGX,ZAX4\%N\$MWKFI":51MF0Q^7(8HT!+[1CYC M@GZU;O&SIQTTW_$%[S:J/77;\/\ @GZ&^$?C)H'BSX-67Q+21[3P_-I;:K+Y MN"\"(A:16QU*E67CN*^+="_:-_:<_:OU+4]0^#NFZ9X.\&V=RUO%J%[' [L0 M 0LC3!PSX()$<>%W $GJ?9_V/_!]O\0OV#-!\,7&Q@'N.-_9I_:9^+7PD^#.@>'O"W M[/6M^(=(19+A-9M;*]9+XR.S&7H&03PHKHOBW^T]\;OB]\-?$7@[4OV M9_$D-IK%HUL9QIM^YA8\K(%-OR58!A[BM9Q=)VIJ]N_7_(B$E4UJ.U^W3_,^ M^_A]X\T;XG^"](\4^'KK[9H^J0+/!)C#8/!5AV92"I'8@BNAKY(_X)H:#XO\ M)? K5-"\7Z!J_AZ:SUJ9K.WUBREM9#"\<;$JLB@E=^_D<9)KZWJ*T5";4=O\ MU<=*3E"\MSAOC?X*UCXC?"?Q+X9T#5!HFKZI:_9X-0,CQ^3EAN;*?-]W<..N M<=Z^0_&/["W@3]G?]F'XC:R2_BGQDNB3_P#$[OHPH@R #Y$62(\CC<2SM>-_MC_\FN?$S_L"S?TKDJ-PIS<=VO\ /_,Z8)2G!/H_\CR[_@F#_P F ML6?_ &%[S_T):U/^"E'_ ":1XG_Z^['_ -*8ZR_^"8/_ ":Q9_\ 87O/_0EK M4_X*4?\ )I'B?_K[L?\ TICKJQG\1>L/_;3GP?P/_M__ -N/F3]G?XV_'7XA M?"/PQ\//@=H%OIEOX=M3#JOBG5$B9%F>5Y B>9E K#C:['.<*.O4W/[67[0 MG[*OC'3++XZ:/:^)?#&H2[1JUC#"CE1]XPR0A4+*#GRY$#$#J!S7TM^PCX8L M/"_[*O@-;&.-6OK1K^XD3K)+*[,Q8]R!A?;:!VK,_P""AGARS\0?LG>,I+J) M7ET[[/>VSE1&&I^UIQC>VFGZ7_4 M^@- UZP\4:'I^L:7Z;?VZ75M<1G*R1NH96'U!%?%FE_\ %\?^"F%]=$F? M1?AQI7E1\Y3[1MVD?7S)W_[\^U=G^PCX_P#[(_8CT[7=8F+6F@1:@S.[,]TC^#;#FD29SZ$,.U? MIO7S!^Q?^QO:_LZ:1-K^ORQZM\0M5CQ>7BL72TC8AC#&QZDD L_\1'H.?I^M MI6ITXT4[VNV_-[V\C--U*DJK5KV2]%M<*^,/VF/VX/$7AWXGI\)_@]X>C\3^ M.#((;FYF0RQPR%=QCC0$;F4_;D^&6AOXNU6XTCQ%IUJAN+O1HK6RE>&,#+;EA1'8 =?+=C_.OIK]DW]I[3 M/VG?AY)K$5JNE:[I\@M]5TT/N6*0C*NA/)1P"1GD$,.<9/MK*)%*L RL,$'H M17S]X\^$G@S]G'X$_%36OA[X=A\/:C/H5W++-;22.[NL4A4Y=C]TL2 .!2E5 MY83;72Z]?\@C3AU>XM2\3.[(P!D9R/%7CS]M3X":6_BSQ.='\;>'[5/-O;>&UM MG%NGOK'&=2OM:-I)-CYA%%#&R)G MTW2N?QK[EFACN(9(I462*12KHXR&!&"".XK:I'ZO:$=79.[ZW5_D9PDJUY/1 M7>B\G8\B_9C_ &E-!_::^'_]OZ5"VG:C:N+?4M*E<.]K+C(PV!N1ARK8&<$$ M @BOD;Q-^W1\1/AS^U'\1_"D@G\8V$,LFF^&O#4-G F;UI8A%ND2,2LH4R<; MB3D#CJ,[_@GO'_PA?[9'Q=\'Z<3'HL<5\JPYX M[Y$BX]0LC#\:3X.:';ZS_ M ,%4?&[LXB" CW'F&G&,9UH27PRA*5ON_'>SZ"FY4Z"?#=WX]U&;1;;1[-#=W>@65M9S&VA7EBPVLY4#D[9 M68#Z&M/PK_P4#\>_'#PAHOASX7^!8]0^*URDAU-I,_V=81(0//!=APV1@.V% M/'SD@'[:\?HLG@3Q(CJ'1M-N0589!'E-Q7P=_P $A-/M_P"Q?B5?>2OVO[18 MP^=CYMFV8[<^F>:FFU4]I&2TBD_/5VM?L.I>GR-/63:\MK[??^!F?$+XZ?M< M?LLW>F^(OB)+I/BGPM6+ M*?0_:4&?R)_.MC]CG_DR?P=_V![K_P!&S5C4ES86K*UG%V5O.-S6"Y<52CTD MKOY22/D?X*_M\_&CQIX7N/">D6I^('Q2U74"-/DFL8(8+&S6-=SL(EC4G<3R MY"KC+'& >O\ &7Q-_;-_9XTY?%_C#^R/%WAF':U[!%:VSI;*3_&8$CD7TW@L MHXR?6;_@D5X3L5\/^/\ Q.T2/J374&G)(1\R1!#(P'H&9ESZ[!Z5^@6LZ3:Z M]I%]IM]"MQ97D#V\\,@RKQNI5E/L0373B?W+O!*]D_+;;_-]SGH?O%[[TN_7 M?^K>1Y[^SO\ 'K0_VC/AK9^+-%1K5V8V][I\CAGL[A0"T9.!D8((; R"#@'( M'QE^Q[_RD9^-7TUC_P!.$-._X)374^C^-OBWX:CG\W3K=[>1 &RNY))H]P^J MXY]A3?V/?^4C/QJ^FL?^G"&J@H_6%.&TJ\9Q7XL^G_ -K; M]K31OV7O"MI*]I_;7BC5-RZ;I0DV*0N-TLK=0BD@<-)U3]NCXD: M9_PDUA-I'A.RN$$]MH\]K9Q/(A&0 LR22)GTD=37DW[97C'6)/\ @H!8/9^' M+CQI<^'!I_V'P_#&\ANBL0N=H5 S'YG+' /3TKV[_AN;X^_]&Q^)/_ '4/\ MY'K"E&])5.KOZ)=/O-*CY:G)T27S;U.B_9O_ &UO$VI_%!OA+\:?#T?A;QR7 M\JTNXD\J*Y?;D1NNX@,PY5T)1\@ #C=YW_P4\TOXL_V/?7[ZQ9?\*A\ZS1-, MV1?:/M>&^?/E^9C.?X\>U>._M">(OC5\??B+X0\8CX#^+/"^L>'RH2>UT:]E M:;;*)(R281C:V['7[U?7'_!3MFD_93F9EVLVK61*^A^;BE67[NG4:2ES6:Z; MI)_<[^32ZA3?[R=--VY;KOMJOZW5S _8%T/X[VVB^$;[Q+XATV[^$LFB?\2S M388X!<19V^3N*PA^!NSESU[U:_:/_;?\1:5\3Q\)_@OX>C\4^./,\BZNY4,L M5O+C+1H@(!91RSN0B8((.#CV/]E&[-A^R7\/KE1N:'P]'(!ZX0G^E?FE^R'\ M:?'G@'QYXT\8>&/AAJ7Q/UK5 %N[JSM[B5K3S)&D;)BC?!D8=\?D;L?3-?0W[)/[6&D?M0>$KJ9;/^QO%&EE4U/2B M^Y5W9VRQD\F-B#UY4@@YX)\,_P"&YOC[_P!&Q^)/_ '4/_D>O/OV+]!^(]O^ MV9K'BW5?AGXB\#Z#XDAOGNH[O2[F&T@+XF"^8\:K_K$&,XZX%*$7)N,DK6;O MV:Z>=PFU%*46[W2]4_\ (_2^BBBN4Z KYW_;$_:XL_V8?#>G1V>G+KGBW6"Z MZ?I\C%8D5WD4KV=EK;3M\SQ&W_X; ML\;:>NN6U_H?A.*=!+%H[P62R!2,@8DCE93CL[@CO@U;_9W_ &T/B7IOQPM? M@_\ &_0X+/7+MQ;V^H10K#*LQ4L@D"$QR(_17CP,D=<\277_ 51TO7;K[)X M%^%7B;Q3=,<+#+(L+G_@,2S'KCBOG;Q-\1/&OQ2_;B^%&O\ CGP6_@349;_3 M8[73)HI(Y3;"Z;:[B3#$EBXSM7@#CN>VC%RJQ@X^[)V\_EYG)5ERTISYO>BK M_P!>1]C?\%$OCAXV^!7PQ\-:MX'UK^Q-0O-8%K/-]E@N-\7D2-MQ*C@)M:CA\V_F48D95D5EVEL\)&<8P6! M^47/^"MW_)%_!W_8P#_TFFKZD_9UT.W\-_ 7X>:?:QK'%%H-D<(, LT*LQ^I M9B3[FN>DE[.,'[RE0P'<$8/W)\6/B?HWP=^'>M>,= M=D8:9ID'FLL6"\K$A4C3/\3,54?6OA3_ (*]0HJ_"R<(/-WZBN[O@?9CC\Z^ MSOBMI/@+Q+\'7?XH1V3>$8K>&[O#?3/%$C!1M.58-G)P #DDC'.*4GSX=5-$ M[M/T_P ]RE'DK*.ZDKV\]OQ/C[PK\=?VLOVIK>?7OAIIFC>!O"(F>*VN[A(7 M\S:>5WSJYD(/!9(U7((Z@UD>)/VHOVG_ -E'Q%ILGQ>TW3_%7AJ^F\H74<," M+(!RPBEMU0(^.0)$Y /'<=?9_P#!2;X0?#'1;+P?\./!/B#5=,TQ/LUA#&JP MPNH.1M9W>4Y))RZ[B3S7B'[8O[37Q'^/'PGMH=5^$-[X'\&Q:C#<+JFI+,[2 M3;7"+'(\<:\@OD!6^H[Z/W6G3C[MUO\ UO\ \,0ES)J)+ M'QE^SGXEU_3)#+IVJ>%KF]MG88)CDM6=21ZX(KY<_P""3\,MQ\"/&L4,[6LS MZXZI.JAC&QMH@& (()!YP1CBO8?AW_R8'IO_ &(3?^D;5Y)_P23_ .2)^+O^ MQ@/_ *3PU7LU&KBJ:V22_P#)V3S.5+#S>]W_ .DHL_L9_M*_$+Q#\>/'?PJ^ M*NN#5]9T[S/L$ILK>VPT$A650(D3=N5E<9SPIK[/UW6K3PWHFH:MJ$H@L;"W MDNIY6Z)&BEF/X &OSM_;8TZ;]G/]K_X??&?3XF33M2EC_M#RP<,\0$4ZGW>W M<8]U)KVC_@I!\8HO!_[-QTS3+E7O/&4J65NT1SNM<"25ACJ"NU/^VE<\VYT( M3C\7PO\ Q7M?YW_4VC%1KR@_A^)>G5?*WWF;^PK\=/B3\>M6^(7C/Q=KW_%" M6,[6^F::;*WB2%B3*%E=86$D#A?E.XA<_W@ :WFH1K.#VBK+LVM[OKY?U;&+G*E[1;R=WY)[67 MY]CN?%O[1'[5/[*-U8:I\4[#2?&GA6YG6%[N"*%!D\[%D@5/+? .#)&0<'&: M^V1\2;;Q=\#Y_'/AN=DAO-"EU.RE=06C;R6==RG(RK#!!R,@U\8^&?\ @J!X M ^(%JNA?%?X<-;6;R)YC*D>IVF]6R'>&5590I&> Y&.*^Q=8UGP[XA^ 6M:E MX2FLY_#EUH-W+92:>H2$QF%_NJ -O.?'7QX\&^,+[QUKG]N76GW\,-M)]D@M_+1HRQ&(40'GU MS7*?%;]KKXK_ !-^-&M?"WX :):37&BL\6H:Y>+&Y5T8)(R^8?+1%8[?F#%B M.!ZY?_!(G_DGOQ _["EO_P"B37'_ !)^#GQT_9+^/GBKXC_"G2)/%7AW7II; MB:&&V-Y\LLAD:&:!")?E?)#IVQEADBNFLH1Q"4M(V_&RM?\ $PHN4J#<=97_ M N[FYXT^)'[9G[.>DMXL\72Z)XU\-VQ!O!';6[) I(&7\A(9 .?O#*CO7V/ M^SS\;=-_:$^%.D^,].MVL?M6^&YLG?>;:=#ATW8&1T(.!D,#@=*^,?#?_!4_ M3[Z*Y\._%GX8R1Q2(UO?K8$3(^1AD>TN ,+UR#(?I7VQ\#_&G@#Q]X M-7^& M_P#9Z^')&*B'3[5;80R #O5 M,[^N ^.7QJ\/_ 'XC?Q#\/K+2? OA-G=;:XG@@*3 'ION$D>0CH71%7 M((X(Q5C2?VT?C-^S;X\TWPS^T-X=AN]'OC^[UZPAC63;G!E4P_NI57(R@57 M(/7 /WEX/\/6/A'PKH^B:9"EOI^GVD5K!%&,!41 H_05\U_\%,/#-CKG[*^L MW]S$K76DWMI=6LF!N1FE6)L'T*R,/RK:=2-.5HJ\;I:^MM_Z_4QI1E6C>3LV MKZ>E_P"OZ1Z?^TG\1M1\'_LW^+?&?A'4T@O[?3%O-/U"...9?F9-KA7#*P*M MW!'-?'_PG_;!^/WQT\!Z/X6^'6CQ:[XTMXY9/$'B[4[>"&WMM\TGDJB )$&$ M83JK%L'"'!-=5X?URZU__@D_=3W;F26'1;BT5F.3Y<5XT:#\%51^%=Q_P2[T M.WTW]F"&]BC59]1U>[FF<#EBI6,9^@2M/9J%6M3>JC;\VO\ A[;V1'M)2ITI M;-MI_=_5OO/%?&W[1'[5O[)^JZ=J?Q/BTOQ?X7O)EA\Y+>W6(MU,:R6Z1M') MM!QYBD'!P&P:^_O!'Q"T?QY\/=)\9:?/Y>BZC8K?I).0OEQE=Q#]@5Y!]"#7 M@/\ P4KA27]DOQ&SJ&:.]L60G^$_:$&1^!(_&O+=(\57F@_\$FWO;9MD[:3+ M8;EXPDM^T#?CM_:._:3_9>MY3 M\8]*M/$?AW4(I+>U\2Z3#!OM+ID/E'$:JA ;G;)&-V#AC@@^I_\ !,7PW9:- M^R[8:C;Q*MWJVHW=Q=28^9V20Q*,^@6,?F:]I_:4\,V/B[X _$'3-0B6:W?1 M+J4;AG;)'$TD;CW5U4_A3Q-L/%Q6MEKWVU]/*PZ%\1--Z7>GEK9>OG<\E_X) MY_&CQE\N>-]8_MO5+?7)+.*?[+#;[8A! X7;$B*?F=CDC//6O/OCA^ MW-XS\0?%:?X6? 7P[#XA\06\CV]UJTT8E59$X?RE+!%5#P9)#MSD8Z$Y'_!. M'6)_#_['?Q,U2UW"YLM1U"YBVC)WI80LN/Q JE_P2/\ #MI-H'Q"\3RJLVKS M7L%B9GY=8PAD;G_:9@3Z[1Z5T581E7DMHQC%V76Z2_/[E)I>5FV M_P -A?$'B/\ ;A^$>DMXJU>72/&&EVJ&>[TV&TM)3"@&266!(I& _P"F;-C& M>G-?2G[)_P"U5HG[47@VYOK:U_LCQ#IK+'J>DM)O\LL#MDC;C=&V#C(!!!![ M$^YGG@\BOS5_97LX_AY_P4B^(GAK1_\ 1]'N/[2B-LO"*@=)E4 <84\#T%8T MY*I-TI+HVOE^=S2HO9P51/JD_._^1Z;K7[1WQ$M/^"BUI\,(O$.SP-))$K:5 M]BMCD'3Q,?WIC\S_ %GS?>]NG%;G_!1#]H#QQ\!=.\ W'@S7?[#&I7EQ'?-] MC@N/,C01D#][&^,;F^[@\UXUXB_Y2Z6/_7:#_P!-0K=_X*]#/AKX:C_I\O?_ M $"*H6E'#22U;7SUZ]S=J]:I'IRK_P!)9M_\+H_:A_:6\W6OA#HUAX%\#!F6 MPU36$@-Q?A3C=B57&#C^%-HY&]L5E_"7]L[XM?"_XX:9\+OCWIEL9=2FCMXM M6CACBE1I6VPR9A_=21%OE)505YRBV_ASP#X:TJTB6&ULM-M[>*- M!@*JQ*H _*OS]_X*@$6?QR^#]Y&B^>J$[B.NVYC*@^V2?SK>*C'$PH)7BW;S MZZ_@<$/C5^UW^U )_$?P\MM*\$>$@[I;23P0&.;!QM#W"2/(1T+( MJKD$<'BM+_@KMX@NK?P=\.]"1BMG>W]U=R@'JT4<:I^DS5]O?#/PW9>#_AWX M9T3385@L;#3;>WB11CY5C49^IZGW-84DG"55][+]7]YTU&TX075-O[[6/SN^ M+O[;_P >?A#X2OO!/C;2U\*?$>.6&XT_Q!96MO-!>6N2)-R,'B)/9D'8@JI' M/W[\"_$FH^,O@OX$U[6+C[9JNIZ'9WEW<;%3S)9(49VVJ HR23@ #T%?+_\ MP5>\,V.H? ;0]:DB7^T=-UN.*&;'S".6.0.F?0E$/_ 17T=^S+_R;G\,/^Q: MT[_TF2M(24Z-236JDE_Y*_NZ7\]2)Q<*L$GHXM_C_P /\M#TNBBBL#0**** M"BBB@ HHHH *X[XE_P#'KH7_ &%H/Y-78UQWQ+_X]="_["T'\FH [&BBB@#C M?AI_Q[:]_P!A:?\ DM=E7&_#3_CVU[_L+3_R6NRH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH P?'?_(GZO\ ]>[5:\+_ /(L MZ1_UYP_^@"JOCO\ Y$_5_P#KW:K7A?\ Y%G2/^O.'_T 4 :E%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QV@?\E(\4 M_P#7.V_]%BNQKCM _P"2D>*?^N=M_P"BQ0!V-<7\;/\ DC?CO_L WW_I.]=I M5+6]&L_$6C7^E:C#]HL+Z"2VN(=S+OC=2K+E2",@D9!!K*K%SIR@NJ9I3DH3 MC)]&?BA^P3_R=O\ #S_KYG_])I:_;RO$/ /[%7P9^&/B[3O$_AGP;_9NN:>S M/;77]J7LOEEE*D[))F4_*Q'(/6O;Z[ZU55(Q2Z7.2G3<9-OK8*^9_P#@HEX# MU;Q[^S!KL6C0RW5SIES!J'9?-:XN4WRO-*-JO,4RD7 957<<_, M#]/M_"%PZ22Z;9*UJKNC!E_\ 72U_])8:_6;X0_LV_#KX#76I7'@7P^^A2:BB1W7_ !,+ MJX64(25RLLK@$;CR!GDU^3/_ 4$_P"3N?'O_72U_P#26&B515,3&2_E_+E1 M5.#IX><7W_-MGT%^SG_P46@^"/P[L/ GQ-\+:Y->Z+;QQ:?=:?'&9)+E=M\*_V?_AY\$HID\$^%+'0Y)AMEN4WRW#KG.UII&9RN>Q;%:U'! M5W*HKM-_/S^9ST^:5"*INRDE\NMOD95G\/;?X3_LPS^$+9_-CT?PQ/:M*!CS M'%N^]_\ @3%C^-?E-_P3U_Y.^\ _[UY_Z13U^TVJ:9;:UI=YIU[%YUG=PO;S M1[BN^-U*L,@@C()Y!S7COP]_8O\ @W\*O&%AXI\+>#O[+UVP+FVN_P"T[R;9 MO1D;Y))F4Y5F'(/6LJ-7EKSK3^TOQ][_ #-:E.]"-&'2_P"2_P CYX_X*Y?\ MDK\#?]AJ3_T0U7?^"2?_ "1/Q=_V,!_])X:^J?BY\"_ _P =M*L=-\I37U94'OI^"?](IW^L.M';7\6F?B9\' M?B9XT_86^.][_;&A2B>)&L-5T>X8QBY@+ AXWP1U4,C@$$>QKZ<^.7_!5'1O M$GP[U#1OA[X?UG3]=U&!K9]0UA88TM%889HQ'(Y=L$@$[<'!YQBON[XB?"'P M5\6K!+/QCX8TWQ##&"(FO( TD6>OER?>3/\ LD5YOX;_ &%?@1X5U1-0L?AU MI\MPIR%U"XN+V+/_ %SGD=/TJG)58J-9;=B5'VL: M\W0L1C[IQ)_P5T_Y*=X#_P"P/+_Z M.-?J#;V\5K!'##&D,,:A$CC4*JJ!@ = !7F/Q=_9C^&GQWU2PU'QSX:_MR\ ML83;V\GV^YM]D9;<1B*1 >>Y!-%6HZE2$EM'_)K]14X![45IJI755;)_HT%.+A3E![O\ SN;'[,O_ ";G\,/^ MQ:T[_P!)DK\>?VQO^3K/B1_V&I/_ &6OV^\,^&].\&^'-+T'1[?['I6F6T=G M:6^]G\N*-0J+N8EC@ #))/J:\>\9?L0?!3X@>*]2\2Z]X+^WZUJ,QN+JZ_M6 M]C\R0]3M28*.G0 "M%57UWZS]G7UU:?Z"C%QPZI==/P31RG_ 4$\!ZMX]_9 M3U6+1H9;JYTR6VU.2WA&6DACSYG'?:K%_P#@%?G_ /L.?M9:1^R[XD\1OK^B MWFJZ/K<,*R2Z;L-S \1^!OC37)=7U3X>V/VZ5M\C65Q<6<;-G))CAD1"2>IQS65*?LY3[2_P"&_1 X M'9?-:XN4WRO-*-JO,4RD7 9 M57<<_,U']G7X; M:G\-KCP!)X/T^W\(7#I)+IMDK6JNZ,&5R\15RV5'S;LG')-0_"']FWX=? :Z MU*X\"^'WT*3442.Z_P")A=7"RA"2N5EE< C<>0,\FM*&-9P_F!O*,WEXW<[=NWMC'%946J=1N7PNU_Z]/R- M:EY02C\2O;Y_U^+.H_9J^%,?P5^"'A/PD(U2[M+19+TK_%8R A3F:1\8#'ICK7(^//V*?@Q\3O%VH^)_$O@W^TMZNO[4O8O M,8*$!V1S*H^50. .E;5*BE755;6M^$?\C&G!PH.F][W_ !E_F>J^"/\ D2] M_P"P?;_^BUKYI_X*8?#W4?'/[-<]WIEO)=3:!J,6J31Q@EO("/'(V/11(&/H M%)KZJL;.'3;*WM+=/+M[>-8HTR3M51@#)Y/ [U,RB12K ,K#!!&0165=^UG* M4>]_QN:T/W45%]K?A9GXU_L-_MA:9^R[J'B.S\0Z/>ZIH.M"&1GTS8;B"6/< M 0KLJLK!SGYAC ZU-^V=^UE>?M6K9CP_X>OM,\$>&W\UIKM097FE^16EVDJG M *JH8Y^8Y/0?HQXD_89^!7BO6I-5O_AW8+>2-N;[%<7%I$3Z^5#(B?\ CM=1 MK'[,?PNUOX>'P+/X,T^W\*-<)=-IVGE[,/,G"R,\+*[-[ECGO6M2<:EI26JM MZ?TEM\C.$'3O&+T=_P"OGU^9\I?\$B?^2>_$'_L*6_\ Z)->'?M(?'#]HCX! M_'I6JR;D5EA5%<%<*Z]CGV-?I=\(?@-X%^ ^G MZA8^!=#_ +#M=0E6:YC^USW'F.HV@YE=R./3%;_C7X?^&?B1HYTKQ3H.G^(- M/SN%OJ%NLRJW]Y=P^5O<8-%2I>LJL.B6_DE_D*G3Y:3IRZM[>K_S/BNZ_P"" ML7PWU/PC)'?>!/$%SJLT!67395MI+)W(Y0RF3<4SW,73M7QS^R3\+M7^.7[2 MVB76D:7]ATG3]6CUJ_DMXS]GL8$E\T1@]!DJ$4?T!K],A_P3Z_9_%X+G_A7L M/F;MVW^U+[9G_<\_;CVQBO:O!?@+PW\.=%32?"^AZ?H&FJ=WV;3[=84+8QN; M:/F8]V.2:JG4A2G[6*][\!3A.PU&W;?!>01W$;#NKJ&!_(U\$?\%8/ M@W-JWAOPW\2;"#>VE$Z9J3*O(AD;="Y]E_?L$_$V/XF?LQ^%)&E$E M_HL9T:[7=DJT.!'GZQ&,_C6U+WL+R=8.WR_X;E^\RJ^[B%/^=?C_ %S'Y\?\ M%./^3K-4_P"P99?^BZ_2O]CS_DU[X9?]@2#^5)\3OV0?A'\9/%Z_M*[@RB#"C;%*J\#VKTKP?X0TCP#X7TSP[H-I]@T;38%MK2V\QY/ M+C7HNYR6/U))J:&=-\9>'-3T'6+;[9I.I6\EI=6^ M]D\R)U*LNY2&&03R"#7E7PY_8U^#WPE\76?B?PIX0_LK7+,.L%U_:=Y-L#H4 M;Y))F4Y5B.1WJL/-4IRE+JK?@_\ ,*\75I1A'=._Y?Y'F/\ P5!_Y-9N?^PQ M9_S>OG[_ ()#?\CI\1O^P?:?^C)*_0KXH?"?PK\9_"K>'/&.E?VQHS3)<&V^ MT2P?O$SM.Z)U;C)XSBN?^$/[-/PW^ U[J5WX%\.?V'<:C&D5T_VZYN/,522H MQ-(X&"3TQ4X>2I<_-]J__I*05HNHH6Z6_.YZ=1116985^<'_ 5L^%GS>#OB M':P]=VC7SJ/K+ 3_ .1A^5?H_7+?$OX7^&/C!X3N/#/B_2EUC1+ATDDM6FDB M^9&#*0\;*P(([$=QT-2T[QDMT_\ A_PN7%JS3V:_X;\;'X-_"_P3J'Q9^)'A M?PE;/))<:I>0V*-DMY49;YF&>@5=S?@:_?\ T/1K3PYHMAI-A$(+&QMX[:") M>B1HH51^ KR7X;_ +&_P>^$?BZT\3^%/!RZ9KEJKK!=MJ-W<>6'4JV%EE9< ME21G&>:]HKLJU5*"C'U?]?UNSDA3<9N3]%_7];!7XI6MJWQJ_;W:.V_?0ZEX MV>3=][_1X[DL3]/+C)K]:_V@?B5!\(O@SXN\632+')I^GR&W#'&^X8;(5_%V M45^??_!*GX/3^(?B'KOQ*OX2UEHT36-E(X^_=RC]XP_W8R0?^NHK/"Z8AU>D M%^?3\%]YIB/]W]G_ #NW]??^!^HU%%%8F@4444 %>0?&O_6:O_V+=[_Z+DKU M^O(/C7_K-7_[%N]_]%R5T8;^/#U7YG)C/]VJ?X7^1\1T445^]G\I!1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?HQ7 MYSU^C%?GO%G_ "X_[>_]M/US@'_F*_[<_P#;@HHHK\^/UP**** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "M.U_Y!WX_P!:S*T[7_D' M?C_6@!E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 7[?_4K4E1V_P#J5J2@#E_BE_R3'Q?_ M -@>\_\ 1+U\/_\ !(3_ )%7XE?]?ME_Z+EK[^U33+;6M+O-.O8O.L[N%[>: M/<5WQNI5AD$$9!/(.:X?X0_ 'P%\!;74K;P+H/\ 8<&I.DETOVRXN/,9 0IS M-(^,!CTQUJJ;Y'4;^TDON=R*D>?V=OLMO[U8]"HHHJ2SX\_X*G?\FRP?]AZU M_P#0):]L_9/_ .3:/AC_ -B_9_\ HI:Z;XJ?"'PE\:_#*^'O&FD_VSHZSI:7KFJ?\ !/;01HJS21P:;H\^H1P9):U6)"Q('\(;8Q]E)[5]-?%SX'^" M?CKHMGI/CC1?[;T^SN/M4$/VJ>WV2[2N[,3H3PQ&"<EZ#8:+H-IHMI;* MFEVELEG#;N2ZB%5"*A+$EAM '.<]ZG_EU*'5R4ON0_\ E["?11:^]_U\SX<_ M81_:.^!?@+X(Z7I%WJVE^$/%=NK_ -K-J$7E2W> ?ANMUXFM?,CO=9UB&TD6WMH(G!5064$YDV9<@+T )+< M?5FO?L(? ?Q)JTFHWGPZL8[F1MS+8W5S:19]HH950?@M=W8? #X=:3X!U3P7 M8>$-,T_PUJD)@OK*SB\DW*D8R\B$.S>C%MP[&M:LHU7SO?>W2_\ D12BZ7NK M;OUM_F>#?LFWWB6;_@GYI$O@5X?^$LMK&_\ [/6XC$BM<)=3$(5)QEL8&?[P M-2%D9^./F)JZE12K3G;27X/?0 MB%-QI1ALTW\_4^,O^"A'QL^!WQ)\!IIGA4Z9XI^(,]W";?5-)M-SP1AOG#SA M1O##Y0@+7T#B,H7),,N 3&Z,6'S +C R".?0?VHO^"B'@WP=X'O--^&7B*' MQ#XVO (K6YL8?.M[+)&969UV.V,X0;N<9 '7Z"^*'[-'PP^,UU]J\8^#-.U> M^P%-\ ]O2P ML.C1M.[E#[K@U4I*J^:IH^MNO_#DQBZ6E/5=+]/Z_KL2_LLWWQ'UCX.:3JOQ M2G63Q3J!:Y\C[*EN]O <>6CH@ #D#<>,C=CC%>N445,Y*4FTK#A%QBDW<*\; M_;'_ .37/B9_V!9OZ5[)6-XR\'Z1\0/"VI^'-?M/M^C:E"UO=VWF/'YD9ZC< MA##Z@@UA4BY0<5U1M"7+)2?0^8_^"8/_ ":Q9_\ 87O/_0EK4_X*4?\ )I'B M?_K[L?\ TICKW3X7_"GPK\&?"J>&_!VE_P!CZ*DSSK:_:)9\.^-QW2LS+M-_M;0[IXWEM?/EAW,C!U.^-E888 \&M\1+VLE*/ M]W\+?Y&.'7LHM2_O?C?_ #/B/]A?]L[PIX'^%ND?#WXD7K^%+_3XR^EZAJ$3 MK;WMI(S.AW@84J2PR<*0!@YR*S?VX_VNM"^,_AJV^$/PIDE\7ZEKEW#'>7-A M$YC8*X9((L@>8S.JDL/E 7JZ-HT/V?3UD MEF\^VCR3L6X#^;C)SC?S6A\*_P!FWX9_!69[CP9X/L-&O'4H;WYY[G:>JB:5 MF<*<#Y0V.*TJ2A5GSS76_KVOV\_,FFITH)0WM]WI^FQ\K?M$Z1)^RY_P3WT; MX=K(K:_K!BTN;R3NWS32-<7(7U'#H/8BOK3X _#U/A5\%_!OA54$G[KJ>)(IP++KFH1L5:*&3[ENK#E=R_,Y'.TJ/XC2_LH_$K]ES]F?PM&8_']G MJ?C&\B4:EK3Z7>%B3@F*','R1 ]NK8!/8#Z3\?\ [%GP:^*/B[4/$_B?P>=4 MUS4&5KFZ.JWL6\JH1?E295&%4#@#I7/?\.[?V>_^B?\ _E:U#_Y(I4I*$&GN M]W^GH.JN>::V6R_7U_KH:.G_ +>7P(U6_MK*U\?P2W5S*L,48TZ\&YV("C)A MQR2*]^KYXTW_ ()^_ /2=0M;ZT\!^5=6LJS12?VQ?MM=2&4X,^#@@=:^AZ)< MEERWN$>:[OL)UX-?EWX.\1S?\$^?VOO$]OXJL;H> ?$YD\C4+>$LOD-+YD4J M@?>,18HZCD9) / /ZBUSWCCX>^&?B7HC:1XJT*PU_36.[[/?P+(JM_>7/*M[ MC!J(2=.:FNS7R9UTO35=[ MB=\95"I4>7GN7VX^O%>1_L1Z/\2/CSX!^)&N_$C7=8N?"OBR&XT_2]/OYWDC M59=_FRPJYX1=RHF..&QTKVO0_P!@_P" WA_5DU&U^'5C)<(VX+>W5S=0Y]XI M960_BM>\6]O%:P1P01I##&H1(XU"JJ@8 '0 535/EDM[JWHNOS_ *1-YWC9 MVL[^K6Q^7_[)?QP/[#_Q$\6_"OXKVUSI&E7-V+B'4E@>2.*0#8)L*"S0RHJ8 M90<%1QUQ]5?%K_@H/\(OA_X0NK_1?$MKXNUMX2;'2]+W/YDA'R^8^-L:@XSN M.[&< GBO:/B3\&_!'Q@T^.R\9>&=/\011@B)[J+][%GKY<@PZ9_V2*\]\)_L M/? SP5JJ:CIGP[T][J,Y0ZA//?(I[$)/(Z@CUQQ3E+VJ7M=]KKK_ )"4?9MN MFM-[,^??^"9/PA\0QW/B[XO^*+>2VN/$^8[#SE*M.CR^;-/@_P +/M"GOM8] M,$\[\!/^4HWQ)_W-0_\ :5?HLJK&JJJA548"@8 'I7G>@?L\_#[PO\4M2^(V MF>'_ +-XRU(2"ZU+[;?\B/XB_P"P=U<)\(?@#X"^ MKJ5MX%T'^PX-2=)+I M?MEQ<>8R A3F:1\8#'ICK44Y0?\%*/^32/$ M_P#U]V/_ *4QUK?L<_\ )D_@[_L#W7_HV:O8_B5\,O#7Q>\(W7ACQ=IO]K:' M=/&\MKY\L.YD8.IWQLK## '@U6TGP+H?PS^%\GAGPW8_V;H>G6,T=K:^;)+Y M:D,Q&YV9CRQ/)/6L*DN7#5H/J[_=&QM"/-B:,UT5OODF?EG_ ,$^?VHM,_9Y MU[6['Q)6U2*!I([.Z0-M+!020R,<[S3WHC8'(95GD=5(/0@ CM7?BHQE+DJ=EJNS2_X;T.+#R: MCSP[O1[:-K_@^IY!_P $S?@;J_PW^&FL^+_$=K+9ZOXLFCEB@N%*RK:QABCL M#R"[2.W^[M/>O,/V/?\ E(S\:OIK'_IPAK]&Z\X\'_L[_#[P#\1M;\>:#X?^ MP^*]:\[[?J'VVXD\[S9%DD_=O(47+J#\JC&,# J%5_?^U:TY7'[TDORU->1^ MQ<+W;DI-^C=_^ ?&'_!0'P1XE^#_ ,>/!_Q_\-V37ME:/;I?[5.V*:)L*)". MB2QGR\]B,=2*^C? _P"WY\$_&7A>+5KCQC:^'KD1![C3=55X[B%L9*@;<28] M4+9^O%?05]8V^I66\5U:S(8Y8)T#I(I&"K*>"".QKPC6OV"_@+X@U)[Z MZ^'5E%.YW%;*\NK6+\(HI50?0"L82Y8>S>UVU\]_Z_IZ37-+VBWLD_EL?/MQ M^V9\0?VA/VF-$\(_ Z[:V\'0[5U&^N]-C=98PV9;EO,4M&@7"H,J6;&1D@5Z M=_P4ZM9KC]E74'BC:18-5LY)& ^ZN\KD_BRC\:^B/A]\+?"/PITEM,\(>'=/ M\/6;$-(EC $:4@8#.WWG..[$FMO7M!TWQ1H]YI.L6%OJ>F7D9BN+.ZC$D4J' MJK*>"*FHHN$80Z.]WN]4_NT^7X#IN2FYSZJUETTM]Y\P?L.?M$_#SQA\)? O MP[LM=67QA9:1Y-SI,EK*K#R@=Y#E-C#'/#'@_6OE[X;>++S_ ()U_M2>)]$\ M66%TW@+Q"2(K^&,MFW#EH+A!_&4#LCJ.1EL9P ?NKX>_L>_"+X4^,[?Q7X4\ M(C1]>MQ((KJ/4;MU4.I5AY;RE,$$C&WCM7H?CGX=^&/B9HQTGQ7H.G^(-.W; MA!?P+*$;&-RDC*MC^(8-;SJ?O?;0W=[I[:_Y=/F8Q@_9>QELK6?70\?\2?MZ M_ [P]X7?6H_'%IJW[LO#8:?'))=2MC(3RRH*$^K[0.Y%>:?L0?'#XP_M$>-? M%7BCQ#/':?#2*25-.M#91(3*S_)$DH4,ZQI]YB3SMYZUZ9IO[ OP#TG4DOH/ MAW:O,C;@MS?7<\6?>*25D(]B,5[MI.DV.@Z;;:=IEE;Z=86R"."UM8EBBB0= M%55 ]!4IPC>2U>VNR_X/\ 7K3YY)1V5[^?_#?UZ>*_M%?MB>#/V9=8T33O M%&F:[?SZM#)- VD6\,BJJ,%(;S)DPOBS_@H]X2\ M*>.K?P1X=BTYM2^*NL7\5CH7DR3%H+8RJUQ(R*VPK@ $L"1DD8P2/M*WC\F" M./.=JA<_05,4G14GOS-?=:WYV?G M$]>^(.G3ZIX!\JQD2 IOCDMHV/G(%/#8Q!_+;&-R-]Y&Q_$I!J(MPJ1J+[+N4TI0E!_:5CR?\ X;8^ M /ASPO!=VGCO2(=.2,>38V,$GFJ,<*+=4W+Z8*C'M7Y_>+/CA)\1?]^II'0_]\UUWQ(_9K^&_Q:O]"O?%'AI+VZT)/+TV2VN[ MBS-LN58!?(D3@%01G..V*Z*DOI=Q:0W6G/# M]G>UN$$D;QXV[&5LAACC!ZU"_@>SZ\W-^-S5O]Y&711:^\^/OV1_VH/@%X/^ M!OAW38-CWB:AJFO?99(X!(0T<2+N (7+M\S 9. ,]:^S=0_8 M'^ >IZH^H3?#NT2=FWE+>]NX8<^T22A /8+BN^U#]GSX5?\$D_P#DB?B[_L8#_P"D\-?6 MGA7X0^$_!?PY;P'H^EO:^$V@FMO[/>[GEQ'+N\Q1([EP#O;HW&>,57^$GP1\ M%? O1+S2/ ^B_P!B:==W'VJ:'[5/<;Y=H7=F5W(X4# ..*MU$ZM:I_.E;_P* MY*BU2I0ZQ;_*QYG^WC\(_P#A;G[-_B.WMX/.U;15_MBQ"KEBT()=1[M&9!CU M(KX2_9_U;4_VO/C1\%/"^K123:/X!TC=?>9RLBP2DJW7D.!:1G/H:_1'XP?M M2?#7X7^$?$5Y?>+="O\ 4]/CFA_L."_BENI;A"?\ M$N?A"_AOX;ZY\0M0LUM;[Q5<[;1 FT)9QL<%1V#2%_P134X9\LISZ*TE_BLX MK\'>WD/$+FA&/5WC_P!NZ-^FWWL^R/%4>K2^&-630988-<:TE%C+<)OC6?8? M++#NN[&?:OA_]F7_ (*!2:?J_B3PA\?]4.@^)K6_9;>\GL1##&!A6MG$2?(5 M8%@[<$,M>9_%#]FKX8_&:Z%UXQ\&Z?J]\%"_;0'@N2HZ*9HF5R!V!. M!647RR;:NFK>GFOZ_P"#I+WHI+1IW_X#/DS]O#]H+X!>.OA)JNGV%UH_C#QO M<*BZ9=Z;;B2:T8.I+FX"_*H4$%=V6R!C'(]*_9/\#Z[X!_81NK+Q!#+:7=UI MFIWT5K."'AAE1V0$'H2/GQ_M^M>F^ _V,_@M\-M634]!\ :=%?QL'CGOI)KY MHF!R&3SW?:P]5P:]>U33+;6M+O-.O8O.L[N%[>:/<5WQNI5AD$$9!/(.:51+ MV-2G#>7?;^O,(M^UA.>T7?\ K_(^#?\ @D5_R3WX@XX_XFEO_P"B32^!/VX/ M%7PB_:$\7^"/C]??9-*5]FFWUMIP2&W 9BDF(U+O'*A4[LMM*@?"'X M#>!?@/I^H6/@70_[#M=0E6:YC^USW'F.HV@YE=R./3%6/B9\$O GQDLXK?QG MX6T_7Q""L4UQ'B:('J$E4AT!_P!EA6]2HI5?:)75K6?HE?U,:=-QI.#>M[W^ M;?\ PY\]?M*?M0?LX^)?A=K$.LZKH?CB[FLY4L+&UM_M-P)F0A"K[?W)!(.X ME<8]>*YO_@E'X'UWPW\'_$FMZG#-:Z9KFHQR:='*"/,2-"KS*#_"Q(4'OY?T MKV;PW^PG\"/"FIQW]C\.K"6XC.5&H7-S>Q_]^YY'0_B*]V@@CM88X88UBAC4 M(D<:A550, #H *F,HTU/E^U9?<[_>.2E-QYOLW?WJQ)7QW_ ,%+O@/JOQ7^ M$^F>(O#]G)J&L>%IY)WM8$+2RVLB@2E0.25*(V/0-7V)16$D]&G9K5&\9='+C;AL9VD@@DC M!&"?%_VWOVK-+_:+L])^#_PDCN/%EQJ5_&]W=VL+JDS(24AB# %AN^=GP% 0 M8)&2/L'QY^QK\%_B7JTFJ:_X TZ;4)6+RW%E)-9-*QZL_D.FXGU.373_ P^ M /P\^#,;CP9X2T[0Y9%V/=1(9+EUZ[6FV]FQ M[8JQ_P $S?\ DT_0_P#L(7O_ *.-?1OC;P3HOQ&\*:EX:\167]H:+J47DW5K MYKQ>8F0<;D96'('0BJ'PS^%WACX.^$X/#/A#3/[(T2"1Y8[7[1+/AG;$_\ !2C_ )-(\3_]?=C_ .E,=8?[ M-?PYC^+G_!.W2_![R+"VKZ7>V\4K#B.7[3,8V/L'"G\*^E?B5\,O#7Q>\(W7 MACQ=IO\ :VAW3QO+:^?+#N9&#J=\;*PPP!X-9,/A_2O@!\';ZS\%>'7FT[P_ M87%U8Z)'=2,TQ4/*8Q))O;+,3R=W7IVK*\8T*L)_::?R4;&UI2K4I0WCI\[W M/A;]A_\ :BTK]F^'7/@[\63-X5N=.U&22UO+F)C%$[8WPR;02H)&]7QM(8\C MC/H_[87[X^%FO>#?A[JP\7>)=218!!BN$,3NF2PV@\8R0 M,BLC]H8?L^?LM_ _QGI/@JQT&W\6^(-.ETNWMK.[-[?XF7:S-([O(D0&6Y(4 ME0!DUIB+RC^]7O6Z==-/2_4BA:,_W3TOUZ:Z^MMU_D3?\$K]-@UK]FGQAI]T MN^VN]?N8)5]4:TMU8?D37C'[._Q*F_X)^?';Q?X!^(UM=V_A35I%:'5(X&=0 M$9A#6,,/9A7OWQ"^%?A#XKZ2NF>+_ [I_B&S4DQK>PAVB)X)C?[R'W4@ MUT5Y.&( MM$6M=+TH-)-,^,A6^7$0]2^,<\$\5X'_ ,$Y?AOXE\/$]H]G%K1N M([#>I43R32AY70'DQH%" ]#DC^$U](>'?V$_@/X7U1-0LOAU82W"'(74+FXO M(O\ OU-(Z'_OFO=K>WBM8(X((TAAC4(D<:A550, #H *QC*%-N<=VK>B>_W MFLE*:47M>_JUL?FYXB_Y2Z6/_7:#_P!-0K>_X*\?\BW\-/\ K\O?_0(J^O[C M]G'X=W?Q=C^)\OA[?XYC*LNJ_;;D8(B\D?NA)Y?^K^7[OOUYJQ\7O@!X"^/% MMIEOXZT'^W(M-=Y+5?MEQ;^6S@!C^YD3.0HZYZ5$7:G1A_(U?_@&U_WLI]'& MWX6.Q\-_\B[I?_7K%_Z *_.O_@J7_P EB^$/_7.3_P!*(Z_2"VMX[.WB@B79 M%$@1%R3A0, -?$-OX6\5 M:7:1VETNI!DAN?+4*)HY,;?F !*DA@<\$8)]H_:@_: D_9M^'MMXM/AF;Q-9 M&_CL[J."Z$!MT<-B4DHV1N55P< /V6?VK-(M/&D^A^'?[6O(A<7 MUI%J;V-U!,WWUGCAECRP;/S,/FZ@D&HI749K>-U?R=O\OZ[:U+7@WI*SMYJ_ M^9\Q?\%#OVMM"^.6EZ9X3\"M<:IX9TJ]%UJ&M>2Z02W)1UBC3< < >:' MMLJ>;L:&.-Y%)\R9C)SEBP"C/45^COPS\+-X'^'/A;PZY4OI.EVMBQ7H6CB5 M#CVR*UCRQP\K=9+?K9:_=>Q$[NM"_2+^6NGW[G2T445SFH4444 %%%% !111 M0 5QWQ+_ ./70O\ L+0?R:NQKCOB7_QZZ%_V%H/Y-0!V-%%% '&_#3_CVU[_ M +"T_P#):[*N-^&G_'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?_ $ 5 M5\=_\B?J_P#U[M5KPO\ \BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ HHH MH *YK5OB/X=T'Q1!X>U/4X=/U*>!;B%;D[$D5F90 Y^7=E#P2"+_P!'3USUZCI0YD>+F^.GEV&]O!)M-;GV+17PW\,/VB_$GP^^ MSV-Q(-7T-6^:UN!F2-2JY%32Q,*NBT9EE^=X7,$HQ?+/L_P!._P#6AVM%%%=1[X4444 % M%%% !1110 4444 %%%>'_';]H>/X?R2:'H0CNM?*_O9FPT=H".,C^)\,HX&DZU=V2_'R1[#K&O:;X>M36C"6-?5'N0*[/X2_M-:QX.FBL/$4D^M:+C:'8[K MB =BK'[P_P!EC]".AN&,L^6K&QT8?B1PJ^QS&DZ;[ZV^:>MO/4^S:*\9\+_M M1>&_%/C:'08;.[@AN9?(M;Z7&V60G"@IU4,>GU&0*]FKNA4C45XNY];AL70Q MD7*A-22=@HHHK0ZPHHHH **** "BBB@ HHHH **** "BBB@ KCM _P"2D>*? M^N=M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:*** "BBB@ HHHH **** "OB;] MH+_@FQ_PO;XN:]XX_P"%B_V'_:K1-]@_L/[1Y6R)(_\ 6?:$SG9G[HZU]LT4 M+27,MQWT<>C,;P7X=_X1#P?H6A?:/M?]EV$%C]HV;/-\N-4W;Q'4'L0#7A'[)7[(5_\ LKZAXC6'QVWB M31-8"-_9TFE?9C#*A.V02>JLQ22DDGTU"BB MBD,**** "BBB@ HHHH **** "BBB@#PW]K+]G#4OVG/!NF>&+?QE_P (EIEO M=_:[I1IOVLW3*N(U/[Z/:%RQQSDXZ8KM_@A\(-'^!/PST;P;HF9+:PC_ 'MT MR[7N9F.9)6&3@LV>,G P.@KNZ*<6XQ<5L]6*24FI/IL%%%%(84444 %>0?&O M_6:O_P!BW>_^BY*]?KR#XU_ZS5_^Q;O?_1_\ ;3]H# @X]^:GHI-*2LQIN+NCQS]G']EGPI^S#I^N6?A;4-9OXM7EB MEG.L312,IC#!=GEQ)@?,.-:?7KJZU&[ M:\NM+%ZB6PD%?2NE:59Z'IEIIVG6L-C86D2P6]M;H$CBC4 * MJJ. !5NBFFU%06R$TG)S>["BBBD,**** "BBB@ HHHH **** "BBB@ HH MHH **** /F7XJ?\ !.[X-_%/6;C5I-+O_#.HW4AEN)O#]RL"RL>I,;H\:D]3 MM49/)JK\-O\ @F[\%_AUJ\.I2:=J7BNYA)/#L3<_ M9-,U%&B'T\^*5O\ QZOK^BA>Z[H'JK,\/^"'[&GPM^ -\NI^'-$DN]=52JZQ MJTOVBY0$$'9P$C)!()15)!P3BO<***J4I2W9,8J.R"BBBI*"BBB@ HHHH ** M** "N.^)?_'KH7_86@_DU=C7'?$O_CUT+_L+0?R:@#L:*** .-^&G_'MKW_8 M6G_DM=E7&_#3_CVU[_L+3_R6NRH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH P?'?_(GZO_U[M5KPO_R+.D?]>OL6OCK]L;_DINF?\ 8'B_]'3UPXS^$?)\3_\ (N?J MCPFI['4+K2[R*[LKF:TNHFW1SP.4=#ZAAR#4%%> ?CZ;3NCZ)^&/[6=]I?E6 M/C".34K49 U"!%\]>@7\-^)]+\8:/#JFCWD=]8S9VRQY' M(Z@@@$'V(!K\V*VO"GC+6O!.IK?Z)J$UA< C=Y;?)( ?NNO1A[$5Z%'&2AI/ M5'V66\35\+:GB??CW^TO\_G]Y^D-%> ?##]J[2M>^SZ=XIB&D7^W:=0##[-( M0.2W0QD^G(]QTKWR*9)XDEB=9(W 974Y# \@@]Q7L4ZD*BO%GZ9@\=A\=#VF M'E?\UZH?1116IW!1110 4444 M8#7$:>7;(?XIF.U?P!.X M^RFOB3X=^"M1^+GCR+3S/(9+AVN;V]?YBB9R[GU)) 'NPKWS]L[4WA\/^&M/ M#D1W%S+.R>IC50#^'F'\ZK_L>Z.8?#/BC6+>-9+^25;6+S#@?(F\#V!+C/T% M>36_?8A4WLC\\S*/]I9S#!3^""NU\KO[]$>]^$?!^E>!M#M])TBU6VM81R<# M?(W=W/\ $Q]?Z5M5\*:9\ZGJ-Y=3I.RWFEWSMY1YPR!.D9'8J! MCW'!^QO _P 0M&^('AJ/6M-N5%OC]_'*0'MV RROZ8]>A'/2NNC7A4]V.ECZ M+*\VPN-O1I+D66X=(X$0M(\A 55 R22> ,5^?OQ?U7 MPWK7CW4+GPM9_9-*8X^7Y4EDR=TB+_"I[#\>,X'H7[0GQ^?QI--X>\/S,F@1 MMB>X4X-XP/\ Z+!Z>O7TJM\'?V=[GQMHEUK^M&2STPP2?8H1\KW#[3M?V0'! M_P!K'IUXL14>(E[.FKV/E52.2S:\SUN%)QE@Y12LU+7ST04445Z)]J%%%% !1110 4444 M%%%% !1110 4444 %<=H'_)2/%/_ %SMO_18KL:X[0/^2D>*?^N=M_Z+% '8 MT45E^*/$%OX2\,ZMKEXDLEIIMI+>3) 9&2-"[!02 3@'&2/K2E)13;V0XIR M:2-2BOF'X*_\%"/AW\=OB-IO@O0-%\3VFJ7ZRM%-J5K;) /+C:1MQ2X=NBG& M%/-?3U:2A*-N9;D1DI72>P4445!0445Y5\=?VF_ '[.NGVTWC#57AO+M6:UT MVSB,UU.!U*H. ,\;F*C/&:5[#M<]5HKY'\$_\%.OA)XX\4:=H4.G>*=-NM0N M([6"2]T^$QM([!5'[J9VY)':OKBM)0E%)M$*2;LF%%%%04%%%% !1110 45Y M]XS^/7@CP'XTT#PAJ>MPGQ1KEU%:6>DVW[V?,C8#NH_U:=]S8S@XR>*[;5M2 MBT;2KW4)E=H;6%YW6, L552Q R1S@4FTH\[V_P MQI7ER+?_ #+=%?+'PC_X M*+?#?XS_ !$T;P9HFB>*K75-5D>.":_M+9(%*HSG<4N&8<*>BGG%?4]:2A** M3:W(4DW9!1114%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 5YE\1M'_ .$A\3/I7G?9_MVC7%KYVW=LWAUW8R,XSG&17IM< M'XB_Y*1IO_7@_P#Z$U5&3A)2CNB)PC4BX2V>AX9_PR#_ -3;_P"4W_[;1_PR M#_U-O_E-_P#MM?1E%>__ *P9E_S]_"/^1\I_JGDO_/C_ ,FG_P#)'SG_ ,,@ M_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7_/W\(_Y!_JGDO_/C_P F MG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U-O\ Y3?_ +;7T911_K!F7_/W\(_Y M!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ .VT?\,@_P#4V_\ E-_^VU]&44?Z MP9E_S]_"/^0?ZIY+_P ^/_)I_P#R1\Y_\,@_]3;_ .4W_P"VT?\ #(/_ %-O M_E-_^VU]&44?ZP9E_P _?PC_ )!_JGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ ME-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG M_P ,@_\ 4V_^4W_[;1_PR#_U-O\ Y3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ MSX_\FG_\D?.?_#(/_4V_^4W_ .VT?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_" M/^0?ZIY+_P ^/_)I_P#R1\Y_\,@_]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU] M&44?ZP9E_P _?PC_ )!_JGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\ M,@_]3;_Y3?\ [;7T911_K!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ M4V_^4W_[;1_PR#_U-O\ Y3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\ MD?.?_#(/_4V_^4W_ .VT?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+ M_P ^/_)I_P#R1\Y_\,@_]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E M_P _?PC_ )!_JGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y M3?\ [;7T911_K!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[ M;1_PR#_U-O\ Y3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/ M_4V_^4W_ .VT?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I M_P#R1\Y_\,@_]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ M )!_JGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T M911_K!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U M-O\ Y3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ M .VT?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I_P#R1\Y_ M\,@_]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ )!_JGDO M_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7 M_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U-O\ Y3?_ M +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ .VT?\,@ M_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I_P#R1\Y_\,@_]3;_ M .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ )!_JGDO_/C_ ,FG M_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7_/W\(_Y! M_JGDO_/C_P FG_\ )'SW:_L:_:(W;_A+]NW_ *AF?_:U'_#&W_4W_P#E,_\ MMU?2NF?ZF?\ SVI*/]8,R_Y^_A'_ "#_ %3R7_GQ_P"33_\ DCYK_P"&-O\ MJ;__ "F?_;J/^&-O^IO_ /*9_P#;J^E**/\ 6#,O^?OX1_R#_5/)?^?'_DT_ M_DCYK_X8V_ZF_P#\IG_VZC_AC;_J;_\ RF?_ &ZOI2BC_6#,O^?OX1_R#_5/ M)?\ GQ_Y-/\ ^2/FO_AC;_J;_P#RF?\ VZC_ (8V_P"IO_\ *9_]NKZ4HH_U M@S+_ )^_A'_(/]4\E_Y\?^33_P#DCYK_ .&-O^IO_P#*9_\ ;J/^&-O^IO\ M_*9_]NKZ4HH_U@S+_G[^$?\ (/\ 5/)?^?'_ )-/_P"2/FO_ (8V_P"IO_\ M*9_]NH_X8V_ZF_\ \IG_ -NKZ4HH_P!8,R_Y^_A'_(/]4\E_Y\?^33_^2/FO M_AC;_J;_ /RF?_;J/^&-O^IO_P#*9_\ ;J^E**/]8,R_Y^_A'_(/]4\E_P"? M'_DT_P#Y(^:_^&-O^IO_ /*9_P#;J/\ AC;_ *F__P IG_VZOI2BC_6#,O\ MG[^$?\@_U3R7_GQ_Y-/_ .2/FO\ X8V_ZF__ ,IG_P!NH_X8V_ZF_P#\IG_V MZOI2BC_6#,O^?OX1_P @_P!4\E_Y\?\ DT__ )(^:_\ AC;_ *F__P IG_VZ MC_AC;_J;_P#RF?\ VZOI2BC_ %@S+_G[^$?\@_U3R7_GQ_Y-/_Y(^:_^&-O^ MIO\ _*9_]NH_X8V_ZF__ ,IG_P!NKZ4HH_U@S+_G[^$?\@_U3R7_ )\?^33_ M /DCYK_X8V_ZF_\ \IG_ -NH_P"&-O\ J;__ "F?_;J^E**/]8,R_P"?OX1_ MR#_5/)?^?'_DT_\ Y(^:_P#AC;_J;_\ RF?_ &ZC_AC;_J;_ /RF?_;J^E** M/]8,R_Y^_A'_ "#_ %3R7_GQ_P"33_\ DCYK_P"&-O\ J;__ "F?_;J/^&-O M^IO_ /*9_P#;J^E**/\ 6#,O^?OX1_R#_5/)?^?'_DT__DCYK_X8V_ZF_P#\ MIG_VZC_AC;_J;_\ RF?_ &ZOI2BC_6#,O^?OX1_R#_5/)?\ GQ_Y-/\ ^2/F MO_AC;_J;_P#RF?\ VZC_ (8V_P"IO_\ *9_]NKZ4HH_U@S+_ )^_A'_(/]4\ ME_Y\?^33_P#DCYK_ .&-O^IO_P#*9_\ ;J/^&-O^IO\ _*9_]NKZ4HH_U@S+ M_G[^$?\ (/\ 5/)?^?'_ )-/_P"2/FO_ (8V_P"IO_\ *9_]NH_X8V_ZF_\ M\IG_ -NKZ4HH_P!8,R_Y^_A'_(/]4\E_Y\?^33_^2/FO_AC;_J;_ /RF?_;J M/^&-O^IO_P#*9_\ ;J^E**/]8,R_Y^_A'_(/]4\E_P"?'_DT_P#Y(^:_^&-O M^IO_ /*9_P#;J/\ AC;_ *F__P IG_VZOI2BC_6#,O\ G[^$?\@_U3R7_GQ_ MY-/_ .2/FO\ X8V_ZF__ ,IG_P!NH_X8V_ZF_P#\IG_VZOI2BC_6#,O^?OX1 M_P @_P!4\E_Y\?\ DT__ )(^:_\ AC;_ *F__P IG_VZC_AC;_J;_P#RF?\ MVZOI2BC_ %@S+_G[^$?\@_U3R7_GQ_Y-/_Y(^:_^&-O^IO\ _*9_]NH_X8V_ MZF__ ,IG_P!NKZ4HH_U@S+_G[^$?\@_U3R7_ )\?^33_ /DCYK_X8V_ZF_\ M\IG_ -NH_P"&-O\ J;__ "F?_;J^E**/]8,R_P"?OX1_R#_5/)?^?'_DT_\ MY(^:_P#AC;_J;_\ RF?_ &ZC_AC;_J;_ /RF?_;J^E**/]8,R_Y^_A'_ "#_ M %3R7_GQ_P"33_\ DCYK_P"&-O\ J;__ "F?_;J/^&-O^IO_ /*9_P#;J^E* M*/\ 6#,O^?OX1_R#_5/)?^?'_DT__DCYK_X8V_ZF_P#\IG_VZC_AC;_J;_\ MRF?_ &ZOI2BC_6#,O^?OX1_R#_5/)?\ GQ_Y-/\ ^2/FO_AC;_J;_P#RF?\ MVZC_ (8V_P"IO_\ *9_]NKZ4HH_U@S+_ )^_A'_(/]4\E_Y\?^33_P#DCYN_ MX8S_ '#R?\)A]WM_9G_VZJG_ R#_P!3;_Y3?_MM?4/_ "XS5E4?ZP9E_P _ M?PC_ )!_JGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ M[;7T911_K!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_P MR#_U-O\ Y3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_ M^4W_ .VT?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I_P#R M1\Y_\,@_]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ )!_ MJGDO_/C_ ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_ MK!F7_/W\(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U-O\ MY3?_ +;7T911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ .VT M?\,@_P#4V_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I_P#R1\Y_\,@_ M]3;_ .4W_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ )!_JGDO_/C_ M ,FG_P#)'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7_/W\ M(_Y!_JGDO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U-O\ Y3?_ +;7 MT911_K!F7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ .VT?\,@_P#4 MV_\ E-_^VU]&44?ZP9E_S]_"/^0?ZIY+_P ^/_)I_P#R1\Y_\,@_]3;_ .4W M_P"VT?\ #(/_ %-O_E-_^VU]&44?ZP9E_P _?PC_ )!_JGDO_/C_ ,FG_P#) M'SG_ ,,@_P#4V_\ E-_^VT?\,@_]3;_Y3?\ [;7T911_K!F7_/W\(_Y!_JGD MO_/C_P FG_\ )'SG_P ,@_\ 4V_^4W_[;1_PR#_U-O\ Y3?_ +;7T911_K!F M7_/W\(_Y!_JGDO\ SX_\FG_\D?.?_#(/_4V_^4W_ .VU]&445YV+S#$X[E^L M2YN7;1+?T2['KY?E."ROF^IPY>:U]6]KVW;[L****\\]<**** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "M.U_Y!WX_UK,K3M?^0=^/ M]: &4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110!?M_]2M25';_ZE:DH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH *X[XE_\>NA?]A:#^35V-<=\2_\ MCUT+_L+0?R:@#L:*** .-^&G_'MKW_86G_DM=E7&_#3_ (]M>_["T_\ ):[* M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#!\ M=_\ (GZO_P!>[5:\+_\ (LZ1_P!>+_T=/7#C/X1\GQ/_ ,BY^J/":***\ _'@HJ]HNAZAXBU M*&PTNSFO[V4X2"W0NQ]3@=AU)Z"OI7X9_LCQV[17_C.X$SJ0RZ9:/\GTD?'/ MT7'^\:VIT9U7:*/4P.6XG,)#> _ACXB^)%XT.B6#3QQD"6 MZD.R&+/]YCW]AD^U?9?P9^$;_"O16MY]:NM3N)AEX=[+:Q$\GRXR>N>K=3Z# MI7=Z5I-EH=C%9:=:0V-I&,)#;QA$'X"K=>U1PL:/O/5GZCE>0T,N:JR?-4[] M%Z+_ #"BBBNT^H"BBB@ HHHH ^>?VRM'ENO">@ZDB;H[2[>)S_=\Q00?IF/] M16;^QGXBA^R^(="=@LX=+V-<\LI&QSCV(3_OJO=OB!X.M_'W@_4]"N3L6ZBQ M')_SSD!W(WX,!]1D5\):'JVN?!WQ^MQY1MM5TR8QS6\F=KKT9#ZJP/!]P1VK MRJ_[FNJO1GY[FKEEF;4\P:O"6C^ZS_"S1]7?'CX#VWQ*LGU32UCMO$L"?*W" MK=J!PCG^]Z-^!XZ?'7VS6?"[:II7G76FM./LU]:;BF_:V=CK[$?J?4U][?#? MXI:'\3-(CNM-N42\" W&GNX\Z!NX([KGHPX/UXJ'Q=\&O"'CC6H=5UC2%N+Z M, &19'C\P#H'"D;OQYQQTJZV'5;]Y2>IUYEDM/,[8S 32D]WT?GIU[]^I\X? ML]_ %_&L\/B'Q! R:!&V8+=A@WC _P#HL'J>_3UKZ@^(&O6_@WP#K.HMMABM M+-Q$BX4;MNV-1Z98J/QK9N;JP\/:699Y;?3M.M8P"\C+'%$@& .P KX\_:( M^.:?$2Z71-&9AH%K+O,_(-W(!@-CL@R< ]>I[ 4^3"4K+=FE3ZKPY@7"+O4D MOFWW]%_6K.2^ NCRZU\7/#44:;A#39*XP1!D%GQ_M$#'LOH:^B:K!TW"G=]3?AK"2PV"YYJSF[_+ MI_G\PHHHKN/K HHHH **** "BBB@ HHHH **** "BBB@ KCM _Y*1XI_ZYVW M_HL5V-<=H'_)2/%/_7.V_P#18H [&N>^(EOI=UX!\2P:YBR:;G0]*Z&N+^-G_)&_'?\ V ;[_P!)WK&L[4I.W1FU%7J1 M7FCXM_9/\ _LM:'\=-!O/AK\2?$_B'QC&EP+33]2MI$@D!A<2;B;*(<(6(^< M]OQE8X+H?\ A&+J:2VM9C;3)-^']-\$7'C"75(9/#,%DVHOJ5MF> M,VZKO,B[ 2PVC/R@DU^-'[=GQ@\/_&WX_7GB#PKJK:QH"6%M:VUPT,L(^527 M 2158#:7:06\L^#_ -E/Q)-\.;*P>74OB]##!J,G MF'4D*WL2":0<@6Y",K8[$*.2>OVS\7/CAX)^!F@+J_C378-(MI"5@B(:2>X8 M?PQQJ"S=1D@8&>2*^;?V-_V*/ W@?3/A[\7++5?$$OB*YT:*^>UN+B V8>XM MOW@"B$/M'F-CY\\#)-?"OQ2\5:U^V-^UDED+YDMM5U==(TL-\R6EF)-JL%_W M\9?\$Q?A)>?#>ZTOP_97VG>*8K8_9M=EOY9'EF M5>#+$6\K:QZA57@\$5\??\$X_BYJGPQ_:*L_"<\\B:-XE9]/N[1B=BW*AC#( M!V8,NSZ.?:HA&G5DZ<=U^)%#))-* MP5$4#)9B> .YKY5\>?\%,_@MX)U:33[:ZUCQ6\3%))]!LT>$$=QKS+_@JQ\:M1\,^&?#OP\TFZ>U77%DO=4:-L-);HP6.(G^ZS[B1W\L#H37 M)?L(_L*>!OBA\*8O'?Q"L+C6_P"U)I4L-.6ZEMHHH8W*&1C$RN6+JW\6, << MUC2C[2,JC^%?C_7Z&M27LW&'5_U_P3ZC^#/[>'PD^-FLV^C:9J]SHFMW+;;? M3M=@%N\S=E1U9HRQ[+OW'L#7IOQ=^-/@WX&^'8-9\;:S_8FG7,XM(9_LLT^Z M4JS!=L2,1PK')&.*_/3X[?\ !,KQ;:?%5'^$=HH\*30I<)-J&I(AL)PQ!C!) M,C 85@V"><9)%?8?C']F>;X_? ;PEX1^+FK72Z[I/EW%W>^&[I<7$\<;QAR\ MT)SN5MS?*/F)P<=9KJMNN_3^O4_)GX'_$"Q\. M_M(>$_&/B?5)AI]KKL=_?:C.))Y-@DW-(P 9V/?@$U^S?@GXU?#_ ./7@'Q# MJ?A?7WU30+=)K.^NX[2>!HOW6Y\++&K$A&!R%(^O2OQ0^"OP_P!.^(WQM\*^ M#M2FNH-,U75H[">6U95F6-GVDJ65E#8]5(]J_8CX9?LW^&OV9_@_XST'PO?: MM?V=]%-1^'OPZTC MP1H=V]G?^*#(;V:%MKK9QX#(".1YC, ?558=Z>)3C&%G=O;^OQ9-&TIROHDE M^O\ 2\ST#XH?\%%O@S\,=6FTS^UK[Q3?0/Y:[I&W_ 6-+\+ M_P#@HK\&?B?JT.F#5;[PK?SN(X8_$5NL"2,>WFH[QK_P)AFOE']@C]AGPS\9 MO!\WCWX@1W%_I$MP]KIVDPSO DP3AY9'0A\;LJ I'W23G@4O[>W[#/AGX.># MH?'OP^BN-/T>&=+;4M)FG>=8@YVI+&[DOC=A2&)^\",EK_A_7D?J."& (.17BWCK]LOX/?#3QI>>$O$GB_^S?$%HZ1S6?\ M9EY+L9U5E&](64Y#*>#WKPO_ ()?_'S4OB)\/]7\#Z[=/>7_ (8$36-Q,Q9V MLWR%C)/7RV7 _P!EE':OBW]O^5X?VOO'4B-M=);1E8=B+6'!I.FH5U3E\+5_ MR_KU'&7/1E-;H_3;XX_MM_"SX!ZD=*UW5+G4]=50\FDZ+")YX@>1O+,J(<<[ M68-@@XP:H?!3]O+X3_'+7H-"TO4;[0]=N&VVVGZ[;K ]P?1'1WC+>B[MQ[ U MY+^SS_P3W^'_ (H^&&F>*OB9;W_BWQ;XEMEU2YGFU">(6YF'F +Y;J6;# LS MELMGM7Y\_M!?#G_AG_X^>(_#&D7UPT>B7R2V%XS8F5"J2Q$D8^=0RC(QR,X% M.,(1J^QJ/7R\M_ZZDN4IT_:T]O\ /K_6Q^]-%8/@+7)/$W@7P[K$O^MU#3;: M[?C',D2N?YUO5E.+A)Q?0N$E4BIKJ%%%%06%%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %<'XB_P"2D:;_ ->#_P#H35WE<'XB_P"2D:;_ ->#_P#H34 ; M-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110!HZ9_J9_\ /:DI=,_U,_\ GM24 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 2_\N,U95:O_ "XS5E4 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5IVO_ "#OQ_K6 M96G:_P#(._'^M #**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH OV_\ J5J2H[?_ %*U)0 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QWQ+_P"/70O^ MPM!_)J[&N.^)?_'KH7_86@_DU '8T444 <;\-/\ CVU[_L+3_P EKLJXWX:? M\>VO?]A:?^2UV5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% &#X[_ .1/U?\ Z]VJUX7_ .19TC_KSA_] %5?'?\ R)^K_P#7 MNU6O"_\ R+.D?]>W_ S_ M &6==\6K%?:^S^'],8!EC90;F53Z+GY/^!<^QKZ#^&/P'\-_#+%S;QMJ6K$8 M:_NP"R_]3_(=@!71445ZB2BK(^^ITX4HJ%-62Z(****9H M%%%% !1110 4444 %>7?&;X%:;\5+87<+KIVOPIMBO,9611T20#J/0CD>_2O M4:*B<(U%RR6AS8C#4L73=&M&\6?GMXH^'GC#X6ZF)+VRO-/>(YCU"T+>6?=9 M5Z?3(/M5ZU^/WQ!LX!#'XGNV0#&9521O^^F4G]:^^F4.I5@&5A@@C(-8-QX M\+W4@DG\-Z1-(#D/)8Q,1^)6O.>#E%_NYV/BY<,U:,F\'B'%/IK^::_(^"M0 M\0>+OB7?)!J>(+C.4MUWRX/JJ#@?@*]N^$7[*ES)=0:KXT18K=:1P!_L@Y/?'0_3FGZ79:3$8K&SM[.,G)2WB6,'\ *M5I3P<8OFF[LZL) MPU2IU/;8N;J2\]OGO<;'&D,:QQJJ(H"JJC '0 4ZBBO0/LPHHHH **** "B MBB@ HHHH **** "BBB@ HHHH *X[0/\ DI'BG_KG;?\ HL5V-<=H'_)2/%/_ M %SMO_18H [&N+^-G_)&_'?_ & ;[_TG>NTKB_C9_P D;\=_]@&^_P#2=ZY\ M1_!GZ/\ (WH?Q8>J_,_(_P#X)R_\G<>#_P#KE>_^DLM?4W_!7;_D0?A[_P!A M.Y_]%+7RS_P3E_Y.X\'_ /7*]_\ 266OJ;_@KM_R(/P]_P"PG<_^BEKTL=M2 M^7_I9Y^%^.IZ/_TDZ3_@DS_R;]XD_P"QEF_])K:L;_@KE_R2OP-_V&I/_1#5 ML_\ !)G_ )-^\2?]C+-_Z36U8W_!7+_DE?@;_L-2?^B&J<=_%7_;G_MI>%^! M_P#;WZEW_@DG_P D3\7?]C ?_2>&ODS_ (*4?\G:>)/^O.R_])TKZS_X))_\ MD3\7?]C ?_2>&ODS_@I1_P G:>)/^O.R_P#2=*K$_P"]P]%_Z2@P_P# G\__ M $H_43]GF![K]F#X>0QG$DGA2Q13Z$VJ 5^)WPU^':^/OBYH?@K4=4_X1]M3 MU-=-DOI8/-^SR,^P93_P"W M'^Q3XO\ "/Q*U/XB?#_2;O5] U*X_M">'2D9[G3KDG<[>6OS%"V7#*#MR0<8 M!+J2C3QTY3^%MW^3_6[%3C*I@XQCNDFON_X;\3M?^'/?_56__+;_ /NNNJ^% M?_!+5OAE\2?#/BU?B@;\Z+J$-_\ 91H'D^=Y;AMF_P"U-MSC&<'KT-?-&J_\ M%"_CGXH\$S> G2Q:_NH#8RZC;:=(-4E5AM86UV]T>;_ /!6W3;B'XR^#K]@WV6?0?)C/;>EQ(6Q[XD3]*^R MO^"?NKV^K?LD^!/LY4FUCN+:55.=KKO%NI&L MNUG]R7Z)_>?K#\2OV@OAY\'M8TO2_&?BBUT"]U.-I;5+I)-KJI )+JI51DC[ MQ&><=#74>&/&6A>//#Z:QXWDB-NQ)4R,QDC2/NX]M_::M][9^>_[!/\ R=O\//\ KYG_ /2:6O>?^"NFE7,/Q(\!ZDP; M[)/I,UNAQQO2;?LU6O[37PO?14 MGCL/$.GR&[TF]ESL27&#&^ 3L<<''((4X.,'?%:*E/LW_E^MS##ZRJ0?5+\[ M_H7D^TQO@?\!1C] :_/;P;XR^/7[!'B+4K=M"N--L+E MP+BTU:T>XTNZ<#"R)(C $X[QN#V/3 7Q?XS^/'[??B72[5=$EO["U?$%KI5H M]OI=HS<-))(Y8 X[NY.,A>N#%>'UF?/!Z-IO\V51E]65I[J]OT_KJ>N_\$B] M)N9?B5X\U-8R;.#2(K9Y.PD>8,H_*-_RKP__ (*"?\G<^/?^NEK_ .DL-?J5 M^R?^S?8?LS_"^+0(YDO];O)/M>JWZ A9IR -J9YV(/E7/N>"QK\M?^"@G_)W M/CW_ *Z6O_I+#14FI8F*CLHM?BOU'1BXT*DGU:?Z?H?L;\,?^2:^$_\ L$6G M_HE*_'__ (*,?\G>>-?^N=C_ .D<-?L!\,?^2:^$_P#L$6G_ *)2OQ__ ."C M'_)WGC7_ *YV/_I'#45/]]?_ &]^:'A_]U_[=7YH_73X+_\ )'? O_8!L/\ MTG2NRKC?@O\ \D=\"_\ 8!L/_2=*[*JQ'\:?J_S,L-_ AZ+\@HHHKG.D**** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH *X/Q%_R4C3?^O!__ $)J[RN#\1?\ ME(TW_KP?_P!":@#9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** -'3/\ 4S_Y[4E+IG^IG_SVI* " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** )?^7&:LJM7_EQFK*H **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MK3M?^0=^/]:S*T[7_D'?C_6@!E%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 7[?_4K4E1V_ M^I6I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.^)? M_'KH7_86@_DU=C7'?$O_ (]="_["T'\FH [&BBB@#C?AI_Q[:]_V%I_Y+795 MQOPT_P"/;7O^PM/_ "6NRH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH P?'?_ ")^K_\ 7NU6O"__ "+.D?\ 7G#_ .@"JOCO M_D3]7_Z]VJUX7_Y%G2/^O.'_ - % &I1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %<=H'_)2/%/_7.V_P#18KL:X[0/ M^2D>*?\ KG;?^BQ0!V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %<'XB_Y*1IO_7@_P#Z$U=Y7!^(O^2D:;_UX/\ ^A-0!LT4 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% &CIG^IG_ ,]J2ETS_4S_ .>U)0 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110!+_P N,U95:O\ RXS5E4 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5IVO\ R#OQ_K69 M6G:_\@[\?ZT ,HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"_;_ .I6I*CM_P#4K4E !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'?$O\ X]="_P"P MM!_)J[&N.^)?_'KH7_86@_DU '8T444 <;\-/^/;7O\ L+3_ ,EKLJXWX:?\ M>VO?]A:?^2UV5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% &#X[_Y$_5_^O=JM>%_^19TC_KSA_\ 0!57QW_R)^K_ /7NU6O" M_P#R+.D?]>U)2Z9_J9_\ /:DH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH E_Y M<9JRJU?^7&:LJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "M.U_Y!WX_UK,K3M?\ D'?C_6@! ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 7[?_ %*U)4=O_J5J2@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ KCOB7_P >NA?]A:#^35V-<=\2_P#C MUT+_ +"T'\FH [&BBB@#SCP/XJTG15UN&]OHK>1]3FD56SRIVC/Z&NF_X6#X M=_Z"T'Z_X5B_#[2[*^AUU[FT@N'&J3J&EB5B!A>,D5U?_"/Z7_T#;/\ [\)_ MA0!G?\+!\._]!:#]?\*/^%@^'?\ H+0?K_A6C_PC^E_] VS_ ._"?X4?\(_I M?_0-L_\ OPG^% &=_P +!\._]!:#]?\ "C_A8/AW_H+0?K_A6C_PC^E_] VS M_P"_"?X4?\(_I?\ T#;/_OPG^% &=_PL'P[_ -!:#]?\*/\ A8/AW_H+0?K_ M (5H_P#"/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^% &=_PL'P[_P!!:#]? M\*/^%@^'?^@M!^O^%:/_ C^E_\ 0-L_^_"?X4?\(_I?_0-L_P#OPG^% &=_ MPL'P[_T%H/U_PH_X6#X=_P"@M!^O^%:/_"/Z7_T#;/\ [\)_A1_PC^E_] VS M_P"_"?X4 9W_ L'P[_T%H/U_P */^%@^'?^@M!^O^%:/_"/Z7_T#;/_ +\) M_A1_PC^E_P#0-L_^_"?X4 9W_"P?#O\ T%H/U_PH_P"%@^'?^@M!^O\ A6C_ M ,(_I?\ T#;/_OPG^%'_ C^E_\ 0-L_^_"?X4 9W_"P?#O_ $%H/U_PH_X6 M#X=_Z"T'Z_X5H_\ "/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4 9W_"P?#O M_06@_7_"C_A8/AW_ *"T'Z_X5H_\(_I?_0-L_P#OPG^%'_"/Z7_T#;/_ +\) M_A0!G?\ "P?#O_06@_7_ H_X6#X=_Z"T'Z_X5H_\(_I?_0-L_\ OPG^%'_" M/Z7_ - VS_[\)_A0!G?\+!\._P#06@_7_"C_ (6#X=_Z"T'Z_P"%:/\ PC^E M_P#0-L_^_"?X4?\ "/Z7_P! VS_[\)_A0!G?\+!\._\ 06@_7_"C_A8/AW_H M+0?K_A6C_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\ [\)_A0!G?\+!\._]!:#] M?\*/^%@^'?\ H+0?K_A6C_PC^E_] VS_ ._"?X4?\(_I?_0-L_\ OPG^% &= M_P +!\._]!:#]?\ "C_A8/AW_H+0?K_A6C_PC^E_] VS_P"_"?X4?\(_I?\ MT#;/_OPG^% &=_PL'P[_ -!:#]?\*/\ A8/AW_H+0?K_ (5H_P#"/Z7_ - V MS_[\)_A1_P (_I?_ $#;/_OPG^% &=_PL'P[_P!!:#]?\*/^%@^'?^@M!^O^ M%:/_ C^E_\ 0-L_^_"?X4?\(_I?_0-L_P#OPG^% &=_PL'P[_T%H/U_PH_X M6#X=_P"@M!^O^%:/_"/Z7_T#;/\ [\)_A1_PC^E_] VS_P"_"?X4 9W_ L' MP[_T%H/U_P */^%@^'?^@M!^O^%:/_"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^ M_"?X4 9W_"P?#O\ T%H/U_PH_P"%@^'?^@M!^O\ A6C_ ,(_I?\ T#;/_OPG M^%'_ C^E_\ 0-L_^_"?X4 9W_"P?#O_ $%H/U_PH_X6#X=_Z"T'Z_X5H_\ M"/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4 9W_"P?#O_06@_7_"C_A8/AW_ M *"T'Z_X5H_\(_I?_0-L_P#OPG^%'_"/Z7_T#;/_ +\)_A0!G?\ "P?#O_06 M@_7_ H_X6#X=_Z"T'Z_X5H_\(_I?_0-L_\ OPG^%'_"/Z7_ - VS_[\)_A0 M!G?\+!\._P#06@_7_"C_ (6#X=_Z"T'Z_P"%:/\ PC^E_P#0-L_^_"?X4?\ M"/Z7_P! VS_[\)_A0!G?\+!\._\ 06@_7_"C_A8/AW_H+0?K_A6C_P (_I?_ M $#;/_OPG^%'_"/Z7_T#;/\ [\)_A0!G?\+!\._]!:#]?\*/^%@^'?\ H+0? MK_A6C_PC^E_] VS_ ._"?X4?\(_I?_0-L_\ OPG^% &=_P +!\._]!:#]?\ M"C_A8/AW_H+0?K_A6C_PC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG^% &=_PL M'P[_ -!:#]?\*/\ A8/AW_H+0?K_ (5H_P#"/Z7_ - VS_[\)_A1_P (_I?_ M $#;/_OPG^% &=_PL'P[_P!!:#]?\*/^%@^'?^@M!^O^%:/_ C^E_\ 0-L_ M^_"?X4?\(_I?_0-L_P#OPG^% &=_PL'P[_T%H/U_PH_X6#X=_P"@M!^O^%:/ M_"/Z7_T#;/\ [\)_A1_PC^E_] VS_P"_"?X4 9W_ L'P[_T%H/U_P */^%@ M^'?^@M!^O^%:/_"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^_"?X4 9W_"P?#O\ MT%H/U_PH_P"%@^'?^@M!^O\ A6C_ ,(_I?\ T#;/_OPG^%'_ C^E_\ 0-L_ M^_"?X4 9W_"P?#O_ $%H/U_PH_X6#X=_Z"T'Z_X5H_\ "/Z7_P! VS_[\)_A M1_PC^E_] VS_ ._"?X4 9W_"P?#O_06@_7_"C_A8/AW_ *"T'Z_X5H_\(_I? M_0-L_P#OPG^%'_"/Z7_T#;/_ +\)_A0!RWC#QMH=_P"&-2M[?4H99Y(65$7. M2?3I5CP_XZT&UT'389=3A26.VB1U.* %_P"%@^'?^@M!^O\ A1_P ML'P[_P!!:#]?\*T?^$?TO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6 M#X=_Z"T'Z_X4?\+!\._]!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!M MG_WX3_"@#._X6#X=_P"@M!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_] M^$_PH_X1_2_^@;9_]^$_PH SO^%@^'?^@M!^O^%'_"P?#O\ T%H/U_PK1_X1 M_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#._P"%@^'?^@M!^O\ A1_PL'P[ M_P!!:#]?\*T?^$?TO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6#X=_ MZ"T'Z_X4?\+!\._]!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX M3_"@#._X6#X=_P"@M!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_]^$_P MH_X1_2_^@;9_]^$_PH SO^%@^'?^@M!^O^%'_"P?#O\ T%H/U_PK1_X1_2_^ M@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#._P"%@^'?^@M!^O\ A1_PL'P[_P!! M:#]?\*T?^$?TO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6#X=_Z"T' MZ_X4?\+!\._]!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@ M#._X6#X=_P"@M!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_]^$_PH_X1 M_2_^@;9_]^$_PH SO^%@^'?^@M!^O^%'_"P?#O\ T%H/U_PK1_X1_2_^@;9_ M]^$_PH_X1_2_^@;9_P#?A/\ "@#._P"%@^'?^@M!^O\ A1_PL'P[_P!!:#]? M\*T?^$?TO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6#X=_Z"T'Z_X4 M?\+!\._]!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#._X M6#X=_P"@M!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_]^$_PH_X1_2_^ M@;9_]^$_PH SO^%@^'?^@M!^O^%'_"P?#O\ T%H/U_PK1_X1_2_^@;9_]^$_ MPH_X1_2_^@;9_P#?A/\ "@#._P"%@^'?^@M!^O\ A1_PL'P[_P!!:#]?\*T? M^$?TO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6#X=_Z"T'Z_X4?\+! M\._]!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#._X6#X= M_P"@M!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_]^$_PH_X1_2_^@;9_ M]^$_PH SO^%@^'?^@M!^O^%'_"P?#O\ T%H/U_PK1_X1_2_^@;9_]^$_PH_X M1_2_^@;9_P#?A/\ "@#._P"%@^'?^@M!^O\ A1_PL'P[_P!!:#]?\*T?^$?T MO_H&V?\ WX3_ H_X1_2_P#H&V?_ 'X3_"@#._X6#X=_Z"T'Z_X4?\+!\._] M!:#]?\*T?^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#._X6#X=_P"@ MM!^O^%'_ L'P[_T%H/U_P *T?\ A']+_P"@;9_]^$_PH_X1_2_^@;9_]^$_ MPH SO^%@^'?^@M!^O^%*]!_X1_2_P#H&V?_ 'X3_"N)U_2K*/XA:?"EG;I"UDS&-8E" MD[CSC'6@"S_PFFB?]!&']?\ "C_A--$_Z",/Z_X5>_L73_\ GPMO^_*_X4?V M+I__ #X6W_?E?\* */\ PFFB?]!&']?\*/\ A--$_P"@C#^O^%7O[%T__GPM MO^_*_P"%']BZ?_SX6W_?E?\ "@"C_P )IHG_ $$8?U_PH_X331/^@C#^O^%7 MO[%T_P#Y\+;_ +\K_A1_8NG_ //A;?\ ?E?\* */_"::)_T$8?U_PH_X331/ M^@C#^O\ A5[^Q=/_ .?"V_[\K_A1_8NG_P#/A;?]^5_PH H_\)IHG_01A_7_ M H_X331/^@C#^O^%7O[%T__ )\+;_ORO^%']BZ?_P ^%M_WY7_"@"C_ ,)I MHG_01A_7_"C_ (331/\ H(P_K_A5[^Q=/_Y\+;_ORO\ A1_8NG_\^%M_WY7_ M H H_\ "::)_P!!&']?\*/^$TT3_H(P_K_A5[^Q=/\ ^?"V_P"_*_X4?V+I M_P#SX6W_ 'Y7_"@"C_PFFB?]!&']?\*/^$TT3_H(P_K_ (5>_L73_P#GPMO^ M_*_X4?V+I_\ SX6W_?E?\* */_"::)_T$8?U_P */^$TT3_H(P_K_A5[^Q=/ M_P"?"V_[\K_A1_8NG_\ /A;?]^5_PH H_P#"::)_T$8?U_PH_P"$TT3_ *", M/Z_X5>_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P * */_ FFB?\ 01A_7_"C M_A--$_Z",/Z_X5>_L73_ /GPMO\ ORO^%']BZ?\ \^%M_P!^5_PH H_\)IHG M_01A_7_"C_A--$_Z",/Z_P"%7O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"@ M"C_PFFB?]!&']?\ "C_A--$_Z",/Z_X5>_L73_\ GPMO^_*_X4?V+I__ #X6 MW_?E?\* */\ PFFB?]!&']?\*/\ A--$_P"@C#^O^%7O[%T__GPMO^_*_P"% M']BZ?_SX6W_?E?\ "@"C_P )IHG_ $$8?U_PH_X331/^@C#^O^%7O[%T_P#Y M\+;_ +\K_A1_8NG_ //A;?\ ?E?\* */_"::)_T$8?U_PH_X331/^@C#^O\ MA5[^Q=/_ .?"V_[\K_A1_8NG_P#/A;?]^5_PH H_\)IHG_01A_7_ H_X331 M/^@C#^O^%7O[%T__ )\+;_ORO^%']BZ?_P ^%M_WY7_"@"C_ ,)IHG_01A_7 M_"C_ (331/\ H(P_K_A5[^Q=/_Y\+;_ORO\ A1_8NG_\^%M_WY7_ H H_\ M"::)_P!!&']?\*/^$TT3_H(P_K_A5[^Q=/\ ^?"V_P"_*_X4?V+I_P#SX6W_ M 'Y7_"@"C_PFFB?]!&']?\*/^$TT3_H(P_K_ (5>_L73_P#GPMO^_*_X4?V+ MI_\ SX6W_?E?\* */_"::)_T$8?U_P */^$TT3_H(P_K_A5[^Q=/_P"?"V_[ M\K_A1_8NG_\ /A;?]^5_PH H_P#"::)_T$8?U_PH_P"$TT3_ *",/Z_X5>_L M73_^?"V_[\K_ (4?V+I__/A;?]^5_P * */_ FFB?\ 01A_7_"C_A--$_Z" M,/Z_X5>_L73_ /GPMO\ ORO^%']BZ?\ \^%M_P!^5_PH H_\)IHG_01A_7_" MC_A--$_Z",/Z_P"%7O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"@"C_PFFB? M]!&']?\ "C_A--$_Z",/Z_X5>_L73_\ GPMO^_*_X4?V+I__ #X6W_?E?\* M*/\ PFFB?]!&']?\*/\ A--$_P"@C#^O^%7O[%T__GPMO^_*_P"%']BZ?_SX M6W_?E?\ "@!+#QUH$<,P?5(5)Z=?\*/^$ZT'_H*0_K_A6AIVA::T,Q;3[4X] M8%]/I2?V%IO_ $#K7_OPO^% %#_A.M!_Z"D/Z_X4?\)UH/\ T%(?U_PJ_P#V M%IO_ $#K7_OPO^%']A:;_P! ZU_[\+_A0!0_X3K0?^@I#^O^%'_"=:#_ -!2 M']?\*O\ ]A:;_P! ZU_[\+_A1_86F_\ 0.M?^_"_X4 4/^$ZT'_H*0_K_A1_ MPG6@_P#04A_7_"K_ /86F_\ 0.M?^_"_X4?V%IO_ $#K7_OPO^% %#_A.M!_ MZ"D/Z_X4?\)UH/\ T%(?U_PJ_P#V%IO_ $#K7_OPO^%']A:;_P! ZU_[\+_A M0!0_X3K0?^@I#^O^%'_"=:#_ -!2']?\*O\ ]A:;_P! ZU_[\+_A1_86F_\ M0.M?^_"_X4 4/^$ZT'_H*0_K_A1_PG6@_P#04A_7_"K_ /86F_\ 0.M?^_"_ MX4?V%IO_ $#K7_OPO^% %#_A.M!_Z"D/Z_X4?\)UH/\ T%(?U_PJ_P#V%IO_ M $#K7_OPO^%']A:;_P! ZU_[\+_A0!0_X3K0?^@I#^O^%'_"=:#_ -!2']?\ M*O\ ]A:;_P! ZU_[\+_A1_86F_\ 0.M?^_"_X4 4/^$ZT'_H*0_K_A1_PG6@ M_P#04A_7_"K_ /86F_\ 0.M?^_"_X4?V%IO_ $#K7_OPO^% %#_A.M!_Z"D/ MZ_X4?\)UH/\ T%(?U_PJ_P#V%IO_ $#K7_OPO^%']A:;_P! ZU_[\+_A0!0_ MX3K0?^@I#^O^%'_"=:#_ -!2']?\*O\ ]A:;_P! ZU_[\+_A1_86F_\ 0.M? M^_"_X4 4/^$ZT'_H*0_K_A1_PG6@_P#04A_7_"K_ /86F_\ 0.M?^_"_X4?V M%IO_ $#K7_OPO^% %#_A.M!_Z"D/Z_X4?\)UH/\ T%(?U_PJ_P#V%IO_ $#K M7_OPO^%']A:;_P! ZU_[\+_A0!0_X3K0?^@I#^O^%'_"=:#_ -!2']?\*O\ M]A:;_P! ZU_[\+_A1_86F_\ 0.M?^_"_X4 4/^$ZT'_H*0_K_A1_PG6@_P#0 M4A_7_"K_ /86F_\ 0.M?^_"_X4?V%IO_ $#K7_OPO^% %#_A.M!_Z"D/Z_X4 M?\)UH/\ T%(?U_PJ_P#V%IO_ $#K7_OPO^%']A:;_P! ZU_[\+_A0!0_X3K0 M?^@I#^O^%'_"=:#_ -!2']?\*O\ ]A:;_P! ZU_[\+_A1_86F_\ 0.M?^_"_ MX4 4/^$ZT'_H*0_K_A1_PG6@_P#04A_7_"K_ /86F_\ 0.M?^_"_X4?V%IO_ M $#K7_OPO^% %#_A.M!_Z"D/Z_X4?\)UH/\ T%(?U_PJ_P#V%IO_ $#K7_OP MO^%']A:;_P! ZU_[\+_A0!0_X3K0?^@I#^O^%'_"=:#_ -!2']?\*O\ ]A:; M_P! ZU_[\+_A1_86F_\ 0.M?^_"_X4 4/^$ZT'_H*0_K_A1_PG6@_P#04A_7 M_"K_ /86F_\ 0.M?^_"_X4?V%IO_ $#K7_OPO^% %#_A.M!_Z"D/Z_X4?\)U MH/\ T%(?U_PJ_P#V%IO_ $#K7_OPO^%']A:;_P! ZU_[\+_A0!0_X3K0?^@I M#^O^%'_"=:#_ -!2']?\*O\ ]A:;_P! ZU_[\+_A1_86F_\ 0.M?^_"_X4 4 M/^$ZT'_H*0_K_A1_PG6@_P#04A_7_"K_ /86F_\ 0.M?^_"_X4?V%IO_ $#K M7_OPO^% %#_A.M!_Z"D/Z_X4?\)UH/\ T%(?U_PJ_P#V%IO_ $#K7_OPO^%' M]A:;_P! ZU_[\+_A0!0_X3K0?^@I#^O^%'_"=:#_ -!2']?\*O\ ]A:;_P! MZU_[\+_A1_86F_\ 0.M?^_"_X4 4/^$ZT'_H*0_K_A1_PG6@_P#04A_7_"K_ M /86F_\ 0.M?^_"_X4?V%IO_ $#K7_OPO^% %3_A/- ^QRK_ &I!N/0<_P"% M9W_"::)_T$8?U_PKH?[!TS[%*?[.M,^OD+_A69_8NG_\^%M_WY7_ H H_\ M"::)_P!!&']?\*/^$TT3_H(P_K_A5[^Q=/\ ^?"V_P"_*_X4?V+I_P#SX6W_ M 'Y7_"@"C_PFFB?]!&']?\*/^$TT3_H(P_K_ (5>_L73_P#GPMO^_*_X4?V+ MI_\ SX6W_?E?\* */_"::)_T$8?U_P */^$TT3_H(P_K_A5[^Q=/_P"?"V_[ M\K_A1_8NG_\ /A;?]^5_PH H_P#"::)_T$8?U_PH_P"$TT3_ *",/Z_X5>_L M73_^?"V_[\K_ (4?V+I__/A;?]^5_P * */_ FFB?\ 01A_7_"C_A--$_Z" M,/Z_X5>_L73_ /GPMO\ ORO^%']BZ?\ \^%M_P!^5_PH H_\)IHG_01A_7_" MC_A--$_Z",/Z_P"%7O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"@"C_PFFB? M]!&']?\ "C_A--$_Z",/Z_X5>_L73_\ GPMO^_*_X4?V+I__ #X6W_?E?\* M*/\ PFFB?]!&']?\*/\ A--$_P"@C#^O^%7O[%T__GPMO^_*_P"%']BZ?_SX M6W_?E?\ "@"C_P )IHG_ $$8?U_PH_X331/^@C#^O^%7O[%T_P#Y\+;_ +\K M_A1_8NG_ //A;?\ ?E?\* */_"::)_T$8?U_PH_X331/^@C#^O\ A5[^Q=/_ M .?"V_[\K_A1_8NG_P#/A;?]^5_PH H_\)IHG_01A_7_ H_X331/^@C#^O^ M%7O[%T__ )\+;_ORO^%']BZ?_P ^%M_WY7_"@"C_ ,)IHG_01A_7_"C_ (33 M1/\ H(P_K_A5[^Q=/_Y\+;_ORO\ A1_8NG_\^%M_WY7_ H H_\ "::)_P!! M&']?\*/^$TT3_H(P_K_A5[^Q=/\ ^?"V_P"_*_X4?V+I_P#SX6W_ 'Y7_"@" MC_PFFB?]!&']?\*/^$TT3_H(P_K_ (5>_L73_P#GPMO^_*_X4?V+I_\ SX6W M_?E?\* */_"::)_T$8?U_P */^$TT3_H(P_K_A5[^Q=/_P"?"V_[\K_A1_8N MG_\ /A;?]^5_PH H_P#"::)_T$8?U_PH_P"$TT3_ *",/Z_X5>_L73_^?"V_ M[\K_ (4?V+I__/A;?]^5_P * */_ FFB?\ 01A_7_"C_A--$_Z",/Z_X5>_ ML73_ /GPMO\ ORO^%']BZ?\ \^%M_P!^5_PH H_\)IHG_01A_7_"C_A--$_Z M",/Z_P"%7O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"@"C_PFFB?]!&']?\ M"C_A--$_Z",/Z_X5>_L73_\ GPMO^_*_X4?V+I__ #X6W_?E?\* */\ PFFB M?]!&']?\*/\ A--$_P"@C#^O^%7O[%T__GPMO^_*_P"%']BZ?_SX6W_?E?\ M"@"C_P )IHG_ $$8?U_PH_X331/^@C#^O^%7O[%T_P#Y\+;_ +\K_A1_8NG_ M //A;?\ ?E?\* */_"::)_T$8?U_PH_X331/^@C#^O\ A5[^Q=/_ .?"V_[\ MK_A1_8NG_P#/A;?]^5_PH H_\)IHG_01A_7_ H_X331/^@C#^O^%7O[%T__ M )\+;_ORO^%']BZ?_P ^%M_WY7_"@"C_ ,)IHG_01A_7_"C_ (331/\ H(P_ MK_A5[^Q=/_Y\+;_ORO\ A1_8NG_\^%M_WY7_ H H_\ "::)_P!!&']?\*/^ M$TT3_H(P_K_A5[^Q=/\ ^?"V_P"_*_X4?V+I_P#SX6W_ 'Y7_"@"C_PFFB?] M!&']?\*/^$TT3_H(P_K_ (5>_L73_P#GPMO^_*_X4?V+I_\ SX6W_?E?\* * M/_"::)_T$8?U_P *OV_CO0%L=AU2$-GISZ_2D_L73_\ GPMO^_*_X5HV^@Z8 MVGY.G6A.>OD+Z_2@#-_X3K0?^@I#^O\ A1_PG6@_]!2']?\ "K_]A:;_ - Z MU_[\+_A1_86F_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ (4?\)UH/_04A_7_ J_ M_86F_P#0.M?^_"_X4?V%IO\ T#K7_OPO^% %#_A.M!_Z"D/Z_P"%'_"=:#_T M%(?U_P *O_V%IO\ T#K7_OPO^%']A:;_ - ZU_[\+_A0!0_X3K0?^@I#^O\ MA1_PG6@_]!2']?\ "K_]A:;_ - ZU_[\+_A1_86F_P#0.M?^_"_X4 4/^$ZT M'_H*0_K_ (4?\)UH/_04A_7_ J__86F_P#0.M?^_"_X4?V%IO\ T#K7_OPO M^% %#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U_P *O_V%IO\ T#K7_OPO^%']A:;_ M - ZU_[\+_A0!0_X3K0?^@I#^O\ A1_PG6@_]!2']?\ "K_]A:;_ - ZU_[\ M+_A1_86F_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ (4?\)UH/_04A_7_ J__86F M_P#0.M?^_"_X4?V%IO\ T#K7_OPO^% %#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U M_P *O_V%IO\ T#K7_OPO^%']A:;_ - ZU_[\+_A0!0_X3K0?^@I#^O\ A1_P MG6@_]!2']?\ "K_]A:;_ - ZU_[\+_A1_86F_P#0.M?^_"_X4 4/^$ZT'_H* M0_K_ (4?\)UH/_04A_7_ J__86F_P#0.M?^_"_X4?V%IO\ T#K7_OPO^% % M#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U_P *O_V%IO\ T#K7_OPO^%']A:;_ - Z MU_[\+_A0!0_X3K0?^@I#^O\ A1_PG6@_]!2']?\ "K_]A:;_ - ZU_[\+_A1 M_86F_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ (4?\)UH/_04A_7_ J__86F_P#0 M.M?^_"_X4?V%IO\ T#K7_OPO^% %#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U_P * MO_V%IO\ T#K7_OPO^%']A:;_ - ZU_[\+_A0!0_X3K0?^@I#^O\ A1_PG6@_ M]!2']?\ "K_]A:;_ - ZU_[\+_A1_86F_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ M (4?\)UH/_04A_7_ J__86F_P#0.M?^_"_X4?V%IO\ T#K7_OPO^% %#_A. MM!_Z"D/Z_P"%'_"=:#_T%(?U_P *O_V%IO\ T#K7_OPO^%']A:;_ - ZU_[\ M+_A0!0_X3K0?^@I#^O\ A1_PG6@_]!2']?\ "K_]A:;_ - ZU_[\+_A1_86F M_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ (4?\)UH/_04A_7_ J__86F_P#0.M?^ M_"_X4?V%IO\ T#K7_OPO^% %#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U_P *O_V% MIO\ T#K7_OPO^%']A:;_ - ZU_[\+_A0!0_X3K0?^@I#^O\ A1_PG6@_]!2' M]?\ "K_]A:;_ - ZU_[\+_A1_86F_P#0.M?^_"_X4 4/^$ZT'_H*0_K_ (4? M\)UH/_04A_7_ J__86F_P#0.M?^_"_X4?V%IO\ T#K7_OPO^% %#_A.M!_Z M"D/Z_P"%'_"=:#_T%(?U_P *O_V%IO\ T#K7_OPO^%']A:;_ - ZU_[\+_A0 M!0_X3K0?^@I#^O\ A1_PG6@_]!2']?\ "K_]A:;_ - ZU_[\+_A1_86F_P#0 M.M?^_"_X4 4/^$ZT'_H*0_K_ (4?\)UH/_04A_7_ J__86F_P#0.M?^_"_X M4?V%IO\ T#K7_OPO^% %#_A.M!_Z"D/Z_P"%'_"=:#_T%(?U_P *O_V%IO\ MT#K7_OPO^%']A:;_ - ZU_[\+_A0!'#\0/#RQ*#JL /X_P"%2?\ "P?#O_06 M@_7_ J[!X?TLPJ3IMF?^V"?X5)_PC^E_P#0-L_^_"?X4 9W_"P?#O\ T%H/ MU_PH_P"%@^'?^@M!^O\ A6C_ ,(_I?\ T#;/_OPG^%'_ C^E_\ 0-L_^_"? MX4 9W_"P?#O_ $%H/U_PH_X6#X=_Z"T'Z_X5H_\ "/Z7_P! VS_[\)_A1_PC M^E_] VS_ ._"?X4 9W_"P?#O_06@_7_"C_A8/AW_ *"T'Z_X5H_\(_I?_0-L M_P#OPG^%'_"/Z7_T#;/_ +\)_A0!G?\ "P?#O_06@_7_ H_X6#X=_Z"T'Z_ MX5H_\(_I?_0-L_\ OPG^%'_"/Z7_ - VS_[\)_A0!G?\+!\._P#06@_7_"C_ M (6#X=_Z"T'Z_P"%:/\ PC^E_P#0-L_^_"?X4?\ "/Z7_P! VS_[\)_A0!G? M\+!\._\ 06@_7_"C_A8/AW_H+0?K_A6C_P (_I?_ $#;/_OPG^%'_"/Z7_T# M;/\ [\)_A0!G?\+!\._]!:#]?\*/^%@^'?\ H+0?K_A6C_PC^E_] VS_ ._" M?X4?\(_I?_0-L_\ OPG^% &=_P +!\._]!:#]?\ "C_A8/AW_H+0?K_A6C_P MC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG^% &=_PL'P[_ -!:#]?\*/\ A8/A MW_H+0?K_ (5H_P#"/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^% &=_PL'P[ M_P!!:#]?\*/^%@^'?^@M!^O^%:/_ C^E_\ 0-L_^_"?X4?\(_I?_0-L_P#O MPG^% &=_PL'P[_T%H/U_PH_X6#X=_P"@M!^O^%:/_"/Z7_T#;/\ [\)_A1_P MC^E_] VS_P"_"?X4 9W_ L'P[_T%H/U_P */^%@^'?^@M!^O^%:/_"/Z7_T M#;/_ +\)_A1_PC^E_P#0-L_^_"?X4 9W_"P?#O\ T%H/U_PH_P"%@^'?^@M! M^O\ A6C_ ,(_I?\ T#;/_OPG^%'_ C^E_\ 0-L_^_"?X4 9W_"P?#O_ $%H M/U_PH_X6#X=_Z"T'Z_X5H_\ "/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4 M9W_"P?#O_06@_7_"C_A8/AW_ *"T'Z_X5H_\(_I?_0-L_P#OPG^%'_"/Z7_T M#;/_ +\)_A0!G?\ "P?#O_06@_7_ H_X6#X=_Z"T'Z_X5H_\(_I?_0-L_\ MOPG^%'_"/Z7_ - VS_[\)_A0!G?\+!\._P#06@_7_"C_ (6#X=_Z"T'Z_P"% M:/\ PC^E_P#0-L_^_"?X4?\ "/Z7_P! VS_[\)_A0!G?\+!\._\ 06@_7_"C M_A8/AW_H+0?K_A6C_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\ [\)_A0!G?\+! M\._]!:#]?\*/^%@^'?\ H+0?K_A6C_PC^E_] VS_ ._"?X4?\(_I?_0-L_\ MOPG^% &=_P +!\._]!:#]?\ "C_A8/AW_H+0?K_A6C_PC^E_] VS_P"_"?X4 M?\(_I?\ T#;/_OPG^% &=_PL'P[_ -!:#]?\*/\ A8/AW_H+0?K_ (5H_P#" M/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^% &=_PL'P[_P!!:#]?\*/^%@^' M?^@M!^O^%:/_ C^E_\ 0-L_^_"?X4?\(_I?_0-L_P#OPG^% &=_PL'P[_T% MH/U_PH_X6#X=_P"@M!^O^%:/_"/Z7_T#;/\ [\)_A1_PC^E_] VS_P"_"?X4 M 9W_ L'P[_T%H/U_P */^%@^'?^@M!^O^%:/_"/Z7_T#;/_ +\)_A1_PC^E M_P#0-L_^_"?X4 9W_"P?#O\ T%H/U_PH_P"%@^'?^@M!^O\ A6C_ ,(_I?\ MT#;/_OPG^%'_ C^E_\ 0-L_^_"?X4 9W_"P?#O_ $%H/U_PH_X6#X=_Z"T' MZ_X5H_\ "/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4 9W_"P?#O_06@_7_" MC_A8/AW_ *"T'Z_X5H_\(_I?_0-L_P#OPG^%'_"/Z7_T#;/_ +\)_A0!G?\ M"P?#O_06@_7_ H_X6#X=_Z"T'Z_X5H_\(_I?_0-L_\ OPG^%'_"/Z7_ - V MS_[\)_A0!G?\+!\._P#06@_7_"C_ (6#X=_Z"T'Z_P"%:/\ PC^E_P#0-L_^ M_"?X4?\ "/Z7_P! VS_[\)_A0!G?\+!\._\ 06@_7_"C_A8/AW_H+0?K_A6C M_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\ [\)_A0!G?\+!\._]!:#]?\*/^%@^ M'?\ H+0?K_A6C_PC^E_] VS_ ._"?X4?\(_I?_0-L_\ OPG^% &=_P +!\._ M]!:#]?\ "C_A8/AW_H+0?K_A6C_PC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG M^% &=_PL'P[_ -!:#]?\*/\ A8/AW_H+0?K_ (5H_P#"/Z7_ - VS_[\)_A1 M_P (_I?_ $#;/_OPG^% &=_PL'P[_P!!:#]?\*/^%@^'?^@M!^O^%:/_ C^ ME_\ 0-L_^_"?X4?\(_I?_0-L_P#OPG^% &=_PL'P[_T%H/U_PH_X6#X=_P"@ MM!^O^%:/_"/Z7_T#;/\ [\)_A1_PC^E_] VS_P"_"?X4 9W_ L'P[_T%H/U M_P */^%@^'?^@M!^O^%:/_"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^_"?X4 9W M_"P?#O\ T%H/U_PH_P"%@^'?^@M!^O\ A6C_ ,(_I?\ T#;/_OPG^%'_ C^ ME_\ 0-L_^_"?X4 9W_"P?#O_ $%H/U_PH_X6#X=_Z"T'Z_X5H_\ "/Z7_P! MVS_[\)_A1_PC^E_] VS_ ._"?X4 9W_"P?#O_06@_7_"C_A8/AW_ *"T'Z_X M5H_\(_I?_0-L_P#OPG^%'_"/Z7_T#;/_ +\)_A0!G?\ "P?#O_06@_7_ H_ MX6#X=_Z"T'Z_X5H_\(_I?_0-L_\ OPG^%'_"/Z7_ - VS_[\)_A0!G?\+!\. M_P#06@_7_"C_ (6#X=_Z"T'Z_P"%:/\ PC^E_P#0-L_^_"?X4?\ "/Z7_P! MVS_[\)_A0!G?\+!\._\ 06@_7_"C_A8/AW_H+0?K_A6C_P (_I?_ $#;/_OP MG^%'_"/Z7_T#;/\ [\)_A0!G?\+!\._]!:#]?\*/^%@^'?\ H+0?K_A6C_PC M^E_] VS_ ._"?X4?\(_I?_0-L_\ OPG^% &=_P +!\._]!:#]?\ "C_A8/AW M_H+0?K_A6C_PC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG^% &=_PL'P[_ -!: M#]?\*/\ A8/AW_H+0?K_ (5H_P#"/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OP MG^% &=_PL'P[_P!!:#]?\*/^%@^'?^@M!^O^%:/_ C^E_\ 0-L_^_"?X4?\ M(_I?_0-L_P#OPG^% &=_PL'P[_T%H/U_PH_X6#X=_P"@M!^O^%:/_"/Z7_T# M;/\ [\)_A1_PC^E_] VS_P"_"?X4 9W_ L'P[_T%H/U_P */^%@^'?^@M!^ MO^%:/_"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^_"?X4 9W_"P?#O\ T%H/U_PH M_P"%@^'?^@M!^O\ A6C_ ,(_I?\ T#;/_OPG^%'_ C^E_\ 0-L_^_"?X4 9 MW_"P?#O_ $%H/U_PH_X6#X=_Z"T'Z_X5H_\ "/Z7_P! VS_[\)_A1_PC^E_] M VS_ ._"?X4 9W_"P?#O_06@_7_"C_A8/AW_ *"T'Z_X5H_\(_I?_0-L_P#O MPG^%'_"/Z7_T#;/_ +\)_A0!G?\ "P?#O_06@_7_ H_X6#X=_Z"T'Z_X5H_ M\(_I?_0-L_\ OPG^%'_"/Z7_ - VS_[\)_A0!G?\+!\._P#06@_7_"C_ (6# MX=_Z"T'Z_P"%:/\ PC^E_P#0-L_^_"?X4?\ "/Z7_P! VS_[\)_A0!G?\+!\ M._\ 06@_7_"C_A8/AW_H+0?K_A6C_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\ M[\)_A0!G?\+!\._]!:#]?\*YKQOXJTG6DT2&ROHKB1-3AD95SPHW#/ZBNV_X M1_2_^@;9_P#?A/\ "N4^(.EV5C#H;VUI!;N=5@4M%$JDC#<9 H [NBBB@#C? MAI_Q[:]_V%I_Y+795QOPT_X]M>_["T_\EKLJ "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** ,'QW_R)^K_]>[5:\+_\BSI'_7G# M_P"@"JOCO_D3]7_Z]VJUX7_Y%G2/^O.'_P! % &I1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=H'_ "4CQ3_USMO_ M $6*[&N.T#_DI'BG_KG;?^BQ0!V-%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %<'XB_P"2D:;_ ->#_P#H35WE<'XB_P"2D:;_ M ->#_P#H34 ;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110!HZ9_J9_\ /:DI=,_U,_\ GM24 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 2_\N,U95:O_ "XS5E4 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5 MIVO_ "#OQ_K696G:_P#(._'^M #**** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH OV_\ J5J2 MH[?_ %*U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5 MQWQ+_P"/70O^PM!_)J[&N.^)?_'KH7_86@_DU '8T444 <;\-/\ CVU[_L+3 M_P EKLJXWX:?\>VO?]A:?^2UV5 !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% &#X[_ .1/U?\ Z]VJUX7_ .19TC_KSA_] %5? M'?\ R)^K_P#7NU6O"_\ R+.D?]>*?\ KG;? M^BQ0!V-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %<'XB_Y*1IO_7@_P#Z$U=Y7!^(O^2D:;_UX/\ ^A-0!LT444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% &CIG^IG_ ,]J2ETS_4S_ .>U)0 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!+_P N M,U95:O\ RXS5E4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 5IVO\ R#OQ_K696G:_\@[\?ZT M,HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@"_;_ .I6I*CM_P#4K4E !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !7'?$O\ X]="_P"PM!_)J[&N.^)? M_'KH7_86@_DU '8T444 <;\-/^/;7O\ L+3_ ,EKLJXWX:?\>VO?]A:?^2UV M5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &# MX[_Y$_5_^O=JM>%_^19TC_KSA_\ 0!57QW_R)^K_ /7NU6O"_P#R+.D?]>U)2Z9_J9_\ /:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH E_Y<9JRJU?^7&:L MJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "M.U_Y!WX_UK,K3M?\ D'?C_6@!E%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 7[?_ %*U)4=O_J5J2@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ KCOB7_P >NA?]A:#^35V-<=\2_P#CUT+_ +"T'\FH M [&BBB@#C?AI_P >VO?]A:?^2UV5<;\-/^/;7O\ L+3_ ,EKLJ "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,'QW_ ,B?J_\ MU[M5KPO_ ,BSI'_7G#_Z *J^._\ D3]7_P"O=JM>%_\ D6=(_P"O.'_T 4 : ME%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 5QV@?\E(\4_\ 7.V_]%BNQKCM _Y*1XI_ZYVW_HL4 =C1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!^(O^2D:;_UX/_Z$ MU=Y7!^(O^2D:;_UX/_Z$U &S1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 :.F?ZF?_/:DI=,_P!3 M/_GM24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 2_P#+C-656K_RXS5E4 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 5IVO_(._'^M9E:=K_R#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +] MO_J5J2H[?_4K4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !7'?$O_CUT+_L+0?R:NQKCOB7_P >NA?]A:#^34 =C1110!QOPT_X]M>_ M["T_\EKLJXWX:?\ 'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?\ T 55 M\=_\B?J__7NU6O"__(LZ1_UYP_\ H H U**** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCM _P"2D>*?^N=M_P"BQ78U MQV@?\E(\4_\ 7.V_]%B@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH *\7^/VN7WA>Q\1:SID_P!FU+3O"VH7=K-L5_+ECBE= M&VL"#A@#@@CUKVBO"/VG?^13\9_]B;JG_I/-6E/6:3[G1ATI5H)[77YGYX_\ M-Q_&W_H=?_*58_\ QFC_ (;C^-O_ $.O_E*L?_C->$T5]I]7H_R+[D?NG]FX M'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[?\-Q_&W_H=?\ RE6/_P 9H_X;C^-O_0Z_^4JQ M_P#C->$T4?5Z/\B^Y!_9N!_Y\0_\!7^1[M_PW'\;?^AU_P#*58__ !FC_AN/ MXV_]#K_Y2K'_ .,UX311]7H_R+[D']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[?\-Q_ M&W_H=?\ RE6/_P 9H_X;C^-O_0Z_^4JQ_P#C->$T4?5Z/\B^Y!_9N!_Y\0_\ M!7^1[M_PW'\;?^AU_P#*58__ !FC_AN/XV_]#K_Y2K'_ .,UX311]7H_R+[D M']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[?\-Q_&W_H=?\ RE6/_P 9H_X;C^-O_0Z_ M^4JQ_P#C->$T4?5Z/\B^Y!_9N!_Y\0_\!7^1[M_PW'\;?^AU_P#*58__ !FC M_AN/XV_]#K_Y2K'_ .,UX311]7H_R+[D']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[? M\-Q_&W_H=?\ RE6/_P 9H_X;C^-O_0Z_^4JQ_P#C->$T4?5Z/\B^Y!_9N!_Y M\0_\!7^1[M_PW'\;?^AU_P#*58__ !FC_AN/XV_]#K_Y2K'_ .,UX311]7H_ MR+[D']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[?\-Q_&W_H=?\ RE6/_P 9H_X;C^-O M_0Z_^4JQ_P#C->$T4?5Z/\B^Y!_9N!_Y\0_\!7^1[M_PW'\;?^AU_P#*58__ M !FC_AN/XV_]#K_Y2K'_ .,UX311]7H_R+[D']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_ MD>[?\-Q_&W_H=?\ RE6/_P 9H_X;C^-O_0Z_^4JQ_P#C->$T4?5Z/\B^Y!_9 MN!_Y\0_\!7^1[M_PW'\;?^AU_P#*58__ !FC_AN/XV_]#K_Y2K'_ .,UX311 M]7H_R+[D']FX'_GQ#_P%?Y'NW_#C_(ON0?V;@?^?$/_ 5_D>[?\-Q_&W_H=?\ RE6/_P 9H_X; MC^-O_0Z_^4JQ_P#C->$T4?5Z/\B^Y!_9N!_Y\0_\!7^1[M_PW'\;?^AU_P#* M58__ !FC_AN/XV_]#K_Y2K'_ .,UX311]7H_R+[D']FX'_GQ#_P%?Y'NW_#< M?QM_Z'7_ ,I5C_\ &:/^&X_C;_T.O_E*L?\ XS7A-%'U>C_(ON0?V;@?^?$/ M_ 5_D>[?\-Q_&W_H=?\ RE6/_P 9H_X;C^-O_0Z_^4JQ_P#C->$T4?5Z/\B^ MY!_9N!_Y\0_\!7^1[M_PW'\;?^AU_P#*58__ !FC_AN/XV_]#K_Y2K'_ .,U MX311]7H_R+[D']FX'_GQ#_P%?Y'NW_#C:GXN^TZ;J.MV5I=0_P!F6:>9%).B.NY801E21D$'TKY=KN_@)_R7 M3X=?]C'IW_I5'45,/14&U!?A^UVF?ZF?_/:DI=,_ MU,_^>U)7Q1^%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% $O\ RXS5E5J_\N,U95 !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %:=K_R#OQ_K696G:_\@[\?ZT ,HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@"_;_ZE:DJ.W_U*U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 5QWQ+_X]="_["T'\FKL:X[XE_\ 'KH7_86@_DU '8T444 <;\-/ M^/;7O^PM/_):[*N-^&G_ ![:]_V%I_Y+794 %%%% !169XE\2:9X/\/ZAK>L MWD=AI6GP-<7-S)G;'&HR3@-A/?7TZ6UO$= M*O4#R.P51N:$ 9)')(%:0ISJZ0BWZ*YE4JTZ5O:22OW=CW>BBBLS4**** "B MBB@ HJ"UOK:^\X6]Q%<&&0Q2^4X;8X )5L=" 1P?45/0 4444 %%97BKQ3I? M@GPWJ6OZW=BQTG3H&N;JX9&?RXU&2=J@L?H 2:\_^&'[47PQ^,WB*30O!WB4 MZSJD=NUT\ T^ZAVQ*54L6DB5>K*.N>:N-.JT445! MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17EGQ M0_:?^&7P8UZ'1?&/B==(U2:W6Z2W%C->#OVQ/@WX\U2+3M(\ M>6#7LK!(X[Z*:R\QB I<*D*FL))^@4445F:! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8/ MCO\ Y$_5_P#KW:K7A?\ Y%G2/^O.'_T 55\=_P#(GZO_ ->[5:\+_P#(LZ1_ MUYP_^@"@#4HHHH **** "BBB@ HHHH ***QO&7B>+P7X4U;7[BTN[^WTVVDN MY;>Q17G=$4LP0,R@G /!(H#NBMAZN':56-KF%*M3K7]G*]@HKG/B)X\TS MX8^"=8\4ZR9?[-TN SS+ 9&Y "H"0"Q) )')ZUXS\(?VXO!/QL\=V7A3P_ MH/B:/4+I9)/.O+6W2&)$4LS.5G8@<8X!Y(HIX>K6C*<(W2W\AU*U.DTINU]C MZ)HKY-U;_@I3\,M&U6]T^;0O%C36LSP.T=G:E2RL5)&;@<9%5?\ AYW\+?\ MH >+_P#P#M?_ ))KHCE^*DE)4W9F,L9AXMQK_";]JGPG\9/!?BGQ-HNGZS:V'AV,R7<=_!"DK@1M)^["RL#PIZD MZA-J:Z5'?0V\!LWE,GE[@ MQF#%-W?;TZ UM2HU*[<:<;M&52K"C'FJ.R/HZBBN9^(7Q(\-?"OPY-KOBK5H M-(TR,[?,FR6=CT1$ +.Q]%!/!]*R2;=D:G345\G_ /#RSX3?VE]E^Q>)A!OV M_;?L,7E8_O8\[?C_ (#GVKZ-\ _$3PY\4?#D.N^%M6@UC2Y25$T.048=5=2 MR,,CY6 /(KIJX6O1CS5(-(YZ>(HU)%RDLFAVR2Q*PZ@22.BM]4)'O6=*C4K2Y:<;OR-*E2% M*/--V1]*45XW\&?VM/AS\<[S^SM U.:SUK:7&E:I%Y%PRCJ5P2C\9.%8D 9( MKV2E4I5*,N6I&S%3JPJKFINZ"BO,/C)^TAX#^!,,(\4ZL4OYUWP:99QF:YD7 M^]M'"CK\S%0<'!KROPK_ ,%&OA'XDU:.RNCKGAY)#M%WJMDGDY[9,4DA'U(P M.Y%:T\+7K1YZ<&UZ$5,12I/EG))GU'14%C?6VJ64%Y9W$5W:7"++#/"X=)$( MR&5AP01SD5/7-MHS=--704444AA1110 4444 %%%% !7':!_R4CQ3_USMO\ MT6*[&N.T#_DI'BG_ *YVW_HL4 =C1110 45YI\;OVBO O[/>AQZCXQU<6LDX M/V73[=?-N[HCJ(XQV_VF(49&2,BOCW7/^"ONDV]^Z:-\,KV_LL_+-?:PEM(1 M[HL,@'_?1IQ3D[1"7NJ[/T-HKY'^"/\ P4J^&GQ7U>TT768+OP/K%TP2+^TG M22S=ST03C&"?]M5'09R<5];U4H2ANB(SC+1,6BBBH+"BBO,?V@_V@O#O[-O@ MJV\4>)K+5+ZPN+Y+!8])BCDE$C([@D22(-N(SWSR.*3:6XTF]CTZBO'/V>%M/UFPBTB6**<:Q#%&S&0,5V>7*^1\ISG':N(^-__!0#X>? M/XB7O@WQ!HWB:\U2TCBEDFTVUMWA(D0.N"\Z-G!Y^6KE%QDH/=_\.1&2E%RC MLO\ .WYGTU16/X/\46OC;PGHOB&QCFBLM6LX;Z".X4+(J2('4, 2 V&&<$CW MK8HE%Q;B]T$9*24ELPHHHJ2@HHHH **** "BBB@ HHKYN^/7[>7@#]G?QZWA M+Q'I'B2]U);6.[\W2[:WDAV/G R\Z'/RG/%'5+N'1L^D:*Y?P7\0M.\=?#G2 MO&EA#=0Z7J6GKJ4,-RBK.L;)O 8!BH;'8,1[U\^?"G_@H]\-?C!\0M$\':-H M?BJVU/5IC!!+?6ELD*L%9LL5N&8#"GHIJU"3FZ:6JZ$N24%-O1GU71114%!1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 5X1^T[_R*?C/_L3=4_\ M2>:O=Z\(_:=_Y%/QG_V)NJ?^D\U:4_CCZG3AOX]/U7YGX]T445]X?T(%%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %=W\!/^2Z?#K_ +&/3O\ TJCKA*[OX"?\ET^'7_8QZ=_Z51UG4^"7H<^) M_@3]'^1^UVF?ZF?_ #VI*73/]3/_ )[4E?!G\]!1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% $O_+C-656K_P N,U95 !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %:=K_P @[\?ZUF5IVO\ MR#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** +]O_ *E:DJ.W_P!2M24 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<=\2_\ CUT+_L+0?R:N MQKCOB7_QZZ%_V%H/Y-0!V-%%% '&_#3_ (]M>_["T_\ ):[*N-^&G_'MKW_8 M6G_DM=E0 445P_QJ^*FF_!?X9ZWXMU,J4L83Y$!.#/.W$<8]V;'T&3VH ^,O M^"F7Q_"K9_"O1[GYCLO=::-NW6& _I(1_N5\.:MX=UOX9Z[HDVHV[6-])!;: MO;(W#"-\/$Q]"0 :]D_9I^&>J_M8_M&2:CXB9[VP6Y;6-=N&'RNN_*P^V]L( M!V4-C[M>C?\ !4;PPFE_%[POJT2".*_T80;5&!NAE8.X0CN MKJ&'Z&H?$7B;1_"&E2:GKVK6.B:;&55[S4;E+>%"QPH+N0!DD <]Z\Z_91\2 M?\)9^SC\/=0W[W&DPVKM_M0@PM^L9KY\_P""I7C;^R_ACX7\,12!9=6U%KJ5 M,\F*!/Y;I%_[YKYZ='_:?8+^:WX_Y'T=.O\ [(J[_EO\[?YGUQX3^)/A'QY) M+/B)X4\!?9O\ A)O$^C>' M?M.[R/[6OXK7S=N-VWS&&[&1G'3(KY0_X)=^"/[&^$/B#Q++'MFUO4_*C;'W MH8%P#_WV\H_"O!O^"GOC+^VOC?I.@H^8=$TM-RYZ2S,7;_QT1UT2PD?KBPT7 MIW^5_P ]#GCC)?4WBI+7M\[?\$_2_1_&WAWQ%H$FN:5K^EZGHD0\U+0+E)'GEE?2_P>^"MQ>?L5:-X#M]1_L&\UO0R9K[R/.:$W699,IN M7)VR%?O"ORK\1?#\:;\6+[P3I>H?VNT.KMI$%[Y/E>>PE\H/LW-@$]MQKIPF M%I2QT^ OA3P[I MGB32-4\0)9OJ.H6-I?Q37,+32EV,L:L64C>JG<.#Q7KWC_XJ^$/A7IZ7OBWQ M%I^@P29\L7DP5Y<==B?>B''$3P6'ITZD/?>B5_E=^K/TA MTG]N3X&ZUJ"65OX_M8YG.T-=V=U;1?C))$J >Y->W:?J-IJUC!>V-U#>V&Y5%+,J;$0H2 <9+>GO7+_\$R?C/JFG^/KWX<7EU)<:)J-M)>6,,C$BWN(_ MF<)Z*Z;B1ZJ#W.8^JT*U.<\/)MQU:?;^K_<:?6\10J0ABHI*;LFN^G^:^\^U M?VG]%T;Q;\']7\-:WXXTSX?VFL-';?VMJC1B/APYC >6,$L$(^]TR>:\F_8I M_9I\)_"'6/$7B+PY\2M*^)!NH$L&FTJ*():?-O96:.>4$MA.#CIWS7E'_!5C MQ=\W@/PNC MG:C@%K.*.6YFCR,C>D*.R9'3 !Z5]0_'O]@G1OA9\!];\;M_F0L;6JU*M.A!/EV?3KOZGW[X M!^)WA7XH^'_[;\*Z[9ZUI@.UYK=\&)@,[74X9#CG# '!KSS7?VT?@IXYB#9Q@RQ1M&/\ OKBOS)_9;\%^./BYXGU/X=^%M=GT+1=< MA677IX\E!:Q-U8 @MR^T*"-V[!.,UZ%^VE^R+X7_ &;?#_A;4/#^N:IJ$^I3 MR6]Q!J;1-DJ@;>FQ%VC)P0<]1S6D\#0I5E3G-VELNOS^9C3S"O6H.I3@KQW? M3Y?+S/U2T76M/\1:5:ZGI5[;ZCIUU&)8+JUD$D4JGHRL."*YWQ%\8O 7@_5) M-,U[QOXRM]< MGCL@Q/RH8HF<#VWLQ^I-?!O[3'B&X^)O[2_C*YT]'O9KK6&L;..,;C)Y9$$: MJ.^=@Q]:QA@5+&/#7T2O?[O\S>>8..#CBK:MVM]_^1^L_P 2/VCOAK\(_LP\ M5>+[#39;A%EBMX]]S,R-RK^7$K-M/9L8/K6Q\-/C!X,^,6E2ZCX.\06NN6T+ M!9A#N22(G.-\;@.F<'&X#.#BOAWXB?L 6VA_!/Q/X]\:>,M4O_']O82:IMR:1K'CNQCU"-MDD5I#-=B-@<%6:%'52#U!(([UZ=X7 M\5Z/XVT*UUK0-3MM7TJZ7=#=VD@DC?G!&1W!!!'4$$&OS-_:Z_8I\*_L[?"G M2?$6D^(]4U'59;^.RN(K_P KRIMT;L6C55!3!3H6;@]?7U[_ ()47FI2^!_' M=M*[-I,.H6[VZL>%E:-O-Q^"Q9_"LWA:,L-.M2FVX[_A_F:K&5XXJ%"K!)3V MZM;[_#? MW#:^)?%NA>'KJ9/-BAU74H;9W3.-RK(P)&01D>E;&A MZ]IGB?2K?5-&U&TU;3;@%H;RQG6:&4 D$JZD@\@C@]0:_)']O[Q@WC;]I[7+ M6 F6+28X-*A53G+*NYP/??(P_"OU+^%GA6'X8_";PSH+[8DT?2H89F[;DC'F M-^+;C^-LVT4T;?W61G!!]B*ZV]U"UTVQGO;NYAM;."-II;B M9PD<:*,LS,> 22>,5^,GP]MI/CW^UQICS SQ:[XF-[,KZUU^Y7/2/#?Q<\"^,M0-AX?\:>'MN?MA?L4^ M&/V=_AOI'B30O$6I7US+>I8W%OJ9C(E+([;XMB+MQL.0=W!Z\<]M3!8>C5C" MI-Z_?J<-/'XBO1E4ITU[M[M[:*_S9^G7A_Q#IGBK1[75M&U"WU33+I/,@N[2 M4212+ZAAP>>/PIOB#Q)I/A/29]4UO4K32--@&9;N^F6&)/JS$ 5\7?\ !*_6 M]0F^&_C:QNIF.D6.HQ26V\_+&SQDR@>@^5#CW)[U\P_M%_&3Q+^UI\;[Q8_=7CM7.\!)XIX>#T5G?R?ZZ_F;K,(K!K M%36KNK>:;7W:7/T)D_;H^!D>H_8CX^MC-NV;EL;LQ9S_ ,]!%LQ[YQ7M&@^( M-,\4Z3;:KHVH6NJZ;B_%#4/ ,\\DFC:O;2 MW4-NQXANH@"64=MR!@?7:OI5_5;;AJ[]OZ3(^N8BC."Q$$HS=E;H] M/\T?IQ115;4KZ+2]/NKV=MD%O$TTC>BJ"2?R%>,VHJ[/<2;=D?CU^W5XN/C3 M]J#Q9Y1\R+3WBTN(+S_JD 8?]_"]?7'AW_@EW\.+CP_IDNJZ]XL35)+6)KM; M>[M5C$Q0%PH-N2%W9QDDX[U^?=KXRL-3^,47BKQ#'<7&F3ZX-3OXK=5>5XC/ MYCJH8@$D9 R0*_0S4/\ @J=\-8[=FL?#'BJXGQ\J7$-M$I/NPG8C\J^IJ0Q% M'"TJ=%.Z6MO1?F[GR5.>&K8NM4KM6OI][_))'R+^V5^S%8?LT^+=$M='U>YU M72=7MY)H1?!?/A:-@&5BH 8'TC@H4Z^M1O3[W;\&D;87VK&TS6^G:M!<2"-?O.51R=HR,GH*Y/1_P!J[X3>(/'4'@_2 M_&EGJ/B"XE\B&"UAFDCD?^ZLP3RC^#5^3W[/?@OQS\2_%&I>$/ FV&[UJR-M MJ-X[&-(;+S$:3>XR50LJ @ EN% .2#]J>!_V5-(_8AL->^+NO^)(_%=YH^ER M+962V'V98[J3"##F1BV=VP' XM@Z&&;]I-[:+JW_ ,'8Z,/CL1BDO906 M^KZ)?Y]3Z_\ 'OQ0\)?"_35O_%GB'3]!MGSY9O)@K2D=0B?><^R@FO,-+_;F M^!NKZ@EG!X_M8YG;:&NK*ZMXOQDDB5 /$O''[;_QUF34=59KRY#7 M5]J$REXK"U4@;8TST!8*J C)/)ZFOIKXL?\ !,;P]X?^'.IZIX2\2ZQ<>(-/ MM7NC#J7DO!=;%+,BA$4H3@X)9OZU,L)0PT5]:FTWVZ%QQF(Q4G]4@G%::]3[ MUTS5+/6M/M[_ $Z[@O[&X020W-K(LD@9 ^1W*J M:Z'_ (*5_M"ZBVO0_"S1;M[;3X84N=9:%L&=W^:.%B/X0N&([EE]*QK8&=/$ M1H1=^;5/R_X%OZN;4WAGG@S_P!=DC,>/?=BO2M1^)?A#1_#EGX@O_%.BV&@WI46VJ76H0Q6TY8$ MJ$D9@K$@$\'L:^!OV=_^";^F_$#X9V/B;QQKFJ:9>:M MS8V.E^6GD1,,HTI M=&W%@0VT;< CG/3YU_:"\-^+/@9J%_\ !W4]6.I>';&_76+%MI ;?&5#J,G; MD$AE_O*2.Y/0\'AY5/84YOG6_;SMYHYUCL1&G[>I37(]N_E?R9^QOA7QMX=\ M=6,M[X;U[3/$-G%)Y,EQI5Y'16/)\:/A]#KIT23QWX93 M61)?L$Z+#\/_V3=/UBZ'DK>O>:Q.S< M80,4!_[XA4_C7YD:#XD\1Z]\8X-=\/0/=>*M0U=KJQC5=[?:I)"R$ \9#,", M\9 SQ44\#&IB:E%/2/Y_TF74S"5/"TZ[2O/\N_Y?>?L!\0/VJ/A3\+O$']B> M)?&=G8:L" ]K%%+'5U[6M:L=(T9D5UO M;Z=88R&&5 +$9)'0=37P_P#"G_@F=J,'B#0O%'C[Q=!>W<=XM]J.BPVC3B?9CX]A\S=MW#3KPIG_?\G;CWSBO9?"OB_1/'.BPZOX>U:SUK3)L MA+NQF66,D=1E3P1W!Y%?GG\;?V$_A?\ "7X1ZMJ[?$6Z7Q9869FCAO;FV2&\ MF49\N. *) 6/ =B,]ZQO^"7/B75[?XP>(-!AFD;1+K2'N[BWW?(LLK2G.A)WCWV9A]-6^,7A_P /QONCTC2A(XSTDF(_B'XDU>PTZ2V9=#TK3BBM!;L[.)&+JP =F9 MMH4$@ABW.!C3PD'AEB*DK:_J]O-V_JQM4QDUBGAJ4;V7Z)Z^2O\ U<^TOAG^ MTU\,/C%JCZ9X2\76NIZDJEQ9R12VTS@K'Q,_:+^&_P=N$M MO%_BVRTF\JWGCV#3Y]6NI%=& MM/."%S&^Y2\A)&W?N7DYQ6];!X>BHU7-\C^]_P!?UN84,;B:TI45!.:?R7K\ M_O\ D?;OPS^,7@OXQ:7-J'@WQ#:ZY;PL%F6'H"<-& I4D>TFS\S79_\%0/B1KMQ\1M&\$B>6W\/6NGQZ@;=3A+B9W<; MV]=H0 9Z$MZUG7P/)B84(/26NO3?_(TP^8.IA9XBI'X7;3KM_G_6Q]<:K^W- M\#='OGM+CQ_:R2H=I:ULKJXC_!XXF4_4&O2/AW\7?!GQ8L9+OPAXDL->CC , MJ6LO[V+/3?&<.F<'[P'2O@/X&_L=? SXR>!=+DM/BE?3^,KFU5[BPAN+:)K> M8J-R?97C\QE5LC<&PV,@\U9^"_[$/QL^#_QNM-=T6ZTJWTS2[[;]NN+[RTU* MS+#>IC0.PW)_"PX;![ UI+"X5-TW-J2[[?U_6IE#&8N48U534HOMO_7]:'Z1 M4445XA[Q@^._^1/U?_KW:K7A?_D6=(_Z\X?_ $ 55\=_\B?J_P#U[M5KPO\ M\BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ J.XMX[NWE@F020RJ4=&&0RD M8(/X5)12WT8]M4?BA\3O#5]\!_CIJ^G6C-!1C.=H= VT^XS@^XKX$_X*=?#?^S?%WAKQO;Q8 MBU* Z==,.GFQ?-&3[E&(_P"V=>S_ /!.'XC?\)9\$KCP[/+OO/#=XT*J3S]G MES)&?^^O-7Z**^KQ3^N9;3Q'VH:/\G][L_F?.TE]5S"=)?#/5?FONU1@?\%- M/B1_8OPYT+P=;RXN-:N_M-PHZ^1#@@'ZNR_]\&N<_P""8/PQ\FQ\4>/KJ'YI MF72;%V'.T8DF(]B?*&?]EJ^?OVX?B$_Q*_:,UJ"U=KBTT4_P#?;-^ %0W]3RI1^U5U M^3_X%D_4J7^U9E;I37XK_P"V;^X\-U;_ ()K?#+6=5O=0FUWQ8LUU,\[K'>6 MH4,S%B!FW/&37Q#^UE\&=$^ _P 6G\+Z!=7]YIZV,-SYFI2(\NY]V1E$08X' M:OV0K\K/^"CO_)R$O_8)M?\ V>IRK%UZF)C3E-N-GI\B\PPU&-"=11][O\SU M_P""/_!/SX>?$KX2^%?%&IZSXG@U#5;%+F>.TNK=8E8YR%#0,0/J37N>@?LY M>&OV=?@M\2;'PW?:K>PZGIES/,VJ2Q2,K+;R* NR-,#![YKJ/V3O^3;_ (>_ M]@F+^M=9\7/^24^,_P#L#7G_ *(>N#,L77E4K47-\MVK>C.S+L-14:-51]ZR M=_5'X]?L]_#O3?BQ\9/#/A/5Y[JVT[4YGCFELG59E B=QM+*P'*CJ#7WA=_\ M$POAJ]NXM?$?BN&"ZN=.T MR9Y)HK)%:9@8G0;0S*#RPZD5]WWO_!3[X;1V[M:>&_%4]QCY8YH+:-2?=A.Q M'Y&OI\T^N<\?JM[6UL?/9?\ 5>67UBU^ESX0^,GPOUC]GOXK7OAV74/-O=-D MCN;34;7,9=2 \<@&$/$MYC[;J&G127!48!E M VR$#L"RD_C7Y%_%SXDZW^T9\7+K76T[;J&JRQVMGIMKF0HHPD<0.,LWJ<#) M)X'2OUW^"/@6;X9_"/PGX8N65KO3=/CAN"IROFXW28/IN+8KAS7F^I4O;_Q+ M_IK^E[:'7@.3Z[4]A\%OU5OUM?4[BH[BXCM+>6>5ML42EW;!. !DFI*KZC:? MVAI]U:[_ "_.B:/=C.,@C./QKX^5[.VY]1&W,N;8_._]I3_@H%<^.K*Y\)?# M*WNK*QN_]'FUJ12MS<*W!2",'X_\ P_CD1DD7Q!9J MRL,$$3KD$>M?IG\"_P!C#P#\#9HM4AAD\0^)8U^75M2 )A;')AC'RQ_7EADC M=@U^;OP=_P"3H/"?_8U0?^E(K[K+JN&O.AA8Z)7;>[_K^D?'9C3Q#I*MB'UL MDME_7],_9^ORB_;X^*%]\0OCU?:#%-(^E>'2-/MK=3\IF(!E?']XL=OT05^K MM?B[XG8ZM^U%J?VK][Y_C"19,]P;P@_I7CY'3C4Q?-+HG]^B_*YZ^;5)4\(^ M7=M+Y:O\TCZJF_X)EV$7PI:[7Q'J+^/%L_M'DXC^PF;;N\D+MW]?EW[_ 'V] MJ\@_X)^_%*^\!_'6T\.23.ND>) UE/;L?E6=5+1/C^]D%/HYK]5NO%?B]X!N MO['_ &H-!FBS&L'BZ'&SJ%^V $#\*[LNQ-7'NM1KNZ:T\OZTMZ'#CL/3P=.G M5I*THO[_ .K?B??_ /P4+^*EW\/O@JFD:;.]M?\ B2Y^PM)&<,MNJEI<'W^5 M?HYKY6_8[_8XT_\ :$T75_$7B35+_3=#M;C[%;Q:;L6::8*&9B[JP"J&48VG M))Y&.?1O^"IUU)_:WP[M]W[KR+V3;_M;H1G\J]J_X)UP)#^S58NBX:74KMW/ MJ=X7/Y**PPTI87*Y5Z>DI/?T=OT_$WQ457S"%&?PQ6WJK_JON/@OX^?"C4_V M5_C5%8Z5JL[FV$6IZ3J6-DNW<=I..-RLC XX..G.*_5;X?\ Q/M?%GP9TCQY M< 0V]QI(U&Y5>D96/=*H^C*P_"OAK_@J-&J_$?P9(%^=M*D!/J!,I?! M_6)F_P"";>KR(["6WT;5H0Q]/-FX'MAL48MRQ>64Z\_BO:_WK]$5AXQP^9RH MQ7NM+3Y)_JSXST'3=>_:V_:(CM[J]:&_\17SR27$B[Q:VZJ6( XR$C7 &1G M&>*Y+_@G1 DW[2EH[KEHM,NW0^AVJN?R8U]Z_MA1K+^S/X_#KN T_C1H.T4EIY7M;[D%/ M$'@?4)VG&BLEY8;SDI#(2'C'^RK@$?\ 70U]MU^8'_!,Z^:W^/>J6^YMEQH, MX*CH2LT+#/Y'\Z_3^O)SJFJ>+;7VDG^GZ'=E,W+#V?1V_7]0HHHKPCV0HHHH M **** "BBB@ KCM _P"2D>*?^N=M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:P M_''B^Q^'_@W7/$NIMLT_2;.6]G/YQ@>YK?QK^VE^T1#'+/Y MVN^(KO9'YA)AL+9'= AL]:TB^\5:EM' MFZC>:C/ Q;')5(7157/0$,1W)KX^_P""5%C#=?M)ZC-*NZ2U\/7,L1_NL9H$ M)_[Y9A^-?KC7HU4J,(0AHFK_ (M?H<%-NK.4Y]_TO^I^/W[<'[$\?[/>IZ1K M7@Z2]U/PMK,[6J6LP\V>TN,%A'N ^=64-M.,C:0<\$_37TW17/&HXTW3EK?\ MK_/Y&TH*4U-:6_K_ "^XX_XH?%SPC\&/#3Z]XRURWT33@VQ&ERTDK_W(XU!9 MV]E!XYZ5\S1?\%5O@U)JGV1M/\5Q0;]OVYM/A\G'][ G+X_X#GVKXA_:O^(F MM?M,?M676AV]TS64.K+XO^#M"W%QI^FV[O"B")1&0192C)7!/SGKVZ57_P""0G_(J_$K_K]LO_10>" Q(/!Q79?#W0]4\3_LI^%M(T75 M_P"P-5OO"5I;6^J>3YIM7:U1?,"[ER1GCD,KO5/BC MXCT_Q!X2MX2T=O:336C32$]9VX*(!D_*^22.0!S-6/\ M$XR>B;U[ZO^OF51 ME_L\)16K2T[;?U\CU+PS_P %2O@OKVHQVMY'XD\/1LSU;2+ZWU+3+R)9K>[M9!)'*A&0RL."*_)/]NKX8_ #P%I^B M/\)-9L&UW[4T-_I>FZK)J,?D[2?,9V>38RL -N\9W=.*^I/^"47B2ZU;X!Z[ MI=Q,TL6EZY(ENK$GRXY(HW*CVWES]6-.,(5*M_^#_D M?6?Q ^(WAGX5^&;CQ!XLUFUT/2(.&N+IL;FP2$11EG8X.%4$G' KY:U+_@JM M\&['4GMH-/\ %FHPJV!>6VGPB)O<"2=7Q]5!KXV_X*$_&+5OBU^T3J?AJ&XD MDT3PW)=.O=6\3RVP M^U:PFH31-%,R_-Y4:L(]JGIO5NG.:QIQO2]M+9[+O_7X7-:DN6I[%;K?R/=? M@M^TC\/OV@+&>;P9KT=]7VHA!J-D'*L&2(.P$D?\+ $$CH17Z@U$?@OX9DU_P 8ZU!HNFJVQ&DRTDSXR$C106=O M90> 2>!FNPK\7O\ @H!\5-2^*W[2VN:4LKS:9X>G_L;3[53D!U($I _O-+N& M?15':L8ISJ1IQW?]?JC;2,'.6R_K_,^X-)_X*F_!?4M;2QGA\3:9;,^W^TKO M3HS;@?WB(Y7DQ_P#/M7Q=_P4D\1:9XL_:(@UC1K^WU32[S0;*6WO+6021RH? M,P58=:^R?A?_ ,$R/A5I?PZLK3QCIUWKGBJXMU>[U%+^:#[/*R\K"B,$VJ> M75LXR>N*_-S]I/X,S_ +XQ:[X+>Z>^M;)EDL[J0 -+;R*'C) XSAL''&0:V< M::JQ@GJON>C7ZW,8RG*FY]']ZU1^Q/[,ZP2?LI?#];IVCMF\,6XE=>JIY W$ M<'G&>U?(W[./P\_9,TGXW>$KSP'\3_%6M>+HKIFTZPOK:189I/+8$,38Q@#; MN/WUZ=:^L_V=?^31? __ &*D/_I/7Y0_L-_\G8?#C_L(-_Z)DKJ2YL?4C>VJ M_P#2I&,GRX.#WT?Y(_:OQIXXT'X<^&[SQ!XEU6VT;1K-=TUW=/M5>P [LQ/ M4 DG@ U\J:W_ ,%5/@SI5_);VMEXJUF)3@75CI\*QM[@2S(WYJ*\>_X*[>(M M775?A]H0DECT)X+F\,:DA);@,J9([E5/'IYA]:Y;]E'P=^R)XN^'NFVGCV\2 M+QRRL;[^W]3N=/B5MQ \J1'2$KC&,L6]:XZ,?:0=1[7M;TT_0Z:LO9R4%N^O M0^U_@K^V[\*/CMJT.C:'K4VG:]-GR=*UB#[/-+CLC M&Y[[5]5^;= M]_P2_EUCXA_\)%\-OB)IVF>"S)'=Z9=I(]Y=V\@(;",FU6"L,JV_.,9Y&3]K M_&_XC7?P2^ ?B+Q7=3QW^K:1I?RS>5Y:3W9"QHVS)VJ9&4[A8 M9")D<@.RDCIFO._ O_!3;X+>,]6CL+JYUKPJTC!$N-=LD6$DG R\,D@4>[8 M[FO@O]COX%_\-;?'34G\8ZA>76G6T3ZMJ\ZR8GNW:0 1[_X=S,22.<*0,'!' MT/\ MR?L'^ ?AS\'[OQQ\/=/GT*?1GC-[8F[EN8KB%W5"P,K,RLK,IX.,9X[ MU;C&C&+J]>W36W]??82DZTG&ET_'K_7YGZ,6=Y!J%I#=6L\=S;3(LD4T+ATD M4C(96'!!'((KB?B]\F_X*O?!Z*Z:)=%\8S1AL"=+"VV'WYN0V/PKW M[X(_M,?#W]H2TN'\&ZX+J\M5#W.FW,;074*GC<4;JN<#_ MLH_"OP6VF^+M6L])UN.T*MJEWK\J7SR!>9%MA)M8YYVK&1VQ7Q'^Q'X@F\*? MM9> VLKMO)N=1;3W=,@312JT>".N#D'![@>E:TX4ZLW3C?UZ&=24Z']2>UL MT\1^(HU./M6EZ>BQ'Z>?+&W_ ([7(_\ !6GQ%J^F_"CPAI5I)+%I&I:I(;XQ MDA9&CCW1(WJ,EFP>Z ]J^=?V./#O[+?B3PH]I\6;HQ>,I+E\+JU[T?QV_S_4VJR]FHKO^&_\ D?>'M7NG$5M::_;B#SG/15D5GCW$\ %@2>!FOI&OS;\;_\$R-#^(GB MV'6_A#XWT>T\#W$09@UV^H-!,#R(73(=",'YGR#GDC&/N>WO+OX,_!$W?B;6 M#XBNO#.BM+>:GY1A:[\B(DN5+-AF"C/)R3GOBG4=.-/VFS704%4E4Y%K?J8O MQP_:A^'7[/5M$?%^MB'4)T\RWTJSC,]W,OJ$'W5X.&(-42TO$\1^'HF./MFJ:>C0CZ^1+(P_[YKX"^"_@W5OVU?VH$A\4ZI.#JTTV MHZI=1'YX[=!DQQYR%'W(UXPH(X.,5]C_ +5'_!/#X::#\%->\0^ ],N=!UW0 M;-[\_P"FS7"7D<:[I%=97;!VAB"N.1TQ3<51@IUNO;HOZ_+8$_:S=.ET_%_U M_P .?72KJU;5-/BD8D03(RK*J^@=6#$>L>>YS^FU56I^S:ML]2*=3G3 MON@HHHK V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ KPC]IW_D4_&?_ &)NJ?\ I/-7N]>$?M._\BGXS_[$W5/_ $GFK2G\@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@"7_EQFK*K5_P"7&:LJ@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "M.U_P"0=^/]:S*T[7_D'?C_ %H 91110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %^W_ M -2M25';_P"I6I* .<^)%U/8_#OQ3CRQ13+JGB745+F0,05V;N/E/7%?JG\4O M^28^+_\ L#WG_HEZ^'_^"0G_ "*OQ*_Z_;+_ -%RU=!>]5?:,?\ TIHBLVHT MDNLI?^DW*?\ PQ7^UA'\R?'V9G7D!O%.JX)]_P!V:Q?"/[4GQJ_9+^,FF^!_ MCA>'Q#X;O"@_M"4K,Z0LVT7,,X"M(H/WEDRV >%/7]+J_,K_ (*P>)M*\3>. MOA]X3TEX[_Q'8QW!N8+?#R1^>T(AC;'1B48A>N"#W%7"I+VL(6NF[6^0.FG" M3O:RO?\ K^OD?1/_ 4B\;:]X)_9UM]4\,:]J6@7SZS;1B]TF\DMI3&R2DKO MC8':<#C..!7L'[,NK7VO?L]_#O4=3O;C4=0NM#M9KB[NY6EEFTV?1_V-_#EA=-ONK74-.@E8G.76"16/Y@UYM\%_C5^T'\6_A; MX6\*?!+P]:Z!H7AW3;?3;SQ3JZQ'S;A(P'$?F;DV@]E1VZ$E+^_F/TCHK\X1^U]\?OV7/B/I6B?'>PM=<\/ZB^?[1M[> M%',60K2020!48ID$HZ[L8^[D&OO_ ,5>.-'\&>"=2\6:G=K%H=A9M?2W"\YB M"[LJ.Y(Q@=R142CRP]I>\?\ (J+YI^SMJ;]%?GIH/[3'[3/[5M]J5W\'=#TO MPAX2M)S NIWRPR/NP#M=Y@RLV""1''\N0"3P3D>-_C[^UO\ LKW%IK7Q'@TK MQ=X7FF6%IUM[<0ECSL$ENL;QL0#@NI'LW2GR/12TOW%S)WY=;=C](J*X3PC\ M9- \6?!JR^):2/:>'YM+;59?-P7@1$+2*V.I4JR\=Q7Q;H7[1O[3G[5^I:GJ M'P=TW3/!W@VSN6MXM0O8X'=B "%D:8.&?!!(CCPNX D]2N67.Z=M5OY=!\T7 M!3OH]O/J?H;17YU:S^U5^T?^RCXFTF+XTZ1I_BGPQJ$VS^TK.*&-V ^\(I(0 MJAP.=DB L!QCJ/O:Z\>:%8^!G\87.H10>'$L/[3:^<_(+?9OW_\ ?/:B4>6' MM+Z!&7-+DMJ;]%?GI'^UG^T#^U-XFU*T^ _AZW\/>%["7RVUK48H7D]C(\VZ M,$C!\M$9AGDD4FM?M&?M/_LJ:A9:A\7]&L/&O@VXG6*;4K&*!"F?X4D@5 C> M@ECPV, ]PU!Z/-&^)_@O2/%/AZZ^V:/JD"SP28 MPV#P58=F4@J1V((KH:F47%N+W0XR4E=;!7Q[^VA^W9H?P;T34/"?@V_AU;Q] M<1M TELX>+2<@@O(PX,H_ACZ@C+8& WT3\;_ 5K'Q&^$_B7PSH&J#1-7U2U M^SP:@9'C\G+#?KH:QOS14=V_N\_/^KGJ_ M_!.GQ?KWCC]FVUU/Q'K6HZ_J3:I=QF\U2[DN9BH*X7>Y)P.PS7T]7R5_P3!_ MY-8L_P#L+WG_ *$M?6M=N(TJ:=E^2./#N\->[_-A7R1XK^'_ ,<[K]M[2?$> MFW6N+\(8W@-Q#'KRI9$"V*OFT\X$_O,?\L^3S[U];U\1^-/VC/B)I/\ P4+T M3X9VGB'RO!%P]N)=+^Q6YW!K4R-^],?F#+<\-^E84M:]-+>^G;YF\_X4V]K: M]]UL?;E%?)/_ 44^.GC?X$^ ?">I>!];_L.\OM4>WN)?LD%QOC$18#$J.!R M.H -<)!\=OVE_P!IJ,ZA\&M'LO"'@N$^5#X@UJ.'SK]UX=@LJN-I8'A(R 00 M7SP",7--KH[?@G^H2:BTGU/O&O&OVN/#?C_Q9\#=9TWX8S7\'C"2>V:V?3=1 M%A.$$RF3$Q= HV!LC<,CCFOE?P)^V9\9?@?\9M)^'WQ^TZUN;74I8T75HX8H MI8UD;8DRM#B*2(-]X;0PYYR-I^E/VWOB;XE^$/[.NN^)_"6I?V3KEK<6B177 MD13;5>=$8;)%93E21R*52/+&,KW3:V[W7],=.5Y2C;5)[]K/^D=+^R_H/C7P MS\"_#&F_$.6\F\8P),+]]0OA>SDF:0INF#N&^0K_ !' P.U>3_ G]J[Q%\9? MVJO'G@2;3K/2O#7AJVNHH8XLR3W$T5U'%YKR'& 1NPJ@8WJWEO;QQ_)>,K93RC&/W2D?<_7FO@_]GS0_CQ?? MM&?$"T\ >(=-T[XAP_:_[;OKF. PS8N5$VP/"RC,N"-JKQZ#BNKE2.>Z6&BX/=QU\K[/S?0_0+]N3P9\7/&WP]T"U^#]QJUOK<.J>;>-I&L M+ILAM_*D&&=I8]PW%?ER><''%>U?"ZQUG3/AKX4L_$33/K]OI5K%J#7$XFD- MPL2B0M("=[;@5C3XZE/1W<79?/KYW.]HK\][']K#]H/] MJCQ%J]O\#/#UAX=\+Z?*(CK.I)$\HSG:7:7*9(&?+2-BN>2>#61X^^,7[8O[ M,<,?B3QRVD^+O"Z2+'/,MK;- A8@ ,8$BD0D\!B-N2!SP*2@].;2_YGANHHO-=SC (9B$ M4#&[DMQ7;P_$_P 4?M"_LNQ^+?A'C*V LH M!*\Y!P,\?G#\#]#^/%Y^U)X^L_!/B'3;#XG1"^_MO4+B. P38ND$^T-"R#,N MPC:B\#C XJZ<&J[A-;*6GG;?T0I23H*<>K7W=O5_HS]"?VX/!_Q7\:?#/2+/ MX0W&JV_B"/54EN6TG5UTV0V_E2 @R-+'E=Q3Y);;2+6+4VNK@7$IN5B42EY S;VW Y;)R>=)I?LLC3;5>(H 9$S\JCVP.*]_P#A/X^DOOV?O"7C M/Q5J48EE\.VNJ:GJ$JK&N3;K)+(0H"J.IP !Z"E\%.IJK*2N_ET\K#=Y3IZ: MN+LOGU\[GHU%?GGC? #PY!I/A^Q1ILQ) MNZB,*SX!//.(?%'QY_:R_98D@UOXFZ=I?CGP@TJ1SW=O% BQY/W1);HAB8] MTD;*3@#)I*#TYM+]P:5XP\.2N^GWRG=#, ) M;>53AXG Z,I_ \$9!!KX ^&?[>WQ=N/%/C?PE!9R?$7QE>:D++PQIYLH(8+1 M$>?SI)3"J%E"B+[S 8!)90#E3VE]/Z_R/TUHK\\/' M7BK]M[X5Z)/XVU>[T?4M%M%-U>Z39VMG,+6(->["OKAI+70-'+W%R8K*R@S)<7Q8;CQ@J3MI!^R#^UY<+_:$GQQ\J]/[S[+_ ,)-J(0'^Z56+9^ &*^@_P#@ MG[\)[#X9_LV^'+R*W1=6\20KJ]]<;?GD\SF%<_W5CVX'3)8]S7TG6TXJA)TX M[K=^9E&3K+G>B>R\C\WO#?[9'QJ_9:\>67A3X_:1)K&AW!Q'JR11^>(P0/,B MECPDZCJRL-_/)!X/Z(^']?T[Q5H=AK.DW<=_IE_ ES;7,)RDL; %6'U!KR#] MLOX1V'Q@_9[\5V%S;I)J&G6DFJ:=.1\T5Q"A<;3VW ,A]F->(_\ !*?XD7?B M?X-:]X6O)6F_X1O4!]E+'.V"<%PGT#K*?^!5,7[:,[KWHV?JGI]]_P"NSDO9 M2@T_=E=>C6OW?UZXW[0O[4'Q,^*7QXD^"7P-E33[NU=H-2UP8W!U'[W]X0?* MBCS@L!O+#"]@V1XH_9Y_:K^"_AZ?QCH7QHO_ !C>V$+7%WH]Q=SW(**,N(H[ MC>DF!GC"D@<WT?2+E;J5I\%=DAC)$0!^ M\7(Q@X!/%8.;ITER?';7K=]EY&ZBJE5\WPWT].[\RS^QM^T['^TY\,Y-3N[: M+3_$NERBTU2U@/[LN5RDL8))".,\'H58!@>H02QCS99=I4L RH,CID9^__ M (H?#G2_BYX!UCPAK4EU#I6JQ"&X:RD$3Z9!-+.)=0D1YF:1BQW,JJ#CH..@%<].RE*4^VGKU_X!M._*E'O MKZ>7ZGPQ\2/#?[47[&MB/&L7Q)G^(_A6WD07\6I337?EJ2!^]CF+,B$D#?$^ M1GG K[?_ &??C5IG[0'PJT?QEID1M?M:M'=6;-N-M<(<21D]P#R#W4@]ZX+] MN[XE:/\ #O\ 9I\71ZG)&UWKEH^DV%JQ&Z::48R!Z(N7)_V?<5Y=^P+I.J?" M[]BG7?$=Y')$UVVH:Y9QR#!\I(%5& ]&,)8>H(/>J]I>C5E/[%FG^GW:_P!, MGV=JE*,-Y-JWZ_?HZ$< M8Y=C#.6#1@#ED97 .0!@D:__ 21T*.?P_\ $?Q/.?.U"[O[>S:9^7PJ-(W/ MN9 ?PK[[U338-8TN\L+J,2VUU"\$L;#(9&4J0?P-544L-%1AK)*[\VU>WH$) M1K2R\DM+^IYG^S+\>]._:-^$^G>++.%;.]W&UU&Q5MWV:Y0#>H/]T@A MESV8=\U\Q_M'_M5?$OQ[\=#\$O@=LM-4MY#!J.M!59Q(!F4!F!6*.,'YGP6+ M#"XX#&=%YP'CDDB9A]1L_P"^17UC\*_V3_!? MPA^*GB3X@:+<:M<:[KZS+=+?W$E[DQ+_ %S7H%,S:3+JMV89 M& SL3S28V)Z .BKZXKTS]AS]KW6/CA+K/@CQY;)9>/\ 05+2R+$(?M<:OLD+ M1]$D1R P .X$ 8(KZMU75+/0],N]1U"YCL[&TB:>>XF8*D<:@EF8GH 37Y MN?L.RR?%[]N#XD?$C2+9[?PVJWLWF!=H;SY0(5;_ &F56M]_N_4_2VOC'_@H?\ M:3_ ?\,)X&\(W\EMXUUB'S M)[RTDVR:;:\Y<,.5D?!"D*]5*37"#R=/L"^ MUKRY8'9&/;@ECV52:^&K'X%ZP_[+7Q=^.7Q%!NO'GB[36GM%G7YK*T>1,$ _ M=+KM '\,84=V%G5_+IYGT_\ \$]/ M%FN>-?V9='U3Q#K.H:]J(][J=T]S,RK*0H+N2Q ' YXJW^VQH_C>P^&\ M'CSX?>(-4TK7?!\W]I3:?:W4BVVH6H(,J30@[9-H&[Y@> X[US__ 3-_P"3 M3]#_ .PA>_\ HXU]1W=K#?6LUM<1K-!,C1R1N,AE(P01Z$&NK%)J=X:-6:]; M+^F@4445D:!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %<=\2_^/70O^PM!_)J[&N.^)?\ QZZ%_P!A:#^34 =C1110!QOPT_X]M>_[ M"T_\EKLJXWX:?\>VO?\ 86G_ )+794 %?EI_P4:^/_\ PL+XB1^!=)N-^A>& MY"+ED;*SWI&&_",?(/IE].'.Z]5^[#\_\ @?FUV/)S*I45-4*2]Z?X M+_@_E?N>7? /]L#Q7^SGX>O])\,:!X;N1?7'VBYO-2MIY+B0A<*I9)D&U><# M'\3>M9G[0G[4?BC]I(Z(WB;3-%L9-)\T0/I,$T982;-P?S)7R!L&,8ZFOVLK MYN_;^^'^J_$/]GJZM=#TF\UK5;/4;:[AL["W:>=QN*-M106.%D).!T!KI6/I M3K1G*E[UTKWVOIVZ(Y7EU:G1E"-7W4GI;?K;?JS"_P"":?B7^VOVDLA,K'Z[6C'X5[S_ M ,$S_"_C#P+I_CK1_%'A;7/#L$TMK=VKZMITUJLC8D20*9%&2 (^!7E?[=G[ M*?CW4/C%JGC;PSH-]XGT?6A%(ZZ7"UQ/;2K&L;(T2Y8@[ P8 CG!QCG27LXY MGS2>EKI^;2_S?S,X^TEE;A%.^S7ES7_R^7H?;_[.'A2#X7_L\^#-,N62U2TT MF.ZNWD.U4>13-*23T 9VY]J_*GXAZO\ \-&?M47TMBS2V_B/Q!'9VK?],#(L M,;>WR &O=_ _PM_:4^+_ (!_L'QKJ/B#0/AUI-DQ>PN+98;^]CB3*VR1!!-* MS8"CS]-QJVF3VT32!"D:AI M$ +;G# =?E)[5T4(PHXJKB)S3:N[>3=_OTV_S.;$2J5L)2PT(-)V5_-*WW:[ M_P"1^F'BK6+3P#X#U;5"%ALM'TZ6<#LJ11D@?DM?D9^QKX=E^(_[57A*2[!F M\J^DUBX8\_-$K2@GZR!?SK]6_CAX+O\ XC?"#Q?X9TN6.#4=4TV:VMWE8JF] MEX#$= >A^M?E)X+^%O[0?P%\>?VIX:\$>)K#7;=7M_M5IHS7T+(W##<$>-@> M.Q]Q?\%,&NE_9O00*3"VM M6HN".R;9,?\ CVRO-O\ @E''8?V/\0W#1_VH;BS5ES\_D[9=IQZ;BWY5]/0_ M#6_^,7[-]EX5^)4\MQK6KZ7&VI7'D1Q2P7+8D!"*H56C; QC^'GJ:_/*\_9K M_:$_9>\<2ZKX,L=5O2NZ*'5O#47VM+B(G.)( &.. 2KH1D#&< T87D5*MA)2 M2;>CZ/;_ "^YAC%.56AC81;26JZK?_Y+[T?H?^U1\2[#X5_ GQ9JMY,B7%Q9 M26%E$QYEN)4*(H'?&2Q]E-?GY_P33\)7>N?M$#6(HV^QZ+IMQ--+CY0TB^4B MD^IW,?\ @!JIJ7P?_::_:H\068\6Z;K0C@.U;CQ%;C3+2U!ZN(MB9/J40L<" MOT-_9K_9XT;]G'P -$L)?[0U2Y87&I:DR;6N9<8P!V1>0JY/4GJ351Y,OH5. M:2VM]-0>X3S&_P#'I&'X5^@'B9O^%$_L8W,2XAN-%\*+;#M_I#0A,_4R/G\: M^!;#X(?$7XI?M21:MK?@+Q/9:/JWB?[7=7E]HUQ%#';&XW$L[(% V#'-?;/_ M 4$L_$FN? -M \+Z!JWB"]U348(IH-)LI;ETA3,A9A&I(&Y$&3QS48A+ZK0 MPU][7_"_YLUP[E]SMX-5LY+:4QH&=V"NH)4EU&>F5/I M7,_\%*?"?CGXB>-O".F>&_!_B'7],TVPEGDN-+TN>YA$TLF"NY$(W!8EX_VA M6^+E&MCZ<+Z1M^'O?\ Y\'"5#+ZL[:ROZZ^[_P $V/\ @E9X+6U\%^-/%9?\%2O&/]J?%;PQX!).Y_7 M;&GYU]C_ +%OP\O/AG^SGX6TO4[*?3M6G$M[>6UU$T4LEVLEQ*(0R*QV("<" M-2,X[U\^?\$U?@CXH\&^-O%WB/Q3X9U;PZ\=A'8V@U:PEM6E\R3>Y02*,X\I M0>W?\ !0SQ>?"W[,NM MVZ2;)]8N;?3DYY(+[W'_ 'S&P_&OGW_@E3X+6XU[QSXLEBRUK;P:;!(1_P ] M&,D@'_?N/\Z[K_@I=X?\9>.M-\$Z!X7\*:YXAMHY;B^NI-)TZ:Z2-@JI&&,: MD X:3@UZ-_P3[^&.I_#/X!HFMZ7=Z/K&J:C<7L]G?V[03QJ-L2!D8!AD1[AD M=&SWKGP\E2P%65]9/_)?HSIQ,76Q]*-M(J[]=7_\B>%_\%6/&.ZX\">%8WX5 M9]3F3/J1'&?TEKV3_@GSXK3,>OEJ?+!^FV'/XU\ MO?MV_#_XC?$S]HG5[O1_ ?BC5=(L;:WL;6[L]&N989%5-[%75"I&]W&0>U?H M/X-^&::/\"-+\",3;;- 72Y77JKM!L=OKN+&IJ2]GEBC%^])W_-__(EPC[7- M'*2]V*M^2?YR/RD^!>GR_'3]KC09KP>;_:NOOJURKOEI=_\-;?83_@F/X+_ +>^.VH:])'N MAT+2Y'1NPFE(C7_QPR_E7M/_ 52\7_8? /@[PTDF'U#4)+V1!W2&/:,_C+^ ME=)_P3:^$.M?#CX=^*-2\1Z)?Z#JVJZBL2VNI6KV\WD0Q_*VQP#@M))V[5X] M_P %%O!/Q ^)/QFTR'0/!/B36]'TK2XXDNM.TFXN(6E=V=\.B$$@; <'M6>( ME&MF%.-_=C;\$Y?F5AH2H9=4E;WI7T]6H_EJ>O?\$P_!":'\$-4\1/$!=:[J M;XDQR880$4?]]F7\Z\Z_X*L>,/G\!^%8WZ"XU.9,_2.,_P#HVOKK]F/P3/\ M#OX ^!M!NK9[2]M]-CEN;>5"CQS2YED5@>0P9R"#Z5\$_MX?#_XC?$S]HC5+ MK1_ GBC5M'L+6WL;6[L]'N9H9 $WL4=4*D;Y&&0>U8\RKYES-Z)O[DK+\;,W M470ROE2U:7WR=W^%SZ!_8I\%W/AW]BG6;VU0IJ6O1:E?1<'.1&T,?3G_ )99 M'^]7Y\_ 'P#XF^)7Q3TG0_!VO0^&_$L@EEL]0FNY;78R1LS!9(E9U8J&Z#UK M]FOA#X-7P#\*O"?ALQA&TW2[>VE7'601@.3]6W'\:_/[]HS]AKQU\._B%/XT M^$]M25GDC*#(>%!CYB>N>E>$ZU_P MUS\=K%?"NL:;XMET^3 >*\TM-*@D _YZ2F.(..^&8]*^Y_V2?V?];^!/@>6# MQ+XEO->UV^*M+ ;R66SLE XCA5CC/)W/@9X'033VLHF[[YR(ACW^*O$_P?TCP]X5\.ZOXAFOM466Z32;&6Z,<4:,1N$:G +LN,^E M>!"*J3C![-I/TOK^!]'.;IPE-;I-KU2T_$^,/V$O@=H'QR^+E]8>*M..I^'] M.TR2ZFMQ/)"'D+HD8+1LK#[S'@_PU]^)^P+\!HV##P&"1_>U:_(_(SUY7_P3 M1^#^O_#[0/&NL>)M U+P_J%_PYJL$VV]U\OTN<;\/_@WX'^%<3)X3\+:9H3N MNQY[6W FD7T>4Y=A]2:^4O\ @J?XO_L_X;^$?#<CBK4<+4]FNEK+ST_)GI'_ 2[\ 1:/\*_$'BV M6$"\UG4/LT3_OD5U_\ P4D:Y7]F6\$ )B.J6@G([)N./_'M ME>H?LK^ Y_AO^S[X(T*[MI+.^CL%N+JWF0I)'-*QE=&4\AE+E2#Z5UOQ.^'> ME?%CP%K7A/658Z?JXK3&5N;%NHM5&2_\ )6OSL9X& MCRX-4WHY1?RYD_RN?$?_ 2ACL-GQ&GC:GME47([7UU[?U?8\S"8BK@ M*?L94VYINW9ZW_#RZ(7_ ()O^$KO7_VDK/5(4;[)HEC<7-Q(!\HWH847/J3) MG_@)]*X+]JJ?^T/VK/')U#Y8_P"VO*?>W2-=JCGTV@5^H?[,?[..D?LW^!#I M-I,-1UF]99]3U,IM,\@& JCJ(UR=H/J3WKY5_;N_8V\4^)O'5U\0O VF2:Y% MJ"*=3TVU&;B.5%"^8B9RZLH7(7)!'0@\:1QU-YA&I?W5'EO\T_\ @?<92R^J MLNE37Q.2E;KLU]_7[S]!+&."&R@2V"BV6-5B$?W=@'&/;&*_';]N;XA6/Q(_ M:0\176ERIC?#W0_VM_&WAF/P-#/XB\-^% MHHO(ENM>MQIXMX ,8\^2,3L@'&U"W'&,5\__ 8\"KXV^.WA7PO;R?;K6YUJ M*%IE7 D@23<[X[#RU8XJL%A(T\2YRFG;MY]7V_X?L+&XR53"J$:;5^^VG1=_ MT^9^F?QFD'P2_84N]-5O(N+7PW;Z0N."9942%C]2WX^R+JUHT"7&,^4_!1B.X#!3CVK\LO#OPG_:/_9K\=7C>$_#GB*UU M%U-N][HVG'4+2XCSP2=CQD<9&X CT%99;R7J7:4[:7_K^M#;,^>U.R;A?WK? M+_@G2?M7?L@>$OV9_AUI5\/%6HZYXHU*\$$$+Q1P0&-5+2R>6-S@,DH_6+\J\,^,W[/O[0_C#3-.\:^-]+USQ- MJU],UM'IUK UW7RT7R_,\^E M1C4QU+V=-QCY]=]7\_R1\'?M+:I/\6_VK_%,5FQG>\UM=)M>^=C+;KCVROZU M^M_B:_L_A3\)M2NH0L%CX>T9VB7LJPPG:/\ QT"OS+_99^ /Q!U7]IGPKK'B MKP3XBTC3X-0?5;J^U329[>$2(&E7+N@&3(%&,]Z^\?VUEU^Z_9S\3Z9X:T;4 M=N3'Q2H4<)%]+?E%?J=V7MRQ%?%R M6E[KTU;_ L?G/\ L.^$V^('[4GA>2[7[1'8RS:O.S<_-&I9&/\ VU*5]\?\ M%"/&/_")_LRZ[;I)Y=QK%Q!IJ<\D,^]Q_P!\1L/QKQ'_ ()J_!'Q/X,\9>,/ M$?BGPSJWAV2.QBL;1=6L);5I?,DWR%!(HSCRDSC^\*Z/_@I=X?\ &?CJP\$Z M!X7\*:[XAM8I;B^NY-)TV:Z1' 5(PQC4@'!DX/K6V.E&MBZ5)/16]-[O\%8P MR]3I82M6DO>=_7:R_P#)F@->V_&K3O@%^UYKVD^$_\ A-[.3QJJ2KIE]HK^:^ I9HV?:8W7 M@MM+ \':1DUK?L"_">]^'_[/)M/$6C7.F:EK5]JK2I5L<^>?*DE9KO;77U^_5#P\:M# KDAS-MW3[7TT]%^3,7XM_\$Y_B M3\.+.\U71+BQ\8:3:JTS/9L8+M449+&%SCC'1'8^U=Y_P3U_:<\87WQ)M/AS MX@U.ZU_1M0@E-E)?2F6:SDCC+X5VY,952-I. =N,3%XFD@:WL MM,AD6462-]]W=%_P#D6=(_Z\X?_0!57QW_ M ,B?J_\ U[M5KPO_ ,BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ HHHH \ M3_;'^&O_ L[]G[Q-911>;J&GQ?VI9X&6\R'+$#W9-Z_\"K\[?V0_CTGP'\8 M>(;VZ?%E?Z-.10Z,"K*PR"#U!K\3?V@/ MAR_PI^,7BKPSL*6]I>,UKQC-N_SQ'_OAE'U!KZ7)Y1K1JX.>TE?]'^ECQ,TB MX>SQ4=X/_@KY;W]3N_V./ $_Q@_:0T:;4%-U;6$SZYJ$C\[C&P9<^NZ5D!]B M:_7FOC+_ ()G?#/^P?AOK7C2YBQ$D$@_P"U(7!_ZYBOLVL< MYK*IB/91V@K?/K_E\AY53<:3JRWD_P"OU?S"ORL_X*._\G(2_P#8)M?_ &>O MU3K\K/\ @H[_ ,G(2_\ 8)M?_9ZRR?\ WR/S_(WS+_=9_+\T??7[)W_)M_P] M_P"P3%_6NL^+G_)*?&?_ &!KS_T0].:6R=5F4")W&TLK Z?\$QOA8K G7?%SC^ZUY:X/Y6U?&/[%G_ M "<_X#_Z^I?_ $1)7[$U]1G.*K8>I!4I6NOU/G;QCRO+^;=_N\UZ%17R4ZU2K/GJ.[\SZ6G3A27+!61 M^0__ !E)_P!5>_\ *I7VO^P7_P +&_X0GQ-_PL?_ (2C^T/[03[+_P )3]I\ MWR_+&=GG\[<^G&:^H:*]7$9G]8I2I>S2OU7K<\VC@/8U%4]HW;_(:_W6^E?C M%\'?^3H/"?\ V-4'_I2*_9U_NM]*_&+X._\ )T'A/_L:H/\ TI%=.1?Q:O\ MA7ZG/G/^[KU_1G[/U^,?Q=MS\/\ ]J'Q(UP,+8>)GO.0>4,_F@_BI!K]G*^$ MOV]/V3=<\7Z\?B)X,T^35;F2%8]5TRV7=.Q086:-1R_R@*5'/R@@'G'+E&)A MAL4G4=DU;YZ-?D=>94)8C#.$-T[_ )K];_(^XI=4M8=*?46G062PFX,^?E\L M+NW9],$FMP<7/B2.^X'1$F\YC_P!\J:B?X]?%Z3P@/ALW MB#5SI.S[%_9!MU^T;.GD[]GF[4)7*A3SAF) XKV*&'64QJUJDT[JT?Z\]#R:]=YBJ M="$6G?WO+^M=_(SO^"IFA2-:?#_65!,4;W=FYQP"PC=?SVM^5>E?\$W-<@U+ M]GN2Q1U,^G:M<12(.H#A)%)^NX_E7J_[2WP1@^/GPKU#PWYR6NI(RW6GW4@^ M6.X3.W=WVL"RG'9L]J_+ZQUCXP_LC^)M0MK9M3\'7MQ^ZF\RW26VN@I.&7>K M1R8R<,,XR>1S7)@>7&8&6"4K33NK]=;_ .?IH=F-YL/BH8NUXVL_NM^5CV;_ M (*=:Y;WWQ?\.:9$ZO-8:.&F ZJ9)7(!]\*#^-?0_P 'O US-_P3[&B%6^TZ MAX=U">-<3B75/$M]&538, MB,D .^!M55X'&< 5^MFEZ/9Z+H]II5G L-A:P);0P ?*L:J%5?I@ 5.86PN" MIX)2O).[\M_U>GH&#D\3C98SE]VR2\]E^2_$_*7_ ()^:Y!HW[3.AQSNL8O[ M2ZM$+?WC&7 ^I*8_&OO3]MO7+?0_V9?&C3NJM=0Q6D2GJSO*@P/?&3^%?#/[ M2W[*_C'X$_$"Y\3>$[.^N?#!NC?6&I:8K-)IS;MX239RFP]'Z$ O[W5O&+VSY@L+.S0!6QC>ZQ(H) )^=^@)YZUZ-?#QS2=+%4I MI15KKKH[_?T..C6EEOM*%2+;>J?1Z6^[1?BCV_\ X)@Z'+=?%OQ1JP!\BST; M[.Q[;I9HRH_*)ORK]*Z\%_8Z_9ZE_9_^&;VVJ^6WB;5I1=ZCY9#+%@8CA##[ MVP$Y/3!FN(CB,2Y0=TM/Z^9ZF6T94%E\6ZUH\5JOE)8ZQ812SPJ. @-Q$SJ!T SQP!BNUS6 M(A'I)=/Q_I]3EY'1FVM8O^OZ1^DO[:'[8"_LNZ=X!/V>_C3^UAXT_M6XL=7OC?.&NO$^OB1+9$]1(X^ M< =$CSCC K]?_@3\&=%^ ?PSTGP=HFZ6&T4O/=R* ]U.W,DK>Y/0=@ .U3[ M-4Z3]IK)[>7_ +?B] %M4OO[)-UXD?3; MF^FBW_9]UR8VD*9&=N2<9&<=17V__P .>_\ JK?_ );?_P!UUD?\% /V)_$\ MWCS4/B7X!TF?6]/U,B?5--T^,O2_\$]_V:?BK;^,+/QCXJOO$7A+ MPC8$RP:/<74UL^IRD';O@R/W0SN))/^O.R_\ M2=*TQ'^]P]%_Z2C'"_[O/Y_^EGZ >*/C3)\ ?V&?#?B^UACN-3A\.:;;6$4H MRAN)(8U0L.ZKDL1W"X[U^=OPE^&/Q2_;W^(&I?VGXODNET]%N+W4=8G>2.V6 M1B%2&%> 3AL*H50%/(XS^A?C/X+W/Q[_ &$_#GA/3WCCU>3P[IEU8-*<(9XH M8W5">P8 KGMNS7YI_"[XJ?%3]BWXAZA]FTA](U6XC^RWFD:]92&&Y4,=IP"I M.#DJR-SDX)!K3W?K5;GWN[?UZ[_(B/-]4I=^.>E?3'_!)-1_PI7Q><#)U\ M@G_MWBKY3^/D7Q^_:)\!7OQ5\?:4VD>$=!$:VEFUN]I$!,Z(7@A;+N,E29') M&. QQ@?1G_!(SQC92>$O'?A4RA=1AO8M36(]6B>,1DCZ-&N?]X55/G]G54WK MV[:Q_34=3EYJ;BM._??_ #L?%_QP5_"7[6WB^745.+3Q;-=2;_XH_M)D!^A4 M@_C7[IP3QW4$^JZC)" MJ:QH]N,SR[%VK/$O\;;0%9!\QVJ0#S7SSX3_ ."@'QQ^$?A"+P'+;V+W-C#] MDM[C6]-E.HVJ@;44#>H8J.GF(QXYS7-2?/AXTOM1_'1+]-/\S>JFL1*K]F7X M:W_5W^1^F=_^UA\(M(\7ZGX7U'Q[I.EZWILQM[JWU!VMUCD'5?,D4(<9[,:] M7CD2:-9(V5T8!E93D$'H0:_(K]E']C;QU\=/BC;>,_'NF7^G>%TO?[3OKS5X M3%+JLF_?L1& +*[?>?&W&<'/%?KL % & *)4U3A'F?O=28SYYRY5[O06OPF M^-ZMX/\ VL_%\M^A"V?BV:Z<,,9C^TF0'Z%2#^-?NS7YV_\ !1;]C/7_ !=X MDD^*'@33)=8N)H4CUK2;--]P61=JW$:#E_E"JRCGY0<')QG2J>QKPJO9?\!_ MH:SA[:C.EW_X*_4_0ZWN([NWBGA=9(95#HZG(92,@C\*_';_ (*;:K:ZE^U3 MJ45O*)7L],L[>?;_ R;"^W_ +Y=?SI_PI_;N^.W@?PS;?#O1;"VUZ\M4^QV M0O=+FN-1ME PL:*CC=MZ .C'@#IQ7C7QZ^'?COP+XHL;_P"(WFKXH\36IUN> M.Z?=<*))9$'FCHKDQD[1]T$#@@@:NE:K&5_=Z>;L_P!+W,XU&Z;37O6U\M5^ MMC]AOV=?^31? _\ V*D/_I/7Y0_L-_\ )V'PX_["#?\ HF2OU>_9U_Y-%\#_ M /8J0_\ I/7Y0_L-_P#)V'PX_P"P@W_HF2NJG_R,:GJO_2I'/4_W&'H_RB?K M+^T]\'?AW\:O 8TGX@:C;Z+#;.9[/5FNH[>6T?&"RM)\I!'!4C!'H0"/SY\8 M?\$NO'"V*ZO\/?%/A_Q]H<\8EM98IQ;2SJ>A3):)A_M>:,U]'_\ !0S]CK6/ MC='8>./!5NMYXHTVW^RW>F[@KWMN"64QD\&1"S?*?O \<@ _(7PQ_;.^-G[* MOA\>")](M_L=HS?9]/\ %FFSK+: DDJF'C;:22<-D#/&*X:*TE9VE?;^OZZ' M75O[MU==^W]?\$\S6X^+7['_ ,1! 9=4\#^(HU29K<2AHKF/)P6"EHYHR01_ M$,@]Q7Z)_M*>.KOXZ?\ !.6X\8QVWV:YU"SLKVZMX02JLEU&LP&>=H96/T%? M%%QX5^-W[>_Q0MM:NM&EE$D:6HU+[(UKI=A;JQ. YSD LS;M?K'X7^" M.@>'_@;:?"Z5&O=!CTDZ3.7&&F5D(D?V9F9F]B:VK\SP_O\ QW37RN_\OT,J M+C'$IP^&VOX?\$_'S]DG]F6W_:C\9:QX>?Q:OA6YL;'[=&QL/M9G4.J, OFQ MXQN4YR>O2OJC_ASW_P!5;_\ +;_^ZZ^?/&WP1^,7[#_Q63Q)H=M>R65C*YL? M$5E;&>TN(#QLG !"$J<,CXY!*DX#4[XH?M7?&O\ :_L;#PC#HZ3013K.=/\ M">G3[YY%X5Y"7D;"Y)X(7/)' QHY>T471^?W_P"73N1R^S.3XE6_P!/-@;3^R?L@7,B/OW>?)G&S&,=^M?&W[:W[6'C MGXH?&36_ GAK6+W2O"^GWS:1#8:?,8#?S*WENTS @N&?("D[0 #C.37W+^P_ M\#?&WP=^'-Q-X_\ $&I:GX@U5D?^R[K4)+F'3(E!VQJ"Q4.=Q+%>.%&3C)^ MOVX/V9O%_P (_C-K_B_3-+O;GPIJU\^JVNK643.EI*[[VCD*_P"K97)VDXR, M$'((&,FOK$(U7>*7^3_5_P!6-()^QG*DK2;_ .!^B\[?,]E^'O\ P22N9;.W MO?'GCI;-RN^?3M$M=Y7C./M$AQD=_P!V1[FOE[]D2W@A_:X^'\,!,MM'KH6) MI,$E1NVD^_ KV70?VM_VF?VF/#:^ ?"VE07,ES$+.\US2=/>*9HRNUC-<,YB MAR,Y950^G->(_#"WG_9U_:R\.VOBAHX)/#7B*.WU"6,DQA1)L>120"5VG<#@ M<5U4>?ZS%2>CV7SU?Y'-6Y?JTK*[Z_<]/G^A^Q_QX^&O@GXM?#N^\.>/)(;? M1IB)%NI+A8'MI5SMEC=N%89/7(()!!!(K\Z/%G_!+[7-5LVUGX5^//#_ (ZT M&1G\EI)Q%(2K$%%DCWQ.000263D'@5]9?MZ?LHWG[2'@G3M4\,F$^+]"$C6L M,CA%O8'P7AW'@-E0RD\9R#C=D? _PN_:2^-O[%L-[X7DT/['823-*-)\5:;- MY<&[:T^T[WC7=Y83S$Y*ACG=_ M#TK[&_X<]_\ 56__ "V__NNO$OCY^RC\2OV4_BH?%O@BSU&[\.VMV;W2=LZO'O"/VG?^13\9_\ 8FZI_P"D\U:4 M_CCZG3AOX]/U7YGX]T445]X?T(%%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %=W\!/^2Z?#K_L8]._]*HZX2N[ M^ G_ "73X=?]C'IW_I5'6=3X)>ASXG^!/T?Y'[7:9_J9_P#/:DI=,_U,_P#G MM25\&?ST%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 2_\ +C-656K_ ,N,U95 !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %:=K_ ,@[\?ZUF5IVO_(._'^M #**** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH OV_P#J5J2H[?\ U*U)0!R_Q2_Y)CXO_P"P/>?^B7K\B_V._@9\7OB]I/B: M?X9?$23P/;6,\"7L2:M>67VAF5RAQ I#8 ;[W3/%?KI\4O\ DF/B_P#[ ]Y_ MZ)>OA_\ X)"?\BK\2O\ K]LO_1M?\ T"6O6_V,]$MM!_9<^&UO;1)$LND173[!C<\N9&8^Y+FO)/\ M@J=_R;+!_P!AZU_] EKVS]D__DVCX8_]B_9_^BEJ:/\ !K?XU_Z256_BTO\ M"_\ TH^:/^"N%I&_PB\%7)7]]'KC1JV.BM;R$C\T7\J^EM+TGPOXF_9ET&W\ M=K:S>%Y/#EE-J1OI3%#Y:P1N6=@1@ @'KVKYO_X*W?\ )%_!W_8P#_TFFK4_ M:\TO7-4_X)[:"-%6:2.#3='GU".#)+6JQ(6) _A#;&/LI/:LT[8>II]N/XK] M-QM7Q%+_ R_,Y[3?^"A7P*^!6BIX,^&?A/7-3TBRDD-N+1/+MY&=B[%7FD, MS98G[R_3@"O+/VI/VM/B1\=O@EK.GGX,ZAX4\%N\$MWKFI":51MF0Q^7(8HT M!+[1CYC@GZUZM^PC^T=\"_ 7P1TO2+O5M+\(>*[=7_M9M0B\J6[D+L1()L8D M!4@!@!);C:M'EERV$$\3^"FNFNOM MLY+NSZ -*DL+!H2RJORR=,9V]2?IK]DV^\2S?\$_-(E\"O#_ ,)9;6-__9ZW M$8D5KA+J8A"I.,MC S_>!KDOV4_^"AFCZMH=YX?^-&O+H/C2SO)$%Y>V?D03 MIG[C>6@6)T(*D.!D ').<;5>;ZU6Y/FNZOI]W]=#&E;ZM34^[^3Z_?M_3,;P MG_P4Q^%?Q2^PZ5\5/ ']FHEPLD<\\,6K64$@! E*L@=",L/E1B,GGK7H7_!1 M3Q=;6?[';-X;N8&T;6;JQMH9; CR7M3F5=FWC81&O3C%>+_\%"/C9\#OB3X# M33/"ITSQ3\09[N$V^J:3:;G@C#?.'G"C>&'RA 6Y(.!@&O8&_9I\2>-/^">. MD_#K4(VC\7V^G)?6MM.<-'.LK31P-GH=C>7[$^U]XOY/9?Y_B>#?LT_M,_%KX2?!G0/#WA;]GK6_$.D(LEPFLVME>LE\ M9'9C+N2!E/4#()X45T7Q;_:>^-WQ>^&OB+P=J7[,_B2&TUBT:V,XTV_5 MD"FWY*L P]Q5S]A_]M3PW\-?!,?PL^*5Q-X4U309I+>TO+Z!Q&4+DF&7 )C= M&+#Y@%Q@9!'/H/[47_!1#P;X.\#WFF_#+Q%#XA\;7@$5K7?\$P?^36+/_L+WG_H2U]:U\E?\$P?^36+/_L+WG_H2U]:UWXC^)\E M^2.'#_P_F_S85^;7Q$_Y2R>&_P#KI:?^D)K]):_-KXB?\I9/#?\ UTM/_2$U MCA_]ZI>IO5_W>KZ?JCLO^"N7_)*_ W_8:D_]$-7UY\#M#M_#?P9\"Z9:QK%! M;:)9H%0<9\E"3^)R?QKY#_X*Y?\ )*_ W_8:D_\ 1#5]F_#'_DFOA/\ [!%I M_P"B4IT_X-3_ !+_ -)(J?QJ?^%_^E'P)_P5PVV_B#X57:(OGJM[\Q'4!X" M?;/\Z]Z_X*.,6_8]\0L>IGT\_P#DQ'7@O_!7?_D)?"W_ ';_ /\ 0K>O>?\ M@HU_R9WK_P#UWT__ -*(ZC_F$A_U\?\ Z4C>7^\+_ _R.B_X)_?\FC^ /^N5 MS_Z535\U?L._\GX?&W_N)_\ IP2OI7_@G]_R:/X _P"N5S_Z535\;_ 'XP>% M?@!^W%\8+[Q[J#Z!8W=QJ5K'O_LM^$=/\31V\OAZ M?PK9K?I=2;(3#]F0OO;(PN JFOMK?_#U].IU:3Q%&S^R_P#TKI^AQ.G_ +>'[/O[.-A= M>#_ACX8UC5-/CN7FW:8N+669L!B)9Y#(WW0,[2, 8R*X#]H#]LOXC_''X+^) M]+TSX)ZEHGA&YMLWVO:CYTT4<(=6W*WE1HK9"X^9OH:Z/_@GG^T!\$OAU\(U MTG6]2TSPKXU2XF>_O-1B\MKQ"Y,;+/C!4(5786!!5CCG)F_;<_;4\)_$?X7Z MS\//AH]QXOO=0B\S4]0L[63[/9VL3"21LE06^Z,L!M"DDMGBM,1#EO"W,_P_ MX9"HRN^9>ZK_ *_FSV'_ ()F_P#)I^A_]A"]_P#1QKPW]CW_ )2,_&KZ:Q_Z M<(:]L_X)CW<=Q^RGID:'+6^IWL;\C@F3=_)A7S'\(/BUX8^ 7_!0+XNZKX[O MWT+3;N?5+9+AK>24!Y+N.6/*QJS89%)!QW%=$FOKG_;DO_28F$=<([?SK\Y' MMW_!6;_D@OAK_L88_P#TGGJ'X_:]=Z%_P3!\.?9':-KSP_HEG(R_\\W6'>#[ M$#'XU1_X*>^)]+\:?LQ>"->T6[6_TG4M:@NK6Y56421M;3%6PP!''8@&O53\ M)7^.'[ /AOP? 56_O?".G2632'"BXCABDB!/8%E )]":XVG'#U4UM.-UZ+5' M9=.O1:>\):_]O:,G_P""=OA>Q\-_LH^$I[2.-9]4:XOKJ11S)(9G09/J%1%_ MX#7MOQ1\,V/C+X;^)]#U*)9[&_TVX@E1AG@QGD>X."/<"O@K]AW]K[0_@CX; MN/A'\5S<>$K[1KN5;.ZO;=]B!W+/!, "48.S$,1M(/48&?3OVJO^"@'P^T#X M;:UH7@778?%7BO5K5[.!M.#-!:B12IE:7&TD G"J2=V,X'-7CHNKS.GKS+2W MFM%\OZT,L&_9N*GHXO7[]7\_^ <3_P $A]\?\$X?@3J MWP;^"MUJ'B&TDL-;\2W2WS6V@@)_V7N8D8?]\L:^@*\G_:N\%R_$']G+X@Z);Q>==3:5+-!&!DM) M%B5 /XA9,\A) LJGZ$LX_X":^D_C'\+=+^-'PTU[P;K Q9ZI;F,3 M#("&CE M7W5PK?A79C4_:773E?Y.QR81KEUZ\R^]M'*?LB>(+7Q)^S+\-;NT=7CCT2VM M&VG.)(4$3CZAD->O5^6?P1^.GC/_ ()[>,]1^&_Q/T*\O?!]S.UQ:W%GAO+) MX,]L6PLD;_+N3(*GGALJ?7OVE_VF_@?^T!\-K2PTOXTZAX+U2PNEU*UFM-*O MM_GJC*JN%B#8&X\HPP>><55=^TDZT-5)W]+O7[OQ%13@O93T:T_R^\^N?C7X MDMO!_P '_&NM7;JD%EH]U*2W0D1-M'XG _&OBC_@D+H$\/AWXD:VRL+>YNK. MS1NQ:-)78#Z"5?SKY.\;?M?_ !,^*WPUL_A=X@\1VE]I)O4676[A62:ZC5@( MQ/(>3&IPY)7>< MDBOUA_95^%>@?!_X'^'="\/:E::Y;/%]KN-7L9%DBO9Y, M%Y48<%>BK_LJM.$'1C5F_M))?)WOY=B9S51TZ:Z-M_E^:3/6Z^0O&_\ P3$^ M%7B;3[R33+O7-%\03.\ZZJ+SSLS,2VYXV&TC)Z+M/N*\=T/]HSQU^R;^U=XC MT3XR:WKVL^"=5WK8WEP\D\4,)DW07$*=,!24<(,YSP2H!^F?&?[?7P2\(^&9 M-6A\9VNNS&(O;Z;I:/+<3-C(0KM C)]9"H%<]O7J=%_?E2?1]=G MY^AX1^PK\=O'N@?&OQ)\"OB)JDVNW&F_:%L;Z\F:6:.2!OGC$C?,\;)EUW'* M[<#@X'W]7YS_ + /@7Q+\7?V@/%WQ^U[3VTS2[M[H6 8$+--,V&$9(&Y(X\H M6[D^H;'Z,5M5YN6'/\7*N;U_JQC3MS3Y/AN[>G_#W"O*_P!H+]H_P?\ LX^$ MCK'B:[WWDP86&DVY!N;UQV1>RC(RYX&?4@'9^.'Q:TSX'_"W7O&>JKYL&FP; MHK=3@SS,0L<8/^TQ SV&3VK\L/@[XV^'OQN^,.J?$G]HWQQ$HAE4V?A]K:XD MCFQRJ$1QL$MTS@)G+'.[C.[&$75DXIV2W?Z+S-I25.*DU>^R_KH>M?"WX-^/ M?^"@/Q(A^)OQ2$VD?#BTW@&U47[,ZJJ@= !@"O+[;]OC]GNRMXK>W\?6L$$2 M"..*/2[Q510,!0!#@ #M7JGPR^+G@SXZ>&[S5?!VKQZ_I$4[64\RP2Q 2;%9 MD(D52?E=>V.:JO&52BZ5.-HV?X]631DH555F[RO_ $D?(O\ P2/OED^$_C>S MW+OAUM)2O73A(XU':^3/VIOVDK3]IOXZP^"[_P 6KX0^$NDWK127 MOER2K.8R1)<%(U8NQ(*Q@C !!.,M14A:4,-3>L4E=^6]_1NUA0DI*IB)+1N_ M^7WVO<[WXL?&WQY_P4 \=/\ #+X46UQI?P]@D5M3U:X5HUG0-Q+.1]V/C*0_ M>8C)'&%^Y_@'\"?#G[._P[M?"_AZ-G53Y][?2C][>3D -*_IT "C@ >]>(_ M"?\ :F_98^"?@VT\,^$_&-II^G0#+M_9MX9;B3 #2ROY&7]$HN,'"BO5OKZ^7]= MK*_-)3J/T71?\'^O7X \3_M%^ /VCOVJ(M<^*7B'^POA;X5=O[(T>:RN)S?L MK#EUAC?&]E#-NQ\JJG/)KWG]J+]MKX)_$+]GOQKX8\-^,A?:QJ%AY%I:#2KV M(.V]3MW/"JKP#U(%>P2?L _ *:1G?X>P%F)8G^T;SDG_ +;5Y1^U1^QA\&?A M[^SWXX\1>'_!,.G:SI]AYUK=+?73F-]ZC.UI2IX)Z@UC4=-8?VWXOU. MB*DZ_/#JU:_1=$<__P $\?VFOAKX1^#_ (7^'>K>)/LGC&\U2>?L%R^]I MIOW0\Q8S&,Y'5N.^*^^J^"_^"=_[-WPX\5_!GPQ\0-5\,QW?B^TU2>6'4S=3 MJR-%,?+.Q9 AQ@=5Y[YK[TKKQ-N;ST]+65O^")QE'4J1[$8K\?OB%\/_ (Q?LH?$>>XTYM=M=(LKW[18:I:&5["XC#Y0 M/CY.1@-&WN,8()_82BNK#8AX:;FE>^Z.3%8=8JGR-VMLS\F_%?\ P4 ^,OQ6 M\/7/A:RL=+LGU",VTDF@6$QNY%8895+2/@D9&54'GC%>U?\ !/K]DOQ%X-\2 M/\1O&NERZ--';O!I.FWBE+@,XVO,Z'E/ERH#8)W,< 8)^^J*ZY8Z,82A1IJ/ M-N<<[5:\+_P#( MLZ1_UYP_^@"@#4HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "N.T#_DI'BG_ *YVW_HL5V-<=H'_ "4CQ3_USMO_ $6* M .QHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K MPC]IW_D4_&?_ &)NJ?\ I/-7N]>$?M._\BGXS_[$W5/_ $GFK2G\@H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@"7_EQFK*K5_P"7&:LJ@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"M.U_P"0=^/]:S*T[7_D'?C_ %H 91110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %^W_ -2M M25';_P"I6I* *NJ:9;:UI=YIU[%YUG=PO;S1[BN^-U*L,@@C()Y!S7#_ A^ M /@+X"VNI6W@70?[#@U)TDNE^V7%QYC("%.9I'Q@,>F.M>A44+2]NHGK:_0* M***!G'?%3X0^$OC7X97P]XTTG^V='6=+D6WVF:#]XH(5MT3JW 8\9QS6WX3\ M*Z7X'\,Z9X?T2U^Q:1IENEK:6_F/)Y<2#"KND^.-%_MO3[.X^U00_:I[?9+M*[LQ.A/#$8)QS75Z7H-AHN@ MVFBVELJ:7:6R6<-NY+J(54(J$L26&T $-,T_PUJD)@ MOK*SB\DW*D8R\B$.S>C%MP[&O0**=WR\O0/M2%D9^./F)KUBBAMR?,]Q)**LCR/X;_LE_"'X2ZHFI>%_ MNG66I1MNBO+EI+R:)O6-YV=D/NI%>N444W)RW8));(\R^*'[-'PP^,UU]J\8 M^#-.U>^P%-\ ]O2PL.C1M.[E#[K@U[#12BW'X= DE+XM0HHHI#"L;QEX/TCX@>%M3\.:_: M?;]&U*%K>[MO,>/S(SU&Y"&'U!!K9HI-)JS&FUJCDOA?\*?"OP9\*IX;\':7 M_8^BI,\ZVOVB6?#OC<=TK,W.!QG%=;115-N3NR4E'1!7FVH_LY_#S5OBS;?$ MR[\/>;XWMRABU3[;<#:5C\M?W0D\LX7CE?UKTFBDM&I+=#W33V9P7Q<^!?@? MX[:58Z;XYT3^W+*QF-Q;Q?:Y[?9(5*DYB=">#T)(KL]+TVVT;3;33[./R;2T MA2"&/<6VHJA5&223@ ^(WPO\ #'Q:\'7'A7Q7IG]JZ#<-&TEI]HEA MW&-@R?/&RL,$ \'M7544=.7IO\^X^M^NWR.=^'_P_P! ^%OA'3_#'A>P_LS0 M[ ,MM:^=)-L#.7;YY&9C\S$\D]:X3XH?LE_"3XRZ[_;7B[P7:ZEJQ4*]Y#<3 MVLL@ P-[0NF\@8 +9( KUVBFVY2YGN))17*MCRWQ9^S'\-/'7P]T#P/KGAL MW_A?02ITZQ.H72>1M0HO[Q90[85B/F8UZ#H/A^P\+Z!I^B:9;_9]+T^VCM+: MW+,^R)%"JN6))P !DDD]ZT:*;DW>[WU?FPY4K:;:+T/"O%?[#GP,\::Q+JFI M_#RQ%Y*VYS8W%Q9(Q)R28X)$7)/?%=KX8^ /PZ\%^$]4\-:%X/TO2]'U2V:T MOX;:':]U$RE2LDOWWX8\EB1GBO0**7V>3IV']KFZG"_"7X(^#/@7HMWI'@C2 M'T73;JX^U2VYO;BX4R[0I8>=(Y7(4#C&<"N?^*7[*/PG^-&M+K'C#P;:ZIJJ MJ$-Y%//:RR # #M"Z%\#@;LX'2O6J*&W)\SW$DHJRV/+?$W[,?PU\8?#?0_ M.L>&S>>$]$=7T_3SJ%TODE595_>+*)&P'8?,QZ^PKO\ PSX;T[P;XE:9;1V=I;[V?RXHU"HNYB6. ,DD^IK3HI\S=]=]7Z]PLM--M%Z=CSCXH M?LY_#7XT2++XR\'Z?K5TJA!>,K0W(4=%\Z,K)@>F[%8WP[_9#^#WPJU6/4_# M7@/3K748V#Q7=TTMY+"PZ-&T[N4/NN#7L%%*,G'X= DE+XM0KSGX8_L\_#[X M-ZYK>L>#_#_]D:CK1S?S?;;B?SOF9_NRR,%^9B?E ZUZ-126CNMQO569%=6\ M=Y;2V\R[XI4*.N2,J1@CCVKS_P"#_P"SU\/_ ("QZI'X$T#^PDU,QM=C[9<7 M'F%-VS_72/C&]NF.M>BT4TW&]NHG[UK] I&4.I5@&4C!!Z&EHI#/@'X)ZG&+WCIZKI\^GR1+7[R4EM+7Y]?OW^\R MO%W@GP_X^TA]*\2Z)I^O::QW&UU&V2>//9@&!P1ZCD5XI)_P3\^ $E\;H_#R M$2EMVU=3O1'G_<$VW'MC%?0U%0O==T4]59GE^J?LP_"G5O MQX/D\!Z)!H$Q M#M!:6BPN) ,"42( XD XWYW8XSBN;_9K_9-T7]F/4/%#:#X@U;4],UAXF@L- M0D!6T"[MV-N%=FR/FV@X4#FO=**I2:;:>^Y+BFDFMCF?'WPS\*?%+1O[*\6^ M']/\06 )9(KZ 2>6Q&-R-U1L?Q*0:\HT/]@WX"^']42_M?AU92SH=P6]N[F[ MB_&*65D/T*U[[123<=44_>5F0V=G;Z;9PVMI!':VL*".*"% B1J!@*JC@ #L M*FHHI!LW/G#_ (=V_L]_]$__ /*UJ'_R M17K'PE^"_@WX&^'[G0_!&C?V)I=Q2P?:IKC=*55"VZ5W8?*BC ...E=O1 M5\\K6N3RQWLCKI?C'P[8>(+)"6C6\B#-$2,%HW&&0X[J0:\^ M\$_L5?!+X>ZU%J^B?#^P34(6#Q2WTT]Z(V!R&59Y'56! ((&1VKVVBIBW'6. M@VE)69'<0)=020R F.12C $C@C!Y'2OG4_\ !.[]GQB2? &2>I_MK4?_ )(K MZ.HI+1W0]U9GSA_P[M_9[_Z)_P#^5K4/_DBNL^&/[(/PD^#?BJ/Q)X/\)_V/ MK4<3PK=?VE=SX1QAAMEE9>1[5['15\\NY/+%[H*P_&W@G1?B-X4U+PUXBLO[ M0T74HO)NK7S7B\Q,@XW(RL.0.A%;E%9M)JS+3:=T6.U^T2SX9VW,=TC,W)]ZR/C]\6+/X(_"'Q+XPNV3?86K?98F/^NN M6^6&,?5RN?;)[5Z%7E_QJ_9Z\.?'R3PW'XJO-4DTG1;T7PT>UFC2TO9!P/M M,99@!N&%9>&;UHG>IHWOI?R_X;8(6AK;;IW_ .'>YXG_ ,$X?@K>^!_A?J'C MSQ#&Q\3^-IA?.TP_>+:Y+1Y]W+/(?9D]*^O*9%$D,:1QHL<: *J*, = !Z4 M^MJDU.5TK+IZ=#*$7%>\[MZOU"BBBLC0**** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ KCOB7_P >NA?]A:#^35V-<=\2_P#CUT+_ +"T'\FH [&BBB@#C?AI_P > MVO?]A:?^2UV5<;\-/^/;7O\ L+3_ ,EKLJ "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** ,'QW_ ,B?J_\ U[M5KPO_ ,BSI'_7 MG#_Z *J^._\ D3]7_P"O=JM>%_\ D6=(_P"O.'_T 4 :E%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QV@?\E(\4_\ M7.V_]%BNQKCM _Y*1XI_ZYVW_HL4 =C1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !7DWQ@\+_\)Q?:CX<^T_8O[8\/W>G_ &GR M_,\KS4DCW[.Q#5G+\%_D3+B#,IQ<95='Y1_P C1TS_ %,_^>U) M2Z9_J9_\]J2N ^>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** )?^7&:LJM7_EQFK*H *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ K3M?^0=^/]:S*T[7_D'?C_6@!E%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 7[?_4K4E1V_^I6I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "N.^)?_'KH7_86@_DU=C7'?$O_ (]="_["T'\FH [&BBB@#C?A MI_Q[:]_V%I_Y+795QOPT_P"/;7O^PM/_ "6NRH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH P?'?_ ")^K_\ 7NU6O"__ "+. MD?\ 7G#_ .@"JOCO_D3]7_Z]VJUX7_Y%G2/^O.'_ - % &I1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<=H'_)2/%/ M_7.V_P#18KL:X[0/^2D>*?\ KG;?^BQ0!V-%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %<'XB_Y*1IO_7@_P#Z$U=Y7!^(O^2D M:;_UX/\ ^A-0!LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% &CIG^IG_ ,]J2ETS_4S_ .>U)0 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110!+_P N,U95:O\ RXS5E4 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 5IVO\ R#OQ_K696G:_\@[\?ZT ,HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"_;_ .I6 MI*CM_P#4K4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!7'?$O\ X]="_P"PM!_)J[&N.^)?_'KH7_86@_DU '8T444 <;\-/^/;7O\ ML+3_ ,EKLJXWX:?\>VO?]A:?^2UV5 !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% &#X[_Y$_5_^O=JM>%_^19TC_KSA_\ 0!57 MQW_R)^K_ /7NU6O"_P#R+.D?]>U)2Z9_J9_\ /:DH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH E_Y<9JRJU?^7&:LJ@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M.U_Y!WX_U MK,K3M?\ D'?C_6@!E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 7[?_ %*U)4=O_J5J2@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCOB7_P >NA?] MA:#^35V-<=\2_P#CUT+_ +"T'\FH [&BBB@#C?AI_P >VO?]A:?^2UV5<;\- M/^/;7O\ L+3_ ,EKLJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** ,'QW_ ,B?J_\ U[M5KPO_ ,BSI'_7G#_Z *J^._\ D3]7 M_P"O=JM>%_\ D6=(_P"O.'_T 4 :E%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 5QV@?\E(\4_\ 7.V_]%BNQKCM _Y* M1XI_ZYVW_HL4 =C1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !7!^(O^2D:;_UX/_Z$U=Y7!^(O^2D:;_UX/_Z$U &S1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 :.F?ZF?_/:DI=,_P!3/_GM24 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2 M_P#+C-656K_RXS5E4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 5IVO_(._'^M9E:=K_R#OQ_K M0 RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** +]O_J5J2H[?_4K4E !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !7'?$O_CUT+_L+0?R:NQKCOB7_P > MNA?]A:#^34 =C1110!QOPT_X]M>_["T_\EKLJXWX:?\ 'MKW_86G_DM=E0 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@^._^ M1/U?_KW:K7A?_D6=(_Z\X?\ T 55\=_\B?J__7NU6O"__(LZ1_UYP_\ H H MU**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ KCM _P"2D>*?^N=M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:*** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X/Q%_R4C3?^O! M_P#T)J[RN#\1?\E(TW_KP?\ ]":@#9HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -'3/]3/_ )[4 ME+IG^IG_ ,]J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"7_EQFK*K5_P"7&:LJ@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "M.U_P"0=^/]:S*T[7_D'?C_ %H 91110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% %^W_ -2M25';_P"I6I* "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "N.^)?\ QZZ%_P!A:#^35V-<=\2_^/70O^PM!_)J .QH MHHH XWX:?\>VO?\ 86G_ )+795QOPT_X]M>_["T_\EKLJ "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,'QW_R)^K_ /7NU6O" M_P#R+.D?]>#_\ H35W ME<'XB_Y*1IO_ %X/_P"A-0!LT444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &CIG^IG_SVI*73/]3/ M_GM24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 2_\N,U95:O_+C-650 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !6G:_\@[\?ZUF5IVO_ "#OQ_K0 RBBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +]O M_J5J2H[?_4K4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !7'?$O_CUT+_L+0?R:NQKCOB7_ ,>NA?\ 86@_DU '8T444 >7^$;'Q#S@&I3!TEAW$OQD].F,?E6_P#V3XT_Z#ME_P" P_PI/AI_Q[:]_P!A M:?\ DM=E0!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H. MV7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+ M_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^- M/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ M $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9 M/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[) M\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10! MQW]D^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C M^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T M4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_ MPH_LGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^ M%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@ M,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+_P ! MA_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[ M9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $'; M+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9/C3_ M *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?] M!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D M^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?& MG_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <= M_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_L MGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C1 M0!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 ><^*M-\5Q>'=0>\UBT MGM5A)DC2W"EE] <5/H>E^+I-$T]K?6K.*W:WC,:-;@E5VC )QZ5T/CO_ )$_ M5_\ KW:K7A?_ )%G2/\ KSA_] % &%_9/C3_ *#ME_X##_"C^R?&G_0=LO\ MP&'^%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H. MV7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+ M_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^- M/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ M $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9 M/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[) M\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10! MQW]D^-/^@[9?^ P_PH_LGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C M^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T M4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_ MPH_LGQI_T';+_P !A_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^ M%=C10!QW]D^-/^@[9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@ M,/\ "C^R?&G_ $';+_P&'^%=C10!QW]D^-/^@[9?^ P_PH_LGQI_T';+_P ! MA_A78T4 <=_9/C3_ *#ME_X##_"C^R?&G_0=LO\ P&'^%=C10!QW]D^-/^@[ M9?\ @,/\*/[)\:?]!VR_\!A_A78T4 <=_9/C3_H.V7_@,/\ "C^R?&G_ $'; M+_P&'^%=C10!QW]D^-/^@[9?^ P_PKG-)T_Q*WC378X=5MDOT2'SYF@!5P4& MW QQ@5ZI7':!_P E(\4_]<[;_P!%B@ _LGQI_P!!VR_\!A_A1_9/C3_H.V7_ M (##_"NQHH X[^R?&G_0=LO_ &'^%']D^-/^@[9?^ P_P *[&B@#CO[)\:? M]!VR_P# 8?X4?V3XT_Z#ME_X##_"NQHH X[^R?&G_0=LO_ 8?X4?V3XT_P"@ M[9?^ P_PKL:* .._LGQI_P!!VR_\!A_A1_9/C3_H.V7_ (##_"NQHH X[^R? M&G_0=LO_ &'^%']D^-/^@[9?^ P_P *[&B@#CO[)\:?]!VR_P# 8?X4?V3X MT_Z#ME_X##_"NQHH X[^R?&G_0=LO_ 8?X4?V3XT_P"@[9?^ P_PKL:* .._ MLGQI_P!!VR_\!A_A1_9/C3_H.V7_ (##_"NQHH X[^R?&G_0=LO_ &'^%'] MD^-/^@[9?^ P_P *[&B@#CO[)\:?]!VR_P# 8?X4?V3XT_Z#ME_X##_"NQHH M X[^R?&G_0=LO_ 8?X4?V3XT_P"@[9?^ P_PKL:* .._LGQI_P!!VR_\!A_A M1_9/C3_H.V7_ (##_"NQHH X[^R?&G_0=LO_ &'^%']D^-/^@[9?^ P_P * M[&B@#CO[)\:?]!VR_P# 8?X4?V3XT_Z#ME_X##_"NQHH X[^R?&G_0=LO_ 8 M?X4?V3XT_P"@[9?^ P_PKL:* .._LGQI_P!!VR_\!A_A1_9/C3_H.V7_ (## M_"NQHH X[^R?&G_0=LO_ &'^%']D^-/^@[9?^ P_P *[&B@#CO[)\:?]!VR M_P# 8?X4?V3XT_Z#ME_X##_"NQHH X[^R?&G_0=LO_ 8?X4?V3XT_P"@[9?^ M P_PKL:* .._LGQI_P!!VR_\!A_A1_9/C3_H.V7_ (##_"NQHH X[^R?&G_0 M=LO_ &'^%']D^-/^@[9?^ P_P *[&B@#CO[)\:?]!VR_P# 8?X4?V3XT_Z# MME_X##_"NQHH X[^R?&G_0=LO_ 8?X4?V3XT_P"@[9?^ P_PKL:* .._LGQI M_P!!VR_\!A_A1_9/C3_H.V7_ (##_"NQHH X[^R?&G_0=LO_ &'^%']D^-/ M^@[9?^ P_P *[&B@#CO[)\:?]!VR_P# 8?X4?V3XT_Z#ME_X##_"NQHH X[^ MR?&G_0=LO_ 8?X4?V3XT_P"@[9?^ P_PKL:* .._LGQI_P!!VR_\!A_A1_9/ MC3_H.V7_ (##_"NQHH X[^R?&G_0=LO_ &'^%']D^-/^@[9?^ P_P *[&B@ M#CO[)\:?]!VR_P# 8?X4?V3XT_Z#ME_X##_"NQHH X[^R?&G_0=LO_ 8?X4? MV3XT_P"@[9?^ P_PKL:* .._LGQI_P!!VR_\!A_A1_9/C3_H.V7_ (##_"NQ MHH X[^R?&G_0=LO_ &'^%M>MU MP?B+_DI&F_\ 7@__ *$U %'^S?%/_07M?^_ _P */[-\4_\ 07M?^_ _PKIZ M* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z>B@#F/[-\4_]!>U_[\#_ M H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ _P */[-\4_\ 07M?^_ _ MPKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z>B@#F/[-\4_]!>U_ M[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ _P */[-\4_\ 07M? M^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z>B@#F/[-\4_] M!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ _P */[-\4_\ M07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z>B@#F/[- M\4_]!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ _P */[-\ M4_\ 07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z>B@# MF/[-\4_]!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ _P * M/[-\4_\ 07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP/\*Z M>B@#F/[-\4_]!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M?^_ M_P */[-\4_\ 07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[7_OP M/\*Z>B@#F/[-\4_]!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/_07M M?^_ _P */[-\4_\ 07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ $%[ M7_OP/\*Z>B@#F/[-\4_]!>U_[\#_ H_LWQ3_P!!>U_[\#_"NGHH YC^S?%/ M_07M?^_ _P */[-\4_\ 07M?^_ _PKIZ* .8_LWQ3_T%[7_OP/\ "C^S?%/_ M $%[7_OP/\*Z>B@#$L=+\7-'+Y>M6:COFW'/Z4?V7XN_Z#5G_P" X_PKK-,_ MU,_^>U)0!RG]E^+O^@U9_P#@./\ "C^R_%W_ $&K/_P''^%=710!RG]E^+O^ M@U9_^ X_PH_LOQ=_T&K/_P !Q_A75T4 U_[\#_ KO/^7&:LJ@#F/[-\4_]!>U_P"_ M _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ OP/\*/[-\4_]!>U_[\#_ M KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ _P *Z>B@#F/[-\4_]!>U M_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ OP/\*/[-\4_]!>U_ M[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ _P *Z>B@#F/[-\4_ M]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ OP/\*/[-\4_] M!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ _P *Z>B@#F/[ M-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ OP/\*/[- M\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ _P *Z>B@ M#F/[-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ OP/\ M*/[-\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ _P * MZ>B@#F/[-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07M?\ MOP/\*/[-\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M?^_ M_P *Z>B@#F/[-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?%/_07 MM?\ OP/\*/[-\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/_07M M?^_ _P *Z>B@#F/[-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC^S?% M/_07M?\ OP/\*/[-\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"C^S?%/ M_07M?^_ _P *Z>B@#F/[-\4_]!>U_P"_ _PH_LWQ3_T%[7_OP/\ "NGHH YC M^S?%/_07M?\ OP/\*/[-\4_]!>U_[\#_ KIZ* .8_LWQ3_T%[7_ +\#_"KT M.E^+S9Y76[,)G[OV8>OTK9K3M?\ D'?C_6@#D?[+\7?]!JS_ / +K'Q#;?V*VJZG;WD!U*$*D4.TA^<'I MTQG\Z]0KCOB7_P >NA?]A:#^34 =C1110!QOPT_X]M>_["T_\EKLJXWX:?\ M'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?\ T 55\=_\B?J__7NU6O"_ M_(LZ1_UYP_\ H H U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ KCM _P"2D>*?^N=M_P"BQ78UQV@?\E(\4_\ 7.V_ M]%B@#L:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH *X/Q%_R4C3?^O!_P#T)J[RN#\1?\E(TW_KP?\ ]":@#9HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** -'3/]3/_ )[4E+IG^IG_ ,]J2@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"7_EQF MK*K5_P"7&:LJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "M.U_P"0=^/]:S*T[7_D'?C_ %H M91110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% %^W_ -2M25';_P"I6I* "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "N.^)?\ QZZ%_P!A:#^35V-<=\2_ M^/70O^PM!_)J .QHHHH XWX:?\>VO?\ 86G_ )+795QOPT_X]M>_["T_\EKL MJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,' MQW_R)^K_ /7NU6O"_P#R+.D?]>#_\ H35WE<'XB_Y*1IO_ %X/_P"A-0!LT444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &C MIG^IG_SVI*73/]3/_GM24 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2_\N,U95:O_+C- M650 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !6G:_\@[\?ZUF5IVO_ "#OQ_K0 RBBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** +]O_J5J2H[?_4K4E !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !7'?$O_CUT+_L+0?R:NQKCOB7_ ,>NA?\ 86@_DU ' M8T444 <;\-/^/;7O^PM/_):[*N-^&G_'MKW_ &%I_P"2UV5 !1110 457O\ M4+72K.6[O;F&SM8ANDGN) B(/4L>!7'V?QU^&VH7BV=K\0O"MS=L=JV\.M6S MR$^@4/FJC%R^%7)E)1^)V.XHI%8.H92&4C((Z&EJ2@HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@#!\=_\ (GZO_P!>[5:\+_\ (LZ1_P!>'[/6=/U"VM3=[=6@AC61 RJ=I25\D%AP<<5[I6E6C4H2 MY:BLS.G5A67-3=T%%><_'+X[^'/V??"EOK_B2.]N+>XNEM(;?3HT>9W*LV0' M=!@!3DY]*X7X;_MI>#?BCH/B_6=)T/Q)#I_A>P.H7TMW;6Z[EPQ")MG;+D(Q M .!\IY%5'#U9TW5C'W5NPE6A&:IM^\]D?0%%?(?_ \[^%O_ $ /%_\ X!VO M_P DT?\ #SOX6_\ 0 \7_P#@':__ "375_9V+_Y]LYOKV&_G1]>45\A_\/._ MA;_T /%__@':_P#R37JTO[5?A.'X"1?%LZ=K1\-R2^4+400_;,^>8/N^;LQN M&?O]/?BLJF"Q%))S@U=I?-[(N&*H5&U&2=DW\EN>S45\A_\ #SOX6_\ 0 \7 M_P#@':__ "33HO\ @IQ\+)'"MHGBV,?WFLK;'Z7!K3^SL7_S[9'U[#?SH^NJ M*\W^#_[0W@3XY6T[>$]:6ZN[=0T^GW"&&YB'J4;JO(^9D5Q5*J MRV$-UJGB66%BDDNB6J21!@>0'D=%8>ZDCWK<^%'[;7PN^+FL6^D6.I76BZO< ML$M[+6H! TS'HJNK-&6)X"[LGL#79]3Q/)[3V;MZ'*\50C+DJ**\[^ M+_Q^\$? S3X;GQ;K"VDUP";:Q@0RW,^.I5!V_P!IL+GC-(-$A8X^V:A8H81]?*ED;_ ,=KZEWD&H:?=1B6"ZMI \>_"'X]>"?CEILU MWX2UA;R2W ^TV4R&*YM\]-\;A5%2G.E+DFK,J$XU(\T'=!17A M'QJ_;(\%? OQM;^%=:T[7=2U2:WCN1_9-O#(BAV954EY4.[Y,Y;/ R2>!FJE1J1A&;6DMO,2J0E M-TT]5N;=%?*&J_\ !2OX3:??O;P6?B74XE.!=6MC$L;>X$DR-CZK7L?P=_:- M\!?'2&8>%=9$]] GF3Z;=1F&YB7IN*'[PR0-RD@$@9K:>#Q%.'/.#2]#&.*H M2ER1FF_4],HHKY:\8?\ !1;X:^#/%6KZ!=:1XGNKK3+N6SEFM+6V:)WC8JQ0 MM< D9!Z@?2LJ-&I7ERTHW9K4JPHQYJCLCZEHKY#_ .'G?PM_Z 'B_P#\ [7_ M .2:]W^!GQST']H#PC<>(O#UIJ-G907;V31ZG'''(7548D!'<8PX[^O%;5,' MB*,>>I!I&,,70J24(23;/1:*Y#XG?%KPI\'?#YUGQ;K$.E69;9$&!>69_P"[ M&B@LQ^@XZG YKY_M/^"E?PFN-46UDL_$MK 7VF]FL8C"!_>(68OC_@.?:LZ. M&K5TW2@VD:5*]*C95))7/J^BL3P;XVT+XA>';77?#FIV^KZ3=#,5S;MD'U!! MY5AW4@$=Q6W6$HN+<9*S1K&2DN:+N@HHHJ2@HHHH *X[0/\ DI'BG_KG;?\ MHL5V-<=H'_)2/%/_ %SMO_18H [&BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "N#\1?\E(TW_KP?\ ]":N\K@_$7_)2--_Z\'_ M /0FH V:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@#1TS_4S_P">U)2Z9_J9_P#/:DH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH E_Y<9JRJU?\ EQFK*H **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K3M?\ MD'?C_6LRM.U_Y!WX_P!: &4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!?M_P#4K4E1V_\ MJ5J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KCOB7_ M ,>NA?\ 86@_DU=C7'?$O_CUT+_L+0?R:@#L:*** .-^&G_'MKW_ &%I_P"2 MUV5<;\-/^/;7O^PM/_):[*@ KS3]H/XY:/\ L_?#B]\3ZH/M%QGR+"Q#8:ZN M"#M0>@X)8]@#WP*]+K\M_P#@IQ\1+CQ!\9].\*)(?L'A^Q1S&#P9YP'9B/\ M<$8_/UKHP]'ZQ6C2[[^G]:?,YL36^KT95>VWKL>?Z?'\8/V\OB1+;M?->)!^ M^D$TC0Z9I<9) PHS@GH,!G;!SG!(]G\0?\$J=?L?#LUSI'CVRU36$CW+I\^F MM;Q.P'W1-YK?@2@]\5]._L*_"VW^&G[/'A^7R%35-?C&KWDNWYF\P9B4^RQ[ M./4MZU]"5ZF*QDJ$W1PWNQCIMUZGDX7!0Q%-5\3[TI:[O;I_738_*+]C#]I3 MQ-\%_BII_@+Q%=7,OA>^O?[+FT^[?N /PRC@@DXR!7ZNUS$/P MO\&6^K3ZI%X1T*/4YY3/+>IIL(FDD)W%V?;N+9YR3G->'_MP?M#>(?@GX'M+ M'PC8W$OB'5]X&HI;F6.PA7&Z0\%=Y)PH/'!/;!Y,166,G#EC:;T?G_PVOR.W M#4'@H3YIW@M5Y+_@Z?/U/I>BOR+^'O[)OQF_:DT%_&EQK,$MM-(ZP7?B?49V MEN2K%6* )(0 P*_-M&0<5E?!WXS?$+]EGXT1^'+[4;IK"RU(6&K:%)<&:V== MX5R@SA6 ^977!X&<@D5U1RU2DZ4:B,?MB M>/[KX;?LZ^+]7L+R?3]3:!+2TN;:0QRQR2R*@9&!!5@"2".1BOSH^ ?[0'QT MUGQ)J&@^%-;\0>+_ !+K%H;6U_M34Y;J*Q7<&><),QC5@ ';A0QZY%<6'PD M\3&4HOX?^'._%8R&%E",E?F_X8_7ZBOQR_:2_9U^*WP9;3/%OCK6HM;FU*?8 MNJ6NHRW$L,^"P1VD56!P"05R/EZ]*^Z?^">OQBU[XK_!N\@\1W.-+WP'\,[ZXTS2K:![GX@ZF]K)=6L)OKFS74'DU.%0-S.3MVDJ,DA9"?;/%*G M@[TU5K34$]K_ -?UU'5QUJCI48.(O%OB*?X;^+]2 MGUIFMGNM*U"\D,DZ[.7A9SRXVY923D;2.F )?VZOVU-9\'^(;GX=^ +YM.O; M90-6UF _OHW89\B(_P ) (+..03@8P:FI@JL*ZH+5O5>GH?\$_\ ]J3Q,OQ B^&'C#4;K5+*^61-.FU"1GGM+B-2QA+-R495 M8!2?E( &,FMY9>N67LZBE*.Z.>.8OFC[2FXQELS]&Z*^,_\ @I5\7==^'G@W MPAI?AK7M0T#4]1OI;B2XTN[DMIC#$F-I9"#M+2KQG'RCTKY4\"_%_P".'QC\ M"K\-_!M]XG\1ZI<7,E[JNIRZA))-Y1"K'!Y\CXAA&TDY9=S.1_O84,%/$4G5 MB[*__#O^NQOB,=##U52DFW:^GX+Y_J?KO17RE^P/^S?XB^!_A;Q!J/C&VDT_ MQ%JUR(Q8FY2988(^C9C9E+.Q8YR>%7WKZMKFKTXTIN$).(9I[N2 A9EMY%,<6TL"/N?.,@C]Y7P7LU#]I; M]HXJI?S_ !1K9YQS# S]?HD0_):_9C2]-MM'TVTL+.(06EK"D$,:]$15"J!] M !2QO^QY?2POVI:O\W^+_ >'?UG'SKK:&B_)/[DW\SY-_P"'8GPM_P"@_P"+ M_P#P,M?_ )&K\]_B=X-LO!?Q:\2^%[&6XET_3=7FL(9+AE,K1I*4!8@ %L#L M /:OW$K\6/CY_P G(>._^QDNO_2AJWR7%U\1BN2K)M6_5&6:X:C1PKG3C9W7 MY2/NB+_@F/\ "YXT8Z]XOR0#_P ?EK_\C4?M4?"W2O@Q^Q!J'A#1+B\NM-L+ MNW,4NH.CS'S+P2-N**HZN<8 XQ7UW;_ZB/\ W1_*OG7_ (*"?\FO^(O^OJS_ M /2A*\2.,KUJU*%2;:YX_P#I2/4CAJ-.C.<(V?)+_P!)9\+?L;_L_P#A[]H; MQUK>B^([S4[*ULM-^V1OI)/^"7_@B;2;A?#_ M (I\06>I[#Y,FI/!<0[NP94B1L?0_GTKY9_8W_: \/?L\^.M;UKQ'9ZG>VM[ MIOV.--+BCDA/;BOJ7Q-_P %0/!4.DSGP]X5UZ\U/81"FIK! M;P[NQ9DED./8#GU%?1YC]?\ ;_[-?EMT[GA8#ZI[-_6+7OU[61\,^"_$FN? M/XR6M]%*;?5?#^IM!$] M=_:$^,UK811FXU+7=1:ZO98U(2)&> M?!1Y_CL[_A^%[V.K*OXM7V?P=/Q_&V_R'5\T_P#!0CQCJ7A']G>\CTR5[=M6 MOH=.GEC.&$+*[N,^C>7M/LQ'>OI:O/OCU\._#OQ0^%>NZ'XIO$TS26B\]M2= MP@LW3YEFR3C"DA? M/XC:5'X6>:#2=5M#=16A'"RH2C^\OOIW[]K:?U<_4#]F[QO>>-/V?_!OB+696:]ETT&YGD^\Y MC+(9#[MLW?C7Y=^)M4UK]J[]I HER1/K^IBTLVDRR6MJ&(3CT2,%B!U.3WK] M5/$&CZ=X)^ NK:;X?"QZ9IOAV:*R*-N'EI;ML;<.N0 <]\YK\R?V$+=)_P!J M3P=O7=L%VZ_46LN#7C9:X.OB<3%?"FU\^9_HCTL=ST\+0H2>LK)OT27ZGKO[ M1W_!/_1_A5\);SQ7X7UW5-2O=)5);^WU#RRDL>0KO'L52FW.[!+< \UT'_!, M7XJWEQ+XC^'UY.TUK##_ &KIZN<^5\X291[$O&V/7<>]?6?[1T:S? /XA(Z[ ME.AW>1_VR:OSG_X)X7S6G[3&E1*S 75A=Q,!T($9?G\4%/"UJF-P>(A7=[*Z M^YO]/Q#%4:>$KT)TE:[M^*7ZGKO_ 4X^*MTNH>'OA]9W#1VAA_M2_C4X\QB MQ6%3Z@;7;'J0>U97[.O_ 3[T;XH_"6Q\5>)]>U33K_5XVFL;?3Q&$ACR0C2 M;U8ONQNP"O!'->:?\%"[AY_VFM85SE8K&T1/8>4&_FQK])/@#;I:_ WX?11K MM1=!L<#_ +8)4.I+"973E1=G)WOZW?\ E]QC(0PST.T]J_9%'61%=3E6&0?45^ M0/[<,:Q?M0^-M@V[I;=C]3;Q:2]M@Z&*E\36OG=)_G?[R\#'V6-K8:&U]/OM^37W'Y^ZW_Q?7_@H4MO M_P ?5C#KR1$=5\BS7+CZ'R6_[ZKKO^"H7C'4G\8>$O"PE=-(CL6U$Q*<+),T MCQ@GU*JG'IO/K69_P39\-R^*OC3XI\77@,KZ?8MF0C_EO<2=?KM27\Z]]_;^ M^$_A#QE\/;7Q'KGB.U\*ZSI.Z.QNKL,R70;DVY1 78DC(*@E>3C&:WK3AA<7 MAJ,M5327S:M_DR*,98FCB:L-'-Z>BU_*Z_/0XW]F?]ASX;>+/@GHFO\ BNQN M-:UC7+;[6)TO985M5;.Q8UC8 D#!)<-SGMQ7R4]K>_LW?M2?8M$OI;F3P_KB MPQ2K]^>$N 48#J6C;:P]S6W\*?VW/B1\'O!"^%-(DTK4-,M]RVDFI6SR2VJL M2<1E77(R20'#8SCIQ6_^QOX3\._&'X\)K_COQ; VNI>_VC;Z3E9Z;]=-.FFC/*G*C6PU.A25JEUK\M=?6 MS1^INJ:A'I6F7=[,<16T+S.?]E5)/\J_&;X/_#.Z_:3^-JZ#_:7]DOJ\MU>S MWWV?S_* 5Y2=FY_"OU4_:<\2'PG^S_X]U%7\N1=*FAC;T>0>6OZN M*_(?X7>(_&?AOQ.6\!2:A'X@NX'M4_LF RW+1M@L(P%+ _*.5P<9YZUXV20E MRUYQWLDGV>O_ #U\VDK4H/9N[]-/\V?9G_#JK_JJ'_EO_\ W57T_P#LS? / M_AG7P#=^&O[=_P"$@\^_DOOM7V/[-MW(B[=OF/G&S.<]^E?FS:_M"?'KX,>) M('UC7_%5G>'$G]G^*A/*DJ9Y'EW'.#TRN#Z$5^DG[,_[05C^T/\ #L:W%;KI M^KV;_9M2L5;<(I<9#)GDHPY&?0CG&:68QQT*#E4J*=/K9+_(C!RP3)SZ8]*]W\ M>?\ !-?2_#?PCO\ 5-+\1ZE?>,-/LFNI8I%C^QW#(NYXT0+O7(! )<\XXYX^ M7_A;_P 33]J3PRUS^\,WBV!WSW)NP?YU^R6L*)-(OE895H'!'_ 36F/Q%3+\ M+0A0=K*[\[6_6]QX6C3QF,K.LKZV^5VOR2L?FE_P3=^*MYX;^+4_@N:=FTCQ M!!(\<#'Y4NHD+AP.V45U..N%]*_3FOQF_97O#I?[3'@%XRR9UF.'Y?1R4Q], M-7[,UCGM-*M"HNJ_+_@?D/*)-0G2?1_G_P ,%%%%?-'OA1110 5QV@?\E(\4 M_P#7.V_]%BNQKCM _P"2D>*?^N=M_P"BQ0!V-%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %>?^*[F&S^(%E<7$J001:=)))+(P M544%B6)/ '>O0*\@^-?^LU?_L6[W_T7)6M*'M*D8/JTC&O4=*E*HNB;^XV? M^%D>$O\ H:=%_P#!A#_\51_PLCPE_P!#3HO_ (,(?_BJ^"J*_1?]5*/_ #]? MW(_'O]?,3_SXC][/O7_A9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#B MJ^"J*/\ 52C_ ,_7]R#_ %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P + M(\)?]#3HO_@PA_\ BJ^"J*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1 M?_!A#_\ %4?\+(\)?]#3HO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O M7_A9'A+_ *&G1?\ P80__%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W( M/]?,3_SXC][/O7_A9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J M*/\ 52C_ ,_7]R#_ %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P +(\)? M]#3HO_@PA_\ BJ^"J*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1?_!A M#_\ %4?\+(\)?]#3HO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O7_A9 M'A+_ *&G1?\ P80__%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W(/]?, M3_SXC][/O7_A9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J*/\ M52C_ ,_7]R#_ %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P +(\)?]#3H MO_@PA_\ BJ^"J*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1?_!A#_\ M%4?\+(\)?]#3HO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O7_A9'A+_ M *&G1?\ P80__%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W(/]?,3_SX MC][/O7_A9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J*/\ 52C_ M ,_7]R#_ %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P +(\)?]#3HO_@P MA_\ BJ^"J*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1?_!A#_\ %4?\ M+(\)?]#3HO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O7_A9'A+_ *&G M1?\ P80__%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W(/]?,3_SXC][/ MO7_A9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J*/\ 52C_ ,_7 M]R#_ %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P +(\)?]#3HO_@PA_\ MBJ^"J*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1?_!A#_\ %4?\+(\) M?]#3HO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O7_A9'A+_ *&G1?\ MP80__%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W(/]?,3_SXC][/O7_A M9'A+_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J*/\ 52C_ ,_7]R#_ M %\Q/_/B/WL^]?\ A9'A+_H:=%_\&$/_ ,51_P +(\)?]#3HO_@PA_\ BJ^" MJ*/]5*/_ #]?W(/]?,3_ ,^(_>S[U_X61X2_Z&G1?_!A#_\ %4?\+(\)?]#3 MHO\ X,(?_BJ^"J*/]5*/_/U_<@_U\Q/_ #XC][/O7_A9'A+_ *&G1?\ P80_ M_%4?\+(\)?\ 0TZ+_P"#"'_XJO@JBC_52C_S]?W(/]?,3_SXC][/O7_A9'A+ M_H:=%_\ !A#_ /%4?\+(\)?]#3HO_@PA_P#BJ^"J*/\ 52C_ ,_7]R#_ %\Q M/_/B/WL_033_ (F>#XX9@WBO0U)Z9U&$=O\ >I/^%F>#_P#H:]#_ /!C#_\ M%5^?E%'^JE'_ )^O[D'^OF)_Y\1^]GZ!_P#"S/!__0UZ'_X,8?\ XJC_ (69 MX/\ ^AKT/_P8P_\ Q5?GY11_JI1_Y^O[D'^OF)_Y\1^]GZ!_\+,\'_\ 0UZ' M_P"#&'_XJC_A9G@__H:]#_\ !C#_ /%5^?E%'^JE'_GZ_N0?Z^8G_GQ'[V?H M'_PLSP?_ -#7H?\ X,8?_BJ/^%F>#_\ H:]#_P#!C#_\57Y^44?ZJ4?^?K^Y M!_KYB?\ GQ'[V?H'_P +,\'_ /0UZ'_X,8?_ (JC_A9G@_\ Z&O0_P#P8P__ M !5?GY11_JI1_P"?K^Y!_KYB?^?$?O9^@?\ PLSP?_T->A_^#&'_ .*H_P"% MF>#_ /H:]#_\&,/_ ,57Y^44?ZJ4?^?K^Y!_KYB?^?$?O9^@?_"S/!__ $-> MA_\ @QA_^*H_X69X/_Z&O0__ 8P_P#Q5?GY11_JI1_Y^O[D'^OF)_Y\1^]G MZ!_\+,\'_P#0UZ'_ .#&'_XJC_A9G@__ *&O0_\ P8P__%5^?E%'^JE'_GZ_ MN0?Z^8G_ )\1^]GZ!_\ "S/!_P#T->A_^#&'_P"*H_X69X/_ .AKT/\ \&,/ M_P 57Y^44?ZJ4?\ GZ_N0?Z^8G_GQ'[V?H'_ ,+,\'_]#7H?_@QA_P#BJ/\ MA9G@_P#Z&O0__!C#_P#%5^?E%'^JE'_GZ_N0?Z^8G_GQ'[V?H'_PLSP?_P!# M7H?_ (,8?_BJ/^%F>#_^AKT/_P &,/\ \57Y^44?ZJ4?^?K^Y!_KYB?^?$?O M9^@?_"S/!_\ T->A_P#@QA_^*H_X69X/_P"AKT/_ ,&,/_Q5?GY11_JI1_Y^ MO[D'^OF)_P"?$?O9^@?_ LSP?\ ]#7H?_@QA_\ BJ/^%F>#_P#H:]#_ /!C M#_\ %5^?E%'^JE'_ )^O[D'^OF)_Y\1^]GZ!_P#"S/!__0UZ'_X,8?\ XJC_ M (69X/\ ^AKT/_P8P_\ Q5?GY11_JI1_Y^O[D'^OF)_Y\1^]GZ!_\+,\'_\ M0UZ'_P"#&'_XJC_A9G@__H:]#_\ !C#_ /%5^?E%'^JE'_GZ_N0?Z^8G_GQ' M[V?H'_PLSP?_ -#7H?\ X,8?_BJ/^%F>#_\ H:]#_P#!C#_\57Y^44?ZJ4?^ M?K^Y!_KYB?\ GQ'[V?H'_P +,\'_ /0UZ'_X,8?_ (JC_A9G@_\ Z&O0_P#P M8P__ !5?GY11_JI1_P"?K^Y!_KYB?^?$?O9^@?\ PLSP?_T->A_^#&'_ .*H M_P"%F>#_ /H:]#_\&,/_ ,57Y^44?ZJ4?^?K^Y!_KYB?^?$?O9^@?_"S/!__ M $->A_\ @QA_^*H_X69X/_Z&O0__ 8P_P#Q5?GY11_JI1_Y^O[D'^OF)_Y\ M1^]GZ!_\+,\'_P#0UZ'_ .#&'_XJC_A9G@__ *&O0_\ P8P__%5^?E%'^JE' M_GZ_N0?Z^8G_ )\1^]GZ!_\ "S/!_P#T->A_^#&'_P"*H_X69X/_ .AKT/\ M\&,/_P 57Y^44?ZJ4?\ GZ_N0?Z^8G_GQ'[V?H'_ ,+,\'_]#7H?_@QA_P#B MJ/\ A9G@_P#Z&O0__!C#_P#%5^?E%'^JE'_GZ_N0?Z^8G_GQ'[V?H'_PLSP? M_P!#7H?_ (,8?_BJ/^%F>#_^AKT/_P &,/\ \57Y^44?ZJ4?^?K^Y!_KYB?^ M?$?O9^@?_"S/!_\ T->A_P#@QA_^*H_X69X/_P"AKT/_ ,&,/_Q5?GY11_JI M1_Y^O[D'^OF)_P"?$?O9^@?_ LSP?\ ]#7H?_@QA_\ BJ/^%F>#_P#H:]#_ M /!C#_\ %5^?E%'^JE'_ )^O[D'^OF)_Y\1^]GZ!_P#"S/!__0UZ'_X,8?\ MXJC_ (69X/\ ^AKT/_P8P_\ Q5?GY11_JI1_Y^O[D'^OF)_Y\1^]GZ!_\+,\ M'_\ 0UZ'_P"#&'_XJC_A9G@__H:]#_\ !C#_ /%5^?E%'^JE'_GZ_N0?Z^8G M_GQ'[V?H'_PLSP?_ -#7H?\ X,8?_BJ/^%F>#_\ H:]#_P#!C#_\57Y^44?Z MJ4?^?K^Y!_KYB?\ GQ'[V?H1_P +.\'?8Y5_X2S0]QZ#^TH<_P#H59G_ LC MPE_T-.B_^#"'_P"*KX*HH_U4H_\ /U_<@_U\Q/\ SXC][/O7_A9'A+_H:=%_ M\&$/_P 51_PLCPE_T-.B_P#@PA_^*KX*HH_U4H_\_7]R#_7S$_\ /B/WL^]? M^%D>$O\ H:=%_P#!A#_\51_PLCPE_P!#3HO_ (,(?_BJ^"J*/]5*/_/U_<@_ MU\Q/_/B/WL^]?^%D>$O^AIT7_P &$/\ \51_PLCPE_T-.B_^#"'_ .*KX*HH M_P!5*/\ S]?W(/\ 7S$_\^(_>S[U_P"%D>$O^AIT7_P80_\ Q5'_ LCPE_T M-.B_^#"'_P"*KX*HH_U4H_\ /U_<@_U\Q/\ SXC][/O7_A9'A+_H:=%_\&$/ M_P 51_PLCPE_T-.B_P#@PA_^*KX*HH_U4H_\_7]R#_7S$_\ /B/WL^]?^%D> M$O\ H:=%_P#!A#_\51_PLCPE_P!#3HO_ (,(?_BJ^"J*/]5*/_/U_<@_U\Q/ M_/B/WL^]?^%D>$O^AIT7_P &$/\ \51_PLCPE_T-.B_^#"'_ .*KX*HH_P!5 M*/\ S]?W(/\ 7S$_\^(_>S[U_P"%D>$O^AIT7_P80_\ Q5'_ LCPE_T-.B_ M^#"'_P"*KX*HH_U4H_\ /U_<@_U\Q/\ SXC][/O7_A9'A+_H:=%_\&$/_P 5 M1_PLCPE_T-.B_P#@PA_^*KX*HH_U4H_\_7]R#_7S$_\ /B/WL^]?^%D>$O\ MH:=%_P#!A#_\51_PLCPE_P!#3HO_ (,(?_BJ^"J*/]5*/_/U_<@_U\Q/_/B/ MWL^]?^%D>$O^AIT7_P &$/\ \51_PLCPE_T-.B_^#"'_ .*KX*HH_P!5*/\ MS]?W(/\ 7S$_\^(_>S[U_P"%D>$O^AIT7_P80_\ Q5'_ LCPE_T-.B_^#"' M_P"*KX*HH_U4H_\ /U_<@_U\Q/\ SXC][/O7_A9'A+_H:=%_\&$/_P 51_PL MCPE_T-.B_P#@PA_^*KX*HH_U4H_\_7]R#_7S$_\ /B/WL^]?^%D>$O\ H:=% M_P#!A#_\51_PLCPE_P!#3HO_ (,(?_BJ^"J*/]5*/_/U_<@_U\Q/_/B/WL^] M?^%D>$O^AIT7_P &$/\ \571U^<]?HQ7S6O\ P4N_9]U2\U2T^*.BVKWEFELMGK"0KEH-A/ESD#^' M!VD]MJ^O'?E]2-+$QE+9IK[[?Y6^9YV8TY5L+*,=U9_=_P !W^1]Q?"R2VF^ M&/A%[(YLVTBS,.,?<\E-O3VQ745^:'[+O_!0VS^%7@&S\(>.='U+5+/3$\K3 M]0TKRWF$6?EBD21T!"] P;I@8XR_&KPW/X.\&:-=:'H=\1'=W- MVP:\NER,1!$)5%)ZX9BW3@9!Z:V KRQ$E%:-[^1RT,PP\,/%RE9I;>:/U&KX M0_:@_P""@.O^$?B%?>!/AKIEKYS@QP1 @$AOERV[)R O M&3TG_!/W]GOQCX!TNY\8>-+O4[*6^@\G3= N;B0""(D%I98B<*[8 52,J,YY M/'QK\<-&\2_LY_M5:CK<]DIN;?76U[39+A"8+J)IS*A]QSM.#D$&JP^%H_6_ M8SES)+\=/R7]:"Q.+K?4O;PCRMM?=KK]^G_#H^BK?2/VT_&6AW&H:MXEC\)Z M:L#7#27K6=FZQA222((C(I SPP!KY2_9_P!"OOBS^T?X/M-1N9]3NM0UF.ZO M;FX=I))E1O.E9F;DDJC?BQ^W]XX^.W@?5_"OA7P8-!AFL99-5NK>Y:\E M%JJYE(/EH(D*Y!)SP< Y(KG_ /@FCI5KJ'[21N+@KYMCHUU<6X;NY:.,X]]L MCUZN'52BJE2<%%I725KZ7>OK;\&>/B73K.E2ISE*[LV[VULM/-7?X'T!_P % M3O&!T_X;^$O#<J0QXY]MTH_*K7_!+[X;P:+\+=;\9S0#^T-: MOC:PRL.1;0@# /8&1GSZ[%]*\(_X*=^+CK7QTTS1$;,6BZ5&K+GI)*S.W_CO MEU]Y_LH^$O\ A"?V<_ &F&/RY#I<=W*O'1;2WTY M1GC=M\QL?\"E(_"OTD\#_">VM?V<=)^'MVOE12>'5TVYP,$/)#B1OKN9C4U/ MW>5I=9O[UJ_RY2Z?[S-G+I!?<]$_Q;/S4_X)\^#K;QE^TUHLM\HFCTFWGU0( MXSND0!4/U#R*WU6OUVN;:&\MY;>XB2>WF0QR12*&5U(P5(/!!':OQJ\*:UXV M_8?^/1N=0T8/?60DMI;:XRD.H6KG&Z.3!X.%8,,X(P1P174_M ?MA>-?VJGT MOPIHOAV31]/:X62/2--E>[NKN<9V[F"J6 ZA0HYY.<#'=C,//&SIRI:PMO\ M-_I_2//P6(A@(5(UM)WV[Z::^O\ FKGZH:#\/_"_A'Y]#\-:1HS*#@Z?810$ M=?[BCU/YU^)-QJ&M^+/C)"3C MD*#7P?\ M.?!OQ;^RW\=_P#A-]!@E&AR:G_:NDZHL9>&&0OO,$O& 0M<1(V.72 QC!] SL!WS M7T7^Q;X]^-GQ,T6YUWXCI9P>'7B"Z>\VG_9[V\UE+KMMZGR7_P %-O%YUSX]V6BH^Z'1=*BC*YZ2 M2EI&_P#'3'^5?;O[%OPHM?A3^S_X;B6W6/5-8MTU74) MQ]37YH_&"YE^-O[6FN06Q,G]L>)!IMN?]@2K A^FU0:_9VSM8K&T@MH%"0PH ML:*.@4# 'Y"N6LW1R^E3_FU?Y_F_P.N@E6S&M4?V=/TO]R_$FHHHKPSW@HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P?'?\ MR)^K_P#7NU6O"_\ R+.D?]>1.P'/V>; Y M^D@3_OHU\I?"?]H9_ ?[-?Q+\"^>4O-6EA_LX9.0LP\NZ_\ (:+^+&OU.^*/ M@>W^)/P[\1>&+D#R]4LI+8,W\#E?D;\&VG\*_#S5--N-'U*[T^[C,-W:S/!- M&>JNK%6'X$&OKWWK7U/GLSYJ%6GBJ>^J^=M']ST]#[*_ MX)E_#/\ MKQ]KWC:ZAW6^C6XL[5F'_+Q-]XCW6-2/^V@K](J\0_8S^&?_"K_ M -G[PW:31>5J.II_:MYQ@^9, 5!]UC$:_P# :]OKR6OW[?A8*_%CX^?\ )R'CO_L9+K_TH:OVGK\6/CY_R?^"7_ *2SX6_8W_9_\/?M#>.M;T7Q'>:G96MEIOVR-]+ECC@';FOK^W_ ."9/PKAE#OK'BR=1_RSDO;< _\ ?-N#^M>&_P#!+[_D MKOBO_L!G_P!*(J_2JOHLVQE>CB.2G-I61X.5X>E6HN52-W?]$GRVWA'0X=/DG $]X[-+<38[-(Q+8SSM&%!Z"O-OVY/^$[_X5!8_\*]_X2+^ MW/[7A\S_ (1GS_M/D^5+NSY/S;,[<]LX]J^B**^;5:;JJK-\S33U\CZ#V<8T MW3@K)IK3S1^0_P#QE)_U5[_RJ5ZS^T1XL\;Z/^Q5\.-&\3RZQ%K.KZA<#5?[ M;,HO)%BDD:-)/-^?'*'GLJ]J_1^O'OVIO@.G[07PMN-#AFCM=:M91>:;<2YV M+,H(VMC^%E)4GMD'G%>S+,XUI4U.FDE).Z\OZO\ (\R&7RI\SC4;;BUKYH^> M?^"8?@30Y?"7B?Q;+:PW&OKJ(T^.:1 SV\*Q(_R$\KN,ASCKL'I7'?\ !3GP M'H>@^)?"'B'3[2&SU35H[F*^\E0OG>7Y921@.K?.1N[@#TKQ[P9XT^,/[%/B MC4HSHLNF)=$1W%GJ]J\EC=%<[75U8!B,G#(_<@U'K4GQ?_;9\?6MZ=)EU%U4 M6\36MNT.G6$>S[WZ6M;[]?^">5"M&GA M)82<'SOI;SW^7_ V/LK]BW5=3^(W['^IZ/>R23O;"^T>U=^28C$"BY[[?-*C MV ':OB[]BW6(_#7[4'@I[PB%9+F:S;?QAY(9(U'UWLH_&OU$^ _PEM/@C\+= M%\)6LHN9+5"]U= 8\^=SND?'IDX'L!7Y_?M=_LE^*OAO\0-0\9>$-.O-1\,W MMRU^LFFHS3:;,6W,&"_,JALE7' & <$<\6%Q5"6,Q$&[1J:)_>OQNV=-?"UO MJ5+2\H.]O7_*R/NS]JG6H- _9V\?W-Q(L:OI,UNF[N\@\M1^+,*^"?\ @FWH M8>)/C)\8/C_9V7A+4-5U?Q9'$ZF+ M3+2S4N[+P"XB0-(1ZOG'6OT'_8C_ &;KSX#^!KV^\01I'XJUQDDN858-]EA0 M'RX=PX+99F;'&2!SMR:5'^R\)5562DJ<7:#N[_)_HCX_ M_P""CFBRZ9^T9+=LI$6HZ7;3HQ'!VAHS_P"@5^@W[,NN0>(OV??A_>0.KK_8 MUM Q7H'C01N/P9"*\Q_;@_9FOOCMX3L-6\.(DGBK1 _E6[,%^V0-@M$&/ 8$ M KGCDCOFO@'P]\9OC#\ [&\\'V&K:OX4AD=C)IEU:*'C8\$QB5"T9/JF,GFL MZ$%F& CAX22G![/MK^C-:\G@\:\1)-PDK:?+]5]Q>_; U2/Q1^T]XV:Q9;@? M;DLT\OGB*2>6X7?\ ^.1O^=?, M7[&O[*/B?QU\1=-\;^+],N]/\-Z=<"_1M2C9)=1G!W)M5N63=AF<\'&!G)QW MO_!4CQCEO!'A6-NGG:G,N?I'&7-; MZ9"\Z^DLB^9)_P"/NU> _MV?LHZO\7C9>,_!]NMYX@L;?[-=Z?N"O=0@EE:/ M/!=?]F^RANU>WJ[M'JO[(OP]\/^ M%?V>?"(T^QMG;6--BOK^8QJ6N995W,'/\07=M /0*!7YP_M8>&;#X5_M+>); M/PL!IEO:7,%Y:I:G:+:1XTE(3'W0KL< =.*Z+X>_M:?%[]G'PZ_@DZ?#%! 6 M%O:>(M/E$]GN))$8W(<9).&# $\5)\&_V:_B'^T]\1CXC\3VU]::)>77VO5- M=U"(Q?:%)RR0 @;F(^4;1M4>F #ZU"A/#8RIC*M1>S=^N]VFON_X8\VI6A6P MD,+&#-*?+S*._>_?RO^?J?=__ 49T_2KG]G6XNKV M.$ZA;:C;?8)' WB1FPX4^\>_(]O:O%?^"69N3XB^("@O]B^R6F\?P^9ODV_C MC?\ K7SSJ7B+XS?M::U8V5R^K^,YX&VPQP6RQ6MN3P781JL2>[MCZU^E7[*/ M[/<7[//PV72[B6.Z\0:A(+K4[F'.SS,86-">JH. >Y+'C.*[:E-9=@*F'JR3 ME-[+Y?Y7]3E51X_%TZM.+48K?YM_K8_,K26'PW_:DM#?_N8M'\7+YQDXVHEW MR?\ OD9K]A?&6L6^@^#];U2ZE6*UL[*:XDD8\!50DG]*^#OVZ_V1_$%]XPO/ MB)X,TV;6+34 KZII]G&7GAE50#*J#EE8 $XY!R>AX^;=2^/7Q?\ &GA>+X=W M.OZQJ>G86V&DI;*UQ(%QB-F5/-<<#Y6)Z553#K-\-2]G))Q5I7^5_P M.XXU MO[-Q=29J_L9:--XC_:>\$+&#^YNY+V0KT"QQ._\P!^-?L/ M7QM^P/\ LMZO\+8K[QOXOLFT_7=0@^S6.G3#][;0$AF>0?PNQ"C;U4 YY.!] MDUP9SB(5JZC3=U%6^?\ 5CHRNC.G3E.:UD_P_JX4445X![04444 %<=H'_)2 M/%/_ %SMO_18KL:X[0/^2D>*?^N=M_Z+% '8T444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 5Y!\:_\ 6:O_ -BW>_\ HN2O7Z\@ M^-?^LU?_ +%N]_\ 1_P#;3]NA?]A:#^35V-<=\2 M_P#CUT+_ +"T'\FH [&BBB@#C?AI_P >VO?]A:?^2UV5<;\-/^/;7O\ L+3_ M ,EKLJ "FR1I-&T +!+B0Y; M[!//9(3Z[()$7/X5T?P]_9O^&7PKNH[KPQX,TS3KV,YCO6C,]PF>NV64LX_ MUZ316WMJO+R\SMZF/L:7-S\JOWL%8WB?P9X?\;626?B+0M-U^T1MZV^J6<=S M&&]0K@C-;-%8^9L<_I'P]\*^']&N](TOPSH^FZ3=HT=Q8V=A%%!,I!!5XU4* MP()!!'0U1\-_"#P'X-U1-2T#P3X=T/445D6\TW28+>8*1@@.B X(Z\UUU%7S MRUUW(Y(Z*VQQNO\ P9^'_BO59M4UOP+X:UC4I\>;>:AI%O/-)@ #<[H2< < MGH*ZZW@BM8(X88UAAC4(D<:A550, #H *DHIB!12;:6K,CQ M)X1T+QE8BR\0:+IVNV8.X6^I6D=Q'GUVN",U4\+_ Y\*>!VD/ASPQHWA\R# M#G2]/BMMWUV*,UT5%"DTK)@XIN[6H5!>V-OJ5K+:W=O%=6TJ[9(9D#HX]"#P M14]%24<9I7P5^'FA:BFH:;X#\,Z??HVY;JUT>WBE4^H94!!KLJ6BJE)R^)W) MC%1^%6.*T_X)?#O2-7AU6Q\ ^&++5(9?/BOK?1K:.=),YWJX3<&SSD'-=K11 M0Y.6[!14=4@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH P?'?\ R)^K_P#7NU6O"_\ R+.D?]>&/#-C_:6N:@S);6OG1Q>854L1OD M95'RJ3R1TKVJZ_X)]?M!:;"URWP^FQ&-W[C5;&1^.>%2 M?]?,_P#Z32U^VE]J%KI=J]S>7,-I;1C+S3R!$4>I)X%>Q6E[.$9+K<\VFN>3 MB_(_#[X+_M/?$S]F?QQ'$-0U-K&SG\G4O"^K22>4P!PZ&-_]5(.S @@9R,@ M_MCX-\56'CKPGH_B+2I#+INJVD5[;L>I210PS[X/-?BY^W;X^\-?$C]I;Q-K M'A2XAOM,V06S7UMCR[F6.,*[J1]X9& W?;D9Z&>')M9\%?\$VHKF"ZNM* MUFT\%27,%S;2M%/ 3&SQLK@AE8 KC'2L)SYL+[:2U7_!_P M#6,.7$JC%Z/_ M ('^>I]7T5^&W@7]L;XM^%;;Q!;IXU\1ZW?:O8_V?;2:CJL]U]C9I$+2Q([, M/-*J4##D;R1S7J_[$7P0^+/_ TQX?U?6](\8>%]-1I-1U+4K^VNK1;Q%&1& M\C@"3>Y0%23D%J<:#Q^N5%?!/\ P4"_;>UCX7ZPWPX\ M 78L==\E9-5UA &DM0XRL,6> Y4ABW50PQSR/FKP/^PE\=/V@/#<7CJ^U"UB M:^07%K+XHU.G%SBY_9[_ -?U\C>;4&H=6?L7 M17XZ_"/]J;XL_L>?$Y_"7C>74M1T6QF6WU'P_J7J]BNG1WFG#<0EPTVU8<]P"SKGOC-54BH0] MJG>/]?GT[BIMRG[)JTCU6BOQ8\"^"?C7^WYXNUR8^)EO_L&R:ZDUF^>&RM?, M+"-(X45MN=C8")CY3DY/+_B3^SG\;_V,;_2-9MM7DMTOIQ!!J7A.^F:,S8W" M)U*(Q) )PRE6 (YY%5[/ELJCLV3S\U^17L?M)7P+_P %%/VOO'/PA\46G@#P M=-%H@OM,2]N=9C&Z[P[R)Y<1/$?"'Y@"W(P5QS]#?LO?%/QA\8O@,NH>*]"U M#0O%]NDME,;JT>S^UN$!2XC#!1AMPSMX#!L8&*_(;]H+PC\4O!GC2VL?BW/J MEQXE:R26)M6U9=1E^SEG"@2+))A=P?Y<\<\T M2U?X:K7]/R/V&_8VOKG4_P!F'X>7EY<2W=W/IWFRSSN7DD22>237L M]?F1^P1\./C_ &_C?X>^([V[UX_" PSND+^(D>R\DP2K'_HGGDX\PK@>7P>> M.M6O^"A?Q\^*]Q\1'\#>%;/Q'X<\*VIC@-[96T]N=6N' R%F &Z,%@@53AB" M3GC&V(C^^M'>3>G;7J<^'?[KWMHI:]_0_2VBOR U3_@FA\;-/\*S^*)KG0Y; MV*V-Y)IJ:C*U^,+N*9\KRRX'I)U[UV/_ 3C_:F\9)\7-.^''B'6KO7?#VL1 MRI:+J$S326--,L+?4=0L!$D$%TS"+?)*L89MO) W9P",XQD=:^2O^"/]9\9:Y<:MKJEF;GSV +6GF@LVYHOF\L]N>./D/]G/P3\8 MO&VN:O!\';G5[;4X+=7OCI&M+IKF$MA=S-+'N&[MDU&&BGS3>^J]-+?\'T+Q M&D8Q6FS]=4_^!ZG[O45\O_%_X_:Q^RG^R?X4O_$2-?\ Q%FTVTTU+>_N/M#/ M?B >=)-(&/F!"&8L&.XX&?FS7Y_?#WX+_'#]O#4M5\0S:Z+^UM)3&^I>(;R2 M.T24@-Y,*(C;< @[40*,C.,C*5-RG.,7=1W?]?UJ/F481E+1RV1^T-%?C)IW MQ"^-G[ GQ4@T'5;Z>6RB"S/H\UTT^FZA;,2-\6?N$X(W*%8$8(Z@_KS\._'6 MF?$WP-H?BK1W+Z;J]I'=P[OO*&&2K?[2G*GW!IRIKD52+NA*;Y^22LSHJ**\ MA_:F_: L_P!F_P"$M_XIF@6]U*1Q9Z99.<+-+-#^-G[!'C_ $ZW&NRZ6\Z_:;:33;IYM-OU!PRM&X ?&0"KH",@ MC&0:Z53LU&;LV8<][N"ND?MC17E?[/?QULOCI\%=*\=06S0S20NM]8VZF1H; MB+B2- .6R1E1U(9>]?F7\3O%WQY_:Z^.#>$UM==T""^FD%CX=N_.L;6TMD). M^=2!N(7EG8$DG"C[JUG[.7M?96U_K^O0M3BZ?M;Z'[$45^+OQB_8K^+/[+?A MF/QO=:OIK64$\<4E[X;U"<36S,<(S;HXR 6P,KGDBOMC_@FS^TAXD^-7@GQ! MH'BV^?5M7\./!Y.I3G,T]O*'"B1OXF4QD;CR0PSD\G14U*,I0=^7?^OF9NHX MM*2M<^RJ*_.+_@J+\5/&OP_^(G@NV\+^,->\-V]QI4LDT.D:G/:I(PF(#,(V M )QQDUP?@O4/VB/VWO ^E^'/#&LRZ-X2T"SCL=1U?5-3EC_M.[" N9Y5#2RD MY^Y@J!@MR165.+J4^>/=_@VK_A^*-9R5.?)+M^=G;^NQ^K-%?A5XN\/_ !4_ M8M^*G]G'5[GP]KL2I=176E7;-;7L1)PW0"1"5(*NO8@BOV+_ &<_BPWQJ^"/ MA3QI/'';W6HVA-U'']Q9XV:.7'H-Z,1Z UHZ:]G[6+NOZ_R,^=J?LY*S/2J* M_)#]J/\ ;*\>_M ?%"3P-\-[_4+#PT;S^SK&UTF4Q3ZM+NV;W=2#L8_=3(7& M"W/3G?'7[ _QK^"_@RX\?O>:>[:?']KNDT7493?6B#EG)V*#MZDH[8P3T&:B M,?<52>B?]?U^-C23M/V<=9+^OZ_ _9&BOS__ ."_X*'?MD:O\'&M/ /@B[^P^);Z MW^TW^J( 9+*!B0B1YZ2/ACNZJ,$L2-)_\ 7]=C]7Z*^?/V]/$^L>#_ -EWQ9JN M@ZM?:)JD+V@BOM-N7MYX\W,:G:Z$,,@D'!Z&OR\\*_M:?&#_ (1/7_"%IXK\ M3:]J?B2:V@BN;C4;B\NH8U\P/#;ABS*TID0$I@X3'?C"G%U%+EW7X[?YF\[4 MU&3V9^XU%?E]_P $W_@C\2O#OQTO-6\1:3XH\(Z'96$DT\&I6]S91:A,_P D M:,KA1)C+OSG!45^H-:5*:IVL[W,H3YV]-@HHHK$U"BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH *\@^-?^LU?_L6[W_T7)7K]>0?&O\ UFK_ /8M MWO\ Z+DKHPW\>'JOS.3&?[M4_P +_(^(Z***_>S^4@HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OT8K\YZ_1BOSWBS M_EQ_V]_[:?KG /\ S%?]N?\ MP4445^?'ZX%%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !6G:_P#(._'^M9E:=K_R#OQ_K0 RBBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** +]O\ ZE:DJ.W_ -2M24 Q^'?BFYMII+>XA MTJZDBFB8JZ,(6(92.001D$5^4_[-?A']HG]J#3]=O/#?QKUS3(]'EBBF75/$ MNHJ7,@8@KLWN*_5/XI?\DQ\7_P#8'O/_ $2]?#__ 2$_P"15^)7_7[9 M?^BY:N@O>JOM&/\ Z4T16;4:2764O_2;E/\ X8K_ &L(_F3X^S,Z\@-XIU7! M/O\ NS6+X1_:D^-7[)?QDTWP/\<+P^(?#=X4']H2E9G2%FVBYAG 5I%!^\LF M6P#PIZ_I=7YE?\%8/$VE>)O'7P^\)Z2\=_XCL8[@W,%OAY(_/:$0QMCHQ*,0 MO7!![BKA4E[6$+73=K?('33A)WM97O\ U_7R/HG_ (*1>-M>\$_LZV^J>&-> MU+0+Y]9MHQ>Z3>26TIC9)25WQL#M.!QG' KV#]F75K[7OV>_AWJ.IWMQJ.H7 M6AVLUQ=W MBEI?N+F3ORZV['Z145PGA'XR:!XL^#5E\2TD>T\/S:6VJR^;@O B(6D5L=2I M5EX[BOBW0OVC?VG/VK]2U/4/@[INF>#O!MGQP.[$ $+(TP<,^""1' M'A=P!)ZE?4_0VBOSJUG]JK]H_\ 91\3:3%\:=(T M_P 4^&-0FV?VE9Q0QNP'WA%)"%4.!SLD0%@.,=1][77CS0K'P,_C"YU"*#PX MEA_:;7SGY!;[-^__ +Y[42CRP]I?0(RYI&Q@'N&H/3FTOW!R6O+K;L?H917/?#[Q MYHWQ/\%Z1XI\/77VS1]4@6>"3&&P>"K#LRD%2.Q!%=#4RBXMQ>Z'&2DKK8*^ M/?VT/V[-#^#>B:AX3\&W\.K>/KB-H&DMG#Q:3D$%Y&'!E'\,?4$9; P&^B?C M?X*UCXC?"?Q+X9T#5!HFKZI:_9X-0,CQ^3EAN;*?-]W<..N<=Z^0_&/["W@3 M]G?]F'XC:R2_BGQDNB3_ /$[OHPH@R #Y$62(\CC<2S?G_ %<]7_X)T^+]>\[A\W^;/CG]H+QYXE\8?MJ?";X8>&?$.KZ/I]DG]K:['I5[);K/%DR>7+L8 M;EV0XPW'[[WK/_;&_:X\:>'_ (E:9\'/A!;+-XWO_+%S?"-)7@:0;DBC5_D# M;/G9V!"J1TY(I_L8#_A<7[4GQL^+TI\^SBN?[$TN7.5,6X#*_2."'_OX?6O? M-)_9/\&:-\?[OXP17&K2^*KGS-\4UQ&UJ"\?EDJGE[@0G ^:LXI*-*,]K.3[ MW>J7I:W]:&TF^>HX;JT5VTW?WW/F>3]CW]J7^S3K _: O#XB_P!;_98U:]%I MNZ[=WW?P\O;^%=1^QM^UUXR\2?$?4_@[\7K=8/'%AYBVU\8TB>=HQEX9%3Y" MP7+*Z##*#UX)^U7=8T9W8*BC)9C@ >M?F7\.=5A^/W_!3RZ\5>%E\W0-'DDF MFOH!\DD4%K]G\S/,&GA,-U>K&T:QAOW@(DC=>5_V:YF[ M&Z5SX9^*GQ2^-W[3O[5'B7X7_#;Q9-X.TO0)9X@UK>2V*A8&$!Q@<5]9?M8?&3XT?L]_LR_#V_N?%$%K\0KC4VM-8U"UL[6:.<;)G 56AV# MA8^50'CZUT:4L/"S^)*_FV]UY:&3O4KS5GHW;R26S\S[AHKF?ACK%YXA^&WA M/5=0F^T7]]I-I=7$VT+OD>%&9L* !DDG %?)G_!1K]HKXA_ >^\ Q^!?$'] MAIJ@NS=C[%;W'F[##L_UT;XQO;ICK4>S?ME1ZMV*IR]I3]HMK7/JOXN>/#\+ M_A?XI\7+9#46T73IKX6AD\L3&-"VW=@XSCK@UYA^Q5\QC*10PHD95!DDG[Q.223GTP!PG[?NF_%O4OA7<7?@K6;*P\&0Z M+>/XHM;A(3)%O$.FVGPHC MUYO[5TV:. W$N/+\[:6A9^5VXPXZ<8JJ,%-SOV2]/>W?D^AE5G:-.4>NOK[M M[>JZGT#\5OA_\<]4_;(\(Z_X;NM<3X5V[V1U&&WUY8+0A6;SMUJ9@7XQGY#G MWK+_ ."H'CSQ-\/_ (1^%+SPOXBU;PW=S:X(9;C2+Z6UDD3[/*=K-&P)&0#@ M\9 K.^-'[1GQ$\)_MX>"/AWI7B'[+X.U)]/%UIOV*W?S!*["3]XT9D&0!T88 M[8JG_P %;O\ DB_@[_L8!_Z335B[^Q@UMS/U^)7^78WC;VTUUY5Z?"[?/N?2 M<*^(O$W[+<(T>ZNY_%>H>#E^QW*W1CN'O'LAL?SF8;7,A!WEA@\Y[UPG[#?@ MWXM^"?AYKMI\8+C5KC7)=4,MHVKZPNI2"W\J,85UEDVC<&^7([G'-=:OB"_\ M*?L@1ZWI4_V74]-\#+>6L^Q7\N6.P#(VU@5.& .""/6O(/V&_C5\2_CW\!/' MFIZUKZ:GXMM[N>STJ\DM+>!87^RHT65CC"D"1LY93^(XKIJ>[5Q#BMEKZ_D:_C+]JWQ%9_MK>&/@SIVGV=IHKLLE_?R9DGN0UJ M\RH@.!&H(&?O$XZCI7U77XVZ[H?QX3]M33=/OO$6FR?&5A']GU58X/LR_P"B ML5RHA\O_ %61_J^OOS7U;^T1XR_:.^"/[+_ASQ3>^,[=/%^GZC)!K\UE864T M4UO*Y%N^&@VKLPB_*HSYG.<9K/E4:$&WK??O=V_ UNY56DNB_!-O[^A]RT5Y M]\ /BA%\9?@WX3\81LIEU*R1KE5QA+A?DF7CIB16KPS_ (*"?M)>)O@?X7\+ M:/X$O_L/C+7[XB*1;>*X=;= P"2*RY9WC49'9L5,XN%3V>[O;^OZV"G)5(< MZVM<^M**Y_X?V>NZ?X'T&W\3ZC_:WB*.RB&HWOE)$);C:/,(5 % W9P !P*Z M"E*/+)QO>P1ES14NX45\7_M0?ML^)O#WQ/A^$OP( M,/%?[8?Q9T76_%> MN:QH]D-1^RZ?J&HS3V\&V_15V1NQ5<*2HP!@<5^@5?F#_P $U_$7R0R$%D66]C<*2.X#8KZ8_;!_;+N?@+JVC^#/!VB1^)?B!K*J M\%K,&:*W5WV1[D0AI'=@0J CIDGH#K.+C"C"WO.*7SNS*$E*I6DG[JE?Y61] M345\#3Z;^WEJ-BVKQZQH>G.P\P:)''IQD'?:"T3#\Y?QKI_V0_VT/&'C[XH7 M_P )_BKHD.E>,K5)?)N8(C TDD0S)%+'D@-MRP9,*0.G0F8TW)M)JZUMZ;E2 MFHJ[V[GI?[;?[2FK_LS?#"PUG0M+M-2U75+[^SX7OF;RK<^6[F0HN"_"8QN7 MKGG&#['\-=:N_$GPY\*ZM?R"6^O])M+JXD50H:1X49C@<#))X%?G#_P4ZTKX MLV]^;WQ%K-E<_"^;5T70=.B2(3P3?9CN+E8@Y'$OWG;J./3Z9_8IT/X[Z;I] ME"9M!MO[#M+2.!98<\8:K^W+\*](F\3:CJFD^)]+LD-Q=V=G:6, MOEQJ,L61(HY& '782<<^]9I7BIMV3[]NYH])."U:_JQ^AE%>!_L<_M0)^U!\ M.;K5;K3X]*\0:7<"UU*UMV)A+%=R2QY)(5AG@DD%2,GJ??*J<'3ERR)C)37, M@KX^_:A^+'B7XC?&OPK\ _AQK5]H6IW4J7_B/7-+G:&>QM5&_P M70@JVSYC MR,[HU_B-?5'C+Q1:>"?".M>(;]MMEI5E->S'_8C0N?T%?$7_ 3*T>\\?:Y\ M4/C%KO[_ %C6M1-C',PSM!Q-,%)_AR\*CT" 44DI5&WM!^)ND_L]_!_5/%&IM<7EGHUJD<4237PY\.K']I_P#;6MI_&$7Q!D^&O@V2=TL4TV66UWA3@B)8@(7EE8$?,>,=A6 M_P##?P#IOPM\":'X2T=IGTS1[5+2![EE:5E7^)RJJ"QY)( Y-*#7O3GJ^GZO MUN*2=HQAHNOZ+T/SX\;>*/VE/V$M6TS6O$?BQOB=X"NKD02M?3R7&21G8SR@ MRPN0&*D,R9'.>E?H'X(^(VB>/?AWI7C73KD+H>H6(OUFF(7RH]N6#^A7!!]" MIKY=_P""HWQ*T?P[\ 1X2GDCEUOQ!>0FVM\@O'%"XD>;'89"IGN7]C6;)9:Q M\&/^"6\]O>B:VU1]!96C;*O$M[\6DO.Z_ST!02Q%. M"VDM5\[7//Y/C)\;?VYOB9KNC?";7Y/ 'P[TA@CZK&[6\KJ20KM*@\PR/AB( MT*@*/F.>35\?/^TM^PW<67BO4/'4WQ0\#-<)%>KJ5Q+<;<\!9/-W/#N)(5T< MC(&[J%/M_P#P3!\-V^B_LO6FH1(HN-7U2[N9G Y.UA"H/T$?ZU[3^T[X;@\6 M_L\_$73)T5UDT.ZD3<.!)'&9$/X,BG\*JN_JBM#[*3=^NEW<5%?69>_I=V7E MK9'2_#'XC:1\5_A_HGC#19=VEZK;+<1[R-T9Z.C?[2L&4^ZFOA#Q1^T;\9?V MO?C%J_@3X(:BGA7PGI9=;C7 WEM(@8KYSS!6= Q!V)& Q')[[>Z_X);ZM)XK M_9N\2^';N:006>K3VT;1MAHXIH48A3V.YG/U-?0'[/7[+_@_]F>TURW\)3:E M.FL31S3MJ6\N&X,D MI52*@H2CNW:W?_AOZZFU_P %'OB5XUL?B)\+/ ?@3Q1JOAO5-8>3S&TJ_FM# M*TLL<,(*+B1/#_@R&V$ODQ&5VDCA:X1%4=6,LJKS@#J2!S7J&J_\ !4R729X; MZ?X,>(+?PK,X$.KW5X8FD0]U0P;"<=A+^-31_@Q:W;;^5]"JO\5I[)+[[:GJ M7[)OP!^,WPC\7ZSJ'Q+^)4GC;2[JQ\BVM'UB]O/)F\Q6W[9U"CY01D<\U3_; M6UCQQ\&;[PO\9/"6L:I/I&B7"6GB'PT;R0V-U:NV!*8<[%<%BN_&060_PU[) M\"OVA/!G[1'A5M;\(W[2^2P2[T^Z41W5FYY"R("<9P<,"5.#@G!QU/Q"\&V7 MQ$\"Z_X8U!!)9ZM936<@;MO0@-]02"/<5-:52#4K:QZ=_+SNG8=&-.5U?26_ MET_"U_4D\#^,]*^(G@_1_$VB7 NM*U2V2ZMY.^UAG!'9@<@CL016[7PA_P $ MM_B%?1:'XV^%>KN?MGAF^:XMD8\K&[LDR#V65,_64U]WU=6,8RO#X7JO1_U8 MBG*35I[K1^J_JX4445B:A1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5QWQ+_ ./70O\ ML+0?R:NQKCOB7_QZZ%_V%H/Y-0!V-%%% '&_#3_CVU[_ +"T_P#):[*N-^&G M_'MKW_86G_DM=E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110!@^._^1/U?_KW:K7A?_D6=(_Z\X?_ $ 55\=_\B?J_P#U[M5K MPO\ \BSI'_7G#_Z * -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH *X[0/^2D>*?^N=M_Z+%=C7':!_R4CQ3_USMO\ MT6* .QKB_C9_R1OQW_V ;[_TG>NTKB_C9_R1OQW_ -@&^_\ 2=ZY\1_!GZ/\ MC>A_%AZK\S\&/ /@+7?B?XNT[PQX9L?[2US4&9+:U\Z.+S"JEB-\C*H^52>2 M.E>X1_\ !.O]H-W /@$(#_$VLZ?@?E/6=^P3_P G;_#S_KYG_P#2:6OV\KV: MS]G&+76YYE-M?:_[5T,=M^R_\2X8D6**/P[=HB(,!5$1 '85Z[7DO[6 MG_)LOQ/_ .Q?O/\ T4:\[$593I23VLSMP]-1JQ:WNC\M?^"=7A&S\6_M5^&? MMT"W$.FPW&HK&ZY7S(XR(V/T=E8>X%?M)7Y ?\$M_P#DZ%?^P)=_SCK]?Z[L M3M!>7ZLX\/O-^?Z+_,_"?XH._CK]K?Q%%K3DK?\ C"2TG:3^&+[7Y>/H$ 'T M%?NI;V\=K!'#"BQ0QJ$1%& J@8 ],5^.?\ P4&^"6K_ A_: U+Q3;6\B:! MXDN3J=C?1CY4N3AIHR>S!\L/4,,=#C[%^$?_ 4W^%NM^ ;*;QQJ-UX;\46\ M*QW=K]@GN([B0+R\+1(P"L>PD%'>.Z^27X6-JGNXJ>3+=PW5K:74@+"%XKMW@)]55E4$#^$8KX@_:3^,&L?MI?M 67 M_"+Z/=20N$TK0],(!F9-S,7< D*S%F8\X50,GY(O#-FDEW'ZDC564[@SLXSGY5(P34I>SP3532[^[5N_E:Z M]"FW/%Q=/=+\DE;YO[['Y@>)/AQ\:?V2?%$UY);:_P"#YXV\H:SI$9HDUZ72_&ED&&]=0M%@GVCJ%DA"@'W M97_&O3?V:_\ @IMJ#>*M6L_C3?";0KZ-?L=W8:.A%O M<^'XEC?'!*3S;A]1N7\Q6=>,:>(IJ/\ 7NLUH2#O"6B1^)O$EE^[O+NZF,=G:2XSY>%^:5 MA_$ 5 Z9)R _]AW]K#X<7?PN^&WPS_M:=/&WDO8'339RX#(9'W>;M\O:5&1\ MV><8K\Y?B5%VH2:;XGDNKVSN%_X^HQ<^80=W59$Y&>"&%:5 M(>TQ?+)VBVW?YK_,QHR]GA4TKR26GR?^1]%3_M%_M=_M%6,@\,Z1J.F:)=Q, M#-H.D_9+9EQR1=S9*\>DHKQ_]A.%Y/VN/AXI=D=;V8L0>3BWE)'XXK[M^*7_ M 4P^$]A\,;Q_"%U>:WXCN[-H;;2S82VXM9&0@&9W4)M4GD1ELXP/4?"'["= MTEK^UI\.WF;:&O98\G^\UO*H'YD5KA?X[7+9?F]?^!]Y-?\ @7/?\ L$0_^CJ^M_\ @H1IL^I?LD>. M5MT,C0K:SLH&3L6YB+'\!D_A7P%_P3O_ &@/!?P#^(/BB\\;ZC)I.GZEIBPP MW26TLX\Q) VPK&K-R,X.,<JO7_ -)-\5K3IV[_ *H]5_X*\:IPT3X=_"9?$WAI9YIH] M4'AS4;OSY&<[\RPR*C8(V\#C;@]*]R_X*-^"XOCI\!O!GQ<\)1S7]AIL9GD( MC*N;&X"D2E>HV,BY'8.2>AKS[]@3]N#PA\'_ '<^ _B#=3Z586]S)=:=JD= MM)<1A7P7B=8PS@[LL"%(^8@XP,UATXTYTW\2;T^=_P"O05=WG":V:7RTM^?Y MW/+_ -H[4OVAOVGK[0[OQ3\%]:T^XTB.6*%]'\+:C$75RI(?S"^<%>,8ZFOO M[_@GOHOB3PS^S-HVC^*='U+0M1L;V[C2SU6VDMYA$92ZG8X! RYQQ7S[\5_^ M"KG]D?$$6GP]\/V?B3PI%$JM=ZDDUO/N>(-"_X1G5]0MEN)]),YF:VWO:-:O>ZGX5N'O'@B7<[6KJ!,5'R:_KY;_([*>MUU:?Y?TA/^"6>GVMK^S+)<0JOGW6MW3SL.NY5C4 _P# M0/SKZGU_P3X=\5W5EE?E[_ M ,$^?VS?"_P)T76?!OCN:XL-$N[K[?9ZG# \ZP2%%61'1 7P0BD%0>>[U>T,MF+R1@ J!&VL44 YWJ,D].,GOQ M"P M)_"OSJ^+G_!5[46UV?2_A?X4M;FU64Q1:IK8DD>ZYP#';QE2N3TW,201E0>* M]5\(V/Q:\>_\$_\ QE=>--4O=7\6:[I5U=6%O-;QQSI:;!LCQ&JEFD5789R< M2 5\$_L3_&#PK\#_ (\:=XE\86S2:2+::U%U'!YS64C@8F"@9. &4[><.<9Z M'.%+]_*G-_"E]^NGX6_S-)5+48U(K=O[M/\ ._H=?\FF6QW.HC^0JLDPWE<9WX.#VS7L7_!(2,GQ-\2I-Y %G8K ML['+S<_I^M)^WC^W/X&^+/PQ?P#X!GN-;2_GAGO=4DMI+>&..-MX1%D"NS%E M7)*@ #J<\'_!(6ZC7Q1\2;4$_FP_.M\/\-3W;;V\]/^',Z] MK0]Z^WYF9_P5T_Y*=X#_ .P/+_Z.-?57_!-_3X;+]D?PE)$FU[J>^FE/]YOM M4J9_[Y11^%?*O_!73_DIW@/_ + \O_HXU]9?\$ZO^30? _\ O7W_ *6SUCA_ M]SD_[S_]*D:8C_>(?+_TD^4O^"NUK&GQ"^']P!^]DTNXC8^RR@C_ -"->V_L MDZE1%>3Q!O\ GH+:3'XC)/X5^SM]8VVIV<]G M>6\5W:7$;136\Z!XY$88964\$$$@@]AR^(/V*_VHK.?5K"62[\-:@WF M1?<%[:.&0NAZ8>)B5/8GGH:^_P#XH?\ !3+X56_PNU*Z\(ZI?:EXLNK1X[/3 M6L)H7MIF4A7ED90F$)R=C-G''K6^(DJE*$X:JVWX_K;Y:G/1BZ=:4)NWG_7W M_,^M?#_@_0?"5OY&AZ)IVBP8QY>GVD<"_D@%?BG^W1JEQJW[6'Q$DN=Q:*^2 MW16[(D,:+CVP,_C7T7_P3Q^*?QN^+7Q:CM=0\;:SJG@C1X7N-5.HE;D2%E*Q M0^;(I<,S?-PV<(U<)_P4[^#=]X)^.3>-8;=SH?BB*.3[0H.R.[C0))&3V)55 M<>N6QT-9N#HUX2F]T_TM^3_IFL9>TI3C%;6_K\4_^&/2=%_;$_:PTO1K"RL? M@2OV*WMXX8-OA#5B/+50%QB;'0#I7S-\5OAW\.B@>9$T:LHW8!PY7!)'3FN'^''_!3;QM\2/BU;^%]$^'&GZS:ZIJ M)M]-ACN9+>Y2 L=KS-^\7*I\SD 8-=%I>W?(KOO\^_XG/&25"\G9=CV;]NB M>[NOV&=8FOXI(+Z2UTQ[B*92KI(9X"RL#R"#G.:^0_\ @E/X1M-<^/VL:O=0 M+,^C:-)+;,RY$/?^P1#_P"CJSPTN:=:7>__ *27B(\M&E'M;_TI'ZAT445RG0%%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>0?&O_6:O_P!BW>_^ MBY*]?KR#XU_ZS5_^Q;O?_1_\ ;3]\_P#1+U^1?['?P,^+WQ>TGQ-/\,OB))X'MK&>!+V)-6O++[0S*Y0X M@4AL -][IGBOUT^*7_),?%__ &![S_T2]?#_ /P2$_Y%7XE?]?ME_P"BY:O# M_%6?:,?_ $IF==^[27>4O_22G_PQ#^U+=_N;OX^SM;/Q(/\ A)=5D^7O\I4 M_3->H?LY_P#!./P]\(?&5OXR\6>()?&_B6VE^T6H>#R;:";KYI!9FE<'D,Q M!YVY (^Q**M591U6C!TXR5GL?'G_ 5._P"398/^P]:_^@2UZW^QGHEMH/[+ MGPVM[:)(EETB*Z?8,;GES(S'W)'+*;4C?2F*'RU@C:7KFJ?\$]M!&BK-)'!INCSZ MA'!DEK58D+$@?PAMC'V4GM6:=L/4T^W'\5^FXVKXBE_AE^9SVF_\%"O@5\"M M%3P9\,_">N:GI%E)(;<6B>7;R,[%V*O-(9FRQ/WE^G %>6?M2?M:?$CX[?!+ M6=//P9U#PIX+=X);O7-2$TJC;,AC\N0Q1H"7VC'S'!/UKU;]A']H[X%^ O@C MI>D7>K:7X0\5VZO_ &LVH1>5+=R%V(D$V,2 J0 NV@B<%5!903F39ER O0 DMQM6CRRY;.3NM? MGO\ J11ES+F^%:Z?IZL^@?V/_!]O\0OV#-!\,7+K:S_8[9O#=S VC:S= M6-M#+8$>2]J%3IGBGX@SW<)M]4 MTFTW/!&&^P-^S3XD\:?\ !/'2?AUJ$;1^+[?3DOK6 MVG.&CG65IHX&ST.QO+]B?:N6HE*@ZEK6DOFMV_PM^!TTVXUHPO>\7\GLO\_Q M/!OV:?VF?BU\)/@SH'A[PM^SUK?B'2$62X36;6RO62^,CLQEW) RGJ!D$\** MZ+XM_M/?&[XO?#7Q%X.U+]F?Q)#::Q:-;&<:;?N86/*R!3;\E6 8>XJY^P_^ MVIX;^&O@F/X6?%*XF\*:IH,TEO:7E] XC*%R3#+@$QNC%A\P"XP,@CGT']J+ M_@HAX-\'>![S3?AEXBA\0^-KP"*UN;&'SK>RR1F5F==CMC.$&[G&0!UWQ%I2 M>G,I;>=_Z^1CA[Q25^5K?R_K\?4V/^":&@^+_"7P*U30O%^@:OX>FL]:F:SM M]8LI;60PO'&Q*K(H)7?OY'&2:^MZ\C_99OOB/K'P X\M'1 '(&X\9&['&*]-_MC_\FN?$S_L"S?TKAK?PI>C.RE_$CZH\N_X)@_\ )K%G_P!A M>\_]"6O8/VIOB-_PJG]GWQOXC23RKJ#3W@M6S@^?+B*,CZ,X/X5X_P#\$P?^ M36+/_L+WG_H2US?_ 4DU6X\8'X7?"+37;[=XLUR.298^HB1A&I/MNE+?]LS MZ5VXJ#JU526\N5?>E?\ "[.3"25.#J/:/,_N;_X8]*_X)]_#D_#O]E[POYT7 MEWNM[]9GXY/G']V3_P!LECKZ'O\ 4+;2K&XO+VXBM+.WC:6:XG<)'&@&2S,> M .87$8+-'%TV ?,X.>BXFM-UJUH==O)>?IH51C[ M.E>?3?U?;UU.L_:$_:J\5_M6>+G^#?P(M[BXTRZ)BU/7DS&+B+.'(?\ Y96X MS\SGE\A0,'#_ %C^RS^S#H/[,?@/^RK!QJ&O7VV75=69<-<2 '"J/X8UR0J^ MY)Y)KQ?X"?'_ /94_9W\%Q:!X8\;VXD<*U[J4VF7AN+V0#[\C>1TY.%'"@\= MR?9_!7[9OP:^(GBG3O#GAWQK#J6M:A)Y5K:K8W2&1L%L;GB"C@'J1TK3EY%[ M.FF[[OO_ ,#R)YN=J=31+9=O^">U4445S&Q^_\ *1GXU?36/_3A#7J7_!4SP3J?BC]GJPU/ M3X'N(M"U>.\NUC4DI"TO9_P!FS]NCX3WOP5\- M6OB+Q7:^'-]_)W2^ M]M)'/AVH8:SWY;?/_@'Z3?M3?\FK_$?_ +%NZ_\ 1)KQ[_@EE_R;#+_V'KO_ M - AKV;]IRSFO_V7_B+!;Q--,WANZVH@R3B$G^0KY/\ ^":O[1WP^\'_ OM MOA]K6O#3O%=]KT@L[&2VF87'G+$L>V14*#+ CYB*QHZRK16[4?\ THS>E&A) M[)O_ -),7]HK_E*!\-O^NFE?^AO7>_\ !6[_ )(OX._[& ?^DTU<%^T5_P I M0/AM_P!=-*_]#>N]_P""MW_)%_!W_8P#_P!)IJQ_YAJ?^-_^E(Z5_O-3_ O_ M $F1[KX@_P"3(;__ +)ZW_INKPS_ ())_P#)$_%W_8P'_P!)X:]S\0?\F0W_ M /V3UO\ TW5X9_P23_Y(GXN_[& _^D\-=G_+[%>B_P#2VON[XK_#^S^*GPV\2>$;[ M]7L9;7>1GRV*_(_P!5;:WX M5^>GQ[\:Z5\)?^"G&D>*_%$TFG:#;PVTTMUY32;8VLVBW[5!8@/D' )X/%?H M?\./B9X9^+GA:#Q'X2U5-8T6:1XDNDC>,%D.&&UU5A@^HKDY?:82$?\ %?RU M.J4N3$N7E'\CXL_X);>/+S1H_'OPCUS,&J:%>M>P6\A^91N\JX0#T614/UD- M8^GQ_P##5'_!2*XNB/M?A3X>KA>"8R]NV%'IDW+LWNL?M7._M77M]^R'^V;; M?$_1[9CIOB;3;B1XHP KW!B,4B_@_DRGW->Y?\$R/A9+X2^"5YXRU)&;6?&% MXUVTLGWS;QEECR?=C*_N'%=%.3J\8V_[?^'3T2OYF%2*I\V'CM)Z?X?B M=_5Z'V'2,=JD^@I:*Y'=K0W/S9_X)JVZ>,/VC/B[XNU(+-JZARLDG+*;BY=I M"!_VS ^AQWK])'19$9'4,K#!5AD$>E?F%9ZY=?\ !/O]LKQ!>:]I]S+\//%I ME:*[MX]V())1(K+_ 'FA+;?Q'>/ M$6M-+TY':XF?'"L"H\H>I?&/<\5K)J5"FTM%&UO/70FUJ]1;7=UZ::GS;^P? MX>M/"?[4/!(Q6O+*^'IR=GR[^C>B\V9.4;XBI%77 M-MY-+?R/;I/^"HQ\4736OP_^#WB3Q5.>%5I=K@]ODACE)^F:\1^"?BSQ5XX_ MX*5:#KOC3PV/"7B&],LD^D>6\;0+_9D@CW*YW!B@4G..3T'2OMOQ%^W3\"O! M_AX7J>.+"_C6/,-AI,;S3/QD($5?D)Z?/M [D5\*_ WXF7_Q,_X*.>'?&VK: M5<:(NO7,TUG:W*%6%LUC+%;G)QNRJK\PX)SBJPZ7M](])*_FUM\_T"LW["=Y M;]/U]#Z#_P""MW_)%_!W_8P#_P!)IJ^M?@RH;X.>!0>AT&Q'_DNE?)__ 5I MLYIO@?X4G2)GAA\0+YC@<+FWF S]37I?P+_:%\(?&+X)P^$? 7B'[1XYT_PB MJ&Q:WEADMYDMUBSN90IQ*5&58]0>E?OB\ATY\U1OX;/KOZL\@_X)#9^Q?%'*A3YUAE1VXGXK]$Z_.?_@D1 M-]G;XIV$RM%=1O8,\;\,/^/A2,=<@CFOT8KHQ7\1/RC^2,*&TK]V>&?MP:A- MIO[*/Q'E@;:[:<(2?]EY41A_WRQK@O\ @F-9QVW[*FF2(,-<:I>RR>["0)_) M17L?[3'@R7XA?L_^/M MX_-NKO2)S F/O2HN]!_WTHKY[_X)4^+8M8_9^U70 M]_\ I.C:S*&CSR(Y41U/T+>9^1KGH?\ +[TC_P"E&U;:E_BE_P"DGVC7@G[4 MW[7WA3]F?02ERZ:OXNNHBUAH4+_.>H$DQ_Y9QY[]6P0H."1I?M;_ +0D'[-_ MP?OO$:)'<:WOSW_93\1?!N\\87WQ3^/'CV M+5O&4UVTUKI5]9W-PJ.#Q/-LB*,>/D0':H XS@+%.'M6U>R6_?T7]?\ N4O M9I.UV]O\WY?UZ^P_LU_LN^+_ -HSXA1_&[XY&26"5UN-*T.X4IYRJJIU?JW!R_T3_P4 TU]2_9'\>I&"6ABMI\+Z)>%?VG/@EJT>AZDNI^&O$EA=6,5\L3H,G?$6"NJME7!ZC^&GB M.:5.T(V4=EY[_>["H.,:JE.5VWJ_ZZ'E'_!-V^6\_9(\*QAE)MKF^A.WL?M, MC8/O\XKV3X[745C\$?B!/,P2*/0+]F8^GV=Z^"?V+/VAK3]DW7O%7P=^+9F\ M.+#J+7%K?S1.T,4I 5E; )$;A4=' V\DDC(-=S^VY^VUX.\2?#._^'7PWU,> M+?$'B/;8S3:;&[Q0PLPW*K8Q([_<"IG&XYP< WC(O$7=/7G6EN[7^8L*_8R_ M>:>) M?%FJ1:5I5L,;Y#EY7[1QJ.76_LJ_#.+]F']F6PM?$CI8W5M;S:U MK3L01"[#>ZDC^XBJIQW0U^=_B'XU^'_VN_V@O[5^+?C!_!OPUTQF:QTQ8YI' M,.["Q((D?$CX!>0]!P.B@:U_WU=P@]DKOM96_&SM_2,J/[NCSS75V7>[O^NO M8]0O+KXC_P#!37XD+;VL=QX1^#NBW.6D<9&?4]I;EE/"CY8PWOE_T:^'GP_T M+X6>#=+\+>&[);#1M-B\J"$')/.69C_$S$DDGJ2:\'\*?MJ_LT>!?#MCH6@> M,K#2=(L8Q%;VEMI5XJ(O_?GDD\DGDDDGFO4OA/\ M&?#KXXWFH6O@?Q)'KMQ MI\:2W*):SP^6K$A3F1%SD@]*EZ1]G33MOYOS?]:#3N^>H]?P7DOZU..C_8J^ M&TGQPNOBG?V]]K'B"XG:Z-IJ,R3623' 601E,Y4#YX:EIEGK6GW M%AJ%K#?6-Q&8IK:XC$D./V-?VRM4E^(.K>(O$'P[ MUMY_L;W5Y--;;66 M:,O!IVG12/=S-C(3RRH,9/K)M [FL;7HP>\;;=O+^O3H:[5I+K??OY_UZGR3 M\%])'[.O_!2W4? _AUFA\.:I)+;-:;\JL$MK]JC3K_ ^T GG /J:_3ROSC_8 MA\%^(_V@_P!I;Q'^T'XCTYM/TA99O[-5@=LD[)Y*I&3]Y8HLJ6[MCOD#]&I) M%AC:1V"(H+,S' '4UI4O"C2C/XE'4A6E6J2ALW][ZM'YN?LH_\ %/\ _!23 MXJZ=;$K;7#:L&0<#'VF.0<>QK]):_.+_ ()YVNA?\ 86@_DU=C7'?$O_CUT+_L+0?R:@#L:*** .-^ M&G_'MKW_ &%I_P"2UV5<;\-/^/;7O^PM/_):[*@ KP_]LKXN:M\%_@/JVOZ! M>+8:])<06EE<-$DFQW<%CM<%3\BOU!KW"O@?_@JOXP\G0O OA>-SFXN)]1E4 M'LBB-,_C(_Y5M0A[2M"'=K\-7^"9C7J>RHSJ=D_OV7XV/#O"?[7'[4OCW[3_ M ,(SJFL^(_LNWS_[)\,6MUY6[.W?Y=L=N<'&>N#5S7_VJOVKO MNFH>))==T MBQ#A?,U;PI!;0L3T7) MQ%*C7=*%&+VZ=['@87#U:]!5IUI*]^KTMU_4X']B_P#;0N?V@KR^\,>*+*UL M?%5I!]JAGL@RPWD((5OE).UU+*2 <$$D 8Q7UC7Y/_\ !-7PW>:M^T='J4"N M+32=,N9KAQ]WYP(E4_4OG'^S[5[7^TM_P4 \:?"?XU:WX.\+Z5X=Y#*T:L^62=%P"V.G:LL9@U+$QI4%JU?\;?Y&V!QKCA95<0](RM?Y)_Y M_M%?F9\6^E PS1I*'5(RV=HP6 MQ@D\X'T3\4OVMKK]FGX2^%K7QD8O%'Q5U"P6>?3X0MO'&SD5=OHO\ @_GT/JJBORIM_P!L MK]ISXG3W>H>$H;U[&$_O8?#OAI+N"#O@L\4K#CU:O0O@!_P4BU^/Q59^'OBK M:VLEC/*+9M:MX/L\UK(3C=-&/E*@]=H4KR>>E;_V;7MI9OM?4YUFF'OK=+O; M0_12BJ.L:U8:!H]WJNHW<5IIMI"UQ/=2MA(XU&68GT %?FY\7O\ @H]X[\8> M*FTCX5V:Z/IYF\FTN#9K=W]ZV< B-U95W=D"EO?L.*AAZF(GR4U_P#OQ&(IX M:'/4>^WF?IC17Y\?!G]NWX@^!?&%KX:^.ND7-C;7JDQ:I?Z8=.N8&_A9X]J* MT9/&0HQG.2*U_P!F?]NKXC_'7XWZ1X1N]%\-VNBW/GS7$UK:W GCACC9AAFG M*Y)"C)7OTKJ>7UKNUFDKWOIU_P CE68T+*]TV[6MK_6I]X45\M_MM?M8:]^S M;_PBMKX9L=)O]0U7SY)UU6*614B38 5$+/^%8Z-#I MEGHT7C>_$LM[=6MNYM]/C#LL2)'([[I2%WDL2H# ;22<8TL)5K052"T;M_7W M,VK8RC0FZ=1V:5S](Z*^,/@G^U-XJ\'?LTZE\4?B]JXUD7UX;?0+&*TAMI[K M;E2!Y:*N&8-R1\JQD\Y KP*X_;A_:*^+FL7;> ]-FMH+?YFLO#FA#4&B0D[3 M(SQRG/OA0<=!6JP%6524%;W=WT,7F%&-.-1W][9=?7_+N?J917YC_"?_ (*, M_$7P=XRATGXGV\>L:8)_(OF>Q6TO[/G!8*@53MZE&3)QC(K]"_B9X\A\!_"_ MQ%XNC,<\>FZ9-?1;LE)"L99 <$9!.!P>]8XC"U,,E*>J?5&^%Q5/%-QAHUT> MAUM%?FSX'_X*B>,IM2NO^$F\-Z%\SA5Y))VDX M7 Y(KC/'7[<7[1OA?Q-#: D,4D>?X3-&967W#_B*Z5EM? MFY79?,Y'FF'Y.=7?R_$_5FBO@R]_X*0:MXE\ >'K#P1X0DUOXGZC$XO+&WMI M9X+5E)&Z.-?GE+ ;@H/R@\DXY\4T_P#;^^.O@'QP8_%TRWB6\H%YX?U328K- MT4X)7*QI(C8/!8GL2#THAEU>9X>$5)7=^RV]?\C]7J*Y"Y M^*F@:?\ "M?B#>7+6WATZ8FJF5ERPA9 ZC ZL=P&/4U^>_BC_@H!\9OBQXDN M=/\ A;X?DT^V3<\-OINEG4K\Q@XW295U';HF!G&3UKFI86K6FX16V_D=-7%T MJ,(U)/26UNI^F]%?E19_MX_M ?"WQ)';^-HOMK##2:7X@T5+&0H3R5\M(V!Z MX)!'L>E?H]\%?BYI'QQ^'&E>+]&5X;>\4K+:R$%[>93AXV(ZX/0]P0>]77P= M6A'G=FNZ,Z&.I8B?LU=2[,[FBBBN$] **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH P?'?_ ")^K_\ 7NU6O"__ "+.D?\ 7G#_ .@"JOCO_D3]7_Z]VJUX M7_Y%G2/^O.'_ - % &I1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 52UC6K#P_I\M]J5Y#8VD8R\UPX11[9/?VK,\=^-M.^'OAF[U MK4WQ!",)&OWYI#]U%]S^@R>U?#'C7QYXD^,7B:)KGS;J623R[/3;4$I'GHJ+ MW)[GJ:Y*^(5'1:L^6I0BN:H]E_G_6I])>)/VO/">ES&+2[.^UH@X,J MJ(8S]"WS?^.US]O^VE9M(1/X4GCCSPT=\KG\B@_G6%X+_8]U/4K:.Y\2:JNE M%AG[':H)91[,V=H/TW5UMU^QGX?> BVU_4HIL.UAOFTR_DX6UU%1&6/H&R5)]LY/I M7IE?"GQ._9[\2_#:%[Y@FK:.OWKZU!_=_P#71#ROUY'O5CP9^TKXM\&^&Y=( M1X=155"VD]Z"[VW(X'/S+C. >A([#%5'%R@^6LK&M#B*KA9NAFE/EDNJ7Z?J MM#[CHKR#]G/XK:O\3]#U3^V88S=:?*B"ZB38LP<,<$=-PV\X[,*]?KT(352* ME'9GV.%Q-/&48UZ7PR"BBBK.L**** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ KCM _P"2D>*?^N=M_P"BQ78UQV@?\E(\4_\ 7.V_]%B@#L:R_%'A M^W\6^&=6T.\>6.TU*TELYG@($BI(A1BI((!P3C(/TK4HI2BI)Q>S'%N+31\L M?"/_ ()T_#?X,?$31O&>B:WXJNM4TJ1Y((;^[MG@8LC(=P2W5CPQZ,.<5]3T M45I*JLSR?X)_LM_#?\ 9_223PAH"0:E,GES:K>2&>[D7N-[?=!X MRJ!0<#BO6***J4G+63)C%1V/FKXJ?\$]?@U\5-6N-5FT>[\-ZG$O^"7GP5\,ZDEW>+X@\2JAW"VU;4%$6?<01Q$C MV)Q7UU11&3@K18Y)2UD4M%T73_#>DVFEZ596^FZ;:1B&WM+6,1Q1(.BJH& / MI7GWQU_9Q\#_ +16AVVF^,=-DG>S9FL[^TE,5S;%@ VQ^1@X&58%3@'&0*]. MHJ7[SNQQ]W1'R]\(?^"=GPN^#7CC3?%FEWOB34]6TV3SK7^TKZ,QQO@C.(HH M\\$\$DW4^9?A/\ \$[_ (._"?7(=8BT[4/%&I6[B2WE\17"3K"P MZ$1HB1DCL65L$ C!K.G_ ."V>O^+=*ULZJ=8C2RO+9889S+YN$ M#6Y;;N[%CQQFOJNBJ]I-24[ZK;^OD3R1<7&VC*6LZ-8^(M)O-+U.TBO].O(6 MM[BUG4-'+&P(96!Z@@FODC5O^"5_P9U'6)+V"Z\4:9;NVX:?::A$8%'H#)"\ MF/JY-?8E%9KW7S+QSO@GP#HW@#P/IGA'2K=O[#T^U%G#!=.9B8L$;6 M+9W=3U^E?.OQ _X)H_!;QUJTNH6]EJWA269B\D.@7:1PEB5;'SG\'_V!?A!\&M8MM8L=(NM?UFU<26]]K]P+AH6'1EC M54C# \AMF01P17T9113E*4MV)14=D%(1D8(R*6BI*/F+XH_\$Z?@U\4-9GU4 MZ9J'A:_N',D[^';E8$D8]3Y3H\:Y_P!E5SUZT?"__@G1\&?ACK$&J#2[_P 4 MWUNXD@?Q#LWDPFOO*D4J?+*9[N2U>TFM=2NK>2WEC8@X94@0Y!52,,.1^ M%?1M%7[25W*^K5OE_39')&W+;3?Y_P!)'@O[1G[&?@K]IS7=)U;Q1JFO6%QI MELUK"ND7$$:,K-N)820N2<^A%>A_!?X1Z/\ OX<:5X*T&YOKO2M-,IBFU&1 M'G;S)6D;<41%/S.<84<8KMZ*F,G&/(MM_P"OO*DE)\SW_I'A/[1O['7@S]I[ M5=%U#Q3J>O6$VDPR00+H]Q#&K*[!B6\R%\G('3%=U\$?@WHOP%^'=AX,\/W5 M_>:7922R1S:E(CSDR.7;)1$7JQQ\O2N\HIQDXQ<%M_3!I2?,]_Z1YI\:/V<_ MA_\ '[3X;;QGH$6H36X(MKZ)VANH,]ED4@X[[3E<\XKP#3_^"4_P;LM02YFU M'Q9?PJV39W&H0")AZ$I KX^C9K[*HI1;A\(2][DQ'<(+<'+L0 7=B2SL0!EF)/ YJUXV\"^'_B1X;N] \3Z3:ZUH]T,2VEV MFY3Z,.ZL.H8$$'D$5NT42]_XM1Q]WX=#XXUC_@E7\&=3U)[FVO?%6DPLV19V M>HQ-$OL#+"[X^K&O7/JEW(9[N5?[N]ONJ<# M*H%!P#BO5Z*KGDE:Y+C%N]CA_C1\(='^.OPYU/P7KUS?6FEZ@8FEFTV1$G'E MR+(-I='7JHSE3Q7GW[.?[&G@K]F/7-7U7PMJFO7]QJ=NMM,NKW$$B*JMN!41 MPH0<^I->\T5,6X7Y>O\ PPY+F24N@4444AA1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !7D'QK_P!9J_\ V+=[_P"BY*]?KR#XU_ZS5_\ ML6[W_P!%R5T8;^/#U7YG)C/]VJ?X7^1\1T445^]G\I!1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?HQ7YSU^C%?GO% MG_+C_M[_ -M/US@'_F*_[<_]N"BBBOSX_7 HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH *T[7_D'?C_6LRM.U_P"0=^/]: &4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110!?M_\ 4K4E1V_^I6I* *NJ:9;:UI=YIU[%YUG=PO;S M1[BN^-U*L,@@C()Y!S7#_"'X ^ O@+:ZE;>!=!_L.#4G22Z7[9<7'F,@(4YF MD?& QZ8ZUZ%10M+VZB>MK] HHHH&<=\5/A#X2^-?AE?#WC32?[9T=9TN1;?: M9H/WB@A6W1.K@V&BZ#::+:6RII=I;)9PV[DNHA50BH2Q)8;0!SG/>K M]%'1KHPZI]4>":]^PA\!_$FK2:C>?#JQCN9&W,MC=7-I%GVBAE5!^"UW=A\ M/AUI/@'5/!=AX0TS3_#6J0F"^LK.+R3*_!&GZAJ4AS)>PM):SRG& 7DA9&?CCYB:]8HH;=G9#[J17KE%%-RPT4HMQ^'0))2^+4*** M*0PK&\9>#](^('A;4_#FOVGV_1M2A:WN[;S'C\R,]1N0AA]00:V:*32:LQIM M:HY+X7_"GPK\&?"J>&_!VE_V/HJ3/.MK]HEGP[XW'=*S-S@<9Q5/7/@EX+\2 M?$S1OB#J>C?:_%VC1>187[W4X$"?/P(@_ED_O'Y*D\^PQW-%7S.ZE?5?\,39 M).*V85\^:S^P)\!_$&L7VJ:AX%-S?WT\ES<3-K%^#)([%F; G &22>*^@Z*G M9W0^ECYP_P"'=O[/?_1/_P#RM:A_\D5N^!OV)?@M\-O%FF^)O#G@S^SM;TZ0 MRVMU_:E[+Y;%2N=KS,IX)Z@U[E15J<>#_V=_A]X!^(V MM^/-!\/_ &'Q7K7G?;]0^VW$GG>;(LDG[MY"BY=0?E48Q@8%>AW%O%=V\D$\ M:30R*4>.10RLI&""#U!%244;I1Z+3Y!U#/_7&.18\>VW%=/XX_9@^%WQ%\+Z)X_4C\B,P>245HMNPHPR"N,8.>M>(Q?L1?! M*U\86WBFU\"6]CK5M=I?0365]=6\<4R.'5EB241C# ' 7'M7N5%)-QES+<++ MEY.G8\V\1?LY_#SQ9\4--^(FJ^'OM7C'33$;74OMMPGEF(DQ_NUD$9P2>JG/ M?-7_ (N? _P3\==%L])\<:+_ &WI]G_=O^YQNSGOG/-87 MPD^"/@KX%Z)>:1X'T7^Q-.N[C[5-#]JGN-\NT+NS*[D<*!@''%=U15%K77)+0%8+AGD@GC4\E1+$ROMSSMSC M/.*=X1\'_#K]F7P(=.TQ[+P9X56Y,N[4M2?R5FDP/];<2'!8@8&[&>@YKT.N M(^,WPAT+XZ_#W4?!OB-[N/2KYHV>2QD6.9&1PZE696&70^'_V[/'V@?M/?$;X9?"+P#J&G^)-0EU$S7>JZ;(MQ':AP%*B125(5 \C@ M'C8O>OT$\+^';'PAX;TK0M-B$&GZ;:QV=O&!C;'&H51^0%>/?L__ +&?PX_9 MPU"YU/PW:WVH:W.AB_M76)EFN(XSU1-J(J ]R%R>A.*]TK6\8P]G'O=^O_ 1 MG[TI\\NBLOU^]A11161H8'C;P#X<^)&A2Z-XHT2QU[2Y#DVU]")%#=F7/W6' M9A@CUKRSPC^Q#\#_ /KD6KZ5\/K 7\3!XWO;BXO$1@IYWX,_9]\ ?#[X@:[XWT#0/L'BC7#*=0OOMEQ)YWF2"1_P!V M\A10]FWU>YX=X/_8C^!W@74TU#2OAYIS72$,C:C+/?*I'0A;B1U!'J M!73^*_V?XMTGR?L>I0WUS T?E,6C^2.14;!)^\IR#@Y M'%>E457-*Z=]5MY$\JLU;?%T+G&!\Q/2M#X8?LV_#'X-3_:/!_@S3=(O<%1?;6GN0IZ@32EI #Z!L5Z M711%N*M'0&E)W9YM\._V=/A[\)_%VM>)_"GA\Z/K.L[_ +=-'?7,B3;I/,/[ MIY#&OSOO^O-/CM^S_P"%_P!H3PW9:3XD-[9R6%TM MY9:GI@/4 ATY_P UNA27/3.M#.N6^G2/+;1_;;BW",P 8_N9$SP!USBO,?^'=O[/?_ M $3_ /\ *UJ'_P D5]#Z?:O8V%M;27,UZ\,:QM_^B?\ _E:U#_Y(KVKX=?#GP[\)_!]CX6\*:?\ MV5H5B9#;VGGR3;-[L[?/(S,6[GBR"#LDF=V3()'RD<&O6:*F+//"^I^'==M3> MZ/J<#6UW;B5XO,C889=R$,,CT(KPC_AW;^SW_P!$_P#_ "M:A_\ )%?1]%): M.Z&]59GSA_P[M_9[_P"B?_\ E:U#_P"2*]!^$/[-/PW^ U[J5WX%\.?V'<:C M&D5T_P!NN;CS%4DJ,32.!@D],5Z=15\\NY/+'L<_XV^'_AKXDZ*VD>*="L-? MTUCN^SZA LJJV,;ER/E;D_,,$5Y!I/[!/P$T75([^W^'5G).C;@EW>W5S#GW MBDE9"/8KBO?Z*F+<7>.A3]Y697T_3[72;&"RL;:&SL[=!'#;V\8CCC4# 55' M '85X1^W%\95^#?[/VNSVTVW7=:4Z1ID:GYS+*"&=1U^1-[?4*.]>_UY;X\ M_9U\,_$SXI>%?''B*ZU+49_#(+:=HSRQ_P!GI*3GSFC\O>SY"'E\?(O'',RB MJC49[/?TZ_?M\[E1E[/WH[K;UZ')?L0_ =_@+\"-*TZ_@\GQ%JI_M/5 1\R2 MN!MB/^X@53_M;O6O?Z**UJ3=2;DS&G#V<5$****S- HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH *X[XE_P#'KH7_ &%H/Y-78UQWQ+_X]="_["T'\FH [&BBB@#C?AI_ MQ[:]_P!A:?\ DM=E7&_#3_CVU[_L+3_R6NRH *_)G_@I%XP'B3]HZXTZ.7?# MH>G6]EM'178&5OQ_>#\J_64G R>E?B3XVN)?C?\ M.:F(F\P^(O$IMH67G]V M\XC3\ FW\J];*Z?M,4K]$_OV_)L\C-JGL\(TNK2^6_Z(]1\$_L^?M76?A+3$ M\+GQ-IGAZ> 7%I:V7BN*UA$0/+:5B?8X'O7ZIVMM'9VL-O"H2&)!&BCH% P!^52U")]-T^=K_4KHB?4]6F M4(T[*#@!FW%[DC@.P$*_C^]8_A6V7U)3J5<55=VE_F[?@C',J<84J.%I*RE+_) M7_\ )F?I?\*O@]X5^#7A.VT#PSI4%E;1HHFGV S73@V-P3-J_B$:3:LQW"*(3""/'L% /YU^TM?C'\8O#^K_LV_M3 MWE[+9F0Z=KBZWI_G A+J S>;'@^A^Z2.A!]*SRR?/B^:H[MI[^J-I^O_@;P3I'PY\)Z9XTO3=-_:8O6T^&.&6ZTVVN+P1C&Z<[@6/N45,_G7V)KP5"LL2ZM962O=O\ KY_(SQV(H/"JC1:;=DDO MZT[?,^K/VL?B1J>D_L)?#:R::07OB6RTV"[DR0S1K;"5P?JRIGUR:S/^"6_P MGL;BT\2_$2]MXY[V*?\ LK3V=03#A \SKZ%@Z+GT##N:[#_@I5\/)%^ ?A6X MTBV/]F^&KZ.%XT&1#;M%Y2GZ JB_\"%>0_L$_M<>#/@OX4UKPEXWN9M(M9KT MZA::E';23H2R(CQNL:LP/R*00I')R1@9UHOVN&Q$J*UE)^O3]#&M'V.)PT*^ MT8KTNKZ_?;\#Z)_X*2:'I>H?LWW6H7D$;:AI^H6S6,S#YT9W". ?0H6R/8'M M7SO_ ,$L/"GV_P")WB[Q"Z933=+2U5L='FD!_P#086_.N6_;A_; L/CY)I_A MCPFDZ^$].F^TR7=PAC>]GP55@AY5%#-C=@DL<@8%?1W_ 2[\*_V3\%_$&NR M)M?5M79%;'6.&-0#_P!]/)4T83PN JRGHWM\[+_-E8BI3Q684HTW=16K]+R_ MR1\U?\%)O&)\1?M%R:6DF^#0]-@M-HZ!W!E;\<2*/PK[-_8I_9JT/X1_#'1= M>O-,@F\::Q:I>75_-&&EMTD&Y((R?N *1NQU;.>@Q^=OBMG^.W[6E[$O[V/7 M_%(M4(Y_W0*E=U,7.#FJ:AI=I-OII?\ 3OU/S_\ B/XL\0?'SXV76HZI MI\.G>(-;OX;-K&WB:-8I/EA5-K$MD8&WDO\ ]EG)@ZCY M,3BF[Z6OUN_UUB<__P $P?A'8>)/%OB'QUJ=JMR=#$=KIWF*"J7$@8O(!_>5 M #V\P^U7?\ @JQXECN/%?@/0$*F6TL[B]D]0)75%'_D)J]^_P""&?V M:=.OF39-KE]*G\9_M1>)(8):JQ2.,'LI*E_?(O^$U_:G\5I:('^RRPZ9&$'+/' M&JM]3OW"OU=\"Z+;_#'X3Z%IDI$5OH6CPQ2MZ"*$;S_XZ37Y'? C3Y?C3^UI MX=EN4,W]I^(&U6Y5N^+/V4Y_AKI,B1:C#HMK:6V]]B/+;B-E4GL&,>/3FOS*^ M&?Q:^)O['/C35+>#2_[)OKI42^TG7;)MDZH6V-U5L#6UVXX$T8BC<(Q&"1A<'..,5AA95E3G64>>, MWJNM^_\ 7D;XJ-#GIX=S<)06CZ=/Z^\Y?1_VT_A'^T7M>@_LV_#W2O _@L>-=>>VMKR\3S(KJ[=46UMSPN&/ +]<^A ]<_. MWQBN'N?BIXL>0$,-2G09]%<@]@:[*>* MA*#E+1H^EP?$&%Q&&E6JOEE'=?Y=[D_[0'QNM/A]I,NC6!BN_$%Y$5\I@'2V MC88WN.Y(Z*>O4\=?B>NR\%^#=?\ C)XR>"&22YNIW\Z]U"?++$I/+N?Y#OTK MU_\ :,^&>A_#GX7^'+32H LL=^5DN'YEG9HCN9C]47CH.U>;4Y\0G5>B1\3C MGBLZA4Q\ERTJ>WW_ )]W\CT[]ES5K'4_A/9Q6EK#:2V<\D%RL6?WDG#>8<\Y M*LOY8& !ZY7S5^Q;<.VF^*X"#Y:2VSJ>V6$@/\ Z"*^E:];#RYJ46?HF2U7 M6RZC)]K?<[?H%%%%=)[84444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !7':!_R4CQ3_USMO\ T6*[&N.T#_DI'BG_ *YVW_HL4 =C1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D'QK_UFK_\ 8MWO M_HN2O7Z\[\::?;ZQXWM["[C\VTNM+E@FCW%=R,65AD'(R">E:T9JG4C-]&C" MO3=6C.G'=IK[T?!%%?:7_#//P^_Z%_\ \G;C_P".4?\ #//P^_Z%_P#\G;C_ M ..5^F_ZTX+^27W+_P"2/Q/_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_ M^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)VX_\ CE'_ SS\/O^A?\ M_)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ;17VE_PSS\/O^A?_ /)V MX_\ CE'_ SS\/O^A?\ _)VX_P#CE'^M."_DE]R_^2#_ %%S+_GY#[Y?_(GQ M;17V_8_LX_#J:*4OX>R5Z?Z;<_\ QRD_X9Q^'?\ T+W_ ).W/_QRC_6G!?R2 M^Y?_ "0?ZBYE_P _(??+_P"1/B&BOM[_ (9Q^'?_ $+W_D[<_P#QRC_AG'X= M_P#0O?\ D[<__'*/]:<%_)+[E_\ )!_J+F7_ #\A]\O_ )$^(:*^WO\ AG'X M=_\ 0O?^3MS_ /'*/^&_P"&_P"&_P"&_P"&_P"&_P"& M_P"&_P"&_P"&A^W7/\ \?A]_P!"_P#^3MQ_\?A]_T+_P#Y M.W'_ ,?A]_P!"_P#^3MQ_\?A]_T+_P#Y.W'_ M ,?A]_P!"_P#^3MQ_\?A]_T+_P#Y.W'_ ,?A]_P!"_P#^3MQ_\?A]_T+_P#Y.W'_ ,?A]_P!"_P#^3MQ_\?A]_T+__ ).W'_QRO1J^6SS- M*.9>S]BFN6^]NMNS?8^ZX8R+$Y+[;ZQ*+Y^6W*WTYM[I=PHHHKY8^Y"BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K3M?^0=^/]:S M*T[7_D'?C_6@!E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 7[?_4K4E1V_^I6I* "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.^)?_'KH7_86@_DU M=C7'?$O_ (]="_["T'\FH [&BBB@#C?AI_Q[:]_V%I_Y+795QOPT_P"/;7O^ MPM/_ "6NRH KZA9C4=/N;0RR0B>)HC)$0'3<",KD$9&>,@U\T?#?_@GI\-_A MAX\T;Q9IVK>)K[4-+G^TP0ZA=6[PLX! +!8%8X)SPPY KZ?HK6G5G1NZ;MP4445D;'$?&3X2Z5\;_ #?>$-:O=0L-,O'C>:33)$CF.QPX7+H MXQD#/':N._9\_9/\'_LVW>M7/AJ]UB_GU5(HYGU::*0HJ%B GEQ)C);G.>@Z M5[116L:LX0<(NR>YE.E"I.,Y*[6P5PGQ8^!W@GXW:3'I_C#0X=46')@N 6CG M@)Z[)%(8=LC.#@9!KNZ*S3:=UN:-)JSV/D.'_@F#\)([X7#:EXJEBW;OLKWT M'ED?WOHSX9_"/PA\'=#.D>#]#MM&LV(:4Q9:69A_%)(Q+.?]XG M';%=A16\\16J+EG)M'/3PU&E+FA!)GS#^UA^UEI'P-U^R\(^)/ K^*-!US36 MEFE^U*J.I=D>(Q,A#_ /P;_9*^*VGKXH/B^^\$!I6\WPSJVO MVML8<$_*/,4R,I&""LAX.,@\#[4^/'[._A#]H?P[;Z7XH@GCFM&9[/4+)PEQ M;,1AMI((*G RI!!P.X!KY.OO^"3MI)=.UG\39H+;/RQSZ&)7 ]V%PH/Y"N[" M5*$*=I2<)]UU[:'!C*5>=2\8J<.SZ.VNOGN?,?[5WB+X?:KXYTWP[\*M/MX/ M"6AVWV:.:U1B;RY=LR2;VR\G1%#,23LXXQ7ZC?LY_#&3X;_L^^%?"=R'L[U= M.S>>7@/'/-F23&01E6?@'X2^(+/7]3O;OQAK-FPDMS>QI% M:Q2#D2"$9RP/3(ISH+#4VY*]VWUW_S8L'AJD*[Q-1*+M9) M=-O\E^)\S?"W_@G_ /#KX2_$#2?&&F:MXDO]3TV1I88M2NK=X2S(RY8) K$C M<2/F'(%?3-%%>=4K5*UO:.]CTZ=&G1O[-6N>0?'3]E;P!^T)]GG\365Q;ZK; MIY46JZ;,(;E8\YV$E65ADG&Y3C)QC)KBOA]_P3Y^$7P_NI+O[!J/B*\*,L4V MMW*R^3N4C"RG!P1@BOI2BG&M5A!TXR:3%*A2G-5)13DNI\U_"+]@ MKP%\%?B!IGC#0-=\42ZG8>8$BO;JV>%PZ,C*X6!21ACT(Y K3^.G[%/@K]H/ MQI'XF\2:SXCM;V.U2S2'3;F!(512Q& \+G)+'/-?0-%5+$UI351RU6Q$<+1C M!TU'1[HP/ /@K3OASX+T7POI/FG3M)M8[2!IR#(RJ,;G( !8]20 ,D\"OG^\ M_P"">OPZU+XD2^-KS6O%%WJDVJ?VM+#+=6Q@>4R^:4(^S[MF>,;LX[]Z^GZ* MF->I"HZL96D^I%-8T"YN;FSMM4M);.6>S95F1 M)%*L4+*P#8)P2#7A_P $OV&_ /P'\=1>+-"U'7]0U.&"2"--4N()(D#C#, D M*'=C(ZXP3Q7T114PJSIJ2@[7T?\ 7S*J4H57%S5^75>7]61C>+O!NB>/O#]U MHGB+2[;6-)N1B6UND#(V.A]B#R".0>E?,>N?\$R?A!JU\\]K<^)=%B8\6MC? MQM&OT,T4C?FU?6M%%.M4HN].5A5*-.LK5(W/#O@]^QG\+O@GJD6K:-H\VHZW M#_JM3U>;[1-%[H,!%/\ M*H/O7N-%%%2I.J[S=QTZ4**Y:<;(****R-0HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@#!\=_\B?J_P#U[M5KPO\ \BSI'_7G M#_Z *J^._P#D3]7_ .O=JM>%_P#D6=(_Z\X?_0!0!J4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 ?"G[27AN3P[\6]78@^3J&V]B8 MCJ'&&_\ 'U+('NK>);2Z7NLJ Y^HPWT:L+]HGX3R M?$GPJEQIT8;7--W20+T,R$?-%GU. 1[C'?-?+'PK^*FK_"/Q$TT*-+9R-LOM M.D.T2 9'_?M"?L]KX MF6X\2^&K<+K"@O=V48P+H=W4?\]/;^+Z]?FOP'\/M7^(7B2+1],@/FYS/-(" M$MT!Y9SVQZ=2>!7VUX+^-W@_QS;1M9ZO#:73#YK*^<0S*?3!.&^JDBNJFUC2 M-+CDN9KVQM(V^=YGE1 ?I['YP\!^"M:^,7C;[,LLDTL\AN+_4)?F\M27^?XGTE^R'X;DTOX>WFJ2@J=4NRT8(ZQQC8#_WUO\ MRKW6J6BZ/:^'])L]-L8A#9VD2PQ(.RJ,#\?>KM>C2A[."CV/M<#AOJ>&IT/Y M5^/7\0HHHK4[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N.T# M_DI'BG_KG;?^BQ78UQV@?\E(\4_]<[;_ -%B@#L:*** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH *X/Q%_P E(TW_ *\'_P#0FKO* MX/Q%_P E(TW_ *\'_P#0FH V:*** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#1TS_4S_Y[4E+IG^IG M_P ]J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@"7_EQFK*K5_Y<9JRJ "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH *T[7_D'?C_6LRM.U_P"0=^/]: &4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!? MM_\ 4K4E1V_^I6I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "N.^)?_ !ZZ%_V%H/Y-78UQWQ+_ ./70O\ L+0?R:@#L:*** .-^&G_ M ![:]_V%I_Y+795QOPT_X]M>_P"PM/\ R6NRH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH P?'?\ R)^K_P#7NU6O"_\ R+.D M?]>3?%C]G?0_B3-)J-N_] MCZXP^:YB0&.8XX\Q>Y_VASZYXKUFBHG"-1$E*\9R2^7^1\>>"/V1_$FL3QR^(IX=#LNK1HXFN#[ #Y1]2 M>/0U]1^"? FC?#W14TS1;06\'WI)&YDF;^\[=S^@[8%=!1752H0H_"M3W\!E M&$R[6C'WN[U?]>@4445T'LA1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !7':!_R4CQ3_USMO\ T6*[&N.T#_DI'BG_ *YVW_HL4 =C1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!^(O^2D M:;_UX/\ ^A-7>5P?B+_DI&F_]>#_ /H34 ;-%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!HZ9_J9 M_P#/:DI=,_U,_P#GM24 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 2_\ +C-656K_ ,N, MU95 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %:=K_ ,@[\?ZUF5IVO_(._'^M #**** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH OV_P#J5J2H[?\ U*U)0 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 5QWQ+_ ./70O\ L+0?R:NQKCOB7_QZZ%_V%H/Y M-0!V-%%% '&_#3_CVU[_ +"T_P#):[*N-^&G_'MKW_86G_DM=E0 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!@^._^1/U?_KW M:K7A?_D6=(_Z\X?_ $ 55\=_\B?J_P#U[M5KPO\ \BSI'_7G#_Z * -2BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X M[0/^2D>*?^N=M_Z+%=C7':!_R4CQ3_USMO\ T6* .QHHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@_$7_ "4C3?\ KP?_ -": MN\K@_$7_ "4C3?\ KP?_ -":@#9HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -'3/]3/_GM24NF? MZF?_ #VI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** )?^7&:LJM7_EQFK*H **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ K3M?^0=^/]:S*T[7_ )!WX_UH 91110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M %^W_P!2M25';_ZE:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH *X[XE_\ 'KH7_86@_DU=C7'?$O\ X]="_P"PM!_)J .QHHHH XWX M:?\ 'MKW_86G_DM=E7FGAO7+[PRVK02>'M6N?/OY9U>&V;;M. /Y5M?\+ NO M^A6UK_P&- '8T5QW_"P+K_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z M_P"A6UK_ ,!C1_PL"Z_Z%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%; M6O\ P&- '8T5QW_"P+K_ *%;6O\ P&-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z M%;6O_ 8T?\+ NO\ H5M:_P# 8T =C17'?\+ NO\ H5M:_P# 8T?\+ NO^A6U MK_P&- '8T5QW_"P+K_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z_P"A M6UK_ ,!C1_PL"Z_Z%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%;6O\ MP&- '8T5QW_"P+K_ *%;6O\ P&-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O M_ 8T?\+ NO\ H5M:_P# 8T =C17'?\+ NO\ H5M:_P# 8T?\+ NO^A6UK_P& M- '8T5QW_"P+K_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z_P"A6UK_ M ,!C1_PL"Z_Z%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%;6O\ P&- M'8T5QW_"P+K_ *%;6O\ P&-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T M?\+ NO\ H5M:_P# 8T =C17'?\+ NO\ H5M:_P# 8T?\+ NO^A6UK_P&- '8 MT5QW_"P+K_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z_P"A6UK_ ,!C M1_PL"Z_Z%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%;6O\ P&- '8T5 MQW_"P+K_ *%;6O\ P&-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\+ MNO\ H5M:_P# 8T =C17'?\+ NO\ H5M:_P# 8T?\+ NO^A6UK_P&- '8T5QW M_"P+K_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z_P"A6UK_ ,!C1_PL M"Z_Z%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%;6O\ P&- '8T5QW_" MP+K_ *%;6O\ P&-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\+ NO\ MH5M:_P# 8T =C17'?\+ NO\ H5M:_P# 8T?\+ NO^A6UK_P&- '8T5QW_"P+ MK_H5M:_\!C1_PL"Z_P"A6UK_ ,!C0!V-%<=_PL"Z_P"A6UK_ ,!C1_PL"Z_Z M%;6O_ 8T =C17'?\+ NO^A6UK_P&-'_"P+K_ *%;6O\ P&- &GX[_P"1/U?_ M *]VJUX7_P"19TC_ *\X?_0!7(>(_%U[K.AWMC'X9UB-YXB@9K8X&:FT?QI> M:=I-E:/X8UEG@@2(LML<$JH&?TH [VBN._X6!=?]"MK7_@,:/^%@77_0K:U_ MX#&@#L:*X[_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: .QHKCO^%@77_0K:U_X# M&C_A8%U_T*VM?^ QH [&BN._X6!=?]"MK7_@,:/^%@77_0K:U_X#&@#L:*X[ M_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: .QHKCO^%@77_0K:U_X#&C_A8%U_T* MVM?^ QH [&BN._X6!=?]"MK7_@,:/^%@77_0K:U_X#&@#L:*X[_A8%U_T*VM M?^ QH_X6!=?]"MK7_@,: .QHKCO^%@77_0K:U_X#&C_A8%U_T*VM?^ QH [& MBN._X6!=?]"MK7_@,:/^%@77_0K:U_X#&@#L:*X[_A8%U_T*VM?^ QH_X6!= M?]"MK7_@,: .QHKCO^%@77_0K:U_X#&C_A8%U_T*VM?^ QH [&BN._X6!=?] M"MK7_@,:/^%@77_0K:U_X#&@#L:*X[_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: M .QHKCO^%@77_0K:U_X#&C_A8%U_T*VM?^ QH [&BN._X6!=?]"MK7_@,:/^ M%@77_0K:U_X#&@#L:*X[_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: .QHKCO^%@ M77_0K:U_X#&C_A8%U_T*VM?^ QH [&BN._X6!=?]"MK7_@,:/^%@77_0K:U_ MX#&@#L:*X[_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: .QHKCO^%@77_0K:U_X# M&C_A8%U_T*VM?^ QH [&BN._X6!=?]"MK7_@,:/^%@77_0K:U_X#&@#L:*X[ M_A8%U_T*VM?^ QH_X6!=?]"MK7_@,: .QKCM _Y*1XI_ZYVW_HL4?\+ NO\ MH5M:_P# 8UA:;XBO[+Q5K&J-X;U=HKU8E1!;-N7:H!SQ[4 >G45QW_"P+K_H M5M:_\!C1_P + NO^A6UK_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6 MO_ 8T =C17'?\+ NO^A6UK_P&-'_ L"Z_Z%;6O_ &- '8T5QW_ L"Z_Z% M;6O_ &-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\ "P+K_H5M:_\ M 8T =C17'?\ "P+K_H5M:_\ 8T?\+ NO^A6UK_P&- '8T5QW_"P+K_H5M:_ M\!C1_P + NO^A6UK_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6O_ 8 MT =C17'?\+ NO^A6UK_P&-'_ L"Z_Z%;6O_ &- '8T5QW_ L"Z_Z%;6O_ M &-'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\ "P+K_H5M:_\ 8T M=C17'?\ "P+K_H5M:_\ 8T?\+ NO^A6UK_P&- '8T5QW_"P+K_H5M:_\!C1 M_P + NO^A6UK_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6O_ 8T =C M17'?\+ NO^A6UK_P&-'_ L"Z_Z%;6O_ &- '8T5QW_ L"Z_Z%;6O_ &- M'_"P+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\ "P+K_H5M:_\ 8T =C17 M'?\ "P+K_H5M:_\ 8T?\+ NO^A6UK_P&- '8T5QW_"P+K_H5M:_\!C1_P + M NO^A6UK_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6O_ 8T =C17'? M\+ NO^A6UK_P&-'_ L"Z_Z%;6O_ &- '8T5QW_ L"Z_Z%;6O_ &-'_"P M+K_H5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\ "P+K_H5M:_\ 8T =C17'?\ M"P+K_H5M:_\ 8T?\+ NO^A6UK_P&- '8T5QW_"P+K_H5M:_\!C1_P + NO^ MA6UK_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6O_ 8T =C17'?\+ N MO^A6UK_P&-'_ L"Z_Z%;6O_ &- '8T5QW_ L"Z_Z%;6O_ &-'_"P+K_H M5M:_\!C0!V-%<=_PL"Z_Z%;6O_ 8T?\ "P+K_H5M:_\ 8T =C17'?\ "P+K M_H5M:_\ 8T?\+ NO^A6UK_P&- '8T5QW_"P+K_H5M:_\!C1_P + NO^A6UK M_P !C0!V-%<=_P + NO^A6UK_P !C1_PL"Z_Z%;6O_ 8T =C17'?\+ NO^A6 MUK_P&-'_ L"Z_Z%;6O_ &- '8UP?B+_DI&F_\ 7@__ *$U6_\ A8%U_P!" MMK7_ (#&N. M13X8UD[O2V-'_":7G_0L:S_X#&@#J:*Y;_A-+S_H6-9_\!C1_P )I>?]"QK/ M_@,: .IHKEO^$TO/^A8UG_P&-'_":7G_ $+&L_\ @,: .IHKEO\ A-+S_H6- M9_\ 8T?\)I>?]"QK/\ X#&@#J:*Y;_A-+S_ *%C6?\ P&-'_":7G_0L:S_X M#&@#J:*Y;_A-+S_H6-9_\!C1_P )I>?]"QK/_@,: .IHKEO^$TO/^A8UG_P& M-'_":7G_ $+&L_\ @,: .IHKEO\ A-+S_H6-9_\ 8T?\)I>?]"QK/\ X#&@ M#J:*Y;_A-+S_ *%C6?\ P&-'_":7G_0L:S_X#&@#J:*Y;_A-+S_H6-9_\!C1 M_P )I>?]"QK/_@,: .IHKEO^$TO/^A8UG_P&-'_":7G_ $+&L_\ @,: .IHK MEO\ A-+S_H6-9_\ 8T?\)I>?]"QK/\ X#&@#J:*Y;_A-+S_ *%C6?\ P&-' M_":7G_0L:S_X#&@#J:*Y;_A-+S_H6-9_\!C1_P )I>?]"QK/_@,: .IHKEO^ M$TO/^A8UG_P&-'_":7G_ $+&L_\ @,: .IHKEO\ A-+S_H6-9_\ 8T?\)I> M?]"QK/\ X#&@#J:*Y;_A-+S_ *%C6?\ P&-'_":7G_0L:S_X#&@#J:*Y;_A- M+S_H6-9_\!C1_P )I>?]"QK/_@,: .IHKEO^$TO/^A8UG_P&-'_":7G_ $+& ML_\ @,: .IHKEO\ A-+S_H6-9_\ 8T?\)I>?]"QK/\ X#&@#J:*Y;_A-+S_ M *%C6?\ P&-'_":7G_0L:S_X#&@#J:*Y;_A-+S_H6-9_\!C1_P )I>?]"QK/ M_@,: .IHKEO^$TO/^A8UG_P&-'_":7G_ $+&L_\ @,: .IHKEO\ A-+S_H6- M9_\ 8T?\)I>?]"QK/\ X#&@#J:*Y;_A-+S_ *%C6?\ P&-'_":7G_0L:S_X M#&@#J:*Y;_A-+S_H6-9_\!C1_P )I>?]"QK/_@,: .IHKEO^$TO/^A8UG_P& M-'_":7G_ $+&L_\ @,: .IHKEO\ A-+S_H6-9_\ 8T?\)I>?]"QK/\ X#&@ M#KO^7&:LJLG_ (3B[^SR1_\ "+ZSEN_V8U2_X2J]_P"A9UC_ ,!C0!T=%C7&]UB%Y>1Q&55;:6 ;'&:Y?\ X;Y^$7_0UZ/_ .#.'_&O M@3_@JS_R6+1?^N-U_P"CJ^(:^DPN5T\11C4C_ /@SA_QK\)J*ZO[%I?SLQ^OS['[L_P## M?/PB_P"AKT?_ ,&C_^#.'_ !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS[' M[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\ M^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A M]?GV/W9_X;Y^$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[# MZ_/L?NS_ ,-\_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I M?SL/K\^Q^[/_ WS\(O^AKT?_P &C_^#.'_ !K\ M)J*/[%I?SL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU M^$U%']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.' M_&OPFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P M9P_XU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@ MSA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#! MG#_C7X344?V+2_G8?7Y]C]VXOV]/A)-(DK3Z5KFMZ=I6J6^WSK.YU"))(]RAER#@C*D'Z&OPET#_D/:;_ -?,?_H0 MKV']M?\ Y.:\8_2S_P#2."L7E--553YGJF_NM_F:+&RY'*W7_,_6G_AOGX1? M]#7H_P#X,X?\:/\ AOGX1?\ 0UZ/_P"#.'_&OPFHK;^Q:7\[,_K\^Q^[/_#? M/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_ MX;Y^$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ M ,-\_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q M^[/_ WS\(O^AKT?_P &C_^#.'_ !K\)J*/[%I? MSL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U%']BT MOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_ ML6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U M%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_QK\)J M*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#!G#_C7X34 M4?V+2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!#7H__ (,X?\:_ M":BC^Q:7\[#Z_/L?NS_PWS\(O^AKT?\ \&C_P#@SA_QH_X;Y^$7_0UZ/_X,X?\ M&OPFHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ ,&C_^#.'_ !H_X;Y^$7_0UZ/_ M .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\& MC_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z& MO1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#.'_&C_AOGX1?] M#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\_"+_ *&O1_\ P9P_XT?\-\_" M+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^[/_ WS\(O^AKT?_P &C_^#.'_ !K\)J*/[%I?SL/K\^Q^[/\ PWS\(O\ H:]'_P#! MG#_C1_PWS\(O^AKT?_P9P_XU^$U%']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ M@SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ M 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H_ M_@SA_P :/^&^?A%_T->C_P#@SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_ M_!G#_C1_PWS\(O\ H:]'_P#!G#_C7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_ M /@SA_QH_P"&^?A%_P!#7H__ (,X?\:_":BC^Q:7\[#Z_/L?NS_PWS\(O^AK MT?\ \&C_P#@SA_QH_X;Y^$7_0UZ/_X,X?\ &OPFHH_L6E_.P^OS['[L_P##?/PB M_P"AKT?_ ,&C_^#.'_ !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\ M-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[ M/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV M/W9_X;Y^$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L M?NS_ ,-\_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/ MK\^Q^[/_ WS\(O^AKT?_P &'?^1@TS_KZB_\ 0Q2>2TK?&P^O3['[LZ]^VO\ #?PGJT^E:YK>G:5J MEOM\ZSN=0B22/C_^#.'_ M !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P M9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ M .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\_"+_ *&O M1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^[/_ WS\(O^ MAKT?_P &C_^#.'_ !K\)J*/[%I?SL/K\^Q^[/\ MPWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U%']BTOYV'U^?8_=G_ M (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_L6E_.P^OS['[ ML_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U%']BTOYV'U^? M8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_QK\)J*/[%I?SL/K\^ MQ^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#!G#_C7X344?V+2_G8?7Y] MC]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!#7H__ (,X?\:_":BC^Q:7\[#Z M_/L?O7>?MI?#K3]%L-9N]8T^WT?4&=;*^DU"(17!0[7"MT.TC!P:S?\ AOGX M1?\ 0UZ/_P"#.'_&ORE^*7_)HOP4_P"OK5__ $J>O *PHY33J1;-E%I6Z+\C]V?^&^?A%_T->C_P#@SA_QH_X;Y^$7_0UZ/_X,X?\ &OPFHK?^ MQ:7\[,_K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U% M']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OP MFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_X MU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_Q MK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#!G#_C M7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!#7H__ (,X M?\:_":BC^Q:7\[#Z_/L?NS_PWS\(O^AKT?\ \&C_P#@SA_QH_X;Y^$7_0UZ/_X, MX?\ &OPFHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ ,&C_^#.'_ !H_X;Y^$7_0 MUZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/P MB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#.'_&C_AOG MX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\_"+_ *&O1_\ P9P_XT?\ M-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^]=U^VE\.K'0[/6[C6=/@T:] M=H[6^?4(A%,ZDAU5NA(([&LW_AOGX1?]#7H__@SA_P :_*;XA?\ )G/PI_[" MVI?^C7KY_K"CE-.HFW)Z-K[G8TGC)1:5NB/W9_X;Y^$7_0UZ/_X,X?\ &C_A MOGX1?]#7H_\ X,X?\:_":BM_[%I?SLS^OS['[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P9P_X MT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#. M'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\_"+_ *&O1_\ MP9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^[/_ WS\(O^AKT? M_P &C_^#.'_ !K\)J*/[%I?SL/K\^Q^[/\ PWS\ M(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U%']BTOYV'U^?8_=G_ (;Y M^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_L6E_.P^OS['[L_\ M#?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U%']BTOYV'U^?8_=G M_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_QK\)J*/[%I?SL/K\^Q^[/ M_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#!G#_C7X344?V+2_G8?7Y]C]V? M^&^?A%_T->C_ /@SA_QK2T_]M+X=:OI>HZI8ZSI]WIFF!#?7<6H1-';!R0A< MC@;B"!G'2OP4KW_X'_\ )MGQ[_ZX:3_Z/EK&ME-.G'F4GNE][2-*>,E)VMW_ M "/U:_X;Y^$7_0UZ/_X,X?\ &C_AOGX1?]#7H_\ X,X?\:_":BMO[%I?SLS^ MOS['[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?S ML/K\^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q: M7\[#Z_/L?NS_ ,-\_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J* M/[%I?SL/K\^Q^[/_ WS\(O^AKT?_P &C_^#.'_ M !K\)J*/[%I?SL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9 MP_XU^$U%']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ M^#.'_&OPFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1 M_P#P9P_XU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C M_P#@SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]' M_P#!G#_C7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!# M7H__ (,X?\:_":BC^Q:7\[#Z_/L?O7-^VE\.H/#\&O2:SIZ:'/,;:+4&U"(1 M/, 24#="< G&>U9O_#?/PB_Z&O1__!G#_C7Y3>(_^3(_"?\ V-L__HF2OG^L M*64TZBE>3T;7W&D\9*-M.A^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ M 9P_P"-?A-16_\ 8M+^=F?U^?8_=G_AOGX1?]#7H_\ X,X?\:/^&^?A%_T- M>C_^#.'_ !K\)J*/[%I?SL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O M^AKT?_P9P_XU^$U%']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$ M7_0UZ/\ ^#.'_&OPFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#? M/PB_Z&O1_P#P9P_XU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^ M?A%_T->C_P#@SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\ M(O\ H:]'_P#!G#_C7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"& M^?A%_P!#7H__ (,X?\:_":BC^Q:7\[#Z_/L?NS_PWS\(O^AKT?\ \&C_P#@SA_Q MH_X;Y^$7_0UZ/_X,X?\ &OPFHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ ,&< M/^-'_#?/PB_Z&O1__!G#_C7X344?V+2_G8?7Y]C]V?\ AOGX1?\ 0UZ/_P"# M.'_&C_AOGX1?]#7H_P#X,X?\:_":BC^Q:7\[#Z_/L?NS_P -\_"+_H:]'_\ M!G#_ (T?\-\_"+_H:]'_ /!G#_C7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_^ M#.'_ !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\ M&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1 M_P#P9P_XUI:7^VE\.MC_^#.'_ !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_" M+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#? M/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_ MX;Y^$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ M ,-\_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q M^[/_ WS\(O^AKT?_P &C_^#.'_ !K\)J*/[%I? MSL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U%']BT MOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_ ML6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U M%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :TM)_;2^'6OVNH7.EZSI]_;Z= M#]HO98-0B9;>(=7?'#_L59/_ &:L:V4TZ<.92?3\ MS2GC)3E9H_5K_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_QK\)J*V_L M6E_.S/Z_/L?NS_PWS\(O^AKT?_P9P_XT?\-\_"+_ *&O1_\ P9P_XU^$U%'] MBTOYV'U^?8_=G_AOGX1?]#7H_P#X,X?\:/\ AOGX1?\ 0UZ/_P"#.'_&OPFH MH_L6E_.P^OS['[L_\-\_"+_H:]'_ /!G#_C1_P -\_"+_H:]'_\ !G#_ (U^ M$U%']BTOYV'U^?8_=G_AOGX1?]#7H_\ X,X?\:/^&^?A%_T->C_^#.'_ !K\ M)J*/[%I?SL/K\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU M^$U%']BTOYV'U^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.' M_&OPFHH_L6E_.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P M9P_XU^$U%']BTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@ MSA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#! MG#_C7X344?V+2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!#7H__ M (,X?\:_":BC^Q:7\[#Z_/L?NS_PWS\(O^AKT?\ \&C_P#@SA_QH_X;Y^$7_0UZ M/_X,X?\ &OPFHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ ,&C_^#.'_ !H_X;Y^ M$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ M#?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#.'_&C M_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\_"+_ *&O1_\ P9P_ MXT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^]^ MA13BUDU$:A%Y*S$!A&6Z;L$'&>]9O_#?/PB_Z&O1_P#P9P_XU^4NB_\ )COB M'_L4TZG->3T=C26-E&VFZ/W9_X;Y^$7_0UZ/\ ^#.'_&C_ M (;Y^$7_ $->C_\ @SA_QK\)J*V_L6E_.S/Z_/L?NS_PWS\(O^AKT?\ \&C_P#@ MSA_QH_X;Y^$7_0UZ/_X,X?\ &OPFHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ M ,&C_^#.'_ !H_X;Y^$7_0UZ/_ .#.'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H: M]'_\&C_\ @SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_ MZ&O1_P#P9P_XT?\ #?/PB_Z&O1__ 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^ M$7_0UZ/_ .#.'_&C_AOGX1?]#7H__@SA_P :_":BC^Q:7\[#Z_/L?NS_ ,-\ M_"+_ *&O1_\ P9P_XT?\-\_"+_H:]'_\&C_ /@SA_QK\)J*/[%I?SL/K\^Q^[/_ M WS\(O^AKT?_P &C_^#.'_ !K\)J*/[%I?SL/K M\^Q^[/\ PWS\(O\ H:]'_P#!G#_C1_PWS\(O^AKT?_P9P_XU^$U%']BTOYV' MU^?8_=G_ (;Y^$7_ $->C_\ @SA_QH_X;Y^$7_0UZ/\ ^#.'_&OPFHH_L6E_ M.P^OS['[L_\ #?/PB_Z&O1__ 9P_P"-'_#?/PB_Z&O1_P#P9P_XU^$U%']B MTOYV'U^?8_=G_AOGX1?]#7H__@SA_P :/^&^?A%_T->C_P#@SA_QK\)J*/[% MI?SL/K\^Q^[/_#?/PB_Z&O1__!G#_C1_PWS\(O\ H:]'_P#!G#_C7X344?V+ M2_G8?7Y]C]V?^&^?A%_T->C_ /@SA_QH_P"&^?A%_P!#7H__ (,X?\:_":BC M^Q:7\[#Z_/L?NS_PWS\(O^AKT?\ \&C_P#@SA_QH_X;Y^$7_0UZ/_X,X?\ &OPF MHH_L6E_.P^OS['[L_P##?/PB_P"AKT?_ ,&C_^#.'_ !H_X;Y^$7_0UZ/_ .#. M'_&OPFHH_L6E_.P^OS['[L_\-\_"+_H:]'_\&C_\ M@SA_QK\)J*/[%I?SL/K\^Q^[/_#?/PB_Z&O1_P#P9P_XT?\ #?/PB_Z&O1__ M 9P_P"-?A-11_8M+^=A]?GV/W9_X;Y^$7_0UZ/_ .#.'_&NU^&'[2WA'XP: MP+'PM?6NKJC;9YK.[280G:S*&V^NT_E7\^-?HK_P2&_Y&#Q3_P!?-O\ ^B+B MN/&99##T75C)NW^9O1Q_X*L_\EBT7_KC=?\ HZOB&OOLN_W6']=3YS%?QI!1117I M'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 7] _Y# MVF_]?,?_ *$*]A_;7_Y.:\8_2S_](X*\>T#_ )#VF_\ 7S'_ .A"O8?VU_\ MDYKQC]+/_P!(X*Y)?[S'_#+\XFR_A/U7ZGA]%%%=9B%%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !6AX=_P"1@TS_ *^HO_0Q6?6AX=_Y/^OJ+_P!# M%*6S&MSU_P#;6_Y.:\9?]N?_ *105XA7M_[:W_)S7C+_ +<__2*"O$*YL+_N M]/T7Y&E;^)+U84445U&04444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M >__ !2_Y-%^"G_7UJ__ *5/7@%>_P#Q2_Y-%^"G_7UJ_P#Z5/7@%<>%^"7^ M*7_I3-JWQ+T7Y(****[#$**** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^@/ MB%_R9S\*?^PMJ7_HUZ^?Z^@/B%_R9S\*?^PMJ7_HUZ^?ZX\+\,O\4OS9M6W7 MHOR"BBBNPQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]_^!__ ";9\>_^N&D_ M^CY:\ KW_P"!_P#R;9\>_P#KAI/_ */EKDQ7\->L?_2D;4?B^3_)G@%%%%=9 MB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 ?0'B/\ Y,C\)_\ 8VS_ /HF M2OG^OH#Q'_R9'X3_ .QMG_\ 1,E?/]<>&VG_ (G^9M5W7H@HHHKL,0HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ KW_P#9T_Y(_P#'7_L!0_\ H 5[_ /LZ?\D?^.O_ & H M?_0Y*X\7_"^:_-&U'X_O_(\ HHHKL,0HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH *]__ &9?^2>?'#_L59/_ &:O *]__9E_Y)Y\_Z+_R8[XA_P"Q MSC_])HJ\ KDP^]3_ !/]#:I]GT"BBBNLQ"BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "OT5_X)#?\ (P>*?^OFW_\ 1%Q7YU5^ MBO\ P2&_Y&#Q3_U\V_\ Z(N*\K-/]TG\OS1V83^,C]4Z***^$/H0HHHH *** M* /QU_X*L_\ )8M%_P"N-U_Z.KXAK[>_X*L_\EBT7_KC=?\ HZOB&OOLN_W6 M']=3YS%?QI!1117I'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 7] _Y#VF_]?,?_ *$*]A_;7_Y.:\8_2S_](X*\>T#_ )#VF_\ M7S'_ .A"O8?VU_\ DYKQC]+/_P!(X*Y)?[S'_#+\XFR_A/U7ZGA]%%%=9B%% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !6AX=_P"1@TS_ *^HO_0Q6?6A MX=_Y/^OJ+_P!#%*6S&MSU_P#;6_Y.:\9?]N?_ *105XA7M_[:W_)S7C+_ M +<__2*"O$*YL+_N]/T7Y&E;^)+U84445U&04444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 >__ !2_Y-%^"G_7UJ__ *5/7@%>_P#Q2_Y-%^"G_7UJ M_P#Z5/7@%<>%^"7^*7_I3-JWQ+T7Y(****[#$**** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH ^@/B%_R9S\*?^PMJ7_HUZ^?Z^@/B%_R9S\*?^PMJ7_HUZ^? MZX\+\,O\4OS9M6W7HOR"BBBNPQ"BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]_ M^!__ ";9\>_^N&D_^CY:\ KW_P"!_P#R;9\>_P#KAI/_ */EKDQ7\->L?_2D M;4?B^3_)G@%%%%=9B%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?0'B/\ MY,C\)_\ 8VS_ /HF2OG^OH#Q'_R9'X3_ .QMG_\ 1,E?/]<>&VG_ (G^9M5W M7H@HHHKL,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ KW_P#9T_Y(_P#'7_L!0_\ H 5[_ M /LZ?\D?^.O_ & H?_0Y*X\7_"^:_-&U'X_O_(\ HHHKL,0HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH *]__ &9?^2>?'#_L59/_ &:O *]__9E_ MY)Y\=)#YBB"1P-\;*P^90>".E>-U]"_\ !/O_ )/$ M^&G_ %^3_P#I+-45-(-H3V/TM\7?L(?LF_#_ $M-2\4>&M+\-ZVL)D()"!Y+H#<0K'&<\'TKDK;]FW]A.^N$M[;4/!,\\AVI'%X^F9V)[ "]Y M-='_ ,%1? WB3X@?LZ:;IOA?P_JGB345\0VTS6>D64MU,(Q#."Y2-2=H+*,X MQR/6ORKL?V4OC3J-Y#;1?";QHDDK!5:?0;J% 3_>=T"J/)@Y3KR M33MOY(][%:/KUI"9XM%G MNFN;6^50241Y"721N,$N5) ! SN'Y2NC1NR.I5E."K#!!]*_>_\ 9[TZ^_9L M_9)\.0_$W4H[*X\.:7)-J,TTH=;6/>[I#N!(8HC)& I.2H SQ7X9Z@MW\2_B M1"QDGF/EQCMG+@5WY=4JRQ%7#N7/&.TOG;\=_+YG+B8 MP^KPK./*WT^7Z?KJ&[J3P3;V\D.?*_M?PQXFFOC M"_IEY9H\^S*:VGFM"+:2;2ZI:?F8QP=223=E?N?C%17K'[4/[/\ ?_LT_ M_!=[>#4H(T2ZL;X)L^T6TF=C%<\,"&4CU4XXQ7WS>?\ !)3P!K'POM]2\.>( M?%'_ E%[8P36ZW]Y:M:)+($)+JMNK%%#$X# X'6NJ>.HPI1K-^[+8R]A/VK MH]5_P/\ ,_*ZOT"_8C^$?[+GC3X)+J/Q=OO#%OXN_M*XC*:MXKDTZ;R $\L^ M2MS&,.HXBE44).*C;5>;Z?<7]7G2G2E*UY-Z>D7O\ UN?& M?QQTOPYHOQD\:Z?X/>WD\*VNKW46EO:7)N83;+(PC*2EF+KMQAMQSUR:XBO9 M]0^"^B6O[7Q^%276H'P]_P )BOA[[2TB?:_LYNQ#NW;-GF;3G.S&>W:ON[XA M?\$?O!_V;1XO!/BCQ!#=2ZC&NH7.N7%O/%!9[',C(D<$9:3<(U4%L?, ?V"?V3]82X\. MZ94*E14M4WM=:/_AR7A*B@ MYZ:;KJ<;^QW^QKK?[67B#41;ZM;Z#X1N8[#RQ '7G MH:G[<'P7\.? 'X[7'@SPLEPNEV>FV;^9=S&66:1HP7D8\#+'G"@*.P%?J]^Q M/^S-X7_9]^'$6H^';_5[V?Q78V&H7RZI-%(L/_C'?ZIK\7B?3=#::&TM[B!;)F@B.P,AA+D''.''MBO/KYDH8 MWEO^[C^=M?QV-L+A_:89SM[TMO2Z:_#<\C_X)V_L??"+XZ_ :Z\1^./"7]MZ MRFLW%HMS_:5Y;XB6.(JNV*9%X+-SC/-?$?[4/@O1OAU^T)X]\->'K/\ L_1- M+U22VM+7S7E\N,8PNYV+'ZDDU^H'_!)'_DUV]_[&*Z_]%054\8?L/?!>U^*W MBSXA?&[Q58*?$NJSS:?I5_K"Z7:)&2-HW[T>23 S\K #=C!QFG4Q3H9C/GD^ M7ET7G[NR[[BHTE4P2LO>YM_*\NO;;\#\>:*_8#XW?\$L?A9XN\"W5S\,;>;P MIXBC@,UBRZA-=V=XV,JDGFL[ -T#(PQG.& Q7YH_LZ_">R^*G[0'A7P#XC:^ MTZSU*_:RO#9LL=S%M5R0I=6 8%<]>IAL=2Q7-R7371G+6H3H1YY:KR/+: M*^\?V[OV#? '[,'PETOQ1X6UCQ)?ZA=:Q%I[QZQ;3G1)U"6\D@VET=1R@ZJ>,UM0Q M-/$4Y5*>RO\ @KBK49T6E/KK^-OT/):*^Z?V]/V%? 7[+?POT+Q)X4U?Q'J% M]?ZRFGRQZQ*W_P!AO_@G#HWQ@\"V7Q$^)%W> M#1K]F;3=$L9/),\2L5,LTF-P5B#A4P< -NYQ64<=1E1=>_NIV^82H3C45*VK M/SWHK]E[']C[]B_6->_X1RPC\-W7B'>8O[.MO&EQ)>;QU'E"[+9'IMKY4_;N M_P"">5A\ O"Y\?> ;R\N_"T:4)SC!IJ^UT;O!U+-IIV/A.BBBO7.$_:;X>_P#!/?\ 9VU3X8^&=;U?P(AN M+C1[:]O+J37-0C7.O\ PF[W M_P"-5\E2]IB,57A*JXJ+TU[N7Y6/3IVIX2A/D4G):_]T]QY=S$"([F%ANCE3/9E(^AR.HK]./^"5_P _B+\'M#\:ZGXUTN[ M\.Z?K36HL=*OODF+1^9OE:+K'D.J_, 3CI@ GXY_X*;?$C1/B-^U-J)T*XCO M+?1-/@T>>YA8,DD\;R/( 1UVF38?=#73AZE2EC7AU4YXV];:?H]/GW*G&-3# M.HX^&GQ\_9^\+^.O$&N>*[/5M4-SYT.FW=LD"^72?I7P1KO@>X_X6AJ7A#0+>XU*Y76)=+L8.&FG83&.-> 6/' M8#)[5Z%.47F%6"FV_>]WHM5MZ;(YI)K#*3BK=^O4Y:BOUD^!?_!*+P%X3\,Q M:O\ %W4)M?U8P^;-::?9C )!D0K(Y7G+[U7G[O&:ZY?^"?_ .RM\8M! MO8O _:!^P822S(/H5S].M9U,TP\)-*\K=5L$,)4FDWI?N M?C;17M7[57[+/B/]E?Q\FB:O*-3TB]1IM+UF*,I'=Q@@,"N3MD4D;ER<9!R0 M17BM>G2JPK052F[IG/4IRI2<)K4****U,SW_ $7_ ),=\0_]CG'_ .DT5> 5 M[_HO_)COB'_LF^+/#I@L[^)=ZQI/!A&QD9 W#(R.XK MQ\VKU*&'3I.S;W[:?K^AUX.G"K649[6_R/G[_A:'[#4?B(>'/L7PS-[O\KSO M^$9B-KGU^U_9_)Q_M>9CWKG?VIO^":'@'Q[X+O\ Q+\*=/C\-^*(8&NX+&PE M+6&IC;N$80DK&Q ^5DPN3R#G(^!?BQ^PG\:_A#=3#4/!-]K>G(Q"ZIX?0W\# MJ!DN1&"\:_\ 715KT#X7?\%//BS\(OA_H?@RPT?PKJ-AHMN+.WGU6SNGN#&I M.U7*7"+\HPHPHX45P_5)."J8*LW+U_K[F=:K\L^6O37+_7]71\G:5HMYK6M6 M>D6D)?4+NX2UAA8A"978*JDG ') YZ5]V?%/_@G+I_[/G[*'B_QQXMU&F;:S#Z/?6VNVUOH,D<,'G2W$DC(RR)(?+!0 $''<]:_5CXV?!_1OCS\,]8\#^ M(+F^L])U3RO.FTV1$G7RY5D&TNCJ.4&,UKC\=.BZ=-:/1R]--$_O(P="$ MZDIRUBMO^#^'XG\Z%%?5?QE_8N32?VPK/X*_#NYO[V*[AMY5O-9D21X$:/S) M9)&C1!M103@+DX Y)%?<5A_P3K_9G^#/A"UF^(US%>N2(Y-:\2Z^^F122DH5E/'WA7P_ M^RI^QKIOQ/\ VFO&?PJ^(5YJ6G/X;L[J22;0YHXV>:&XAB!#2Q.#&RR%A\H) MRO3I58?'T*[DM5RIMI[V6XZF%J4XJ6Z;2T[O8]4M_P#@FA;_ R_9L\;_$'X MAZE]O\3VGA^XOK#1]/D*V]E*(RRM+(.97''RC" Y^^.:_/FOZ/OB!\.M-^)' MPWUKP5J<]U!I6K6#Z=/-:.JSK&R[25+*RAL>JD>U?DI\:_V*_!'PW_;%^&WP MGTS5?$$_AWQ+%;27EU=W$#7<9DFE1O+9850<1KC*'DFO-P&/E7KRC4?Q;+II M7X'Q917WQ^W1^P-\/OV8_@W9>+/"^L>);_ %&;5X=/:+5[ MJWDA$;QRN2!' AW9C7OCD\5\M?LN_"O2?C9\>_"'@C7+B\M-*UBXDBGFT]T2 M=0L,CC875E!R@ZJ>,U[%#%4\1!U(;+_ASDK4)X>W/U5_Q:_0\LHK[Q_;N_8- M\ ?LP?"72_%'A;6/$E_J%UK$6GO'K%S;R1"-HI7) C@0[LQCOCD\5)^PC_P3 MOTSX[>$8?B%\0+V[A\-3S/'IVDV#B*2\$;[7DDDP2L>Y64*N&."=P&,YQQU& M5&5>_NK3YE5,/4ISC!K66J_'_(^"J*_9>']C_P#8OG\0#PU''X;E\1>9Y/\ M9J^-+@WGF#^'R1=[MWMMKYH_;G_X)RZ5\%O!=U\0?AS=7LV@V;K_ &GHU\_G M/:HS!1+%)@$H"5!5LD9SNP"!S0S2A*2BTU?9M:&SP52SLTVNG4^"=)TRXUK5 M+/3K.,S7=W,EO#&O5G=@J@?4D5^BW[?'[*?P;_9O_9UTB]\/^%/LWC34+ZUT M]-3;4KN0DK&TD\GEO*8_F$9'W<#?QCBOES]@[P"/B+^UA\/K"2)I+6SOO[5G MQT"VRF9<^Q=$'_ J^D?^"QGC[^T/B)X%\&Q2-LTS3I=2G4'Y2\\FQ,CU"P'\ M'JL;.;KX>A!VN[OT7Z:-$86,6JM22NHJWS>GWJZ?D?GYI&DW>O:M9:980-Y) K]K/"_\ P3/^ .E>%]'M=<\&?VIK$5K#%=W[ZS?Q M&YG" .^U)U4;FR<* !G@5^?'_!,WX0CXH?M.Z3J-U!YNE>%8FUF?4WM(78?] MLS6.8U*DJM'"T96NLZ0\>&+RQJ)H@I_VURF?1S7X(TLIQ$ZD)TJKO M*+Z[V??YW7R-<;3A[E6GM)=/+_@6"BOT?_9'_P"";WPT^/G[/OACQUK^N>*[ M/5]4^U>=#IMW;) OEW,L2[5>W=A\J#.6/)/TKL_A1_P3I^"/PGTG3O\ A>7B M73;WQ3K!Q;Z3?:Z-.@3)^6.+:\RKCZ-*I.E*_-%VM;=^7W M'-'#5)P4ULS\K:W/ W@W4_B)XRT7PQHT<MX.\37FIV.F- M=179ETF6..;>F<#,D;KCDY^6ORG\)_L<^"]>_;RUWX)W&IZ\GA6Q25HKR.XA M%\=MJDPW.82GWF(X0>IU8[#QIQI2AHD MXI^;OLC_@H%^QMX+_93L?!,_A+4]>U%];ENTN!K5Q!*$$0A*[/+ MACQGS&SG/0=*J?L/_L$7G[3RS^)_$E_^_]6)Q4)\\(\B3:TMUU?]?(^0J*_:1OV%_V M1]+\06WA*\TW2QXIF0&+3;GQ7^%(9%34=+O6$DUAO;"R)( "\62JD-\RY!)8$[:4*DU"S5]FUH M)X*K9M6;73J9O[ OPQ_9T\=^"/$]S\:;SP];:O!J*1V"ZSXE?2W,!B!)5%GC MWC=GG!],UX)^UQX=\!>$_C]XETOX92V,_@J$6_V&33=0-_ Q%>(?M0?!'0_@I^TKK'P\T.[U"ZT6SFLXXY]0DC>Y(EAB=LLB*O!8.FIOFM\/3[.O]=V9QO'!RJN[_X;T/$J*_5?XC?\$@O!:^%? M^*%\1^)#XBEN+=$DUN[MI+6*%I5$TC)';HS%8]Y"AAE@!7;>!?V OV5],N%\ M$W]U9>,/&]LA-U%<>)7BU#.,DFV@F38HSP"G QDGJ<_[4P_+S*[\K:^OH5]5 MJ72?W]/^'/QRHK[B_;M_X)[1?L_:.?'?@2YN]0\&>:([^QO&#SZ:SMA&#@#? M$20O(W*2N2VO]:F56C.C)0:U>WG_7X=3YFHK]FM4_8G_8 M]\!:A9:!XD@T6RUN9%\JWUGQ?/;7=QG@,(_M*9R?[JXSTKRS]KK_ ()B>"-$ M^&>N>,OA']'T?Q9J&LZ?;:7=-=POHTT43LY0 MH0QDBD!&#V KGS''.E7A2@[)6YDM-$T#5;RWN]:OD\W[+:0W#1*[[0H>5MH 4;=QS]T MD?H9)^P'^RG\(=%TZT\=24HK[.[Z'XUT5^G'[6'_!+;0=.\&ZAXO\ @[)>1W-C"US+ MX;GF-S'<0JN2;:0Y??@$[6+;N@(. ?SN^&/PYUOXN>/M$\'^';<7&L:O<"W@ M5R0B]2SN<'"JH9B<>O8=)\ ?V._A9X!^,&G_%7 MX/\ B.&]\//9W.GW&GVNH+J-KEPN&AG#,P(*_,K,V=V01C!\ZKFE"49PA?9Z MVTO9V\]]M#7ZG5]V3[K3K:ZO^!\=_P#!3;]F7X:_L]Z;\/I?A_X;_L"359;Y M;P_;KFY\T1K 4_UTC[<;VZ8SGFO@^OU _P""SG_('^%/_7?4O_0;:OR_K;*J MDZF&4IN[N]_4Z,PA&$X**M[OZL****]<\L**** "BBB@ HHHH **** "BBB@ M HHHH *_17_@D-_R,'BG_KYM_P#T1<5^=5?HK_P2&_Y&#Q3_ -?-O_Z(N*\K M-/\ =)_+\T=F$_C(_5.BBBOA#Z$**** "BBB@#\=?^"K/_)8M%_ZXW7_ *.K MXAK[>_X*L_\ )8M%_P"N-U_Z.KXAK[[+O]UA_74^T#_D/:;_U\Q_^A"O8?VU_^3FO&/TL_P#T MC@KDE_O,?\,OSB;+^$_5?J>'T445UF(4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %:'AW_D8-,_Z^HO_ $,5GUH>'?\ D8-,_P"OJ+_T,4I;,:W/7_VU MO^3FO&7_ &Y_^D4%>(5[?^VM_P G->,O^W/_ -(H*\0KFPO^[T_1?D:5OXDO M5A111749!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110![_ /%+_DT7 MX*?]?6K_ /I4]> 5[_\ %+_DT7X*?]?6K_\ I4]> 5QX7X)?XI?^E,VK?$O1 M?D@HHHKL,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z ^(7_ "9S\*?^ MPMJ7_HUZ^?Z^@/B%_P F<_"G_L+:E_Z->OG^N/"_#+_%+\V;5MUZ+\@HHHKL M,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "O?_ ('_ /)MGQ[_ .N&D_\ H^6O M *]_^!__ ";9\>_^N&D_^CY:Y,5_#7K'_P!*1M1^+Y/\F> 4445UF(4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110!] >(_^3(_"?_8VS_\ HF2OG^OH#Q'_ M ,F1^$_^QMG_ /1,E?/]<>&VG_B?YFU7=>B"BBBNPQ"BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "O?_V=/^2/_'7_ + 4/_H 5[_\ LZ?\D?\ CK_V H?_ $.2N/%_POFO MS1M1^/[_ ,CP"BBBNPQ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M KW_ /9E_P"2>?'#_L59/_9J\ KW_P#9E_Y)Y\)\-/\ K\G_ /26:OGJOH7_ ()] M_P#)XGPT_P"OR?\ ])9JSJ?!+T)ELS]=?VNOVE?^&5_A?:^,/^$<_P"$G\_4 MXM.^Q?;OLFW?'(^_?Y'Q&)&'T4 MVJ@_F*^B?^"BWP6\9_'?X#V'AWP-HW]N:Q%KEO>/;?:H;?$2Q3*S;I71>"Z\ M9SSTK\V(O^":G[1LDBJWP]6-2<%VUO3L+[G%P3^0KY++Z.$J4V\0U>_5VTLO M-'T6,E5@X>Q[:V5];O\ 2Q^H5FWPM_X**? !+B:WOI-$GF>/RFE,%YIMX@QD M[&*EE#!AGD\I; M:]O)'M^8.RNAP,D$XYK]COV&/V;]3_9?^";^']?O;>ZUS4+^35+W[*Y:"!F1 M$6-6(&<+&I)QU)QD &OB?P7\2O"OQ:_X*QQ>(1/;W&B_;I+/3KAB#'/-!9&& M)U/0[I$)0]\IBNG!2C2QE6GAW>FHM_-);>>Z7?SL\\&IUE[U[+YM[^5M7 MV\KG51?L?_M6_M,>!])T?XL_$*ST7PU',+M-.U%8[B^1PI57=84 ?ACP\V1G MD U])_L:_L?^'?V4=4\0P6?CN3Q5XBU2WB%[:[([=(XT=MCB .[CEB-S,1Z8 MJ7_@H!\(/BG\8_A/8:9\+=4E@NX+LOJ&DPWPLVU&!D*A/,+*I"DY*.P4@YZJ M >)_X)R_L=>+?V:[;Q-K_C>6TMM9UV*"WBTFUF$QMHT+,3)(ORER6 PA8 +G M<8* S M>&8,MCDXN;BOT_D\3MX)_9_;Q"J;VTGPQ]O"^IBM=^/_ !VOR[_X*]6LL7[2 MVA3M_JI?#-N$Z]KBYS_,5^C?Q8)'[&OBHC@_\(-:)26EE_[9^9^#'B/Q9K/B[7=1UG6=3NM2U349&DN[JXE+/,Q.3N)ZCIQT&! MZ5^Q'_!)_P#Y-13_ +#MY_*.OQAK]GO^"3__ ":BG_8=O/Y1U]%F45'!SC%6 M2M^:/"I2W_ &4Z/_TXK7Z8_P#!1+QEJG@?]D?Q MK>:/=265[<_9K SPG:ZQS3HD@![90LO_ *OS.UC_E)>W_93H_\ TXK7Z*_\ M%0?^3._%'_7[8?\ I3'7D8Q*6'P*>S:7W\A[MW'%XJ2W3E_[D.1ED\2VN MT^F8+C-?G?\ L'_\G>?#'_L)G_T5)7Z)_P#!73_DV#2_^QEM?_1%Q75F7^]8 M=^:_-''EN]9?W7_Z3(\V_P"",O\ R+_Q1_Z^K#_T">OG3_@J9_R=WK7_ &#+ M'_T57T+_ ,$9+R$Z7\4[7>/M"S:?*8^^TK.,_F#7._\ !2+]DOXC>-/B]XG^ M)VE:9;3>#+'0([NZU"2\C0Q_9XSYD?EY\PMA>HJ<1.-/-^:;LK+_P!( M1&%BW@9Q2U;?_I9[K_P21_Y-=O?^QBNO_14%?GS_ ,%!O&6H>,?VM?'IO;B2 M:'3+I=-M(G/RPQ1(HVJ.P+;V^K$U^@W_ 21_P"37;W_ +&*Z_\ 14%?FU^V MM_R=A\4?^PW-_2JCKG$[_P OZ0%3TRVZ_F_6?^2/UA_X)MZE=:I^QQX$>[N) M+AXC>0(TC%BL:7Q22.<* M@DNY8PQ/8 N"?I11CS9GB$M_>_-&5?3+U_71GV]_P5\_Y-NT#_L9H/\ TGN* M^#?^"=7_ ">5\.?^NUW_ .D<]?JA^W9^SYK7[2/P'N/#?AR2W77K.^AU.SBN MG\M)V175HR^/E)61L$\9 R0,D?+7[!/_ 3[^('PK^+]A\0_B);VOA]-'29; M+2TNX[F>::2-HM[&)F14"NQ^\6)QP*Y\LQ-*EA:L9RL_>^=XV5OF=N/IRJ2I M\BOI;T]Y_H[G=?\ !8C_ )-_\(?]C/'_ .DES74_\$\?VBO!7Q2^ /A_X>7F MHV=KXJT:R.EW.BW$@CDNH!E5DB!(\P%"-VWE3G.,@GEO^"Q'_)O_ (0_[&>/ M_P!)+FO+OV??^"8_PV^,WP8T?QE#\1-;OKO5;'S8_L,4$$5I<[<-%(I$C-Y< M@*D!E)QQC-84(T99=-5]N;M?6W^5PK.:Q<'3^*WX7_X;S_$]:\??\$C?ACK5 MQ/>>$/$>O^#+TL'@C\Q;VU@8="JN%E//K+FOD+]LO]D?XW_"72SXB\6>,-0^ M)?A"&4)_:\M_<3O:Y("F:&5F,>XG *LZYP"P) /KG@/]G[]NCX7^*H](T'Q3 M*-+\'_LF_$"7Q/<6Y:[T2 M;3T7[HN+N6,I&J#D\N0>^ ">Q-.6(K85P<:JJ)O;=]/FF_7?HRZ=*%:3A*#B M^_3_ (/W'X&T445]@>$?T3_#W5O[ ^ /AK4_*\_[%X8MKGRMVW?LM5;;G!QG M'7%?!G_#Z+_JCO\ Y<__ -QU]U^#M/N-6_9QT.QM8_-NKGPI!#%'D#<[6:A1 MD\#)(ZU^/7_#M?\ :._Z)U_Y7--_^2*^.H4\/4QF(6)M9/2[MUE?MY'JTY5( MX+#NEO;7KTC;]3]*?V8?VW/!'[8QUKPD^AWN@:TMDTMQI=W,)([FV)V.8YDV MDXW+N!53\PQGG'YY_P#!0S]D/3/V9?&VD:GX5\X>#?$*R&WMIY&D>RGCV[XM MYY9"&4J6);A@2<9/U+_P3M_86\>_ OXB7WCSQ_':Z/.-/DL+/28;I+B8M(RE MI)&C)0 !, !F)+$G&!GC?^"Q7Q1TV^O/ _@"TFCGU&Q:75KY5.3 '4)"I]"P M\QL=ZZ_DM?73K8VASU?47_!- M?_DS'P!];_\ ]+KBOA[]@OP?8^*?^"@OBB[O8Q*=$EU?4K=6Z>;]H\E3CV$S M$>X![5]P_P#!-?\ Y,Q\ ?6__P#2ZXK\WOVUB9;;0[O6M1 MTO4)VX$44TS@2$]E5Q&Q/HIK?EE+-,7&&[52WK17,]Y<1D-%_J6950, Q);)V@;>20\KQ M&'HX9QJNS3=_/_/30K'TZE62=/5-:>7]/6Y]'_\ !53PC9:_^R?J.JW$8-WH M6I6=W;2=P9)1 P^A64_D/2OQ9K]5_P#@K=\?-,T_P+IGPHTZY2XUO4;F+4=3 MCC(/V:VCR8U?T9WVL!Z1DGJ,_E16N2QE'#R;VWFAZ?X\\.W/B>R_M'PY%J$#:E:;G7S;82+YJ M@H0P)3=T(-?LK\9OV%OA?\3OV?\ 4-*^&?A;PSH6L7=M#>:-KEO;(6D(*R(# M<8+E)%RI.3PV><5YN/Q%*A32K1YHR=O3;^E;7#]1DS_HGB:'[*HQW,X+0@>F7!/I78_'K]E'X9?M0>&) M9-5TNR75KB$-8^*-,1!=1G!V-YB_ZV/G[C$J0>,'!'XW:A^QG\\UKD]_M"9BQ[[\5^OG["?P8\4? /]G?2_#?C*=1JYN9[U[- M9A*E@DA!$(8':2,%CM.-SM@GJ?!QF%P^'I^WH5+/IK^31Z5"O6E45.I"_?3\ M_P C\;M+\!ZE\+OVE]*\(ZN%&HZ+XHM[*9E!VN4N4 =<_P +###V(K]?O^"D M7_)FOC_Z6?\ Z60U^7'QO^(^C>.OVY=5\6:?^,W[-?C'PGX6MX[S7;Z*![6WDE6(3-'/'(5#L0H)"'! M) SC)'6M<=4G*EA*M71NS?\ Y(V&#C&GC:\([*R7WR/P^^"%]\0K3XE:3!\+ MKG5;?QE>/]FM%T>0I-*#RRMSC9A\_LB_ /P[^SA\/=1\)>'O%DOBT_VBUS M?3R21XAN&BC!01H3Y8VJK;6)/S9SR*_([]OQ%C_;'^)(50H^WPG &.3;0DG\ MZ_5?]A3]FK5OV8/@U-X?U^_MKW7=2U"34[M;)BT,!9$C6-6(!;"Q@DX')(&0 M,G\I/V]K>2S_ &P_B6LW#'48Y!U^ZT$3+^A%89?*^;W<^;W7KMUA_7R-ZRM@ MOAY?>6G_ ($?KS^U9_R9_P#$?_L5KC_T37XW_L5_\G7?"S_L.V_\Z_:KXS>$ MK[XJ?LT^*?#WA_RKG4-;\.2V]CND"I*[P?(-QX )(Y/'-?D'X!^$_B?]DO\ M:N^$2?$BS@T:XGU"SU!XENXYA!"]PT.Z1T)08*ECAB,=Z>424:U2#>K:LOO. M7,(2J8-.*NE%_DC[U_X*Z?\ )L&E_P#8RVO_ *(N*_/?_@GW_P GB?#3_K\G M_P#26:OUF_;>^ NK_M&? '4O"WAZ6V37([F'4+);I]D M1)(VVF106ZV-R!B2%PZR%MK=_EW#! &16>&5*675(UOAYN MFNMM/U_JQ>*YEB:+I_%R_AS._P"C^1[9\1?^"1_PI\37%U=^%]9UWP;#+,KOOI;ZXEEM M%X :6WE=MBY.,HS@=RM>C^$_V M>&%O>-[FSN'_X1R:TN]G[J*ZNI(#&$ MC!Y&^1@%'49'I4SQ%;"J,H55471=?\U]XZ=.%>HZ=2#BWN^G^3/@K_@CGX!_ MM#XB>._&4L9V:9IT6FPL1P7GDWM@^H6 ?]]U\U_MV?$#_A9'[5GQ!U%)&DM; M._\ [+@R> MLHA./8LCM_P "K]!?^"=VGV_P1_8;USQ]?J8Q>-J.OR;Q@^5 MAC0#V/D$C_?K\H/#^BZM\4?B!I^EVQ-WK?B#4D@1FR=\\T@&2?\ >;)->U33 MKYG-K["4?F]_N:?I<\WF]E@>9_;DW\E_47YGZT?\$F_A'_PA7P#O?&-U#LU# MQ;>M)&S*0WV2 M'&.?5_.;W#"O#_ -N;]DWX_P#[0G[0VM>(M$\"M>^&[:&' M3]*F;5["/?!&N2VQYPPW2/(<$ X(XK[T\<:]I/[*/[,U[>V<<9L/!^A+!90S M'"S21QB.%&(P__ "77DTYUL5C*F)PZ M3MHK]ME\[+\3M48T,+&G5TYM_7=K[W^!^BO[&_A_QSX1_9W\*^&OB+H[:-XC MT6)M.,+7,-P'MT8B!@T3NO\ J]JXSG*'CI7XX?MG?"$_!/\ :0\9>'H8#!I< MMT=1TX;<+]FG_>*J^RDM'_P U][?L4?\%&O%O[07QHC\$>-]*\.:9#?64TFG MS:/!/%(]Q& ^QO,FD!!C$AX .5%8?_!87X0_;- \'_$NS@S+92MHVH.JY/E/ MF2!F/8*XD7ZR"JA*KA? M\%7O^33YO^PW9_\ L]?"W_!+7_D[[0O^P=??^B37Z0_M_?!CQ5\=OV>;SPWX M-L4U/75U&VNX[-YXX/-5&(8!Y&500&SR1T/>O@G]@CX9ZY\'/V^[?P=XDBA@ MUO3-/NEN8X)!(BE[02 !AP?E<=*Y,IG%87$0;U:F[>7(E?L;^ Y-/@55A\+1:H40??E MDA^T.?RWI<^89F;>7W=0=W-?2OQ-_X* M4?&+XI>!K[PGJ#Z#I^E:A:-97OV'31BNR\6?\$HO MBU:_%*32-"CTZ\\&S73&#Q#+?1J+>W+';YL)(D,@7&0BL">_I]<_M5? 'X ? M _\ 9GU34M8\">'SJ.GZ8NGZ9=3H5_;R5[/K+I]_WN_0XS_@C?\ \DG\?_\ 8;B_]$+7 MR9_P4 _Y/N\3?]?6F?\ I-;U]9_\$;_^23^/_P#L-Q?^B%KY,_X* ?\ )]WB M;_KZTS_TFMZO#_\ (\^2_P#;##_F4U/^WO\ TIGZM?M:>--3^'O[,OQ U_19 MVM-5M-(<6UPAPT+OA ZGU7=D>X%?@+I>O:CH>MVNL6%[/::K:SK=0WD3D2QR MJVX.&ZY!&-T>]QO$T.1DI!GS?,VYPK*%SQNQS7EY/ M6I49U/:246[6;\KG?C82J48**OO=>MNA^F7BY1\8OV1]2EU:.-7\0>#6N9A_ M"DDEGOW#TPQ!'TK\C_V,8_VA]>UZ]T;X(:QJ&FVR.MQJ,CRH--MRV%$DJRAD M+$+T"LY"G (7C]1_VP_B)HG[.W[)FOVD4RVLDVD_\([HMLK 2/(\)A3:.^Q, MN?9#[5P7_!*/^QO^&4X/[-,/]H_VQ=_VGY?W_.W+LW_]LO*Q[5.&JJE'$UX1 MO!M)+IN]_DT35@W##T9OWM;OKLOU3/%YO^"5OBSQ_P"(K_QG\8/B[9#5KZ8)/I-(8E3 BVJ !@5]V?V#IF@?L]-HVEZBVNZ/9>&&M+74)IE MG-W"EJ521G4;7W* _Q-[ZK\]_S/QY M_P"";?\ R>=\/?K??^D-Q7V1_P %D/\ DE'@#_L-R_\ HAJ^,_\ @G'<1VW[ M9GP[:5PBL]Z@)[LUE. /Q)%?HO\ \%(OV=_&_P"T1\.O"6G>!=-BU74-/UWFS7UK#-[)+_ -+9YV"_AU5Y/\FNI$HU"]U_['++CDQPV\3(N?0&>0_C6U^TM_P35U#]I'XO:MXW MOOBQ+IL5TL4-KIDFA?:5LH40*(U?[2F06W/PHY<_6N'_ ."5?C9?A[XB^)7P M0\030VWB+3]5EO((U?*SR1X@N50D#.WRHV'<@DXX-<_^W3_P3Q^(GQ%^-6I> M._AS96NOV>O&*2\T][R*VFM9U0(S?O6560A%;ABV688Q@US8B3_M'G4^52BK M2W6R[Z='KTM;J:4%_LLHZ;H?_!0OXP6T$,:VWA\ M:K'8QA1B+=>I&-OIA"R_0UKV7_!)/P?H?PCCU?QMX_U#0/$=I9/=ZM>0&&33 M+7;ECA617*JN 27&2"1@'%?-_P#P3P^+6B?!K]J^U%UJ&?#NN13Z$NHW2>1@ M.ZM!(ZY(3<\<8(R0N\\\9K7#TXU*E>4*G/)QDG[MKM[??;YF=:7L\/"+ARQY MHO5[).[T?K\CW_\ X+(>.M6CU+X?^#XKF:'19+>?4[B!3A)Y@XCC+>I0;\>F M^O+/^"3/CK4]"_:2N/#D-Q)_9.NZ5 X9!C<0IW-DCBN!_X)V? ML)^+O@7XQO\ Q]\0X;?2]7^R/8:?H\-Q'16-IU:F(A*GM>/R2:YO3K]YS/_!9S_D#_ I_ MZ[ZE_P"@VU?E_7Z@?\%G/^0/\*?^N^I?^@VU?E_7H9/_ +HO5_F/,OCA_A_5 MA1117MGD!1110 4444 %%%% !1110 4444 %%%% !7Z*_P#!(;_D8/%/_7S; M_P#HBXK\ZJ_17_@D-_R,'BG_ *^;?_T1<5Y6:?[I/Y?FCLPG\9'ZIT445\(? M0A1110 4444 ?CK_ ,%6?^2Q:+_UQNO_ $=7Q#7V]_P59_Y+%HO_ %QNO_1U M?$-??9=_NL/ZZGSF*_C2"BBBO2.4]"_9[^'NG?%CXV^"_!VKS75MIFM:E%9W M$MDZK,J,>2A964'ZJ?I7Z?\ _#GWX-?]#+XZ_P# ^R_^1*_.C]BO_DZ[X6?] MAVW_ )U^H?\ P5._Y-$UC_L*6/\ Z-KP,TK5:4J,:#_&WB#X?ZY;ZQ MX;UF]T/4[=P\=U8SM$X(/?!Y'L>#T-?T'?#'69_BI\"/#&J>([6-;CQ#X>MY M]0MV3"$S6ZF0;3T!W'CWKGQCQ>7P5=5>97V?W^?8ZL.Z&(G[*4+>?]>I_.O1 M7T3^R/\ LCI^U9X^\3^'8_%?_"+IH]J;I;G^S_MGG#S1&%V^;'CKG.3]*^GO M!G_!'\_\+.OK'Q+XUO+SP59VL3C4-/LDL[J[N'W;HD5VF550!"7.<[\ <$CV MJF,H47:I*SM"_V6_%7AC2?"7B/5=8 MN=6MI+B;3M4$4DUN@8*C[XU0$.=X"[/^69Y/2O8_V=?^"2^J>-/#]EK_ ,4- M>NO"\5W'YL>@Z9&IO50@%3+*X*QM_L;&(R,E3D!+&T'16(;M%Z?<.6'J1J>R MMKN?GC17ZU^)O^".GPWNM)F3P]XU\4Z;J9'[J?4S;7<(/^U&D43$?1Q7YR?M M#?LZ^+OV:?';^&O%=NA\Q/.L=2MB6MKV'.-\9(!R#PRGE3[$$Q0Q^'Q$N2#U M\RJF&JTX\S6AY?17T#^R-^QQXG_:N\1W:65TNA>%]-*C4-5#?=^I?\$=?AC)HTL>G^,_%MMJQCQ'=7+VLT"OCJ8EA1B,]O,' MUJL1C:&%ERU'J12H3K:Q6A^1]%?HIX._X(YZ]JUOJ/\ PD/Q%@T&ZMKV2"%+ M;1OM<=S I2=7-Q&1N#$%2N5*D9/6OD#PS\"_P#A(OVET^$G]M_9]WB*;0/[ M8^R;O]7,T?F^3O'7;G;O[XSWK2CBZ->7)3E=VN14ISHP=2HK)?I_PWSZ'E5% M?HKX@_X(\ZQIFN^'+33/B&NLV=]=LFI7+Z+]F%C;JA8RC_2'WL6"H$XY;.< MU2_;,_X)Y_#/]G'X(W7C+1_%_B$ZM%2.V"B[(XRA"AWSEN$ M/'>N?^TL->*4KW=MF;QPE9MJVVI^>]%?H;^S#_P2GD^(G@O3_%7Q+UZ_\/0Z ME"+BTT32D1;I8F */+)(K*A(Y\L(2 1D@Y4>U:E_P1X^$\ME*NG^+?&5K=E2 M(Y;FXM)HU;L2BVZ$CVW#ZT5LRP]&;A)ZKL*GAJE6*DEHS\B**]D_:E_9B\0_ MLL_$1?#>LW,6J65U#]JT[5;="B74.XJ24).QP1AER<9')!!KZ1^'7_!*VY^( MWP/T7Q_9?$5DO-5T9=5AT5-!WL7:/>L E^TC))PN[:.N<5M+&4(TE7'7 MABAMT]GS?/I]_Z[#6&JN'M+?Y_=^FY^ M?-%?K=H__!'7X9PZ+#'JGC/Q9=ZN(\2W5F]K!;L_JL30NP'L9#]:^!OVNOV4 M=;_91\?6VCWMZNLZ'J437&EZLL7E>>JD!T=,G:Z$C(!((92.N Z688>M4]E" M6KV\QRPM6$.=K0\*HHHKT3E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH OZ!_R'M-_Z^8__ $(5[#^VO_R,?I9_^D<%8_X9?G$V7\)^J_4\/HHHKK,0KZ*_85_ M9U\-_M.?&*^\)^*;W5;#3H-'FU!9=(EBCF,B2Q( 3)&XVXD;MG@YTV&5O)OHWD"-%)'G:V0Q )& M02",$ U\_@Z>*QE%5%6:;NK>CMO_ , ]3%RHX1ZPNK7/0OVQ?V%O$7[*LMIJ MT6HCQ-X,OIC!#JBP^5);RX)$4R9(!(!PP.&VGA3@5\PU^^?[1[OX98B)(R/?:WR_'N=&:_X!\B45^FGP:_X)#Z=J#>()OB+XHU:.VAU">TTJ/14BMI9X(Y&1;F7S%E M"^9CY^%/PYO=0\:71D@MX8985%PMQ(@8PE MEPK;002^% R<@;2:]"GCJ%:K[&F[NU_Z_KRW.6>'J4X.,]0_M25 S:?X9$<<=N?[IFE1_,.,=$4 YZ]:T/B5_P M1S\,S:'*_@#QOJ]IJ\:EDA\1B*X@F..%+PQQM'D_Q;7_ -VL99IA8RY>;\-" MHX2M-7L?E=170_$+X?Z_\+/&6J>%O$^G2:7K>FR^3<6TF#@XR&4CAE8$$,." M""*^J_V-O^"<^K?M&:%%XQ\4:M-X8\%R.R6HMHP]Y?[259H]WRQH&!&]@V2I M 7'S5W2KTX4_;2E[O,?[4/A MP:OY/VVT\CSOLWF[5%&R G'S#=C^Z:^OM9T6Z\.?LQWNDWRJE[8>$'M9U5MP$B61 M5@#WY!KYS,,SC+#-X:=I+_)GJ8/!R^MTU5C>+_.\?TN?SST5[=^R+^S3_P - M4_$Z[\(?\)'_ ,(O]GTR74?MGV'[7NV21ILV>9'C/F9SGMTYKH?VS?V//^&1 M=4\+6?\ PEW_ E?]N0W$V_^S?L?D^4R#&/.DW9W^V,=Z^BGB*5.K&C)^]+9 M??\ Y,\R-.(FS;YL>/OYSD].E7OVROV1/\ AD?Q!X;TS_A+/^$K_MBUEN?- M_LW['Y.QPNW'FR;LYZY%*>(I4ZL:$G[TME]_^3"-.4X2G%:1W_#_ #1\[45] M6_L>_L ^)OVH+5_$=_J/_"*^"(I3$NH-#YL]ZZGYT@3(&!R#(QP#P Q# ?9L MG_!'GX1FU*IXK\:K<[>)&NK0IGUV_9LX]LUAB,=0P\N2;U\C2EAZE9>^3Q#X2U*0Q66LQ1&(B0#)AFCR=CXR1@D, 2,$$#]5OV+ M?V7/^&5_AYJFB_\ "3?\)/\ VO>KJ?G_ &#[)Y68439M\V3=]W.VI.]]%ZZ7^Y/J7'"U/:JG-6ZOT_X?0_&W]I[X1V/P(^.7B;P)IU]<:G: M:.;>-;NZ"K)*SVT4CDA1@#<[8'.!@9/4^6U^FG_!1/\ 8=Y^)'QZ_P"$U_Y] M)O\ A'_[*]H+;'VCSO\ @7^K]O>OS+K3 8E8BA%WO))_^,WANR\9_$/4KSPUX:O4$MAIMBJK?7D9^[*6<%8D M/!'RL6'/RC!/SM^QW\*K7XT?M)>"/"^HQ>?I4UX;J^C(RKP0HTSHWLVS8?\ M>K]8_P#@H9\<]2^ /[.=U<>&YSIVNZS=1Z-8W,/#6H9&:1T]"(XV (Z%@>U8 MYCBIT%"E1^.?X*]OQ?W68L)15:%]8@\-ZQ# MH-MXA?:BV.H>,+B&\D8\#]U]I4DGV6O*_P!I+_@DUHS:!?:[\'KV[M]3@0S# MPWJ,_G0W"@?<@E/S(_!P)"P8D#*CFOR]N+B6ZGDGGD>::1B[R2,69F)R22>I M)[U]\_L>_P#!2RQ^!GPCE\(>/+#7O$\VGS8T:6S\IQ%;%1^X=Y)%8!6!VX#8 M5LYA=HY895*NC X*L#R"",$&HJ]'_ &@OB/I7QH^,_B/QAH'AZ3PY:ZW37W)\!?^"14&N^$[+6/BEXEU+2M0O85F&B:&(DD MM >0LLTBN&?!&55, Y&YJ].6)C1HQJXCW6^GGU1R.GS573I._P#D?FI17ZX: M]_P1U^&%QIDZ:+XR\76&HE2(I[^2UNHE;L6C6&,L/8./K7YL_M#? 7Q!^S?\ M3K_P9XB:&XGA1;BUO;?/EW=NY.R50>1G:P*GHRL.>IBACZ&(GR0>I=3#5*<> M:2T/-:*^^/ __!*BX\<_!+1_'UI\1V%UJ>AQZQ#HT?A_>Q=X?,6 2?:1DDD+ MNV^^.U>D?!G_ ((_:1=>%;:\^*'BK5H-Z]H6F()-0TW5$0W<,6<-,LD:JKJ,@E=BD $Y/;XV^%OPQ\ M0?&3QYI'A#PO9_;=9U*7RXE9MJ( "6D=OX4506)]!QD\5MA\52Q,7*F]M_(B MM1G0MS]3E*^HOV!OV7/"O[4_COQ-HOBO4-8T^UTS35O(7T::*)VP'UKZ_P#!/_!'3P);^'[=?%WC7Q%?ZV5S-)HI@M;96/\ "JR12,0.FXD9 MZX'2O2_V3?V';C]E#XS^*-6T[7?[?\)ZOI(M[9[E!'=V\JS*WER ?*X*\AUQ MG!!4<9\^KF>'<9PA+6SL_.QI]5K6C*W6-_2ZO^!^>W[?7[+?A3]ECQQX9T;P MIJ&L:A:ZGISWM?K+3^NQV5J<8XWV<(W7*M-ND=?Q_$^"KJ(074T:Y*H[*,]> M#45;OA7P5K'CCQEI_A?0+*35-9U"Z%I:V\0P9')P.O ',]:N=>D4-+%X=:&"VA) R@:6*1I,'/S83/]T5[=;$TL-!2J M/?\ $X?92J5)1BMOP/B_]AW]GOP[^TQ\:9O"'B>]U2PTU-*GOA+I$L<5Y.W9Y M<,>,^8V$KG2;FQ>WU%56\M9&:) MERR@+(IV-R I' P>2/&O^"SG^K^%'UU+_P!MJ\5X[VV-HJC+W7NO/WO^ =]' M#(27=^4. MUS'N^5$# C>0V2I&WO7UNW_!'OX/^40OBCQN),?>-[9D?E]E_K7J5\?0P\_9 MS>IP4L/4K+FBM#\@J]@_9O\ V6/''[4'B2?3?"EM##8690ZAJ]Z^RVM%;.W. M,LS':<*H)XYP,D>B?MH?L+ZQ^RC)IVL6FK_\))X.U*)JX^E'"RKTW=[+U[/Y7?\ PX?5Y^WC1DM]?EW7SLO^ M&/RG_:V^ ]E^S=\7Y? ]CJEQK(M=/M9YKVX18_,EDCW.50?=7/0$L0.I->,U M^K__ 4(_8=_X3VZ\;_&O_A-?L/]EZ*)_P"P_P"RO,\W[/%T\_SAC=C^X<>] M?%7[(O[%?BG]J[5KJ>UNT\/^$M/D\J^UN>(R_O,9$4,>1O?!!.2 H.2?A+]CV_P#"6>-/ MM>W'F_:;3R]WKL^S9Q[;OQKX:_:^_8?\4?LIWEK?R7J^)/!U_+Y-KK,,)B:. M7!/E31Y.QL D$$A@IZ'(&E+,L-6FJ<9:LF6$K1BY6V/FRBBBO3.,**** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "M#P[_R,&F?]?47_H8K/K0\._\ (P:9_P!?47_H8I2V8UN>O_MK?\G- M>,O^W/\ ](H*\0KV_P#;6_Y.:\9?]N?_ *105XA7-A?]WI^B_(TK?Q)>K"BB MBNHR.W^$/P5\9_'CQ/-X>\#:-_;FL0VS7CVWVJ&WQ"K*K-NF=%X+KQG//2O8 M_P#AVO\ M'?]$Z_\KFF__)%>A_\ !(G_ ).OSZ)XHT6^T#5X.7L]0@:&0#G# ,.5.#AAP>QK]%_V?_\ @K3XA\5? M$71?#_Q#\+:+;Z9JMW'9KJ6A>=";1I&VJ[I+))O7<5SAE(&3SC!^@?\ @I9\ M$=)^)W[..M^(GM8QXB\)Q?VE97N '$(8>?$3U*E,MC^\BFL)X[$X6I%8J*Y9 M=5_P_3J:4\/1KJ4:4GS+O^'WGXET5K>%?"6M^.==M=%\.Z3>ZYJ]T2L-CI\# M32O@9.%4$X !)/8 DU[_ ?\$W_VC+B!94^'$@5AD"36-/1O^^3< C\J]NI5 MITK>TDEZNQYT8RGI%7/FJBNY^*GP-\>_!'4HK'QQX6U#P[--GR9+F,-#-C&? M+E4E'QD9VL<9YK(\&_#?Q;\1KBY@\)^%M:\43VJAYX]&T^:[:)2< L(U;:"1 MU-5&I"4>>+NNX2C*+M)69SM%>H^$?V7OBSXX\;3>$=+\ :XOB."!;J:PU"U- MBT,39VO(9]BHK8."Q&<'&:])\!?L3?%?PS\=/ ND>-OA=KDVASZS8_VE);VQ MO;,6IN%$OF3VY>-%V[LY88'/%2JM+F47-*_F').S:B]#PJR^&OBC4/ NH^,X M-$NV\*Z?/';7&K,FV 2N<+&K'&]L]0N2,@G (KFJ_;C_ (*&?#6_UC]D>Z\+ M>!O"US?O;WMBMKHWA_3VE,<22=$AB4X51Z# K\;HOA=XSF\92>$8_".NR>+( M_OZ"NFS&^7Y-_,&W>/D(;IT.>E>?@<=]<51M6L[+TLG?[VSIQ&'>'Y=;W7XW M:M^!S%%=IK'P2^(GAW5M*TO5O 7B?2]2U9VBT^SO='N(9KQUQN6)&0&0C(R% M!QD5ZO+_ ,$\/VAX=).HM\-KLVXC\W8NH6;38QG'DB;S,_[.W/M7?*M2@E*4 MDEZG.JA% M:_@3X>>)OB?XBAT+PGH5]X@U:;E;6PA,C!<@%VQPJ@D99L 9Y(K6Z:NMB'H[ M,YZBOH_4/^"=?[1&FZ?)>3?#>X>&-=Y6WU*RFEQ[1I.7)]@,U\^:QHVH>'=4 MNM-U6QN=,U&U-I%P;2^^V/%8B"=?O0DW#Q@R+_$@RRY&0,BKE4A& M_,[6$HR>R/(:*Z7XB?#7Q/\ "7Q5<^&_%^BW.@ZU;@,]K= 9*GHRL"593V92 M0<'FN:IQE&:YHNZ%*+B[25F%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH M **** /?_BE_R:+\%/\ KZU?_P!*GKP"O?\ XI?\FB_!3_KZU?\ ]*GKP"N/ M"_!+_%+_ -*9M6^)>B_)!111788EO1])NM>U:RTRQB\^^O9TMH(MP7?([!57 M)( R2.2<5]'_ /#M?]H[_HG7_EE?O=^T MM\3M4^#7P*\8>--%M[.ZU31[/[1;PWZ.\#-O5<.$96(PQZ,*\?,<94P:@Z:3 MYK[^5O\ ,Z\'16)J2@^EOQO_ )'X^M_P39_:.523\.ORUO3C_P"W%>5_%C]G M;XD_ V2$>.?"&H:!#,VR*ZD59;9VP3L$T9:,M@$[=V<#.*^L-$_X+$?%*WU* M%]7\'>$+[3P?WL%C%=6TK#T61IY I^J&OT?\/ZGX-_:\_9_M;RYT_P"V^%?% M>GGS;.Z +PMDJRY'22.13AAT9 17-6QF-PL54K03C>VG_#F].CAJTN2,FF?S MUT5W6L?!WQ*GQ5\2>!/#^C:GXHUC1[^ZLS;Z3927,TBP2LC2>7&"<< YQQFK MNG?LW_%34O&6F>%%^'OB.U\0ZFC26EAJ&FRVCRQJ0&DS,% 121ER0HR,FOZNO3._"%SH=A=R>3#=B>& MYA,F"=A>%W56(!(!()P<=#5?X1_LT_$[X[+/)X&\'7^NVL+%)+P%(+96&,IY MTK+'NP0=N[.#G%$:M.47-232ZWT"4)1:4E9L\SHKV_XB?L3?&_X5:#-K7B3X M>ZA;Z7 I>:YLIH+Y85 )+R?9Y'** #EFP!ZUXA3A5A4UA)/T"4)0^)6"BNJ^ M'/PJ\7_%S71HW@WP[J'B+4"]/\6>$O!?]K>'[_P S[->?VK90[]DC1O\ )),K##(PY Z>E>,ZUH>H M^&M6NM+U?3[K2]3M7\NXL[V%H9HF'\+HP!4^Q%?M_P#\$U_^3,? 'UO_ /TN MN*Y\;B'A\+[>G9NZ7E9IO]#6C3]I5]G+0_%C0?AOXC\3?$*W\#Z;IWVGQ1/? M'38[#SXTW7 8J4\QF"#D$9+8]Z[[XN_L@?%SX$>%XO$7CGPE_8>CRW*V:7/] MI6EQF5E9E7;%*[N^$=)_MWQ-8>*;F?3]-^S27' MVB87#[4\N,AWSZ*0:]E_:Z_:2_:"^+?POM=%^*/PL_X0SPY'J<5S'J'_ CV MH6&ZX6.0+'YEQ(R'*LYVXR=OL:Q5>M.G1G&WO6;OYVVU]>YI&G35:K"=[1O: MW?7?RT7XGQS178>#_@WX_P#B%ILNH^%? _B3Q-I\4I@DNM'TBXNXDD #%"\: M$!@&4XSG##UK9^'G[-OQ/^*GB74M \,>"-6O]6TR1H;^&6'[,+.0$@QS/*56 M-\@_*Q!X/'%>BYQC>[V.3E=KV/-JO:#HE[XFUS3M'TV'[3J.H7$=I;0[U3S) M9&"HNYB ,L0,D@>M>K_%+]CGXR_!G0FUKQ=X$OM/TE/]9>V\T-Y%"/61H'<1 MCMEL#)Q7FW@75=2T/QOX>U+1;/\ M#6+/4;>XLK/RFE\^=)5:./8I#-N8 84 MY.<"E3J0J:PDFO(*D9TUJK>IZI\3OV)_C1\&_!E[XL\8>#/[(T"R:-9[S^U+ M*?87=8T^2*9F.691P._I7A]?,>;-*R+N=57DUNHRBOH;PW_P3[_:#\5:3#J-C\-; MZ*VF76ME+CWBGE1U_%17G'Q8^ ?Q"^!M[#;>.?">H>'C.<0SSJ'MY3U M*I,A:-B!U 8D5LJ])RY%-7[71'LYVYN5V. HJ2WMY;RXB@@B>>>5@D<4:EF= MB< #DDGM7T'X?\ ^">_[0GB;2X-0L_AK>Q6\R[T6_O;2SEQ_M132HZGV*@U M='#YC!2 MY&^1E4?*I/)'2NX^*W[*/Q;^".FC4?&?@?4-)TS(#7\;1W5O&20 'EA9T0DD M ;B,]JZS_@GW_P GB?#3_K\G_P#26:I]K"<'.FT[?,)QE#XE8Y?XQ?LE_%;X M ^'[/6_'GA7^PM+N[H64,_\ :-I<;YBC.%VPRNP^5&.2,<=:\BK]=?\ @L1_ MR;_X0_[&>/\ ])+FOR*KBR_$SQ5)SFE>]M/D=6*HQHS48]@HHHKTSD"BBB@ MHHHH ^@/B%_R9S\*?^PMJ7_HUZ^?Z^@/B%_R9S\*?^PMJ7_HUZ^?ZX\+\,O\ M4OS9M6W7HOR"BBBNPQ-+PSIL6M>)-*T^=G6&[NXH':,@,%9PI(R#S@U^M_\ MPY]^#7_0R^.O_ ^R_P#D2OR;\!_\CSX=_P"PC;_^C5K]W?VVO^33?BE_V!)O MZ5X6<5ZF'ITY4W:_-^'*=>7P5;$5(3U24?Q"G_@CY\&\''B;QR#V_T^ MS_\ D2O$?VDO^"3MQX&\(WWB3X8:]?\ B(:?$9KC0M5C1KN2-02S0R1A0[ 8 M_=E 3@X8G"G\^='UK4?#VH0W^E7]UIE]"=T=U9S-%*A'.592"#]*_>K]B7XC M:_\ %C]F'P1XD\42-<:U<02PSW,@PUP(II(EE;U+*@)/S\/_\ !52XTW3T6.RM?$>O1PHF-JJ(+O"C MV'3\*^Z/VY/V7M<_:JTSP+X'C!UJ4 M45]C?L9_\$[]5_:5T(>,/$6L2>&/!9F:*W:WB$EW?E#M, MW_V-?V =<_:BL9O$NJ:JWACP3;SF!;M(?-N+V12-Z0J2 %&<&0Y / 5L-C:& M*HSI.NI>ZB9T:E.:IM:O;S/DRBOU]7_@CW\'_* /BCQN9,?>%[9XS]/LO]:^ M3/VQO^"=.K_LW^'9/&7AS6I/%'@Z.58[K[1"([NPW$*C/M.V1"Q W +@L/EQ MS7+3S/#5)J"E9LW>#K)7L?&M%>D_L_\ P \5?M(?$"#PIX4@C\_89[J]N25@ MLX 0#)(0"<9( !)) ^GZ2>'?^".OPTM]'@CU[QIXKU#5 O[VXTYK:U@9O\ M9C>&5@/JYKIQ&+HX6WM'J^ASTJ4ZS:@MC\DJ*^W_ -KG_@F=K'P)\,7GC/P5 MJ]QXL\+60,E]:W4(6]L8AC]Z2ORRH.=Q 4J,':0&8?$%7A\32Q,>:D[CJT9T M7::"BBOT<_8!^'/P)\%_!=?C'\4)]+AUJ#5+B"SEUZY#11>2JLIM[;_EI+R2 M,*[ @;<5=:M&A3=22O;L913G.,%N_P#)O]"C^R'_ ,$P=/\ BQ\,_P#A*OBC M<^(O#=PQ\:?M#?#O3?A+\;O&?@ M[2)[JYTS1=1DM+>6^=7F9%Q@N555)^BBOW5_9]_: T#]H_PKJGB7PQ;W46BV MNJ2Z;!-=KL>Y$:(3*$ZJI+\ \X ) )P/Q3_;6_Y.P^*/_8;F_I7A87%5ZV/< M*ONKE;Y>WPV^=F>I.C2A@^:+N^9*_P#X%?Y77X'B=%%%?1GE!1110 4444 % M%%% !1110 4444 %>_\ P/\ ^3;/CW_UPTG_ -'RUX!7O_P/_P"3;/CW_P!< M-)_]'RUR8K^&O6/_ *4C:C\7R?Y,\ HHHKK,0HHHH _3W]G?_@F#\+/BU\$? M!GC'6-?\86VIZUIT=W<0V-Y:I"KMG(0-;,P'U8UZ)_PY]^#7_0R^.O\ P/LO M_D2O>?V)_P#DTWX7?]@2'^M?A-X^D>'XA>(W1F1UU2Y*LIP0?-;D&OEXRQ&( MQE6C&JXJ+?GUL>I3C3A@Z=:4;MJ/XJY^F'Q(_P"".OAB3P_._@'QMK%MK4:L MT4/B(13V\QP<(6BCC:/)Q\V'Q_=-?FGK7@+5?!WQ!G\(^)+*;2]6L[X65Y;/ M@/&VX X/(((.0PR""",@U^IW_!);XO>+OB%\//&.A>)-0N]8L?#]U;#3KV]D M,LB+*LFZ#>>2J^6I )XWX'& /G7_ (*C:+9:7^V)X\776JZ19BX@AO[RU>!FWJN'"VRL1ACT85^9M? MT(?M0?#S5_BQ^S[XN\(:"D3ZOK%K':V_GOLC4F5,LS8.% !)P"<#@$\5\J>$ M?^".GP^M]!@3Q1XU\2ZAK6W,TVD&WM;?/HJ212M@>I;GK@=*\_ YCR*;Q,[Z MJQUU\,I0A[*.NM_PM^I^35%?5'[:W["^I_LIS:?K6G:J_B+P7J4YMH;R:,1W M%K-@L(I0#ALJI(=< [6!5>,\C^R3^R%XD_:P\67MGIUW'H?A[3%5M2UJ>(RB M(MG9'&@(WR-@G&0 23T!^BIXFE5I.M&7NK?R_K_ (8\NI2G2FH26KV\SP6B MOUZM?^"//PC2W1;GQ5XUFN,?-)%=V<:D^H4VS$#\37SQ^US_ ,$Q9?@GX'U' MQOX%\077B#0],02W^FZI&@NX(?XI5D0!9 ,@E=BD $Y/2N*.:864E'F_ Z/J M=:U['P917LG[+O[+WB;]J;QX^@:%+%IMA9QK/J>KW"%H[2(G ^48WNW.U,C. M#R "1^B.D_\ !'?X50V,2:GXO\8W=X% DFM)[2"-F[D(UNY ]BQ^IKIQ&,HX M5I5'JS"E1G6OR+8_(JBOT@_:#_X)(_\ "+^$[[7?A?XDU#6KBQA:9]#UE(VG MN%49;RIHU4;\#A"G/]X=#^>GA;PKJWC;Q+IOA_0["74M9U&X6UM;.$?/)(QP M!SP/W^ ML;G2[ZXLKRWDM;RWD:&:WF0H\;J2&5E/(((((/I4%>HFFKHY&FG9GL7[,?[+ MOBS]J7QM+H?ATPV-C9HLVI:O=@F&TC8X' Y9VPVU!C.TY( )'Z'Z)_P1V^%U MOID*:QXQ\77VH!0)9[&2UMHF;N5C:"0J/8N?K7SE^PI^W1\/_P!EGX;ZMH'B M#PUKU_JFHZDU[+?:4D#AD\M$1,/(A^7:QZG[YKP7]J?]I+5OVA/C1JGBR#4- M4M]%BG T.RN9-C6,*@!<*C%4RIOE@EOWV_S_ .R MC[*-)U*FLK[?UZ7^:1]&?M4_\$MM2^$OA34?%_P]UNY\4:+I\;3WFE:A&HO8 M(5&6D1TPLH R2-JD <;J^":_H _9$UK7_%7[+?@#4O&XN+PY>: M(EA&[D_>+1;"2>3G)ZU^"GBU;"/Q5K*Z5SI:WLPM/^N/F-L_\=Q66!KUO;U< M+6?-R=?1V_X;YFM:G3E0AB(*U[:>JO\ \/\ (RJ***]P\X**** "BBB@ HHH MH **** "BBB@#Z \1_\ )D?A/_L;9_\ T3)7S_7T!XC_ .3(_"?_ &-L_P#Z M)DKY_KCPVT_\3_,VJ[KT04445V&(Z)0\B*>A(%?KY#_P1_\ @W)#&Y\2^.'\Z_H'_:J_Y-5^*/\ V*M__P"DSUXV;UJE"C2E M3=FW*_R4?\SNP5.-2HU)7T/G4_\ !'SX-XX\3>.L_P#7_9__ ")7D'[07_!( M\^&?"MYK?PM\1ZAKEU91-*^A:RD;3W*@$GR98U4;\#A"G/\ >'0_G1IFJ7NB MWT-[I]Y<6%Y"P:.XM96CD0CH592"#]*_=;]@/XE>(OBM^RYX4USQ325)/)KCQ4,7@Z?MHUKV?8VHU*%6:IRIVN?CG^ MS!\*=+^-'Q^\)>!=?FOK+3-6N98;F2P=([A-L,C_ "ET902!DAUL;*4L/5B^6,TF_1V80H M1C.M3:ORZ+\3\+:*_7*'_@CO\+5TE8Y?&/B]]3\O!N4EM5A+X^]Y7D%L9[;\ M^_>OSS_:H_9AU_\ 98^(@\.:OI[.#U_,YI86K"'.UHOP/&:*^MOV,O^"?\ K7[4%C-XGUC57\,> M"8)C ES'")+F^D4C>L()"JJ]#(^VV> M/R^R_P!:=?'T,/+DF]2*6'J5ES16A^0-%?6?[:/[ ^J_LM6=IXDTK6&\2^#+ MRX^S?:)H1%9\ MN45^OL?_ 1[^#XA ?Q1XW:7'++>687/T^RG^=?+?[8'_!-C4_V?O"MSXU\( MZU-XH\*6K#[;;W4(2\L4) $A*_+*F3R0%*Y!P1DCEAFF&G)1YK7-W@ZUKV/B M:BN]^"/P2\4_M!?$"R\(>$K1)]1N%,LDT[%(+6%2-TLK '"C(Z DD@ $D"OT ML\*_\$=/AU;:- GB3QKXHU'5L?O9]*-M:0$_[,;Q2MCZMS[=*ZL1BJ6%M[5Z MLYZ5*=9M06Q^2U%?=_[5W_!+W5/@[X5O_&'@#6KGQ3H&GQF:^TV^B47UM"HR MTJL@"RJ!DMA5( SAN:Q)"96:4C=Y,*9&Y\$$Y("A@><@'YPK[*_9=_X*0:A^S5 M\,K3P3'\/]/URQMYIIQ=QW[VD\KR.6+2'9(&(R%& /E4#WJL1*K&E)T5>73^ MOZU,H*+FE-V74^KG_P""//PF-D53Q9XT6[VX$K7-H8]WKL^S9Q[;OQKX(_:X M_8W\3_LH>(K..^NDU[PQJ1(T_7((3$KN!EHI4R?+D'4#<0PY!X8+ZK^QOX3^ M._QB_:>\/_%6)->32[K43=ZKXEO1)'9W%H)&$UNCMA95.UHQ&F0IQPH7(^JO M^"N'C;P]IOP!TSPQ>20R^(M3U6&YL+;(,D<<0;S)L=EPVS/.%%%% !1110 4 M444 %>__ +.G_)'_ (Z_]@*'_P!#DKP"O?\ ]G3_ )(_\=?^P%#_ .AR5QXO M^%\U^:-J/Q_?^1X!111788A1110!^F?[,W_!,OX7_&;X$^#_ !KK>O>+K75= M8M#/<0V%Y:I K"1UP@>V9@,*.K&O(_V^OV%?#7[+?A/POXB\':EKFI:??WLE MA??VU/#*8Y"F^$IY<4> 0DN5VOR/8 MP-"%;"4W)7E*"^]K_,_''X-_#Z7XK?%;PEX/A\T?VUJ<%G(\.-\<;.!(XSQ\ MJ;F_"OU0_P"'/OP:_P"AE\=?^!]E_P#(E?)__!*#X<_\)=^TM)XAFA9[7PQI MDUVLG\(GE_*=-MW#2:#?1V$X'9VMH9__ $&9 M:[5.592IZ%3R1@FJ&/H8B?)!ZBJ86K3CSM:'E]%?> MWAW_ ()3W_BOX%Z7X^TOX@M=ZEJ6@1:S:Z FA#=)+) )4MQ,;GN6"[]OOCM7 MK?A__@D+X&TSX]NM.>!-/MV"ECA'B+LJ#JQ==V,X7. MJV88:AS*4_L-_L!_#[]IGX-7'BWQ1K'B:PU*/59K$1:1 M=6\<.Q$C8'$D#G=ESWQTXKY'_:&^'>F_"7XW>,_!VD3W5SIFBZC):6\M\ZO, MR+C!>$/"MD;W6-0U^9$#$B.)!@M+(V/E11DD^W&3@ M'EIXBTLA'$40-X"[L> ,#/4X& MWWLYJE&I22JQO#(P'L7/UKYH_:\_X)JZU\ _#=WXR\'ZM-XL\)6IW7L%Q"$O;"/@>8VW MY94!^\RA2N02N 6'+',\+*?(I?Y&WU2MR\UCY'\ > =?^*/C#3?"WA?39-7U MW49#';6<152Y"EB26( 52220 2:^AOVH/V'[K]E?X0^%-=\0:ZFI^*M9U) M[:XM+$?Z':QB(L%#, TCY'+?*.< '&X^W_\ !+?]E;_A(M6T7XW_ /"4?9_[ M$U&\L/["_L_=YV;4Q[_/\T;?]?G&P_=Z\\?9_P"V1^R9_P -;>$_#^B_\)5_ MPBO]DWK7GG_V=]L\W=&4V[?-CV]//V@-7^%'A)5UG5-/U2[L&OI5\B%8H)F MC>YEY;RTX!(RQR0HW$@']#O"/_!'3X>VVBP)XH\:^)M1U?&99M(-O:6^?14D MBE;CIDMSUP.E>A6QM"C&,YR^+5>G%?"VJ^-_$FF M:!H=E)J.L:E<):VMK#]Z21C@#G@?4\ '_VDOC='X.\37FIV.F-IUQ=F;298XYM\>W:,R1NN/F.?EK[3^%__!'? MPROAN"3XB>,M8GUV10\EOX;:&"WMR0,H'EBD,F#GYL)GT[GT?]G_ /X)[K^S M+^T98^,O#/B*;6_"LFG75G-:ZFJK>6SN%*-N0!9%)4@X52,C@\D<%7,L/:<( M2UL[/SMH:+"UFHRMU7W75_P/C'_@H%^QMX+_ &4['P3/X2U/7M1?6Y;M+@:U M<02A!$(2NSRX8\9\QLYST'2OC>OU _X+.?\ ('^%/_7?4O\ T&VK\OZO*ZLZ MV&4ZCN[O\SHQU.%.4%!6NOU84445ZQYH4444 %%%% !1110 4444 %>__LR_ M\D\^.'_8JR?^S5X!7O\ ^S+_ ,D\^.'_ &*LG_LUC#G%<;12:NK,1]S_P##X+XR_P#0M>!?_ "]_P#DND/_ 6"^,N/^1:\"C_M MPO/_ )+KX9HKA^H8;^1'3]8J_P Q]/?&3_@HS\9_C1X=GT&\U2P\-:1=1F*Z MMO#MLUN;E#C*O([O( >A"L 02"".*^:+"_N=+OK>]LKB6TO+>19H;B!RDD3J M0596'(((!!'((J"BNFE1IT%:E&QG.I.I\;N?9GA'_@K%\;_#&A6^G747AGQ) M+"NS^T-6L)?M#CMN,,T:D^^W)QSD\UQ\'_!1?XS_ /"W+3Q_>:K9:E<6<$UM M;Z'<0.NEQ1R## 0QNK$Y .XN6^49)'%?,=%9?5,.I.7(KOR[C]M4Y>7F=O\ M(]O_ &F?VN/%7[55QH5QXLT3P]IUWHZRQP7&BV\\3NDA4E'\R:0$ KD8 QD^ MM>G^(?\ @J!\4_$OPSU#P-=:!X/CTF]TI]'DFAL[H3B%HC$6#&Y*[]IZ[<9[ M=J^0:*/JE#D5/D7*NA2KU%-55+WNX5]-_L]_\%!/B)^S7\/1X.\,Z-X8OM,% MW+>>;JUK<23;Y-N1F.=%Q\HQ\OXU\R45O4IQJQ<)JZ9@GRR4ENCO;KXT:W=? M'(_%5[73QXA_MU?$/V98W^R?:!.)MNW?O\O<,8WYQW[U[1\>/^"BOQ(_:&^& MM_X(\1Z)X6LM*O)899)M+M+F.<&.0.N"]PZXRHS\O2OEJBLY8>E)0C*.D=O+ M;_)&WMJG-*=]9;^?]7.M^$OQ,U3X-_$;0O&FBP6=UJFCS_:+>&_1W@9MI7#A M65B,,>C"O:/VC/V^OB#^TYX#M_"?BC1_#5AIT-]'J"RZ1:W$ MHK9W4D?D7-M<1B6WNHMP;RY$/49 Y!##L1FO?/B-_P %2/B[\2_ ^L^%KW2_ M">G6.K6DEE Y?"7A?1_#-_ILE[)?&75[6XDFWNJJ1F.=!MP@[9Z\UXC M\4/B)J7Q:^(6O>,=7@M;;4]:NFN[B*Q1EA5VZA S,P'U8UR]%5[&FJCK6]YZ M7^[_ "1/M)*'LT_=O>WGK_FSZI^!G_!1SXE?L_\ PSTOP/X>T/PK>:3IS3/% M-J=IBB-&G&HZJ7O/=ASR<5"^A];?"_\ X*?_ !K^&?AF MWT1[C1O%MO;*L<%QXBM99KB- OF12QE^G5]S>]4?%W_!2KXT^,O%FA:Q=W M^EVMCI%Y%?QZ#8VKQ6-Q+&,!C)/( M-N)&Z '('-ZTRX19[2X(QRT;K)TN>TLX/"_AZ:48%[IFFR--'_N^?-(G MYJ:^0?$7B35?%^N7NLZWJ-SJVK7LAEN;V\E,DLKGNS'D_P#UJSJ*TI8:C1=Z M<4F*=:I45I.Z/JSX(?\ !2'XE_ /X8Z/X%\/Z'X4O-)TOSO)FU*TN7G;S)7E M;O%>C^+O\ @K%\_Z+_R8[XA_['./_P!) MHJ\ KW_1?^3'?$/_ &.EP:#;O:^*?"D39CTG5]Q-NN%_M!_\%,_B9\;M!O?#NF6 MUGX'\.WBF.XATUVENYXR,-&]PV/E/<(J$C()()%?(5%<$\3I9QB&*^URSF>YV 84,\4T88@#[S L>Y M)YKX^HKMJ4H5H\M171S1E*#YHNS/8OB)^UE\1?B+\:++XI2ZI%H?BZQBCAM+ MC18O)2"--V%"L6W [VR'+;@Q!R.*]XM?^"NGQLM]+2UDTOP?6"%=A))(2^W"YSC"KQ7FU%5'#T8S4XQ2:T M&ZU1IIRWW/J[X._\%+OC#\&_!=CX7M?["\1Z981K!9MKUI+)+;PJ %B5XI8R M5 '&[<0.,X \J_:,_::\8?M/^*;#7?%Z:;!/8VWV6VM]+MVBB1"Q8_>9F)) M/=C7DU%'U>C[3VW*N;N)59J'LT].Q]9?"G_@IQ\:OA7X9M]"^TZ/XLL[55CM MI/$=K)-/%&!@)YD4L;.!ZN6/OBJOC7_@I5\:?'/B30]2NK_2['3])O8;]=#T M^U>&RN98GWJ)_P!X977(&4\S;P#C(S7RO14_5:#G[3D5Q*K-0]FGH?2/[1W[ M>?C_ /:?\$V?A?Q3H_ANPT^UODU!)-'MKB.4R*CH 3).XVXD/;/ YKSGX)_M M'?$+]GG5IK[P/XAFTM;@K]JLI$6:UN<=-\3@J3CC<,, 3@BO-**NG0I4X.$( MZ/H$ZDZC3D[M;'W&G_!7[XSK"$/A_P $.V,>8VGW>X^_%UC]*^=_CQ^U3\2? MVCKN%O&FO-245G#!X>G+GC!7 M+=>K)H_M\?$&^_9Z3X.1:3X;L/#"Z9'I1N[6UN%O6A0KDES.4W/@[ MCLP=S8 [>0_!GXKZC\#_ (D:/XVT?3M-U35-*9Y+:#5HY)+<.R,FXJCH20&) M'S<$ UQ5%:QHTX.3BK.6_F92DY14'LMCZ<_:"_X*$_$O]H_X>OX-\0Z=X=TO M2);F.YF.BVUQ'+*8R2J,9)Y!MW8; .57FOF.BBBE1IT$XTXV3U*G4G4LYN] MCI/AO\0-6^%7CW0?%^A/&FK:-=I>6_G F-F4\HX!!*L,J0""03R*^C_C)_P4 MH^(_QR^&^L^"?$OACP;_ &1JD:I)):6=VDT3*ZNCQLURP#*R@C((XY!KY,HI M5*%.M9U(WML%.I*FVX.USZL^"'_!2'XE_ /X8Z/X%\/Z'X4O-)TOSO)FU*TN M7G;S)7E;#[G2]&M5L[>:]L[IIF1>A>LD+%2C[ MMP*G.00>E5J*(4:=.;J05I/=@ZDG35)OW5T]-#[0\+_\%9OC=X=T&VTZZMO" MWB":%-AU'5-/F^T2>A;RIXT)]]HSWS7DVA_ME^.]%_:,O/C2;71;[Q;=1-"\ M-S:R"S"F$0@!$D5N$48^;MSFO"**SCA:,).48)-II^CW&ZDY14&]%9_=JON9 M[Q^TU^V3XT_:LMO#\'BW2]!TY-$>=[\8?!7Q3'XB\%:[J21L"KKT.&!&0#U -H5*DZC3F[V/M^W_ ."O7QIAM%A?1/!<\@7!N)-/N@Y]R%N0N?H*^:_C MA^T=X_\ VB=,] 6.6( R3@5YI16,,)0 MIRYX0293K5)1Y7)V/H3]FG]M[QU^ROX>U?1O">E>'M0M=4NENYGUFVGE=7"! M %,(+6QL]6U.[M?.ATV-T@7RUCC7:'=V'"# M.6/.:\RJSI=[_9NI6EWL\S[/,DNS.-VU@<9[=*ZJ5.E'$*NU[VFOEI_D<]24 M_82HQ>COI_7F?O5^VUJ5WH_[*'Q!O["ZFLKZUL(YX+FWD,3-&A/OMY[YKI_ MCM_P5._X77\'_$O@7_A6/]C?VS:BV^W_ -O^?Y/S*V[R_LJ[ON]-PZU\%5\[ ME^ E%3CB8;M6V9Z^(Q,7"'LI:J]_P/0_C9\?O'/[0GB==<\;ZU)J=Q$&2UMD M41V]HA.2D4:\*.F3RQP-Q.*O_ 3]I?Q]^S;K\^I^"M6%M%= "\TVZC\ZTNP. MGF1Y'(SPRD,,D9P2#Y;17O1I0C#V<8KE[=#S)2E.7-)ZGV7XN_X*P?&_Q1H4 M^G6D?AKPU+,NW^T-(T^7[0H[[3--(H)]=N1VP:R/A-_P4T^+7PC\!VGA6UL_ M#OB*VMY)Y3?^((+JYNY6EE:5_,D6X7=\SMU&?K7R717/]2P_*X:=_P M5S^-ECI<-I-IG@^_GCC"-?7&G3B:0@??8)<*F3UX4#VKXFHK6IAZ56*C.-TM MB(U)QDYIZLZK6OB?XDUKXE7_ (]_M*33_%-YJ$FIM?:<3;M'<.Q8M'M/R\D] M*^I/"O\ P5E^.'AW2(;*\A\+^))HQ@WVJZ=*)W_WO(FB3_QVOC&BB>'I5(*$ MHII;>0_:SYW4OJ]_,]]^/W['B59]%T6$V]M*RG(,F M69Y.<':SE00" ",UX%115TZ5.BN6FK(F=251WF[GUA\)_P#@IM\:?A3X8@T$ M76D>++.V41VTGB2VEGGA0# 021RQLP'^V6/;.,"DU;_@II\:=:^(6A>*;FZT M@0:.\DL'A^&UDCTZ1WB>(O*JRB20@2$@-)@$ @=<_*%%9/"T'-S<%=_J5&M4 MC'D4M#WC]IK]LGQI^U9;>'X/%NEZ#IR:(\[VYT6WGB+F4(&W^9-)G'EKC&.I MZUX/116M.E"C'DIJR%.I.HTYN]@HHHK4S"BBB@ HHHH **** "BBB@ HHHH M**** "OT5_X)#?\ (P>*?^OFW_\ 1%Q7YU5^BO\ P2&_Y&#Q3_U\V_\ Z(N* M\K-/]TG\OS1V83^,C]4Z***^$/H0HHHH **** /QU_X*L_\ )8M%_P"N-U_Z M.KXAK[>_X*L_\EBT7_KC=?\ HZOB&OOLN_W6']=3YS%?QI!1117I'*>U?L5_ M\G7?"S_L.V_\Z_;CX_? K0?VC/AS<^"_$EWJ5CI=Q/%<--I4L</!T)=?L.VFK? MM&?MC>#[SQUK%_XJETF%]0>;6+E[F1UMT+0J6=B2%E9&QSW]37VS_P %4/C] MXB^$?PN\.^'O"^HW&CZAXGN9EN+^T3L<*B3H45F/91(8R2>@!/:OTP_X*.?LOZ[^T M=\+M'NO","WOB?P[-/C-H-WXI\(:MX2\,:+?Q7M_=: MU:/:F41.'$42. 9"Y7&Y05 ))/0'[4_X*L_%[3?!O[/+^"_M"MKGBNYA2.W5 MOF6VAD6624C^[N1$]R_L:692A4Q&'5)WG=;=KJWZ_(K *475=1>Y;_/F^=K+ MU/0_^">/@^S\#_LA^"&AC5)=3AEU6ZD45P24VNS1YSV,;I[=1VK\X/C?^P/\7/"/QDU30_#W M@C5O$6BWM](^E:GIL!EMF@=B4$LOW864$*WF%>5)!(P35&489G6]KOK;TO\ MY6MY$QN\N@EOI?\ &_X[^9^J/[$?Q9U?XU?LS^#_ !/K\OVG6WCFL[NXQ@SO M#*\7F'_:955C[DU^6_PS_P"4ET/_ &42\_\ 2R6OU?\ V3?@O M"KZ:.XU.SA>:]DB.4^T2R-+(JG RJE]H/<+FOR@^&?\ RDNA_P"RB7G_ *62 MTL"X2S"JZ?PZ[;;K;R['/C%)9;:>]OT9^G?[=WQEUCX&_LV>(O$/AVX^QZ]- M)#I]E=;0QA>5P&< \;@@QQRXQN"RLPZ9&,8P2.YK]7/\ @KA-)%^R[IZHY59/$EHK@?Q#R;@X/X@' M\*_*_P#9[\.Z5XN^.WP_T77%1](O]=LK>ZCD^[)&TRAD/LP^7\:K(Z47"4WO MS:/M9+];LZ\TDZ:AVY6_Q:_)'VSX5^)G[9O[57PCFT#3?#UI9^'M61(F\620 MC29WAR"3&_F*&C8#:3%$V02!7M/["G["_P 1/V9_'-[XC\3>,]/DL;JT>WET M'2))IH9V8J5DD9U0!E*G&%8\GD9->]?M;-\2]%^ 6K?\*:@V>*;;R5BALX4> M9;52!(+=&!4N%Q@8SC.T;MM?*/\ P3X^%?Q]U#XO3>/_ (L7/BF'1;33Y[:U M@\676;[9\)VY\CR]3!YXW9MNWTK[,_93_Y-!^''_8K6_P#Z M)KDJMQRB+7\S_P#;CJ24LPBFOL__ "/_ Q^-^B_M ^,?%'[3^A?$34-?U"3 M5WUV"59%G?\ =VYG&;=!GB+82NSH02#U-?M#^UM\2-1^$?[./CSQ5I$WV;5K M'3RMI/M#&*:1UB1P"",JT@//'%?@CX#_ .1Y\._]A&W_ /1JU^WO_!1+_DS7 MXC_]<+7_ -+(*]3-Z,(PP].*TNU\O=_S./+*DJV-J<_7E?WN1^=__!,?X@>( MY/VO;.&?6KZ[37[2\_M/[3$_\ KUOO_2:2OK;_ (+(?\DH M\ ?]AN7_ -$-3S-*&-PW+II'_P!+:_+0SP$FZ=>[[_\ I"/R?HHHKZ4\T*** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"_H'_ "'M-_Z^8_\ T(5[ M#^VO_P G->,?I9_^D<%>/:!_R'M-_P"OF/\ ]"%>P_MK_P#)S7C'Z6?_ *1P M5R2_WF/^&7YQ-E_"?JOU/#Z***ZS$*^W?^"1/_)SFK?]BS=?^E%M7Q%7V[_P M2)_Y.&+?YNS=O\R&3./+7&,=3UKB/A#_P3Q^"OP \36OBN+^TM M8U33W\^UO/$M]&\=JXZ2*J)&F1G@L#@@$8(S7SM_P6<_U?PH^NI?^VU?F57S M> PU:MADX57%.^EO-^9[6,J0A42G#FT1^G__ 4D_;?\*Z[X"O/A7X!UB#7[ MK49$&L:I82>9;0PHP?R8Y =KLS!=Q4D !@>3@=Q_P1Y_Y-^\6?\ 8S2?^DMO M7Y$5^N__ 1Y_P"3?O%G_8S2?^DMO796PD,'@*L(ZWLV_FCECB)8C$TV]$KV M7R9X%_P4?_:P^(FD_M%:AX-\*>+]9\*Z-X=@MXS'HU[):-//)$LKO(T9#,,2 M*H4D@;[>0R3%CR7 M(A89]';UKYR_X*#2-)^V-\2RQR?MD _ 6L('Z5[=_P $B?BGI_A/XP^)?!^H M3K;OXHL8VLV=L"2XMR[>6/]50IJ.6\X7^^SE^%_P)Q-2^*M/ MX5)+[G9?UZG2_P#!6C]H#Q-;^/\ 2_AAI.IW.F>'XM-2_P!1BM93']MEE9PJ M28^\BJH.T\$N20<#'%?\$L_V@/$OAKXY:?\ #BXU*YO/"OB"&=([">0O':7$ M<3RK)&#]S(1E('!W GH*]J_X*>?L?^,_B=XITKXD>!M)N/$ MIQ&"ZN+B1&C+&)AN5%1GY8#)9<9P<88*>'67SC-K:5^]]>7]+?\ -,9&J\1 M%QOTM^%_^";O_!8SX;V)LO 'CF"*.+47GET6YD51NF0KYL63WVE9<.A[U]PV=QIW[6'[)[+I]XD5OX MP\-O;^=G?]FG>$HP;'>.7((]5->34C/^S(/IS2_+3\>;[SO3A]>2>_+^J_2Q M^&VE?'#QYH_Q(7Q];^*]4_X2[SQ.^J/$_V9''D9E%S]QP!SM4ECTVYXK]G/&/AR#P?^SWKF@VK,]MI?A>>RB9NI M6.T9 3[X6NW.IT)82*IM7UM;M;_AK?/S.;+8U5C4Y7MU];JWZ_U8_+G_ ()$ M_P#)SFK?]BS=?^E%M7H7_!9K_D:?A=_UY7__ *'!7F7_ 25U2WL?VIKF">0 M1R7OA^[@@4G[[B2&0@>^U&/X5],_\%6?V??&WQ9TKP/XB\&Z!>>)/[$^U6]] M9Z;$TUT%E,11UB7+. 8V!V@D9!QC)'5C9*&98>-=%N/#8U*R33[#3[X;+IU\P/)(\1YC&44 -ACSP!@GS?_@L MIQ\0/AL1_P! RZ_]&I48BI"IFV'L[VNG_P" S?ZAAX2C@Z[:M>UOO@OT/NK5 M63]FS]D&[DT**-9/"?A-I+4,ORM-';DAF Z[I/F/KDU^(W@OX^>-O!OQ:LOB M*GB#4KWQ%%=I.7O4# M#*V?F1@-I4Y&#TK]M/!^J:9^U=^R/$MG>1K M'XJ\-R:?/(OS?9KEH3%*I'JDF[\J_)?PO^P!\:-6^+5IX-U+P3JFF6WVI4N] M<>$G3XX-PWRK9W?[4'_ 4DU7]I#X;WO@H^ -+T/2[N2*5KB:]DN[B)XW#JT;!8U4\$ M'*GAB.]?7_\ P2B\?>)_B!\&_%MUXH\1ZMXDN;;7?(@FU>^ENGBC^SQ'8K2, M2JY).!QS7G'[;W[$OP#^!_P)UGQ=I>G:EH&M1F.VTR"WU621+FZ(;Z6-&JT<12]J][_=9_K^I\F?\ !13XK>-O^&FOB1X0_P"$QU__ (1/S;1? M[!_M2?[#M^RP28\C=LQO^;IUYZU\D5]C_P#!1+X&^/G_ &D/B5XV3PGJC>$% M2SO#K@MV^Q^7Y$$/^M^Z6$@V[0=PZXQS7QQ7KY[1LX'N17[8?'WX8>'_P!M3]FV73]"U:VE@U2*+5-$U8#?&DZ\H6[@$%HV M[J&;C(Q7FYM'V=:CB6O=5D_E*_Y/3O9FF7V_>T;ZRNU\U;]%?U/P0HKW#6OV M(_CIH?BK^P)?AEK]U=F38EU96IGLVR>&^TIF)1_O,,=\5^HW[%/[&MC\#?@? MJ.D^/],TO6=:\12+=ZQ97D,=S;0HJD1VYW J^P%B3R-SM@D $^I7QU&C1]JI M)]E??^E_EU.:&'J3J*FU;OY'XL^'=?O?"OB#3-:TV18=1TVYBO+:22-9%66- MPZ$JP*L 0.""#WK]#VUC]LW]L3X4V_AV;P[9>'O#.HLDDWB"93I4UW$%)"NI MDW-$^0?W<.&P.<9!\L\):?\ "SXI_P#!271M-\,Z#IMC\._[7,5O9VXQ:WDD M$#MO"DE=DDR#"KA2I7CDU^A_[=E]\8=-^"RS?!B.[?65O%&H#2X5EO1:%'!\ MA2"2V_9G8-X'3O7G8S%1E"C>FKRU7-TO;^GVML=>'H2C5J14OA6MNN^G];O8 MX;]@O]C3QW^RW>:Y=>*/&5CJ-GJ=N(AH.E&:2VCE#@B??($^;;N7 3^+J<5\ MN_\ !8RTBC^,G@:Y5,3RZ$R._JJW#E1^&YOSKW+_ ()Q_"7XUZ;XL\0>/OBY M=>(1'=:<-/TZU\47DLUXVZ57=_+E8M$H\L## $YZ8%>$?\%BEN!\;O!3-G[* M?#V(^1C>+F7=Q]"EM[?X9:>?]+H=%%1^IU^6+2TWZ^]'7^NUS M]$?V6+@6O[+/PPF(R(_"UBY'TMT-?AS\0OC]XX^(?Q6G\?7WB/4%UY;MKBQN M(KAU^PKN)2.'GY%4< #\&;72XKV[M+>1D6[GE=\>;C[ZJJ)M!X!)/7IU_\ P2%^-/B'6]0\6_#S5M2N MM2TFRLH]1TV.YD,@LP'$.?&VE3^'[W5K:.PT_2[Q=ERL(8/))(AY3+! %;#?*V0,C.N'G0662C)J^O MK>^GGV^7D&*C5>*@X_W?NTO^OS\SQW_@L?\ \E:\!?\ 8$D_]'M7W=^QG_R: M#\-?^P!'_(U\(_\ !8__ )*UX"_[ DG_ */:ON[]C/\ Y-!^&O\ V (_Y&N" MI_R)H_XG^M7,:2R:)I$\EMN7)2669 M(]X]#L,B_P# J]1_X*[?&_Q#H%YX4^'6CZI<:9IE_92:EJD=J[1FZ4N8XHW8 M8R@V2$KT)()' KQ;_@ES\2;+P/\ M47>D:A.L$/B:PGTZ!F. ;A9%EC!/N(W M4>I8#O7TU_P5'_99\8?&*V\+^-/!.DS:_>Z-!-97^FV@W7+0LP=)(TZOM;>" MJY;YUP#@X]+&.M3^)'C71+SPQ MA)I^G:?J4+0W4KR.I>1HFPR M*H3 W $[LC@9,'_!9S_5_"CZZE_[;4L1*G+-*3@[]_6TOTL1@XRCAJO-MK;[ ME^MSSG]E?]H+]J_Q1\.!X-^&/A>R\0:!I]H=.MM4N=/CMDL %P-EP9(HVE7< M&PV]B>2#GGTO]FW_ ()S_&CP+\9-$^(7B;Q[I^DSVU['>WJV=W/>WE\N\-+! M,Q5%(=&/"<_@3]F6TT;X6V]C%J-KX;_XD88+Y,ET8-TU#XB7/C.P\.Z+K5OJ.IMK\TMK8L()1) MLA@)6.3<4 'E*5&0<@5<<1[3$5?9'5K)XR?X6+E@TV6P@L8]4OI;E;6/9*-D0=CL7"KPN!P/2O0_^"K"S-^R7?&/ M.P:Q9&7G^'.?\ !&65#HGQ3C#+YBW&GL5SR 5GP?T/Y5PX%7RW%7_F M7_N,Z<9?ZUA[=O\ Y,\?_P""GGQ6\;:/^T?XA\+6'C'7[+PQ<:7:I-HMOJD\ M=E(KQ?.&A#;"&[Y'/>OT1_8P\%V_@7]DOX>66CQQ)/=Z)%J;-)G:]QJ7WA>#0[>[FUB&V8VD4<49$FZ M7[H8;2=N=V,$"ON_]B#QY8?%C]D?P6MC=F*YL-*70;OR)-LMM- GE9R#E6*A M''?# T5;/*8\F]U>V_VM_F6[?7US;6T[7M&_S_X)\?7G_!.[]J&^^)C?$&3X MH>&!XP-P;A=435[X2(22=B_Z+@1\X\O[NWC&.*^V/VKO!3>//V2?'FE^(([> M74(O#TE](8"3$MW;Q^<&0D [1)'QD X[5^<&M?!_]M'2_BD?!D/B7XEWLAUZ^.FO#N($S7 D*(-HW%6(<=-N>*]&_:>_97^-GP7^$>O\ B?4?VF== M\0:#;P>5>:?JFI:A;_:EDPGD*GG2K(7+;=K8!!.2!FM,1'VL*:E5BE]FR_RV MU_'S"B_9UW+D;?77?^OR/S@HHHKZX\(**** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M#P[_R,&F?]?47_ M *&*SZT/#O\ R,&F?]?47_H8I2V8UN>O_MK?\G->,O\ MS_](H*\0KV_]M;_ M ).:\9?]N?\ Z105XA7-A?\ =Z?HOR-*W\27JPHHHKJ,C[=_X)$_\G.:M_V+ M-U_Z46U?4O\ P4V_9L^(_P"T(OP^'P_\._V^=*-]]L_TZVMO*\SR-G^ND3=G M8W3.,7,)(?['L+4GYY3(1YK >BQ[R3 MTSM'4BOA2\_X*]?&BYA9(]#\%VC,,"2'3[HLON-URP_,5\J?%CXS^-/CCXF; M7_&^OW.NZCMV1F;"10)_3D\U=3"8K&SA]9LHQ[?C]]K;^A%* MK0PW-.G=R??RV^ZY]A_\$Y?VE/@;^SSX;UM_&5S?:5XSU.XVRZJ^FO<0K:J! MLAC:+>X^;.];^+$NF^!?A_INO^%_M1BM;/R;J34[ MV)6(WJ4;",PP0OE-MS@YKI/^"=_["O@37_A7I?Q,\?:1#XHU'5VDET_3KX%[ M2U@1VC#-%G;*SE2WS@@#;@ @FJ7C'_@JOX1^&][>>&OA3\*;?^SK1WMK>YE= M-/@+*Q4%+:&,DH<9&64XZ@&C$*E5QDHQINI-:-7LET_KYD4.>.&YN91@WOUU M_P _R78^K?VVO">F_$+]D?Q\=3L5+V>CR:Q;"X3]Y;3PIYJD=U;@J?9F'0FO MBK_@C3_R/WQ)_P"P9:_^C7K[L_:FOI9/V1_B5?@],/B8_UU-L4^;V#\U^<3ZZ_:W_:T M\+?L=+9ZB?#+>(O%7B=]PM8;@6V^*!57?+,43LT_RL>9L3=GR\_='7';-?7G_!4[_DT36/\ L*6/_HVO MS\_X)B_\GB>$_P#KUOO_ $FDKDR>G&5'$56O>2G'Y.1M)T2*0A&#S /)^\P2B;806P,G:!W MKQ_]A/\ X* :Y^TYXYUCP?XMT#3-,U6&S?4;*ZT<2)"\:.BO&Z2.YW#>I# X M(!X&.>6_X+(,?^%3^ !GC^VY>/\ M@U?.'_!)7_DZBY_[%V\_P#1D%98+#TJ MN#JU)J[5[>5E?3YLUQ=6=.K3C'2]K^=W;\CNO^"Q/@'3M'^(G@7Q9:6RP7VM M65Q:WLB #S3;M'Y;-ZMME*Y]%4=J^O?V7/A3X:_8[_97/B#4;/R]3&CG7_$5 MY'&&N)&6(RF('NL:Y15Z9R>K$U\V_P#!9IMH^$Y]&U+_ -MJ^]]>\>2>'?@G M=^,M$TQO$C6>A'5+33X9?+-X%@\Q45PK8+ <':>O2LY5)1RN$4]'*5_1-V_K MR-I4XRQR;U?*M/N7]>I^?OPY_P""O6N:[\6;*P\2>#=)L?!6H7:6RM922F]L MU=PHD>1F*2A'YH8;RYC4!KFSD M<1A7QU*.Z$$] 7'>N)T__@LE=ZOJ%M8V'P4FO;ZZE6&"VM_$9DDED8@*BJ+/ M+,20 !R2:YC]J7_@H3XH\;?"3Q'X"\3_ )U?P,VNVXMTO-6U"53$0ZMN$&K1J4IT:/(XO^9.ZT_2]_4QI58-S56I>+\GIOK^5O-'M7_!'_ M /Y-O\2?]C3]OQ?\ D>??'SXP M:A\>?BYXD\ 5[_\4O\ DT7X*?\ 7UJ__I4]> 5QX7X)?XI? M^E,VK?$O1?D@HHHKL,3K?A#_ ,E8\%?]ANR_]'I7[O?M:>!-<^)O[.?CKPOX M:L?[2UW4K$0VEKYT<7F/YB'&^1E4< ]2*_"'X0_\E8\%?]ANR_\ 1Z5^]W[2 MWQ.U3X-? KQAXTT6WL[K5-'L_M%O#?H[P,V]5PX1E8C#'HPKYG/-J7J__;3T M\KO]8G;>T?SD?D=H/_!,3]H75]2BM;OPA9Z) YPU[?:S:-%'[D0R2/\ DIK] M:/A!X%T;]E?]GG2-!U'58AI7A?3I)[_5)1Y<9;+2SR8/0%F<@=<8')K\TV_X M+!?&5E('AOP,I]187G_R77A?Q\_;1^*G[1MH-.\4ZY';Z"&#_P!BZ3%]GM&8 M'(9QDM)@@$;V8 C(Q6F(H8_&15*IRQC>^G]>;["I3PU&7M%=L]]_X)Z^,%^( M7[?OB7Q0D;11ZS%J^H)&V,HLLH<*<=P& K]!OVJ?V@/"W[*_A-?'^K:*VLZ[ M=%=(L+:%Q'+-G=*4,A!\N,;2S$ \A>#Q7YH_\$HO^3L8/^P)>_\ LE>[_P#! M9R^==*^%=F"PC:;4967/!(6W _+&_#5O,[2KI6BZ3'^ZMHR$+%Y".=H )./F9F M'(R6'YD_\$U=4M],_;&\$_:&V"X2\MXV[;VM9=H_'&/J17ZE_MB?M27?[*/@ MK1O$L7@UO%UG?7WV&;;J/V,6S%"Z$GR9,[MK#MT]Z,RI1H2HX:E'W7K:^[^M;K2/,6VGC5E5XVCD9V5QN!SN((SPN.?C;_@I9^SKI_P (?CU87GA>P6ST M?Q? ;N&QMU 2*[#[)DC4#A26C8#L9"!@8%?1?A/_ (*T^)/'EY/:^&?V?-5\ M175O$9YH-)UJ6Z>.,$ NRQV)(7) R>.17SI^U-^V5/\ M ?$KX:2Z_\ #VX\ M!2>$=2\^YM[R]:XDE1Y8&8%6@B*8$)['.?:NC#8>K''4YQIZT>ZZ?G]Y^D/@#P=X1_85_9;N;IK12FB:;_:&KW$*JL^HWFT M9RQZEG(1 3P-H[5\J_!+_@K9J?B[XOV&C>.?#N@^'O!VJ7(MX]0@GD233MW" M//)(Q1TS@,P6, $MT&*^J/V]]#N_%G['OQ%@TP--(MC%>XCR=T44T_"-UXI\0QZ+?^'[5D2>]TO4 PC+N$0;)%1VRS ?*I]3Q7 MZ=_\$U_^3,? 'UO_ /TNN*NO"E3RMPHSYESKY:2T_7YA&4YXF,IQL[??_6WR M/S)^!'_*0;0?^QWF_P#2AZ^]_P#@KI_R;!I?_8RVO_HBXKX(^!'_ "D&T'_L M=YO_ $H>OO?_ (*Z?\FP:7_V,MK_ .B+BLJOP8+_ +=_]M*PO^]XO_"_RJ%' M_@C_ /\ )M_B3_L:;C_TEM:POVMOV_E_99^(6H?#_P"&?A+1I]5CG.I:U?:D MDAA-SK2C7S:5.>W*GZV4?\R(3=/!*2WO;\9:_I\S]A?V:_C/9 M?M0? G2O%MSI,=FNII-:7^FR$2Q"1&:.11G[R-C(![-@U^,J>$+7X?\ [:UO MX:L5*6.D^/8[*W1CDK$E^%09[X4"OT^_X)8_\FAZ-_V$[[_T;7YQ?$#_ )2' M:G_V4D:I9ZY\6-9LH[R^M;LZ7HPGC#+;LJ*TTZY_ MB.]4##D /ZU])?\ !3;_ ),S\:_]=]/_ /2V&N:_X)/ZQ::C^RHEI 5^T:?K M=Y#<*.NYMD@)_P" NOY5P8.75W'^;](_\,;XJ*EBJ,7M;_P"29YW^UA_P M5!UGX/\ Q@U'P3X'\-Z3JD.B3"WU*_U=I7\Z7 +QQ+&Z[-I.TLQ;D'Y>.?4M M>_:H^ '[17[-83X@>*="T.+7]/87FB7%XL]]IUP"5RL:@R;D<;D;8,C:<8-? MEQ^V1X?O?#/[4WQ/L[]&6:37;F[7=GYHYG\V-OQ1UKM_A3_P3Q^+'QF^%.G> M/?#0T673M0\TVUC=7CP7;A)&0G#1[,$J<'?R/2NV.!PLL%3J3?*W9\WFU_37 M:PJE>K3QDX0U2;27DGO_ %O?T)?V%/BA\)_@9\:[_P 2?$26[O191-!HE]:6 M)GMXY"Q#7#*<2*=@ 7"DC>V0"!7T]\??^"MEQI?C2WTOX.:1I/B31UC3S=4U MJTN@;F5NJ10AHG7;P,MG)S@8 )\N_P""?_[#.E?%KQAXPU+XE6OVC2_"5^VD M/HL-S\EQ?+GS \L3AA0 M4XPG)6@F_G?;3[K=]_4^J/@_XJG_ &@O@-I>J>,?"4FA2Z_930:CH&I0L %W M/$P*R '8X&YZO]HE^Q6^XHD:W$B1D%N3E%4YX!SD #BOR7_9,N M!>?\%$-!G"[1+XDU)PI[92X.*Y,&I4\97I\O*K.ZWM9Z*_E=FN):E@XROS:K M7Y/\['V3_P %B/\ DW_PA_V,\?\ Z27-?D57ZZ_\%B/^3?\ PA_V,\?_ *27 M-?D57?DW^[OU_1&6/_B1]/U84445[QYH4444 %%%% 'T!\0O^3.?A3_V%M2_ M]&O7S_7T!\0O^3.?A3_V%M2_]&O7S_7'A?AE_BE^;-JVZ]%^04445V&)N^ _ M^1Y\._\ 81M__1JU_1%\4OAUIOQ;^'NO^#=8GNK;3-:M6M+B:Q=4F5&ZE"RL MH/'=37\[O@/_ )'GP[_V$;?_ -&K7[N_MM?\FF_%+_L"3?TKYO/OX5+UE^43 MNRO_ 'JIZ0_.9XGHW_!(_P"".CZA%=W>I>+M7MXSEK2^U*!(G]F,4$;X^C"O M2OCK^U5\+?V0_AN-(TZ[TV;5]/LQ:Z/X3TN57D!"XC$BJ3Y48QDLW4 XW-P? MPGHK>>6U*UE7K.2[6M^I<<5"F^:%-)GU1_P3]UZ]\4_MW>$-:U*;[1J.HW6I MWES-C&^62SN7=L>Y)K[S_P""IWQ>U_X8? /3+'PYJ5QI-YX@U1;*>[M)&CF% MNL;R.JNN"NXA >>02.YK\_/^";?_ ">=\/?K??\ I#<5]D?\%D/^24> /^PW M+_Z(:L,UC%8G"PMI:*M_V^S;!SERU9WUU_)GAO\ P2-\;:Y;_'[6?#:ZE<-H M=]HMQ=SV+R$Q&=)(MLH4\!L,PSW!YKO_ /@LY8QB^^%-X!B5H]2A/'50;*_Y&=!^7Z2)P?O M8:LGY_E%_F><_LK_ +07[5_BCX<#P;\,?"]EX@T#3[0Z=;:I] MO+Y=X:6"9BJ*0ZY4L7?KG!K[6\,>$Y_ G[,MIHWPMM[&+4;7PW_Q(PP7R9+H MP;HY'/1M\AW%CU+$GK7YZ? ;X7_M5_%_]H3P]J'Q$N?&=AX=T76K?4=3;7YI M;6Q802B39# 2L2>R731:?Y?,^H_^"JEK%/\ LD:C)(@9X=6LGC)_A8N5R/P8C\:C_P""7GQ. M\.^+?V8])\*V-W!%K_AV6XAO[!7VRA9)Y)4F"YR58/C=TW*P[4O_ 5869OV M2[XQYV#6+(R\_P .YOZ[:^2OV7?^"!] ^)6A?%RT\*RWL)GLI]#AG MEN;=N59'D#Q%'5@RL%)Z'DUYV"C3G@*T:TK1Y]]]>56_4[<4Y+$47#5\NWES M,]E^)7_!*76KKQA>>+O GQ>U2VUQI3<6[Z\)&N5ESG)O8G#CGOY9(]Z\!_; MM?VN_ OAB:R^)_B6_P!7\%3A;:74-#DB%A,#@!)O)CC< G _?* QZ9-=_P"& M_BU^W7\)?%2^&;KPOJ_C=86%O$^I:)]MLWYP'-["$)!'\3R\9YP:^_OB]<6] M]^S+XJN/B!96VGI+X8GDUBSCD$L4$AMR9$1S][:_"GN0*NK7K86$9S<:D%ML MW\NOYCIPAB*KA9PD]W_7_ N?,G_!(7P/9:1\!_$/B=8T.I:SK3P23 ?,(8(T M"(3[-)(?^!5SO[5W["OQ\_:(^,FH^)[?QOX:M_#]O,O]A:?1-8Q*!@A$ MMV59"06+ DDGK@ #2_X) ?$FQU7X1>*/!#SHNJZ1JAOT@Z,UM.B ,/7#QN#Z M;E]:\R_;.^&?[4GA7XX:S?\ @+7_ (C:SX,UNY^TZ,O#OP1TCPK\4=4L?%'B*"WELKV^MII)X[N$LP3>\B(SMY956+#)()).)-!UG[%]LO\ 2M2UF^$%CA2S*]REPX.U>K!, @XR.3^8>LWESJ.L7UW> MWSZI>3SR2S7TDCR-<.S$M(6?YF+$DY;DYYYKIP%-+$U9JHI-[V6E[_=WM;Y$ MUY/ZO"/*TNE_3[^U_E8?LC_ ,$D?^37;W_L8KK_ -%05^;7[:W_ M "=A\4?^PW-_2OTE_P""2/\ R:[>_P#8Q77_ **@K\VOVUO^3L/BC_V&YOZ5 M\]#_ )'$_P#!_P#('I0_Y%O_ &_^LSQ.BBBOH3S0HHHH **** "BBB@ HHHH M **** "O?_@?_P FV?'O_KAI/_H^6O *]_\ @?\ \FV?'O\ ZX:3_P"CY:Y, M5_#7K'_TI&U'XOD_R9X!111768A1110!^_7[$_\ R:;\+O\ L"0_UKQ35/\ M@DG\'M8UR\U2Y\0>-6ENKA[F2);^T";F8L0/]%SC)]<^]>U_L3_\FF_"[_L" M0_UK\)/B%_R/WB7_ +"=S_Z-:OD*5.I5Q]:-.?*[O7_MX]BG*,,!2E)75HZ? M]NG[I:;-\$OV&?A>]A'J.F^$M%C9KAHIKGSKV^F(&6"Y,DSD # & . HX_' MO]H#X]7/[2'[1TWC22"2SL9KRWMM.LY2"T%K&P$:MCC<>6;!(W.<'%>)5I>& M/^1DTG_K[A_]#%?09?@%1Q4:]27-*ZU?]?TCS<7B>;#2I0CRJS/Z!OVEOB#? M?"O]GOQUXJTQQ%J>FZ1+):2,NX),5V1MCOAF!_"OQ4_9E^*GB[3_ -J3P-KR M>(=1EU;5->L[6_NI[EY'O(I9T21)2Q.\%6/7/8]0*_7W]NS_ ),_^)7_ &"U M_P#1L=?BQ^SI_P G _#/_L9M-_\ 2J.O'R*,93J-KLOEJ>AF+:H0MY_DC]=_ M^"GUG'=?L<^*Y74%K:[L)8R1T8W4:?R:Z\&_![P_;^*H+ MFX-[<:=/I@EC21E5/,EG5D*+A%&7D"\<=:_1G_@IM_R9GXU_Z[Z?_P"EL-9G M_!+GPKHVB?LF:%JNGV\*:EK%W=SZC<*!YDDB7$D2!CUPJ(N!VR3W-XT]=Q*I;I#N553HJB48QUSDU^@7QNTF:S_9=\=:=J=V=5N8/ M"%[#<7;IM-Q(MFX:0C)QN()QGO7YU_'+PC^V3\5/CMKOAA3XNMM'DOIH[*73 M9Y+'1%LS(?+9IHRL; (02'+2=003Q7Z$_%[0)_#'[)'C#1!-]HN-.\%W5F9E MXWF.R9"W/KM)K#&2E+#4W*44ND5T5OZ_I'5@XJ./2Y6W?5OKJNG6_P#6Y\'_ M /!'WXH>'?#_ (B\;^#-2NK>QUO6_LUUIQF8*;ORA('B4GJP#A@O4C>?X37T M)^U=_P $YH?VD/'<_C"T^(NJZ)J!QD'FO7Q ML$\8ITJJC5LM'Z+KMM;0\S"R<:#BX'.V^Y=:G#V4*L M6TN:*L_7?7M;\3Z"_;N_9E^,'[3,VB:/X+\4Z'HG@VU@9[W3]2O;F![NZ+G! M<10N'15"[03P2W'0UT7[#7P'^*_[//A/6O#/Q#\3:3XBT8212:+'IUY<7#68 MPPECS-$FV,XC*JN0#OX&>?-O^"C7PX^.E_>:#XO^$&O^+A8V]JUGJFA^&-4N M(9 P3#^]@G%U(J+>J:UO?[_\ @>1UXBWU MB+Y6W;2VVVO_ ?/U1\__P#!37P/:>"_VM?$,EDBQ0ZU:VVK-&@ D=2DA^K M/&S'W8U\J5Z=^TEI'BGPS\8=<\/^,?&[_$#7='9;&;6&OY[P?*-WE"2;YOD+ M,I7H&#"O,:^FP,>3#0CS75M'Y=/P/*Q4G*M)M6?7UZ_B%?=W[!/_ 3[NOBY M<:?\0?B'9O:>!XV$UAI&8=5@SWZOV^7D\U_P3C_9!M?V@_&UWXJ\ M5VOG^!_#LJJ]J_W=0NR RPG_ &%&&<=]R#HQQ^DO[5FM?&;2? \&A? [P:NI MZQ>QM%)K!O;.WCTN( "..:5-TA['!50.YP*XLPQSH-4*7QOKVO_ %\O5E8; M#JO><_A7XGCW_!0O]LG2/@GX#OOAQX1NX9/&^J6OV21+1@!H]JRX+-M^[(4. M$7@@'=P H;\YN/$&GR22NQRS,QN M37S1J^E76@ZM>Z9?1>1>V<[VT\6X-LD1BK+D$@X(/(.*TR^E0H)QA M-2F]79_UHK_B7BJDZEKQ:BMOZ^7X%2BBBO7. **** "BBB@ HHHH **** "B MBB@#Z \1_P#)D?A/_L;9_P#T3)7S_7T!XC_Y,C\)_P#8VS_^B9*^?ZX\-M/_ M !/\S:KNO1!111788C[?_7Q_[P_G7]'WCKP/8_$SXQK^<&W_P!?'_O#^=?T#_M5?\FJ_%'_ +%6_P#_ M $F>O!SS^!1]9?E$]++_ .*_0\!TO_@D7\$]+OHKFYU;QAJ<$9#-:WFHVZQ. M,]&,=NC8^C"O5/BS^T=\(_V,_AC#HUK=:?%/IEKY&D^$],F5[F0@'8&4$E%) MR6E?KRE?HG_P4V^+VN_"7]F_/AS4)]*U/7=4A MTO[;:R-'-%$4DE?8PY4D1;<@@X8XK\TO^"??_)XGPT_Z_)__ $EFK[P_X+$? M\F_^$/\ L9X__22YKFS"G#ZQ0IVTT5O*Z-,)4E^^J/>WXV>I\O\ _!*?QUKN MG_M.+H4>IW)TC6-.NWO+-Y6,8>[F&':[+_P!*DOR(RZ3E2Q"?=_\ I$7^>IXA^R#^T/\ M27O@B/P M7\*O"EAXHT#2XGMH+B[TU(8;(D[B/M'F11F3+[L.68YR0:])^!/_ 3C^.&B M?/B'XJ\>V&C7]O?17]Y-;WL]Y?W.'5GBD.%4AP"I^=A@]"*^U?@5X53P9 M^RCX6T_X?PV*7I\,17.G-(!Y$]Y);B02R%>N^5MS'ODU^>_PM^&O[7'QD^/F MBCQY/XSL=$TW6+>[U:36)Y+33/+AE#L(HE*Q2[MF!Y2L"2"2!S1[=SQ554N6 M%MV]WJ_Z?RW)5-+"0E*\D]HKIHK?\#YV/L7_ (*=0I+^QKXQ9U#-'Z'T/ MVR(9_(G\ZXW_ ()1_%'P]X@_9XB\%V]U##XDT&\N7NK%G EDBED,B3A>I7Y] MA/8I[C/8?\%/!(?V-_%VS[HNM/+\_P /VN+^N*^)/V4?^"=?B3XP>"=#^).C M?%:S\*?:&=K672+>>:\M9$9D968/%L<$'[I/!R"0:\_!1IRP%9579<^_GRQ. MK%.2Q%)PU=MOG(^@/C%_P2OU+Q1X\U'QIX.^+.J66MSSM=PKKB/--'*6+#;= MQN'51G ^0D =37@'[6>E_MA?#GP7-9_$+Q3?ZYX&:);.XU+0)8_LLB,-FRX, M<<VMLY@@FO=%.HVDZYPLAO( M@'P1@_O)01GY@#7Z'ZQ?/JG[/]]=_$S3K+27G\.R2^(; 2"2WMR;JPPPI( /3+3DGUP/2IOVQ/V(/CK^TI\7;S6['QIX M;MO"-KY:Z+I=[J%W$;550;G,:6[*)&?>=P)."HS@ #*_X(Y_$?3YO!?C?P') M,D>J6^H+K,,3$!I89(TB^(6J^ M"]9,4EK:^%]4O76QDV!9(C!"^47^!/@SIGACXH:U8^*/$-F98&U"UN);A M9[6=NO]V-)G M5!^"@5^A_AS]BG]I?5?AO8Z[JO[1_BCPWXAFMVN+G0[_ %B^,=IR2%>X2X/. MW!;"84DCG&3^9GBJ[O+[Q-JMQJ&KMX@OI+J5I]6::28WC[CF;?( [;C\V6 ) MSSS6^!@EBJDU43?5):7OOV[_ *$UI?[+&/*TKJS?;73\ON,NBBOU1_8[_8F^ M 'QT_9YT#Q3=:+=ZIKUQ!):ZC)+JLZ?9[Q"5?"1.H Z.H.?E91Y]*#JU%33LV<1^R?_ ,%+_"?PG\&^!/AIK'@^]M=$L(5M;KQ&E\KE M)7D9FD-OY8_=AG))#EL#[I/%>D_\%)/V,](\6>"=;^,/AJ>]'B33(1=:E!/= MR7$-W:#[S()&/E&-3N"IA=H;Y-M*^$_[(OC2*_N%WWNDMH5E&^W?/-- M'Y2@*>I"EG/LC'M7SV.E2A4IXG"R]^3;WO>[6Z\WI_P4>I@XSUPU5>Y%)>EO M/TUO^C/P>HHHKZL\<**** "BBB@ HHHH *]__9T_Y(_\=?\ L!0_^AR5X!7O M_P"SI_R1_P".O_8"A_\ 0Y*X\7_"^:_-&U'X_O\ R/ ****[#$**** /WJ_8 M,_Y,_P#AG_V#6_\ 1TE<#_P3I\=6GQ+^!/BKP]<,MU#I'B#4K$QO_';3R-,I M(/.#YL@Y_NUWO[![!?V/?AH2< :8Y)_[;25\2_\ !)/X@_V9\;_B#X1=_P!Q MK5E]OARW'F6\Q& /4I.Q_P" 5\?6HJO7QL7TN_\ R9M_@F>MA9^SP&%FG_)^ M,6OS:/H[_@F[\ 9O@?H'Q0EU"!HKN;Q-<:7#-(,&2TLRR(_T9GD/Y5N?L ^/ MQ\4+7XT>)A/Y\>H>/;R6!N_D""!8?_(:J/PKUW]I;QQ%\)_V?/B#XE@,=K/: M:5'[<%Y\7=,^"$DOP8CN&U]+M!>+I\*RW@L M]C[OLZ$'+[O+^Z"V,[>:]"=:-/"86#BFVHV;V6BU_P _3JIYI^P9^Q7X^_9=US6=2\3^,[&]L-1M# ?#^DM-+;"7>C+.7D"8<*KK M@)T?[W%?.O\ P63M8D^)/P[N @$TFDW",_=\WZ;:RDY/,Z'/-2>M[?X9:>??\.AI3Y?J=;D32\^ MOO1/T(_9KNTT_P#9>^&5U)_JX?"6G2-]!:1D_P J_%/XI?M??%CXH^(O$=W> M>._$%KI&L--$VAVVHRQ6*6SY A\E2$*[#M)(R>22237[*?!V1H?V+_!TB,5= M? EJRL.Q%@O-?@)75A(0J9ABN97L_P Y2O\ DC*M*4,)1Y7:_P"B7^9^R/\ MP21_Y-=O?^QBNO\ T5!7T9\,?@'X:^&/C/QMXNLHC=>)?%FH/>WVH3*-R1D_ M)!'_ '44,I5:V/J4Z.[C]Z2CI\W8,-. M%/!*I4^%2?W\TM?DKO\ X-CX^_X*(_&_QW\2/CUKGACQ1 ^B:1X9NWMM.T1) M-T87 VW+' WO(A5@<<*P4=R?M_\ X)(^!;+0?V==2\2)&AU'7M7F\V8#YO*A M CC0GT#>8W_ S7,?\%7OV:?^$L\'VGQ9T*UW:KH48M=82)26FLRWR2G'>)F. M3_=+$ M\<^&8-(ANB=!LYM3O8FL(%(\O"I;%4D. S%2@KZM_P""KWQ$ M\5_#GX9^"+KPGXGUGPQ^_; M?\#W=[>/>W5Q/J$DMW,[.\TC65P2[,W)+$YR>23S7W5_P54^%?B_XH_"_P % M0>$/#FI>);FUUIC/;Z7;//)&KPLHKM&[[^^[G M/AI)JLXJRUM]S.0_X) ^&4U#PC\1O'VH32:AX@U35UL9KVZ)=-U/[>;*5E\PD 6\ZC! MY\MXD!Q_?%8O[>7PW_:7T'XR7WB/X;Z_\0=3\&ZPL+PV/A?5+QA83",(\9MX M7RJDKOW!=OSD9S48AR_M*\9):+E;VV6WX_BMV+#_ .Z233O=W77?_AOEY'VI M^R[X#^(7PY^#MAX8^)^N6/B?7K*22*/4+.XEN1+:G!C61Y8T9F7++R#P%Y-? M!_[$/PPUW5OVB_%?ACQ'<0M--H-_J]\R6O)VB2X2Y/.W!.$^4DCG%>(_\ !.OX MJ'PA^VA?VWB7Q&=>N/$D%UHYUR2Y>9;VY$B/'+YLF&82&$A2W)\Q>.:NA3?M M:\HU$VXR323WM]W?UN9U)*.'IQY6H\T7=]KZ_P!=$CW/_@KM\;/$?A>U\(> M=$U.XTS3M6MY[[5/LLC1OVO-,M1NN)('*LKQKU?$CQKH-[X7M+6RELM/L=4A:"ZGED(#.8FPR*J!A\P&2XQP#48&=".75(S M:O[U_77E_2W_ "\=&K+$4W3VO&WIIS?J:'_ 6<_P"0/\*?^N^I?^@VU?E_ M7Z@?\%G/^0/\*?\ KOJ7_H-M7Y?UWY/_ +HO5_F/,OCA_A_5A1117MGD!111 M0 4444 %%%% !1110 5[_P#LR_\ )//CA_V*LG_LU> 5[_\ LR_\D\^.'_8J MR?\ LU5FG^Z3^7YH[,)_&1^J=%%%?"'T(4 M444 %%%% 'XZ_P#!5G_DL6B_]<;K_P!'5\0U]O?\%6?^2Q:+_P!<;K_T=7Q# M7WV7?[K#^NI\YBOXT@HHHKTCE.U^"OQ(_P"%/_%?PMXU_L[^UO[#OH[W[#Y_ MD^=M/W=^UMN?7:?I7U#^U1_P4D_X:8^$-YX'_P"%=_\ ".?:+J"Y^W_VW]JV M^6V[;Y?V=,Y]=W%?%-%Z?YI%TZDJ3DX.W,K/TU_S844 M45TD'T%^QO\ M8?\,E^+]>US_A%O^$J_M2Q6R^S_ -H_8_*Q('W;O*DSTQC M^M5OVQ/VI?\ AK'Q_I'B;_A&/^$6_L_3%T[[+]O^V>9B623?N\J/'^LQC!Z= M>:\&HKGEAZ\MG]_P#F:0J3IPG3B]);_A_D@K[#_9\_X*<_$OX+:+:: M!K5K:^//#]HOEV\>HRM#>0H!A46X ;*C_;1SV! %?'E%74IPK1Y*BNB(R<) M:1-%X?\ A?8:5J3+B.ZU#6'O(D/J8UAB)_[[%?!WQ0^* MOBGXS>,;OQ1XPU>;6=9N<*9I(JU%RR>A]V?L(_!7]H'PUX=@^+'PEU+PU>:3J32VEYX=U2\D7[6( MG9=LJ; JL#EE82 @-Z,RGV?XS?\ !3GXD_"36+SP?K/P/C\.>,EC @DO-::\ MMG9@-LB)'"OFKST63KD9!!%?)/['7[='B+]E.2^TE],7Q-X.U"87$VEM-Y,L M$V IEADP0"0!E2"#M'*\D_;]O_P6$^$+0J9_"WC:.;'S+'9V;J#[$W0S^5>5 MC:-6=?FE24X].C_#_@G3AJD8P:YN67WK^K'OW['.I>-]:^ .BZW\1Q>1>+=5 MGN[^[2_B\F2-'G!L41A,+@8&*_&N/XQ0> _VM]0^)=K8KK=M9>++O5X MK59_)%PAN9'4!]K;001S@U]4_M)?\%8KGQYX2U'PS\,_#UYX=BU"$P3ZYJLJ M"[2-@0ZQ11EE1B./,+L1DX .&'YX5>7X:I&M.O./(GHEY?\ LDAXJ=.=!4; M\S>[_KO?Y'V-^UU_P4._X:H^%]KX/_X0#_A&/(U.+4?MO]L_:]VR.1-FS[/' MU\S.=W;IS7Q[;W$MG<13P2O#/$P>.2-BK(P.001T(/>HZ*]>A0IX97X9 MTO8N/NWO:[WV[E?6:OM%5OJE;IM>_P"9>T'5/[#US3M1\KSOL=S'<>7NV[]C M!L9P<9QUQ7V_^T3_ ,%0O^%^?!KQ)X"_X5I_87]L1Q)_:']O?:/)V3)+GR_L MR;L[,?>'7/M7PE1716P]/$'FZE-V;M^%[?FSU7]F+XZ M?\,X_&+2?'?]B?\ "0_8(IX_[/\ M?V7?YD31Y\S8^,;L_=.<5ZW^V1^WA_P MUMX3\/Z+_P (/_PBO]DWK7GG_P!K?;/-W1E-NWR(]O7./:!_R' MM-_Z^8__ $(5[#^VO_RV*^9***SHT:>'A[.FK(UJ59U7S3=V%?7?['O[?\ _P ,G_#_ M %;PQ_P@?_"4_;]3;4?M7]L?8]F8HX]FWR),_P"KSG(Z].*^1**JI3C6@ZC4Q1 MH&![L''M7Y^T5QRR_"SESN&O]=-C>.)JP7*I%W7-2M M/%+J3SKC0KYV50^ #)# M(,F)R >&4]U)P1\[T5V2IPE#V;7N]CGYFY<[>O<_1?QA_P64\1:EH<]OX:^ M&UAH6JR+M2^O]6:^2/\ VA$(8LGTRV/4'I67'_P5JU*Z^$K^$=8^'KZOJUQI M#Z;=Z[)KP1KB5XBCSF(6N!DDML#8'3-?GY17 \LPCBX.&C\W_F=<<97C)34M M5Z&YX'\;ZW\-_%VE^)O#FH2:7K>F3"XM;J+&48<<@\$$$@J<@@D$$&OT"\,_ M\%F-;L]%@AU_X86.JZJJXEO+#67LXG/J(FAE*_\ ?9_"OSAHKKK8>EB$E5C> MQSTZDJ3O!V/O>S_X*Z>.'^)L>NZGX4LY_"MO;30P>&K"^:W+2.5VS37#1R&1 ME 8 !%7Y\XR,UXC^V5^UW_PUQX@\-ZG_ ,(G_P (I_8]K+;>5_:7VSSM[AMV M?*CVXQTP:^=J*PA@,-3G&I&%G';?S7SW>YJ\35DI1AZD&:W=N 9$((,O\ [1W[ M4WCG]J#Q';:EXMN;>&TL@RV.DZ>ACM;4-C<5!)+,<#+,2>,# P*WOV2_VP_$ MW[)OB#4Y]+T^VU[0]6""_P!)NI&BWLF[8\<@!\MQN(SM8$'D< CP*BM8T*<: M;HQC[KZ?U_5R9U)U)*Y_LY_ME?$G] MF266#PQJ$-]H,[^9-H6K(TUHS=W0!E:-O=&&>-P; KPRBNB48SBXR5TS%:-- M'Z76_P#P6@N%MU6?X11R3X^9X_$912?4*;4D?G7@7[17_!2+XF_'K1;SP[:Q MVO@OPO= QW%EI3,UQ*5&#*P/J" :_07P/_ ,%D/$NC^'K: MT\4_#NQ\1ZM$NU]1LM4:P67'1FB,,H#>N"!GH!TK\[**Z:V'I8B*C55TC"G. M5.7-!V9]T7G_ 5G^(6H?%K1O$4NA6MOX.TXR[O"EE=&,W>^)D!FN2C%BK,& M&$"\?=S\U>9?MF?ME6'[7,?AF8^ V\*:GHAF070UC[8LT,FTE"GD1X(9 0FAJ\15?,F_BW/T"^&?_ 5@_P"%<_"7 MPWX)_P"%6_VA_8^DPZ7]N_X2'RO.\N(1^9L^RMMSC.W<<>M?G[116U/#TZ4Y MU(*SEO\ C_FS.52O@KP]XAU+PGKEAK.CWLVFZK83+<6UW;MMDBD4Y5@?7 M-9]%%+#TJ,Y5*:LY;[^?^;%*^T@9Z =*S+3_ (*]^,F^)7]MW_@ZTF\* MQ6DD$'ANSU P,969")Y;AHG+E0K*%"(/GSC(S7P#17/_ &?A>9RY-_ZVV_R- MEB:JCR\Q]!_MD?M9?\-:^+- UO\ X17_ (17^RK)K/R/[1^V>;F0ONW>5'MZ MXQ@_6O=_@S_P54_X5'\(?#7@;_A5_P#:W]C6"V/V_P#X2#R?.P#\WE_96V]> MFX_6O@6BJ>!P\J*P[C[E[VN_/SOU8OK%1U?;7]ZUK^6G^2+46I7%KJB:A:32 M6=W',)X9H7*O$X;E??'PM_P""O_C'PKX9@TWQEX,L_&E_ H1= M4@U Z?+*H &95$4BL_7YE"CV[G\_:*VJX>E7CR5(W1G&I.,W43U9]_:A_P % M>O&=_P#$71]6'@ZTM/"5B)&E\/VVH%9KQVC9%,MT8C\J$[@JQC)'.>,>.?MG M?MI?\-=KX4'_ AW_")_V";G_F*?;?/\[R_^F,>W'E^^<]L5\R45C# X>G*, MXPLX[;^?W[]37ZS6::-/@/X,M/"6M:!;>.-"T^,1:?YMV;2 MZMHQTB\T(X= /N@KD=,X WOC3_P5H\?_$#07TGP9X?MOA\LPVSWZ7AOKS'I M$YCC6/(R"=I;G@J>:^%**<\'AZE3VTH>]O\ \.MF3"O4IQY(O0^Z_CY_P4XM M/C]\&=<\!:K\+/L9U*"-5U&/Q#O\B=&5TE$?V49 =0=NX9&1GO7S]^RQ^U5X MF_94\:7>M:%:VVJZ?J,2P:CI5V65+A%;*E7'*.N6PV"!N.0:\5HJJ>%HT8RA M".DMT3.K.IR\SVV/T#^+O_!6BZ^)WPS\2>$K?X76^EG6]/FT^2[N-;-RL:2H M49A&+=,D G'S=?6OEO\ 9S_:H\>?LQ>()[_PC>Q26-WC[;H]^IDM+K' +*"" MK#LRD'L!PU*?/"&OS+EB:LH\KEH%%%%=YS!1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 5H>'?^1@TS_KZB_\ 0Q6?6AX=_P"1@TS_ *^HO_0Q2ELQK<]?_;6_Y.:\ M9?\ ;G_Z105XA7M_[:W_ "&_A_\ M$ZIJ7BGQ!I7AK3G\/7$"WFKWL5K"TAGMR$#R, 6 M(5CC.>#Z5Z=_P5I^*'@SXD)\,_\ A$O%NA>*/LAU#[1_8NI0WGD[OL^W?Y;- MMSM;&>N#Z5^>%%<-7"1JXB&(;UC_ ,'_ #.JEB'2IRII?%_D@HHHKN.4_4[_ M ()V_MS>!-$^%.E_#3QYK5OX6U313)'8:AJ#".TNK=G:0 R_=C="Q7Y\ @+@ MDD@>B>./$7[%OPK\37OQ2>3P;K?BHRFZ2/0;U=3EEN<[@\=K'(T4MVC_$'PGX8U3Q3X=N8!I6KZ]:17%G/)$RA)%=P05;'.!ZBOC'_@D_\ M$;PG\-?'7Q!E\6^*=$\,0W&GVT<$NL:C#:I,RRN2$:1@&('IFO@RBBGET*2J M1C+2?X;_ .85,1*K&"DM8N]^^W^1]E_\%3_'GAGXA?'O0-0\*^(M)\2V$?AZ M&![K1[Z*[B607$Y*%XV(#88'&HZ]B0>?B#X5^(/A+\ M.O\ @I:-0\)Z_H&C?#:VM9([>_\ MJ0V$3?V>$91-(P4YDW?-D[B>IS7P-17 M#0R^.'E-PF[24E;U5K^J-JF)=:"C-*ZMKZ._XGZ:?\%7OBYX&^(WPS\$6OA/ MQIX>\3W-OJ\DLT.C:K!=O$AA(#,L;L0,\9->!_\ !,+QOX=\ ?M)7&I^)]?T MOPWIIT&ZA%YJ]Y':PF0R0D)OD8#<0#@9SP:^1Z*TP^!C0HSHJ5U*_P"*L16K MNM.,VMK?@[GZ'_\ !6GXH>#/B0GPS_X1+Q;H7BC[(=0^T?V+J4-YY.[[/MW^ M6S;<[6QGK@^E=-^P;_P44\+^&? >E_#?XHWKZ0=+06NEZ])&SV[P9PD,VT$H M4!P'(V[1\Q4C+?F511# 4HX;ZK+5;^>__!*J8FEZW\-[+Q&K&=;FWUZ%A$YZO';"8HC^Z1ALGWKX\_X*%?MZ:1\=-)B^'WP M]EFF\)1SK<:CJTL31?V@Z /A[\ ?$&G>*O''AOPSJ$OB2>>.U MUC5[>TE>,VULH<)(X)4E6&<8RI]*^&OVT/$&E^*OVI/B+JVBZE::OI=UJ.^W MOK"=9X)E\M!E'4E6&0>0>U>*T5U?5(_7'B[ZM6M_X#_\B8^W?L/86TO?\_\ M,****[SF"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]_P#BE_R: M+\%/^OK5_P#TJ>O *]_^*7_)HOP4_P"OK5__ $J>O *X\+\$O\4O_2F;5OB7 MHOR04445V&)T_P +;R#3_B;X1NKJ>.VM8-8LY99IG")&BS(69F/ ))-?L1 M^VG^T!\+_%7[+?Q#TG1?B1X1UC5+K3PEO8V&NVL\\S>8APB)(68X!X [5^*% M%>?C,''&**D[WX7_S"BBBO0.8^KO^"9OC3P_X#_:; MAU3Q-KNF>'=,&CW<1O=6O([6'>VS:N^1@N3@X&>U>P_\%:?BAX,^)"?#/_A$ MO%NA>*/LAU#[1_8NI0WGD[OL^W?Y;-MSM;&>N#Z5^>%%<%7"1JXB&(;UC_P? M\SHHUG1A."7Q?Y)?H:WA'Q5J?@;Q3I/B+1K@VFK:7=1WEK,.=DB,&4X[C(Y' M<5^Q?PR_;H^!/[3WPY?0/B+O;F%4U/0O%#+':.PP=\4[X0C=RO*N",X M& :_%ZBKQ6%IXN*C/IL^Q%&K*C/G@?MKX5^)W[)7[(_AG5+SP=XC\*6,=T0U MQ'H.I_VO?7)&=J96263;DG )"+DGC)-?EU^U]^TU?_M2?%B;Q&]O)IVAV<7V M/2-/D;+0P!B=SX./,$;SP#I?@+XLZDNC:MI\"V-MK5ZI>TOH -J"9\'8X7Y2S_ "L! MDMDXKV#PG%^QM\(O%ESX]\/:Y\.M+UT*[BXLM=BG:'((;R+<2L(R02,1(#@D M=\5^)=%16RZ%2I*I"3BY;VZBIXATX*G)72VN?:__ 4*_;CT_P#:*FL?!G@@ MS'P1ILXNYK^:-HGU&X *J0C898U#' 8 DG) P*^O/^"?OQX^&G@S]DOP1H_B M#XB>%-"U:W-[YUAJ6MVUO/%NO9V7=&[AAE2",CD$&OQLHK1Y?2^J_58NRNG? MK=)K]1O%3E556730^@_@OXGT?2_VY-$UZ]U:QL]#C\82W3ZG<7*);+"9W(D, MI.T)@@[LXYK[8_X*B_&CX??$#]G33=-\+^.O#7B345\0VTS6>D:O;W4PC$,X M+E(W)V@LHSC'(]:_*2BB6!C)45S?P[?.UO\ (5/$NG5JU4OC37I?F_\ DC]3 M_P#@E?\ &3P!\/?@#X@T[Q5XX\-^&=0E\23SQVNL:O;VDKQFVME#A)'!*DJP MSC&5/I7Q)^W%XBTGQ;^U9\0M7T/5+/6=*NKN%H+[3[A)X)0+>($I(A*L,@C@ M]0:\+HK7ZJOK;Q=]6K6^[_(CVS]@J-M+W_/_ #/UX_X)M_'#X<^!?V6])TGQ M)X_\+^'M434;QVL=5UFVMIU5I 44J>$C3Q,L2GJUM]W^0.LWA7A; M:7O?[_\ ,_8K_@H?\=?AMXV_9-\7:/X=^(7A77M6GFL3%8:9K=M"=;V+J%O;\RVTBY"7$:DX) ) M#+QN&.(/V//V MG/[,\2>+/$/@?5+R%%\FXU+6!I=X$!)"2J9(I&4$GY) 1R>.:Y3]I#_@H=\, M?@K\.9O#'PHU'3?$'B2.U%EIL.BH&T[34V[555Y"R6\$N9\ 8"NC\<8[5^)E%=.(R^%:JJT9.,O+[ORT,:6(E3BX25T^_W M_GJ?NI\#_P!N;X+?$+0=4%KXBT/P'I>D7ITW3[+7M0MM.>XMTC0I-%"S+MC) M+*!V"UO;GQ/H?\ PBUKXBOIX]>CU&$V!MY(IFB; MSPWE@8=1UX;CKQ7R;12HY?"A5=2+>JM^6OX?B%3$RJTO9-=;_GI^)^HW_!5; MXP^ OB)\#_"UAX4\;^'/$U]#XBCGEM='U:WNY4C%M<*798W)"Y91D\9(]:_+ MFBBNC"8582#A%WUN16K.M)2:"BBBNTYPHHHH **** /H#XA?\F<_"G_L+:E_ MZ->OG^OH#XA?\F<_"G_L+:E_Z->OG^N/"_#+_%+\V;5MUZ+\@HHHKL,2]H.J M?V'KFG:CY7G?8[F.X\O=MW[S@XSCKBON_XV_\%6/^%Q?"?Q3X)_X5=_9' M]N63V?V[_A(//\G=CYMGV5=W3IN'UKX"HKFQ&&I8J*C65TK]^N^WH:4JDJ$W M.F[-V_"]OS84445TF9Z9^S;\:/\ AGOXS^'O'W]C_P!O_P!D^?\ \2_[5]F\ MWS()(O\ 6;'VX\S/W3G&.^:]D_;(_;P_X:V\)^']%_X0?_A%?[)O6O//_M;[ M9YNZ,IMV^1'MZYSD_2OD^BN>MAZ5><:E17<=OD[_ )FL*LZ::B]]SVG]DK]H M_P#X9;^*DGC/_A'O^$FWZ=-8?8OMOV3'F,C;]_ER=-G3;WZUV7[9W[:7_#7: M^%!_PAW_ B?]@FY_P"8I]M\_P [R_\ IC'MQY?OG/;%?,E%*6'I3JQK27O+ M9_?_ )A"K.G&4(O1[GV;^S5_P4Z\:? ?P9:>$M:T"V\<:%I\8BT_S;LVEU;1 MCI%YH1PZ ?=!7(Z9P !O?&G_ (*T>/\ X@:"^D^#/#]M\/EF&V>_2\-]>8]( MG,<:QY&03M+<\%3S7PI16<\'AZE3VTH>]O\ \.MF5"O4IQY(O0^Z_CY_P4XM M/C]\&=<\!:K\+/L9U*"-5U&/Q#O\B=&5TE$?V49 =0=NX9&1GO7AG[-'[9WQ M"_9>GGM_#MQ;ZIX>NI!)<:'JBL]N7XS)&5(:-R!C*G!XW!L#'@]%53PE&E&4 M(1TENMU^),JTY\O,_AV/TPC_ ."T,JP@2?"!&EQRR^)"JY^GV0_SKYG_ &H/ MV^?B#^TUIIT&[BM?#/A'S1*='TTLQN"IRAGE;F3:>0 %7."5) (^9Z*RAE^% MIR4XPU7J:O%5FN7F.N^%?Q8\4_!7QI9^*O!^JRZ1K%KE1(@#)+&?O1R(>'0X M&5/H#P0"/O+PW_P6:UJUTF&+7OA;8ZGJ2KB6YT_6GM(G/J(VAE*_]]FOS?HK M>MAJ.(M[6-[&-.I.D[P=CZS_ &FO^"COQ _:'T&Y\,VEC;>"_"=T +FQL9FF MN+I>NR6 5[_\#_\ DVSX]_\ 7#2?_1\MFX_6OA+Q#JW]O:_J>I^5Y'VVZEN?*W;MF]RVW. M!G&>N*SZ*YH8:E3J2K17O2WW]37VL_9JC?W5;\-$%6=+O?[-U*TN]GF?9YDE MV9QNVL#C/;I5:BNN,G%J2W1A**DG%[,^]?CM_P %3O\ A=?P?\2^!?\ A6/] MC?VS:BV^W_V_Y_D_,K;O+^RKN^[TW#K7Q7\.?%W_ @'Q \,^)_LGV_^Q=3M MM1^R^9Y?G>3*LFS=@[<[<9P<9Z&N>HKDP^&I85MT5:_]=3>I5G6BHS=TC[A_ M:;_X*9?\-&?!G6_ /_"M_P#A'O[2DMW_ +0_MW[3Y?E3I+CR_LR9SLQ]X8SG MGI7EG[*/[3&XGT6\ ?^"M&JZ+\,;;PMXR\ -XYU M P36]]K$VNBV-XLC/]Z/[,X7Y6"\-CCH.@^ **Q_LW".#@X:/U_/?Y&GUJMS M*2EJCT3X/_'CQ7\ ?'I\4> [^3292Q1K.X83PSP;LB*8842#&.0%.>1M-?<& MA?\ !9S5;?384UGX56=_?A0)9['7'M8F;N5C:"0J/8N?K7YMT5T5L+1Q%O:1 MO;[_ +]S*%6=-MP=K_UL?;WQT_X*L_$+XH>';O0O"NB6G@"QO(FAN+JWN6N[ MXJ1AA',518P02,A-P[,*^*M-U.\T;4K74+"ZFLK^UE6>"ZMY#')%(I!5U8EAOX4;?UW"I6G6^-W/O[X6_P#!7[QOX6T&&P\9^#[#QK=0 MJ$74K>].G32 #K*!'(C-[JJ#V[U6^+W_ 5T\=>-?#LVE^#/"UGX$EN$:.74 M6O3?W* ]XB8XU0]>2K'GC!YKX*HKFEE^%E+F<%^GW;&D<36@K*1)<7$MY<2S MSRO//*Q>261BS.Q.223R23WJ.BBO0VT1S7OJS[:_9=_X*1VO[,_P?T[P/;_# M!=;EMYY[FXU,:[]F-S))(6#&/[,^,+L3[Q^X.G2O6O\ A]%_U1W_ ,N?_P"X MZ_,NBN&K@,/6FZDXW;\W_F=$,14IQY8.R^1^FG_#Z+_JCO\ Y<__ -QU^@4445VG.%%%% !1110 4444 %%%% !1110!] >(_^3(_"?_8V MS_\ HF2OG^OH#Q'_ ,F1^$_^QMG_ /1,E?/]<>&VG_B?YFU7=>B"BBBNPQ'1 MMYA3Q,8QJJZ5[?.U]O1&E.I.D^:#LPHHHK/VQ/V_O M^&LOA_I'AC_A!/\ A%O[/U1=2^U?VQ]L\S$4D>S;Y$>/]9G.3TZ.O'7AN;2?!GAFU\ R7"&.;4OMQOKI5/_/%C'&L9ZC<58C/&#S7P;16=3!8 M>K4]I.%V73Q%6E'E@[(^\?BS_P %1(/C)\$]9^'^O?"W(/NSJ M%*SB,VO:15?;N[8SWKY[_9M_:^^('[+NH71\+7=O>:->.'N]$U-&DM96 QY@ M 8,CXXW*1G W!@ *\2HJJ>%HTU*,8Z2W73[B95JDE&+?P[?\.?I?;_\ !:"= M;=1-\(8Y)L9L%@",A55!Z@X&/EJBL8Y?A824U#5>IK]:K6MS'3?#CXE>)?A)X MPL/%'A/59M&UNR;,5Q#@Y!ZHRG(92."K @U]Z^%?^"R^O6.D0P^(OAC8:QJ2 MC$EUIVKO91O[^6T,I'_?7Y5^SG:XNKI#]Z-YR%Q&>,JJ*3R"2"17R!113HX> MEAURTHV*J59U7>;N%>Q?LX?M6>._V7]>N+[PG=PSZ?>%?MVCZ@ADM;G (#$ MAE<9X92#V.1Q7CM%;2BI)QDKIF76Y^E;?\%G[O[%M'PDA%WMQYI\0GR]V.NS M[-G'MN_&OB_]HK]J+QU^TYXEAU3Q?>Q):V@*V.DV*&.TM <;BBDDEFP,LQ)/ M3( 'DE%<=+ X>C/GA#7^NYTRQ-64>5RT"BBBNXY@HHHH **** "BBB@ KW_ M /9T_P"2/_'7_L!0_P#H 5[_^SI_R1_XZ_P#8"A_]#DKCQ?\ "^:_-&U' MX_O_ "/ ****[#$**** /O+X%_\ !4K_ (4M\&O#G@+_ (5E_;/]CVC6O]H? MV_Y'FY=FW>7]F;;][IN/2OEK]GSXWW7P"^-6B?$&UTXZH=/EF:33OM/D"XCD MC=&0R;6QP^<[3R!Q7F5%<\_G>_^;+YY>RC1O[L;6^6WF?:_P"U M-_P4KNOVDOA%>>!;?P$/"T5[,N$.$]?T3_A!_\ A*O[5OEO//\ [6^Q^5B,)MV^1)NZ9SD?2OD^BLHX M*A"G*C&/NRU>K\O\D:3KU*DXSD]8[?C_ )L]2^.GQVO/B_\ 'O6/BAIUC)X5 MU"\NK:[M[>&[\][22&*-%99=B9.8@P.T8S[9KZ^\ _\ !8SQ1H?ARVL_%GP_ MLO$^JPH$?4K/4SI_G8XW-'Y,@W'OM(&>@'2OSOHJI82C.E&C*/NQV\OGN2JT MU-U$]7N?=&J_\%9OB%JOQ6T'Q!_8=K8^#]+DD>3PK9790WV^)D'GW)1B=I;< M-J!<@94D CSG]LO]M*P_:ZT_PT&\ MX5U31)9O+O1K/VP20R!=T93R(\?,B$ M-GC!&.>/EVBHC@)JN]WON??GA'_@JO_P (K\%=(^'_ M /PJ_P"U?V?H,6B?VC_PD&SS-EN(?-\O[*<9QNV[CZ9[U\!T45M3P]*G4G5@ MO>GOY[O]69RJSE"--O2.WX?Y'V1^R1_P41_X99^%\_@[_A7_ /PD_F:C+?\ MVW^VOLF-ZHNS9]GDZ;.N[OTKYM^-?Q*_X7!\6/%'C7^SO[(_MN^>\^P^?YWD M;L?+OVKN^NT?2N)HH6'IQK/$)>^U:_EI\NB$JDU2]BG[M[_/7_-GZ">#?^"M M%WIWPMT_PAXO^&4?C.:/3_[-O]0FUSR!J$>TH3)$;9^63AOF.3D\9P/CCX=_ M&;7_ (+_ !*/C#X>W=QXBV\OGN?I%X?_P""S>KVNEP1ZY\+++4=25<2 MW%AK;VD3MZK&T$I4>V\UX3^T]_P44\?_ +1NB3^&X;.V\'>$9R//TZPE:6:Z M P=LTY W+D9VJJ@]]U?*=%81R_"QESJ&O]=-C7ZU6MR\QT/P\\?:S\+O'&B^ M+/#]P+76=(N5NK:1EW+N'56'=6&5([@D5^@NG?\ !9W48M+ACO\ X46MSJ0C M EN+?7FAA9\C7GQY\46 M_P <-5^*?AVZ/A?Q'>:G/J:&P;*0M*Y9H\-D.AW$%6!!'45]I^$?^"RWB'3] M'AA\2_#33]:U)1A[O3M6>QC?T/EM%+@^OS8]ATK\YJ*FIA*%6$:O&?@_PO;Z7XR\'VGCB\MU$<>J1:@=/GD4# MK*/*D5V_VE"Y[@G)*:M_P5Z\::E\0M"U2+PA:6'A+3WDDN= M[\^??LT3HHD MNC$<*K,KA5B&2O)/;X#HK!X##.;FX*[_ *VV+CB*L8\BEH?4'[9W[;7_ UW M9^%(/^$,_P"$3_L&2Y?=_:GVWS_.$8Q_J8]N/+]\Y[8KY?HHKHHT:>'AR4U9 M$5*TZS3F[VT"BBBMS(**** "BBB@ HHHH **** "O?\ ]F7_ ))Y\(U]N_\$B?^3G-6_P"Q9NO_ $HMJRK2<:4Y M+=)O[DRHZSBGU:_,]7_X5U/_!6 MGXH>,OANGPS_ .$2\6Z[X7^UG4/M']BZE-9^=M^S[=_ELN[&YL9Z9/K7Y^:- M^UM\:]"U2WO[;XK^,)9X'#HEYK5Q=0DC^]%*S(X]F4BO PLL=BJ2JJK:]^BZ M.W8]3$1H8>2BX7TONSUG]IC_ ()P_$']GGPW<^*+>^L_&7A:UP;J\L(GBN+5 M3_RTEA.<)G'S*S8ZG YKPKX#_"S_ (79\7O#'@;^T_[&_MJZ^S?;_L_G^3\C M-N\O'H)=3LV3$9\^W!E7:>BG< M>#V-?@[\%_!GB7QE\;=!\-^!M;_L#Q)=WSP:;JOVN6V\AP&(;S8@77Y01E1W MKIP.*K5)U:%=^]#K]Z_0PQ5&"H1Q%+1/]5=?\$]\_:^_X)\?\,I_#?3_ !9_ MPGW_ E'VO4X].^Q_P!C?8]NZ.1]^_SY,X\O&,=^O%?'U?8/[7W[./Q^^$7P MWT_6/BG\4/\ A-?#\VIQVT-A_P )!J%_LN#'(RR>7<1JHPJN-P.?FQW->&_L M^_LX^-/VEO&3>'_!UE&Y@02WNH7CF.ULXR^UM$9XF*BXJ,'&Z^_5_P##'F%%?I'??\$8]5CT:26S^*MG/JHCREK- MH;QP,^/NF43LP&>_EGZ5Y'X1_P""5/QH\5+JPEN?#6@S:=?/9-#JMW<*TVU5 M831&.!U:-@XP._\ A8W_ M D7V&:WA_L_^P_LN_S95CSYGVE\8W9^Z_9QU3PEX5T]M2U MS4=0L4@@#!1@7",S,QX554$DGL*Y,?BITGAW1E93EKYJ\>_DV;8>BFZL:JUB MOQM+_(_!^BOTAT/_ ((RZQ<:+#+K'Q3LK#563,MK9Z*]S"C>@E:>,L/?8/I7 MQ[^TI^R]XQ_9=\80:+XH2"YM;Q&ET_5K(LUO=H" V,@%77(W*1D9'4$$]M/& MX>K/V<)W9@\/5C'G<=#G/@[\#?&WQZ\4+H/@G0KC5[L8,\R_);VJ'^.:4_*@ MX/4Y., $\5<_:%^"=]^SS\4M0\#:EJ5OJNH6%O;2SW%JC+%OE@24JN[DA2^W M<0,XS@9Q7ZR_\$Z/V9/%'[./@3Q"WB6_TB^'B22TO[3^RII9-D8B;B3S(TPW MSCID=>:^=_\ @HG^Q3XX\3>//'_QJM=5\/Q^%K6Q@N'LYKB<7Q6&".-@$$)3 M)*G'S]/2N&IF48XOV3:4$M_/3\M5\CHP^&]KAY5)+WGLO^WM_FM?G\S\VJ*^ ME?V6_P!@SQ[^U!8OK=G/:^&?",FEC [C)\MPP!CDVC.T\$9VEL''A-=%* MK"M'GINZ)J4Y4WRS5F%%%%:F84444 %%%% !1110 4444 %%%% 'O^B_\F.^ M(?\ L_[5^&['OCM7YY5 M_0UKO_)L]_\ ]BC)_P"D9KP\WQ-7"T.>B[/Y=O,[\OI0KXJ-.HKI_P":_P S M^>6OIG]B_P#8O_X:\;QS9\=?M=?L MU?\ #*WQ0M/!_P#PD?\ PE'GZ7%J7VW[#]DV[Y)4V;/,DSCRLYW?Q=.*\2K[ M;_X*Z_\ )T&E?]BQ:?\ I1-_B1X3M]=\8>)8/A_\ ;(UEMM.?3S>W>P\@S)YD8B)&#MW, MPS\P4C%<)^U%_P $Y_'?[..@R^)K34+?QGX2@Q]IO[.!H)[3) W2P%FPF2!N M5FQWV]]WCL/&I[)S5_ZZ[&<,_%ECX'GG0/'IL5F=0N M(P>TN)(U5O96;WP>*WK5J>'CS579&4(2J2Y8J[/@:BOOSXK?\$A?&_A'P[/J M7@WQ=8^-[FW0R/ILUD=/GD '2+,DBLWLS+]<\5\$7EG<:?>3VMU!);74#M%+ M#,A1XW4X964\@@@@@U%'%4<1?V4KV+J4:E))S5B*BOKO]G+_ ()I_$?X[:#9 M^)-3N[7P/X9O$\RVN=0B:6ZN8R/EDCMP1\A[%V3(P0""#7LOB/\ X(RZU:Z3 M-)H/Q2L=3U)5S';:AHKVD3GT,BS2E?\ O@UG5QV'HRY)SU7K^@Z="I57-!:' MYOT5V7Q:^$/BOX'^-;OPKXQTJ32M6MP'"DAHYXSG;+$XX=#@\CN"#@@@>W_ M+_@GC\1OVC/AS;>-/#>M>%['2[B>6W6'5;JYCG#1MM8D);NN,]/FK=UZ4:?M M7+W>YG[.2G[-K4^7J*^XO@C_ ,$H_'WQ*L;K4?%6OVG@;3UFDAM,V;WEQ=!& M*^:(BT>V-L94LP8CG: 03D_M#?\ !+_XA?!O3[34_#%^OQ%TV:>*UD6QLVM[ MN&21PB$P[W!0L5&X.<9Y )KG^O8;G5/GU?ZFOU>KRN7+HCXSHK]$? ?_!'' MQ/K7ANVO/%?Q"L?#.K2KO?3;/3#?B'(R%:7SHQN'0[01GH3UKYH_:K_8Z\8? MLIZU9)K,T&M>']2++8ZW9(RQR,O)CD0\QR8YVY((Z,<-AQQV'G4]E&>O]==@ M^KU>3GY=/ZZ;G4?L9?L1_P##76G^*;K_ (33_A%/[#EMX]O]E?;/.\T.O? W]N_\)']FMH+C[?\ 8_LN[S$W;?+\Q\8] M=W->C?L9? CXU?&33_%,OPF^(?\ P@T%A+;KJ"?VW>Z?]H9PYC.+9&#X"M][ M&,\=37G/[4WP[\>?"WXO7N@?$CQ-_P )=XIBMH)9=4^WW%[OC9,HOFSJKG X MP1@=JFNO;7^D>1T5]@^*_P#@EO\ %WPK MX!NO%1U/PQJT$-LERFG:7<7O2?AS_P1W\6>(/# M=O?>+_'=EX2U290YTNTTXZ@T((!VR2>=&H<<@A=PXX8U4L=AHIMS6A,:%25K M1W/SUHKZ4_:N_83\:_LLV]OJ]Y>6WB7PEK^'8[WP[;VUG"ES;:Q>7$Z6M]&S,,1E(78 M.NWYD8#&X8+ @US+,,+*3BIZFWU:MR\W+H?&=%>E?M!? /Q!^S;\0G\&^)KS M3;[4UM8KLS:3+))#LDSM&9(T;/!S\M>:UV4ZD*L5.#NC"490?+)69[G^R!^S M'_PU=\2M1\)?\)+_ ,(M]DTN34_MGV#[9OV2Q1[-GF1XSYNN?\ M$:;K3M$U"[L?BN+^]@MY)8+1O#GEB:15)5"_VL[=Q &<'&>AKS[_ () _P#) MRGB'_L5KC_TJM:_6UO$=HGBJ/06=1>RV37R)W,:NJ,?P+K^=>!FN*KT*L:=" M5KQOLGK>7?R1Z.#I4IP#PK#>74T%M9_V-]K,D<;;#)O\ /CQEPXQ@_=Z\\>'?MA?# M=OA7^TSX_P##T<96V_M-[RU4+@>3<8FC ]@) O\ P&OVM^"?ANV^!?P+^''A M.X\N.YAM;/3F7[H>ZD7=*1[EC(U=.*QKC@X5J>DIVM\_Z2^9E'#I8F5*7PQN MWZ+^K_(_+3]KK_@GC_PRO\+[7QA_PG__ D_GZG%IWV+^QOLFW?'(^_?]HDZ M>7C&WOUXK)_8W_8/_P"&MO">OZW_ ,)Q_P (K_95\MGY']D?;/-S&'W;O/CV M]<8P?K7V[_P5T_Y-@TO_ +&6U_\ 1%Q7Q%^QO^S[\<_C%X3U^^^%'Q)_X0C3 M+.^6"\MO[=OM/\Z8QA@^VWC96^7 R>:PPF)K5L)4J3G9I[V6GP_Y_B;XNA3I M5:,81TDKM=]9?Y+[CQ[]I'X*?\,]_&?7? /]L_V__9?D?\3#[+]F\SS(4D_U M>]\8WX^\>=NA1T_ M>S*KMA&5>1QC X%?M5^U9_R9_P#$?_L5KC_T33QN)K4,)1J4YW;O=V6NB"E1 MISQ,H2C9=C\!:*Z'X?\ P^\1?%+Q;I_AGPKI4^LZY?/L@M8 ,GN6)) 50.2S M$ 9)K[[\*_\$:->OM&@F\1?$ZPTC5&&9+33]'>]B0^GFM-$3_WQ^=>Q6Q%+ M#I.K*USSJ=.55V@KGYQT5]5_M/?\$[?B!^SCHLWB2*[MO&/A*$@3ZEI\3136 MH. &FA).U23C>G*Z7]:]@JTYT?XBL._ _AVYU;P?XHLO'36J-++IQLVL; MIU':)=\BNV/X2RD]LG KE_M+")V<_P _SV-EA:TM5$^#1D\#DU]"+^Q#\1-* M^ OB/XK^)[3_ (171--MXIK2QOT(O+[S)HXP?*X,28WJZQ++$63S<;4"1/EOE/#8^M?LG^U9\)M7^. M7P!\6>!]!N;*TU;5HX4@FU%W2!2EQ'(=Q1'8<(>BGG%8X_'?5N2--J[>ODM- M?GK]QI@:"K5VJJM&-OGW7R5OO/Y\**]*_:"^ ?B#]FWXA/X-\37FFWVIK:Q7 M9FTF622'9)G:,R1HV>#GY:]^_9\_X)@_$CXS:#:>(->OK7P#H-VGF6QOX&GO M9D(!5Q;@KM0Y/WW5N,[2"#7?]9H^S]MS>[W.7V<^?V=M>Q\;T5^CGBK_ ((S MZ]9:1-+X=^)VGZOJ2C,=KJ6D/91/[&19I2/^^?RZU\&_$[X7^)_@[XRO?"WB M[29M'UJT(+PRX*NI^ZZ,.'0]F!(Z^AJ*.,H8B7+3E=_UW-)X>K37-):'*T5] M0_ +_@GC\1OVC/AS;>-/#>M>%['2[B>6W6'5;JYCG#1MM8D);NN,]/FKMO@C M_P $KOB'\3CJ%WXDUFS\%:-;W4UI!XE2*)&DD=@JH@R6)X [FJH8 MFEB;^RE>PZE&=&SFK7&T5]W?!?\ X)*^//B!X:M]9\9>)+7P!]J020:*ISCSD\R-8R1@[=S$9PP4@BIOB__P $C?'?@GP[/JO@WQ19^.Y+9#)+IQLC M873J/^>2F217;K\I92<<9.!6$\?A:<^24]?ZZ[%PP]6HN:,3X+HJQ_9]W_:' MV#[--]N\WR/LWEGS/,SMV;<9W9XQUS7WA\)O^"1'CGQEX=M]3\9>*['P/-<( MLD>FQV37]S&I'24"2-4;V#-[X/%=-6O3HQYZDK(RC"4Y^)]AJVHJ,QVVHZ.]G$Y]#(LTI'_?)KX&^(WPY\0_";QEJ7A7Q3 MILFE:WI\FR>WD((Y&596'#*P((8<$&LJ.,H8B7+3E=_UW-9X>K3CS2CH5FG^Z3^7YH[,)_&1^J=%%%?"'T(4444 %%%% 'XZ_\%6?^2Q: M+_UQNO\ T=7Q#7V]_P %6?\ DL6B_P#7&Z_]'5\0U]]EW^ZP_KJ?.8K^-(** M**](Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"_H M'_(>TW_KYC_]"%>P_MK_ /)S7C'Z6?\ Z1P5X]H'_(>TW_KYC_\ 0A7L/[:_ M_)S7C'Z6?_I'!7)+_>8_X9?G$V7\)^J_4\/HHHKK,0HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH *T/#O_(P:9_U]1?\ H8K/K0\._P#(P:9_U]1?^ABE M+9C6YZ_^VM_RK"BBBNHR"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M#W_XI?\ )HOP4_Z^M7_]*GKP"O?_ (I?\FB_!3_KZU?_ -*GKP"N/"_!+_%+ M_P!*9M6^)>B_)!111788A1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'T!\ M0O\ DSGX4_\ 86U+_P!&O7S_ %] ?$+_ ),Y^%/_ &%M2_\ 1KU\_P!<>%^& M7^*7YLVK;KT7Y!111788A1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>_\ P/\ M^3;/CW_UPTG_ -'RUX!7O_P/_P"3;/CW_P!<-)_]'RUR8K^&O6/_ *4C:C\7 MR?Y,\ HHHKK,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z \1_\ )D?A M/_L;9_\ T3)7S_7T!XC_ .3(_"?_ &-L_P#Z)DKY_KCPVT_\3_,VJ[KT0444 M5V&(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 5[_^SI_R1_XZ_P#8"A_]#DKP"O?_ -G3_DC_ M ,=?^P%#_P"AR5QXO^%\U^:-J/Q_?^1X!111788A1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 5[_ /LR_P#)//CA_P!BK)_[-7@%>_\ [,O_ "3S MXX?]BK)_[-7)BOX3]5^:-J/QKY_D> 4445UF(4444 %%%% !1110 4444 %% M%% !1110 5]N_P#!(G_DYS5O^Q9NO_2BVKXBK[=_X)$_\G.:M_V+-U_Z46U8 M8C^!4_PR_)E0^./JOS1^C/[3'PX^!'Q";PZGQJN=#@:W,PTE=8U]]++%MGFA M-LT?F=(\]<<=,\X/A;]@/]G+29K36M*^'FGWRX6:&2XU"[OX)%Z@[)9G1P?H M0:^7/^"SG^K^%'UU+_VVKAO^"7O[6TG@+Q;'\*?%%^W_ C>M3?\2>:XD^6R MO&/^J&>B2GMT#XX^=C7RN%PU>I@_:T*C35]$^S>WGU\SV\55ITZL8U(III:] MO^ >S_MG_P#!2+0_!WA_7OA]\/+/4CXMDC:PN=0O[&6QCTQ6!5MD';!3XY\. MP&5A"F9-0LUR7A./O,HRR=3PRC[W'YP_L'_\G>?#'_L)G_T5)7?E3HNA-P7O M_:_3Y;_CZG'F:FEK\-G;]?GM^'H?H1_P5\_Y-NT#_L9H/_2>XKL_^"8OPZLO M!'[*>A:K' J:CXDGGU*\F_B?$C11#/H$C7CIEF]:XS_@KY_R;=H'_8S0?^D] MQ7HG_!-?QI9^,/V1?"-O!*C7.C/<:9=1JP)C=9F=0?3,SLOOY$;TWRXK$R[7?W"Z_9W\.:@R*;BS\1PI')C MY@KV\^X ^AVK^0K\^_V#_P#D[SX8_P#83/\ Z*DK]$_^"NG_ ";!I?\ V,MK M_P"B+BM\?"%/%8?D5M5^:.? 2=3VRD[^ZW\^67^0O_!+WX[>.?C;X%\7CQIK MG]M#1+BTL]/_ -$@@\F(Q-\O[I%W?=7ELGCK7S9_P4>_:D^)^@_&OQW\+K'Q M-Y'@6>SM89-*^P6K;DEMHGD'FF(RC+,3P_&>,5ZM_P $:?\ D1_B7_V$;/\ M]%25\R?\%,O#VJ2?MA>,)X].NI(6T^RO!)'"S+Y*VT:-)D#A0RL">@(HJ4J7 M]JRA**Y>7:VGPQ?^;^\C!3E_9\I7U3=O_!EE;Y:>A^EO[$^K:7XL_8[\"P>% M[]+&2'1OL$D\"*[6MZH*RL4/!829?!ZY!Z&OF7Q+^S+^V=\.?%DOB7PK\7YO M'RPS>;'876L2Q"X&(5CE@=V7 4L1C=U7FNN^'/\ P5*^,&G^+HO"?B_X M5P^(M;\U;R:_9Q@Z?IS%OD.#R'(Y!K\&:[,KKPJPE&,%%IZVV=^OX$XRFX\L^9M/O_7F M%%%%>V><%%%% !1110 4444 %%%% !1110![_HO_ "8[XA_['./_ -)HJ\ K MW_1?^3'?$/\ V.2.'DM0C D="&)!]"#7S> M?1;PEUW_ $9Z6624<;!OM^L3^>^OTR_X(P?>^+?TTK_V[K\X?%'A?5?!7B+4 M=!UNQFTW5].G:VNK6==KQR*<$'_'H1@BOU!_X(Y^!M4TGP1\0/%-W:36^FZQ M=6EK92R*56?R!,9&3/4 RA!JM/1I6\_>B3<,C-%(=O3:ZX8KT&XCM7XQ_'G]GOQA\&?BWJ7A+4M$OY))KV1-*GC MMG9=2B+?NWA('SD@KE5R020>17[%?L(_"_5O@C^RWX:TCQ1$=-U5A<:E>6\Q MVFU$LC.J/GHP3;N!Z'([5T8Z&&67QE!*VEGUVU_X/F$955CVD^K^[I;\+>1\ M0_\ !/GX Z?9?MN>/+:\@%Y9_#^2]CL_/&3YXN#!"Y[9">8WL<'M7JO_ 5, M_:G\:?"S5_#7@+P5KEUX;>^L6U+4;_3W\JY9#(4BC24?-&,QN25P3\O.,@\/ M_P $]OC1IFN?MO\ Q8;[1&MOXT>^N].=S@RLET9449YR8F=L?[)J]_P5Z^"_ MB#4_$'A7XC:7IEUJ&CV^G-IFI36T9D%H4D:2-Y,#Y582.-QX!4 X)&8JWEBL M,L1MRK?O9[W\_P ;&E-12Q7LM^9V]/=_2_XG+?LI_P#!4:Y^&/@G5-%^*Q\1 M>-[N*5'TF_A,4LXC*D/'/+(ZLV" 58[V^9@3@"O.OA\OA?\ ;5_;]TO4;;PN MV@>'=6N_[3U+2Y9UG$OD0EY"V$4 2M&NY>>78YYK8_8;_P""?UO^TEX6U[Q) MXVEU[PYHJ-%#HUS8^7%]L?YC*^)8VWHOR ,N 26&3@XVOAGX'\,_L7_\%&/" M7A:U\6-KNFNGV*\NKJV6%K66[A=8H6(8@G+0$M\O^LZ#%>I;#4\7/V>E7E=K M;7Y=-M-[7OU\SS&ZTL+_ -.[J]^U];?*]O\ (^R/^"B'[3&L_LU_!_34\)/' M9^)=>NC96ETT:M]DB1-TDBJ05+#**,C WY[5^?/[+O[>GQ1\!_%[1?\ A)O& M&K>+/#.J7T=MJ5EK5V]R(XY'"F2)G),93=NVKA3C!'I]Q_\ !4?X!^(?C%\' M]$UGPOITVL:KX8O))Y+"U0O-);2H%D,:CEF5DC.TF*_-']EC]GOQ3\=/ MC)H6CZ;I-U_9MG?Q2:O?M$RPV4*.&DWL1@.0"%4\DD>Y'#D\,/.E-UDM_>OV M_P OU.O,Y5(QC[+MI_BN_P#@:'ZY%5?^"6/_)H>C?]A.^_]&UY='F_L^JN MG,K?A?\ KO)-/\ #'C+5/#.A^%] M3>QLK'2YS#'(T+!7>8+Q-N=6.V3TSQI=JI$NA1ZO,J M<#FW$K 9Z=Z_!?\ :A_Y.1^*/_8S:C_Z4/7[7Z#_ ,F8V'_8AI_Z;Q71F%*% M/*ZM?]@RQ_P#15?1?_!&7_D7_ (H_]?5A_P"@ M3U\Z?\%3/^3N]:_[!EC_ .BJTK?\CE>B_P#2$987_<*GJ_\ TL_7G6O%L7@' MX+WGB::'[1%HV@MJ#19QO\JW\S;^.W%?C)X8_;S^-5S\:]*\57OC?4IXI-0C M\[0UF*Z:T+. T(ML[ -I*AL;^^[/-?KC\^5%?*__!''X2PK)J+W4>BV\K+ M\T4:HLLH4]MQ>+/^X*^MOVU?^32?B?\ ]@.7^E?+?_!&_P :6=QX!\?>$C(J MZC:ZG%J@C)&6BEB6,D#OAH>?3'TA%Q)H]R]M/=7+QK*Q:5"& MVJ'50@(&0Q.>,?37_!-']IKQ'^T!\,]=TWQA>_VIXA\-7,41U%E"R7%O*K&( MR8X+@QR+NQR N\>_8?C]^SI MX-BD(?4O$<^IS*I_@@MG10?8M.3_ ,!KZ#M8],\40:+K:Q1W.Q!=V-P1DH)( MB-RGW1R/H:_-O]H#Q]_PEW_!53X;:1%(S6_ANZT_3]N?E$C[IW(]_P!ZH/\ MNUY&$YJ]6CA9;098\_][7X@^*/@3:Z3\;M$AB\521SV&I02/;S M)>P'*J["%FC^=&PP&.0>!FOA#_@G%I>@?"7]M#XI>![R5%U2WCO-+TF6=@&D M6"Z&]!GJS(BM@=D;TKL?"NG_ +??B[X>Z;XKM/&^DVWV^$W$>C7^GV%M?HN3 MMWH]F$4L & +]",X.0/COX4_ 7XQ?M2?%KQ5K.@7MFWBW3=2-YJVLG4H;7R+ MIY'/FH8>N71R&A4J,#':JP]'EJUW.<4FFFHO;I>W97?7K8FK-2P\(Q4FU)-- M_?:_GI\E=['Z#K.WMUB?0EN[C3XWDRQ:7[1; MY=B05&QEP-N01FOFOQ-\5OVW?V9_ -Q8:YH5OXHTJT+L/%;0#5;B*(+DEWCD MR$7!.^>//)RV,"J?CS]IK]JW]B?4+'1_'_\ 8_C[2)88W@UBXM)98".08A=( ML),HV\^8&;D'D&OM3]D/]H[5_P!IOX=WGB35O ]UX,6&Y^SP&:8RP7R; 3+$ MS(A(!)4\$<<,3D#CY:N'HBNRH>6 MKFUMX@ID9 P(WDR(H)!P"QZX-? W_!.'Q2-%!'4M7VC_P58^ /B/XJ_#WPOXJ\,:=<:S=^&9ITN[&SB,D MQMYQ'F15'+;&B7( )PQ/136N81A'$T*9\D_L<_MU?$WPG\:_#VD^*O%FJ^+O#&O7\6GWEMK5V]T\!E<(LT3R$LFUF M!*@[2,C&<$?8'_!6+X0:;XK^ <7CI;9$UWPO=PC[4J_/):S2")XB>X#O&XST MVMC[QK\^/V+?V?\ Q/\ &CX[>%QI^EW(T/1]3@OM6U)XB(+>.&0.4+'C>VW: M%ZY.<8!(_1[_ (*K?$;3_"?[,-SXVMH,C<8XI%FE?']T;%4GU MD7UIYC&$,3AW25I75[=KK]+_ "\AX&4I*JIOW;?H[_/;YFA_P2Q_Y-#T;_L) MWW_HVOBS]NC]M+XFW'[0'B3PSX6\7ZIX4\.^&KPV%O;Z+]*E M3C4S2?,KV5_G[H0O'+N9;\UODW+_ "/VE_8W^*&K?&K]FCP5XK\0NMSK%[;2 MPWDP0*)GBFDA,A4< MY>XXP,D\#I7YN?L0?!W1_%'[?>OV-S;12Z7X1O-3U* M"U9 4+0W/DP\'/W6D1Q[H*^\?^":_P#R9CX ^M__ .EUQ7QE^PSXPL?"_P#P M46\?V5[(L3ZY<:UIUL6Z&478G"_BL#?CBE"*I8_%QIZ652UO)Z?=T[$S?-A* M2F[KFC_3_4^P_P!NJQ_:#\1^']"T'X&V-PD5T9I-8U2QU*VLKJ,#:(HHWEE1 ME#9=BR<_*HR!D&E^PCIO[1?A6SUW0/CA974^FQ1QS:1JNH:I:WUSOW$20O)' M*[N,%6!?I@C/0#*_X**_$3XY?"/0/#OBKX4ZK<6>@P^=#KB6NEV]Z83\K13- MYL3E4P) 6& #MSU%?/W[/OC[]MW]I'POJ'B'PWX]T_3=)M9%BBN-;TBRMUO6 M.=P@*V3!PN "3@98 $G..'#4YSP*OVG_%4OA_6?AU]@BMK1Y[CQ'I4LALHY 1MC9'4["V3C]XQXZ8R1X'_ M ,%C_".A:;XH^'GB&U@AM]?U."\M[UXU >>*(P^4S^I7S'4'KCCL*THU9TL7 M"EB*:YGLUOL_\K=';R)Y8U:$W1D[+=/;I_P_773<_.2BBBOICR HHHH **** M "OT5_X)#?\ (P>*?^OFW_\ 1%Q7YU5^BO\ P2&_Y&#Q3_U\V_\ Z(N*\K-/ M]TG\OS1V83^,C]4Z***^$/H0HHHH **** /QU_X*L_\ )8M%_P"N-U_Z.KXA MK[>_X*L_\EBT7_KC=?\ HZOB&OOLN_W6']=3YS%?QI!1117I'*%%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 7] _Y#VF_]?,?_ *$* M]A_;7_Y.:\8_2S_](X*\>T#_ )#VF_\ 7S'_ .A"O8?VU_\ DYKQC]+/_P!( MX*Y)?[S'_#+\XFR_A/U7ZGA]%%%=9B%%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !6AX=_P"1@TS_ *^HO_0Q6?6AX=_Y/^OJ+_P!#%*6S&MSU_P#; M6_Y.:\9?]N?_ *105XA7M_[:W_)S7C+_ +<__2*"O$*YL+_N]/T7Y&E;^)+U M84445U&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >__ !2_Y-%^ M"G_7UJ__ *5/7@%>_P#Q2_Y-%^"G_7UJ_P#Z5/7@%<>%^"7^*7_I3-JWQ+T7 MY(****[#$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^@/B%_R9S\*?^PM MJ7_HUZ^?Z^@/B%_R9S\*?^PMJ7_HUZ^?ZX\+\,O\4OS9M6W7HOR"BBBNPQ"B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH *]_^!__ ";9\>_^N&D_^CY:\ KW_P"! M_P#R;9\>_P#KAI/_ */EKDQ7\->L?_2D;4?B^3_)G@%%%%=9B%%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 ?0'B/\ Y,C\)_\ 8VS_ /HF2OG^OH#Q'_R9 M'X3_ .QMG_\ 1,E?/]<>&VG_ (G^9M5W7H@HHHKL,0HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ KW_P#9T_Y(_P#'7_L!0_\ H 5[_ /LZ?\D?^.O_ & H?_0Y*X\7_"^: M_-&U'X_O_(\ HHHKL,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M*]__ &9?^2>?'#_L59/_ &:O *]__9E_Y)Y\;3UBTB**282/+$X)$DB#;B-N^>1Q7SK14RBIQ<'LTU] MXT[--=#[!_X*!?MA>#/VK%\$CPEIFNZ=_8AN_M']M6\,6_S?)V[/+FDSCRVS MG'4=:^0(9GMY4EB=HY$8,KJ<%2.00>QIM%8X>A##05.GLO\ AS6M5E7=Y^A^ MI/P7_P""N'A+1_AGHFF_$;1/$VH^++2'[/=WVDVMM)#=;>%E)>="'9<%AMQG M..#@?)&F_&[X7^"?VSM*^*/A'2M?M/ D.HG4Y=)FM($NH'='$D<2+.4*;FRN M77 .W'R@GYMHK&&#I4ZLJL%9N]^VOD$JTY4O8RV/O']N[]O/P!^T_P#"72_" M_A;1_$EAJ%KK$6H/)K%M;QQ&-8I4(!CG<[LR#MC@\UD_L$S_ +0/PCLIO'/@ M7P#<>./AWJSM!?Z;%?0(9I(B5WQ+O,B2*9?\%7O!G@-[_2=0^&_CG3?%UHGSZ/ MK5K!9A)"H90[^:SJI!!#>6<@@@5[K^QQ\6/$?QR^"%EXZ\36\=G>ZS?7[DDUY#XB_;0_8X^(=Y;ZMXIN-!UG5(D"QSZUX/N+JX MB4'(4.UJ^ #Z'%<)^T%_P56\":#X-O-$^$<%UK6MS6Y@MM4DLVM+*Q!!&]4D M =V7C"[ O3GC!^;EAY2AR4Z#4WU=[?C_ $CUE-1\&^-O'=AX; M_;2UOQAF^/)M2D6UP\DD,5^7.S)4$E5XR0.>HKZE_;(_X**_#?]H;X M"ZSX(\.:)XILM5O+BUECFU2TMHX (YE=LE+AVSA3CY>M?G=-,]Q*\LKM)([% MF=CDL3R23ZTVOIW@Z=2%*-35T[6]5;_)'EO$2]I4G'[=_P ;_P"9Z9^S3\3- M+^#?QU\'>--:@O+K2]'O/M%Q#8(CSLNQEP@9E4G+#JPKZL_;H_;Z^'W[3GP; MLO"?A?1_$MAJ,.KPZ@TNKVMO'"8TCE0@&.=SNS(O;'!YKX'HK6MA:=:<9SWC ML9T:TZ',X?:5GZ6:_4^F?V'_ -L9_P!DWQ7K)U#2)M<\,:XD2WMO:R!;B%XR MVR6/=\K'#N"I(SD?,,<_4G[07_!4CX8_%#X+^+_"&B^%O%1U#7-,FL(Y-2AM MH88FD4J')2=R=I.<;><8XK\PJ*SQ&!H8J?/46HZ->=!6@S[0_9)_X*3^(?V? MO#EKX/\ %&D-XO\ "-J=MFTW/U^U?TK\@J*FME^'Q$W.:U?8*>(J4ERQ>A]BBNF MAAZ>'AR4E9$5:TZSO-A111709!1110 4444 %%%% !1110 4444 >_Z+_P F M.^(?^QSC_P#2:*O *]_T7_DQWQ#_ -CG'_Z315X!7)A]ZG^)_H;5/L^@4445 MUF(5]I_L2_\ !1"X_9ST4>"_&&FW6O>"5E:6TEL2IN]/9B2RJK$+)&6);:2I M!9B"$+B[FA'7:&-L^,>QQ7.?%S_@JS\+/ OAEK#X8V%QXKU18?+LQ]C>QTZVQ MP-X<+(0.NQ$P<8W+UK\AZ*\G^R*&B;=NU]/R.[Z[4WLK]S;\;^--8^(OB[5O M$WB"\?4-9U2X>ZNKA_XG8]AV & . .!7[M_L8L8_V1?AFRG#+H,1!_ U^ M!-?KO^S/^WA\"_A]^SCX'\+Z_P"./L&NZ;I"6MU:?V1?2>7( S5DEY,C"3_P!K52H]T[M^;B6?M:_\ !4"]^,7A.]\'?#S1[SPS MH.H1F'4-2U%T^VW$3##0JB%EB4C()W,6!Q\O.?A&\D6:\G=#E6D9@?8FH:Z% MEN&W3[OTV-)8NK"4HPEIK9_P#!_4U/"_BC5?!?B+3M>T.^FTS5].G6 MYM;N X>*13D$?X'@C@\5^F7PG_X+$:(/#\-O\2/!NIKK$*!7O?#?E2Q7!QRY MBEDC,9]@S#Z=*_+FBNS$8>EB8\M57L<=.I*E+F@S]2?BI_P6(T'_ (1^:#X< M^#-5DUB5&5+SQ)Y4,-NV.'\N*20R8_NED^O:OS*\2>*-6\8>(]0U_6;^;4=9 MOYVNKF\F;,DDC')8GMSZ<#M6716>'P='"MRIK7N:5<14K+ED]#]"/V=?^"LV MM>"=#LM ^)VA7'BNVM4$4>NZ=*JWQ0#@2QOA)6[;]R' YW')/LGB/_@L5\-; M?29GT#P7XJU#4PO[J#4EMK2%F_VI$EE8#Z(:_).BL:N6X:M)S<;-]BJ>)JTX M\J>AZI^T5^TCXP_::\;_ /"0^*[B-$@0PV&F6H*VUE$3DJ@))))P68DEB!V M ^N/V+_^"AWPY_9S^!6G^"_$FB^*+[5+>\N;AIM*M+:2 K(^Y0"]PC9QU^6O MSSHKHEA:4J/L+6B9>UFZBJMZ_P# L=C\9/&5E\1/BUXS\4:;%<0:?K6L76H6 M\=TJK*L?PK]%8TAB*D*_P!97Q:_B[_H M=?\ !WQA9_#WXM>"_%&HQ3S:?HNM6>HW$=JJM*T<4R2,$#$ L0IQD@9[BON3 M]LC_ (**_#?]H;X"ZSX(\.:)XILM5O+BUECFU2TMHX (YE=LE+AVSA3CY>M? MG916E?#4\0X.I]AW7KH_T1%.K*ES"OV4]+\9VWB MW2]>U%]:FM9+/OC&,]Z\H_;0^.F@_M%_'74/&GANTU& MRTNXL[:W2'58HXYPT:;6)".ZXST^:O#**)8:G+$?67\6WX6_(4*LJ=)T8[/_ M #O^9^HOQ&_X*C?"KQ=\#O$7@VS\/^,8M4U'0)]*BFGLK00K*]N8PS$7)8+D M]0I..U?F+H]XFGZO8W4@9HX)TE8+U(5@3CWXJI13PV'AA9NI3W;N*K4E6I*C M/97_ !LOT/T[_:%_X*>?"WXL_ WQCX,TC0/%]MJFLZ<]G;S7MG:K KG&"Y6Y M9@..RGZ5\F_L5:+\:;/X@W/C7X-:"=?N_#ZQQZI:M#BOG:O?OV-?VK]0_91^(T^JBQ;5_#FJQK;:MIR,%D=%)*2QD\>8A+ M8!X(9@<9##GIX.&%A4]@O>DNNS\GZIM?GH74K.MRQJ;+MOT_R/T:\4?\%--% M^%D-I9?$KX3>/O!WB*:(N+-[2![>0@X8Q3/+'YB@_P 02NG_ &)?VHO$7[5F MM?$3Q'>:4-"\*:?+9V.D:>N9"K8E>9WEP-\C!HL@ !0%&.2S>E?-^Q?LY16'?.]+ZV6M]+^EM_F M>OSW<;55R]=KO^GK^!\8?\%3-6AU+]KK6(8F#-8Z996TN#T;R_,Q^4@KY&KI M?B5\0M9^+'CW7/%_B"99]7UBY:YG9 0BD\!%&3A54!0,\!17-5]1@Z+P^'A3 MENEKZO5_B>5B:D:M64X[?Y:'T?\ L(?M(>&OV7_BYJOBGQ58ZM?Z?=:++IR1 MZ/#%)*)&FAD!(DDC&W$3=\Y(XK4_;Z_:D\*?M3^./#.L^%-/UC3[73-.>TF3 M688HG9S(7!41RR C![D5\N45=3#TZE:%>7Q1V_'_ #9$*TZ=.5-;2W_#_)'Z MA? +_@JE\._A[\&/!WA?Q5H7BV\UW1M.BL+BXT^UMI(9!$-B,K/:P_V!?VWO O[*_@CQ/HWBS2O$.H M76J:BEW"^C6T$J*@B"$,9)HR#D=@:^(Z*B.!HPHRH+X9;_A_D:5,14J3A4EO M';\?\V>Q?M;?&/1?CU^T!XD\<^'[6_L])U+[-Y,.I1HDZ^7!'&VY4=U'*'&& M/&*^VOC9_P %/OA9\2/@/XL\%:9H'C"#5=6T:73H)KNSM5@61H]H+%;EF"Y] M%)]J_,.BBI@J-2C"A+X8[?U\AK$U%4=7JST/X$_';Q5^SO\ $"U\7>$[F..] MC0PSVUPI>"[A8@M%(H()4D Y!!! ((K])?"O_!8OX=76D0OXE\$^*--U3'[V M'2A;7< /^R[RQ-^:_G7Y+T5>(PE'%6]HM494JLZ+;@]S]"?VFO\ @JW>_$+P MK?>&/ACH=]X9M;^(PW.N:E(@O1&P(=(8XRRQDCCS-['!. IPU?'WP#^/WBO] MG'Q_!XK\)W$:W 0P75GBG0PE'#Q<:<=]_, M=:M.M;G>Q^L_A/\ X+&?#RZTF)_$W@CQ-IFIX_>0Z2;>\ASZAY)(C_X[Q[]: MYWXK?\%B-&_L*:W^&_@O4GU:5"J7WB0Q116Y[-Y43N9/H77\>E?EU17&\JPK M=^7\6;K&5DMS4U_Q3JWBCQ-?>(=5OYKW6KZY:\N+V1OWCS,VXOD=#GTZ=J_4 M+X9_\%@_!J>#]/A\=^$O$$?B.&)8[F70HX)[:=@ #(/,FC9-QR=N&QG[QK\J M:*[:V%I5Z:IS6BV\O0YX59PFZB>KW\SZ!_;0_:/TC]H_XWP^-O"^G:CH5M;Z M?;V<9O75;AI(W=A+\C$(?G &&/W*O\ M@L7\.[71YG\->"?$^I:IC]U#JHMK2 G_ &GCEE;\EY]NM?F_\?/V@?%_[1WC MJ3Q/XONXY)PGDVME;*4MK.+.?+B4DD#)R2223U/2O-Z*BA@*&'ESP6OF:5,5 M5J1Y&]#]#/V+_P#@H=\.?V<_@5I_@OQ)HOBB^U2WO+FX:;2K2VD@*R/N4 O< M(V<=?EKXJ^./CBQ^)GQD\:^+-+BN(-.UO5[K4+>*[55F2.21G4.%9@&P><$C MWKB**UCA:<*SKKXG_P #_(CVTU1]A]F]_GK_ )L_2#]D?_@I#\-/@'^S]X7\ M"^(-#\5WFK:6;GSIM-M+9X&\RYEE7:SW",?E< Y4<@_6OA#Q9\0)KKXOZUXV M\.SW6F3S:Y/J^GS'"3P%IVEC)P2 PR.A(R.]<=151P\(5Y8E?%*]_F[DRJ2E M35)['Z>_!W_@L)IT'A^"T^)WA'49M6@0(VI^&_*=;H_WFAE=/+/3.'()S@*. M*TOB=_P6*\-1^'YH_A[X+U>YUJ12L<_B3RH((#CARD,DC28./EW)_O5^6%%< M<\KPLY7H8QJSA-U$]7OYGZU^)?^"Q?PVM=+F?P_X* M\5:EJ0'[J#4A;6D)/^U(DLI'X(:_.#]H3]H+Q3^TE\0KCQ9XIEB27RQ;VEC: M@B"S@!)$: DGJ222%-!FUBWM%N8IWCEC38QER!\[#]*^3?^&0?C M!_T)-U_X$V__ ,CF]E4_E?W'CM%>Q?\ M#(/Q@_Z$FZ_\";?_ ..4?\,@_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[ MCQVBO8O^&0?C!_T)-U_X$V__ , M@]E4_E?W'CM%>Q?\,@_&#_H2;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1] M9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ M ,.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_ M\";?_P".4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7 M_@3;_P#QRC_AD'XP?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R# M\8/^A)NO_ FW_P#CE'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\= MHKV+_AD'XP?]"3=?^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/9 M5/Y7]QX[17L7_#(/Q@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:' M\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#' M*/K-#^=?>@]E4_E?W'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ F MW_\ CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T M)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4? M\,@_&#_H2;K_ ,";?_XY1]9H?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$ MV_\ \.T5[%_P ,@_&# M_H2;K_P)M_\ XY1_PR#\8/\ H2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*] MB_X9!^,'_0DW7_@3;_\ QRC_ (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)NO_ FW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.O MO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X$V__P %[C4 M=)NOLODW*3PJ'VVL2-PS@\,K#IVKEEB*/UB+YU:SZKO$U5.?LVN5[K]3Y&HK MV+_AD'XP?]"3=?\ @3;_ /QRC_AD'XP?]"3=?^!-O_\ '*ZOK-#^=?>C+V53 M^5_<>.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^ M]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP M?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#C ME'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=? M^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/ MQ@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':* M]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E? MW'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0> MRJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,"; M?_XY1]9H?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_ MPR#\8/\ H2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3 M;_\ QRC_ (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/ M^A)NO_ FW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O M^&0?C!_T)-U_X$V__P @]E4_E?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ_P# FW_^ M.4?6:'\Z^]![*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'*/^&0?C!_T)-U M_P"!-O\ _'*/K-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\";?_ ..4?\,@ M_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X$V__ M ,@]E4_E?W'CM%>Q?\,@_&#_H2 M;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\=HKV+_AD M'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5 M[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^]![*I_*_ MN/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3=?\ M@3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#CE'_#(/Q@ M_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O_P#' M*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/Q@_Z$FZ_ M\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':*]B_X9!^, M'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E?W'CM%>Q? M\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?RO[CQ MVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY1]9H M?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\8/\ MH2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;_\ QRC_ M (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)NO_ F MW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T M)-U_X$V__P @]E4_E M?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ_P# FW_^.4?6:'\Z M^]![*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'*/^&0?C!_T)-U_P"!-O\ M_'*/K-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\";?_ ..4?\,@_&#_ *$F MZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X$V__ ,@]E4_E?W'CM%>Q?\,@_&#_H2;K_P)M__ M (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3= M?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8 M/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^]![*I_*_N/':*]B_ MX9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3=?\ @3;_ /QR MCZS0_G7WH/95/Y7]QX[6AX=_Y/^OJ+_T,5ZE_PR#\8/\ H2;K_P ";?\ M^.5,O^W/\ ](H*\0KZY_:G_9P^)'CWX\>)]=T#PO<:CI-W]E\FY2>%0^VU MA1N&<'AE8RZKL:5:C+V53^5_<>.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P". M4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#Q MRC_AD'XP?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO M_ FW_P#CE'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD' MXP?]"3=?^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[ M17L7_#(/Q@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I M_*_N/':*]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=? M>@]E4_E?W'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'U MFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V_ M_P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H M2;K_ ,";?_XY1]9H?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P) MM_\ XY1_PR#\8/\ H2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,' M_0DW7_@3;_\ QRC_ (9!^,'_ $)-U_X$V_\ \.T5[ M%_PR#\8/^A)NO_ FW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO M[CQVBO8O^&0?C!_T)-U_X$V__P @]E4_E?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ M_P# FW_^.4?6:'\Z^]![*I_*_N-WXI?\FB_!3_KZU?\ ]*GKP"OL7X@?L[_$ M36/V;?A7X;L_#,\^MZ1<:D]]:":(-")+AFC))?!RI!X)KQS_ (9!^,'_ $)- MU_X$V_\ \R_(\=HKV+_AD'XP?]"3=?^!-O M_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRNKZS0_G7WHR]E4_E?W'CM%>Q?\ #(/Q M@_Z$FZ_\";?_ ..4?\,@_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVB MO8O^&0?C!_T)-U_X$V__ ,@]E4 M_E?W'CM%>Q?\,@_&#_H2;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?S MK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";? M_P".4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3; M_P#QRC_AD'XP?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^ MA)NO_ FW_P#CE'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+ M_AD'XP?]"3=?^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7 M]QX[17L7_#(/Q@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^] M![*I_*_N/':*]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K- M#^=?>@]E4_E?W'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ MCE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_ MX$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_ M&#_H2;K_ ,";?_XY1]9H?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ M\.T5[%_P ,@_&#_H2; MK_P)M_\ XY1_PR#\8/\ H2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9 M!^,'_0DW7_@3;_\ QRC_ (9!^,'_ $)-U_X$V_\ \-/V=_B)J?[,GP\\,VWAF>77--U&^FN[, M31!HD>1RA)+X.01T->-_\,@_&#_H2;K_ ,";?_XY7+A\11C&5YKXI=5W-JM. M;:M%[+\CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3=?\ @3;_ /QR MNKZS0_G7WHQ]E4_E?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ M_P# FW_^.4?6:'\Z^]![*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'*/^&0 M?C!_T)-U_P"!-O\ _'*/K-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\";?_ M ..4?\,@_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T) M-U_X$V__ ,@]E4_E?W'CM%>Q?\ M,@_&#_H2;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\ M=HKV+_AD'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^ M]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP M?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#C ME'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=? M^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/ MQ@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':* M]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E? MW'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0> MRJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,"; M?_XY1]9H?SK[T'LJG\K^X\=KW_X'_P#)MGQ[_P"N&D_^CY:PO^&0?C!_T)-U M_P"!-O\ _'*]C^$_[._Q$\/_ -^,&AZAX9GMM5UJ'3ET^V::(F@]E4_E?W'CM%>Q? M\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?RO[CQ MVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY1]9H M?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\8/\ MH2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;_\ QRC_ M (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)NO_ F MW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T M)-U_X$V__P @]E4_E M?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ_P# FW_^.4?6:'\Z M^]![*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'*/^&0?C!_T)-U_P"!-O\ M_'*/K-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\";?_ ..4?\,@_&#_ *$F MZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X$V__ ,@]E4_E?W'CM%>Q?\,@_&#_H2;K_P)M__ M (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3= M?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,:\;_X9!^,'_0DW7_@3;__ !RN7#XBBE*\U\3ZKN;5:RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3=?\ M@3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#CE'_#(/Q@ M_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O_P#' M*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/Q@_Z$FZ_ M\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':*]B_X9!^, M'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E?W'CM%>Q? M\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?RO[CQ MVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY1]9H M?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\8/\ MH2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;_\ QRC_ M (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)NO_ F MW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T M)-U_X$V__P &9[2^UG2(K>PA::(F>0,Y*@AR!U'7%R MJ?RO[CQVBO8O^&0?C!_T)-U_X$V__P @]E4_E?W'CM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_ MZ$FZ_P# FW_^.4?6:'\Z^]![*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'* M/^&0?C!_T)-U_P"!-O\ _'*/K-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\ M";?_ ..4?\,@_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C M!_T)-U_X$V__ ,@]E4_E?W'CM% M>Q?\,@_&#_H2;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\ MK^X\=HKV+_AD'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6: M'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_A MD'XP?]"3=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW M_P#CE'_#(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?] M"3=?^!-O_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7 M_#(/Q@_Z$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N M/':*]B_X9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E M4_E?W'CM%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_. MOO0>RJ?RO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P < MH^LT/YU]Z#V53^5_<>.U[_\ LR_\D\^.'_8JR?\ LU87_#(/Q@_Z$FZ_\";? M_P".5['\!_V=_B)X3\%_%>RU;PS/9W6L>'GL[&-IHB9YCNP@PYQU[X%Q?\ #(/Q@_Z$FZ_\";?_ ..4 M?\,@_&#_ *$FZ_\ FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X M$V__ ,@]E4_E?W'CM%>Q?\,@_& M#_H2;K_P)M__ (Y1_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\=HKV M+_AD'XP?]"3=?^!-O_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8/^A)NO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^]![* MI_*_N/':*]B_X9!^,'_0DW7_ ($V_P#\RJ?RO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3 M=?\ @3;_ /QRCZS0_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#CE'_# M(/Q@_P"A)NO_ )M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O M_P#'*/\ AD'XP?\ 0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/Q@_Z M$FZ_\";?_P".4?\ #(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':*]B_X M9!^,'_0DW7_@3;__ !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E?W'CM M%>Q?\,@_&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?R MO[CQVBO8O^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY M1]9H?SK[T'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\ M8/\ H2;K_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;_\ MQRC_ (9!^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)N MO_ FW_\ CE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O^&0? MC!_T)-U_X$V__P @] ME4_E?W&[HO\ R8[XA_['./\ ])HJ\ K[%TK]G?XB6_[)^M>%)/#,Z^()_%"7 M\=CYT6YH!!&I?._;C((QG/%>.?\ #(/Q@_Z$FZ_\";?_ ..5RT,113G>:W?5 M>1K4IS?+:+V/':*]B_X9!^,'_0DW7_@3;_\ QRC_ (9!^,'_ $)-U_X$V_\ M\@]E4_E?W'CM%>Q?\,@_ M&#_H2;K_ ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?RO[CQVBO8 MO^&0?C!_T)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_PR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY1]9H?SK[ MT'LJG\K^X\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\8/\ H2;K M_P ";?\ ^.4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;_\ QRC_ (9! M^,'_ $)-U_X$V_\ \.T5[%_PR#\8/^A)NO_ FW_\ MCE'_ R#\8/^A)NO_ FW_P#CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_ MX$V__P @]E4_E?W'C MM%>Q?\,@_&#_ *$FZ_\ FW_ /CE'_#(/Q@_Z$FZ_P# FW_^.4?6:'\Z^]![ M*I_*_N/':*]B_P"&0?C!_P!"3=?^!-O_ /'*/^&0?C!_T)-U_P"!-O\ _'*/ MK-#^=?>@]E4_E?W'CM%>Q?\ #(/Q@_Z$FZ_\";?_ ..4?\,@_&#_ *$FZ_\ M FW_ /CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_T)-U_X$V__ ,@]E4_E?W'CM%>Q?\,@_&#_H2;K_P)M__ (Y1 M_P ,@_&#_H2;K_P)M_\ XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!- MO_\ '*/^&0?C!_T)-U_X$V__ ,.T5[%_PR#\8/^A) MNO\ P)M__CE'_#(/Q@_Z$FZ_\";?_P".4?6:'\Z^]![*I_*_N/':*]B_X9!^ M,'_0DW7_ ($V_P#\RJ? MRO[CQVBO8O\ AD'XP?\ 0DW7_@3;_P#QRC_AD'XP?]"3=?\ @3;_ /QRCZS0 M_G7WH/95/Y7]QX[17L7_ R#\8/^A)NO_ FW_P#CE'_#(/Q@_P"A)NO_ )M M_P#XY1]9H?SK[T'LJG\K^X\=HKV+_AD'XP?]"3=?^!-O_P#'*/\ AD'XP?\ M0DW7_@3;_P#QRCZS0_G7WH/95/Y7]QX[17L7_#(/Q@_Z$FZ_\";?_P".4?\ M#(/Q@_Z$FZ_\";?_ ..4?6:'\Z^]![*I_*_N/':*]B_X9!^,'_0DW7_@3;__ M !RC_AD'XP?]"3=?^!-O_P#'*/K-#^=?>@]E4_E?W'CM%>Q?\,@_&#_H2;K_ M ,";?_XY1_PR#\8/^A)NO_ FW_\ CE'UFA_.OO0>RJ?RO[CQVBO8O^&0?C!_ MT)-U_P"!-O\ _'*/^&0?C!_T)-U_X$V__P .T5[%_ MPR#\8/\ H2;K_P ";?\ ^.4?\,@_&#_H2;K_ ,";?_XY1]9H?SK[T'LJG\K^ MX\=HKV+_ (9!^,'_ $)-U_X$V_\ \.T5[%_P ,@_&#_H2;K_P)M_\ XY1_PR#\8/\ H2;K_P ";?\ M^.4?6:'\Z^]![*I_*_N/':_17_@D-_R,'BG_ *^;?_T1<5\F?\,@_&#_ *$F MZ_\ FW_ /CE?F MX=?6O,S*O2GA91C--Z=5W1U86G.-5-IGZ2T445\6>\%%%% !1110!4;2;)Y' M=K.W9W.YF,2Y)]3Q1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4 M_LBQ_P"?*W_[]+_A1_9%C_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A1_9% MC_SY6_\ WZ7_ JW10!4_LBQ_P"?*W_[]+_A35T73XU"K86RKZ"%0/Y5=HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MJ?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/ M[(L?^?*W_P"_2_X5;HH J?V18_\ /E;_ /?I?\*/[(L?^?*W_P"_2_X5;HH MI+HNGQJ%6PME7T$*@?RIW]D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"% M']D6/_/E;_\ ?I?\*MT4 5/[(L?^?*W_ ._2_P"%']D6/_/E;_\ ?I?\*MT4 M 4AHNGJQ86%L&;J?)7)_2G?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P * MMT4 5/[(L?\ GRM_^_2_X4?V18_\^5O_ -^E_P *MT4 5/[(L?\ GRM_^_2_ MX4?V18_\^5O_ -^E_P *MT4 4QHVGABPL;8$]3Y*\_I2_P!D6/\ SY6__?I? M\*MT4 5/[(L?^?*W_P"_2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+ M_A1_9%C_ ,^5O_WZ7_"K=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT M4 5/[(L?^?*W_P"_2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+_A1_ M9%C_ ,^5O_WZ7_"K=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT4 5/ M[(L?^?*W_P"_2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+_A1_9%C_ M ,^5O_WZ7_"K=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT4 5/[(L? M^?*W_P"_2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+_A1_9%C_ ,^5 MO_WZ7_"K=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT4 5/[(L?^?*W M_P"_2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+_A1_9%C_ ,^5O_WZ M7_"K=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT4 5/[(L?^?*W_P"_ M2_X4?V18_P#/E;_]^E_PJW10!4_LBQ_Y\K?_ +]+_A1_9%C_ ,^5O_WZ7_"K M=% %3^R+'_GRM_\ OTO^%']D6/\ SY6__?I?\*MT4 5/[(L?^?*W_P"_2_X4 MTZ+I[,&-A;%EZ'R5R/TJ[10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ M (4?V18_\^5O_P!^E_PJW10!4_LBQ_Y\K?\ []+_ (4?V18_\^5O_P!^E_PJ MW10!3_L;3]V[[#;;L8SY*Y_E2_V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[] M+_A1_9%C_P ^5O\ ]^E_PJW10!4_LBQ_Y\K?_OTO^%']D6/_ #Y6_P#WZ7_" MK=% %3^R+'_GRM_^_2_X4?V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[]+_A1 M_9%C_P ^5O\ ]^E_PJW10!4_LBQ_Y\K?_OTO^%']D6/_ #Y6_P#WZ7_"K=% M%3^R+'_GRM_^_2_X4?V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[]+_A1_9%C M_P ^5O\ ]^E_PJW10!4_LBQ_Y\K?_OTO^%']D6/_ #Y6_P#WZ7_"K=% %3^R M+'_GRM_^_2_X4?V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[]+_A1_9%C_P ^ M5O\ ]^E_PJW10!4_LBQ_Y\K?_OTO^%']D6/_ #Y6_P#WZ7_"K=% %3^R+'_G MRM_^_2_X4?V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[]+_A1_9%C_P ^5O\ M]^E_PJW10!4_LBQ_Y\K?_OTO^%']D6/_ #Y6_P#WZ7_"K=% %3^R+'_GRM_^ M_2_X4?V18_\ /E;_ /?I?\*MT4 5/[(L?^?*W_[]+_A1_9%C_P ^5O\ ]^E_ MPJW10!4_LBQ_Y\K?_OTO^%(=&T]B";&V)'3]RO'Z5K;SL@D"E&/RDD9R 1V-4? M^%E>&O\ H*)_W[?_ .)JC=6\5S\5HEFB25?[*SM=01_K#ZUU7]DV/_/E;_\ M?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ MOTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ M (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H MP_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"% M']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FM MS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ MA97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X M:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY M6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^ M?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z" MB?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B M?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I M?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[ M]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W M_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ M^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* , M/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V3 M8_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K< M_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A9 M7AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97 MAK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ MSY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_G MRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H M*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H* M)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ M?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ MOTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFMS^R;'_GRM_^_2_X4V72;'RG_P!#M^A_Y9+_ (4 8J_$SPRPR-47\8I! M_P"RT?\ "RO#7_043_OV_P#\35#X7Z?:S^"K%Y;:&1RTF6:,$_?;VKJ_[)L? M^?*W_P"_2_X4 8?_ LKPU_T%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$UN?V M38_\^5O_ -^E_P */[)L?^?*W_[]+_A0!A_\+*\-?]!1/^_;_P#Q-'_"RO#7 M_043_OV__P 36Y_9-C_SY6__ 'Z7_"C^R;'_ )\K?_OTO^% &'_PLKPU_P!! M1/\ OV__ ,31_P +*\-?]!1/^_;_ /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ M ._2_P"% &'_ ,+*\-?]!1/^_;__ !-'_"RO#7_043_OV_\ \36Y_9-C_P ^ M5O\ ]^E_PH_LFQ_Y\K?_ +]+_A0!A_\ "RO#7_043_OV_P#\31_PLKPU_P!! M1/\ OV__ ,36Y_9-C_SY6_\ WZ7_ H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_ M[]O_ /$T?\+*\-?]!1/^_;__ !-;G]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_ MX4 8?_"RO#7_ $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$UN?V38_P#/E;_] M^E_PH_LFQ_Y\K?\ []+_ (4 8?\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_; M_P#Q-;G]DV/_ #Y6_P#WZ7_"C^R;'_GRM_\ OTO^% &'_P +*\-?]!1/^_;_ M /Q-'_"RO#7_ $%$_P"_;_\ Q-;G]DV/_/E;_P#?I?\ "C^R;'_GRM_^_2_X M4 8?_"RO#7_043_OV_\ \31_PLKPU_T%$_[]O_\ $UN?V38_\^5O_P!^E_PH M_LFQ_P"?*W_[]+_A0!A_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV_P#\ M36Y_9-C_ ,^5O_WZ7_"C^R;'_GRM_P#OTO\ A0!A_P#"RO#7_043_OV__P 3 M1_PLKPU_T%$_[]O_ /$UN?V38_\ /E;_ /?I?\*/[)L?^?*W_P"_2_X4 8?_ M LKPU_T%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$UN?V38_\^5O_ -^E_P * M/[)L?^?*W_[]+_A0!A_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 36Y_9 M-C_SY6__ 'Z7_"C^R;'_ )\K?_OTO^% &'_PLKPU_P!!1/\ OV__ ,31_P + M*\-?]!1/^_;_ /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ ._2_P"% &'_ ,+* M\-?]!1/^_;__ !-'_"RO#7_043_OV_\ \36Y_9-C_P ^5O\ ]^E_PH_LFQ_Y M\K?_ +]+_A0!A_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ OV__ ,36Y_9- MC_SY6_\ WZ7_ H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_[]O_ /$T?\+*\-?] M!1/^_;__ !-;G]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_X4 82_$SPRW35%_& M*0?^RTO_ LKPU_T%$_[]O\ _$UF_#73[6;3=4,EM#(1J,R@M&#@?+Q77?V3 M8_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K< M_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A9 M7AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97 MAK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ MSY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_G MRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H M*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H* M)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ M?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ MOTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ M (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H MP_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"% M']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FM MS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ MA97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X M:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY M6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^ M?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z" MB?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B M?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I M?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[ M]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W M_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ M^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* , M/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V3 M8_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K< M_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A9 M7AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97 MAK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ MSY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFMS^R;'_G MRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ (FC_A97AK_H M*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H P_\ A97AK_H* M)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"%']DV/_/E;_\ M?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FMS^R;'_GRM_\ MOTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X:_Z"B?\ ?M__ M (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY6_\ WZ7_ H MP_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^?*W_ ._2_P"% M']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z"B?\ ?M__ (FM MS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,/_A97AK_ *"B?]^W_P#B:/\ MA97AK_H*)_W[?_XFMS^R;'_GRM_^_2_X4?V38_\ /E;_ /?I?\* ,/\ X65X M:_Z"B?\ ?M__ (FC_A97AK_H*)_W[?\ ^)K<_LFQ_P"?*W_[]+_A1_9-C_SY M6_\ WZ7_ H P_\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:W/[)L?^ M?*W_ ._2_P"%']DV/_/E;_\ ?I?\* ,/_A97AK_H*)_W[?\ ^)H_X65X:_Z" MB?\ ?M__ (FMS^R;'_GRM_\ OTO^%']DV/\ SY6__?I?\* ,,_$SPTHS_:B? M]^G_ /B:/^%E^&O^@HG_ '[?_P")J/Q]IMI#X.U1X[6%'$7#+& 1R/:J>DZ? M:MI-D3;0DF!"28Q_='M0!H?\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 3 M47]FVG_/K#_W['^%']FVG_/K#_W['^% $O\ PLKPU_T%$_[]O_\ $T?\+*\- M?]!1/^_;_P#Q-1?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X4 2_\+*\-?]!1 M/^_;_P#Q-'_"RO#7_043_OV__P 347]FVG_/K#_W['^%']FVG_/K#_W['^% M$O\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-1?V;:?\^L/_ '['^%'] MFVG_ #ZP_P#?L?X4 2_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 347]F MVG_/K#_W['^%']FVG_/K#_W['^% $O\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1 M/^_;_P#Q-1?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X4 2_\+*\-?]!1/^_; M_P#Q-'_"RO#7_043_OV__P 347]FVG_/K#_W['^%']FVG_/K#_W['^% $O\ MPLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-1?V;:?\^L/_ '['^%']FVG_ M #ZP_P#?L?X4 2_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 347]FVG_/ MK#_W['^%']FVG_/K#_W['^% $O\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_; M_P#Q-1?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X4 2_\+*\-?]!1/^_;_P#Q M-'_"RO#7_043_OV__P 347]FVG_/K#_W['^%']FVG_/K#_W['^% $O\ PLKP MU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-1?V;:?\^L/_ '['^%']FVG_ #ZP M_P#?L?X4 2_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 347]FVG_/K#_W M['^%']FVG_/K#_W['^% $O\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q M-1?V;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X4 2_\+*\-?]!1/^_;_P#Q-'_" MRO#7_043_OV__P 347]FVG_/K#_W['^%']FVG_/K#_W['^% $O\ PLKPU_T% M$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-1?V;:?\^L/_ '['^%']FVG_ #ZP_P#? ML?X4 2_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 347]FVG_/K#_W['^% M']FVG_/K#_W['^% $O\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-1?V M;:?\^L/_ '['^%']FVG_ #ZP_P#?L?X4 2_\+*\-?]!1/^_;_P#Q-'_"RO#7 M_043_OV__P 347]FVG_/K#_W['^%']FVG_/K#_W['^% $O\ PLKPU_T%$_[] MO_\ $TA^)GAE ,%0#(XZT =3_PLKPU_P!!1/\ OV__ ,31_P +*\-?]!1/^_;_ /Q-1?V; M:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A0!+_P +*\-?]!1/^_;_ /Q-'_"RO#7_ M $%$_P"_;_\ Q-1?V;:?\^L/_?L?X4?V;:?\^L/_ '['^% $O_"RO#7_ $%$ M_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$U%_9MI_P ^L/\ W['^%']FVG_/K#_W M['^% $O_ LKPU_T%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$U%_9MI_SZP_] M^Q_A1_9MI_SZP_\ ?L?X4 2_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV M_P#\347]FVG_ #ZP_P#?L?X4?V;:?\^L/_?L?X4 2_\ "RO#7_043_OV_P#\ M31_PLKPU_P!!1/\ OV__ ,347]FVG_/K#_W['^%']FVG_/K#_P!^Q_A0!+_P MLKPU_P!!1/\ OV__ ,31_P +*\-?]!1/^_;_ /Q-1?V;:?\ /K#_ -^Q_A1_ M9MI_SZP_]^Q_A0!+_P +*\-?]!1/^_;_ /Q-'_"RO#7_ $%$_P"_;_\ Q-1? MV;:?\^L/_?L?X4?V;:?\^L/_ '['^% $O_"RO#7_ $%$_P"_;_\ Q-'_ LK MPU_T%$_[]O\ _$U%_9MI_P ^L/\ W['^%']FVG_/K#_W['^% $O_ LKPU_T M%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$U%_9MI_SZP_]^Q_A1_9MI_SZP_\ M?L?X4 2_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV_P#\347]FVG_ #ZP M_P#?L?X4?V;:?\^L/_?L?X4 2_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ MOV__ ,347]FVG_/K#_W['^%']FVG_/K#_P!^Q_A0!+_PLKPU_P!!1/\ OV__ M ,31_P +*\-?]!1/^_;_ /Q-1?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A0!+ M_P +*\-?]!1/^_;_ /Q-'_"RO#7_ $%$_P"_;_\ Q-1?V;:?\^L/_?L?X4?V M;:?\^L/_ '['^% $O_"RO#7_ $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$U% M_9MI_P ^L/\ W['^%']FVG_/K#_W['^% $O_ LKPU_T%$_[]O\ _$T?\+*\ M-?\ 043_ +]O_P#$U%_9MI_SZP_]^Q_A1_9MI_SZP_\ ?L?X4 2_\+*\-?\ M043_ +]O_P#$T?\ "RO#7_043_OV_P#\347]FVG_ #ZP_P#?L?X4?V;:?\^L M/_?L?X4 2_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ OV__ ,347]FVG_/K M#_W['^%']FVG_/K#_P!^Q_A0!+_PLKPU_P!!1/\ OV__ ,31_P +*\-?]!1/ M^_;_ /Q-1?V;:?\ /K#_ -^Q_A1_9MI_SZP_]^Q_A0!+_P +*\-?]!1/^_;_ M /Q-'_"RO#7_ $%$_P"_;_\ Q-1?V;:?\^L/_?L?X4?V;:?\^L/_ '['^% $ MO_"RO#7_ $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$T^UTRS.[-I >G_ "S7 M_"I_[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XF MK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65 MX:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_ MW[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% % M7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[ M+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_ MSZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG M_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B M:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X: M_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^ M_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I M?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XF MK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65 MX:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_ MW[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% % M7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[ M+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_ MSZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG M_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B M:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X: M_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^ M_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I M?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XF MHO[-M/\ GUA_[]C_ H_LVT_Y]8?^_8_PH E_P"%E>&O^@HG_?M__B:/^%E> M&O\ H*)_W[?_ .)J+^S;3_GUA_[]C_"C^S;3_GUA_P"_8_PH E_X65X:_P"@ MHG_?M_\ XFC_ (65X:_Z"B?]^W_^)J+^S;3_ )]8?^_8_P */[-M/^?6'_OV M/\* )?\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:B_LVT_Y]8?^_8_P MH_LVT_Y]8?\ OV/\* )?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:B M_LVT_P"?6'_OV/\ "C^S;3_GUA_[]C_"@"7_ (65X:_Z"B?]^W_^)H_X65X: M_P"@HG_?M_\ XFHO[-M/^?6'_OV/\*/[-M/^?6'_ +]C_"@"7_A97AK_ *"B M?]^W_P#B:/\ A97AK_H*)_W[?_XFHO[-M/\ GUA_[]C_ H_LVT_Y]8?^_8_ MPH E_P"%E>&O^@HG_?M__B:/^%E>&O\ H*)_W[?_ .)J+^S;3_GUA_[]C_"C M^S;3_GUA_P"_8_PH E_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)J+^ MS;3_ )]8?^_8_P */[-M/^?6'_OV/\* )?\ A97AK_H*)_W[?_XFC_A97AK_ M *"B?]^W_P#B:B_LVT_Y]8?^_8_PH_LVT_Y]8?\ OV/\* )?^%E>&O\ H*)_ MW[?_ .)H_P"%E>&O^@HG_?M__B:B_LVT_P"?6'_OV/\ "C^S;3_GUA_[]C_" M@"7_ (65X:_Z"B?]^W_^)H_X65X:_P"@HG_?M_\ XFHO[-M/^?6'_OV/\*/[ M-M/^?6'_ +]C_"@"7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFHO[- MM/\ GUA_[]C_ H_LVT_Y]8?^_8_PH E_P"%E>&O^@HG_?M__B:/^%E>&O\ MH*)_W[?_ .)J+^S;3_GUA_[]C_"C^S;3_GUA_P"_8_PH E_X65X:_P"@HG_? MM_\ XFC_ (65X:_Z"B?]^W_^)J+^S;3_ )]8?^_8_P */[-M/^?6'_OV/\* M)?\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:B_LVT_Y]8?^_8_PH_LV MT_Y]8?\ OV/\* )?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:B_LVT M_P"?6'_OV/\ "C^S;3_GUA_[]C_"@"7_ (65X:_Z"B?]^W_^)H_X65X:_P"@ MHG_?M_\ XFHO[-M/^?6'_OV/\*/[-M/^?6'_ +]C_"@"7_A97AK_ *"B?]^W M_P#B:/\ A97AK_H*)_W[?_XFHO[-M/\ GUA_[]C_ H_LVT_Y]8?^_8_PH E M_P"%E>&O^@HG_?M__B:/^%E>&O\ H*)_W[?_ .)J+^S;3_GUA_[]C_"KD&EV M?E+_ *)!_P!^U_PH @_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_ M9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O M^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W M_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X M65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y M](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D M'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ M (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ MH*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO M^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_" MC^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_ M9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O M^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W M_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X M65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y M](/^_2_X4 5?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D M'_?I?\*/[+LO^?2#_OTO^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[ M?_XFK7]EV7_/I!_WZ7_"C^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ M (65X:_Z"B?]^W_^)JU_9=E_SZ0?]^E_PH_LNR_Y](/^_2_X4 5?^%E>&O\ MH*)_W[?_ .)H_P"%E>&O^@HG_?M__B:M?V79?\^D'_?I?\*/[+LO^?2#_OTO M^% %7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFK7]EV7_/I!_WZ7_" MC^R[+_GT@_[]+_A0!5_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)J6Z MTRS$8Q:0=?\ GFO^%5?[-M/^?6'_ +]C_"@"7_A97AK_ *"B?]^W_P#B:/\ MA97AK_H*)_W[?_XFHO[-M/\ GUA_[]C_ H_LVT_Y]8?^_8_PH E_P"%E>&O M^@HG_?M__B:/^%E>&O\ H*)_W[?_ .)J+^S;3_GUA_[]C_"C^S;3_GUA_P"_ M8_PH E_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)J+^S;3_ )]8?^_8 M_P */[-M/^?6'_OV/\* )?\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B M:B_LVT_Y]8?^_8_PH_LVT_Y]8?\ OV/\* )?^%E>&O\ H*)_W[?_ .)H_P"% ME>&O^@HG_?M__B:B_LVT_P"?6'_OV/\ "C^S;3_GUA_[]C_"@"7_ (65X:_Z M"B?]^W_^)H_X65X:_P"@HG_?M_\ XFHO[-M/^?6'_OV/\*/[-M/^?6'_ +]C M_"@"7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFHO[-M/\ GUA_[]C_ M H_LVT_Y]8?^_8_PH E_P"%E>&O^@HG_?M__B:/^%E>&O\ H*)_W[?_ .)J M+^S;3_GUA_[]C_"C^S;3_GUA_P"_8_PH E_X65X:_P"@HG_?M_\ XFC_ (65 MX:_Z"B?]^W_^)J+^S;3_ )]8?^_8_P */[-M/^?6'_OV/\* )?\ A97AK_H* M)_W[?_XFC_A97AK_ *"B?]^W_P#B:B_LVT_Y]8?^_8_PH_LVT_Y]8?\ OV/\ M* )?^%E>&O\ H*)_W[?_ .)H_P"%E>&O^@HG_?M__B:B_LVT_P"?6'_OV/\ M"C^S;3_GUA_[]C_"@"7_ (65X:_Z"B?]^W_^)H_X65X:_P"@HG_?M_\ XFHO M[-M/^?6'_OV/\*/[-M/^?6'_ +]C_"@"7_A97AK_ *"B?]^W_P#B:/\ A97A MK_H*)_W[?_XFHO[-M/\ GUA_[]C_ H_LVT_Y]8?^_8_PH E_P"%E>&O^@HG M_?M__B:/^%E>&O\ H*)_W[?_ .)J+^S;3_GUA_[]C_"C^S;3_GUA_P"_8_PH M E_X65X:_P"@HG_?M_\ XFC_ (65X:_Z"B?]^W_^)J+^S;3_ )]8?^_8_P * M/[-M/^?6'_OV/\* )?\ A97AK_H*)_W[?_XFC_A97AK_ *"B?]^W_P#B:B_L MVT_Y]8?^_8_PH_LVT_Y]8?\ OV/\* )?^%E>&O\ H*)_W[?_ .)H_P"%E>&O M^@HG_?M__B:B_LVT_P"?6'_OV/\ "C^S;3_GUA_[]C_"@"7_ (65X:_Z"B?] M^W_^)H_X65X:_P"@HG_?M_\ XFHO[-M/^?6'_OV/\*/[-M/^?6'_ +]C_"@" M7_A97AK_ *"B?]^W_P#B:/\ A97AK_H*)_W[?_XFHO[-M/\ GUA_[]C_ H_ MLVT_Y]8?^_8_PH E_P"%E>&O^@HG_?M__B:/^%E>&O\ H*)_W[?_ .)J33], MLVO(P;2 CG_EFOH?:MC^R;'_ )\K?_OTO^% &'_PLKPU_P!!1/\ OV__ ,31 M_P +*\-?]!1/^_;_ /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ ._2_P"% &'_ M ,+*\-?]!1/^_;__ !-'_"RO#7_043_OV_\ \36Y_9-C_P ^5O\ ]^E_PH_L MFQ_Y\K?_ +]+_A0!A_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ OV__ ,36 MY_9-C_SY6_\ WZ7_ H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_[]O_ /$T?\+* M\-?]!1/^_;__ !-;G]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_X4 8?_"RO#7_ M $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$UN?V38_P#/E;_]^E_PH_LFQ_Y\ MK?\ []+_ (4 8?\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-;G]DV/_ M #Y6_P#WZ7_"C^R;'_GRM_\ OTO^% &'_P +*\-?]!1/^_;_ /Q-'_"RO#7_ M $%$_P"_;_\ Q-;G]DV/_/E;_P#?I?\ "C^R;'_GRM_^_2_X4 8?_"RO#7_0 M43_OV_\ \31_PLKPU_T%$_[]O_\ $UN?V38_\^5O_P!^E_PH_LFQ_P"?*W_[ M]+_A0!A_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV_P#\36Y_9-C_ ,^5 MO_WZ7_"C^R;'_GRM_P#OTO\ A0!A_P#"RO#7_043_OV__P 31_PLKPU_T%$_ M[]O_ /$UN?V38_\ /E;_ /?I?\*/[)L?^?*W_P"_2_X4 8?_ LKPU_T%$_[ M]O\ _$T?\+*\-?\ 043_ +]O_P#$UN?V38_\^5O_ -^E_P */[)L?^?*W_[] M+_A0!A_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 36Y_9-C_SY6__ 'Z7 M_"C^R;'_ )\K?_OTO^% &'_PLKPU_P!!1/\ OV__ ,31_P +*\-?]!1/^_;_ M /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ ._2_P"% &'_ ,+*\-?]!1/^_;__ M !-'_"RO#7_043_OV_\ \36Y_9-C_P ^5O\ ]^E_PH_LFQ_Y\K?_ +]+_A0! MA_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ OV__ ,36Y_9-C_SY6_\ WZ7_ M H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_[]O_ /$T?\+*\-?]!1/^_;__ !-; MG]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_X4 8?_"RO#7_ $%$_P"_;_\ Q-'_ M LKPU_T%$_[]O\ _$UN?V38_P#/E;_]^E_PH_LFQ_Y\K?\ []+_ (4 8?\ MPLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-;G]DV/_ #Y6_P#WZ7_"C^R; M'_GRM_\ OTO^% &'_P +*\-?]!1/^_;_ /Q-'_"RO#7_ $%$_P"_;_\ Q-;G M]DV/_/E;_P#?I?\ "C^R;'_GRM_^_2_X4 8?_"RO#7_043_OV_\ \31_PLKP MU_T%$_[]O_\ $UN?V38_\^5O_P!^E_PH_LFQ_P"?*W_[]+_A0!A_\+*\-?\ M043_ +]O_P#$T?\ "RO#7_043_OV_P#\36Y_9-C_ ,^5O_WZ7_"C^R;'_GRM M_P#OTO\ A0!A_P#"RO#7_043_OV__P 31_PLKPU_T%$_[]O_ /$UN?V38_\ M/E;_ /?I?\*/[)L?^?*W_P"_2_X4 8?_ LKPU_T%$_[]O\ _$T?\+*\-?\ M043_ +]O_P#$UN?V38_\^5O_ -^E_P */[)L?^?*W_[]+_A0!A_\+*\-?]!1 M/^_;_P#Q-'_"RO#7_043_OV__P 36Y_9-C_SY6__ 'Z7_"C^R;'_ )\K?_OT MO^% &'_PLKPU_P!!1/\ OV__ ,31_P +*\-?]!1/^_;_ /Q-;G]DV/\ SY6_ M_?I?\*/[)L?^?*W_ ._2_P"% &'_ ,+*\-?]!1/^_;__ !-'_"RO#7_043_O MV_\ \36Y_9-C_P ^5O\ ]^E_PH_LFQ_Y\K?_ +]+_A0!A_\ "RO#7_043_OV M_P#\31_PLKPU_P!!1/\ OV__ ,36Y_9-C_SY6_\ WZ7_ H_LFQ_Y\K?_OTO M^% &'_PLKPU_T%$_[]O_ /$T?\+*\-?]!1/^_;__ !-;G]DV/_/E;_\ ?I?\ M*/[)L?\ GRM_^_2_X4 8?_"RO#7_ $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ M_$UN?V38_P#/E;_]^E_PH_LFQ_Y\K?\ []+_ (4 8?\ PLKPU_T%$_[]O_\ M$T?\+*\-?]!1/^_;_P#Q-;G]DV/_ #Y6_P#WZ7_"C^R;'_GRM_\ OTO^% &' M_P +*\-?]!1/^_;_ /Q-'_"RO#7_ $%$_P"_;_\ Q-;G]DV/_/E;_P#?I?\ M"C^R;'_GRM_^_2_X4 8?_"RO#7_043_OV_\ \31_PLKPU_T%$_[]O_\ $UN? MV38_\^5O_P!^E_PH_LFQ_P"?*W_[]+_A0!A_\+*\-?\ 043_ +]O_P#$T?\ M"RO#7_043_OV_P#\36Y_9-C_ ,^5O_WZ7_"C^R;'_GRM_P#OTO\ A0!A_P#" MRO#7_043_OV__P 31_PLKPU_T%$_[]O_ /$UN?V38_\ /E;_ /?I?\*/[)L? M^?*W_P"_2_X4 8?_ LKPU_T%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$UN?V M38_\^5O_ -^E_P */[)L?^?*W_[]+_A0!A_\+*\-?]!1/^_;_P#Q-'_"RO#7 M_043_OV__P 36Y_9-C_SY6__ 'Z7_"C^R;'_ )\K?_OTO^% &'_PLKPU_P!! M1/\ OV__ ,31_P +*\-?]!1/^_;_ /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ M ._2_P"% &'_ ,+*\-?]!1/^_;__ !-'_"RO#7_043_OV_\ \36Y_9-C_P ^ M5O\ ]^E_PH_LFQ_Y\K?_ +]+_A0!A_\ "RO#7_043_OV_P#\31_PLKPU_P!! M1/\ OV__ ,36Y_9-C_SY6_\ WZ7_ H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_ M[]O_ /$T?\+*\-?]!1/^_;__ !-;G]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_ MX4 8?_"RO#7_ $%$_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$UN?V38_P#/E;_] M^E_PH_LFQ_Y\K?\ []+_ (4 8?\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_; M_P#Q-;G]DV/_ #Y6_P#WZ7_"C^R;'_GRM_\ OTO^% &'_P +*\-?]!1/^_;_ M /Q-'_"RO#7_ $%$_P"_;_\ Q-;G]DV/_/E;_P#?I?\ "C^R;'_GRM_^_2_X M4 8?_"RO#7_043_OV_\ \31_PLKPU_T%$_[]O_\ $UN?V38_\^5O_P!^E_PH M_LFQ_P"?*W_[]+_A0!A_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV_P#\ M36Y_9-C_ ,^5O_WZ7_"C^R;'_GRM_P#OTO\ A0!A_P#"RO#7_043_OV__P 3 M1_PLKPU_T%$_[]O_ /$UN?V38_\ /E;_ /?I?\*/[)L?^?*W_P"_2_X4 8?_ M LKPU_T%$_[]O\ _$T?\+*\-?\ 043_ +]O_P#$UN?V38_\^5O_ -^E_P * M/[)L?^?*W_[]+_A0!A_\+*\-?]!1/^_;_P#Q-'_"RO#7_043_OV__P 36Y_9 M-C_SY6__ 'Z7_"C^R;'_ )\K?_OTO^% &'_PLKPU_P!!1/\ OV__ ,31_P + M*\-?]!1/^_;_ /Q-;G]DV/\ SY6__?I?\*/[)L?^?*W_ ._2_P"% &'_ ,+* M\-?]!1/^_;__ !-'_"RO#7_043_OV_\ \36Y_9-C_P ^5O\ ]^E_PH_LFQ_Y M\K?_ +]+_A0!A_\ "RO#7_043_OV_P#\31_PLKPU_P!!1/\ OV__ ,36Y_9- MC_SY6_\ WZ7_ H_LFQ_Y\K?_OTO^% &'_PLKPU_T%$_[]O_ /$T?\+*\-?] M!1/^_;__ !-;G]DV/_/E;_\ ?I?\*/[)L?\ GRM_^_2_X4 8?_"RO#7_ $%$ M_P"_;_\ Q-'_ LKPU_T%$_[]O\ _$UN?V38_P#/E;_]^E_PH_LFQ_Y\K?\ M[]+_ (4 8?\ PLKPU_T%$_[]O_\ $T?\+*\-?]!1/^_;_P#Q-;G]DV/_ #Y6 M_P#WZ7_"C^R;'_GRM_\ OTO^% &'_P +*\-?]!1/^_;_ /Q-'_"RO#7_ $%$ M_P"_;_\ Q-;G]DV/_/E;_P#?I?\ "C^R;'_GRM_^_2_X4 8?_"RO#7_043_O MV_\ \31_PLKPU_T%$_[]O_\ $UN?V38_\^5O_P!^E_PH_LFQ_P"?*W_[]+_A M0!A_\+*\-?\ 043_ +]O_P#$T?\ "RO#7_043_OV_P#\36Y_9-C_ ,^5O_WZ M7_"C^R;'_GRM_P#OTO\ A0!A_P#"RO#7_043_OV__P 31_PLKPU_T%$_[]O_ M /$UN?V38_\ /E;_ /?I?\*/[)L?^?*W_P"_2_X4 8?_ LKPU_T%$_[]O\ M_$T'XE^&A_S%%_"*0_\ LM;G]DV/_/E;_P#?I?\ "N1^)^GVMOX95XK:&-OM M,0W)& >M 'BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH L6G\?X58JO:?Q_A5B@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@#/HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M**** "BBB@ HHHH *N6_^I7_ #WJG5RW_P!2O^>] $E%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 0W7^K'UJK5JZ_U8^M5: "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@"SI__ !^1_C_(UM5BZ?\ \?D?X_R-;5 !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 5QWQ4_Y%=?^OJ+^==C7'?%3_D5U_P"OJ+^= '8T444 %%%% !1110!QTG_) M68O^P3_[4-=C7'2?\E9B_P"P3_[4-=C0 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4R;_5/_ +II],F_U3_[IH Y3X4_\B/8?[TG M_HQJZZN1^%/_ "(]A_O2?^C&KKJ "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** ..^&/_(+U7_L)S?^RUV-<=\,?^07JO\ V$YO_9:[&@#R[]I3XV_\,\_" M/5/&_P#8O]O_ &*6"+[#]J^S;_,E6//F;'QC=G[ISBO!?V;O^"D6C_'?XG6G M@W5/"/\ PA\]_&PL;IM5%VDTXY$)'DQ[2PW8.3D@#&2*ZK_@I1_R:1XG_P"O MNQ_]*8Z_&_2]3N]%U*TU"PN)+2^M)5G@GB.'CD4AE8'L00#6V&49N7M-D[?@ MO\R,1S1C'DW:_5G]&-?'/[3G_!0[_AG+XK77@O\ X0#_ (2'R+:&Y^W?VS]F MW>8N[;L^SOT]=W->P_LF_'^U_:*^#NF>(MT::W;C['J]JG'E72@;F [*X(<> MS8[&OS7_ ."G'_)UFJ?]@RR_]%UG.+IUHTWW_1L<)*=*4UV_5(_6WX?^*O\ MA.O ?AWQ)]E^P_VOIUO?_9?,\SRO-C5]F[ W8W8S@9QT%>!?M4?MX>$_V;=0 M&@6]A)XJ\7M&LKZ;!,(H;56^Z9I<-M8CD(%)(QG:""?7OV?_ /D@_P .^_\ MQ3UA_P"DZ5^)^M:I:>.OVC+N]\>7L]MINI>)&_M>Y!)>&!KC$F#VVID#T Z< M8K:5-2Q;H1T5W^=C*G4MA56EJ[+\5?\ 0^DKK_@K5\4GO&:V\+>$(K7=\L4M MO=.X'H7%PH)]]M>[?L]_\%0M!^(GB*Q\.^/-#3PE?7CK#!JMK<&2R:1C@"0, M T()P 2HYKZ"\*_LR_ F\\)V2Z+\/O!VK:/-"/(OEL8+QI4(X87#!G;_ M 'MQ/O7P5^TK_P $X/'-K\5M0E^$WA-M2\&W4:7$*-J=M%]ED.0\(\Z57(!& M0>>& R<4U*FI\DHZ?U]P2 9V1)D9/3))"C(R12?L\V/BO2?@GX/L/'-J]EXJL;!+6^CDGCG;=&2 MBL7C9E8LBJQ()Z\\U^0'[4GQ8UG]IC]HK4&M))+NT^W_ -C:#9AOD6(2>6FT M=C(WSD^K>@%8NFY5O84W?S\O^#T-8R7LO;35MM/-GT)XT_X*X^+;C4''A'P1 MHNG62L0IUJ6:[D<9X)$;1!3CM\V/4UI_#;_@KAJJZE%#X^\%6,MB[@/>>'9' MBDA7U$,K.'^F]:^E_@3^P3\+OA3X3LX-;\,Z9XR\1O$IO]1UJV6Z1I",L(HI M 410<@8&XCJ37E_[:W[!/A;7_ -]XJ^&?A==(\6:<%D;2=$MR(M0BR R+ @P M) #N&P#.""#D$:2E3I.UKHB,9U5>]F?8GP_^(7A_XI>$[#Q+X7U.'5M&ODW1 M7$61[%64\JP/!4@$&O#_ -K[]L;_ (93F\,1_P#"(_\ "4?VVMPV?[3^Q^3Y M1C_Z8R;L^9[8QWKQC_@FK\.?B_\ "75/$&E^+?">HZ/X+U2W%W"]_)&A@O%( M7B(MO&]"<_+_ ,LUS7*?\%?O^/SX8_\ 7/4/YP5-:*A5A&+T?^3T^]%T6YPD MY+5+^F?7O[*?[1G_ TY\-[KQ7_PCW_"->1J,EA]D^V_:MVQ(VW[_+3&=^,8 M[=:]GKXQ_P""4O\ R;CJO_8PW'_HF"OLZM,1",*G+':R_)&5"3G"\N[_ #85 MY_\ &KXZ>$/@#X0D\0^+]1^RVY)2WM80'N;N3&?+B3(W'W) '4D#FO0*_$/] MK[XO:O\ M$_M$ZHEK))=:?:7IT;1+)3\NQ9-@91_>D?YB?<#L*YHQE4J*G'= M_P!?>=#:A!U);(]_\PL58A'UR66ZE=<\$K$T04D=LM MCU-7/AS_ ,%<-9CU**+QYX)T^XL7M?2OP!_8&^& M7PJ\(V,?B'PUIOC'Q/)"K7]]K-NMU%YA&2D43@HJJ20#C<>I/IY[^V=^P3X2 M\3?#W4?$WPW\+QZ+XNTU/.&F:';[8M0C!^:,0(,"3&2I0 DC!SD8WE*G2=K7 M1C&,ZJO>S>W]?Y_,^N/AS\2/#OQ9\(6/B;PMJ<6JZ/>+F.:/(*L/O(ZGE6!X M*GD5T-U<1V=O+/,P2*)"[L>@4#)/Y5\ ?\$UOAK\8?A)XCUVP\4^$=2T?P3J MUM]H#W[QQF"[0@*1$S;QN0LI^7^%,]*^H_VO?'/_ KO]FOQ_K"R^3 M$;>TS\L4\%U+(!Z%Q.H)]]HKV?X#_P#!4_1?&6O66A_$/0(_"TMTZQ)K5C.9 M+,2$X'FHPW1+G^+< $U]$> _V:?@+>>#;!O#W@/P?KNBRPCR-1:R@OGF M7'WOM#AF8^^ZOA_]J;_@G'XOC^*4UW\'O"?V_P )WL"SFW_M*VA%G.20\2B> M56*\!AU W$9XQ0I4XS4)1T_K[A< X.,:B4)N*=]=/,UIN4XIM M6[GNM%? W@7_ (*V^%]:\10V?BCP->^&=*E8)_:5KJ OO*R<;GC\J,[1U.TL M?0&O3/B1_P %)OA7\-/&5UX=NM/\1ZQ+"D,JW^D6]M+:SI+$DJ-&[7"D@JZ_ MPBJ]E.Z26XE*+OY'U;17'?%3XI:5\(?AOJ_C;6;>\N=*TR%)YH;%$>=E9U4! M0S*I.6'5AWKRW]GG]MKP-^TMXLO_ ]X8TKQ#87MG9F^DDU:V@CC*!U3 ,8?L\_MM>!OVEO%E_X>\,:5XAL+VSLS?22:M; M01QE ZI@&.9SNRX[8Z\THQ<[\NMO^'')J*3EU_K]3Z#HKS+X]?M$>#?V<_"L M>M^+;R53<.8[/3[-!)S MN_"GB>=2;>ROG62&Y(!)6*5<98 $[652>V>:]C^-_P 9=%^ ?P[O_&?B"UO[ MS2[.2**2'38T>T5\L^&_P#@H]\) M?$7@;Q'XID76]&L]&DAA^RZE;PBYO990Y2.W2.9]QQ&V2Q4#@DXYKQVW_P"" MO6AMKPAG^&NH1Z)OQ]LCU6-[G9Z^08@N?;S/QJO9RYN6VO\ 3%S1MS7/T(HK MYJ^(W_!0'X4> _AWHOBFVU*7Q%+K4)FL-(T\#[20"5;S@Q B"L"IW)-'L=6TN[BOM-OH4N+:ZA;I.EA\+[JYT\-\L]SK:PRD>IC$#@'VWGZU]*?LZ_MJ?#S] MI"=M-T>>XT;Q(B%VT75%5)9% RS1,I*R <]"& &2H'-:^SG:]C-U(IV;/?** MYGXE>/\ 3_A7X"USQ;JT-U<:;H]JUW/%9JK3,B]0@9E!/U(KQGX ?MU> OVC MO'$OA7PUI'B.QU".SDO3)JMM;QQ;$95(S'.YSEQVQUYJ(Q*Q17F9=P&%#,H)Y'5A7COP M _;J\!?M'>.)?"OAK2/$=CJ$=G)>F35;:WCBV(RJ1F.=SG+CMCKS2BG-M1W6 MO]?<$FHI-]3Z,HKRO]H#]I/P7^S=X;@U7Q9=3-/=,R66F62"2ZNF&-VU20 H MR,LQ &0,Y(!^/KW_ (+ 6<=XRVGPKGGM,_++-KPC ?VAM;B\.QP7GACQ1(A:+3M1*M'+O^0KX=_Z_1_2@#IZ*** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@"Q:?Q_A5BJ]I_'^%6* "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** ,^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JY;_Z ME?\ />J=7+?_ %*_Y[T 24444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!#=? MZL?6JM6KK_5CZU5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +. MG_\ 'Y'^/\C6U6+I_P#Q^1_C_(UM4 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'?%3_D5U_Z^HOYUV-<= M\5/^177_ *^HOYT =C1110 4444 %%%% ''2?\E9B_[!/_M0UV-<=)_R5F+_ M +!/_M0UV- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !3)O]4_\ NFGTR;_5/_NF@#E/A3_R(]A_O2?^C&KKJY'X4_\ (CV'^])_ MZ,:NNH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X[X8_\@O5?^PG-_[+ M78UQWPQ_Y!>J_P#83F_]EKL: /E[_@I1_P FD>)_^ONQ_P#2F.O@?]C_ /9] MMOVBOAW\7M"1(U\06=K8WNCW#<;+A3/\A/97&4/U!["OOC_@I1_R:1XG_P"O MNQ_]*8Z^<_\ @D'_ ,A[XF?]>UA_Z'/6V&CS0K+^MHDXB7*Z3]/_ $IG@O[% M'Q^N_P!F?XX_8M=,EEX>U24:7K=O,"OV9U8JDS#L8W)S_LE_:MG_ (*:2+-^ MU1J3HP=&TNR964Y!!CX(->B_\%/OV;?^$3\50?%/0K7;I.M2"#5XXUXAO,?+ M*?02 <_[2GNU?%?B[QMJ_CJYTZYUFY-Y3\C.4?8RG%?#):?>O\ *S\T?N]^S]_R0GX=_P#8O:?_ M .DZ5^??[T\;:OX^^'>E3:_HNJ2M>7^DV2[[JTG8DR,D8YDC8G=A< ML"3Q@9K[O^%/B"/PG^S#X2UN:VN+V'3?"=K>/;VBAII5CM%'?$.M>% M;R.3$\%I?"'P3\4+8P^+/"FD^(!MVK)?6B22H/]B3& MY#[J0:_*7_@H5^S=X+_9Z\;>'1X+DFM;36K::>72)IS-]E*,JAD9B7V-N/WB M3E&Y[ C73DHS6_\ 7R*=%VI?:9>Z3+>6=U'G# MJ8F*G'4'U!Y!!!K\3?V384O/VFOADDR^8IU^T8AO42 @_F!7Z2?\$QKJ[UK] ME466H*SVD&JWEK;[SD&%@C,![;WD_6OS0\1:3JO[-7[1$EO- RWWA/74N(E; MCS4CE$D;#V= I^C5I1C&CC;7T?*UZ)W_ %1E4-@6C;'S1N/X74\%3R"*\K_;,_:-M?V>/A#J%[ M9ZA#!XPU!#;:+;$*\AE. 9MC9!2,98DC&=H[UQ3O3=I+4ZX6J6<=CWNOS;_X M*_?\?GPQ_P"N>H?S@KT?]A?]M+XA?M&>,K[PUXD\/Z5+::?8FZGUNP$D#(=P M5%="65FX-?@Q\0O#NJ?LX_M%7]FT+1WGAG7%N[ M3=P)(TE$L#@^C)L/XUG@Y*&*3EUM^#U_,VQ,7/#24?/\5I^7XG[TT5R?PN^) MWA_XP>"-,\4^&KZ.^TV^B#_(P+PO@;HI /NNIX(-><_M@_M#6?[//P?U74X; M^&#Q5?1-;:);,%>1IV&/-V'.5C!W'(QP ?O '"I>F[26II3M4LX['N5?#7_! M6/QS_8_P=\,^%XI-LNM:KY\BYY,4"$D?3?)&?PH_89_;8^(G[0WCJ?PKXDT# M2KFUL[%KNXUNQ5[=X\$*H=,LK,S,!A=G )P<5X9_P4RURX^(W[3_ (8\#6#^ M8]A9VUDD8YQ<5I4O6Q#=+?IZ/9?A^!G3_TVZ^N M[_,_,7PSXZ\;_"#6KA=#US6_".I1OMN(;6XEM7W#^&1 1GZ,*^K/@O\ \%2? MB#X2OK:T\?VUMXTT4L%ENHXDMK^-/_<8C KP1,P' ML&9C]6-? W[,>I1_#']JWP2^LD6:Z=KPLKHS<")BS0L6],%N?3%:4Z48XWEZ M65OGJ_T,YU)/!N2WN[_*]OOU/U@7]B3X*KX#_P"$5_X0+23;^1Y/]I&!3J.[ M'^L^TX\S=GGKCMC'%?C/\5/ LWPQ^*7B3PE/,UP^C:E+9+,PP9$1R$;';*X. M/>OZ"F8*I8D 9)-?@I^TEXML?'7[0WCS7=,D$VGWFM3M!*IR)$#[0X/H0N1 M]:SPLI/&0UWW^]6_4Z)QBJ#LMFOR9^M7[<7_ "9]X\_[!\'_ */BKXE_X),? M\EV\3_\ 8O2?^E$%?;?[<"EOV/\ QZ "3_9\!X_Z[15\._\ !)V\BA_: \06 M[MB2;P[-LZ<[;B D?7'\C2PO\6MZ/_TEG-4_W6CZK\XGVU_P4&_Y-#\?_P#7 M.T_]+(*^+/\ @DQ_R7;Q/_V+TG_I1!7V1_P45U:VTW]D?QE'<2K&]X]G;P*3 MR[_:HGP/7Y48_0&OC?\ X),?\EV\3_\ 8O2?^E$%&"^*K\__ $@UQ?\ "IK^ M\OSC_D?7_P"U=^Q/H?[26M6_B35?&NJ>'9].LOLT2%(I;*% S,S[#M())^8[ M^BCIBO/8KC]C7X%^!++P[J\_@OQ9>6\'E3WT>GQZK>W4N/G8R1K(8R3G W + MT&*^9?\ @I-\=]?\:?&[5? T=_/;>%O#OEP+81N5CN+@HKO+(!]X@L%&!3/H M*SI1T7^M_SW_,NJTJJCO)+_ "_+8^$/!^M:5I7[1VBZKX26ZM=#A\40 MSZ9'.,3);_:@8U8;C\VS /)^IK]3_P#@I1_R:1XG_P"ONQ_]*8Z_,!M,T;1? MVKH].\.H(]!L_&26]@BRF4"!+T*@#DDM\H'))S7Z?_\ !2C_ )-(\3_]?=C_ M .E,=56:EAJ+6W,M]]X!33CB:J>]GM_V\?!/_!//X"Z!\=/C-=KXIM1J.A:% M8F_DL78A+B4NJ1J^.J\LQ'?: <@D5[=_P5"^ _@CX?\ @WP=XE\*^&=+\-74 MFH/IUQ'I-JEM',AB+J61 %+ H?FQGYN<\8Q?^"1?_)2O'O\ V"(?_1U>M_\ M!6[_ )(OX._[& ?^DTU:8IM>SMY?^E6_+0RPNKJ7\_\ TF_YZGAW_!,S]F_P MI\6M6\4>*_&&E6^NV>BM#;6>G7BA[=IG#,SR1GA]JJH"MD?,3C(&,S_@IU\& M?"OPK^(_A6_\*:):>'[76K"4W%GI\2PV_FQ.HW+&N I*NN0 !QGKFO>_^"1O M_))_''_8;3_T0E/BI= MD_OM?^O-F?,XX*;CO?\ ^2_R_ _6GP?^Q/\ !GPEX)A\./X#T?60(?+GU+5+ M1)KV9B,,_G$;T)/.$*@=L5^6O[3GPONOV2?VDI;7PK?W%I#:/#K&BW6_,L,; M$E5)[[65UYZ@<]37[=12I-ⅅ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ⅅ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�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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2024
May 08, 2024
Document Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-40367  
Entity Registrant Name BARINTHUS BIOTHERAPEUTICS PLC  
Entity Incorporation, State or Country Code X0  
Entity Tax Identification Number 00-0000000  
Entity Address, Address Line One Unit 6-10, Zeus Building  
Entity Address, Address Line Two Rutherford Avenue  
Entity Address, City or Town Harwell, Didcot  
Entity Address, Country GB  
Entity Address, Postal Zip Code OX11 0DF  
City Area Code +44 (0)  
Local Phone Number 1865 818 808  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   39,033,158
Entity Central Index Key 0001828185  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
American Depositary Shares    
Document Information    
Title of 12(b) Security American Depositary Shares  
Trading Symbol BRNS  
Security Exchange Name NASDAQ  
Ordinary shares    
Document Information    
Title of 12(b) Security Ordinary shares, nominal value £0.000025 per share  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
ASSETS    
Cash, cash equivalents and restricted cash $ 129,971 $ 142,090
Research and development incentives receivable 5,196 4,908
Prepaid expenses and other current assets 7,964 9,907
Total current assets 143,131 156,905
Goodwill 12,209 12,209
Property and equipment, net 11,532 11,821
Intangible assets, net 24,317 25,108
Right of use assets, net 7,408 7,581
Other assets 885 882
Total assets 199,482 214,506
Current liabilities:    
Accounts payable 1,162 1,601
Accrued expenses and other current liabilities 8,330 9,212
Deferred income 1,434 0
Operating lease liability - current 1,909 1,785
Total current liabilities 12,835 12,598
Non-Current liabilities:    
Operating lease liability - non-current 10,897 11,191
Contingent consideration 1,867 1,823
Other non-current liabilities 1,330 1,325
Deferred tax liability, net 537 574
Total liabilities 27,466 27,511
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Ordinary shares, £0.000025 nominal value; 38,952,956 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding:38,643,540) 1 1
Additional paid-in capital 388,720 386,602
Accumulated deficit (192,079) (176,590)
Accumulated other comprehensive loss – foreign currency translation adjustments (24,895) (23,315)
Total stockholders’ equity attributable to Barinthus Biotherapeutics plc shareholders 171,833 186,784
Noncontrolling interest 183 211
Total stockholders’ equity 172,016 186,995
Total liabilities and stockholders’ equity 199,482 214,506
Deferred A shares    
Stockholders’ equity:    
Deferred A shares, £1 nominal value; 63,443 shares authorized, issued and outstanding (December 31, 2023: authorized, issued and outstanding: 63,443) $ 86 $ 86
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - £ / shares
Mar. 31, 2024
Dec. 31, 2023
Ordinary shares, nominal value (in gbp per share) £ 0.000025 £ 0.000025
Ordinary shares, authorized (in shares) 38,952,956 38,643,540
Ordinary shares, issued (in shares) 38,952,956 38,643,540
Ordinary shares, outstanding (in shares) 38,952,956 38,643,540
Deferred A shares    
Deferred shares, nominal value (in gbp per share) £ 1 £ 1
Deferred shares, authorized (in shares) 63,443 63,443
Deferred shares, issued (in shares) 63,443 63,443
Deferred shares, outstanding (in shares) 63,443 63,443
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total revenue $ 0 $ 468
Operating expenses    
Research and development 11,125 9,814
General and administrative 5,994 12,138
Total operating expenses 17,119 21,952
Other operating income 205 0
Loss from operations (16,914) (21,484)
Other income/(expense):    
Interest income 775 1,588
Interest expense (12) 0
Research and development incentives 594 1,157
Total other income, net 1,357 2,745
Loss before income tax (15,557) (18,739)
Tax benefit 37 516
Net loss (15,520) (18,223)
Net loss attributable to noncontrolling interest 31 43
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (15,489) $ (18,180)
Weighted-average ordinary shares outstanding, basic (in shares) 38,773,482 38,013,399
Weighted-average ordinary shares outstanding, diluted (in shares) 38,773,482 38,013,399
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (0.40) $ (0.48)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (0.40) $ (0.48)
Net loss $ (15,520) $ (18,223)
Other comprehensive (loss)/gain – foreign currency translation adjustments (1,577) 4,580
Comprehensive loss (17,097) (13,643)
Comprehensive loss attributable to noncontrolling interest 28 37
Comprehensive loss attributable to Barinthus Biotherapeutics plc shareholders (17,069) (13,606)
License revenue    
Total revenue [1] $ 0 $ 468
[1] Includes license revenue from related parties for the three months ended March 31, 2024 and 2023 of nil and $0.5 million, respectively.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue recognized $ 0 $ 468
Related Parties    
Revenue recognized $ 0 $ 500
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] License revenue License revenue
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total stockholders’ equity attributable to Barinthus Biotherapeutics plc stockholders
Ordinary Shares
Additional Paid-in-Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Non-Controlling Interest
Deferred A Shares
Deferred Shares
Deferred B Shares
Deferred Shares
Deferred C Shares
Deferred Shares
Beginning balance (in shares) at Dec. 31, 2022     37,683,531         63,443 570,987 27,828,231
Beginning balance at Dec. 31, 2022 $ 243,201 $ 242,896 $ 1 $ 379,504 $ (103,243) $ (33,460) $ 305 $ 86 $ 8 $ 0 [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation 2,222 2,222   2,222            
Issue of ordinary shares, net of issuance cost (in shares)     673,494              
Issue of ordinary shares, net of issuance costs 1,789 1,789 $ 0 [1] 1,789            
Foreign currency translation adjustments 4,580 4,574       4,574 6      
Cancellation of deferred shares (in shares)                 (570,987) (27,828,231)
Cancellation of deferred shares 0     8         $ (8) $ 0 [1]
Net loss (18,223) (18,180)     (18,180)   (43)      
Ending balance (in shares) at Mar. 31, 2023     38,357,025         63,443 0 0
Ending balance at Mar. 31, 2023 233,569 233,301 $ 1 383,523 (121,423) (28,886) 268 $ 86 $ 0 $ 0
Beginning balance (in shares) at Dec. 31, 2023     38,643,540         63,443    
Beginning balance at Dec. 31, 2023 186,995 186,784 $ 1 386,602 (176,590) (23,315) 211 $ 86    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Share based compensation 1,615 1,615   1,615            
Issue of ordinary shares, net of issuance cost (in shares)     309,416              
Issue of ordinary shares, net of issuance costs 503 503 $ 0 [1] 503            
Foreign currency translation adjustments (1,577) (1,580)       (1,580) 3      
Net loss (15,520) (15,489)     (15,489)   (31)      
Ending balance (in shares) at Mar. 31, 2024     38,952,956         63,443    
Ending balance at Mar. 31, 2024 $ 172,016 $ 171,833 $ 1 $ 388,720 $ (192,079) $ (24,895) $ 183 $ 86    
[1] Indicates amount less than one thousand
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (15,520) $ (18,223)
Adjustments to reconcile net (loss)/income to net cash used in operating activities:    
Share based compensation 1,615 2,222
Depreciation and amortization 1,430 1,221
Non-cash lease expenses 359 279
Unrealized foreign exchange (gain)/loss (1,026) 3,504
Change in contingent consideration 60 85
Non cash interest expense 12 0
Deferred tax benefit (37) (516)
Changes in operating assets and liabilities:    
Accounts receivable (including related parties) 0 4,961
Prepaid expenses and other current assets 1,875 4,090
Research and development incentives receivable (331) 2,102
Accounts payable (524) (1,707)
Accrued expenses and other current liabilities (823) (1,315)
Deferred income 1,434 0
Operating lease liabilities (346) 0
Other assets 0 123
Net cash used in operating activities (11,822) (3,174)
Net cash used in operating activities    
Purchases of property and equipment (308) (2,507)
Net cash used in investing activities (308) (2,507)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issue of ordinary shares, net of issuance costs 503 1,789
Issue of shares from the exercise of stock options [1] 0 0
Payment of contingent consideration 0 (100)
Net cash provided by financing activities 503 1,689
Effect of exchange rates on cash, cash equivalents and restricted cash (492) 935
Net decrease in cash, cash equivalents and restricted cash (12,119) (3,057)
Cash, cash equivalents and restricted cash, beginning of the period 142,090 194,385
Cash, cash equivalents and restricted cash, end of the period 129,971 191,328
Supplemental cash flow disclosures:    
Cash paid for interest 0 0 [1]
Cash paid for income taxes 0 0 [1]
Non-Cash investing and financing activities    
Issue of ordinary shares 0 0 [1]
Purchases of property and equipment included in accounts payable and accrued liabilities 95 2,247
Asset retirement obligation 0 282
Changes to right-of-use asset resulting from lease reassessment event $ 0 $ 4
[1] Indicates amounts less than one thousand
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Business and Basis of Presentation
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business and Basis of Presentation Nature of Business and Basis of Presentation
Barinthus Biotherapeutics plc is a public limited company incorporated pursuant to the laws of England and Wales in March 2021. Barinthus Biotherapeutics plc and its direct and indirect subsidiaries, Barinthus Biotherapeutics (UK) Limited, Barinthus Australia Pty Limited, Vaccitech Oncology Limited (“VOLT”), Barinthus Biotherapeutics North America, Inc., Barinthus Biotherapeutics Switzerland GmbH and Barinthus Biotherapeutics S.R.L., are collectively referred to as the “Company” or “Barinthus Bio”. The Company is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. The Company is headquartered in Harwell, Oxfordshire, United Kingdom.
The Company operates in an environment of rapid technological change and substantial competition from pharmaceutical and biotechnology companies. The Company is subject to risks common to companies in the biopharmaceutical industry in a similar stage of its life cycle including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its vaccine product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of any of its products that are approved, and protection of proprietary technology. There can be no assurance that the Company’s research and development will be successfully completed, that adequate protection for the Company’s intellectual property will be obtained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company’s development efforts are successful, it is uncertain when, if ever, the Company will generate significant product sales. If the Company does not successfully commercialize any of its products or mitigate any of these other risks, it will be unable to generate revenue or achieve profitability.
Basis of presentation
The Company’s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Certain notes or other information that are normally required by GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes as of and for the year ended December 31, 2023. The condensed consolidated balance sheet as of December 31, 2023, was derived from the audited financial statements but does not contain all of the footnote disclosures from the annual financial statements.
As of March 31, 2024, the Company had cash, cash equivalents and restricted cash of $130.0 million and an accumulated deficit of $192.1 million, and the Company expects to incur losses for the foreseeable future. The Company expects that its cash, cash equivalents and restricted cash will be sufficient to fund current operations for at least the next twelve months from the issuance of the financial statements. The Company expects to seek additional funding through equity financing, government or private-party grants, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or rights of the Company’s stockholders. If the Company is unable to obtain sufficient capital, the Company will be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects, or the Company may be unable to continue operations. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.
The unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.
Unaudited Condensed Financial Information
The accompanying Condensed Consolidated Balance Sheets as of March 31, 2024, and December 31, 2023, the Condensed Consolidated Statements of Operations and Comprehensive Loss, Condensed Consolidated Statements of Changes in Stockholders’ Equity and the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 are unaudited. These unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities Exchange Commission (the “Annual Report”) on March 20, 2024. In our opinion, the unaudited condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2024, our results of operations for the three months ended March 31, 2024, and 2023, and our cash flows for the three months ended March 31, 2024, and 2023. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other interim periods.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Annual Report, except as discussed below related to newly adopted accounting pronouncements.
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue, income and expenses during the reporting period. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.
As of the date of issuance of these unaudited condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the unaudited condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.
Segment information
Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker ("CODM"), the Company’s Chief Executive Officer, in making decisions regarding resource allocation and assessing performance. The CODM approves key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts and approves the Company's consolidated operating budget. The Company views its operations and manages its business as one operating segment, the research and development of vaccines and immunotherapies. As the Company operates in one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.
Recently issued accounting pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” of the extended transition period related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company.
We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our condensed consolidated financial statements or do not otherwise apply to our current operations.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Foreign Currency Translation in General and Administrative Expenses
 3 Months Ended
Mar. 31, 2024
Foreign Currency [Abstract]  
Foreign Currency Translation in General and Administrative Expenses Foreign Currency Translation in General and Administrative Expenses
The aggregate, net foreign exchange gain or loss recognized in general and administrative expenses for the three months ended March 31, 2024, was a gain of $1.2 million (three months ended March 31, 2023: $3.5 million loss).
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Net Loss Per Share
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2024, and 2023 (in thousands, except number of shares):
Three months ended March 31,
20242023
Numerator:
Net loss$(15,520)$(18,223)
Net loss attributable to noncontrolling interest31 43 
Net loss attributable to Barinthus Biotherapeutics plc shareholders$(15,489)$(18,180)
Denominator:
Weighted-average ordinary shares outstanding, basic38,773,48238,013,399
Weighted-average ordinary shares outstanding, diluted38,773,48238,013,399
Net loss per share attributable to ordinary shareholders, basic$(0.40)$(0.48)
Net loss per share attributable to ordinary shareholders, diluted$(0.40)$(0.48)
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential ordinary share equivalents outstanding would have been anti-dilutive. As of March 31, 2024, 7,645,076 potential ordinary shares issuable for stock options were excluded from the computation of diluted weighted-average shares outstanding because including them would have had an anti-dilutive effect (March 31, 2023: 6,807,859).
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net
 3 Months Ended
Mar. 31, 2024
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
During the three months ended March 31, 2024, the Company’s additions to property and equipment, net were $0.4 million which primarily related to an increase in leasehold improvements from the Company’s U.S. office in Germantown, Maryland (three months ended March 31, 2023: $4.8 million).
Depreciation expense for the three months ended March 31, 2024 was $0.6 million (three months ended March 31, 2023: $0.4 million, respectively).
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets, Net
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets, Net Intangible Assets, Net
The gross amount of amortizable intangible assets, consisting of acquired developed technology, was $31.6 million as of March 31, 2024 and December 31 2023, respectively, and accumulated amortization was $7.3 million and $6.5 million as of March 31, 2024 and December 31, 2023, respectively. The amortization expense for the three months ended March 31, 2024 was $0.8 million (three months ended March 31, 2023: $0.8 million). The estimated annual amortization expense is $3.2 million for the years 2024 through to 2031.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets
 3 Months Ended
Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets (in thousands):
March 31,
2024		December 31,
2023
Prepayments and accrued income$5,093 $5,402 
Value Added Tax receivable1,196 3,031 
Other1,675 1,474 
Total$7,964 $9,907 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities
 3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities (in thousands):
March 31,
2024		December 31,
2023
Accrued manufacturing and clinical expenses$4,437 $4,003 
Accrued bonus660 2,412 
Accrued payroll and employee benefits1,152 789 
Accrued professional fees1,048 942 
Accrued other1,033 1,066 
Total$8,330 $9,212 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Grant Income
 3 Months Ended
Mar. 31, 2024
Other Income and Expenses [Abstract]  
Grant Income Grant Income
Coalition for Epidemic Preparedness Innovations (“CEPI”) Funding Agreement

On December 20, 2023, Barinthus Biotherapeutics (UK) Limited (the “Company”), the Chancellors, Masters and Scholars of the University of Oxford (“Oxford,” together with the Company, the “Partners”) and the Coalition for Epidemic Preparedness Innovations (“CEPI”) entered into a Funding Agreement (the “Funding Agreement”) pursuant to which CEPI will provide funding of up to $34.8 million to the Company to advance the development of VTP-500, the Company’s vaccine candidate against Middle East Respiratory Syndrome (“MERS,” and such development activities, the “Project”). In December 2023, VTP-500 received PRIME (PRIority MEdicines) designation by the European Medicines Agency.

Pursuant to the Funding Agreement, the Company has agreed to pay CEPI on a country-by-country basis increasing mid-single digit percentage royalties of net sales and net income with respect to future cash sales of VTP-500, less certain deductions, for a period starting on December 20, 2023 (“Effective Date”) and ending the later of: (i) the expiration of the last valid patent claim included in intellectual property developed under the Project covering VTP-500 in such country, (ii) the expiration of Regulatory Exclusivity (as defined in the Funding Agreement) for VTP-500 in such country, and (iii) the tenth (10th) anniversary of the first commercial sale of VTP-500 (the “Royalty Term”). The Company shall also pay CEPI a mid-double digit percentage of net revenue earned on VTP-500 until CEPI has received payments from the Company under the Funding Agreement equaling the total amount of funding paid by CEPI to the Company and a low double-digit percentage of such net revenue thereafter. Sales for the benefit of end users in specified low and middle income countries (“LMICs”) and upper and middle income countries (“UMICs”) are excluded from the calculations of net sales and net revenue. Sales of product for the benefit of end users in LMICs and UMICs are subject to tiered discounted pricing requirements under the Funding Agreement. The Company is further required to pay a mid-double digit percentage of any proceeds earned on any priority review voucher related to VTP-500 during the Royalty Period.
For the period ended March 31, 2024, $1.6 million proceeds have been received and $0.2 million income has been recognized in relation to this contract. This is presented as other operating income in the Statements of Operations and Comprehensive Loss.

The Funding Agreement cash payments are restricted as to the use and management of the funds. The remaining unused amounts of the Funding Agreement cash payments of $1.4 million as at March 31, 2024 are reflected in Cash, cash equivalents and restricted cash in the condensed consolidated balance sheets until expenditures contemplated in the Funding Agreement are incurred.

Deferred income

Deferred income primarily relates to payments received from CEPI in advance of the eligible research and development expenses being incurred and are disclosed as deferred income separately in the condensed consolidated balance sheets. Deferred income is released to the condensed consolidated statement of operations and comprehensive loss in the period in which such research and development activities are actually performed in a manner that satisfies the conditions of the Funding Agreement.

Changes in the deferred income during the three months ended March 31, 2024 and 2023, are as follows (in thousands):

Three Months Ended March 31,
20242023
Beginning balance$— $— 
Cash payments received1,629 — 
Other income recognized related to the Funding Agreement(205)— 
Foreign exchange translation10 — 
Ending balance$1,434 $— 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Ordinary Shares
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Ordinary Shares Ordinary Shares
All ordinary shares rank pari passu as a single class. The following is a summary of the rights and privileges of the holders of ordinary shares as of March 31, 2024:
Liquidation preference: in the event of the liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to holders of the ordinary shares shall be distributed amongst all holders of the ordinary shares in proportion to the number of shares held irrespective of the amount paid or credited as paid on any share.
Dividends: The Company may, subject to the provisions of the Companies Act 2006 and our Articles, by ordinary resolution from time to time declare dividends to be paid to shareholders not exceeding the amount recommended by the Company’s board of directors. Subject to the provisions of the Companies Act 2006, in so far as, in the board of directors’ opinions, the Company’s profits justify such payments, the board of directors may pay interim dividends on the Company’s ordinary shares.
Voting Rights: Each holder of ordinary shares has the right to receive notice of, and to vote at, the Company’s general meetings. Each holder of ordinary shares who is present (in person or by proxy) at a general meeting on a show of hands has one vote and, on a poll, every such holder who is present (in person or by proxy) has one vote in respect of each share of which they are the holder.
Preemption rights: Pursuant to section 561 of the Companies Act 2006, shareholders are granted preemptive rights when new shares are issued for cash. However, it is possible for our Articles, or shareholders at a general meeting representing at least 75% of our ordinary shares present (in person or by proxy) and eligible to vote at that general meeting, to disapply these preemptive rights by passing a special resolution. Such a disapplication of preemption rights may be for a maximum period of up to five years from the date on which the shareholder resolution was passed. In either case, this disapplication would need to be renewed by our shareholders upon its expiration (i.e., at least every five years) to remain effective.
On April 21, 2021, our shareholders approved the disapplication of preemptive rights for a period of five years from the date of approval by way of a special resolution of our shareholders. This included the disapplication of preemption rights in relation to the allotment of our ordinary shares in connection with the IPO. This disapplication will need to be renewed upon expiration (i.e., at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).
On November 6, 2023, we held a general meeting where our shareholders approved resolutions granting our board of directors or any duly authorized committee of the board of directors the authority to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company free from pre-emption rights. Pursuant to such approval, our board of directors was authorized to allot shares up to an aggregate nominal amount of £1,928 free from statutory pre-emption rights. The granting of this authority and the corresponding disapplication of preemptive rights was in addition to all subsisting authorities. This disapplication will need to be renewed upon expiration (i.e., at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Shares
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Deferred Shares Deferred Shares
All deferred shares rank pari passu as a single class. The deferred shares do not have rights to dividends or to any other right of participation in the profits of the Company. On a return of assets on liquidation, the deferred shares shall confer on the holders thereof an entitlement to receive out of the assets of the Company available for distribution amongst the shareholders (subject to the rights of any new class of shares with preferred rights) the amount credited as paid up on the deferred shares held by them respectively after (but only after) payment shall have been made to the holders of the ordinary shares of the amounts paid up or credited as paid up on such shares and the sum of £1.0 million in respect of each ordinary share held by them respectively. The deferred shares shall confer on the holders thereof no further right to participate in the assets of the Company.
On March 29, 2023, all deferred B shares (nominal value of £0.01 each) and deferred C shares (nominal value of £0.00000736245954692556 each) previously in issue were transferred back to the Company and subsequently cancelled. These deferred shares had previously been issued to certain pre-IPO shareholders in connection with the implementation of certain stages of the Company’s pre-IPO share capital reorganization. The Company received shareholder approval on April 21, 2021 (pursuant to the shareholder resolutions passed on that date) in order to effect the transfer back and cancellation of the deferred shares for nil consideration in accordance with sections 659 and 662 of the Companies Act 2006.
The Company’s deferred A shares with a nominal value of £1.00 each remain in issue for the purposes of satisfying the minimum share capital requirements for a public limited company as prescribed by the Companies Act 2006.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Fair Value
The Company’s financial instruments consist of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, certain accrued expenses, and contingent consideration. The carrying amounts of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair value due to the short-term nature and maturity of these instruments.
As of March 31, 2024, the Company had a contingent consideration liability of $1.9 million related to the acquisition of Avidea Technologies, Inc. The fair value of the contingent consideration is a Level 3 valuation with the significant unobservable inputs being the probability of success of achievement of the milestones and the expected date of the milestone achievement. Significant judgment is employed in determining the appropriateness of certain of these inputs.
The following table summarizes changes to our financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy (in thousands):
Three Months Ended March 31,
20242023
Beginning balance$1,823 $1,711 
Change in fair value recognized in net loss/(gain)60 (38)
Foreign exchange translation recognized in other comprehensive loss(16)37 
Ending balance$1,867 $1,710 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
The Company identified qualitative indicators of impairment due to a sustained decline in the price of the Company’s American Depositary Shares, whereby the market capitalization continues to be below the value of the net assets of the Company. Therefore, the Company performed an interim qualitative assessment as of March 31, 2024 to determine whether it was more likely than not that the fair value of the reporting unit is less than its carrying amount. Based on this assessment, management determined it is not more likely than not that the fair value of the reporting unit is less than its carrying amount and hence no impairment loss has been recognized.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
During the three month period ended March 31, 2024, in accordance with the terms of the Annual Increase of the Barinthus Biotherapeutics plc Award Plan 2021 (the “Plan”), the total number of ordinary shares available for issuance under the Plan increased by 4% of the Company’s issued and outstanding ordinary shares as of January 1, 2023.
For the three months ended March 31, 2024, the Company granted 1,627,958 options to employees and directors with a weighted average grant date fair value of $2.90 and a weighted average exercise price of $3.67 per share (March 31, 2023: granted 1,987,289 options, weighted average grant date fair value of $2.01 and a weighted average exercise price of $2.53 per share). For the three months ended March 31, 2024, 70,946 options (March 31, 2023: 57,970 ) were forfeited.
The fair value of each stock option issued to employees was estimated at the date of grant using the Black-Scholes model with the following weighted-average assumptions:
Three Months Ended March 31,
20242023
Expected volatility108.8 %97.4 %
Expected term (years)6.06.0
Risk-free interest rate4.0 %3.6 %
Expected dividend yield— %— %
As of March 31, 2024, 7,645,076 options with a weighted average exercise price of $6.20 were outstanding. As of March 31, 2024, there was $6.2 million unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted average period of 1.9 years. As of March 31, 2023, 6,807,859 options with a weighted average exercise price of $9.69 were outstanding.
Share based compensation expense is classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended March 31,
20242023
Research and development$712 $1,119 
General and administrative903 1,103 
Total$1,615 $2,222 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
In-License Agreements
The Company is party to a number of licensing agreements, most of which are with related parties. These agreements serve to provide the Company with the right to develop and exploit the counterparties’ intellectual property for certain medical indications. As part of execution of these arrangements, the Company paid certain upfront fees, which have been expensed as incurred because the developing technology has not yet reached technical feasibility, the lack of alternative use, and the lack of proof of potential value. The agreements cover a variety of fields, including influenza, cancer, human papillomavirus infection, (“HPV”), hepatitis B virus (“HBV”) and MERS. The Company’s obligations for future payments under these arrangements are dependent on its ability to develop promising drug candidates, the potential market for these candidates and potential competing products, and the payment mechanisms in place in countries where the Company retains the right to sell. Each agreement provides for specific milestone payments, typically triggered by achievement of certain testing phases in human candidates, and future royalties ranging from 1 to 5% for direct sales of a covered product to 3 to 7% of net payments received for allowable sublicenses of technology developed by the Company. The obligation to make these payments is contingent upon the Company’s ability to develop candidates for submission for phased testing and approvals, and for the development of markets for the products developed by the Company. The Company has not made or accrued any material payments under these license agreements during the three month periods ended March 31, 2024 and 2023.
Leases
The Company leases certain laboratory and office space under operating leases, which are described below.
The Harwell Science and Innovation Campus, Oxfordshire
On September 3, 2021, the Company entered into a lease agreement for the lease of approximately 31,000 square feet in Harwell, Oxfordshire which expires in September 2031. The property is the Company’s corporate headquarters. As the Company’s leases typically do not provide an implicit rate, the Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date, being the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The Company has provided the lessor with a refundable security deposit of $0.7 million which is included in Other assets.
Germantown, Maryland
On June 14, 2022, the Company entered into a lease agreement for the lease of approximately 19,700 square feet in Germantown, Maryland. The site will house the Company’s, state-of-the-art wet laboratory in the United States of America. The lease expires on February 28, 2034, with the Company having a single right to extend for an additional five years on the same terms and conditions other than for the base rent. The Company has a rent-free period up to February 29, 2024, and is entitled to up to $3.5 million for leasehold improvements to the premises desired by the Company. The Company has provided the lessor with a refundable security deposit of $0.2 million which is included in Other assets.
The Company recorded a right-of-use asset and a lease liability on the effective date of the lease term. The Company’s right-of-use asset and lease liability are as follows (in thousands):
March 31,
2024		December 31,
2023
Right-of-use asset$7,408 $7,581 
Lease liability, current1,909 1,785 
Lease liability, non-current10,897 11,191 
Three months ended March 31,
20242023
Other information
Operating cash flows from operating leases$346$220
Weighted average remaining lease term (years)8.719.71
Weighted average discount rate7.5 %7.6 %
Three months ended March 31,
20242023
Lease Cost
Short-term lease costs$—$152
Fixed lease costs359279
Total lease cost$359$431
Future annual minimum lease payments under operating leases as of March 31, 2024, were as follows (in thousands):
Remainder of 2024$1,430 
20251,926 
20261,951 
20271,975 
20282,001 
Thereafter7,974 
Total minimum lease payments$17,257 
Less: imputed interest(4,451)
Total lease liability$12,806 
Other contingencies
As of the date of this Quarterly Report on Form 10-Q, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. However, from time to time, we could be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Regardless of the outcome, legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions
 3 Months Ended
Mar. 31, 2024
Related Party Transactions [Abstract]  
Related Party Transactions Related Party Transactions
During the three months ended March 31, 2024, the Company incurred expenses of $0.2 million (three months ended March 31, 2023: $0.1 million) from Oxford University Innovation Limited which is a wholly owned subsidiary of the Company’s shareholder, the University of Oxford. As of March 31, 2024, the Company owed $0.01 million (December 31, 2023: $0.002 million) to Oxford University Innovation Limited.
During the three months ended March 31, 2024, the Company recognized license revenue of nil (three months ended March 31, 2023: $0.5 million), from Oxford University Innovation Limited. As of March 31, 2024, the Company was owed nil (December 31, 2023: nil) from Oxford University Innovation Limited.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net Income (Loss) Attributable to Parent $ (15,489) $ (18,180)
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates
The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue, income and expenses during the reporting period. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.
As of the date of issuance of these unaudited condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the unaudited condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.
Segment information
Segment information
Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker ("CODM"), the Company’s Chief Executive Officer, in making decisions regarding resource allocation and assessing performance. The CODM approves key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts and approves the Company's consolidated operating budget. The Company views its operations and manages its business as one operating segment, the research and development of vaccines and immunotherapies. As the Company operates in one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.
Recently issued accounting pronouncements
Recently issued accounting pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” of the extended transition period related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company.
We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our condensed consolidated financial statements or do not otherwise apply to our current operations.
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Net Loss Per Share (Tables)
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted net loss per share
The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2024, and 2023 (in thousands, except number of shares):
Three months ended March 31,
20242023
Numerator:
Net loss$(15,520)$(18,223)
Net loss attributable to noncontrolling interest31 43 
Net loss attributable to Barinthus Biotherapeutics plc shareholders$(15,489)$(18,180)
Denominator:
Weighted-average ordinary shares outstanding, basic38,773,48238,013,399
Weighted-average ordinary shares outstanding, diluted38,773,48238,013,399
Net loss per share attributable to ordinary shareholders, basic$(0.40)$(0.48)
Net loss per share attributable to ordinary shareholders, diluted$(0.40)$(0.48)
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets (Tables)
 3 Months Ended
Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of prepaid expenses and other current assets Prepaid Expenses and Other Current Assets (in thousands):
March 31,
2024		December 31,
2023
Prepayments and accrued income$5,093 $5,402 
Value Added Tax receivable1,196 3,031 
Other1,675 1,474 
Total$7,964 $9,907 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities (Tables)
 3 Months Ended
Mar. 31, 2024
Payables and Accruals [Abstract]  
Schedule of accrued expenses and other current liabilities Accrued Expenses and Other Current Liabilities (in thousands):
March 31,
2024		December 31,
2023
Accrued manufacturing and clinical expenses$4,437 $4,003 
Accrued bonus660 2,412 
Accrued payroll and employee benefits1,152 789 
Accrued professional fees1,048 942 
Accrued other1,033 1,066 
Total$8,330 $9,212 
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Grant Income (Tables)
 3 Months Ended
Mar. 31, 2024
Other Income and Expenses [Abstract]  
Schedule of changes in deferred income
Changes in the deferred income during the three months ended March 31, 2024 and 2023, are as follows (in thousands):

Three Months Ended March 31,
20242023
Beginning balance$— $— 
Cash payments received1,629 — 
Other income recognized related to the Funding Agreement(205)— 
Foreign exchange translation10 — 
Ending balance$1,434 $— 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value (Tables)
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of financial instruments carried at fair value and classified within Level 3
The following table summarizes changes to our financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy (in thousands):
Three Months Ended March 31,
20242023
Beginning balance$1,823 $1,711 
Change in fair value recognized in net loss/(gain)60 (38)
Foreign exchange translation recognized in other comprehensive loss(16)37 
Ending balance$1,867 $1,710 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of weighted-average assumptions of fair value stock option issued to employees
The fair value of each stock option issued to employees was estimated at the date of grant using the Black-Scholes model with the following weighted-average assumptions:
Three Months Ended March 31,
20242023
Expected volatility108.8 %97.4 %
Expected term (years)6.06.0
Risk-free interest rate4.0 %3.6 %
Expected dividend yield— %— %
Schedule of share based compensation expense
Share based compensation expense is classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands):
Three Months Ended March 31,
20242023
Research and development$712 $1,119 
General and administrative903 1,103 
Total$1,615 $2,222 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Tables)
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of right-of-use assets, lease liabilities and other information The Company’s right-of-use asset and lease liability are as follows (in thousands):
March 31,
2024		December 31,
2023
Right-of-use asset$7,408 $7,581 
Lease liability, current1,909 1,785 
Lease liability, non-current10,897 11,191 
Three months ended March 31,
20242023
Other information
Operating cash flows from operating leases$346$220
Weighted average remaining lease term (years)8.719.71
Weighted average discount rate7.5 %7.6 %
Schedule of lease cost
Three months ended March 31,
20242023
Lease Cost
Short-term lease costs$—$152
Fixed lease costs359279
Total lease cost$359$431
Schedule of maturities of minimum lease liabilities
Future annual minimum lease payments under operating leases as of March 31, 2024, were as follows (in thousands):
Remainder of 2024$1,430 
20251,926 
20261,951 
20271,975 
20282,001 
Thereafter7,974 
Total minimum lease payments$17,257 
Less: imputed interest(4,451)
Total lease liability$12,806 
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Business and Basis of Presentation (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Cash, cash equivalents and restricted cash $ 129,971 $ 142,090 $ 191,328 $ 194,385
Accumulated deficit $ 192,079 $ 176,590    
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details)
 3 Months Ended
Mar. 31, 2024
segment
Accounting Policies [Abstract]  
Number of operating segments 1
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Foreign Currency Translation in General and Administrative Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Foreign Currency [Abstract]    
Net foreign exchange gain (loss) $ 1.2 $ (3.5)
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Net Loss Per Share - Computation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Numerator:    
Net loss $ (15,520) $ (18,223)
Net loss attributable to noncontrolling interest 31 43
Net loss attributable to Barinthus Biotherapeutics plc shareholders $ (15,489) $ (18,180)
Denominator:    
Weighted-average ordinary shares outstanding, basic (in shares) 38,773,482 38,013,399
Weighted-average ordinary shares outstanding, diluted (in shares) 38,773,482 38,013,399
Net loss per share attributable to ordinary shareholders, basic (in usd per share) $ (0.40) $ (0.48)
Net loss per share attributable to ordinary shareholders, diluted (in usd per share) $ (0.40) $ (0.48)
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Net Loss Per Share - Additional Information (Details) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Shares issuable for stock options that were excluded from the computation of diluted weighted-average shares outstanding (in shares) 7,645,076 6,807,859
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Property and Equipment, Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Property, Plant and Equipment [Abstract]    
Additions to property and equipment $ 0.4 $ 4.8
Depreciation expense $ 0.6 $ 0.4
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Intangible Assets, Net (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Intangible Assets, net      
Amortization expense for intangible assets $ 0.8 $ 0.8  
Estimated annual amortization expense for 2024 3.2    
Estimated annual amortization expense for 2025 3.2    
Estimated annual amortization expense for 2026 3.2    
Estimated annual amortization expense for 2027 3.2    
Estimated annual amortization expense for 2028 3.2    
Estimated annual amortization expense for 2029 3.2    
Estimated annual amortization expense for 2030 3.2    
Estimated annual amortization expense for 2031 3.2    
Developed technology      
Intangible Assets, net      
Gross amount of amortizable intangible assets 31.6   $ 31.6
Accumulated amortization for amortizable intangible assets $ 7.3   $ 6.5
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepayments and accrued income $ 5,093 $ 5,402
Value Added Tax receivable 1,196 3,031
Other 1,675 1,474
Total $ 7,964 $ 9,907
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accrued manufacturing and clinical expenses $ 4,437 $ 4,003
Accrued bonus 660 2,412
Accrued payroll and employee benefits 1,152 789
Accrued professional fees 1,048 942
Accrued other 1,033 1,066
Total $ 8,330 $ 9,212
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Grant Income - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 20, 2023
Mar. 31, 2024
Mar. 31, 2023
Deferred Income [Line Items]      
Cash payments received   $ 1,629 $ 0
Other income recognized related to the Funding Agreement   205 $ 0
Coalition for Epidemic Preparedness Innovations      
Deferred Income [Line Items]      
Maximum funding amount $ 34,800    
Maximum royalty payment period 10 years    
Cash payments received   1,600  
Other income recognized related to the Funding Agreement   200  
Restricted cash   $ 1,400  
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Grant Income - Changes in deferred income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Deferred Income [Roll Forward]    
Beginning balance $ 0 $ 0
Cash payments received 1,629 0
Other income recognized related to the Funding Agreement (205) 0
Foreign exchange translation 10 0
Ending balance $ 1,434 $ 0
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Ordinary Shares (Details)
 3 Months Ended
Nov. 06, 2023
GBP (£)
Apr. 21, 2021
Mar. 31, 2024
vote
Subsidiary, Sale of Stock [Line Items]      
Number of votes per common share (in votes) | vote     1
Percentage of ordinary shares present to exercise preemptive rights     75.00%
Maximum period to exercise preemptive rights     5 years
Maximum aggregate nominal amount of shares authorized to be allotted free from pre-emption rights | £ £ 1,928    
IPO      
Subsidiary, Sale of Stock [Line Items]      
Maximum period to exercise preemptive rights 5 years 5 years 5 years
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Deferred Shares (Details) - GBP (£)
£ / shares in Units, £ in Millions
Mar. 31, 2024
Dec. 31, 2023
Mar. 29, 2023
Deferred A Shares      
Deferred shares [Line items]      
Ordinary shares, liquidation preference £ 1.0    
Deferred shares, nominal value (in gbp per share) £ 1 £ 1 £ 1.00
Deferred B Shares      
Deferred shares [Line items]      
Deferred shares, nominal value (in gbp per share)     0.01
Deferred C Shares      
Deferred shares [Line items]      
Deferred shares, nominal value (in gbp per share)     £ 0.00000736245954692556
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value - Additional information (Details)
$ in Millions
Mar. 31, 2024
USD ($)
Avidea  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Contingent consideration liability $ 1.9
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value - Change in Financial Instruments Classified within Level 3 (Details) - Contingent Consideration Liability - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning balance $ 1,823 $ 1,711
Change in fair value recognized in net loss/(gain) 60 (38)
Foreign exchange translation recognized in other comprehensive loss (16) 37
Ending balance $ 1,867 $ 1,710
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill impairment loss $ 0.0
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options granted (in shares) 1,627,958 1,987,289
Weighted-average grant date fair value of options granted (in usd per share) $ 2.90 $ 2.01
Weighted average exercise price of options granted (in usd per share) $ 3.67 $ 2.53
Options forfeited (in shares) 70,946 57,970
Options outstanding (in shares) 7,645,076 6,807,859
Weighted average exercise price of options outstanding (in usd per share) $ 6.20 $ 9.69
Unrecognized compensation cost related to options $ 6.2  
Stock options    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted-average period over which unrecognized compensation cost is expected to be recognized 1 year 10 months 24 days  
Barinthus Biotherapeutics plc Share Award Plan 2021 | Restricted share units, options, share appreciation rights and restricted shares    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Percentage of issued and outstanding ordinary shares available for issuance under the Plan 4.00%  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation - Weighted-average assumptions (Details) - Enterprise Management Incentive Share Option Scheme
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Expected volatility 108.80% 97.40%
Expected term (years) 6 years 6 years
Risk-free interest rate 4.00% 3.60%
Expected dividend yield 0.00% 0.00%
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation - Share based compensation expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation expense $ 1,615 $ 2,222
Research and development    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation expense 712 1,119
General and administrative    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Share based compensation expense $ 903 $ 1,103
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Additional Information (Details)
$ in Millions
 3 Months Ended
Jun. 14, 2022
USD ($)
ft²
Sep. 03, 2021
USD ($)
ft²
Mar. 31, 2024
Oxfordshire      
Commitment and Contingencies      
Size of space under lease agreement (in square feet) | ft²   31,000  
Refundable security deposit   $ 0.7  
Maryland      
Commitment and Contingencies      
Size of space under lease agreement (in square feet) | ft² 19,700    
Refundable security deposit $ 0.2    
Additional lease term 5 years    
Leasehold improvement expense $ 3.5    
In-License Agreements | Minimum      
Commitment and Contingencies      
Percentage of future royalties for direct sales of a covered product     1.00%
Net payments received for allowable sublicenses of technology developed     3.00%
In-License Agreements | Maximum      
Commitment and Contingencies      
Percentage of future royalties for direct sales of a covered product     5.00%
Net payments received for allowable sublicenses of technology developed     7.00%
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]      
Right-of-use asset $ 7,408   $ 7,581
Lease liability, current 1,909   1,785
Lease liability, non-current 10,897   $ 11,191
Other information      
Operating cash flows from operating leases $ 346 $ 220  
Weighted average remaining lease term (years) 8 years 8 months 15 days 9 years 8 months 15 days  
Weighted average discount rate 7.50% 7.60%  
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Lease Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]    
Short-term lease costs $ 0 $ 152
Fixed lease costs 359 279
Total lease cost $ 359 $ 431
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Maturities of minimum lease liabilities (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Remainder of 2024 $ 1,430
2025 1,926
2026 1,951
2027 1,975
2028 2,001
Thereafter 7,974
Total minimum lease payments 17,257
Less: imputed interest (4,451)
Total lease liability $ 12,806
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Related Party Transactions (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Related Party Transaction [Line Items]      
Amounts owed to other party $ 1,162   $ 1,601
Total revenue 0 $ 468  
License revenue      
Related Party Transaction [Line Items]      
Total revenue [1] 0 468  
Related Parties      
Related Party Transaction [Line Items]      
Total revenue 0 500  
Oxford University Innovation Limited | Related Parties      
Related Party Transaction [Line Items]      
Amounts owed to other party 10   2
Amounts owned from other party 0   $ 0
Oxford University Innovation Limited | Related Parties | License revenue      
Related Party Transaction [Line Items]      
Total revenue 0 500  
Oxford University Innovation Limited | Expenses      
Related Party Transaction [Line Items]      
Amounts of related party transactions $ 200 $ 100  
[1] Includes license revenue from related parties for the three months ended March 31, 2024 and 2023 of nil and $0.5 million, respectively.
EXCEL 69 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 70 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 71 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 73 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 101 239 1 true 32 0 false 9 false false R1.htm 0000001 - Document - Document and Entity Information Sheet http://www.barinthusbio.com/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 0000008 - Disclosure - Nature of Business and Basis of Presentation Sheet http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentation Nature of Business and Basis of Presentation Notes 8 false false R9.htm 0000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.barinthusbio.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 0000010 - Disclosure - Foreign Currency Translation in General and Administrative Expenses Sheet http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpenses Foreign Currency Translation in General and Administrative Expenses Notes 10 false false R11.htm 0000011 - Disclosure - Net Loss Per Share Sheet http://www.barinthusbio.com/role/NetLossPerShare Net Loss Per Share Notes 11 false false R12.htm 0000012 - Disclosure - Property and Equipment, Net Sheet http://www.barinthusbio.com/role/PropertyandEquipmentNet Property and Equipment, Net Notes 12 false false R13.htm 0000013 - Disclosure - Intangible Assets, Net Sheet http://www.barinthusbio.com/role/IntangibleAssetsNet Intangible Assets, Net Notes 13 false false R14.htm 0000014 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 14 false false R15.htm 0000015 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 0000016 - Disclosure - Grant Income Sheet http://www.barinthusbio.com/role/GrantIncome Grant Income Notes 16 false false R17.htm 0000017 - Disclosure - Ordinary Shares Sheet http://www.barinthusbio.com/role/OrdinaryShares Ordinary Shares Notes 17 false false R18.htm 0000018 - Disclosure - Deferred Shares Sheet http://www.barinthusbio.com/role/DeferredShares Deferred Shares Notes 18 false false R19.htm 0000019 - Disclosure - Fair Value Sheet http://www.barinthusbio.com/role/FairValue Fair Value Notes 19 false false R20.htm 0000020 - Disclosure - Goodwill Sheet http://www.barinthusbio.com/role/Goodwill Goodwill Notes 20 false false R21.htm 0000021 - Disclosure - Share-Based Compensation Sheet http://www.barinthusbio.com/role/ShareBasedCompensation Share-Based Compensation Notes 21 false false R22.htm 0000022 - Disclosure - Commitments and Contingencies Sheet http://www.barinthusbio.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 0000023 - Disclosure - Related Party Transactions Sheet http://www.barinthusbio.com/role/RelatedPartyTransactions Related Party Transactions Notes 23 false false R24.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 24 false false R25.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 25 false false R26.htm 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.barinthusbio.com/role/SummaryofSignificantAccountingPolicies 26 false false R27.htm 9954472 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.barinthusbio.com/role/NetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.barinthusbio.com/role/NetLossPerShare 27 false false R28.htm 9954473 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssets 28 false false R29.htm 9954474 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilities 29 false false R30.htm 9954475 - Disclosure - Grant Income (Tables) Sheet http://www.barinthusbio.com/role/GrantIncomeTables Grant Income (Tables) Tables http://www.barinthusbio.com/role/GrantIncome 30 false false R31.htm 9954476 - Disclosure - Fair Value (Tables) Sheet http://www.barinthusbio.com/role/FairValueTables Fair Value (Tables) Tables http://www.barinthusbio.com/role/FairValue 31 false false R32.htm 9954477 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.barinthusbio.com/role/ShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.barinthusbio.com/role/ShareBasedCompensation 32 false false R33.htm 9954478 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.barinthusbio.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.barinthusbio.com/role/CommitmentsandContingencies 33 false false R34.htm 9954479 - Disclosure - Nature of Business and Basis of Presentation (Details) Sheet http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentationDetails Nature of Business and Basis of Presentation (Details) Details http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentation 34 false false R35.htm 9954480 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies 35 false false R36.htm 9954481 - Disclosure - Foreign Currency Translation in General and Administrative Expenses (Details) Sheet http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpensesDetails Foreign Currency Translation in General and Administrative Expenses (Details) Details http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpenses 36 false false R37.htm 9954482 - Disclosure - Net Loss Per Share - Computation (Details) Sheet http://www.barinthusbio.com/role/NetLossPerShareComputationDetails Net Loss Per Share - Computation (Details) Details 37 false false R38.htm 9954483 - Disclosure - Net Loss Per Share - Additional Information (Details) Sheet http://www.barinthusbio.com/role/NetLossPerShareAdditionalInformationDetails Net Loss Per Share - Additional Information (Details) Details 38 false false R39.htm 9954484 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.barinthusbio.com/role/PropertyandEquipmentNetDetails Property and Equipment, Net (Details) Details http://www.barinthusbio.com/role/PropertyandEquipmentNet 39 false false R40.htm 9954485 - Disclosure - Intangible Assets, Net (Details) Sheet http://www.barinthusbio.com/role/IntangibleAssetsNetDetails Intangible Assets, Net (Details) Details http://www.barinthusbio.com/role/IntangibleAssetsNet 40 false false R41.htm 9954486 - Disclosure - Prepaid Expenses and Other Current Assets (Details) Sheet http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails Prepaid Expenses and Other Current Assets (Details) Details http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsTables 41 false false R42.htm 9954487 - Disclosure - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities (Details) Details http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables 42 false false R43.htm 9954488 - Disclosure - Grant Income - Additional Information (Details) Sheet http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails Grant Income - Additional Information (Details) Details 43 false false R44.htm 9954489 - Disclosure - Grant Income - Changes in deferred income (Details) Sheet http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails Grant Income - Changes in deferred income (Details) Details 44 false false R45.htm 9954490 - Disclosure - Ordinary Shares (Details) Sheet http://www.barinthusbio.com/role/OrdinarySharesDetails Ordinary Shares (Details) Details http://www.barinthusbio.com/role/OrdinaryShares 45 false false R46.htm 9954491 - Disclosure - Deferred Shares (Details) Sheet http://www.barinthusbio.com/role/DeferredSharesDetails Deferred Shares (Details) Details http://www.barinthusbio.com/role/DeferredShares 46 false false R47.htm 9954492 - Disclosure - Fair Value - Additional information (Details) Sheet http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails Fair Value - Additional information (Details) Details 47 false false R48.htm 9954493 - Disclosure - Fair Value - Change in Financial Instruments Classified within Level 3 (Details) Sheet http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details Fair Value - Change in Financial Instruments Classified within Level 3 (Details) Details 48 false false R49.htm 9954494 - Disclosure - Goodwill (Details) Sheet http://www.barinthusbio.com/role/GoodwillDetails Goodwill (Details) Details http://www.barinthusbio.com/role/Goodwill 49 false false R50.htm 9954495 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 50 false false R51.htm 9954496 - Disclosure - Share-Based Compensation - Weighted-average assumptions (Details) Sheet http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails Share-Based Compensation - Weighted-average assumptions (Details) Details 51 false false R52.htm 9954497 - Disclosure - Share-Based Compensation - Share based compensation expense (Details) Sheet http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails Share-Based Compensation - Share based compensation expense (Details) Details 52 false false R53.htm 9954498 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 53 false false R54.htm 9954499 - Disclosure - Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details) Sheet http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details) Details 54 false false R55.htm 9954500 - Disclosure - Commitments and Contingencies - Lease Cost (Details) Sheet http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails Commitments and Contingencies - Lease Cost (Details) Details 55 false false R56.htm 9954501 - Disclosure - Commitments and Contingencies - Maturities of minimum lease liabilities (Details) Sheet http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails Commitments and Contingencies - Maturities of minimum lease liabilities (Details) Details 56 false false R57.htm 9954502 - Disclosure - Related Party Transactions (Details) Sheet http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.barinthusbio.com/role/RelatedPartyTransactions 57 false false All Reports Book All Reports [EFM.6.05.45.coverPageFactNotVisible] Submission type 10-Q has 1 cover page fact(s) in ix:hidden that should be visible or referenced by an -sec-ix-hidden style property: EntityTaxIdentificationNumber - brns-20240331.htm 4 - brns-20240331.htm 4 [dqc-0071-Revenue/Cost-Single-Member] The filing has reported a value for the element us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax with a value of 0.000000 using the ProductOrServiceAxis in the role http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS on the table us-gaap:StatementLineItems. However, the only member used to disaggregate the total for us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax was the member us-gaap:LicenseMember. If only one member is used on this axis then the filer should either: 1. Retag the filing using the element TypeOfRevenueExtensibleList/TypeOfCostGoodOrServiceExtensibleList with a value of us-gaap:LicenseMember and the member us-gaap:LicenseMember should be removed from the value as it represents the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; or, 2. Tag the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax with a value of 0.000000 without the product of service axis. This rule will not generate an error if the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax is reported. The properties of this us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax fact are: Context: c-100, Unit: usd. brns-20240331.htm 4 [dqc-0071-Revenue/Cost-Single-Member] The filing has reported a value for the element us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax with a value of 500000.000000 using the ProductOrServiceAxis in the role http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS on the table us-gaap:StatementLineItems. However, the only member used to disaggregate the total for us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax was the member us-gaap:LicenseMember. If only one member is used on this axis then the filer should either: 1. Retag the filing using the element TypeOfRevenueExtensibleList/TypeOfCostGoodOrServiceExtensibleList with a value of us-gaap:LicenseMember and the member us-gaap:LicenseMember should be removed from the value as it represents the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; or, 2. Tag the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax with a value of 500000.000000 without the product of service axis. This rule will not generate an error if the aggregate value of us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax is reported. The properties of this us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax fact are: Context: c-101, Unit: usd. brns-20240331.htm 4 brns-20240331.htm brns-20240331.xsd brns-20240331_cal.xml brns-20240331_def.xml brns-20240331_lab.xml brns-20240331_pre.xml brns-20240331_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 76 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "brns-20240331.htm": { "nsprefix": "brns", "nsuri": "http://www.barinthusbio.com/20240331", "dts": { "inline": { "local": [ "brns-20240331.htm" ] }, "schema": { "local": [ "brns-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "brns-20240331_cal.xml" ] }, "definitionLink": { "local": [ "brns-20240331_def.xml" ] }, "labelLink": { "local": [ "brns-20240331_lab.xml" ] }, "presentationLink": { "local": [ "brns-20240331_pre.xml" ] } }, "keyStandard": 199, "keyCustom": 40, "axisStandard": 16, "axisCustom": 0, "memberStandard": 17, "memberCustom": 14, "hidden": { "total": 8, "http://xbrl.sec.gov/dei/2023": 6, "http://fasb.org/us-gaap/2023": 2 }, "contextCount": 101, "entityCount": 1, "segmentCount": 32, "elementCount": 445, "unitCount": 9, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 409, "http://xbrl.sec.gov/dei/2023": 32, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.barinthusbio.com/role/DocumentandEntityInformation", "longName": "0000001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "brns:ResearchAndDevelopmentIncentivesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } }, "R3": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "gbpPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "gbpPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } }, "R5": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": null }, "R6": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-34", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-34", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } }, "R8": { "role": "http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentation", "longName": "0000008 - Disclosure - Nature of Business and Basis of Presentation", "shortName": "Nature of Business and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPolicies", "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpenses", "longName": "0000010 - Disclosure - Foreign Currency Translation in General and Administrative Expenses", "shortName": "Foreign Currency Translation in General and Administrative Expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ForeignCurrencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.barinthusbio.com/role/NetLossPerShare", "longName": "0000011 - Disclosure - Net Loss Per Share", "shortName": "Net Loss Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.barinthusbio.com/role/PropertyandEquipmentNet", "longName": "0000012 - Disclosure - Property and Equipment, Net", "shortName": "Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.barinthusbio.com/role/IntangibleAssetsNet", "longName": "0000013 - Disclosure - Intangible Assets, Net", "shortName": "Intangible Assets, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssets", "longName": "0000014 - Disclosure - Prepaid Expenses and Other Current Assets", "shortName": "Prepaid Expenses and Other Current Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "brns:PrepaidExpenseAndOtherAssetsCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "brns:PrepaidExpenseAndOtherAssetsCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilities", "longName": "0000015 - Disclosure - Accrued Expenses and Other Current Liabilities", "shortName": "Accrued Expenses and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.barinthusbio.com/role/GrantIncome", "longName": "0000016 - Disclosure - Grant Income", "shortName": "Grant Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.barinthusbio.com/role/OrdinaryShares", "longName": "0000017 - Disclosure - Ordinary Shares", "shortName": "Ordinary Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.barinthusbio.com/role/DeferredShares", "longName": "0000018 - Disclosure - Deferred Shares", "shortName": "Deferred Shares", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "brns:StockholdersEquityDeferredSharesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "brns:StockholdersEquityDeferredSharesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.barinthusbio.com/role/FairValue", "longName": "0000019 - Disclosure - Fair Value", "shortName": "Fair Value", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.barinthusbio.com/role/Goodwill", "longName": "0000020 - Disclosure - Goodwill", "shortName": "Goodwill", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.barinthusbio.com/role/ShareBasedCompensation", "longName": "0000021 - Disclosure - Share-Based Compensation", "shortName": "Share-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingencies", "longName": "0000022 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.barinthusbio.com/role/RelatedPartyTransactions", "longName": "0000023 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": null }, "R25": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.barinthusbio.com/role/NetLossPerShareTables", "longName": "9954472 - Disclosure - Net Loss Per Share (Tables)", "shortName": "Net Loss Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsTables", "longName": "9954473 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)", "shortName": "Prepaid Expenses and Other Current Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables", "longName": "9954474 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)", "shortName": "Accrued Expenses and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "brns:AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.barinthusbio.com/role/GrantIncomeTables", "longName": "9954475 - Disclosure - Grant Income (Tables)", "shortName": "Grant Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredIncomeTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.barinthusbio.com/role/FairValueTables", "longName": "9954476 - Disclosure - Fair Value (Tables)", "shortName": "Fair Value (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.barinthusbio.com/role/ShareBasedCompensationTables", "longName": "9954477 - Disclosure - Share-Based Compensation (Tables)", "shortName": "Share-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingenciesTables", "longName": "9954478 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "brns:LesseeOperatingLeaseRightOfUseAssetAndOtherInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "brns:LesseeOperatingLeaseRightOfUseAssetAndOtherInformationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentationDetails", "longName": "9954479 - Disclosure - Nature of Business and Basis of Presentation (Details)", "shortName": "Nature of Business and Basis of Presentation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": null }, "R35": { "role": "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "9954480 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpensesDetails", "longName": "9954481 - Disclosure - Foreign Currency Translation in General and Administrative Expenses (Details)", "shortName": "Foreign Currency Translation in General and Administrative Expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails", "longName": "9954482 - Disclosure - Net Loss Per Share - Computation (Details)", "shortName": "Net Loss Per Share - Computation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": null }, "R38": { "role": "http://www.barinthusbio.com/role/NetLossPerShareAdditionalInformationDetails", "longName": "9954483 - Disclosure - Net Loss Per Share - Additional Information (Details)", "shortName": "Net Loss Per Share - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.barinthusbio.com/role/PropertyandEquipmentNetDetails", "longName": "9954484 - Disclosure - Property and Equipment, Net (Details)", "shortName": "Property and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentAdditions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentAdditions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails", "longName": "9954485 - Disclosure - Intangible Assets, Net (Details)", "shortName": "Intangible Assets, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails", "longName": "9954486 - Disclosure - Prepaid Expenses and Other Current Assets (Details)", "shortName": "Prepaid Expenses and Other Current Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:PrepaidExpenseCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "longName": "9954487 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-5", "name": "brns:AccruedManufacturingAndClinicalExpensesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "brns:AccruedManufacturingAndClinicalExpensesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails", "longName": "9954488 - Disclosure - Grant Income - Additional Information (Details)", "shortName": "Grant Income - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DeferredIncomeAddition", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-64", "name": "brns:FundingAmountMaximum", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } }, "R44": { "role": "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails", "longName": "9954489 - Disclosure - Grant Income - Changes in deferred income (Details)", "shortName": "Grant Income - Changes in deferred income (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DeferredIncome", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DeferredIncomeTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.barinthusbio.com/role/OrdinarySharesDetails", "longName": "9954490 - Disclosure - Ordinary Shares (Details)", "shortName": "Ordinary Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-5", "name": "brns:CommonStockNumberOfVotesPerShare", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "brns:CommonStockNumberOfVotesPerShare", "unitRef": "vote", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.barinthusbio.com/role/DeferredSharesDetails", "longName": "9954491 - Disclosure - Deferred Shares (Details)", "shortName": "Deferred Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-8", "name": "brns:OrdinarySharesLiquidationPreference", "unitRef": "gbp", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-8", "name": "brns:OrdinarySharesLiquidationPreference", "unitRef": "gbp", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails", "longName": "9954492 - Disclosure - Fair Value - Additional information (Details)", "shortName": "Fair Value - Additional information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-75", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-75", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details", "longName": "9954493 - Disclosure - Fair Value - Change in Financial Instruments Classified within Level 3 (Details)", "shortName": "Fair Value - Change in Financial Instruments Classified within Level 3 (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-76", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-76", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.barinthusbio.com/role/GoodwillDetails", "longName": "9954494 - Disclosure - Goodwill (Details)", "shortName": "Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "longName": "9954495 - Disclosure - Share-Based Compensation - Additional Information (Details)", "shortName": "Share-Based Compensation - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails", "longName": "9954496 - Disclosure - Share-Based Compensation - Weighted-average assumptions (Details)", "shortName": "Share-Based Compensation - Weighted-average assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-83", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-83", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails", "longName": "9954497 - Disclosure - Share-Based Compensation - Share based compensation expense (Details)", "shortName": "Share-Based Compensation - Share based compensation expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails", "longName": "9954498 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "shortName": "Commitments and Contingencies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-92", "name": "brns:NumberOfSquareFeetUnderLeaseAgreement", "unitRef": "sqft", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-92", "name": "brns:NumberOfSquareFeetUnderLeaseAgreement", "unitRef": "sqft", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails", "longName": "9954499 - Disclosure - Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details)", "shortName": "Commitments and Contingencies - Right-of-use Assets, Lease Liabilities and Other Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeasePayments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } }, "R55": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails", "longName": "9954500 - Disclosure - Commitments and Contingencies - Lease Cost (Details)", "shortName": "Commitments and Contingencies - Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ShortTermLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ShortTermLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails", "longName": "9954501 - Disclosure - Commitments and Contingencies - Maturities of minimum lease liabilities (Details)", "shortName": "Commitments and Contingencies - Maturities of minimum lease liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails", "longName": "9954502 - Disclosure - Related Party Transactions (Details)", "shortName": "Related Party Transactions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-98", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-4", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "brns-20240331.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "verboseLabel": "Amounts owed to other party", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r15", "r578" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts owned from other party", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r218", "r219" ] }, "us-gaap_AccruedBonusesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedBonusesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued bonus", "label": "Accrued Bonuses, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedEmployeeBenefitsCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll and employee benefits", "label": "Accrued Employee Benefits, Current", "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "brns_AccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AccruedLiabilitiesAndOtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of accrued expenses and other current liabilities", "label": "Accrued Liabilities And Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities and other current liabilities." } } }, "auth_ref": [] }, "brns_AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AccruedLiabilitiesAndOtherCurrentLiabilitiesTextBlock", "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Expenses and Other Current Liabilities", "label": "Accrued Liabilities And Other Current Liabilities [Text Block]", "documentation": "The entire disclosure of the components of accrued liabilities and other current liabilities." } } }, "auth_ref": [] }, "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Total", "label": "Accrued Liabilities and Other Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "brns_AccruedManufacturingAndClinicalExpensesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AccruedManufacturingAndClinicalExpensesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued manufacturing and clinical expenses", "label": "Accrued Manufacturing and Clinical Expenses, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing and clinical expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss \u2013 foreign currency translation adjustments", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses." } } }, "auth_ref": [ "r135", "r136", "r137", "r138", "r346" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r11", "r23", "r335", "r338", "r371", "r428", "r429", "r683", "r684", "r685", "r691", "r692", "r693" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r634" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r68", "r578", "r756" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-in-Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r313", "r314", "r315", "r446", "r691", "r692", "r693", "r736", "r759" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r640" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r640" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r640" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r640" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r48", "r49", "r279" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net (loss)/income to net cash used in operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "dei_AdrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdrMember", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "American Depositary Shares", "label": "ADR [Member]", "documentation": "American Depositary Receipt (or American Depositary Share, ADS)." } } }, "auth_ref": [ "r599" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r605", "r616", "r626", "r651" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r608", "r619", "r629", "r654" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r640" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r647" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r612", "r620", "r630", "r647", "r655", "r659", "r667" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r665" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r308", "r316" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense for intangible assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r34", "r38" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.barinthusbio.com/role/NetLossPerShareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issuable for stock options that were excluded from the computation of diluted weighted-average shares outstanding (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r186" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r326" ] }, "brns_AssetRetirementObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AssetRetirementObligations", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Asset retirement obligation", "label": "Asset Retirement Obligations", "documentation": "Amount of asset retirement obligations." } } }, "auth_ref": [] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r103", "r128", "r159", "r193", "r208", "r212", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r328", "r332", "r347", "r405", "r483", "r578", "r591", "r704", "r705", "r744" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r123", "r134", "r159", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r328", "r332", "r347", "r578", "r704", "r705", "r744" ] }, "brns_AvideaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "AvideaMember", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Avidea", "label": "Avidea [Member]", "documentation": "This member stands for Avidea." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r662" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r663" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r658" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r658" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r658" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r658" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r658" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r658" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r661" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r660" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r659" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r659" ] }, "brns_BarinthusBiotherapeuticsPlcShareAwardPlan2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "BarinthusBiotherapeuticsPlcShareAwardPlan2021Member", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Barinthus Biotherapeutics plc Share Award Plan 2021", "label": "Barinthus Biotherapeutics plc Share Award Plan 2021 [Member]", "documentation": "Barinthus Biotherapeutics plc Share Award Plan 2021" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r324", "r571", "r572" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r50", "r51", "r324", "r571", "r572" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Change in contingent consideration", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement." } } }, "auth_ref": [ "r325", "r686" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1", "r52" ] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Purchases of property and equipment included in accounts payable and accrued liabilities", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r27", "r28", "r29" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash, cash equivalents and restricted cash", "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of the period", "periodEndLabel": "Cash, cash equivalents and restricted cash, end of the period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r25", "r81", "r156" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r81" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r638" ] }, "brns_ChangesToRightOfUseAssetResultingFromLeaseReassessmentEvent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ChangesToRightOfUseAssetResultingFromLeaseReassessmentEvent", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes to right-of-use asset resulting from lease reassessment event", "label": "Changes to right-of-use asset resulting from lease reassessment event", "documentation": "Amount of changes to right-of-use asset resulting from lease reassessment event." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DeferredSharesDetails", "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r119", "r129", "r130", "r131", "r159", "r180", "r181", "r183", "r185", "r191", "r192", "r220", "r245", "r247", "r248", "r249", "r252", "r253", "r256", "r257", "r260", "r263", "r270", "r347", "r436", "r437", "r438", "r439", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r471", "r493", "r518", "r535", "r536", "r537", "r538", "r539", "r674", "r688", "r694" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares [Line items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r129", "r130", "r131", "r191", "r256", "r257", "r258", "r260", "r263", "r268", "r270", "r436", "r437", "r438", "r439", "r568", "r674", "r688" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r639" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r639" ] }, "brns_CoalitionForEpidemicPreparednessInnovationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "CoalitionForEpidemicPreparednessInnovationsMember", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Coalition for Epidemic Preparedness Innovations", "label": "Coalition For Epidemic Preparedness Innovations [Member]", "documentation": "Coalition For Epidemic Preparedness Innovations" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 15)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r20", "r63", "r406", "r470" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r90", "r239", "r240", "r543", "r701" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "verboseLabel": "Ordinary\u00a0Shares", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r691", "r692", "r736", "r755", "r759" ] }, "brns_CommonStockNumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "CommonStockNumberOfVotesPerShare", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of votes per common share (in votes)", "label": "Common Stock Number of Votes Per Share", "documentation": "The number of votes that each common share is entitled." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, nominal value (in gbp per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r67" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r67", "r471" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r67" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r12", "r67", "r471", "r489", "r759", "r760" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, \u00a30.000025 nominal value; 38,952,956 shares authorized, issued and outstanding (December\u00a031, 2023: authorized, issued and outstanding:38,643,540)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r67", "r407", "r578" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r644" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r643" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r645" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r642" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss attributable to Barinthus Biotherapeutics plc shareholders", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r24", "r140", "r142", "r149", "r400", "r418" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedLabel": "Comprehensive loss attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r7", "r55", "r58", "r140", "r142", "r148", "r399", "r417" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r58", "r99", "r140", "r142", "r147", "r398", "r416" ] }, "brns_ContingentConsiderationLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ContingentConsiderationLiabilityMember", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration Liability", "label": "Contingent Consideration Liability [Member]", "documentation": "Represents the information pertaining to contingent consideration liability." } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Axis]", "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r162", "r163", "r254", "r258", "r378", "r559", "r561" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "brns_DeferredBSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredBSharesMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred B Shares", "label": "Deferred B Shares [Member]", "documentation": "Represents information pertaining to deferred B shares." } } }, "auth_ref": [] }, "brns_DeferredCSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredCSharesMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred C Shares", "label": "Deferred C Shares [Member]", "documentation": "Represents information pertaining to deferred C shares." } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of prepaid expenses and other current assets", "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs." } } }, "auth_ref": [] }, "us-gaap_DeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncome", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Deferred Income", "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r676", "r753", "r754" ] }, "us-gaap_DeferredIncomeAddition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeAddition", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails", "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payments received", "label": "Deferred Income, Addition", "documentation": "Amount of increase in deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_DeferredIncomeCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income", "label": "Deferred Income, Current", "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r676" ] }, "brns_DeferredIncomeForeignExchangeTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredIncomeForeignExchangeTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign exchange translation", "label": "Deferred Income, Foreign Exchange Translation Gain (Loss)", "documentation": "Deferred Income, Foreign Exchange Translation Gain (Loss)" } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeLineItems", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Income [Line Items]", "label": "Deferred Income [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_DeferredIncomeRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails", "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income recognized related to the Funding Agreement", "negatedTerseLabel": "Other income recognized related to the Funding Agreement", "label": "Deferred Income, Revenue Recognized", "documentation": "Amount of revenue recognized previously reported as deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_DeferredIncomeRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeRollForward", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeChangesindeferredincomeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Income [Roll Forward]", "label": "Deferred Income [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTable", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Income [Table]", "label": "Deferred Income [Table]", "documentation": "Disclosure of information about deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_DeferredIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of changes in deferred income", "label": "Deferred Income [Table Text Block]", "documentation": "Tabular disclosure of deferred income not accounted for under Topic 606." } } }, "auth_ref": [ "r753", "r754" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred tax benefit", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r9", "r96", "r117", "r322", "r323", "r690" ] }, "brns_DeferredShares.Member": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredShares.Member", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred A shares", "verboseLabel": "Deferred A Shares", "label": "Deferred A Shares. [Member]", "documentation": "This member stands for deferred A shares" } } }, "auth_ref": [] }, "brns_DeferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredSharesMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred Shares", "label": "Deferred Shares [Member]", "documentation": "Represents information pertaining to deferred shares." } } }, "auth_ref": [] }, "brns_DeferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredStockParOrStatedValuePerShare", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares, nominal value (in gbp per share)", "label": "Deferred Stock, Par Or Stated Value Per Share", "documentation": "Face amount or stated value per share of deferred stock." } } }, "auth_ref": [] }, "brns_DeferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredStockSharesAuthorized", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares, authorized (in shares)", "label": "Deferred Stock, Shares Authorized", "documentation": "The maximum number of deferred shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [] }, "brns_DeferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredStockSharesIssued", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares, issued (in shares)", "label": "Deferred Stock, Shares Issued", "documentation": "Total number of deferred shares of an entity that have been sold or granted to shareholders" } } }, "auth_ref": [] }, "brns_DeferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredStockSharesOutstanding", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares, outstanding (in shares)", "label": "Deferred Stock, Shares Outstanding", "documentation": "Number of shares of deferred stock outstanding." } } }, "auth_ref": [] }, "brns_DeferredStockValueIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredStockValueIssued", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred A shares, \u00a31 nominal value; 63,443 shares authorized, issued and outstanding (December\u00a031, 2023: authorized, issued and outstanding: 63,443)", "label": "Deferred Stock, Value Issued", "documentation": "Aggregate par or stated value of issued deferred stock." } } }, "auth_ref": [] }, "brns_DeferredTaxLiabilityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "DeferredTaxLiabilityNet", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liability, net", "label": "Deferred Tax Liability, Net", "documentation": "Amount of classified as non-current liabilities, net value of deferred tax liability." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r9", "r39" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r198" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r97" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r277", "r281", "r309", "r310", "r312", "r574" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r600" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r633" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share attributable to ordinary shareholders, basic (in usd per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r150", "r169", "r170", "r171", "r172", "r173", "r178", "r180", "r183", "r184", "r185", "r189", "r342", "r343", "r401", "r419", "r562" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share attributable to ordinary shareholders, diluted (in usd per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r150", "r169", "r170", "r171", "r172", "r173", "r180", "r183", "r184", "r185", "r189", "r342", "r343", "r401", "r419", "r562" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.barinthusbio.com/role/NetLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r177", "r186", "r187", "r188" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rates on cash, cash equivalents and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r740" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average period over which unrecognized compensation cost is expected to be recognized", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r311" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost related to options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r735" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "brns_EnterpriseManagementIncentiveShareOptionSchemeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "EnterpriseManagementIncentiveShareOptionSchemeMember", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Enterprise Management Incentive Share Option Scheme", "label": "Enterprise Management Incentive Share Option Scheme [Member]", "documentation": "Information pertaining to the Enterprise Management Incentive Share Option Scheme." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Country", "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r597" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r597" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r673" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r597" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r672" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r597" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r597" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r597" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r597" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Equity [Abstract]", "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r12", "r120", "r143", "r144", "r145", "r164", "r165", "r166", "r168", "r174", "r176", "r190", "r221", "r222", "r271", "r313", "r314", "r315", "r319", "r320", "r334", "r335", "r336", "r337", "r338", "r339", "r341", "r353", "r354", "r355", "r356", "r357", "r358", "r371", "r428", "r429", "r430", "r446", "r518" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r641" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r605", "r616", "r626", "r651" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r602", "r613", "r623", "r648" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r647" ] }, "brns_ExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ExpensesMember", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expenses", "label": "Expenses [Member]", "documentation": "Expenses" } } }, "auth_ref": [] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r59", "r101" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.barinthusbio.com/role/FairValue" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r344" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r13" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails", "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails", "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3." } } }, "auth_ref": [ "r13", "r59" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.barinthusbio.com/role/FairValueTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of financial instruments carried at fair value and classified within Level 3", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r13", "r59" ] }, "brns_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignExchangeTranslation": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityForeignExchangeTranslation", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange translation recognized in other comprehensive loss", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Foreign Exchange Translation", "documentation": "Amount of foreign exchange translation of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value recognized in net loss/(gain)", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r345" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/FairValueAdditionalinformationDetails", "http://www.barinthusbio.com/role/FairValueChangeinFinancialInstrumentsClassifiedwithinLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration liability", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r13" ] }, "brns_FiniteLivedIntangibleAssetExpectedAmortizationCurrentYear": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationCurrentYear", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Current Year", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, Current Year" } } }, "auth_ref": [] }, "brns_FiniteLivedIntangibleAssetExpectedAmortizationYearSeven": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationYearSeven", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2031", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Seven", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, Year Seven" } } }, "auth_ref": [] }, "brns_FiniteLivedIntangibleAssetExpectedAmortizationYearSix": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationYearSix", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2030", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Six", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, Year Six" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated amortization for amortizable intangible assets", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r126", "r235" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r87" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r87" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r87" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r87" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated annual amortization expense for 2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r87" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r233", "r234", "r235", "r236", "r383", "r384" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount of amortizable intangible assets", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r86", "r384" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets, net", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r383" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r35", "r37" ] }, "us-gaap_ForeignCurrencyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyAbstract", "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency [Abstract]", "label": "Foreign Currency [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpenses" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation in General and Administrative Expenses", "label": "Foreign Currency Disclosure [Text Block]", "documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items." } } }, "auth_ref": [ "r348", "r359", "r592", "r593", "r594", "r595", "r675" ] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/ForeignCurrencyTranslationinGeneralandAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net foreign exchange gain (loss)", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r349", "r350", "r351", "r352", "r515" ] }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossUnrealized", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized foreign exchange (gain)/loss", "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r83", "r491", "r589", "r738", "r739", "r758" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r609", "r620", "r630", "r655" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r609", "r620", "r630", "r655" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r609", "r620", "r630", "r655" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r609", "r620", "r630", "r655" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r609", "r620", "r630", "r655" ] }, "brns_FundingAmountMaximum": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "FundingAmountMaximum", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum funding amount", "label": "Funding Amount, Maximum", "documentation": "Funding Amount, Maximum" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r77", "r495" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r75" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r125", "r226", "r397", "r567", "r578", "r698", "r699" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/Goodwill" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill." } } }, "auth_ref": [ "r225", "r228", "r230", "r567" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment loss", "label": "Goodwill, Impairment Loss", "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r9", "r227", "r229", "r231", "r567" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IPO", "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "brns_InLicenseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "InLicenseAgreementsMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-License Agreements", "label": "In-License Agreements [Member]", "documentation": "Represents the information pertaining to In-License Agreements." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r73", "r106", "r193", "r207", "r211", "r213", "r402", "r412", "r564" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r237", "r238", "r501" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r238", "r501" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax benefit", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r109", "r118", "r175", "r176", "r199", "r318", "r321", "r420" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for income taxes", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r26" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable (including related parties)", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other." } } }, "auth_ref": [ "r686" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income", "label": "Increase (Decrease) in Deferred Revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r555" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r677", "r686" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r8" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r8" ] }, "brns_IncreaseDecreaseInResearchAndDevelopmentIncentivesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "IncreaseDecreaseInResearchAndDevelopmentIncentivesReceivable", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development incentives receivable", "label": "Increase (Decrease) in Research and Development Incentives Receivable", "documentation": "Amount of increase (decrease) in research and development incentives receivable." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r612", "r620", "r630", "r647", "r655", "r659", "r667" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r665" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r601", "r671" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r601", "r671" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r601", "r671" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNet" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets, Net", "label": "Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r232" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r33", "r36" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r60", "r108", "r146", "r197", "r360", "r502", "r589", "r757" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r151", "r154", "r155" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r78", "r196" ] }, "us-gaap_LeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCost", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease cost", "label": "Lease, Cost", "documentation": "Amount of lease cost recognized by lessee for lease contract." } } }, "auth_ref": [ "r364", "r577" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of lease cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r741" ] }, "us-gaap_LeaseholdImprovementsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsGross", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvement expense", "label": "Leasehold Improvements, Gross", "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r89" ] }, "brns_LesseeOperatingLeaseExtendedTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "LesseeOperatingLeaseExtendedTerm", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional lease term", "label": "Lessee Operating Lease, Extended Term", "documentation": "Term of lessee's operating lease extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of maturities of minimum lease liabilities", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r742" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r370" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r370" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r370" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r370" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r370" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r742" ] }, "brns_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due in year four and after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r370" ] }, "brns_LesseeOperatingLeaseRightOfUseAssetAndOtherInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "LesseeOperatingLeaseRightOfUseAssetAndOtherInformationTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of right-of-use assets, lease liabilities and other information", "label": "Lessee Operating Lease Right of Use asset and Other Information [Table Text Block]", "documentation": "Tabular disclosure for Company's right-of-use asset and lease liability and other information." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r16", "r159", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r329", "r332", "r333", "r347", "r469", "r563", "r591", "r704", "r744", "r745" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r72", "r105", "r410", "r578", "r689", "r697", "r737" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r18", "r124", "r159", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r329", "r332", "r333", "r347", "r578", "r704", "r744", "r745" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-Current liabilities:", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicenseMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "License revenue", "label": "License [Member]", "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark." } } }, "auth_ref": [ "r708" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "stpr_MD": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "MD", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maryland", "label": "MARYLAND" } } }, "auth_ref": [] }, "brns_MaximumAggregateNominalAmountOfSharesAuthorizedToBeAllottedFreeFromStatutoryPreEmptionRights": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "MaximumAggregateNominalAmountOfSharesAuthorizedToBeAllottedFreeFromStatutoryPreEmptionRights", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum aggregate nominal amount of shares authorized to be allotted free from pre-emption rights", "label": "Maximum Aggregate Nominal Amount Of Shares Authorized To Be Allotted Free From Statutory Pre-emption Rights", "documentation": "Amount of maximum aggregate nominal amount of shares that the board of directors are authorized to allot free from statutory Pre-emption rights." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r276", "r381", "r427", "r461", "r462", "r526", "r528", "r530", "r531", "r533", "r553", "r554", "r566", "r568", "r573", "r580", "r706", "r746", "r747", "r748", "r749", "r750", "r751" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r639" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r639" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r276", "r381", "r427", "r461", "r462", "r526", "r528", "r530", "r531", "r533", "r553", "r554", "r566", "r568", "r573", "r580", "r706", "r746", "r747", "r748", "r749", "r750", "r751" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r22", "r104", "r159", "r220", "r245", "r247", "r248", "r249", "r252", "r253", "r347", "r409", "r473" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r658" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r666" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r640" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r153" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r153" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r81", "r82", "r83" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss attributable to Barinthus Biotherapeutics plc shareholders", "terseLabel": "Net Income (Loss) Attributable to Parent", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r74", "r83", "r107", "r122", "r139", "r141", "r145", "r159", "r167", "r169", "r170", "r171", "r172", "r175", "r176", "r182", "r193", "r207", "r211", "r213", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r343", "r347", "r415", "r492", "r516", "r517", "r564", "r589", "r704" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net loss attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r57", "r100", "r139", "r141", "r175", "r176", "r414", "r685" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently issued accounting pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "brns_NonCashInterestExpenseOnConvertibleLoanNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "NonCashInterestExpenseOnConvertibleLoanNotes", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non cash interest expense", "label": "Non-Cash Interest Expense On Convertible Loan Notes", "documentation": "Amount of non-cash interest expense on convertible loan notes." } } }, "auth_ref": [] }, "brns_NonCashLeaseExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "NonCashLeaseExpenses", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash lease expenses", "label": "Non-Cash Lease Expenses", "documentation": "The amount of non-cash lease expenses." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r639" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r609", "r620", "r630", "r647", "r655" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r637" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r636" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r647" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r666" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r666" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Cash investing and financing activities", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Controlling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r53", "r271", "r691", "r692", "r693", "r759" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r79" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r696" ] }, "brns_NumberOfSquareFeetUnderLeaseAgreement": { "xbrltype": "areaItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "NumberOfSquareFeetUnderLeaseAgreement", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Size of space under lease agreement (in square feet)", "label": "Number Of Square Feet Under Lease Agreement", "documentation": "Represents the information pertaining to number of Square Feet Under Lease Agreement." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r193", "r207", "r211", "r213", "r564" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed lease costs", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r365", "r577" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesMaturitiesofminimumleaseliabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total lease liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r362" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability - current", "verboseLabel": "Lease liability, current", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r362" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liability - non-current", "verboseLabel": "Lease liability, non-current", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r362" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r363", "r367" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use assets, net", "verboseLabel": "Right-of-use asset", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r361" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r369", "r577" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r368", "r577" ] }, "brns_OrdinarySharesLiquidationPreference": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "OrdinarySharesLiquidationPreference", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares, liquidation preference", "label": "Ordinary Shares, Liquidation Preference", "documentation": "The amount of liquidation preference on ordinary shares to be paid after which the deferred shares have the entitlement to receive out of the assets of the Company." } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Nature of Business and Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r65", "r98", "r433", "r434" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "brns_AccruedLiabilitiesAndOtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r17" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r102", "r127", "r404", "r591" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r133", "r578" ] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment and Contingencies", "label": "Other Commitments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTable", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Commitments [Table]", "label": "Other Commitments [Table]", "documentation": "Disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss)/gain \u2013 foreign currency translation adjustments", "verboseLabel": "Foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4" ] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other income/(expense):", "label": "Other Income and Expenses [Abstract]" } } }, "auth_ref": [] }, "brns_OtherInformationLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "OtherInformationLesseeAbstract", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesRightofuseAssetsLeaseLiabilitiesandOtherInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other information", "label": "Other Information, Lessee [Abstract]", "documentation": "Other Information, Lessee" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r19" ] }, "us-gaap_OtherOperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncome", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating income", "label": "Other Operating Income", "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r76" ] }, "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeAndExpenseTextBlock", "presentation": [ "http://www.barinthusbio.com/role/GrantIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Grant Income", "label": "Other Operating Income and Expense [Text Block]", "documentation": "The entire disclosure for other operating income and other operating expense items." } } }, "auth_ref": [ "r499" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r639" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r607", "r618", "r628", "r653" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r610", "r621", "r631", "r656" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r610", "r621", "r631", "r656" ] }, "brns_OxfordUniversityInnovationLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "OxfordUniversityInnovationLimitedMember", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Oxford University Innovation Limited", "label": "Oxford University Innovation Limited", "documentation": "Represents the information pertaining to Oxford University Innovation Limited." } } }, "auth_ref": [] }, "brns_OxfordshireMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "OxfordshireMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Oxfordshire", "label": "Oxfordshire [Member]", "documentation": "Oxfordshire" } } }, "auth_ref": [] }, "us-gaap_ParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ParentMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Total stockholders\u2019 equity attributable to Barinthus Biotherapeutics plc stockholders", "label": "Parent [Member]", "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r635" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of contingent consideration", "label": "Payment for Contingent Consideration Liability, Financing Activities", "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date." } } }, "auth_ref": [ "r6" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r80" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r638" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r638" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r637" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r647" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r640" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r636" ] }, "brns_PercentageOfFutureRoyaltiesForDirectSalesOfCoveredProductLicenseAgreement": { "xbrltype": "percentItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "PercentageOfFutureRoyaltiesForDirectSalesOfCoveredProductLicenseAgreement", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of future royalties for direct sales of a covered product", "label": "Percentage of Future Royalties for Direct Sales of Covered Product , License Agreement", "documentation": "Percentage of future royalties for direct sales of a covered product under the In-License Agreements." } } }, "auth_ref": [] }, "brns_PercentageOfNetPaymentsReceivedForAllowableSublicensesOfTechnologyDevelopedLicenseAgreement": { "xbrltype": "percentItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "PercentageOfNetPaymentsReceivedForAllowableSublicensesOfTechnologyDevelopedLicenseAgreement", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net payments received for allowable sublicenses of technology developed", "label": "Percentage Of Net Payments Received For Allowable Sublicenses Of Technology Developed License Agreement", "documentation": "Percentage of net payments received for allowable sublicenses of technology developed under the In-License Agreements." } } }, "auth_ref": [] }, "brns_PercentageOfSharesNecessaryToExercisePreemptiveRights": { "xbrltype": "percentItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "PercentageOfSharesNecessaryToExercisePreemptiveRights", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of ordinary shares present to exercise preemptive rights", "label": "Percentage Of Shares Necessary To Exercise Preemptive Rights", "documentation": "The minimum percentage of shares required to exercise preemptive rights." } } }, "auth_ref": [] }, "brns_PeriodOfPreemptiveRightsToBeExercised": { "xbrltype": "durationItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "PeriodOfPreemptiveRightsToBeExercised", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum period to exercise preemptive rights", "label": "Period Of Preemptive Rights To Be Exercised", "documentation": "The period allowed to exercise preemptive rights." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "totalLabel": "Total", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r682" ] }, "brns_PrepaidExpenseAndOtherAssetsCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "PrepaidExpenseAndOtherAssetsCurrentTextBlock", "presentation": [ "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Expenses and Other Current Assets", "label": "Prepaid Expense and Other Assets, Current [Text Block]", "documentation": "The entire disclosure on prepaid expense and other current assets." } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepayments and accrued income", "label": "Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r132", "r223", "r224", "r558" ] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issue of ordinary shares, net of issuance costs", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of shares from the exercise of stock options", "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised", "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised." } } }, "auth_ref": [ "r5", "r14" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r214", "r382", "r421", "r422", "r423", "r424", "r425", "r426", "r556", "r569", "r579", "r678", "r702", "r703", "r707", "r753" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r214", "r382", "r421", "r422", "r423", "r424", "r425", "r426", "r556", "r569", "r579", "r678", "r702", "r703", "r707", "r753" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "verboseLabel": "Net loss", "terseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r122", "r139", "r141", "r152", "r159", "r167", "r175", "r176", "r193", "r207", "r211", "r213", "r220", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r327", "r330", "r331", "r343", "r347", "r402", "r413", "r445", "r492", "r516", "r517", "r564", "r575", "r576", "r590", "r685", "r704" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Abstract]", "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAdditions", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/PropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to property and equipment", "label": "Property, Plant and Equipment, Additions", "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/PropertyandEquipmentNet" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment, Net", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r88", "r112", "r115", "r116" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r403", "r411", "r578" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r635" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r635" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r274", "r276", "r304", "r305", "r306", "r380", "r381", "r427", "r461", "r462", "r526", "r528", "r530", "r531", "r533", "r553", "r554", "r566", "r568", "r573", "r580", "r583", "r700", "r706", "r747", "r748", "r749", "r750", "r751" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r274", "r276", "r304", "r305", "r306", "r380", "r381", "r427", "r461", "r462", "r526", "r528", "r530", "r531", "r533", "r553", "r554", "r566", "r568", "r573", "r580", "r583", "r700", "r706", "r747", "r748", "r749", "r750", "r751" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r602", "r613", "r623", "r648" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Domain]", "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r275", "r375", "r376", "r464", "r465", "r466", "r467", "r468", "r488", "r490", "r525" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Parties", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r160", "r161", "r375", "r376", "r377", "r378", "r464", "r465", "r466", "r467", "r468", "r488", "r490", "r525" ] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts of related party transactions", "label": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r62", "r375" ] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Axis]", "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r375", "r376", "r743" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Domain]", "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Transaction [Line Items]", "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r496", "r497", "r501" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party Transactions [Abstract]", "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party [Axis]", "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r275", "r375", "r376", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r464", "r465", "r466", "r467", "r468", "r488", "r490", "r525", "r743" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "verboseLabel": "Related Party Transactions", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r372", "r373", "r374", "r376", "r379", "r441", "r442", "r443", "r498", "r500", "r501", "r522", "r524" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparty Name [Domain]", "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r162", "r163", "r254", "r258", "r378", "r560", "r561" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r64", "r317", "r752" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "brns_ResearchAndDevelopmentIncentiveIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ResearchAndDevelopmentIncentiveIncomeExpense", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development incentives", "label": "Research And Development Incentive Income (Expense)", "documentation": "Represents the research and development incentives (expenses) for the period." } } }, "auth_ref": [] }, "brns_ResearchAndDevelopmentIncentivesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ResearchAndDevelopmentIncentivesReceivable", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development incentives receivable", "label": "Research and development incentives receivable", "documentation": "Amount of research and development incentives receivable." } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r603", "r614", "r624", "r649" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r604", "r615", "r625", "r650" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r611", "r622", "r632", "r657" ] }, "us-gaap_RestrictedCashCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashCurrent", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash, Current", "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits." } } }, "auth_ref": [ "r679", "r687" ] }, "brns_RestrictedShareUnitsStockOptionsShareAppreciationRightsAndRestrictedSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "RestrictedShareUnitsStockOptionsShareAppreciationRightsAndRestrictedSharesMember", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted share units, options, share appreciation rights and restricted shares", "label": "Restricted Share Units Stock Options Share Appreciation Rights And Restricted Shares [Member]", "documentation": "Information pertaining to aggregate awards under a specific share-based compensation plan." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/NatureofBusinessandBasisofPresentationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "negatedLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r69", "r94", "r408", "r431", "r432", "r440", "r472", "r578" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r120", "r164", "r165", "r166", "r168", "r174", "r176", "r221", "r222", "r313", "r314", "r315", "r319", "r320", "r334", "r336", "r337", "r339", "r341", "r428", "r430", "r446", "r759" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical", "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenue", "verboseLabel": "Revenue recognized", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r194", "r195", "r206", "r209", "r210", "r214", "r215", "r217", "r272", "r273", "r382" ] }, "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]", "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]", "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer." } } }, "auth_ref": [ "r569" ] }, "brns_RoyaltyPaymentTermMaximum": { "xbrltype": "durationItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "RoyaltyPaymentTermMaximum", "presentation": [ "http://www.barinthusbio.com/role/GrantIncomeAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum royalty payment period", "label": "Royalty Payment, Term, Maximum", "documentation": "Royalty Payment, Term, Maximum" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r666" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r666" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Domain]", "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of share based compensation expense", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r47" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/NetLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of computation of basic and diluted net loss per share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r695" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.barinthusbio.com/role/IntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r35", "r37", "r383" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://www.barinthusbio.com/role/RelatedPartyTransactionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r61", "r62", "r496", "r497", "r501" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r278", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of weighted-average assumptions of fair value stock option issued to employees", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r95" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.barinthusbio.com/role/DeferredSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred shares [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r92", "r93", "r94", "r129", "r130", "r131", "r191", "r256", "r257", "r258", "r260", "r263", "r268", "r270", "r436", "r437", "r438", "r439", "r568", "r674", "r688" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r596" ] }, "us-gaap_SecurityDeposit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecurityDeposit", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Refundable security deposit", "label": "Security Deposit", "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease." } } }, "auth_ref": [ "r680" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r598" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r215", "r216", "r458", "r459", "r460", "r527", "r529", "r532", "r534", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r557", "r570", "r583", "r707", "r753" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment information", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r200", "r201", "r202", "r203", "r204", "r205", "r215", "r565" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r305" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r304" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r306" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationSharebasedcompensationexpenseDetails", "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r278", "r280", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r715" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r289" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted-average grant date fair value of options granted (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r299" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options outstanding (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r285", "r286" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price of options outstanding (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r285", "r286" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price of options granted (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r289" ] }, "brns_ShareBasedCompensationPercentageOfSharesAvailableForIssuanceAsPercentageOfIssuedAndOutstandingShares": { "xbrltype": "percentItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "ShareBasedCompensationPercentageOfSharesAvailableForIssuanceAsPercentageOfIssuedAndOutstandingShares", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of issued and outstanding ordinary shares available for issuance under the Plan", "label": "Share-Based Compensation, Percentage Of Shares Available For Issuance As A Percentage Of Issued And Outstanding Shares", "documentation": "Total number of shares available for issuance under the Plan as a percentage of the Company's issued and outstanding shares." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.barinthusbio.com/role/ShareBasedCompensationWeightedaverageassumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r303" ] }, "brns_SharesCancelledDuringPeriodSharesDeferredShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "SharesCancelledDuringPeriodSharesDeferredShares", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cancellation of deferred shares (in shares)", "label": "Shares Cancelled During Period, Shares, Deferred Shares", "documentation": "The number of deferred shares cancelled during the period." } } }, "auth_ref": [] }, "brns_SharesCancelledDuringPeriodValueDeferredShares": { "xbrltype": "monetaryItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "SharesCancelledDuringPeriodValueDeferredShares", "crdr": "debit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "negatedLabel": "Cancellation of deferred shares", "label": "Shares Cancelled During Period, Value, Deferred Shares", "documentation": "The value of deferred shares cancelled during the period." } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails": { "parentTag": "us-gaap_LeaseCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease costs", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r366", "r577" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r84", "r157" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/DeferredSharesDetails", "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r119", "r129", "r130", "r131", "r159", "r180", "r181", "r183", "r185", "r191", "r192", "r220", "r245", "r247", "r248", "r249", "r252", "r253", "r256", "r257", "r260", "r263", "r270", "r347", "r436", "r437", "r438", "r439", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r471", "r493", "r518", "r535", "r536", "r537", "r538", "r539", "r674", "r688", "r694" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r12", "r21", "r120", "r143", "r144", "r145", "r164", "r165", "r166", "r168", "r174", "r176", "r190", "r221", "r222", "r271", "r313", "r314", "r315", "r319", "r320", "r334", "r335", "r336", "r337", "r338", "r339", "r341", "r353", "r354", "r355", "r356", "r357", "r358", "r371", "r428", "r429", "r430", "r446", "r518" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r215", "r216", "r458", "r459", "r460", "r527", "r529", "r532", "r534", "r542", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r557", "r570", "r583", "r707", "r753" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r164", "r165", "r166", "r190", "r382", "r435", "r457", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r486", "r487", "r488", "r490", "r494", "r495", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r518", "r584" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r164", "r165", "r166", "r190", "r382", "r435", "r457", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r484", "r485", "r486", "r487", "r488", "r490", "r494", "r495", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r518", "r584" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r606", "r617", "r627", "r652" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of ordinary shares", "label": "Stock Issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r27", "r28", "r29" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of ordinary shares, net of issuance cost (in shares)", "label": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r12", "r66", "r67", "r94", "r436", "r518", "r536" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of ordinary shares, net of issuance costs", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r12", "r66", "r67", "r94", "r446", "r518", "r536", "r590" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity attributable to Barinthus Biotherapeutics plc shareholders", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r67", "r70", "r71", "r85", "r473", "r489", "r519", "r520", "r578", "r591", "r689", "r697", "r737", "r759" ] }, "brns_StockholdersEquityDeferredSharesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.barinthusbio.com/20240331", "localname": "StockholdersEquityDeferredSharesDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/DeferredShares" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Shares", "label": "Stockholders Equity Deferred Shares Disclosure [Text Block]", "documentation": "The entire disclosure for Deferred Shares as disclosed by the entity." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITY" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r53", "r54", "r56", "r120", "r121", "r144", "r164", "r165", "r166", "r168", "r174", "r221", "r222", "r271", "r313", "r314", "r315", "r319", "r320", "r334", "r335", "r336", "r337", "r338", "r339", "r341", "r353", "r354", "r358", "r371", "r429", "r430", "r444", "r473", "r489", "r519", "r520", "r540", "r590", "r689", "r697", "r737", "r759" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.barinthusbio.com/role/OrdinaryShares" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary Shares", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r91", "r158", "r255", "r257", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r269", "r271", "r340", "r521", "r523", "r541" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "documentation": "Different names of stock transactions and the different attributes of each transaction." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of Stock [Axis]", "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://www.barinthusbio.com/role/OrdinarySharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsidiary, Sale of Stock [Line Items]", "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental cash flow disclosures:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r646" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r638" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r645" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r665" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r667" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.barinthusbio.com/role/DocumentandEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r668" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r669" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r667" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r667" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r670" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r668" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://www.barinthusbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r326" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r664" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.barinthusbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r30", "r31", "r32", "r110", "r111", "r113", "r114" ] }, "us-gaap_ValueAddedTaxReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ValueAddedTaxReceivableCurrent", "crdr": "debit", "calculation": { "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": { "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.barinthusbio.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value Added Tax receivable", "label": "Value Added Tax Receivable, Current", "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r681" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average ordinary shares outstanding, diluted (in shares)", "totalLabel": "Weighted-average ordinary shares outstanding, diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r179", "r185" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.barinthusbio.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS", "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average ordinary shares outstanding, basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r178", "r185" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.barinthusbio.com/role/NetLossPerShareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "b", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(f)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-4" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//830/tableOfContent" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r556": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r557": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r558": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r560": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r561": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r562": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r563": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r564": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r565": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47" }, "r566": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r576": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r577": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r588": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r589": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r590": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r591": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r592": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-13" }, "r593": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-14" }, "r594": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-15" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-16" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d-3" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r610": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r611": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r618": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r619": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r620": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r621": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r622": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r623": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r624": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r625": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r626": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r627": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r628": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r629": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r630": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r631": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r632": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r633": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r635": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r636": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r637": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r638": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r639": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r640": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r641": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r642": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r643": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r644": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r645": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r646": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r647": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r648": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r649": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r650": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r651": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r652": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r653": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r654": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r655": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r656": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r657": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r658": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r659": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r660": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r661": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r662": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r663": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r664": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r665": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r666": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r667": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r668": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r669": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r670": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r671": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r672": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r673": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r674": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r675": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-3" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481174/470-10-25-2" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r722": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r723": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r724": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r725": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r726": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r727": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r728": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r729": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r730": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r731": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r732": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r733": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r734": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r735": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r736": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r737": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r738": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r739": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r740": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r741": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r742": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r743": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r744": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r745": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r746": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r747": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r748": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r749": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r750": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r751": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r752": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r753": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r754": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r755": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r756": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r757": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r758": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r759": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r760": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 77 0001828185-24-000036-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001828185-24-000036-xbrl.zip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

Z3"!]"\DF"SM"5Y*=J\J+F#C$/BU\_14#,R4$AF5T8O<6D'U M;.>73)IDKI"O@Q:3_ )*D-M](AUWF@,F:CP.?F[5F<@"J("61Z2MS0!$JXH MSG(\<:#FVT9*9V>XC9-G,:76E40;Q882?3# MGID7";M.DT+JFL/ME)&R)6(Q6]ZRP^= M5$?AEPF9+T9E=F0S_)NLAOKL)(5?GOWV%-W)?BY]\[Z>[GU_'/VO(B?SF96L M]K!C:.5<":(S,W^2;8K@KYF!,0G3&_V!@;Z&G8^Y-7:UWQ\ $,4B!Y"1F5CC M';6JZ4-4"(6]JJ[*])F^8\I4O'K]&J#;E<>@[J&\E#!K(EW$$>32%,D,M_?W MA(4NL)7,N*0G@M.IWGA\/*1Q M>M:/:&3ZC#,2]%#6R=EJ9Q <9&9".]Q"); MJ(!87N]PF/6;$>@-M).^)[^@NZG&XJN7WUXO7C2L27O0Y<>_I'V\GR^/S3O> MRE]R/9!)U-:/UBB9(=(XI=*I *);DI\R!N1HYMM,Z8[]X=DDW6*RQYY\12?_ M^]SAEUG>3)8A6J\+B78L7,V=?\3I)591UO=[<.-T!#X/ MJ@$%-M\E22$ A(O^T M[VF4AD62$B-[!":Q(?1"^_#JV,]Q-R?K,TZA>L>I.P;?$7N?]0G@7R@L6._D M]OPY&A(IHTX5)B<@6%WDB0R0=J,I@ 96%1,*B.,'H#T0^<[3+['''V&HPX05 M28)8U0\HCG&)W )L2M"NC8XM_W6)"AB*]G?=3BBTV !B=1]JG8[]K*\:.>K- MNN/+5/* F^34!5I$ O>5830H^^DY28G6.I6GT!_DF!-B\6+#AZF=GV+?/T^Y;6V5KZA> M"YZ4)7AG]6%8II#X[(I,DY])VBAF1^95M>,+.SFAC]?]K#&OC/"B&:'-5 A MZU^=TM@5VV!0CXTI#"CT*=\<7JX8-6MSL$+;&7"LQ'V^>24M/6JZ6["J^896 MWBU=WF)G J7ZQ-%].#+?['EJ3>;1,6FP! 9:)-.UF5">AF5#T7>YNY/ST>IG M*1H7X+LBNK&%!8MU53H.R)ZL]>>W2L%FYM]$6HB3VO<6YXR#X _EH MZQKW+$+VK3_$Q\'E2K5#PG$)4XG&;EM)W4],:Q5EEVXWC9+%3T ;*5U6(Y^7 M.:I0R$X0P6;$ S+#AO\Y\)?A:A[<\>HKN,OA\W&C*$H4? MT:K3Z(P3PHRC0@[UPGCA%4Y%CC<7=$*5OHKO&ISM=NI?:+0H@@T\ KR<5,O; M6;C1L'>P1TC#Q1M)BMI.X5UGLOT;D%/V+U(HMZ\UQT\^\__XW: TGF?Q[@^6 M:\%IJ\U/: !L2'@Z:D$@_W \?GYW,,=A1/M-?QUKGW"XX-*Z%Q MI@)"U7!)?B=)D%-C#AB-$IR/I +B$Y<7B.=I>>04*\O4Y9M9[M$",?ECK#BO M_HXK^3:PP$-?[5WZ?\KZQTH5AR3;(:F 5W-[E,CX)OB_^R)[6*-B68Q/TKX, M'CMF+B'B< +L^I"FS%^J_ZLMB_YWNR Y'">#?S_V.!%]L41_*L 99+$(/(F@ M FI ^,7L"+&#Y:.6_ZSS5(D2Y(0.#IJH^#\W@7V[^#_S=0#\[QF[B0)_K:]N MG4O^2T2%NSNI #S=7TDJ"8E#E"VT#$8N<%5FLNEA^S#"&73591GGF\)EG?HD M*Z7%/BL$:KP!+/A_]T%.ZD5 ]I_!(%3 2_]!\M4C+!5 NLI&48.$0XZ(ME1 M]DIQ.\DXTZ&;"M"R\UQHT/3^C#J,SR1)L>QH>Q-34;$5516X:U3 AV3CA)6] M_40 6=HJB_A7@RJ0'F+#NDPH]W'V'T5PJ'#G/*):@8]RJL/-K=5/IBE@ND_] MC^C2ZP"Q9;>*C6T%3*($%'I-MV&^?UV%J( $VV!*^P3J]'S5%J(L(]SY&Z4O MD[ED)ULCR?*&6/Z45-U*?U3W;++LGTRLT=Z)W O0]D.:ZOJF;35-%*4">BMA M4E1 &7R0"E 3UP$N3E !O#2"JU5",H,L(4[U#]1)'&TC\@2UQ>)X5'.LA<-X MV;#9_&/UU<@3\ C:*F$)P0;OKV=&Q4Q,N#+V+O7=KA(*N!T!%'\9W:=T]MX9 MP-$.1)Y61'/4GTB"$J6+)G]S1TWR=WSSME+R26PSJKQW?@N_A=8KGWYX^SJI MZL6GLFN(2\Y1 9\SQE.\VL=&=[IQD._+CH0(R%+RJCO:E<0NM@AN*>%0YL$. MMOFMYN>::EZOX0Q?F>D9Z)PJ_GW]:WD'>>7T[05?^QU-HAE,@["#U38='6Q- M?]*6P>@=9-[D;L"FE?.FQV;_C]33]\EHJ0-^MB.D"?D#PF$O$'Z6()2WP>57 MG;S$PC%33 70Z!Q7HOALR%3X^:F.]X4 B7>U770\&)2KY RP'<3=S#_O0[=4 M/^>3,MD?AN03*H@$)V MV_ZZ9H[2S/QBE4!R+ GHBF/$,PW!I+S%5)U_0/U"/L3GSZL*'WQ?VI7.;&LV MP,;D$;7@+39&0XO8()_,5AV/28@#YSO+Z<,S>9K6+X>2C"%)NE\&YG/)LL2; M"SY)K@31U3C)0"L@05O\ARL54#&!D;I1U6;Y[#&'*,^;E_;$EDD1XFU:ZJ@$_T_O+F@-RQ;^/BF8S M9><@>@VGZS9:"R;?\^=(F1"4Z\:7>1HQ#/I"$B/DX07$,/GO017Z$IP::QG< M54ZWA &!MTT>K3]] 2OH>'TPT<1(8;B-V7("3>VDMGO?DXO^,?=BYHEXH* V M.NU7@QSNY\?)?&XDUU^=!GM#$,")MD"_^QAM9-PF!#^M(^ MP.[*I/+\?8TP/],YJY:%"KUP92AM&,&-P 4<62OADC6C\:<3:/?0&,_$[S$7 M!Y^4-:)>!10G91M\VS2;B#\IF2&)$P1D9J(=VHX;(;W;J$&<,A\>2OX.%X<) M$Z2_^?BW+51,U& $KG-J?YAP?H,TE8R*Z;>=_70_X]MKMK:(]69QRN@"7[,D M3!;'%5PE.9W9\0GMQ!G]QI[7F?CEQ7[Y!3E2XDMN_X@Z(@L%G<%'<%K\0N&$ M&=2FMJ5\#Y9)PBRY/X==*F6OH#7UW7(P'O#C,#/_?;SFN(K3\V M88T&X!4GA.06[D@.M)C"RQ))$L&*&0TU0KXY4@13!LV^_M@YBKSM_/I>HUO9 MG?);(MY[?]SBG;;\]D'3=D2,2AG677,'&A'2=Q.7$94 M@T@I:QV#Q+._R6*A-=B\]8%?D([8(N4&"GTP39J7T62Y-0TQZ9VF0(ZN'Q>P M10C[!3Y"M/!^Z;?1>4:3 99,B1M1L3D*H! ?&J2RT5%T7@U2VHXS3Z].TJ#C M@O"XB_)+.!?LQJAE\QSF][L'-U^L*PM4*PR%FFL \\G M4@&,%0GT(KJ7<]#*@[NN%.Y#)$%TH3T!NX>WPJ+2N9+]2_8F[)<3UH!S"53 MFR3%4T$JX'GUR \724F7&Y45-=%Y*1AO>GZ'B]K2@H!S:2FQZB,EE0(WNY^5 M1SVQMS]KWLY[:*3&D(,%@%CHX)4P^Z8Z 9 15P-LB4*AL+T/SGPQ-)!>!'D<;X8S(Z20N MSL"E6+Z9<'XQJTU#:'(H!O](A13]Q^//DCH#BT O'G$!/HVZV'S#)U\7NQ8& M<[J<5^)XU=>DNMC&(_1IZQL7GZ"8,YOJ6J/).#8LG MT\"F2E^-H_\-_!V\&[4?EQD-T;&A G2O3-K_QP4U%O;;-!9QFX]!S\]F!'U\\:.T@L MHXU&$;'$3H0I8D-TA)8S%? GAL!%:9$#GNHF8L-(' N4QQ!&Q!R*II%*MF@L MTVYP)F?IX5XKA-F,$-GIU-\GU%L2US5E+M2_\."X)FK%QD_<0G;G[=K MEB8W-8/,*<-6$L.RKDS35J! &;D N5%P;4BV=E\^>C_1!/">PS!XX,$UE[,- M_.;=JB5U>PA1CV;\B+J*0('UC^.5FD'*F5,=HB&BMYBD_M=G8(L*^"<%MT<0 M22:E,J'P@@VTY[J.M"/GWUU%D9,I-UI=V72D?5RV'*_U*GS(_"/VYZ_%(')' M $MLI87O3C/0R0P[V@@.0&K]7E*/+L +DN:].79GT+V4 '&SB4$\%I^-XIW T*/6,SG58\@Z 6[ M,E>.S/GJW)Q"_\Y>J%)]=>X/_UD?9? ZHCTV/(.'4+?DH*R^)&XL&\T)%12N MUYB_9WJ9V]G3A%LEN^Y!P/>KK%0 !ZE*,4_BF7;R9X009I @4A,K*>- \L?& M6O3S?@_QF_QIW@.WY6LL_G!N^+41R)399H/6H]J-$*T:I1(?B9 0%<%2KB ; M29E^%4WM),@B<<7\L+M44%[)L65D><.#*8QLK.A>%W.4'JSU03*O- M;[1Q)2*61H?%3KX81>3_#HL9\4.$8;R/_(#6(U+HW%,&,[&XN1+FP=^9A)LE M]3[M^"A" V9'XRZZ/DQ,.*T\-3(9>@F([V?)ZO8C"WN8LL:-W?_9:L)SW@^\ MRI%1Y_GWA"YR>:.J+Q)Z?)^DC(,F9C?4Q'I=B]>_44X%^&:],TY^@'Y')Y99 M3/*F1=-9@N02\&)?R0N?ZH4.[UA6)QU)776G\$Q^L;,YOP3S<+'NG4XW\QZG M:JOQF0]:TE<5CYE;SOE!"P]0/R?,<\MK*XNYG:C\\FEAR_K./]+"TP.>(-N[Z6'_4/VJ*GLTRX?QM<]=D392OO AU;S$- M4WPYN6;DH3!R=6(!-"0FORWJZSIZ=*@2_!_[-;($SE3@&IQQ@2YKZ(TZ13L/ MEDEK3VA%BFL@A3W]AGTH\(KDE\6W=35?F,@Z?I 6%)JK#;O M;!@5$ %A4F$A5'16+[!Q,K-TEC^+F]Y,:2JSOCB'>>']Z9EDP_F$J.7S?P#P M'P0<$0%3'&H4+7"@G!\'+2GBON>QF6Y,\"I?U>%.>F1LFB8Q V&K[B**0?VS]??< M/%;YZ1E,^H=?PY9/\4PX%!-H>4FCVR+H 7(X8KT3P0JZ1=%H"QU!>?G8[[06 MZ'RG_ *QK@16-T#;KB*F??6Y$0MWG8)HI;8Q[78FWH'&7VNW<$PN[]UM>Y39 MJ^8/W)%:[(5?AP]25(;$EP]<2@_#^^ECF^Y(' */1R).]BCTAIBIJMAIHO'0 M,4U(K:/[LW(&;SS0%] ;JOEZPKN6105(-@E1 7E\)NA_:=W<3(?)(/C80M5Q M",@NX'Q>WW: MK>Y6,EM;-N*1R5Q'5,#9%4F[A*J9 M&=)"\M'6-J@"LMU :U>T-(8=P=?\@$+?:DUB#C76&_6@YHR*!^\ M.8L,$V?\4%M9*T"LSLQ*(SE>68S;]B9Z]92MIHSX+#IX[R "KQNN0$6^GDFGO1Q#%WR5GE8!>S_EW0NC@XE\;%7YNBKLY(61T MASIOGS$U!\3QA:BKGW,5CK_/[ VJ7MNI6MR["I-&$3RQ"X:"XCBZC_BIWW*I M?(W/V_KE[U1+":%F&;YV+:?QG_/I:52;>^@[D;0[>1+)0(Y"^>:+3>[5>5/H MA:#"B(LDVW?MK-K(-X:[U3@:C\UB.*4",-Z=DDPD06ST6CC,M$@M#VK2SO?G M@2^DTJU@978Y!-C#9F5.O$.2CL1;D[^^$8=I;-AX.KO*594H7?E'HMV_4(CX ML2A?8&AR#?$1+DM X!O(WU!5<'%"*XD/._G,SDE RB9%_=YN6T>0,$U67_CS MD.Y<=F )8@'\-GA:K'G"A/1FARQT!]20,R@[/NW=@-I"VHQ)2C33HK%5!RXL MWO3#6Y"5H)0]NY+K%I=IB#9/,FR+3;HW?X(81H9ELAQ*AF0PCY#$EQI$?@Y7 M3C467*<3/DBR W7T:PIGY*9@$0QP-*I"/1"F9)/E('C_YXA')'>'"3X);8S) MEB2?_$GH%8W7%$TYDOQ BV+[=F2,?$H(,I"D*=C@EM\5/YMM-LB2]$/#\"NK M>SR+5G)N0+K,#BKU #$1K+N7D3.)M=(^'5O.(40F?!F&,1R] MCG:4%I[0E&HQ/6\KG7ANI>^*XO(UUEW>I*_V)=!C3MZ0'_(3\JQ?OE?71FGR M?WS*4)YQ2:@,^?NWS3)=#,@&,B-FE(RY7(*1O )3FIA'E#6-_YF44G>Z&[&) M+2[CR[JN__GE#IT &&1(R,&?$H!+@PS5-5S1SE5)#GVM^=!AC6-WN?ML?7>8 M7I_V5EY>+:M:;]WC.M MD2B*B("&2:)C?.AO\EZQ^NK:=@X5P$Z3;>P)F-+T-UHS%G(_>.C. :$QJMUE MR!$S$JV/!_E.]^* ^")".T[DR<-08F+$,VO3TM*HR!-A]0..4R7-?%Z95\?/ M(04S38Z_$=+DLQ&W?D3^-^_&7&X6H0*Z2T-HXM,!E "V^3=C>,"V0W8$8!G. MB^BNID&'-91&ER=M+?[-&;X @&0AES=+."Y M[/:^$#-Y0:\'.<9[S$ 4AB0RRRBC[&2(4L'"128_(*TNPW^9MG\P?=QQ: M_G[3%! =($7C$=S[NY[]^J"I^) D_(GOS=TSF.G5LM(:JK%SXJ%9=)O[_J% ;T7CLK8G@D MF8:HV+&:)&HC6A\I0[&9RR8UBWN,&U;\C:.5HTPW PSFO3_]&BY6,155:Q&/ M22^^:\>LS<9KQ%D"P=6<\+UT*U4P->YX*"0&^9-Y0NZ>KP2OVG=+$FZM15?I ML3(++35UEB9:OS&Y.2Y4H;G2_)E)^FE\F%%4M5<49Q>]\F( &TX;7UU/3H%? M)9A-=CV59(<9C]WE]#TD/)[IYI,764'?*\K=:8M-*^RZJ+&4Q%!IS2.+4Q(9 MIP(@88;-"IO2:=\RXL"N-%43?'*H4I2-NN/\=[<]VAWC<>P7]B&KR9];;\\: MNQ<:OWM):;&B4^SR0[,FQD4Z$GLD)+;3!"Y(*'9R$HG:C[2;*%DD*D^4LT6/ M/E4Q^':$9D>*9B2B\,[^4#LBQ##=[HO_ED?#S)-#@XB<'TXFO!=CO8LVY=W, MH-6?JCJ.#:JO*HS9?LE\= 'N K.B=;)8G[TNP3O.0DN6*>NGOJF]E;5R3MX( MO^F6&_(FQG/39Y..MQ4*K#=?B?;J(%J4<-P1/@[N8_X[J_ OPY!,X$6$R\)' ME0NX$&1HL^(&EYS<9-$SLSS*%X^M+WP$TV5TQ'!"U^,H^PLU*K!)-C/T+/URJ,)T*$^^6/SCJ,2]D?H,B-GN!%1L_I0F M.(02[63N(CUFJDJ01X7'(1S["SM5Q!=."Q6NI!O5S3QE(ZY'S.#!>,_Q5TEJ M&@DO+_SS[OKYI(>:&U9G,'N$VV&1H*47ZT,;27XR5O*HJWW^GDXNJPMZ44IW M->)Z]NH-N'SO:KUO<19.L]&F-ZGDT!#GJSDZEG:<^B5S=Z?X!#4+<.,GH M=);X>H7)M<\_^8*"]X-[%=8Z M96AP05Q&OH>]M<%Y]/DD[0?Z+I$--2-^#^O26_R WI!CN1"^K?'P5JBEU3LW M+Y.]R=&^_L)5'Q\U3*Z0Z7\* "0IJ!"7K5.H/,S:EYZ5JDKLOR MFHF> O4W+[HE3-056CM.I'XPF3D1D'7S*&B3%3Y,FMB$IPY#$CD1-;$[9[ U M'7$S!+1D]<]VS3Q"L)HV#P-;+T19!98+^.%,&R]L**D1SK^5 +K91Y MU;$XCY.'*%!$;RO8/XUF&?7TK(&498;-GQ6O(FO=+FO_%5>_MGZ6"E!<:98P M*U%9;C56B*G'QVF)U32HA)"J,:.G+TXO]AH$ M5"1L6'V%,,!TR1DD;2R:J_EE2G4,RN]T##A'!4S^HXR8A:A%J6IOY MDC74P_2-GU4%)/TAH[T=K[8R)O!"H(VA:JNNTNRILMS7!FR[I M&$5\]K*?6G*3P7VVL4INOY8=<6?@Y__;9.M_/+_82_;?#>R^7>XJ)^DO$1&< M!'N3H3W!%SNR8IIO5GTN7;VC$<)=>.W]6]W[+"-5M_)N%8IR5?";1^H [\)H M%#[(@R1/D,*Q/<5EA)<0BK:,1G)]KX52=J<77_7T>)^O,5&66F]/ X\=ZIMI MO8O7;/JHK^^M:K'7H7=N"O8,*]&TI&-@_E%FQVY 6RS+ M)7P(O S7GV_^E!TQ8O"YQ+N,-2)Z^Y5/7ZLB2X M#Q_=AJ(.K:=#+VT[K43[4^AML) 78RF;(P@VA[=L<;;6!5W#+"_M(M1I#*EX M^\X=KOK="+]BZ5X*/:4/P4P%V!_&ZUURH+^8=]_7W;$FGF?WC]6R?\"0SZ]O MS]\J(%]D1Q1J]IG>M^$0B$UIOH-H?0AGAAF-E\J:5OJCF#>])5YG++Q:3LDB1!9*T5PK2IZ>W3? UW)VM6O,I9]1_3XROJK$)3 M:>!)(WT>!3&U&$UM4_9*2RX]['P"-&_#Q.34)17*'3H_,B'%KW]MO>C;2Y8\ MW^-NR'1W"TWMF(0Y?R=TZ\1[5]@Y*1$UGX'E.M\SEYUP*_"87- ]T_4(J9N= M1QS8=COV4.];N(183,]D;&;V6=;!V27[8W3T3$9?'Y0@*I$Y4ET$(86(6P>M MRE?59:=)?N08."]\&.RV*7ASU.7N4<_0/[+1-ZTO]*H.F]_I6?2:S8WI -?H M&]]^8+9G_?2.?(WA*N3#?WE1$XRB/^KQ_%BY\Z23-[$A7'P%Q]&F^_/G^C\. MX3Q"9;9OKEQJ_;'QUS((P3S8R:/L;X\DU&A-#!1Y?ASYM3]M'>HNF?J!V<7< M9;YN55'Y?U8GU"Y,>(JTZ0[(D96W.>LJ:U* M?Z)^]\TEVY=^0?3(>%E7@@BB-5W]13R>$$.Q[3_Y9IG[-DE4E+6//R)X^FS@!L1$ M7Z=Z9>#XJJ9ZXAO8&HV07R"H8IU>5$_<]8@L09A6N8DTX5%O)7@Y!7ALC#7: MS_4X?SW_5BV 1XU]Y;:VEPB'P"<#UKB@^[<="F^=1&)B26SYBY.=S'8!1ALI M82'(7?Y>)8+7RDM-[B,5PYRN.BK %OS0;QB+HM /8^V78LHN%L@TT-38@GEM M/!V.^== W,]U6.X_T:A%+:<-])WEVZIF$AV_[B"NUGX!O&1B.'''A)'8@A?W M.J@ UEDGNQD3;-/.Z%<7KO9C_4[V4K^:9.%W=Q(H+?H+/,C"6P73!^*_-ES" M!ILOD4/@K(1SK?7XP.\."9IR-=82Z=X_YI_=;-[/-]=@H[SVYQ']N6N8 M(MA9<@B)C:A 6**!CNL5G^_^=>)6(TZ66IOSVKXVKR[S&)Q_<,$HZMX?.,>A M,P=\!/RNN<1\A2RG+NSE@B\^M5JGZ! M")3/[1\UD'2:M3IWZ7S$E]XNY4@:/"(;"T5$^X\I<4N@2M=MS\5!M+_QL"<+ M^Z;?T0?TL_NJ9]>/KW3]*&T-=[W/U=LC(&4YV0H,]I-L@81Y"3)AR>/DU61; MX7)UN;P;RG]Z5F9$6+F*^6%-8HW9::^7N2[4'+;F_2OWU4Q>D#THC H 5A*< M&^V_J17HN%RJ;@Y'\Q5(3[\VN*RT\\#B( ++#*+0ZV%=^IYK?ZT"W;!>UWJ$C,VQ:_Z5_=D\K.WJ<'9;;X7U) MO+6O#,#E)5Q1!K#]DM"R6N(ST](,),0M-32=ZSC5*:W*F6/2AGJE?CZ]M_M# M,?3\%=_S)COLV@N$*OZ A; GR]$V%'HPUMYP+&,5?=QI]NSN-*>77Y3.5>*Y MNQ*$TS+D6X((48*D0,ZT220!OY4TYRCZNF\FO^/978'L[KG6YY^[$ZC:HH $ M9Q=G:)K]J>ULF%JBR,"N#U,420_&2%Q(BP4SJ%]@>%ZJ3MQ5MY6>E4"ZG?]85%++P=KV@?\TP>I M[9EYR(D?%=!^6?NKB$2@&KL!]W_*R/K_-P7_[W;]?]@4O+@(FH2>2/;-M^I< M,YUKPQ^HUY82YK1^]ER+"O*EDVTG72><6Y1\7UV?6!/H =Q6D!75E$C>2>82 MM+EV7=^^[OB9);^XQ'\IF@)B7UVC,WQ&]>-[Y4H'WUA3/ M/>VX^%!_N#1*,7](6D6:Q;,PQ3+8E:?SO;9>+I#.0.R0XU5">+> M7D" B@!4Y I/!L(7=?SP0X;;<_O[ MARQ5O\>6*9PP(6P^C>IDLOC(/PL0>GJ _F-6-7M\YO5+^2NVWM?X+Y_I>N<6 M[Y1,2";>)HD0F@I5\C"H\]#3T+SK_A7!]PXV MZ":<_2-6B.!*%*$UAG;1S;PEQ-F-";//SO5B?4GQ^PZI$_+IZ9^(A1Q;G_5U M>ON\Z$7*E?LP8=O#V/9EV4ETH\WB;R5P^&!Q<'O'5?=3 MGY,GN=!?,JE3:\VI_Y>/:('LKI%Q8:_2=[V[5M$7V/6?ZZ\)LI#3*4 ?.HQ< MS?)ONG8JP!IG5;46@'I.=.[(\$Z]T2NZ._\X,ODYW)B[Z^(%/X'.1K#7OJHR M5.;^;?48-:8?N2^#6)ZK::KQY0E&ZGWR?+'$<90UZ?SI1C2X9;$]_*/'U M^'-5;6U-,.BHZP&GLK]SIP=%@?Q%A0NFAFT.7_KMWL89[V F5ID2$!)5/JWF MTG^OXY* =)KW8(E?(H?%;^&$*1,PR@!T0YHN7M],O('A7H]8U,NU$I\H2!E7 MJQB$V]SG^V1+$EYQO H-495-/!IO='L6(V#Z2O,?&Z8S+1;^X#I]37D>=_&V MON2$?)O?C6K$!R1EG'TGLSSF9O'27I5/MXX4GZ7V3@W]RI=P*I5C$"<\NF IPW\-Y QR!@E9YKN66>MYWH8Y]7]W0?E&Y& M6++[L2#E#1F66WE%)@/_8&'5YHU*-S,\OE<<6-B-=:_X^A^[$M-X MVO2"5!@(7-E64$&Z8429S%9#;)4.K>/7+D@,-52(U?'?XJ;C!WNJ@:4;O!<0 M('U34_7LF9X#9"2D8K =%0-U4'9;!V65E M3/H2D(ZD2/X*N^2Q([7=R+-D7'=_=ZQ*=-\$>@\T,:OQ]D5@8 //^@/DDU*A M9?DV <9E9/N<>FNSD'_M8?%J=(8V#^>#N+CV0A-;Z[2"36:=6>.<25*WK:BO MAPJ0W* <\ T^NL#:S .[@;V)ZL+VVY6?\FTDV@X"U[09RF <>YGD5! M.4D_\GDL*NP-[/I2D]CCT5=7H*?./[R\<('195U91O!'X-B_"U7+,MMCI]N? MUXV1Y)T""IS]ACD?$!TS12U6C#8B]X#$=A63.; M;A_T99>3X7@:\K]V>$DC1RK\A+@L[1R?G'_*)BOK+NM4'=Y08YY.!GF&V7$+ M3316M('*6&CRZMQ6G.,IN'WK#(*-+GK/14*2E9L_U"A%_;GJ^B-,TZ\(-Q<) MW)#!<6)&?CI!&A^ I6O?^\B[%WW(?&Y;\-8D4_[S9J(MK3]\O19'!7CMLUO4 MTJWHQP1'H'#2BZA RGWH\+3/:+L<+TG*_I?_YQLOW"=?%SWY[K]CG09V4I,( M]S#W9;%; -N]*"C*A;NQ V%U,:-L6Y>\*"( MD=.:!7UF,"H)RW,V[?.(2(],T6V_S_*3]V3@AIRQ?V+4GK:*[MWN47C #\[3 M-_XMEA]@,O_/?K&L\[%4H_7B'$LW1:!AJ%$]SVQ+\2%Z)V5@_][ZU ,Z@8\* MUV)4>3C64 PTP<$2@CA/TI'_".-81L*0Y0 34Z D?]X7(;RNW$_$]=*'DA MQZC7@>_=K!+4V#VT?Y[6S&H1Z)9<4JD )G^BAR.%K1;X&BO?\?I YFOJ2KCH MO)G"P>B='>$76^%"#[?V3@_T8A8JJ( 0*L!!CWD:JB(L7_WNA:7X2E)^WJ\R M*S.-_!\NOUKLL\X+OC\"A.E:)+*?OB$+4@&R]>S)#^594H[,$.A_U !5("8 M&4TH"(.'3@.*IZ;,S37=9;?:>;LFY?E@O1H 5^=O$LMCBV<26CA>);?#38!7 M+;H'@-C=A>D]2C@50#&I8J%H(!T)GMBU=A0]"6BSY,H I0*FS3C"/\V@??=U M*OPK:@:%I/DKI/YD5(T,&P^*F9TR)KK:#%)NP\X0?'%%W E=S>P_)U^'>ZF[ MWZ@$LY:Z5]E%_7AO__.-B7R[Y+3ZDF3KW'-'&F/1"4TO1)XV3&>8UV%ZKFW' MVWL]"U+_I7ZQR2[B2PTP3+77W;4P=IF%'FJEC&W.7YKS&IM?/TUC=O9V$?%I M[)FR3GYWI5UH* (;^U\I_/"A@9E25I/QUX,PDE(-_B]I1U !B25/J(!XL2'X M% D)V=5QF'2&=LCHBUVB2M;97T5372L])^8)!TRL5JJYE%;0&1E+ M R4B(LSDG6YTK+&(X],[KV8ME[/TYDUL T!Z52-O7I:7 M58<.#,R=?SLSTR44(WONC+'ZWVWO'^"S$![PXL(VN73066[.V\PP%QI7>-)? M'L0SYGG"YA_P..9H[VBE69F<#I/&26.20V!N&+$2;?W,]FO5Z3G*952 ?6[N MVH #J6G[Y)(O#!;9S=^?723+LWU\N'6\/U/OC:_E>@7:O&8-V7(Z0B.R(B=PYS3IIWK=X-WV&6]D5 M,O];3*SV9A)NDM,AL1#PI53D*G5_1 M)E-?V6Q.^7@$/$\9S*SRS/Q0V8&MP\E]7=I8Y.),JK82BYA@Y<]4^>?QBM?N M7/PE.N&UE"9;XED2G)!8(MX=F1?:90&81%/*)85G,A[MHTU$IQ;])S?32RJ] MO'[.M&5=#S_OD//M^3VZ%8/Q/NG"_A5N9 .D_Q>/L8H:3^\I1*\'1^ML[7AW M+!6P/;P8?CBGXH4:*_V8:3C^_7FTTBV%,^^\;OQ9HM%>3>')/Y0\)P3Q,7Q8 M_I.IB@M)'UG?>9V'-3>!7PIOM+9>=7I$5"/4$M@6(3&>5<[Q,U##'SII<-SD M*\1RO]A!&(6^9A&'T4.K,&MI'*ME;=1PU0F]WSXO1J 6?4;T0*N"F_0:B#1D\ST&075)R/M>N:,1I,IP=GC_% M-*E+=U^+;!I^M#'T$B"V#\*L9A60X.2B(W^;M\_0J(]/$QS[O2]ELUT2ZO[Y MG&4-4EE%Z,9%MI^BMF>(AO-6?7:O%;UJZ^W3PGGRK(DD7,C?D U!J\ MFZDBF9+3 -W;C'8W@P]>Z-4TO8D2)?ME(BD7L;IQV+4VO_^#O?<.:VK;UL87 M-J2)*+U%!46EB=);% 4$! 3$("TH(B "(M($$J5+%1!16I0J-2*])=*;B-10 MI 207D(+@;1?W.=WG[L]^YSO[ON=??8YY_GX8SY/LI(QYQCOG&..=ZRYUIRV MP=)\\HN/\U4Y@KA?6&?==+YI':,U%:,+,X'7:A;7R.F2,R7-](/D;2I[' LD M]UGS92D]LUXV, (G^SYWH0+[3Q!40/[PDM2:WLQ^9K,@?SS#OHEKOO7'!6]> M^*8P67:?(%)'$5BU7;'RJ??;]' K9NY9%; M>SVO4"+?YB[2G0H@$2V= B%O<3D1G(GN6I(+>F,7YCN'FB^=I?G;J>",>5"1 M;_\[KWV.[^UW HM,/M?/:'@<' >I!7Y4>;;TRPF.8LIG\%3@^:C$*E.FD6YW M=Y^9@* ]'17X>MN9%K^&@_&?/A"V3R&P40SI"U@51>?B5H^'07(UB/W&?H+& M[!>LW1G$'AW8[RM !?95X9!X_5I:8O+Q%*:OQ%W]@5LD=^]>*N"K'"=]6UEB M3UY6FK?/(KHC+B1;G^.U882<&T?N1C6Z%20#K]6JON.C3E1OS4A/'/^Z,2 N M&_GL&X_9:D,HF)$HAS]#3B@&!\"9'UL\6;_FY\SKP)GMY0:7OIU1IG5@RN\\ M;)Q18]'MPR"78V@"MAR42&V[V MC)A*9#%'[#V2:78].LY8Y=FEIPZ+2$YX[2555L)1[/,2@F>4:W:8$4=0A$.F M2KIL).3[.M/93/;- 3-YDEV6NE&=FHM_8DJI;GJI+]AR9$^&AQ&7O$+.?5Z+ M].&Y#"J@1]:G$><0BM@J?7-G1+QI9'96?9:GOQDZJ"//<<*N_XRJB;%LH7CT MLZ2D&9D=6J3=#ZPR>M+CC MUQ?F-U-_V["TK"R&"N!OM?J_WY:2SUS)0/:O;/:+_'AFI):@>7M"GY,0W&R: MG/,MF5G3(Q#*:"4$FG$86[HB"&^.9;J]EZ^?M[* IZB![ M>*T"C'704V0\25 \H0]><[[S%GHV,,-CE7)I=8)28(N M_#Z<(R.5GBCV82XZ@+^HF3?75X]D'S^IOV2/'72ZWD'.FCC0YV1$. M8L07O*\Y-*S^>^]L\T0&0P1LIM>&>&]/H\R@>DBDADV_*!&J07 FVHV6,=&X1DA2VD.)V9Z;YAXYA-QR.2J^:%W@T??YL/1<$ MC4JW3^9A\]U.)G\OBM3@/HF/>WRYZ=)H]9Z1\ZI+.*@?26[<@DV: M"C#.[KB'951YU0G([@N5NP.,ND>]?D'_^='5/6AN%+@#M]X Y;#1#U"TV$0' M3YM,A(ZJ1X=C]KVX=KJAW"B.3E_A"\#-063"Z=?,_!ZF=5/HZ6S(*+G.M'1#]1F 1E M,"E#0VNKRBT%!2,&CHZ=3$'*>\BNLQO,RB_9AG W(6 M?%%T'APYQK(IR>4CTIU7O.>NH_B=UR;-S0C>QC)&I0_TQSQF4*)-F=]R]/(+ M^INGY<_HL$4V3FXK?-?'0F7CO\5O=%IT;SJ(WV]3ZE!=9EK04IW"KS&PH0+X MC2L)0N-4H(E%'RM1/B86KZB\$M9^0!X_^F9VGN:"7E$4%RY\WB,3F+VV)>:7I%V,6U]B9GM0V11#"T_[ QZ JI'!%+XB[O?,HEY M?+];#K-)3A"J>$TV\)Q5@B0:(0XG0U(U&R931!4#K_G$BY_U]J4""(\U%26\ M>5^>&S@ [V)J6F\OGK1VZ5&A[5;,P]';G0IGV[>MK #Z D@'M-"QOC1QHOR@ MJJG.@WEOFX"G5&#V!"H.:<8J<=_ =O:-.,1,(DUD:,RU;);=0/UQRL#_>!__ MYUW(JG@GBUFWSPC2F$J!^]B.V'5ZZW_U.^A_^WW^E:8$7U3AI+G %CDV"T_/5K#16(+0.3'D5M9NTGQ1#CJ8 P:%["A@J CV_1(D6T MZO%4U"@5"'(A>% !M2V*WC1@LJ^PD^]/=04>OKMH9_./#!N(DG3 M_N'H3:GKH0(G"]J>BLYS6AOT+#LR?U03>9YZ_LK%Q]\.MDVQ1:><9_'IPHU1 M&.9P8]C@*&EG3ONALN?($A8)>''MH7=N3KBBIQ?%./=;^[G6'[J(S)K-M^]+ MYJMTPDCE:B3?C5/WWL]N<(N/7[-)/Z 2TD0%@#'/RZ8UO6+2[ M+S[$/IJ=Y-FK[%Z@A/EI7U.[]-/O39ZFF&N% MOYI1F%6$%!N8-N5AZ0]6B52\G%-+GU00+?D 85BU'O?P@\G92\U1SGW%]G'R MOY:@LYMYFE(E;,CMWO+ET(%+!#*0S^N!@E[,.A^-", M,/>5CS4;@K= (RU/9<'CM[:0::H\)"%<<.T(\YP@Z]>E8@?9XQE2-AEO@E>U MA(Y\@8^*"!1:!')4KW+D2-QJ+7;MJ3?(D+"[=,JGGF@"ZS?5_#0":Z]3%<:) M$M(N8:3[7]G#>G,B,P8%A8X>9_EDE%R_\G@"Y8UCK44/BDZ4IJ!.JTJB M+&XRB3"X/&BX71IS\.S#\^F''RH]=9A:6"$(+Z7'Z_7#C][S&P:+N<[>@>P= M":SSWV9[L^J+9I0*4-T**TC=Z@N";0YC1 MQ:W4Y:N.LC+8N8_=BW2X<<=9PJ)(.'%84N3*]<]:2O*3'#L11 625"P6O4C$ M0AF^!1?56"C)I5CN;58>C+EVERW.5BB:)/,=L0\^G@*C(^A,,*G C6JJ5H.* M[M7IN'KSJCNP^TA:?YGT&M=ZEY]HC?RG>U6K'NR-)+YB#(.*9=6>_ W+Y1MNS1QVVEEQ%M(2&)09YB6?3[K$)W#$-=\F\>?CQY*I;]O6%2GY:Z M@D16!_P@V@I)Y\-!>);I67\1XV,@D75[>E\H?GX0^W"VI0UK9:C!O2'T0E1_ M,FO1:!PYQ-H434AL2.@,67*V+M&1#M:M>';\AF&#E;+$(QW^=>C%+F,Q77O= M&X_Z'EQY6&Q-KZNI67E.>>]XOA*VTV\#RC2G:M]3G&BR=,R^Y?SY]TTSQP"3 M36'@O/X>%+R:"O@](2GVHH1U)ATZ'!JYGJ0/9>&+/[2[/;#RNH:R5U/MK+KG MV;0XB7ZR PM]CRW%OI8(P*_W8OVN"ND: M3C"U4,$Y?8X-=8YSN8KWM0]ANJ@ ]'R.82"$2P9F 8G?O&OM M655;*1)5#79+]0S3*>V73HQ^[NCTXKRL(N@.Z['(2W-0J04$[AHB@+=DO=/! M=<*"\Y2RZQ;? ML=104:'K?]"\O)?^[YS>V%8.&!UY'OFOBHP(@""C0%XK3;'I!F,2BHCT_TE>6 M/7>4B*]L>[H7\;[>E_<#V@X1L.:CA+KYZ0--EK;RUEL3*,06=+QF&,T=UC&B^ MF"Y*5B?FU,!!M11Z-.PKHFB(\,9)60>;^["RSF_+W2">DXASB8LP^ T.K2_B J(C)$^1P6##VT@@V "8=H]0JU$#)<>_1OEU]\3 M=P[5H=S)'ZKM#V44S,'X2E\H]/052)3BHS\-97V3!..D+#"-T*%8=1PYHC$X M,-,""G$[6V9WP9D.W!B[U;)X0#-[$?80!_(K089;RA+/MPMW=QXO1_>>W*XN M$1%;](X=\#CUL<$X+/2=CE&80G-7MK:"I65%XL<>F^\4^/.-^,5@;(4T.K@L M(?UM=I]$N\;!!7YK*_!6/Q5HJ^G/MJM4009O)*K(-AUG24[78;ZJ=#:ECXF5+7]]96GLG9_T&KU_U2Z>L"]G11O0\,YQ+PM%5#Y<[GC'NBV2\+' M7 C%_%Y>SI]B[[_?FTU_EM5_=A&-),13 <%*+G+@6XJN1<3/YY>]WUOX(VY$ M$.QI_QG:(@=F470LXO[Z +-_WKE?_XO"#!*@ BV(7"J J3)&TC+0EJ)T."8) MO /DH)2H0#080G-;]UQ++MIGVZNTS_+P#;J+O+]W1'%,C7&";7U9)ZYUWY== M(4<5G-LNN'/1^O5DE)0W A^L6C%19T,EUAT^_.ZKB:CQ[G-;T",GK'X M!ZLKP?>./XY:,G%])IM\[ 6(P%#/V@ !.^,\FKG.<_?4/2FWF[(;(+\?!C2?%2ZC*YU.>ZO!CW1XGMSRGE%R0/\=NF9Q7Z./NV TR11 MH[%/-MS7JDREMJIJH)N_/. @V/*[7E;\CWC(P1P4@IY*MT=OCE.!G:,0KY^_ M7S_0\8\>Z_<["Z^B[@N&]UEHW^/C7IE!6VVKS"7YN]+$>PK\"%NVT*" M!DN7Y/=NW\20Q)B0.QPE2-(!:;J!+G./7WV'UWVJI +OS$RIP"?KBP(1',T_ M7='<%=T5W17]=Q7EA?W=G,X\.(1DX9TWZU$J1; UB9@)>7NO5)XGNQC.:VD_ MI!N71K"^9>NW+^3C,/^1G -P;6#%KD")PKD?0V8@M_^K21<%D=9^*[HKNBOX;B;_,F94(/"9&Q50*Z4E&D^; M*CJ,3'LEJXWMX%I)G)3FB)J*C,TNAP12=!&PF?O=4/_J5B!N,5 M,I-B\X^99W:VP)5R)'=LA],MZI?P:>Q-J_-+X8\ZGRHJBB91@8"<+4I@LO5? M](VSI"6117F_S$R1H3-@[-D:FC:V)G^)RRE% @./+3TX7]=^>^I5>4]T5\2L_3_N5I])U=9G/_,K+ M?YH<@,>/(0J_]G/P;J.[C?Y;-=J?C"3YHT$+YOK_W?;]*579JDA,&RW*:'UQ MQ=/J5^%H_\GKHO[;5;_2&ZD_&ON5SZ7]RE7I>KO,RW[EYC\Y*N F#1'_M:.# M?ST[7!30W6UTM]%_WT8].']9A"V0 (,L-+F-L+X.43ONTE2 8,(%W1!U@/Z( M:H6IY2N_^OYSIO-4B5W+].RL;M@PGVY5#LQB^D3M<\=$--L:.&4\?N"1\IP)8%(P-_A631J/,7T"KR&?@ M\5SPFDDQ=&>2-C6EY4[P[ER3@.BS:'TV8O9T0 =$-FED:;+P23'' )H?.4Q@S28O/"^B)LD0K4^Y!.T)@\ M4I,*U":!)S5)CFR>2!:8><1B[R6L) M;PCVF'EW3R*WA* M)9,*8#[#=PXC;Y-IE&=JNMIZ@V98V-5VQSGY;+M!+$'%?SY&%)G M_^_IWWST#YPN[';PKD/MXKV+]R[>NWCOXKV+]R[>_U2\526'>[!B:^DNA*RK M7@)^.059#,(I3UVA 6[OL&/;W-*=.SMAM-K94W2TQ_A8D?JT.I"P(5HU))%< M_0R'A-'DC/NOB#X+2LEJPC$J;3R/#AUL^XAXET=K_6<]UB#X?BH0F[ :3ZZ@ M G/L'!,<FDMBI M #(?2@6T4ZKW?$A[V9/-^2TE EDQT.TYJ)[A%+;V>_JG[!<[.W<[:-ZO=8_'N_^5_$_."I&S(UO1.Y6STK>QD #IJ?^_95V1YXO/"VSYUFA MOT0_-^W2/_(3/1^T3$J< ^Z M+8+@!R\:Q](^YSG82,_5O]':('6P3_;I7[K-YB4K1!=A4.M72\ZS<0O]5!WR7"*-EV4H3("+_ M)!7HMLO]),KKI:N8A(GM&N@V&=083X6XDLV"@O?#M@E?EDX=3LYKXW,NZ-F&K$]"4]&XJ\[;W,I&5 J M2P5V3DR4K[ZY>V[#PJ2U"OZFAM\\I^-2VJ9>Z&EDLLJY_W]7TKVK& HC#=.3 M8335"^2@.XJHX\@R]%^_!D! MH/O/[J8"@I0@6C_:U0 ^1Z] M(75K\^+]M4H%ALQ^X0?$S5"#].B0$4D89&EMSM3Q/!ZH(QPC']2"J0H6])9TD%5G4H MNESC663?^[2Q>6-SG*,YD'"2<@8^=VVHK*&&:\HO]'1!_>$_:+?=O;.L(= U M6S C?%$\&SZ+02(6?GLEB@G73C(D#98X8E))?USSOUEEP3%N48%G5&#-$2%( M!1:":*EHVO>":Q <)@^^D>ZH.;$-;DVA]2_D5L@?U04;]"%48*J%)$(%K!_0 M\#ZEO4U!/5T%D=Z JC HB.""EQIA8(Q@GSV5. YY5Z?AV7(Z=301:E_:+=G MFIF#/92K5* 92J2[3'/BUE]ZGJ@(;P41%JB U6GXAH)H%!=),H'450**6B%% MT1 3_=#PAV[&^]=9/Y+6(^0W\*D4']H\6WA3GYQ0(06M@^6N:_3"9-;_HD+> M'ZK"K\L6F8MRS:,!C%>@S6KI79"G$/0L>LT:=9RFRQ*G"4 MS)+CB[CX3U7F?X7C!H3"P$(%A.A#X0O3-%"OF$-FC&&AM&!X'#UEM:I/]AFF MS<1AH6M%^EM:)+2T^VUP>%2?XNE4U.&=_W*DW?CR'U5VX\MN?-F-+_^T^"(Z M"+8>"]ZA;P0/&7VB<*RJ!^-3_+/-VP7ZLI*%5>^$"#^4:VJKG[[N*93A.>++ M1 7V$6ES4,./C>.AM);FQ/HXI/WM]*TWRAK'/@0O)N*H@(ZN3J,@;S=)+DLZ ME:.ZCV3D[<#PPD^-/F:6I4&4WU89I#V5C[XW-J"W@Q5?*F'=UZD9H/?#4]%6IME.V-U0EYI"_TO MWDQTV58Z))I]OZYUQ8OA<71YK<2-%W1[E8*_BZ9I+$9FW-)C_%!+WXWVI@*V M-8I$_ -RC(\":\.(MI)HU"'[1[KO.Z3?]?>K+,\=&K]Z)Z25FU%/^^F%1AC/ M/)/'JN2$>MML/_/6Z+&^Q$5WMO'"&*^H>.ZEI'*.L?@;N6+JYDKQRM;%*'>2 MQ]IV4OGK^GEXJ'99??MZPFIQWW4/(9:&%*@AC0>FD?B1R'DO!TFM??-SS<>L@'N01G M]DQPF&3:L?F>H$P\GS#DE7^P-,91(MM^^W4SO:&6G UL9I*#8P%4PDI+F^%$ M:9)5+XG+VU/FM-"5RD(40]$29[>M-4O<_Z*[,BTQ@-\L:JQ,-K M LBY:7WP3U3@PEHE^B+Z#C@ _G$F0I5!(FW5G5C/29&@=)>'9^9/5$C/53\] MVJZJ_:U)JOUVZ?H"] JAD\* (2J21 E"^?=3CG?+B#XOMI P2T0>9C%\7.E^ M1>11$ZB569\1=8OG&/_6]AC^)*VC?4F*Y Q51E9N0KS)JGI0JIM2F-2A.(\' M+Q8O)NH)CGQ9>3TU(UA7/A.9%I)AH*9W5K;/"X5P@4.2SW2_S/>2RTJG>7;_ M3!.<_S'ZD!V:1]DABZ"R-(7++T"Z<;["QY^:/OK@X[GP](S7E4M-?"Z=Y@D3 MHH.;K'X[)Y%+/C".D_UO?51HT(02O)?$3_@B%Z<7+U>Y=Z3BH_4C.2T,7ISE'C/K6+5#<#Q>?*\7E0L! MMYEWV<2'/ERXF4^@2(P@,^ZCN42\;>8@^HV'U*M;Z7:U7MRX\\U)IQF5Z*"Y M8X7@Q0XL?' +VV :%>R\Z3U(@EC??@^5R)8V%'ODI53(V=+#],9LA5/YD$,[ MV#EJH*I651XW$T61&IM/(%F*]#R63>#3\0[A;$TX&/FIY;;$I69YEZ70]85I M;>Y1,\HR.+F$Y"Y;AR5G\GP9W2C=J'3 ?5L#$T2<%WUQ89/(3PY(-L)D'73X M29N#'&>8*SG#RSGDE7QHP4"F^GB1:_@ZE(W2J\K4A1* ?4U1P6&"\ZA T8:N MY(V8H6Y,AY=/>=.YJN0P4+8P9IZ>=$23HNN^16D219(Y]M]8#5Y4P5EB)LK" M5(_[.*T:^R&.S!=U9,U!=NKFW)_S"-F-U0AJG;NP]F&O^SF7!#\4RDT] AZ.C]3%&XU'_.T6VF5>Y+6M# MHBN@X2H\"XY^L187K[.J&5@2=00ZSV7:8.K=G&<^W'HX(C6N=8_\X>7/UB@% M94@'Z&-4G8709%;S"@,!9%F!*NYVLQ?1FNY)/N+&X"SL;__8C?_M?%9X?Z^4 M]"K[=\.4-IJ?EN<:)'.^W%D@#&\HOPHE9N$WR($^^XGB),FOU5I876C#D\!- MRL<$G\(%+MFU!J%SNL?/"OE=J))"&FHP3)11@=MH@LBAB%7_3Z50-E5ABU$6 M7O*;XI$C3?K"G4<*C<2ZK1_>/(8UH@=DEUUN:0IHW+#P)F8/3Q]Y)]][(S\7 MK#*+'/0#QDOTR*P1-,2'<"";$XS6Z*+_:WN7D]&JOE]IBJ6;FT+81?IFF MK)>)SQYK64V=)"9(X?SMG6N98>8R9P%*)L!; E_;-^-R@U54%*[W1)UX9 M#%_.V>"[5$TCE1+FQIL'8VP44%N-=!/(4X2TMX. MP^W9,AUJ,M^^BK;,<-'=N!L[P#B-QB;36$7G#B.!BPH2[9C/87W'FD^3SG4X_GXL<*X^W M!"T^7PQ9OGV[4L%(Y>#R."@"4$R3!KR2'; )&IPJWC,B7>5_8 MC41IA6E..\>E+@A>SB%].AKY&D!$PL,E2]E9J(5.P/V-+.BQ3$]PMN$K&6R?GN=P_Q L2A_Q*(N[MUXQDC\?K+] MH;?^!K\+]P=_U \#VZXPS2..EK R7IJT[^@2! M:SYI0O1)TVC5:C>'+!/"<(/LD$)$<8@;7\CB$(]/[[GG)AK&:QXLY;6MG>:8 M6.K+Y4X%G0>;./I3/Y4"(MGDC&NXKIE%B.#/B\9V@7 MU-J!U/*N/%L&8^WN6Q[^*KXL(QK7?[)[T0J;F1S0)(]Y2F?=;'7>&_).S\ K MT.1,*7G%([7/<>ZC0GI"_1GY7(^%WN_OD?WZS^ X;4DZ3_UZ*5HZP>7&4$(V MJ9_^-F V*I.)N'>.X< 54:&X&^4\>Y]05 MQM1=H0YF66\<*K+*2(UUH)%':>)QC94>2]'HE!+[H M2H-.*Q4)%%Q3W00WT'*X^PC;KS0JNB#%2-8CAX/'$RG,P=CIV$DJ$"8;;-+K MQF>#]E>OC'Y75/CTZ6P/<,E#=/UPLQV+7WHXYGO,.8BAQD7E4$I0M=:[.2I0 M3+^XX)MAEY P.(<2P\WY?:&<'"U,Q]WFX^'9^["E95FTN2.W]UVP7FR1,VP( MAGZ'\<]B+'EI6X)NV292.(,794 AP<&JC;C/HRMKU2L$C3NR%9M$Z" I"5XR M;3U:,3:42&%X-PX2)$A0@08TXV,"26XBQ,JA7.S!2?';V1%5 ;<91/D.J]Z\ M)J%_;$9H'!H&^H!H0@?(&;%&_HL)\LU+6_^M.\+Y1."KEJ%:.)CM5H6Z@-Q>6\O5ZFR65KEZ/RVE?^< M5_?'UVHO OOX/50<-JTG;6O)?).=]2K6GRC'*E!%W6[ZHE\2=:./ MN*U]OW6@>W9>X5)2]J1, 5A 42)9)JVKO4?W*+&E]FO O/:C?E%G CAX J[( M#NF#\\#O3'7#'XB"_="'EIU7[E0%C1I7]]_5$MQG1VJ]&YUVA<_@DCQ3[%,% M88 MQ^N,A[-X$U".\9;-Y^MON FHYF"6 !>A'2YK+^-G2$.)0YL"C M@Y=.!6P=[+3)GTVH3H@H*CW(%_#Q:L&;>8Z7JUN!/F#B65A3I3-M_ XY-,$9 M4<OUKCSHV&6=H_Y\8H'!;0QM&W/&PBO6?>)48#R!DPHPH^]U\I$N$8*S?=$-^!10.>I#U\8V MX_"@MI!8OIC_&W.7M?!C"L3)!-(VA6>_K4&N:M'7=WK3$?ZZG MPVZ^*.]!E99A6QN?8(YF"4S;QX$<2F+#C>$;"8XXQ+4^GTO@8!\=CN+X>(C' M89EO][0R--8&;]_@URAO$]1"RM%%Q3U9B]!UJXK:E(>N/_'-2+E@V M,ALK7Q&X^@"-_:+=*Q)^9-KZFHNT: MSMMOBFPF1?F]1PYZPJVIP *?IB511,4]'V5Z\W4CY0Z0H)EYC4XN)7+N\S; M$9D =H(31"3B<&:U'M##,/X1RXZW@Y54P'X6TSFCDG-A_Y'&4W2G&:X;?]1P MK0*>=3!W!Z2G]D &2]X5U=XH*M(M2-;W>YQ\?M*T3VQC0?XSQL/U9+44\J:' M50Y];S0T=:RL>3$+YXQW)B<_#AMC)1@MCDKW2N8_WN@=-JQZ$5-8'-OZO3H3 M_%I#<^336),\,AYLM0)$A:!+@NL7&$[8BS]809?8-E\L;;MG3N2Z L*=W=&D M,/%,KBRQAJ3LQSTPE.VXH!=OF'QI6Z?S5$/+)A,=23"73Z&2\.2P>U75!C0S M@BTPW#374'O^[)A[@D^WR;3Y")&#A.;45)]^GSWU46.&]XQ M%Y%#G4PT!G.! LQ9@-]W8#.MYQ@A+LBM\KVI U9*1(SY$D48 9YQ MR$PSZ:@<]B#A'5%O3C&B5] I#FN2> OQZ/NU'+5/J.;/5I.4B@2B+851BZAK M06+M5>6PK[RR7#8V[+* *;PR<-YT^)R@D?=5BV!RD4RDM6%Z3E==5UQ22HTT M%7@:"W^(^V!>XJ!EH?[C7*L8R[QM?PKC+>(Q@@X>'EQ+$2;XII:&81?P\?JH M,J+Y%IW3Q3$^IS#6]HA/A$LQ=MDXJSA> M7Y+ R2BZ <=KTB849Q]IPC91E6#=;$JIF*A2@=X@0G[#$BZ\4H[=*.C$:I*. M9HU'U?F*Z%&!P.\3%K);C8JUC:A8WX((Q7VMV]9A#LW"W8_HK![JTWFGM)7O M2.?HO41V<#F8>7S?XN^JOY'$WO^9E)_?N==3SHCP?%*A;8T9BA40^LLZO M2?GSY_DI9M$#PREI25&':(984#Z/7\_58H*B"EH2"$]>)EF5)7=O:G_7']+!TW6! M[X$&[T/9[U<6IQQ?[1V*RZCJ9+#+6V(K6[D:FSL#<,'*N8UG5%F)W 0H%AVN MJF1?:=OH5;P /U"3T?YEIR!SR$?0*OSU^KF8\X<6K9QF1M$T.F0'?JHJ2$Y' M"9;Y5^MZ90_,1;AQ#,9KO9*?'GWSZ7-TY60LXA7Z#$F$R$^0M"17EXSY>?"F M5*=P%&J9BK8L'^=J=LRY)J<0D#5Z1_Y2\XRE$S32K<_N9GQU;\8?$(4HC/N)?)Z2>*-"W#7*D=[-)?7-"J?N M<0?(8>W#5XZ+%K4'*=M^?C"C0J^=362EU'(ABM6O,EO>)6S MOX_TUJ>=P]%XAFR3=$.D\N"8\U#WB M!L>T;#.&DM.=!Z!XS6[2)4>L:(>32]%[?&0DHRB@$4M+@B$/AXR Q&9 K(GS ['GQX#J6V?3Y3Y7['NU M;^E+BKU:>J]8'][13L0O]UY?HH7B&_0'R7K08$\S[."J2F=38B>KV7W<_3," M?@NJ)WW%/Q\XIG7CUN2HG&T2Z!K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�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�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end XML 79 brns-20240331_htm.xml IDEA: XBRL DOCUMENT 0001828185 2024-01-01 2024-03-31 0001828185 dei:AdrMember 2024-01-01 2024-03-31 0001828185 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001828185 2024-05-08 0001828185 2024-03-31 0001828185 2023-12-31 0001828185 brns:DeferredShares.Member 2023-12-31 0001828185 brns:DeferredShares.Member 2024-03-31 0001828185 us-gaap:LicenseMember 2024-01-01 2024-03-31 0001828185 us-gaap:LicenseMember 2023-01-01 2023-03-31 0001828185 2023-01-01 2023-03-31 0001828185 us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001828185 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001828185 us-gaap:CommonStockMember 2023-12-31 0001828185 brns:DeferredShares.Member brns:DeferredSharesMember 2023-12-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001828185 us-gaap:RetainedEarningsMember 2023-12-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001828185 us-gaap:ParentMember 2023-12-31 0001828185 us-gaap:NoncontrollingInterestMember 2023-12-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001828185 us-gaap:ParentMember 2024-01-01 2024-03-31 0001828185 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001828185 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001828185 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001828185 us-gaap:CommonStockMember 2024-03-31 0001828185 brns:DeferredShares.Member brns:DeferredSharesMember 2024-03-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001828185 us-gaap:RetainedEarningsMember 2024-03-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001828185 us-gaap:ParentMember 2024-03-31 0001828185 us-gaap:NoncontrollingInterestMember 2024-03-31 0001828185 us-gaap:CommonStockMember 2022-12-31 0001828185 brns:DeferredShares.Member brns:DeferredSharesMember 2022-12-31 0001828185 brns:DeferredBSharesMember brns:DeferredSharesMember 2022-12-31 0001828185 brns:DeferredCSharesMember brns:DeferredSharesMember 2022-12-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001828185 us-gaap:RetainedEarningsMember 2022-12-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001828185 us-gaap:ParentMember 2022-12-31 0001828185 us-gaap:NoncontrollingInterestMember 2022-12-31 0001828185 2022-12-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001828185 us-gaap:ParentMember 2023-01-01 2023-03-31 0001828185 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001828185 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001828185 brns:DeferredBSharesMember brns:DeferredSharesMember 2023-01-01 2023-03-31 0001828185 brns:DeferredCSharesMember brns:DeferredSharesMember 2023-01-01 2023-03-31 0001828185 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001828185 us-gaap:CommonStockMember 2023-03-31 0001828185 brns:DeferredShares.Member brns:DeferredSharesMember 2023-03-31 0001828185 brns:DeferredBSharesMember brns:DeferredSharesMember 2023-03-31 0001828185 brns:DeferredCSharesMember brns:DeferredSharesMember 2023-03-31 0001828185 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001828185 us-gaap:RetainedEarningsMember 2023-03-31 0001828185 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001828185 us-gaap:ParentMember 2023-03-31 0001828185 us-gaap:NoncontrollingInterestMember 2023-03-31 0001828185 2023-03-31 0001828185 us-gaap:DevelopedTechnologyRightsMember 2024-03-31 0001828185 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001828185 brns:CoalitionForEpidemicPreparednessInnovationsMember 2023-12-20 0001828185 brns:CoalitionForEpidemicPreparednessInnovationsMember 2023-12-20 2023-12-20 0001828185 brns:CoalitionForEpidemicPreparednessInnovationsMember 2024-01-01 2024-03-31 0001828185 brns:CoalitionForEpidemicPreparednessInnovationsMember 2024-03-31 0001828185 us-gaap:IPOMember 2024-01-01 2024-03-31 0001828185 us-gaap:IPOMember 2021-04-21 2021-04-21 0001828185 2023-11-06 0001828185 us-gaap:IPOMember 2023-11-06 2023-11-06 0001828185 brns:DeferredBSharesMember 2023-03-29 0001828185 brns:DeferredCSharesMember 2023-03-29 0001828185 brns:DeferredShares.Member 2023-03-29 0001828185 brns:AvideaMember 2024-03-31 0001828185 brns:ContingentConsiderationLiabilityMember 2023-12-31 0001828185 brns:ContingentConsiderationLiabilityMember 2022-12-31 0001828185 brns:ContingentConsiderationLiabilityMember 2024-01-01 2024-03-31 0001828185 brns:ContingentConsiderationLiabilityMember 2023-01-01 2023-03-31 0001828185 brns:ContingentConsiderationLiabilityMember 2024-03-31 0001828185 brns:ContingentConsiderationLiabilityMember 2023-03-31 0001828185 brns:RestrictedShareUnitsStockOptionsShareAppreciationRightsAndRestrictedSharesMember brns:BarinthusBiotherapeuticsPlcShareAwardPlan2021Member 2024-01-01 2024-03-31 0001828185 brns:EnterpriseManagementIncentiveShareOptionSchemeMember 2024-01-01 2024-03-31 0001828185 brns:EnterpriseManagementIncentiveShareOptionSchemeMember 2023-01-01 2023-03-31 0001828185 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0001828185 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-03-31 0001828185 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-03-31 0001828185 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-03-31 0001828185 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-03-31 0001828185 srt:MinimumMember brns:InLicenseAgreementsMember 2024-01-01 2024-03-31 0001828185 srt:MaximumMember brns:InLicenseAgreementsMember 2024-01-01 2024-03-31 0001828185 brns:OxfordshireMember 2021-09-03 2021-09-03 0001828185 brns:OxfordshireMember 2021-09-03 0001828185 stpr:MD 2022-06-14 2022-06-14 0001828185 stpr:MD 2022-06-14 0001828185 brns:OxfordUniversityInnovationLimitedMember brns:ExpensesMember 2024-01-01 2024-03-31 0001828185 brns:OxfordUniversityInnovationLimitedMember brns:ExpensesMember 2023-01-01 2023-03-31 0001828185 brns:OxfordUniversityInnovationLimitedMember us-gaap:RelatedPartyMember 2024-03-31 0001828185 brns:OxfordUniversityInnovationLimitedMember us-gaap:RelatedPartyMember 2023-12-31 0001828185 brns:OxfordUniversityInnovationLimitedMember us-gaap:LicenseMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001828185 brns:OxfordUniversityInnovationLimitedMember us-gaap:LicenseMember us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 shares iso4217:USD iso4217:GBP shares iso4217:USD shares brns:segment brns:vote pure iso4217:GBP utr:sqft 0001828185 2024 Q1 false --12-31 00-0000000 http://fasb.org/us-gaap/2023#LicenseMember http://fasb.org/us-gaap/2023#LicenseMember 10-Q true 2024-03-31 false 001-40367 BARINTHUS BIOTHERAPEUTICS PLC X0 Unit 6-10, Zeus Building Rutherford Avenue Harwell, Didcot GB OX11 0DF +44 (0) 1865 818 808 American Depositary Shares BRNS NASDAQ Ordinary shares, nominal value £0.000025 per share Yes Yes Non-accelerated Filer true true false false 39033158 129971000 142090000 5196000 4908000 7964000 9907000 143131000 156905000 12209000 12209000 11532000 11821000 24317000 25108000 7408000 7581000 885000 882000 199482000 214506000 1162000 1601000 8330000 9212000 1434000 0 1909000 1785000 12835000 12598000 10897000 11191000 1867000 1823000 1330000 1325000 537000 574000 27466000 27511000 0.000025 0.000025 38952956 38952956 38952956 38643540 38643540 38643540 1000 1000 1 1 63443 63443 63443 63443 63443 63443 86000 86000 388720000 386602000 -192079000 -176590000 -24895000 -23315000 171833000 186784000 183000 211000 172016000 186995000 199482000 214506000 0 468000 0 468000 11125000 9814000 5994000 12138000 17119000 21952000 205000 0 -16914000 -21484000 775000 1588000 12000 0 594000 1157000 1357000 2745000 -15557000 -18739000 -37000 -516000 -15520000 -18223000 -31000 -43000 -15489000 -18180000 38773482 38013399 38773482 38013399 -0.40 -0.48 -0.40 -0.48 -15520000 -18223000 -1577000 4580000 -17097000 -13643000 -28000 -37000 -17069000 -13606000 0 500000 38643540 1000 63443 86000 386602000 -176590000 -23315000 186784000 211000 186995000 1615000 1615000 1615000 309416 0 503000 503000 503000 -1580000 -1580000 3000 -1577000 -15489000 -15489000 -31000 -15520000 38952956 1000 63443 86000 388720000 -192079000 -24895000 171833000 183000 172016000 37683531 1000 63443 86000 570987 8000 27828231 0 379504000 -103243000 -33460000 242896000 305000 243201000 2222000 2222000 2222000 673494 0 1789000 1789000 1789000 4574000 4574000 6000 4580000 570987 8000 27828231 0 -8000 0 -18180000 -18180000 -43000 -18223000 38357025 1000 63443 86000 0 0 0 0 383523000 -121423000 -28886000 233301000 268000 233569000 -15520000 -18223000 1615000 2222000 1430000 1221000 359000 279000 1026000 -3504000 60000 85000 12000 0 -37000 -516000 0 -4961000 -1875000 -4090000 331000 -2102000 -524000 -1707000 -823000 -1315000 1434000 0 -346000 0 0 -123000 -11822000 -3174000 308000 2507000 -308000 -2507000 503000 1789000 0 0 0 100000 503000 1689000 -492000 935000 -12119000 -3057000 142090000 194385000 129971000 191328000 0 0 0 0 0 0 95000 2247000 0 282000 0 4000 Nature of Business and Basis of Presentation<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barinthus Biotherapeutics plc is a public limited company incorporated pursuant to the laws of England and Wales in March 2021. Barinthus Biotherapeutics plc and its direct and indirect subsidiaries, Barinthus Biotherapeutics (UK) Limited, Barinthus Australia Pty Limited, Vaccitech Oncology Limited (“VOLT”), Barinthus Biotherapeutics North America, Inc., Barinthus Biotherapeutics Switzerland GmbH and Barinthus Biotherapeutics S.R.L., are collectively referred to as the “Company” or “Barinthus Bio”. The Company is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. The Company is headquartered in Harwell, Oxfordshire, United Kingdom. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in an environment of rapid technological change and substantial competition from pharmaceutical and biotechnology companies. The Company is subject to risks common to companies in the biopharmaceutical industry in a similar stage of its life cycle including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its vaccine product candidates, competitors developing new technological innovations, the need to successfully commercialize and gain market acceptance of any of its products that are approved, and protection of proprietary technology. There can be no assurance that the Company’s research and development will be successfully completed, that adequate protection for the Company’s intellectual property will be obtained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company’s development efforts are successful, it is uncertain when, if ever, the Company will generate significant product sales. If the Company does not successfully commercialize any of its products or mitigate any of these other risks, it will be unable to generate revenue or achieve profitability.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain notes or other information that are normally required by GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s audited consolidated financial statements and related notes as of and for the year ended December 31, 2023. The condensed consolidated balance sheet as of December 31, 2023, was derived from the audited financial statements but does not contain all of the footnote disclosures from the annual financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company had cash, cash equivalents and restricted cash of $130.0 million and an accumulated deficit of $192.1 million, and the Company expects to incur losses for the foreseeable future. The Company expects that its cash, cash equivalents and restricted cash will be sufficient to fund current operations for at least the next twelve months from the issuance of the financial statements. The Company expects to seek additional funding through equity financing, government or private-party grants, debt financings or other capital sources, including collaborations with other companies or other strategic transactions. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaborations or other arrangements. The terms of any financing may adversely affect the holdings or rights of the Company’s stockholders. If the Company is unable to obtain sufficient capital, the Company will be forced to delay, reduce or eliminate some or all of its research and development programs, product portfolio expansion or future commercialization efforts, which could adversely affect its business prospects, or the Company may be unable to continue operations. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on terms acceptable to the Company to fund continuing operations, if at all.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Condensed Financial Information</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Balance Sheets as of March 31, 2024, and December 31, 2023, the Condensed Consolidated Statements of Operations and Comprehensive Loss, Condensed Consolidated Statements of Changes in Stockholders’ Equity and the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and 2023 are unaudited. These unaudited condensed consolidated financial statements have been prepared on the same basis as the audited annual consolidated financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities Exchange Commission (the “Annual Report”) on March 20, 2024. In our opinion, the unaudited condensed consolidated financial statements include all adjustments of a normal recurring nature necessary for the fair presentation of our financial position as of March 31, 2024, our results of operations for the three months ended March 31, 2024, and 2023, and our cash flows for the three months ended March 31, 2024, and 2023. The results of operations for the three months ended March 31, 2024, are not necessarily indicative of the results to be expected for the year ending December 31, 2024, or any other interim periods.</span></div> 130000000 -192100000 Summary of Significant Accounting Policies<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies of the Company are set forth in Note 2 to the consolidated financial statements contained in the Annual Report, except as discussed below related to newly adopted accounting pronouncements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue, income and expenses during the reporting period. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of issuance of these unaudited condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the unaudited condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment information</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker ("CODM"), the Company’s Chief Executive Officer, in making decisions regarding resource allocation and assessing performance. The CODM approves key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts and approves the Company's consolidated operating budget. The Company views its operations and manages its business as one operating segment, the research and development of vaccines and immunotherapies. As the Company operates in one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” of the extended transition period related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our condensed consolidated financial statements or do not otherwise apply to our current operations.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue, income and expenses during the reporting period. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of issuance of these unaudited condensed consolidated financial statements, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, assumptions and judgments or revise the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information is obtained and are recognized in the unaudited condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the Company’s financial statements.</span></div> <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment information</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker ("CODM"), the Company’s Chief Executive Officer, in making decisions regarding resource allocation and assessing performance. The CODM approves key operating and strategic decisions, including key decisions in clinical development and clinical operating activities, entering into significant contracts and approves the Company's consolidated operating budget. The Company views its operations and manages its business as one operating segment, the research and development of vaccines and immunotherapies. As the Company operates in one operating segment, all required financial segment information can be found in these condensed consolidated financial statements.</span></div> 1 1 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective date. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to “opt out” of the extended transition period related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our condensed consolidated financial statements or do not otherwise apply to our current operations.</span></div> Foreign Currency Translation in General and Administrative Expenses<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate, net foreign exchange gain or loss recognized in general and administrative expenses for the three months ended March 31, 2024, was a gain of $1.2 million (three months ended March 31, 2023: $3.5 million loss).</span></div> 1200000 -3500000 Net Loss Per Share<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2024, and 2023 (in thousands, except number of shares):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Barinthus Biotherapeutics plc shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,489)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18,180)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average ordinary shares outstanding, basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,773,482</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,013,399</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average ordinary shares outstanding, diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,773,482</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,013,399</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to ordinary shareholders, basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.40)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.48)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to ordinary shareholders, diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential ordinary share equivalents outstanding would have been anti-dilutive. As of March 31, 2024, 7,645,076 potential ordinary shares issuable for stock options were excluded from the computation of diluted weighted-average shares outstanding because including them would have had an anti-dilutive effect (March 31, 2023: 6,807,859).</span></div> <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2024, and 2023 (in thousands, except number of shares):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Barinthus Biotherapeutics plc shareholders</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15,489)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(18,180)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average ordinary shares outstanding, basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,773,482</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,013,399</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average ordinary shares outstanding, diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,773,482</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">38,013,399</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to ordinary shareholders, basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.40)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.48)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to ordinary shareholders, diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.40)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -15520000 -18223000 -31000 -43000 -15489000 -18180000 38773482 38013399 38773482 38013399 -0.40 -0.48 -0.40 -0.48 7645076 6807859 Property and Equipment, Net<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company’s additions to property and equipment, net were $0.4 million which primarily related to an increase in leasehold improvements from the Company’s U.S. office in Germantown, Maryland (three months ended March 31, 2023: $4.8 million).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended March 31, 2024 was $0.6 million (three months ended March 31, 2023: $0.4 million, respectively).</span></div> 400000 4800000 600000 400000 Intangible Assets, Net<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross amount of amortizable intangible assets, consisting of acquired developed technology, was $31.6 million as of March 31, 2024 and December 31 2023, respectively, and accumulated amortization was $7.3 million and $6.5 million as of March 31, 2024 and December 31, 2023, respectively. The amortization expense for the three months ended March 31, 2024 was $0.8 million (three months ended March 31, 2023: $0.8 million). The estimated annual amortization expense is $3.2 million for the years 2024 through to 2031.</span></div> 31600000 31600000 7300000 6500000 800000 800000 3200000 3200000 3200000 3200000 3200000 3200000 3200000 3200000 Prepaid Expenses and Other Current Assets (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Prepayments and accrued income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,093 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,402 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Value Added Tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.64pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,964 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,907 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> Prepaid Expenses and Other Current Assets (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Prepayments and accrued income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,093 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,402 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Value Added Tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,675 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,474 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.64pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,964 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,907 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 5093000 5402000 1196000 3031000 1675000 1474000 7964000 9907000 Accrued Expenses and Other Current Liabilities (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued manufacturing and clinical expenses</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,437 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,003 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued bonus</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,412 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued payroll and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,048 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">942 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,330 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,212 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> Accrued Expenses and Other Current Liabilities (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued manufacturing and clinical expenses</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,437 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,003 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued bonus</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">660 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,412 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued payroll and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">789 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,048 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">942 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,033 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,066 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,330 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,212 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 4437000 4003000 660000 2412000 1152000 789000 1048000 942000 1033000 1066000 8330000 9212000 Grant Income<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Coalition for Epidemic Preparedness Innovations (“CEPI”) Funding Agreement</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2023, Barinthus Biotherapeutics (UK) Limited (the “Company”), the Chancellors, Masters and Scholars of the University of Oxford (“Oxford,” together with the Company, the “Partners”) and the Coalition for Epidemic Preparedness Innovations (“CEPI”) entered into a Funding Agreement (the “Funding Agreement”) pursuant to which CEPI will provide funding of up to $34.8 million to the Company to advance the development of VTP-500, the Company’s vaccine candidate against Middle East Respiratory Syndrome (“MERS,” and such development activities, the “Project”). In December 2023, VTP-500 received PRIME (PRIority MEdicines) designation by the European Medicines Agency. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Funding Agreement, the Company has agreed to pay CEPI on a country-by-country basis increasing mid-single digit percentage royalties of net sales and net income with respect to future cash sales of VTP-500, less certain deductions, for a period starting on December 20, 2023 (“Effective Date”) and ending the later of: (i) the expiration of the last valid patent claim included in intellectual property developed under the Project covering VTP-500 in such country, (ii) the expiration of Regulatory Exclusivity (as defined in the Funding Agreement) for VTP-500 in such country, and (iii) the tenth (10th) anniversary of the first commercial sale of VTP-500 (the “Royalty Term”). The Company shall also pay CEPI a mid-double digit percentage of net revenue earned on VTP-500 until CEPI has received payments from the Company under the Funding Agreement equaling the total amount of funding paid by CEPI to the Company and a low double-digit percentage of such net revenue thereafter. Sales for the benefit of end users in specified low and middle income countries (“LMICs”) and upper and middle income countries (“UMICs”) are excluded from the calculations of net sales and net revenue. Sales of product for the benefit of end users in LMICs and UMICs are subject to tiered discounted pricing requirements under the Funding Agreement. The Company is further required to pay a mid-double digit percentage of any proceeds earned on any priority review voucher related to VTP-500 during the Royalty Period.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the period ended March 31, 2024, $1.6 million proceeds have been received and $0.2 million income has been recognized in relation to this contract. This is presented as other operating income in the Statements of Operations and Comprehensive Loss. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Funding Agreement cash payments are restricted as to the use and management of the funds. The remaining unused amounts of the Funding Agreement cash payments of $1.4 million as at March 31, 2024 are reflected in Cash, cash equivalents and restricted cash in the condensed consolidated balance sheets until expenditures contemplated in the Funding Agreement are incurred.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Deferred income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deferred income primarily relates to payments received from CEPI in advance of the eligible research and development expenses being incurred and are disclosed as deferred income separately in the condensed consolidated balance sheets. Deferred income is released to the condensed consolidated statement of operations and comprehensive loss in the period in which such research and development activities are actually performed in a manner that satisfies the conditions of the Funding Agreement. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes in the deferred income during the three months ended March 31, 2024 and 2023, are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income recognized related to the Funding Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 34800000 P10Y 1600000 200000 1400000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Changes in the deferred income during the three months ended March 31, 2024 and 2023, are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments received</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income recognized related to the Funding Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,434 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0 0 1629000 0 205000 0 -10000 0 1434000 0 Ordinary Shares<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All ordinary shares rank pari passu as a single class. The following is a summary of the rights and privileges of the holders of ordinary shares as of March 31, 2024:</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidation preference: in the event of the liquidation, dissolution or winding up of the Company, the assets of the Company available for distribution to holders of the ordinary shares shall be distributed amongst all holders of the ordinary shares in proportion to the number of shares held irrespective of the amount paid or credited as paid on any share.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends: The Company may, subject to the provisions of the Companies Act 2006 and our Articles, by ordinary resolution from time to time declare dividends to be paid to shareholders not exceeding the amount recommended by the Company’s board of directors. Subject to the provisions of the Companies Act 2006, in so far as, in the board of directors’ opinions, the Company’s profits justify such payments, the board of directors may pay interim dividends on the Company’s ordinary shares.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voting Rights: Each holder of ordinary shares has the right to receive notice of, and to vote at, the Company’s general meetings. Each holder of ordinary shares who is present (in person or by proxy) at a general meeting on a show of hands has one vote and, on a poll, every such holder who is present (in person or by proxy) has one vote in respect of each share of which they are the holder.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preemption rights: Pursuant to section 561 of the Companies Act 2006, shareholders are granted preemptive rights when new shares are issued for cash. However, it is possible for our Articles, or shareholders at a general meeting representing at least 75% of our ordinary shares present (in person or by proxy) and eligible to vote at that general meeting, to disapply these preemptive rights by passing a special resolution. Such a disapplication of preemption rights may be for a maximum period of up to five years from the date on which the shareholder resolution was passed. In either case, this disapplication would need to be renewed by our shareholders upon its expiration (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at least every five years) to remain effective.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2021, our shareholders approved the disapplication of preemptive rights for a period of five years from the date of approval by way of a special resolution of our shareholders. This included the disapplication of preemption rights in relation to the allotment of our ordinary shares in connection with the IPO. This disapplication will need to be renewed upon expiration (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2023, we held a general meeting where our shareholders approved resolutions granting our board of directors or any duly authorized committee of the board of directors the authority to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company free from pre-emption rights. Pursuant to such approval, our board of directors was authorized to allot shares up to an aggregate nominal amount of £1,928 free from statutory pre-emption rights. The granting of this authority and the corresponding disapplication of preemptive rights was in addition to all subsisting authorities. This disapplication will need to be renewed upon expiration (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, at least every five years) to remain effective, but may be sought more frequently for additional five-year terms (or any shorter period).</span></div> 1 1 0.75 P5Y P5Y P5Y P5Y P5Y 1928 P5Y P5Y Deferred Shares<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All deferred shares rank pari passu as a single class. The deferred shares do not have rights to dividends or to any other right of participation in the profits of the Company. On a return of assets on liquidation, the deferred shares shall confer on the holders thereof an entitlement to receive out of the assets of the Company available for distribution amongst the shareholders (subject to the rights of any new class of shares with preferred rights) the amount credited as paid up on the deferred shares held by them respectively after (but only after) payment shall have been made to the holders of the ordinary shares of the amounts paid up or credited as paid up on such shares and the sum of £1.0 million in respect of each ordinary share held by them respectively. The deferred shares shall confer on the holders thereof no further right to participate in the assets of the Company.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023, all deferred B shares (nominal value of £0.01 each) and deferred C shares (nominal value of £0.00000736245954692556 each) previously in issue were transferred back to the Company and subsequently cancelled. These deferred shares had previously been issued to certain pre-IPO shareholders in connection with the implementation of certain stages of the Company’s pre-IPO share capital reorganization. The Company received shareholder approval on April 21, 2021 (pursuant to the shareholder resolutions passed on that date) in order to effect the transfer back and cancellation of the deferred shares for nil consideration in accordance with sections 659 and 662 of the Companies Act 2006.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s deferred A shares with a nominal value of £1.00 each remain in issue for the purposes of satisfying the minimum share capital requirements for a public limited company as prescribed by the Companies Act 2006.</span></div> 1000000 0.01 0.00000736245954692556 1.00 Fair Value<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s financial instruments consist of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, certain accrued expenses, and contingent consideration. The carrying amounts of cash, cash equivalents and restricted cash, accounts receivable, accounts payable and accrued expenses approximated their respective fair value due to the short-term nature and maturity of these instruments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company had a contingent consideration liability of $1.9 million related to the acquisition of Avidea Technologies, Inc. The fair value of the contingent consideration is a Level 3 valuation with the significant unobservable inputs being the probability of success of achievement of the milestones and the expected date of the milestone achievement. Significant judgment is employed in determining the appropriateness of certain of these inputs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to our financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:71.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,823 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,711 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value recognized in net loss/(gain)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">60 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign exchange translation recognized in other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,867 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,710 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1900000 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes to our financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:71.113%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.182%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Beginning balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,823 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,711 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Change in fair value recognized in net loss/(gain)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">60 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Foreign exchange translation recognized in other comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Ending balance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,867 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,710 </span></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1823000 1711000 -60000 38000 -16000 37000 1867000 1710000 Goodwill<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company identified qualitative indicators of impairment due to a sustained decline in the price of the Company’s American Depositary Shares, whereby the market capitalization continues to be below the value of the net assets of the Company. Therefore, the Company performed an interim qualitative assessment as of March 31, 2024 to determine whether it was more likely than not that the fair value of the reporting unit is less than its carrying amount. Based on this assessment, management determined it is not more likely than not that the fair value of the reporting unit is less than its carrying amount and hence no impairment loss has been recognized.</span></div> 0 Share-Based Compensation<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three month period ended March 31, 2024, in accordance with the terms of the Annual Increase of the Barinthus Biotherapeutics plc Award Plan 2021 (the “Plan”), the total number of ordinary shares available for issuance under the Plan increased by 4% of the Company’s issued and outstanding ordinary shares as of January 1, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2024, the Company granted 1,627,958</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options to employees and directors with a weighted average grant date fair value of $2.90 and a weighted average exercise price of $3.67 per share (March 31, 2023: granted 1,987,289 options, weighted average grant date fair value of $2.01 and a weighted average exercise price of $2.53 per share). For the three months ended March 31, 2024, 70,946 options (March 31, 2023: 57,970 ) were forfeited.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option issued to employees was estimated at the date of grant using the Black-Scholes model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108.8 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">97.4 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, 7,645,076 options with a weighted average exercise price of $6.20 were outstanding. As of March 31, 2024, there was $6.2 million unrecognized compensation cost related to stock options, which is expected to be recognized over a weighted average period of 1.9 years. As of March 31, 2023, 6,807,859 options with a weighted average exercise price of $9.69 were outstanding. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation expense is classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">712 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,119 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">903 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,103 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,615 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,222 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.04 1627958 2.90 3.67 1987289 2.01 2.53 70946 57970 <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option issued to employees was estimated at the date of grant using the Black-Scholes model with the following weighted-average assumptions:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">108.8 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">97.4 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected term (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.0</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expected dividend yield</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div> 1.088 0.974 P6Y P6Y 0.040 0.036 0 0 7645076 6.20 6200000 P1Y10M24D 6807859 9.69 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share based compensation expense is classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">712 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,119 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">903 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,103 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,615 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,222 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 712000 1119000 903000 1103000 1615000 2222000 Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In-License Agreements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is party to a number of licensing agreements, most of which are with related parties. These agreements serve to provide the Company with the right to develop and exploit the counterparties’ intellectual property for certain medical indications. As part of execution of these arrangements, the Company paid certain upfront fees, which have been expensed as incurred because the developing technology has not yet reached technical feasibility, the lack of alternative use, and the lack of proof of potential value. The agreements cover a variety of fields, including influenza, cancer, human papillomavirus infection, (“HPV”), hepatitis B virus (“HBV”) and MERS. The Company’s obligations for future payments under these arrangements are dependent on its ability to develop promising drug candidates, the potential market for these candidates and potential competing products, and the payment mechanisms in place in countries where the Company retains the right to sell. Each agreement provides for specific milestone payments, typically triggered by achievement of certain testing phases in human candidates, and future royalties ranging from 1 to 5% for direct sales of a covered product to 3 to 7% of net payments received for allowable sublicenses of technology developed by the Company. The obligation to make these payments is contingent upon the Company’s ability to develop candidates for submission for phased testing and approvals, and for the development of markets for the products developed by the Company. The Company has not made or accrued any material payments under these license agreements during the three month periods ended March 31, 2024 and 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain laboratory and office space under operating leases, which are described below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Harwell Science and Innovation Campus, Oxfordshire</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 3, 2021, the Company entered into a lease agreement for the lease of approximately 31,000 square feet in Harwell, Oxfordshire which expires in September 2031. The property is the Company’s corporate headquarters. As the Company’s leases typically do not provide an implicit rate, the Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date, being the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease payments in a similar economic environment. The Company has provided the lessor with a refundable security deposit of $0.7 million which is included in Other assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Germantown, Maryland</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2022, the Company entered into a lease agreement for the lease of approximately 19,700 square feet in Germantown, Maryland. The site will house the Company’s, state-of-the-art wet laboratory in the United States of America. The lease expires on February 28, 2034, with the Company having a single right to extend for an additional five years on the same terms and conditions other than for the base rent. The Company has a rent-free period up to February 29, 2024, and is entitled to up to $3.5 million for leasehold improvements to the premises desired by the Company. The Company has provided the lessor with a refundable security deposit of $0.2 million which is included in Other assets.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a right-of-use asset and a lease liability on the effective date of the lease term. The Company’s right-of-use asset and lease liability are as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right-of-use asset</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,408 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,581 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,909 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,785 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,191 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.711%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Other information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">346</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">220</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.71</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.71</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Lease Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Short-term lease costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">152</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Fixed lease costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">279</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">431</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual minimum lease payments under operating leases as of March 31, 2024, were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.424%"><tr><td style="width:1.0%"></td><td style="width:82.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,974 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,806 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other contingencies</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Quarterly Report on Form 10-Q, we do not believe we are party to any claim or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. However, from time to time, we could be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. Regardless of the outcome, legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</span></div> 0.01 0.05 0.03 0.07 31000 700000 19700 P5Y 3500000 200000 The Company’s right-of-use asset and lease liability are as follows (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Right-of-use asset</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,408 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,581 </span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,909 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,785 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Lease liability, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,897 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,191 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:72.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.711%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Other information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating cash flows from operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">346</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">220</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.71</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.71</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div> 7408000 7581000 1909000 1785000 10897000 11191000 346000 220000 P8Y8M15D P9Y8M15D 0.075 0.076 <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2024</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Lease Cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Short-term lease costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">—</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">152</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Fixed lease costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">279</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">359</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">431</span></td></tr></table></div> 0 152000 359000 279000 359000 431000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual minimum lease payments under operating leases as of March 31, 2024, were as follows (in thousands):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.424%"><tr><td style="width:1.0%"></td><td style="width:82.907%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,430 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,926 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,975 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,974 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">17,257 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(4,451)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total lease liability</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,806 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 1430000 1926000 1951000 1975000 2001000 7974000 17257000 4451000 12806000 Related Party Transactions<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company incurred expenses of $0.2 million (three months ended March 31, 2023: $0.1 million) from Oxford University Innovation Limited which is a wholly owned subsidiary of the Company’s shareholder, the University of Oxford. As of March 31, 2024, the Company owed $0.01 million (December 31, 2023: $0.002 million) to Oxford University Innovation Limited.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company recognized license revenue of nil (three months ended March 31, 2023: $0.5 million), from Oxford University Innovation Limited. As of March 31, 2024, the Company was owed nil (December 31, 2023: nil) from Oxford University Innovation Limited.</span></div> 200000 100000 10000.00 2000.000 0 500000 0 0 false false false false Includes license revenue from related parties for the three months ended March 31, 2024 and 2023 of nil and $0.5 million, respectively. Indicates amount less than one thousand Indicates amounts less than one thousand

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